PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Capitanio, U; Montorsi, F				Capitanio, Umberto; Montorsi, Francesco			Renal cancer	LANCET			English	Review							NEPHRON-SPARING SURGERY; LYMPH-NODE DISSECTION; BLIND PHASE-III; CELL CARCINOMA; RADICAL NEPHRECTOMY; INTERFERON-ALPHA; PERCUTANEOUS BIOPSY; ACTIVE SURVEILLANCE; THERMAL ABLATION; RISING INCIDENCE	The diagnosis and management of renal cell carcinoma have changed remarkably rapidly. Although the incidence of renal cell carcinoma has been increasing, survival has improved substantially. As incidental diagnosis of small indolent cancers has become more frequent, active surveillance, robot-assisted nephron-sparing surgical techniques, and minimally invasive procedures, such as thermal ablation, have gained popularity. Despite progression in cancer control and survival, locally advanced disease and distant metastases are still diagnosed in a notable proportion of patients. An integrated management strategy that includes surgical debulking and systemic treatment with well established targeted biological drugs has improved the care of patients. Nevertheless, uncertainties, controversies, and research questions remain. Further advances are expected from translational and clinical studies.	[Capitanio, Umberto] Univ Vita Salute San Raffaele, Dept Urol, Milan, Italy; [Montorsi, Francesco] IRCCS San Raffaele Sci Inst, Div Expt Oncol, URI, Renal Canc Unit, Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Capitanio, U (corresponding author), Hosp San Raffaele, Dept Urol, Via Olgettina 60, I-20132 Milan, Italy.	capitanio.umberto@hsr.it	capitanio, umberto/AAC-5344-2022; Montorsi, Francesco/AAN-2473-2020	capitanio, umberto/0000-0001-9225-1795	Recordati	Recordati	UC has received consultancy and lecturer honoraria and FM has received research support, consultancy fees, and lecturer honoraria from Recordati.	Asimakopoulos AD, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-75; Babaian KN, 2014, J UROLOGY, V192, P36, DOI 10.1016/j.juro.2014.01.086; Baillargeon-Gagne S, 2010, BJU INT, V105, P359, DOI 10.1111/j.1464-410X.2009.08745.x; Ball MW, 2015, J UROLOGY, V193, P36, DOI 10.1016/j.juro.2014.06.067; Bekema HJ, 2013, EUR UROL, V64, P799, DOI 10.1016/j.eururo.2013.04.033; Bellmunt J, 2014, CLIN TRANSL ONCOL, V16, P1043, DOI 10.1007/s12094-014-1219-1; Bergstrom A, 2001, BRIT J CANCER, V85, P984, DOI 10.1038/sj.bjc.6692040; Beuselinck B, 2015, CLIN CANCER RES, V21, P1329, DOI 10.1158/1078-0432.CCR-14-1128; Bex A, 2011, WORLD J UROL, V29, P793, DOI 10.1007/s00345-010-0615-6; Bex A, 2010, EUR J NUCL MED MOL I, V37, P1117, DOI 10.1007/s00259-009-1359-7; Bianchi M, 2012, ANN ONCOL, V23, P973, DOI 10.1093/annonc/mdr362; Blom JHM, 2009, EUR UROL, V55, P28, DOI 10.1016/j.eururo.2008.09.052; Breau RH, 2010, CURR OPIN UROL, V20, P375, DOI 10.1097/MOU.0b013e32833c7ada; Brugarolas J, 2008, J CLIN ONCOL, V26, P3457, DOI 10.1200/JCO.2008.16.4590; Brugarolas J, 2013, CANCER J, V19, P324, DOI 10.1097/PPO.0b013e3182a102d1; Capitanio U, 2008, UROLOGY, V72, P1090, DOI 10.1016/j.urology.2008.06.059; Capitanio U, 2015, EUR UROL, V67, P683, DOI 10.1016/j.eururo.2014.09.027; Capitanio U, 2011, EUR UROL, V60, P1212, DOI 10.1016/j.eururo.2011.09.003; Choi JE, 2015, EUR UROL, V67, P891, DOI 10.1016/j.eururo.2014.12.028; Chow WH, 2007, J NATL CANCER I, V99, P569, DOI 10.1093/jnci/djk114; Clark JI, 2003, J CLIN ONCOL, V21, P3133, DOI 10.1200/JCO.2003.02.014; Coppin C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001425.pub2; Corrao G, 2007, CURR DRUG SAF, V2, P125, DOI 10.2174/157488607780598296; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Crepel M, 2010, UROLOGY, V76, P883, DOI 10.1016/j.urology.2009.08.028; Crepel M, 2010, UROLOGY, V75, P271, DOI 10.1016/j.urology.2009.04.098; Crispen PL, 2008, CANCER-AM CANCER SOC, V112, P1051, DOI 10.1002/cncr.23268; Dabestani S, 2014, LANCET ONCOL, V15, pE549, DOI 10.1016/S1470-2045(14)70235-9; De Meerleer G, 2014, LANCET ONCOL, V15, pE170, DOI 10.1016/S1470-2045(13)70569-2; Deckers IA, 2015, INT J CANCER, V136, P1104, DOI 10.1002/ijc.29060; Delea TE, 2015, J MANAG CARE SPEC PH; Dharmawardana PG, 2004, CURR MOL MED, V4, P855, DOI 10.2174/1566524043359674; Divgi CR, 2013, J CLIN ONCOL, V31, P187, DOI 10.1200/JCO.2011.41.2445; Ellimoottil C, 2014, J UROLOGY, V192, P1604, DOI 10.1016/j.juro.2014.07.099; EORTC, 2010, RAND PHAS 3 TRIAL CO; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Escudier B, 2014, J CLIN ONCOL, V32, P1412, DOI 10.1200/JCO.2013.50.8267; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Ferlay J, 2013, IARC CANCERBASE; Ficarra V, 2009, EUR UROL, V56, P786, DOI 10.1016/j.eururo.2009.07.040; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Flanigan RC, 2004, J UROLOGY, V171, P1071, DOI 10.1097/01.ju.0000110610.61545.ae; Funahashi Y, 2009, EUR UROL, V55, P209, DOI 10.1016/j.eururo.2008.07.048; Gati A, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27810; Gervais DA, 2005, AM J ROENTGENOL, V185, P64, DOI 10.2214/ajr.185.1.01850064; Gordon MS, 2009, J CLIN ONCOL, V27, P5788, DOI 10.1200/JCO.2008.18.8821; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Gratzke C, 2009, BJU INT, V104, P470, DOI 10.1111/j.1464-410X.2009.08439.x; Haferkamp A, 2007, J UROLOGY, V177, P1703, DOI 10.1016/j.juro.2007.01.039; Hemal AK, 2007, J UROLOGY, V177, P862, DOI 10.1016/j.juro.2006.10.053; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Hilton S, 2014, SURG ONCOL CLIN N AM, V23, P863, DOI 10.1016/j.soc.2014.06.001; Hofbauer SL, 2014, KOREAN J UROL, V55, P505, DOI 10.4111/kju.2014.55.8.505; Hoffmann NE, 2002, UROLOGY, V60, P40, DOI 10.1016/S0090-4295(02)01683-7; Hollenbeck BK, 2006, UROLOGY, V67, P254, DOI 10.1016/j.urology.2005.08.050; Hollingsworth JM, 2006, JNCI-J NATL CANCER I, V98, P1331, DOI 10.1093/jnci/djj362; Huang WC, 2009, J UROLOGY, V181, P55, DOI 10.1016/j.juro.2008.09.017; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hutson TE, 2014, J CLIN ONCOL, V32, P760, DOI 10.1200/JCO.2013.50.3961; Hutson TE, 2013, LANCET ONCOL, V14, P1287, DOI 10.1016/S1470-2045(13)70465-0; Ibragimova I, 2013, EPIGENETICS-US, V8, P486, DOI 10.4161/epi.24552; Jewett MAS, 2011, EUR UROL, V60, P39, DOI 10.1016/j.eururo.2011.03.030; Karakiewicz PI, 2007, J CLIN ONCOL, V25, P1316, DOI 10.1200/JCO.2006.06.1218; Karami S, 2015, INT J CANCER, V137, P238, DOI 10.1002/ijc.29359; Katsanos K, 2014, CARDIOVASC INTER RAD, V37, P427, DOI 10.1007/s00270-014-0846-9; Kim DY, 2014, WORLD J UROL, V32, P631, DOI 10.1007/s00345-014-1293-6; Kunkle DA, 2008, J UROLOGY, V179, P1227, DOI 10.1016/j.juro.2007.11.047; Kutikov A, 2015, EUR UROL, V67, P260, DOI 10.1016/j.eururo.2014.08.034; Kutikov A, 2010, J CLIN ONCOL, V28, P311, DOI 10.1200/JCO.2009.22.4816; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Lam John S, 2004, Curr Urol Rep, V5, P1, DOI 10.1007/s11934-004-0001-2; Lane BR, 2013, J UROLOGY, V189, P1649, DOI 10.1016/j.juro.2012.11.121; Leveridge MJ, 2011, EUR UROL, V60, P578, DOI 10.1016/j.eururo.2011.06.021; Levi F, 2008, BJU INT, V101, P949, DOI 10.1111/j.1464-410X.2008.07451.x; Ljungberg B, 2014, GUIDELINES RENAL CEL; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; MARINCOLA FM, 1995, J CLIN ONCOL, V13, P1110, DOI 10.1200/JCO.1995.13.5.1110; Mehrazin R, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2015.01.013; Mehrazin R, 2014, J UROLOGY, V192, P659, DOI 10.1016/j.juro.2014.03.038; Mehta A, 2014, FUTURE ONCOL, V10, P1819, DOI [10.2217/FON.14.120, 10.2217/fon.14.120]; Messing EM, 2003, J CLIN ONCOL, V21, P1214, DOI 10.1200/JCO.2003.02.005; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Miller DC, 2006, J UROLOGY, V175, P853, DOI 10.1016/S0022-5347(05)00422-2; Moore LE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002312; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Motzer Robert J, 2015, J Natl Compr Canc Netw, V13, P151; Motzer RJ, 2014, NEW ENGL J MED, V370, P1769, DOI 10.1056/NEJMc1400731; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Motzer RJ, 2013, J CLIN ONCOL, V31, P3791, DOI 10.1200/JCO.2012.47.4940; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Muselaers CHJ, 2013, EUR UROL, V63, P1101, DOI 10.1016/j.eururo.2013.02.022; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID, V2; Parekh DJ, 2013, J AM SOC NEPHROL, V24, P506, DOI 10.1681/ASN.2012080786; Perdeaux E, 2013, JAMA-J AM MED ASSOC, V309, P1460, DOI 10.1001/jama.2013.2243; Pierorazio PM, 2015, EUR UROL, V68, P408, DOI 10.1016/j.eururo.2015.02.001; Pizzocaro G, 2001, J CLIN ONCOL, V19, P425, DOI 10.1200/JCO.2001.19.2.425; Rendon RA, 2010, CUAJ-CAN UROL ASSOC, V4, P136, DOI 10.5489/cuaj.10038; Rini BI, 2007, J UROLOGY, V177, P1978, DOI 10.1016/j.juro.2007.01.136; Rini BI, 2014, J CLIN ONCOL, V32, P752, DOI 10.1200/JCO.2013.50.5305; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Rohrmann S, 2015, INT J CANCER, V136, pE423, DOI 10.1002/ijc.29236; Ruiz JN, 2014, CLIN GENITOURIN CANC, V12, P341, DOI 10.1016/j.clgc.2014.04.001; Russo P, 2008, UROL CLIN N AM, V35, P679, DOI 10.1016/j.ucl.2008.07.009; Sacco E, 2009, UROL INT, V83, P1, DOI 10.1159/000224860; Scosyrev E, 2014, EUR UROL, V65, P372, DOI 10.1016/j.eururo.2013.06.044; Shah S, 2010, LANCET, V376, P1024, DOI 10.1016/S0140-6736(10)60956-7; Shuch B, 2015, EUR UROL, V67, P85, DOI 10.1016/j.eururo.2014.04.029; Shuch B, 2013, J UROLOGY, V189, P430, DOI 10.1016/j.juro.2012.07.139; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simmons MN, 2012, J UROLOGY, V187, P1667, DOI 10.1016/j.juro.2011.12.068; Simmons MN, 2010, J UROLOGY, V183, P1708, DOI 10.1016/j.juro.2010.01.005; Singh P, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-014-0316-2; Sivarajan G, 2015, MED CARE, V53, P71, DOI 10.1097/MLR.0000000000000259; Sooriakumaran P, 2013, LANCET, V381, P783, DOI 10.1016/S0140-6736(12)61954-0; Srigley JR, 2013, AM J SURG PATHOL, V37, P1469, DOI 10.1097/PAS.0b013e318299f2d1; Srinivasan R, 2015, CLIN CANCER RES, V21, P10, DOI 10.1158/1078-0432.CCR-13-2993; Sternberg CN, 2013, EUR J CANCER, V49, P1287, DOI 10.1016/j.ejca.2012.12.010; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Sun M, 2012, ANN SURG ONCOL, V19, P2380, DOI 10.1245/s10434-012-2247-0; Terrone C, 2011, EUR UROL, V59, P553, DOI 10.1016/j.eururo.2010.12.041; Theis RP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-387; Thompson RH, 2015, EUR UROL, V67, P252, DOI 10.1016/j.eururo.2014.07.021; Thompson RH, 2009, J UROLOGY, V181, P993, DOI 10.1016/j.juro.2008.11.017; Tomaszewski Jeffrey J., 2014, Cancer Biology Medicine, V11, P162, DOI 10.7497/j.issn.2095-3941.2014.03.002; Vaishampayan U, 2013, CURR ONCOL REP, V15, P76, DOI 10.1007/s11912-012-0289-x; Van Poppel H, 2007, EUR UROL, V51, P1606, DOI 10.1016/j.eururo.2006.11.013; Van Poppel H, 2011, EUR UROL, V59, P543, DOI 10.1016/j.eururo.2010.12.013; Volpe A, 2015, EUR UROL, V68, P61, DOI 10.1016/j.eururo.2015.01.025; Volpe A, 2012, EUR UROL, V62, P491, DOI 10.1016/j.eururo.2012.05.009; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Woldrich JM, 2013, BJU INT, V111, P1261, DOI 10.1111/j.1464-410X.2012.11497.x; Zini L, 2009, CANCER-AM CANCER SOC, V115, P1465, DOI 10.1002/cncr.24035; Zucchetto A, 2007, ANN ONCOL, V18, P596, DOI 10.1093/annonc/mdl438	140	552	572	8	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					894	906		10.1016/S0140-6736(15)00046-X	http://dx.doi.org/10.1016/S0140-6736(15)00046-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE9RA	26318520				2022-12-28	WOS:000370974400034
J	Murray, CJL; Barber, RM; Foreman, KJ; Ozgoren, AA; Abd-Allah, F; Abera, SF; Aboyans, V; Abraham, JP; Abubakar, I; Abu-Raddad, LJ; Abu-Rmeileh, NM; Achoki, T; Ackerman, IN; Ademi, Z; Adou, AK; Adsuar, JC; Afshin, A; Agardh, EE; Alam, SS; Alasfoor, D; Albittar, MI; Alegretti, MA; Alemu, ZA; Alfonso-Cristancho, R; Alhabib, S; Ali, R; Alla, F; Allebeck, P; Almazroa, MA; Alsharif, U; Alvarez, E; Alvis-Guzman, N; Amare, AT; Ameh, EA; Amini, H; Ammar, W; Anderson, HR; Anderson, BO; Antonio, CAT; Anwari, P; Arnlov, J; Arsenijevic, VSA; Artaman, A; Asghar, RJ; Assadi, R; Atkins, LS; Avila, MA; Awuah, B; Bachman, VF; Badawi, A; Bahit, MC; Balakrishnan, K; Banerjee, A; Barker-Collo, SL; Barquera, S; Barregard, L; Barrero, LH; Basu, A; Basu, S; Basulaiman, MO; Beardsley, J; Bedi, N; Beghi, E; Bekele, T; Bell, ML; Benjet, C; Bennett, DA; Bensenor, IM; Benzian, H; Bernabe, E; Bertozzi-Villa, A; Beyene, TJ; Bhala, N; Bhalla, A; Bhutta, ZA; Bienhoff, K; Bikbov, B; Biryukov, S; Blore, JD; Blosser, CD; Blyth, FM; Bohensky, MA; Bolliger, IW; Basara, BB; Bornstein, NM; Bose, D; Boufous, S; Bourne, RRA; Boyers, LN; Brainin, M; Brayne, CE; Brazinova, A; Breitborde, NJK; Brenner, H; Briggs, AD; Brooks, PM; Brown, JC; Brugha, TS; Buchbinder, R; Buckle, GC; Budke, CM; Bulchis, A; Bulloch, AG; Campos-Nonato, IR; Carabin, H; Carapetis, JR; Cardenas, R; Carpenter, DO; Caso, V; Castaneda-Orjuela, CA; Castro, RE; Catala-Lopez, F; Cavalleri, F; Cavlin, A; Chadha, VK; Chang, JC; Charlson, FJ; Chen, HL; Chen, WQ; Chiang, PP; Chimed-Ochir, O; Chowdhury, R; Christensen, H; Christophi, CA; Cirillo, M; Coates, MM; Coffeng, LE; Coggeshall, MS; Colistro, V; Colquhoun, SM; Cooke, GS; Cooper, C; Cooper, LT; Coppola, LM; Cortinovis, M; Criqui, MH; Crump, JA; Cuevas-Nasu, L; Danawi, H; Dandona, L; Dandona, R; Dansereau, E; Dargan, PI; Davey, G; Davis, A; Davitoiu, DV; Dayama, A; De Leo, D; Degenhardt, L; Del Pozo-Cruz, B; Dellavalle, RP; Deribe, K; Derrett, S; Des Jarlais, DC; Dessalegn, M; Dharmaratne, SD; Dherani, MK; Diaz-Torne, C; Dicker, D; Ding, EL; Dokova, K; Dorsey, ER; Driscoll, TR; Duan, L; Duber, HC; Ebel, BE; Edmond, KM; Elshrek, YM; Endres, M; Ermakov, SP; Erskine, HE; Eshrati, B; Esteghamati, A; Estep, K; Faraon, EJA; Farzadfar, F; Fay, DF; Feigin, VL; Felson, DT; Fereshtehnejad, SM; Fernandes, JG; Ferrari, AJ; Fitzmaurice, C; Flaxman, AD; Fleming, TD; Foigt, N; Forouzanfar, MH; Fowkes, FGR; Paleo, UF; Franklin, RC; Furst, T; Gabbe, B; Gaffikin, L; Gankpe, FG; Geleijnse, JM; Gessner, BD; Gething, P; Gibney, KB; Giroud, M; Giussani, G; Dantes, HG; Gona, P; Gonzalez-Medina, D; Gosselin, RA; Gotay, CC; Goto, A; Gouda, HN; Graetz, N; Gugnani, HC; Gupta, R; Gupta, R; Gutierrez, RA; Haagsma, J; Hafezi-Nejad, N; Hagan, H; Halasa, YA; Hamadeh, RR; Hamavid, H; Hammami, M; Hancock, J; Hankey, GJ; Hansen, GM; Hao, YT; Harb, HL; Haro, JM; Havmoeller, R; Hay, SI; Hay, RJ; Heredia-Pi, IB; Heuton, KR; Heydarpour, P; Higashi, H; Hijar, M; Hoek, HW; Hoffman, HJ; Hosgood, HD; Hossain, M; Hotez, PJ; Hoy, DG; Hsairi, M; Hu, GQ; Huang, C; Huang, JJ; Husseini, A; Huynh, C; Iannarone, ML; Iburg, KM; Innos, K; Inoue, M; Islami, F; Jacobsen, KH; Jarvis, DL; Jassal, SK; Jee, SH; Jeemon, P; Jensen, PN; Jha, V; Jiang, GH; Jiang, Y; Jonas, JB; Juel, K; Kan, HD; Karch, A; Karema, CK; Karimkhani, C; Karthikeyan, G; Kassebaum, NJ; Kaul, A; Kawakami, N; Kazanjan, K; Kemp, AH; Kengne, AP; Keren, A; Khader, YS; Khalifa, SEA; Khan, EA; Khan, G; Khang, YH; Kieling, C; Kim, D; Kim, S; Kim, Y; Kinfu, Y; Kinge, JM; Kivipelto, M; Knibbs, LD; Knudsen, AK; Kokubo, Y; Kosen, S; Krishnaswami, S; Defo, BK; Bicer, BK; Kuipers, EJ; Kulkarni, C; Kulkarni, VS; Kumar, GA; Kyu, HH; Lai, T; Lalloo, R; Lallukka, T; Lam, H; Lan, Q; Lansingh, VC; Larsson, A; Lawrynowicz, AEB; Leasher, JL; Leigh, J; Leung, R; Levitz, CE; Li, B; Li, YC; Li, YM; Lim, SS; Lind, M; Lipshultz, SE; Liu, SW; Liu, Y; Lloyd, BK; Lofgren, KT; Logroscino, G; Looker, KJ; Lortet-Tieulent, J; Lotufo, PA; Lozano, R; Lucas, RM; Lunevicius, R; Lyons, RA; Ma, S; Macintyre, MF; Mackay, MT; Majdan, M; Malekzadeh, R; Marcenes, W; Margolis, DJ; Margono, C; Marzan, MB; Masci, JR; Mashal, MT; Matzopoulos, R; Mayosi, BM; Mazorodze, TT; Mcgill, NW; Mcgrath, JJ; Mckee, M; McLain, A; Meaney, PA; Medina, C; Mehndiratta, MM; Mekonnen, W; Melaku, YA; Meltzer, M; Memish, ZA; Mensah, GA; Meretoja, A; Mhimbira, FA; Micha, R; Miller, TR; Mills, EJ; Mitchell, PB; Mock, CN; Ibrahim, NM; Mohammad, KA; Mokdad, AH; Mola, GLD; Monasta, L; Hernandez, JCM; Montico, M; Montine, TJ; Mooney, MD; Moore, AR; Moradi-Lakeh, M; Moran, AE; Mori, R; Moschandreas, J; Moturi, WN; Moyer, ML; Mozaffarian, D; Msemburi, WT; Mueller, UO; Mukaigawara, M; Mullany, EC; Murdoch, ME; Murray, J; Murthy, KS; Naghavi, M; Naheed, A; Naidoo, KS; Naldi, L; Nand, D; Nangia, V; Narayan, KMV; Nejjari, C; Neupane, SP; Newton, CR; Ng, M; Ngalesoni, FN; Nguyen, G; Nisar, MI; Nolte, S; Norheim, OF; Norman, RE; Norrving, B; Nyakarahuka, L; Oh, IH; Ohkubo, T; Ohno, SL; Olusanya, BO; Opio, JN; Ortblad, K; Ortiz, A; Pain, AW; Pandian, JD; Panelo, CIA; Papachristou, C; Park, EK; Park, JH; Patten, SB; Patton, GC; Paul, VK; Pavlin, BI; Pearce, N; Pereira, DM; Perez-Padilla, R; Perez-Ruiz, F; Perico, N; Pervaiz, A; Pesudovs, K; Peterson, CB; Petzold, M; Phillips, MR; Phillips, BK; Phillips, DE; Piel, FB; Plass, D; Poenaru, D; Polinder, S; Pope, D; Popova, S; Poulton, RG; Pourmalek, F; Prabhakaran, D; Prasad, NM; Pullan, RL; Qato, DM; Quistberg, DA; Rafay, A; Rahimi, K; Rahman, SU; Raju, M; Rana, SM; Razavi, H; Reddy, KS; Refaat, A; Remuzzi, G; Resnikoff, S; Ribeiro, AL; Richardson, L; Richardus, JH; Roberts, DA; Rojas-Rueda, D; Ronfani, L; Roth, GA; Rothenbacher, D; Rothstein, DH; Rowley, JT; Roy, N; Ruhago, GM; Saeedi, MY; Saha, S; Sahraian, MA; Sampson, UKA; Sanabria, JR; Sandar, L; Santos, IS; Satpathy, M; Sawhney, M; Scarborough, P; Schneider, IJ; Schottker, B; Schumacher, AE; Schwebel, DC; Scott, JG; Seedat, S; Sepanlou, SG; Serina, PT; Servan-Mori, EE; Shackelford, KA; Shaheen, A; Shahraz, S; Levy, TS; Shangguan, S; She, J; Sheikhbahaei, S; Shi, PL; Shibuya, K; Shinohara, Y; Shiri, R; Shishani, K; Shiue, I; Shrime, MG; Sigfusdottir, ID; Silberberg, DH; Simard, EP; Sindi, S; Singh, A; Singh, JA; Singh, L; Skirbekk, V; Slepak, EL; Sliwa, K; Soneji, S; Soreide, K; Soshnikov, S; Sposato, LA; Sreeramareddy, CT; Stanaway, JD; Stathopoulou, V; Stein, DJ; Stein, MB; Steiner, C; Steiner, TJ; Stevens, A; Stewart, A; Stovner, LJ; Stroumpoulis, K; Sunguya, BF; Swaminathan, S; Swaroop, M; Sykes, BL; Tabb, KM; Takahashi, K; Tandon, N; Tanne, D; Tanner, M; Tavakkoli, M; Taylor, HR; Te Ao, BJ; Tediosi, F; Temesgen, AM; Templin, T; Ten Have, M; Tenkorang, EY; Terkawi, AS; Thomson, B; Thorne-Lyman, AL; Thrift, AG; Thurston, GD; Tillmann, T; Tonelli, M; Topouzis, F; Toyoshima, H; Traebert, J; Tran, BX; Trillini, M; Truelsen, T; Tsilimbaris, M; Tuzcu, EM; Uchendu, US; Ukwaja, KN; Undurraga, EA; Uzun, SB; Van Brakel, WH; Van De Vijver, S; van Gool, CH; Van Os, J; Vasankari, TJ; Venketasubramanian, N; Violante, FS; Vlassov, VV; Vollset, SE; Wagner, GR; Wagner, J; Waller, SG; Wan, X; Wang, HD; Wang, JL; Wang, LH; Warouw, TS; Weichenthal, S; Weiderpass, E; Weintraub, RG; Wang, WZ; Werdecker, A; Westerman, R; Whiteford, HA; Wilkinson, JD; Williams, TN; Wolfe, CD; Wolock, TM; Woolf, AD; Wulf, S; Wurtz, B; Xu, GL; Yan, LJL; Yano, Y; Ye, PP; Yentur, GK; Yip, P; Yonemoto, N; Yoon, SJ; Younis, MZ; Yu, CH; Zaki, ME; Zhao, Y; Zheng, YF; Zonies, D; Zou, XN; Salomon, JA; Lopez, AD; Vos, T				Murray, Christopher J. L.; Barber, Ryan M.; Foreman, Kyle J.; Ozgoren, Ayse Abbasoglu; Abd-Allah, Foad; Abera, Semaw F.; Aboyans, Victor; Abraham, Jerry P.; Abubakar, Ibrahim; Abu-Raddad, Laith J.; Abu-Rmeileh, Niveen M.; Achoki, Tom; Ackerman, Ilana N.; Ademi, Zanfina; Adou, Arsene K.; Adsuar, Jose C.; Afshin, Ashkan; Agardh, Emilie E.; Alam, Sayed Saidul; Alasfoor, Deena; Albittar, Mohammed I.; Alegretti, Miguel A.; Alemu, Zewdie A.; Alfonso-Cristancho, Rafael; Alhabib, Samia; Ali, Raghib; Alla, Francois; Allebeck, Peter; Almazroa, Mohammad A.; Alsharif, Ubai; Alvarez, Elena; Alvis-Guzman, Nelson; Amare, Azmeraw T.; Ameh, Emmanuel A.; Amini, Heresh; Ammar, Walid; Anderson, H. Ross; Anderson, Benjamin O.; Antonio, Carl Abelardo T.; Anwari, Palwasha; Arnlov, Johan; Arsenijevic, Valentina S. Arsic; Artaman, Al; Asghar, Rana J.; Assadi, Reza; Atkins, Lydia S.; Avila, Marco A.; Awuah, Baffour; Bachman, Victoria F.; Badawi, Alaa; Bahit, Maria C.; Balakrishnan, Kalpana; Banerjee, Amitava; Barker-Collo, Suzanne L.; Barquera, Simon; Barregard, Lars; Barrero, Lope H.; Basu, Arindam; Basu, Sanjay; Basulaiman, Mohammed O.; Beardsley, Justin; Bedi, Neeraj; Beghi, Ettore; Bekele, Tolesa; Bell, Michelle L.; Benjet, Corina; Bennett, Derrick A.; Bensenor, Isabela M.; Benzian, Habib; Bernabe, Eduardo; Bertozzi-Villa, Amelia; Beyene, Tariku J.; Bhala, Neeraj; Bhalla, Ashish; Bhutta, Zulfiqar A.; Bienhoff, Kelly; Bikbov, Boris; Biryukov, Stan; Blore, Jed D.; Blosser, Christopher D.; Blyth, Fiona M.; Bohensky, Megan A.; Bolliger, Ian W.; Basara, Berrak Bora; Bornstein, Natan M.; Bose, Dipan; Boufous, Soufiane; Bourne, Rupert R. A.; Boyers, Lindsay N.; Brainin, Michael; Brayne, Carol E.; Brazinova, Alexandra; Breitborde, Nicholas J. K.; Brenner, Hermann; Briggs, Adam D.; Brooks, Peter M.; Brown, Jonathan C.; Brugha, Traolach S.; Buchbinder, Rachelle; Buckle, Geoffrey C.; Budke, Christine M.; Bulchis, Anne; Bulloch, Andrew G.; Campos-Nonato, Ismael R.; Carabin, Helene; Carapetis, Jonathan R.; Cardenas, Rosario; Carpenter, David O.; Caso, Valeria; Castaneda-Orjuela, Carlos A.; Castro, Ruben E.; Catala-Lopez, Ferran; Cavalleri, Fiorella; Cavlin, Alanur; Chadha, Vineet K.; Chang, Jung-Chen; Charlson, Fiona J.; Chen, Honglei; Chen, Wanqing; Chiang, Peggy P.; Chimed-Ochir, Odgerel; Chowdhury, Rajiv; Christensen, Hanne; Christophi, Costas A.; Cirillo, Massimo; Coates, Matthew M.; Coffeng, Luc E.; Coggeshall, Megan S.; Colistro, Valentina; Colquhoun, Samantha M.; Cooke, Graham S.; Cooper, Cyrus; Cooper, Leslie T.; Coppola, Luis M.; Cortinovis, Monica; Criqui, Michael H.; Crump, John A.; Cuevas-Nasu, Lucia; Danawi, Hadi; Dandona, Lalit; Dandona, Rakhi; Dansereau, Emily; Dargan, Paul I.; Davey, Gail; Davis, Adrian; Davitoiu, Dragos V.; Dayama, Anand; De Leo, Diego; Degenhardt, Louisa; Del Pozo-Cruz, Borja; Dellavalle, Robert P.; Deribe, Kebede; Derrett, Sarah; Des Jarlais, Don C.; Dessalegn, Muluken; Dharmaratne, Samath D.; Dherani, Mukesh K.; Diaz-Torne, Cesar; Dicker, Daniel; Ding, Eric L.; Dokova, Klara; Dorsey, E. Ray; Driscoll, Tim R.; Duan, Leilei; Duber, Herbert C.; Ebel, Beth E.; Edmond, Karen M.; Elshrek, Yousef M.; Endres, Matthias; Ermakov, Sergey P.; Erskine, Holly E.; Eshrati, Babak; Esteghamati, Alireza; Estep, Kara; Faraon, Emerito Jose A.; Farzadfar, Farshad; Fay, Derek F.; Feigin, Valery L.; Felson, David T.; Fereshtehnejad, Seyed-Mohammad; Fernandes, Jefferson G.; Ferrari, Alize J.; Fitzmaurice, Christina; Flaxman, Abraham D.; Fleming, Thomas D.; Foigt, Nataliya; Forouzanfar, Mohammad H.; Fowkes, F. Gerry R.; Paleo, Urbano Fra; Franklin, Richard C.; Fuerst, Thomas; Gabbe, Belinda; Gaffikin, Lynne; Gankpe, Fortune G.; Geleijnse, Johanna M.; Gessner, Bradford D.; Gething, Peter; Gibney, Katherine B.; Giroud, Maurice; Giussani, Giorgia; Gomez Dantes, Hector; Gona, Philimon; Gonzalez-Medina, Diego; Gosselin, Richard A.; Gotay, Carolyn C.; Goto, Atsushi; Gouda, Hebe N.; Graetz, Nicholas; Gugnani, Harish C.; Gupta, Rahul; Gupta, Rajeev; Gutierrez, Reyna A.; Haagsma, Juanita; Hafezi-Nejad, Nima; Hagan, Holly; Halasa, Yara A.; Hamadeh, Randah R.; Hamavid, Hannah; Hammami, Mouhanad; Hancock, Jamie; Hankey, Graeme J.; Hansen, Gillian M.; Hao, Yuantao; Harb, Hilda L.; Maria Haro, Josep; Havmoeller, Rasmus; Hay, Simon I.; Hay, Roderick J.; Heredia-Pi, Ileana B.; Heuton, Kyle R.; Heydarpour, Pouria; Higashi, Hideki; Hijar, Martha; Hoek, Hans W.; Hoffman, Howard J.; Hosgood, H. Dean; Hossain, Mazeda; Hotez, Peter J.; Hoy, Damian G.; Hsairi, Mohamed; Hu, Guoqing; Huang, Cheng; Huang, John J.; Husseini, Abdullatif; Huynh, Chantal; Iannarone, Marissa L.; Iburg, Kim M.; Innos, Kaire; Inoue, Manami; Islami, Farhad; Jacobsen, Kathryn H.; Jarvis, Deborah L.; Jassal, Simerjot K.; Jee, Sun Ha; Jeemon, Panniyammakal; Jensen, Paul N.; Jha, Vivekanand; Jiang, Guohong; Jiang, Ying; Jonas, Jost B.; Juel, Knud; Kan, Haidong; Karch, Andre; Karema, Corine K.; Karimkhani, Chante; Karthikeyan, Ganesan; Kassebaum, Nicholas J.; Kaul, Anil; Kawakami, Norito; Kazanjan, Konstantin; Kemp, Andrew H.; Kengne, Andre P.; Keren, Andre; Khader, Yousef S.; Khalifa, Shams Eldin A.; Khan, Ejaz A.; Khan, Gulfaraz; Khang, Young-Ho; Kieling, Christian; Kim, Daniel; Kim, Sungroul; Kim, Yunjin; Kinfu, Yohannes; Kinge, Jonas M.; Kivipelto, Miia; Knibbs, Luke D.; Knudsen, Ann Kristin; Kokubo, Yoshihiro; Kosen, Soewarta; Krishnaswami, Sanjay; Defo, Barthelemy Kuate; Bicer, Burcu Kucuk; Kuipers, Ernst J.; Kulkarni, Chanda; Kulkarni, Veena S.; Kumar, G. Anil; Kyu, Hmwe H.; Lai, Taavi; Lalloo, Ratilal; Lallukka, Tea; Lam, Hilton; Lan, Qing; Lansingh, Van C.; Larsson, Anders; Lawrynowicz, Alicia E. B.; Leasher, Janet L.; Leigh, James; Leung, Ricky; Levitz, Carly E.; Li, Bin; Li, Yichong; Li, Yongmei; Lim, Stephen S.; Lind, Maggie; Lipshultz, Steven E.; Liu, Shiwei; Liu, Yang; Lloyd, Belinda K.; Lofgren, Katherine T.; Logroscino, Giancarlo; Looker, Katharine J.; Lortet-Tieulent, Joannie; Lotufo, Paulo A.; Lozano, Rafael; Lucas, Robyn M.; Lunevicius, Raimundas; Lyons, Ronan A.; Ma, Stefan; Macintyre, Michael F.; Mackay, Mark T.; Majdan, Marek; Malekzadeh, Reza; Marcenes, Wagner; Margolis, David J.; Margono, Christopher; Marzan, Melvin B.; Masci, Joseph R.; Mashal, Mohammad T.; Matzopoulos, Richard; Mayosi, Bongani M.; Mazorodze, Tasara T.; Mcgill, Neil W.; Mcgrath, John J.; Mckee, Martin; McLain, Abigail; Meaney, Peter A.; Medina, Catalina; Mehndiratta, Man Mohan; Mekonnen, Wubegzier; Melaku, Yohannes A.; Meltzer, Michele; Memish, Ziad A.; Mensah, George A.; Meretoja, Atte; Mhimbira, Francis A.; Micha, Renata; Miller, Ted R.; Mills, Edward J.; Mitchell, Philip B.; Mock, Charles N.; Ibrahim, Norlinah Mohamed; Mohammad, Karzan A.; Mokdad, Ali H.; Mola, Glen L. D.; Monasta, Lorenzo; Montanez Hernandez, Julio C.; Montico, Marcella; Montine, Thomas J.; Mooney, Meghan D.; Moore, Ami R.; Moradi-Lakeh, Maziar; Moran, Andrew E.; Mori, Rintaro; Moschandreas, Joanna; Moturi, Wilkister N.; Moyer, Madeline L.; Mozaffarian, Dariush; Msemburi, William T.; Mueller, Ulrich O.; Mukaigawara, Mitsuru; Mullany, Erin C.; Murdoch, Michele E.; Murray, Joseph; Murthy, Kinnari S.; Naghavi, Mohsen; Naheed, Aliya; Naidoo, Kovin S.; Naldi, Luigi; Nand, Devina; Nangia, Vinay; Narayan, K. M. Venkat; Nejjari, Chakib; Neupane, Sudan P.; Newton, Charles R.; Ng, Marie; Ngalesoni, Frida N.; Nguyen, Grant; Nisar, Muhammad I.; Nolte, Sandra; Norheim, Ole F.; Norman, Rosana E.; Norrving, Bo; Nyakarahuka, Luke; Oh, In-Hwan; Ohkubo, Takayoshi; Ohno, Summer L.; Olusanya, Bolajoko O.; Opio, John Nelson; Ortblad, Katrina; Ortiz, Alberto; Pain, Amanda W.; Pandian, Jeyaraj D.; Panelo, Carlo Irwin A.; Papachristou, Christina; Park, Eun-Kee; Park, Jae-Hyun; Patten, Scott B.; Patton, George C.; Paul, Vinod K.; Pavlin, Boris I.; Pearce, Neil; Pereira, David M.; Perez-Padilla, Rogelio; Perez-Ruiz, Fernando; Perico, Norberto; Pervaiz, Aslam; Pesudovs, Konrad; Peterson, Carrie B.; Petzold, Max; Phillips, Michael R.; Phillips, Bryan K.; Phillips, David E.; Piel, Frederic B.; Plass, Dietrich; Poenaru, Dan; Polinder, Suzanne; Pope, Daniel; Popova, Svetlana; Poulton, Richie G.; Pourmalek, Farshad; Prabhakaran, Dorairaj; Prasad, Noela M.; Pullan, Rachel L.; Qato, Dima M.; Quistberg, D. Alex; Rafay, Anwar; Rahimi, Kazem; Rahman, Sajjad U.; Raju, Murugesan; Rana, Saleem M.; Razavi, Homie; Reddy, K. Srinath; Refaat, Amany; Remuzzi, Giuseppe; Resnikoff, Serge; Ribeiro, Antonio L.; Richardson, Lee; Richardus, Jan Hendrik; Roberts, D. Allen; Rojas-Rueda, David; Ronfani, Luca; Roth, Gregory A.; Rothenbacher, Dietrich; Rothstein, David H.; Rowley, Jane T.; Roy, Nobhojit; Ruhago, George M.; Saeedi, Mohammad Y.; Saha, Sukanta; Sahraian, Mohammad Ali; Sampson, Uchechukwu K. A.; Sanabria, Juan R.; Sandar, Logan; Santos, Itamar S.; Satpathy, Maheswar; Sawhney, Monika; Scarborough, Peter; Schneider, Ione J.; Schoettker, Ben; Schumacher, Austin E.; Schwebel, David C.; Scott, James G.; Seedat, Soraya; Sepanlou, Sadaf G.; Serina, Peter T.; Servan-Mori, Edson E.; Shackelford, Katya A.; Shaheen, Amira; Shahraz, Saeid; Levy, Teresa Shamah; Shangguan, Siyi; She, Jun; Sheikhbahaei, Sara; Shi, Peilin; Shibuya, Kenji; Shinohara, Yukito; Shiri, Rahman; Shishani, Kawkab; Shiue, Ivy; Shrime, Mark G.; Sigfusdottir, Inga D.; Silberberg, Donald H.; Simard, Edgar P.; Sindi, Shireen; Singh, Abhishek; Singh, Jasvinder A.; Singh, Lavanya; Skirbekk, Vegard; Slepak, Erica Leigh; Sliwa, Karen; Soneji, Samir; Soreide, Kjetil; Soshnikov, Sergey; Sposato, Luciano A.; Sreeramareddy, Chandrashekhar T.; Stanaway, Jeffrey D.; Stathopoulou, Vasiliki; Stein, Dan J.; Stein, Murray B.; Steiner, Caitlyn; Steiner, Timothy J.; Stevens, Antony; Stewart, Andrea; Stovner, Lars J.; Stroumpoulis, Konstantinos; Sunguya, Bruno F.; Swaminathan, Soumya; Swaroop, Mamta; Sykes, Bryan L.; Tabb, Karen M.; Takahashi, Ken; Tandon, Nikhil; Tanne, David; Tanner, Marcel; Tavakkoli, Mohammad; Taylor, Hugh R.; Te Ao, Braden J.; Tediosi, Fabrizio; Temesgen, Awoke M.; Templin, Tara; Ten Have, Margreet; Tenkorang, Eric Y.; Terkawi, Abdullah S.; Thomson, Blake; Thorne-Lyman, Andrew L.; Thrift, Amanda G.; Thurston, George D.; Tillmann, Taavi; Tonelli, Marcello; Topouzis, Fotis; Toyoshima, Hideaki; Traebert, Jefferson; Tran, Bach X.; Trillini, Matias; Truelsen, Thomas; Tsilimbaris, Miltiadis; Tuzcu, Emin M.; Uchendu, Uche S.; Ukwaja, Kingsley N.; Undurraga, Eduardo A.; Uzun, Selen B.; Van Brakel, Wim H.; Van De Vijver, Steven; van Gool, Coen H.; Van Os, Jim; Vasankari, Tommi J.; Venketasubramanian, N.; Violante, Francesco S.; Vlassov, Vasiliy V.; Vollset, Stein Emil; Wagner, Gregory R.; Wagner, Joseph; Waller, Stephen G.; Wan, Xia; Wang, Haidong; Wang, Jianli; Wang, Linhong; Warouw, Tati S.; Weichenthal, Scott; Weiderpass, Elisabete; Weintraub, Robert G.; Wang Wenzhi; Werdecker, Andrea; Westerman, Ronny; Whiteford, Harvey A.; Wilkinson, James D.; Williams, Thomas N.; Wolfe, Charles D.; Wolock, Timothy M.; Woolf, Anthony D.; Wulf, Sarah; Wurtz, Brittany; Xu, Gelin; Yan, Lijing L.; Yano, Yuichiro; Ye, Pengpeng; Yentur, Goekalp K.; Yip, Paul; Yonemoto, Naohiro; Yoon, Seok-Jun; Younis, Mustafa Z.; Yu, Chuanhua; Zaki, Maysaa El Sayed; Zhao, Yong; Zheng, Yingfeng; Zonies, David; Zou, Xiaonong; Salomon, Joshua A.; Lopez, Alan D.; Vos, Theo		GBD 2013 DALYs Collaborator; HALE Collaborator	Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; LOW SOCIOECONOMIC-STATUS; SYSTEMATIC ANALYSIS; NONCOMMUNICABLE DISEASES; CHANGING RELATION; MORTALITY TRENDS; EUROPEAN-UNION; RISK-FACTORS; BURDEN; INEQUALITIES	Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable comparisons of health loss over time and across causes, age-sex groups, and countries. The GBD can be used to generate summary measures such as disability-adjusted life-years (DALYs) and healthy life expectancy (HALE) that make possible comparative assessments of broad epidemiological patterns across countries and time. These summary measures can also be used to quantify the component of variation in epidemiology that is related to sociodemographic development. Methods We used the published GBD 2013 data for age-specific mortality, years of life lost due to premature mortality (YLLs), and years lived with disability (YLDs) to calculate DALYs and HALE for 1990, 1995, 2000, 2005, 2010, and 2013 for 188 countries. We calculated HALE using the Sullivan method; 95% uncertainty intervals (UIs) represent uncertainty in age-specific death rates and YLDs per person for each country, age, sex, and year. We estimated DALYs for 306 causes for each country as the sum of YLLs and YLDs; 95% UIs represent uncertainty in YLL and YLD rates. We quantified patterns of the epidemiological transition with a composite indicator of sociodemographic status, which we constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population. We applied hierarchical regression to DALY rates by cause across countries to decompose variance related to the sociodemographic status variable, country, and time. Findings Worldwide, from 1990 to 2013, life expectancy at birth rose by 6.2 years (95% UI 5.6-6.6), from 65.3 years (65.0-65.6) in 1990 to 71.5 years (71.0-71.9) in 2013, HALE at birth rose by 5.4 years (4.9-5.8), from 56.9 years (54.5-59.1) to 62.3 years (59.7-64.8), total DALYs fell by 3.6% (0.3-7.4), and age-standardised DALY rates per 100 000 people fell by 26.7% (24.6-29.1). For communicable, maternal, neonatal, and nutritional disorders, global DALY numbers, crude rates, and age-standardised rates have all declined between 1990 and 2013, whereas for non-communicable diseases, global DALYs have been increasing, DALY rates have remained nearly constant, and age-standardised DALY rates declined during the same period. From 2005 to 2013, the number of DALYs increased for most specific non-communicable diseases, including cardiovascular diseases and neoplasms, in addition to dengue, food-borne trematodes, and leishmaniasis; DALYs decreased for nearly all other causes. By 2013, the five leading causes of DALYs were ischaemic heart disease, lower respiratory infections, cerebrovascular disease, low back and neck pain, and road injuries. Sociodemographic status explained more than 50% of the variance between countries and over time for diarrhoea, lower respiratory infections, and other common infectious diseases; maternal disorders; neonatal disorders; nutritional deficiencies; other communicable, maternal, neonatal, and nutritional diseases; musculoskeletal disorders; and other non-communicable diseases. However, sociodemographic status explained less than 10% of the variance in DALY rates for cardiovascular diseases; chronic respiratory diseases; cirrhosis; diabetes, urogenital, blood, and endocrine diseases; unintentional injuries; and self-harm and interpersonal violence. Predictably, increased sociodemographic status was associated with a shift in burden from YLLs to YLDs, driven by declines in YLLs and increases in YLDs from musculoskeletal disorders, neurological disorders, and mental and substance use disorders. In most country-specific estimates, the increase in life expectancy was greater than that in HALE. Leading causes of DALYs are highly variable across countries. Interpretation Global health is improving. Population growth and ageing have driven up numbers of DALYs, but crude rates have remained relatively constant, showing that progress in health does not mean fewer demands on health systems. The notion of an epidemiological transition-in which increasing sociodemographic status brings structured change in disease burden-is useful, but there is tremendous variation in burden of disease that is not associated with sociodemographic status. This further underscores the need for country-specific assessments of DALYs and HALE to appropriately inform health policy decisions and attendant actions.	[Murray, Christopher J. L.; Barber, Ryan M.; Foreman, Kyle J.; Achoki, Tom; Afshin, Ashkan; Bachman, Victoria F.; Bertozzi-Villa, Amelia; Bienhoff, Kelly; Biryukov, Stan; Blore, Jed D.; Bolliger, Ian W.; Brown, Jonathan C.; Bulchis, Anne; Coates, Matthew M.; Coffeng, Luc E.; Coggeshall, Megan S.; Dandona, Lalit; Dansereau, Emily; Dicker, Daniel; Duber, Herbert C.; Estep, Kara; Fitzmaurice, Christina; Flaxman, Abraham D.; Fleming, Thomas D.; Forouzanfar, Mohammad H.; Gonzalez-Medina, Diego; Graetz, Nicholas; Haagsma, Juanita; Hamavid, Hannah; Hancock, Jamie; Hansen, Gillian M.; Hay, Simon I.; Heuton, Kyle R.; Higashi, Hideki; Huynh, Chantal; Iannarone, Marissa L.; Kassebaum, Nicholas J.; Kyu, Hmwe H.; Levitz, Carly E.; Lim, Stephen S.; Lind, Maggie; Lofgren, Katherine T.; Lozano, Rafael; Macintyre, Michael F.; Margono, Christopher; McLain, Abigail; Mokdad, Ali H.; Mooney, Meghan D.; Moradi-Lakeh, Maziar; Moyer, Madeline L.; Msemburi, William T.; Mullany, Erin C.; Naghavi, Mohsen; Ng, Marie; Nguyen, Grant; Ohno, Summer L.; Ortblad, Katrina; Pain, Amanda W.; Phillips, Bryan K.; Phillips, David E.; Richardson, Lee; Roberts, D. Allen; Roth, Gregory A.; Sandar, Logan; Schumacher, Austin E.; Serina, Peter T.; Shackelford, Katya A.; Singh, Lavanya; Slepak, Erica Leigh; Stanaway, Jeffrey D.; Steiner, Caitlyn; Stevens, Antony; Stewart, Andrea; Temesgen, Awoke M.; Templin, Tara; Thomson, Blake; Wagner, Joseph; Wan, Xia; Wang, Haidong; Wolock, Timothy M.; Wulf, Sarah; Wurtz, Brittany; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Ebel, Beth E.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Kassebaum, Nicholas J.] Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Alfonso-Cristancho, Rafael; Anderson, Benjamin O.; Blosser, Christopher D.; Jensen, Paul N.; Mock, Charles N.; Montine, Thomas J.; Quistberg, D. Alex] Univ Washington, Seattle, WA 98195 USA; [Fuerst, Thomas] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Foreman, Kyle J.; Cooke, Graham S.; Jarvis, Deborah L.; Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, London, England; [Ozgoren, Ayse Abbasoglu; Cavlin, Alanur] Hacettepe Univ, Inst Populat Studies, Ankara, Turkey; [Bicer, Burcu Kucuk] Hacettepe Univ, Inst Publ Hlth, Ankara, Turkey; [Abd-Allah, Foad] Cairo Univ, Fac Med, Cairo, Egypt; [Abera, Semaw F.] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia; [Abera, Semaw F.] Kilte Awlaelo Hlth & Demog Surveillance Site, Mekelle, Ethiopia; [Aboyans, Victor] Dupuytren Univ Hosp, Limoges, France; [Abraham, Jerry P.] Univ So Calif, Calif Hosp, Family Med Residency Program, Los Angeles, CA USA; [Abraham, Jerry P.] Harvard Univ, Inst Global Hlth, Boston, MA 02115 USA; [Thorne-Lyman, Andrew L.] Harvard Univ, Dept Nutr, Boston, MA USA; [Abraham, Jerry P.; Ding, Eric L.; Wagner, Gregory R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Campos-Nonato, Ismael R.; Shrime, Mark G.; Salomon, Joshua A.] Harvard Univ, Boston, MA 02115 USA; [Benzian, Habib] UCL, Dept Epidemiol & Publ Hlth, London, England; [Abu-Raddad, Laith J.] Weill Cornell Med Coll Ar Rayyan Qatar, Doha, Qatar; [Abu-Rmeileh, Niveen M.] Birzeit Univ, Inst Community & Publ Hlth, Ramallah, Palestine; [Chiang, Peggy P.] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia; [Meretoja, Atte] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Meretoja, Atte] Univ Melbourne, Dept Florey, Melbourne, Vic, Australia; [Ackerman, Ilana N.; Ademi, Zanfina; Blore, Jed D.; Bohensky, Megan A.; Brooks, Peter M.; Colquhoun, Samantha M.; Patton, George C.; Taylor, Hugh R.; Weintraub, Robert G.; Lopez, Alan D.] Univ Melbourne, Melbourne, Vic, Australia; [Ademi, Zanfina; Amini, Heresh] Univ Basel, Basel, Switzerland; [Tanner, Marcel; Tediosi, Fabrizio] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ademi, Zanfina] Univ Basel, Basel, Switzerland; [Adou, Arsene K.] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire; [Adsuar, Jose C.; Paleo, Urbano Fra] Univ Extremadura, Caceres, Spain; [Afshin, Ashkan; Micha, Renata; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Shangguan, Siyi; Shi, Peilin] Tufts Univ, Boston, MA 02111 USA; [Agardh, Emilie E.] Inst Publ Hlth Sci, Stockholm, Sweden; [Alam, Sayed Saidul; Naheed, Aliya] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Alasfoor, Deena] Minist Hlth, Al Khuwair, Oman; [Alegretti, Miguel A.] Univ Republica, Fac Med, Dept Med Prevent & Social, Montevideo, Uruguay; [Cavalleri, Fiorella] Univ Republica, Fac Med, Montevideo, Uruguay; [Alemu, Zewdie A.] Debre Markos Univ, Addis Ababa, Ethiopia; [Alhabib, Samia] King Abdullah Bin Abdulaziz Univ Hosp, Riyadh, Saudi Arabia; [Gething, Peter] Univ Oxford, Dept Zool, Oxford, England; [Ali, Raghib; Bennett, Derrick A.; Briggs, Adam D.; Hay, Simon I.; Piel, Frederic B.; Rahimi, Kazem; Scarborough, Peter] Univ Oxford, Oxford, England; [Gibney, Katherine B.] Melbourne Hlth, Parkville, Vic, Australia; [Alla, Francois] Univ Lorraine, Sch Publ Hlth, Nancy, France; [Allebeck, Peter; Roy, Nobhojit] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Havmoeller, Rasmus; Sindi, Shireen] Karolinska Inst, Stockholm, Sweden; [Almazroa, Mohammad A.; Basulaiman, Mohammed O.; Saeedi, Mohammad Y.] Minist Hlth, Riyadh, Saudi Arabia; [Alsharif, Ubai; Endres, Matthias] Charite, D-13353 Berlin, Germany; [Alvarez, Elena] Govt, Madrid, Spain; [Alvis-Guzman, Nelson] Univ Cartagena, Cartagena De Indias, Colombia; [Amare, Azmeraw T.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Hoek, Hans W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Amare, Azmeraw T.] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Ameh, Emmanuel A.] Ahmadu Bello Univ, Zaria, Nigeria; [Amini, Heresh] Kurdistan Univ Med Sci, Kurdistan Environm Hlth Res Ctr, Sanandaj, Iran; [Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon; [Anderson, H. Ross] Univ London, St Georges, London, England; [Antonio, Carl Abelardo T.] Univ Philippines Manila, Coll Publ Hlth, Dept Hlth Policy & Adm, Manila, Philippines; [Panelo, Carlo Irwin A.] Univ Philippines Manila, Manila, Philippines; [Arnlov, Johan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Arnlov, Johan] Dalarna Univ, Falun, Sweden; [Arsenijevic, Valentina S. Arsic] Univ Belgrade, Inst Microbiol & Immunol, Sch Med, Belgrade, Serbia; [Arsenijevic, Valentina S. Arsic] Univ Childrens Hosp Belgrade, Belgrade, Serbia; [Asghar, Rana J.] South Asian Publ Hlth Forum, Islamabad, Pakistan; [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Iran; [Atkins, Lydia S.] Minist Hlth, Wellness Human Serv & Gender Relat, St Lucia, Qld, Australia; [Avila, Marco A.; Barquera, Simon; Campos-Nonato, Ismael R.; Cuevas-Nasu, Lucia; Gomez Dantes, Hector; Gonzalez-Medina, Diego; Heredia-Pi, Ileana B.; Lozano, Rafael; Montanez Hernandez, Julio C.; Servan-Mori, Edson E.; Levy, Teresa Shamah] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Awuah, Baffour] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada; [Bahit, Maria C.] INECO Neurociencias, Rosario, Argentina; [Balakrishnan, Kalpana] Sri Ramachandra Univ, Madras, Tamil Nadu, India; [Banerjee, Amitava] Univ Birmingham, Birmingham, W Midlands, England; [Barker-Collo, Suzanne L.] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [Del Pozo-Cruz, Borja] Univ Auckland, Auckland 1, New Zealand; [Barregard, Lars] Univ Gothenburg, Dept Occupat & Environm Hlth, Gothenburg, Sweden; [Barrero, Lope H.] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia; [Basu, Arindam] Univ Canterbury, Sch Hlth Sci, Christchurch 1, New Zealand; [Gaffikin, Lynne] Stanford Univ, Sch Med, Stanford, CA USA; [Basu, Sanjay] Stanford Univ, Stanford, CA 94305 USA; [Beardsley, Justin] Univ Oxford, Ho Chi Minh City, Vietnam; [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia; [Beghi, Ettore; Cortinovis, Monica; Giussani, Giorgia] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy; [Bekele, Tolesa] Madawalabu Univ, Bale Goba, Ethiopia; [Bell, Michelle L.; Huang, John J.] Yale Univ, New Haven, CT USA; [Benjet, Corina; Gutierrez, Reyna A.] Natl Inst Psychiat Ramon Fuente Muniz, Mexico City, DF, Mexico; [Bensenor, Isabela M.; Kemp, Andrew H.; Lotufo, Paulo A.; Santos, Itamar S.] Univ Sao Paulo, Sao Paulo, Brazil; [Benzian, Habib] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY USA; [Thurston, George D.] NYU, Sch Med, Nelson Inst Environm Med, New York, NY USA; [Hagan, Holly] NYU, New York, NY USA; [Bernabe, Eduardo; Hay, Roderick J.; Wolfe, Charles D.] Kings Coll London, London, England; [Deribe, Kebede] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Beyene, Tariku J.; Mekonnen, Wubegzier] Univ Addis Ababa, Addis Ababa, Ethiopia; [Bhala, Neeraj] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Bhala, Neeraj] Univ Otago, Sch Med, Dunedin, New Zealand; [Bhalla, Ashish; Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Bhutta, Zulfiqar A.] Aga Khan Univ, Med Ctr, Karachi, Pakistan; [Nisar, Muhammad I.] Aga Khan Univ, Karachi, Pakistan; [Bikbov, Boris] AI Evdokimov Moscow State Univ Med & Dent, Moscow, Russia; [Bikbov, Boris] Acad VI Shumakov Fed Res Ctr Transplantol & Artif, Moscow, Russia; [Driscoll, Tim R.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Blyth, Fiona M.; Kemp, Andrew H.; Leigh, James] Univ Sydney, Sydney, NSW 2006, Australia; [Basara, Berrak Bora; Yentur, Goekalp K.] Minist Hlth, Gen Directorate Hlth Res, Ankara, Turkey; [Uzun, Selen B.] Minist Hlth, Ankara, Turkey; [Bornstein, Natan M.] Tel Aviv Saurasky Med Ctr, Tel Aviv, Israel; [Bose, Dipan] World Bank, Washington, DC 20433 USA; [Boufous, Soufiane] Univ New S Wales, Transport & Rd Safety TARS Res, Kensington, NSW 2033, Australia; [Resnikoff, Serge] Univ New S Wales, BHVI, Kensington, NSW 2033, Australia; [Degenhardt, Louisa; Mitchell, Philip B.] Univ New S Wales, Kensington, NSW 2033, Australia; [Bourne, Rupert R. A.] Anglia Ruskin Univ, Cambridge, England; [Boyers, Lindsay N.] Georgetown Univ, Washington, DC USA; [Brainin, Michael] Danube Univ Krems, Krems, Austria; [Brayne, Carol E.] Cambridge Inst Publ Hlth, Cambridge, England; [Brazinova, Alexandra] Trnava Univ, Fac Hlth Sci & Social Work, Trnava, Slovakia; [Majdan, Marek] Trnava Univ, Dept Publ Hlth, Trnava, Slovakia; [Breitborde, Nicholas J. K.] Ohio State Univ, Columbus, OH 43210 USA; [Breitborde, Nicholas J. K.] Univ Arizona, Tucson, AZ USA; [Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Buchbinder, Rachelle] Cabrini Inst, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Lloyd, Belinda K.] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic 3004, Australia; [Gabbe, Belinda; Gibney, Katherine B.; Thrift, Amanda G.] Monash Univ, Melbourne, Vic 3004, Australia; [Buckle, Geoffrey C.; Gosselin, Richard A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Budke, Christine M.] Texas A&M Univ, College Stn, TX USA; [Bulloch, Andrew G.; Patten, Scott B.; Tonelli, Marcello; Wang, Jianli] Univ Calgary, Calgary, AB, Canada; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Carapetis, Jonathan R.] Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Cardenas, Rosario] Univ Autonoma Metropolitana, Mexico City, DF, Mexico; [Carpenter, David O.] SUNY Albany, Albany, NY 12222 USA; [Caso, Valeria] Univ Perugia, I-06100 Perugia, Italy; [Castaneda-Orjuela, Carlos A.] Colombian Natl Hlth Observ, Bogota, Colombia; [Castaneda-Orjuela, Carlos A.] Univ Nacl Colombia, Dept Publ Hlth, Epidemiol & Publ Hlth Evaluat Grp, Bogota, Colombia; [Castro, Ruben E.] Univ Diego Portales, Santiago, Chile; [Catala-Lopez, Ferran] Spanish Med & Healthcare Prod Agcy AEMPS, Minist Hlth, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain; [Catala-Lopez, Ferran] Univ Valencia, Dept Med, CIBERSAM, Valencia, Spain; [Chadha, Vineet K.] Natl TB Inst, Bengaluru, India; [Chang, Jung-Chen] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Hoy, Damian G.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Knibbs, Luke D.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Scott, James G.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Charlson, Fiona J.; Erskine, Holly E.; Ferrari, Alize J.; Gouda, Hebe N.; Mcgrath, John J.; Whiteford, Harvey A.] Univ Queensland, Brisbane, Qld, Australia; [Chen, Honglei] NIEHS, Div Intramural Res, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Jiang, Ying] Univ Occupat & Environm Hlth, Dept Hlth Dev, Kitakyushu, Fukuoka 807, Japan; [Jiang, Ying; Takahashi, Ken] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan; [Chimed-Ochir, Odgerel; Jiang, Ying; Takahashi, Ken] Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan; [Chowdhury, Rajiv; Murray, Joseph] Univ Cambridge, Cambridge, England; [Christensen, Hanne] Bispebjerg Hosp, Copenhagen, Denmark; [Christophi, Costas A.] Cyprus Univ Technol, Limassol, Cyprus; [Cirillo, Massimo] Univ Salerno, I-84081 Baronissi, Italy; [Colistro, Valentina] Univ Republica, Montevideo, Uruguay; [Colistro, Valentina] Minist Salud Publ, Montevideo, Uruguay; [Colquhoun, Samantha M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Criqui, Michael H.; Jassal, Simerjot K.; Stein, Murray B.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Cooper, Leslie T.] Mayo Clin, Rochester, MN USA; [Coppola, Luis M.] Hosp Municipal Ramon Santamarina, Tandil, Argentina; [Crump, John A.] Univ Otago, Dunedin Sch Med, Ctr Int Hlth, Dunedin, New Zealand; [Derrett, Sarah] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; [Poulton, Richie G.] Univ Otago, Dunedin, New Zealand; [Derrett, Sarah] Massey Univ, Coll Hlth, Sch Publ Hlth, Palmerston North, New Zealand; [Danawi, Hadi] Walden Univ, Minneapolis, MN USA; [Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil; Murthy, Kinnari S.; Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England; [Davey, Gail] Wellcome Trust Brighton, Brighton, E Sussex, England; [Davey, Gail] Sussex Ctr Global Hlth Res, Brighton, E Sussex, England; [Davis, Adrian; Fay, Derek F.] Publ Hlth England, London, England; [Davitoiu, Dragos V.] Univ Med & Pharm Bucharest, Bucharest, Romania; [Dayama, Anand] Jacobi Med Ctr, Dept Surg, Atlanta, GA USA; [Lalloo, Ratilal] Griffith Univ, Sch Dent & Oral Hlth, Brisbane, Qld 4111, Australia; [De Leo, Diego] Griffith Univ, Brisbane, Qld 4111, Australia; [Dellavalle, Robert P.] Eastern Colorado Healthcare Syst, US Dept Vet Affairs, Denver, CO USA; [Deribe, Kebede] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Des Jarlais, Don C.] Mt Sinai Beth Israel, New York, NY USA; [Des Jarlais, Don C.] Icahn Sch Med Mt Sinai, New York, NY USA; [Dessalegn, Muluken] Africa Med & Res Fdn Ethiopia, Addis Ababa, Ethiopia; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Lunevicius, Raimundas] Univ Liverpool, Sch Med, Liverpool L69 3BX, Merseyside, England; [Dherani, Mukesh K.; Pope, Daniel] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Dokova, Klara] Med Univ Varna, Fac Publ Hlth, Dept Social Med, Varna, Bulgaria; [Dorsey, E. Ray] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Edmond, Karen M.; Hankey, Graeme J.] Univ Western Australia, Perth, WA 6009, Australia; [Elshrek, Yousef M.] Univ Tripoli, Fac Agr, Dept Food Sci, Tripoli, Libya; [Ermakov, Sergey P.] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia; [Ermakov, Sergey P.] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Moscow, Russia; [Eshrati, Babak] Arak Univ Med Sci & Hlth Affairs, Arak, Iran; [Esteghamati, Alireza; Farzadfar, Farshad; Hafezi-Nejad, Nima; Sheikhbahaei, Sara] Univ Tehran Med Sci, Communicable Dis Res Ctr, Endocrinol & Metab Res Inst, Tehran, Iran; [Heydarpour, Pouria; Sahraian, Mohammad Ali] Univ Tehran Med Sci, Multiple Sclerosis Res Ctr, Neurosci Inst, Tehran, Iran; [Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Faraon, Emerito Jose A.] UP Coll Publ Hlth, DHPA, Manila, Philippines; [Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Te Ao, Braden J.] Auckland Univ Technol, Auckland, New Zealand; [Felson, David T.] Boston Univ, Boston, MA 02215 USA; [Fernandes, Jefferson G.] German Hosp Oswaldo Cruz, Inst Educ & Sci, Sao Paulo, Brazil; [Foigt, Nataliya] Acad Med Sci, Inst Gerontol, Kiev, Ukraine; [Fowkes, F. Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Franklin, Richard C.] James Cook Univ, Townsville, Qld 4811, Australia; [Gankpe, Fortune G.] Leras Afrique, Cotonou, Benin; [Gankpe, Fortune G.] CHU Hassan II, Fes, Morocco; [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Giroud, Maurice] Univ Hosp Dijon, Dijon, France; [Gona, Philimon] Univ Massachusetts, Boston, MA 02125 USA; [Pourmalek, Farshad] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Gotay, Carolyn C.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Goto, Atsushi] Tokyo Womens Med Univ, Dept Publ Hlth, Tokyo, Japan; [Gugnani, Harish C.] St James Sch Med, Kralendijk, Netherlands; [Gupta, Rahul] West Virginia Bur Publ Hlth, Charleston, WV USA; [Gupta, Rajeev] Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Halasa, Yara A.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Hamadeh, Randah R.] Arabian Gulf Univ, Manama, Bahrain; [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Detroit, MI USA; [Hao, Yuantao] Sun Yae Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Zheng, Yingfeng] Sun Yae Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China; [Maria Haro, Josep] Parc Sanitari St Joan Deu CIBERSAM, Barcelona, Spain; [Maria Haro, Josep] Univ Barcelona, Barcelona, Spain; [Hay, Roderick J.] Int Fdn Dermatol, London, England; [Hijar, Martha] Fdn Entornos AC, Cuernavaca, Morelos, Mexico; [Hoek, Hans W.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Moran, Andrew E.] Columbia Univ, New York, NY USA; [Hoffman, Howard J.] Natl Inst Deafness & Other Commun Disorders, Epidemiol & Stat Program, NIH, Bethesda, MD USA; [Mensah, George A.] NHLBI, Ctr Translat Res & Implementat Sci, NIH, Bethesda, MD 20892 USA; [Sampson, Uchechukwu K. A.] NHLBI, NIH, Bethesda, MD 20892 USA; [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Hossain, Mazeda; Mckee, Martin; Pearce, Neil; Pullan, Rachel L.; Tillmann, Taavi] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Hotez, Peter J.] Baylor Coll Med, Houston, TX 77030 USA; [Hoy, Damian G.] Secretariat Pacific Community, Publ Hlth Div, Noumea, New Caledonia; [Hsairi, Mohamed] Natl Inst Publ Hlth, Tunis, Tunisia; [Hu, Guoqing] Cent S Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Huang, Cheng] George Washington Univ, Washington, DC USA; [Husseini, Abdullatif] Qatar Univ, Doha, Qatar; [Iburg, Kim M.] Aarhus Univ, Aarhus, Denmark; [Innos, Kaire] Natl Inst Hlth Dev, Tallinn, Estonia; [Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan; [Shibuya, Kenji] Univ Tokyo, Tokyo, Japan; [Islami, Farhad] Amer Canc Soc, New York, NY USA; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Jeemon, Panniyammakal; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark; [She, Jun] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Kan, Haidong] Fudan Univ, Shanghai 200433, Peoples R China; [Karch, Andre] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany; [Karch, Andre] German Ctr Infect Res DZIF, Hannover Braunschweig Site, Braunschweig, Germany; [Karema, Corine K.] Minist Hlth, Malaria & Other Parasit Dis Div, Kigali City, Rwanda; [Karimkhani, Chante] Case Western Univ Hosp, Cleveland, OH USA; [Karthikeyan, Ganesan; Paul, Vinod K.; Satpathy, Maheswar; Tandon, Nikhil] All India Inst Med Sci, New Delhi, India; [Kaul, Anil] Oklahoma State Univ, Tulsa, OK USA; [Kazanjan, Konstantin] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Kengne, Andre P.; Matzopoulos, Richard; Msemburi, William T.; Stein, Dan J.] South African Med Res Council, Cape Town, South Africa; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa; [Matzopoulos, Richard] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Kengne, Andre P.; Mayosi, Bongani M.; Stein, Dan J.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Keren, Andre] Hadassah Kerem Univ Hosp, Cardiol, Jerusalem, Israel; [Khader, Yousef S.] Jordan Univ Sci & Technol, Irbid, Jordan; [Khalifa, Shams Eldin A.] Supreme Council Hlth, Doha, Qatar; [Khan, Ejaz A.] Hlth Serv Acad, Islamabad, Pakistan; [Khan, Ejaz A.] Expanded Programme Immunizat, Islamabad, Pakistan; [Khan, Gulfaraz] UAE Univ, Al Ain, U Arab Emirates; [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kieling, Christian] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Kim, Daniel] Northeastern Univ, Boston, MA 02115 USA; [Kim, Sungroul] Soonchunhyang Univ, Seoul, South Korea; [Kim, Yunjin] Southern Univ Coll, Johor Baharu, Malaysia; [Kinfu, Yohannes] Univ Canberra, Canberra, ACT 2601, Australia; [Knudsen, Ann Kristin] Norwegian Inst Publ Hlth, Dept Hlth Registries, Oslo, Norway; [Kinge, Jonas M.; Skirbekk, Vegard; Vollset, Stein Emil] Norwegian Inst Publ Hlth, Oslo, Norway; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Kosen, Soewarta] NIHRD, Ctr Community Empowerment Hlth Policy & Humanitie, Jakarta, Indonesia; [Krishnaswami, Sanjay; Zonies, David] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada; [Kuipers, Ernst J.; Polinder, Suzanne; Richardus, Jan Hendrik] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands; [Kulkarni, Chanda] Rajrajeswari Med Coll & Hosp, Bangalore, Karnataka, India; [Kulkarni, Veena S.] Arkansas State Univ, Jonesboro, AR USA; [Lai, Taavi] Fourth View Consulting, Tallinn, Estonia; [Lalloo, Ratilal] Univ Adelaide, Sch Dent, Australian Res Ctr Populat Oral Hlth, Adelaide, SA, Australia; [Lallukka, Tea] Finnish Inst Occupat Hlth, Disabil Prevent Res Ctr, Helsinki, Finland; [Shiri, Rahman] Finnish Inst Occupat Hlth, Helsinki, Finland; [Lallukka, Tea] Univ Helsinki, Fac Med, Helsinki, Finland; [Lam, Hilton] Natl Inst Hlth, Inst Hlth Policy & Dev Studies, Manila, Philippines; [Lan, Qing] NCI, Rockville, MD USA; [Lansingh, Van C.] Help Me See Inc, New York, NY USA; [Lansingh, Van C.] Inst Mexicano Oftalmol, Queretaro, Mexico; [Larsson, Anders] Uppsala Univ, Uppsala, Sweden; [Lawrynowicz, Alicia E. B.] Inst Nacl Epidemiol Dr Juan H Jara, Mar Del Plata, Buenos Aires, Argentina; [Leasher, Janet L.] Nova SE Univ, Coll Optometry, Ft Lauderdale, FL 33314 USA; [Leung, Ricky] SUNY Albany, Rensselaer, NY USA; [Li, Bin] Jinan Cent Hosp, Jinan, Peoples R China; [Duan, Leilei; Li, Yichong; Liu, Shiwei; Wang, Linhong; Ye, Pengpeng] China CDC, Natl Ctr Chron & Noncommunible Dis Control Preven, Beijing, Peoples R China; [Li, Yichong] Anolinx LLC, Salt Lake City, UT USA; [Lipshultz, Steven E.] Wayne State Univ, Miami, FL USA; [Simard, Edgar P.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Liu, Yang; Narayan, K. M. Venkat] Emory Univ, Atlanta, GA 30322 USA; [Lloyd, Belinda K.] Eastern Hlth, Turning Point, Melbourne, Vic, Australia; [Logroscino, Giancarlo] Univ Bari, Bari, Italy; [Looker, Katharine J.] Univ Bristol, Bristol, Avon, England; [Lortet-Tieulent, Joannie] Amer Canc Soc, Atlanta, GA 30329 USA; [Lucas, Robyn M.] Australian Natl Univ, Canberra, ACT, Australia; [Lunevicius, Raimundas] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Lyons, Ronan A.] Swansea Univ, Swansea, W Glam, Wales; [Ma, Stefan] Minist Hlth Singapore, Singapore, Singapore; [Ma, Stefan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Weintraub, Robert G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Mackay, Mark T.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Malekzadeh, Reza] Shariati Hosp, Digest Dis Reseach Inst, Tehran, Iran; [Malekzadeh, Reza] Shiraz Univ Med Scinces, Shiraz, Iran; [Marcenes, Wagner] Queen Mary Univ London, London, England; [Meaney, Peter A.] Univ Penn, Pereleman Sch Med, Philadelphia, PA 19104 USA; [Margolis, David J.; Silberberg, Donald H.] Univ Penn, Philadelphia, PA 19104 USA; [Marzan, Melvin B.] Univ East Ramon Magsaysay Mem, Med Ctr, Quezon City, Philippines; [Masci, Joseph R.] Elmhurst Hosp Ctr, Mt Sinai Serv, Elmhurst, NY USA; [Mashal, Mohammad T.] Minist Publ Hlth, Kabul, Afghanistan; [Mazorodze, Tasara T.] AIDC EC, Port Elizabeth, South Africa; [Mcgill, Neil W.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Meaney, Peter A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Mehndiratta, Man Mohan] Janakpuri Superspecialty Hosp, New Delhi, India; [Melaku, Yohannes A.] Mekelle Univ, Mekelle, Ethiopia; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Memish, Ziad A.] Saudi Minist Hlth, Riyadh, Saudi Arabia; [Meretoja, Atte] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Mhimbira, Francis A.] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth, Perth, WA 6845, Australia; [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada; [Ibrahim, Norlinah Mohamed] Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Bandar Tun Razak, Malaysia; [Mohammad, Karzan A.] Univ Salahaddin, Erbil, Iraq; [Mola, Glen L. D.] Univ Papua New Guinea, Boroko, Papua N Guinea; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Moore, Ami R.] Univ N Texas, Denton, TX 76203 USA; [Moradi-Lakeh, Maziar] Iran Univ Med Sci, Dept Community Med, Tehran, Iran; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan; [Tsilimbaris, Miltiadis] Univ Crete, Dept Med, Iraklion, Greece; [Moschandreas, Joanna] Univ Crete, Iraklion, Greece; [Moturi, Wilkister N.] Egerton Univ, Egerton, Kenya; [Mueller, Ulrich O.] Univ Marburg, Marburg, Germany; [Mukaigawara, Mitsuru] Okinawa Chubu Hosp, Okinawa, Japan; [Murdoch, Michele E.] West Herts Hosp NHS Trust, Watford, England; [Naidoo, Kovin S.] Univ KwaZulu Natal, Durban, South Africa; [Naldi, Luigi] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy; [Nand, Devina] Minist Hlth, Suva, Fiji; [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India; [Nejjari, Chakib] Fac Med, Fes, Morocco; [Neupane, Sudan P.] Univ Oslo, Oslo, Norway; [Ngalesoni, Frida N.] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Nolte, Sandra; Papachristou, Christina] Charite, D-13353 Berlin, Germany; [Nolte, Sandra] Deakin Univ, Melbourne, Vic, Australia; [Vollset, Stein Emil] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Norheim, Ole F.] Univ Bergen, Bergen, Norway; [Norman, Rosana E.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Norrving, Bo] Lund Univ, Dept Clin Sci, Lund, Sweden; [Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda; [Oh, In-Hwan] Kyung Hee Univ, Seoul, South Korea; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Tokyo 173, Japan; [Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Ikoyi, Nigeria; [Opio, John Nelson] Lira Municipal Council, Lira Dist Local Govt, Lira, Uganda; [Ortiz, Alberto] IIS Fdn Jimenez Diaz, Madrid, Spain; [Pandian, Jeyaraj D.] Christian Med Coll Ludhiana, Ludhiana, Punjab, India; [Park, Eun-Kee] Kosin Univ, Coll Med, Busan, South Korea; [Park, Jae-Hyun] Sungkyunkwan Univ, Sch Med, Suwon, South Korea; [Pereira, David M.] Univ Porto, Fac Farm, Dept Quim, REQUIMTE LAQV,Lab Farmacognosia, P-4100 Oporto, Portugal; [Perez-Padilla, Rogelio] Natl Inst Resp Dis, Mexico City, DF, Mexico; [Perez-Ruiz, Fernando] Hopsital Univ Cruces, OSI EE Cruces, Baracaldo, Spain; [Perez-Ruiz, Fernando] Biocruces Hlth Res Inst, Baracaldo, Spain; [Perico, Norberto; Trillini, Matias] Mario Negri Inst Pharmacol Res, Ranica, Italy; [Pervaiz, Aslam] Postgrad Med Inst, Lahore, Pakistan; [Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Peterson, Carrie B.] Aalborg Univ, Aalborg Esst, Denmark; [Petzold, Max] Hlth Metr Unit, Gothenburg, Sweden; [Petzold, Max] Univ Witwatersrand, Johannesburg, South Africa; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Phillips, Michael R.] Emory Univ, Atlanta, GA 30322 USA; [Plass, Dietrich] Fed Environm Agcy, Sect Exposure Assessment & Environm Hlth Indicato, Berlin, Germany; [Poenaru, Dan] McGill Univ, Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada; [Poenaru, Dan] MyungSung Med Coll, Addis Ababa, Ethiopia; [Popova, Svetlana] Ctr Addict & Mental Hlth CAMH, Toronto, ON, Canada; [Prasad, Noela M.] Fred Hollows Fdn, Sydney, NSW, Australia; [Qato, Dima M.] Univ Illinois, Chicago, IL USA; [Rafay, Anwar; Rana, Saleem M.] Contech Int Hlth Consultants, Lahore, Pakistan; [Rahman, Sajjad U.] Hamad Med Corp, Doha, Qatar; [Raju, Murugesan] Univ Missouri, Columbia, MO USA; [Rafay, Anwar; Rana, Saleem M.] Contech Sch Publ Hlth, Lahore, Pakistan; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Refaat, Amany] Suez Canal Univ, Ismailia, Egypt; [Remuzzi, Giuseppe] IRCCS Mario Negri Inst Pharmacol Res, Centro Anna Maria Astori, Bergamo, Italy; [Resnikoff, Serge] Int Hlth & Dev, Geneva, Switzerland; [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [Rojas-Rueda, David] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Rothstein, David H.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Roy, Nobhojit] HBNI Univ, BARC Hosp, Bombay, Maharashtra, India; [Ruhago, George M.; Sunguya, Bruno F.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Saha, Sukanta] Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Brisbane, Qld, Australia; [Sanabria, Juan R.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Sanabria, Juan R.] Chicago Med Sch, Canc Treatment Ctr Amer RFU, N Chicago, IL USA; [Sawhney, Monika] Marshall Univ, Huntington, WV USA; [Schneider, Ione J.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Seedat, Soraya] Univ Stellenbosch, Cape Town, South Africa; [Shaheen, Amira] An Najah Univ, Nablus, Israel; [Shahraz, Saeid] Tufts Med Ctr, Boston, MA USA; [Shangguan, Siyi] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Shinohara, Yukito] Tachikawa Hosp, Tokyo, Japan; [Shiri, Rahman] Finnish Inst Occupat Hlth, Helsinki, Finland; [Shishani, Kawkab] Washington State Univ, Spokane, WA USA; [Shiue, Ivy] Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Shiue, Ivy] Univ Edinburgh, Alzheimers Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Sigfusdottir, Inga D.] Reykjavik Univ, Reykjavik, Iceland; [Singh, Abhishek] Int Inst Populat Sci, Bombay, Maharashtra, India; [Soneji, Samir] Dartmouth Coll, Lebanon, NH 03756 USA; [Soreide, Kjetil] Stavanger Univ Hosp, Stavanger, Norway; [Soshnikov, Sergey] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Moscow, Russia; [Sposato, Luciano A.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Kajang, Cheras, Malaysia; [Stathopoulou, Vasiliki] Attikon Univ Hosp, Athens, Greece; [Stovner, Lars J.] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Steiner, Timothy J.] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Stovner, Lars J.] St Olavs Hosp, Norwegian Advisory Unit Headache, Trondheim, Norway; [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, Athens, Greece; [Stroumpoulis, Konstantinos] Ctr Hosp Publ Cotentin, Cherbourg, France; [Swaminathan, Soumya] Natl Inst Res TB, Madras, Tamil Nadu, India; [Swaroop, Mamta; Yano, Yuichiro] Northwestern Univ, Chicago, IL 60611 USA; [Sykes, Bryan L.] Univ Calif Irvine, Irvine, CA USA; [Tabb, Karen M.] Univ Illinois, Champaign, IL USA; [Tanne, David] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Tanne, David] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Tavakkoli, Mohammad] Westchester Med Ctr, Valhalla, NY USA; [Ten Have, Margreet] Netherlands Inst Mental Hlth & Addict, Utrecht, Netherlands; [Tenkorang, Eric Y.] Mem Univ Newfoundland, St John, NF, Canada; [Terkawi, Abdullah S.] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA; [Terkawi, Abdullah S.] Outcomes Res Consortium, Cleveland, OH USA; [Terkawi, Abdullah S.] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia; [Thorne-Lyman, Andrew L.] WorldFish, George Town, Malaysia; [Topouzis, Fotis] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece; [Toyoshima, Hideaki] Anjo Kosei Hosp, Hlth Care Ctr, Anjo City, Japan; [Traebert, Jefferson] Univ Southern Santa Catarina, Palhoca, Brazil; [Tran, Bach X.] Johns Hopkins Univ, Baltimore, MD USA; [Tran, Bach X.] Hanoi Med Univ, Hanoi 100803, Vietnam; [Truelsen, Thomas] Univ Copenhagen, Rigshosp, Dept Neurol, DK-2100 Copenhagen, Denmark; [Tuzcu, Emin M.] Cleveland Clin, Cleveland, OH 44106 USA; [Uchendu, Uche S.] Dept Vet Affairs, Washington, DC USA; [Ukwaja, Kingsley N.] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Nigeria; [Van Brakel, Wim H.] Netherlands Leprosy Relief, Amsterdam, Netherlands; [Van De Vijver, Steven] African Populat & Hlth Res Ctr, Nariobi, Kenya; [van Gool, Coen H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Van Os, Jim] Maastricht Univ, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Vasankari, Tommi J.] UKK Inst Hlth Promot Res, Tampere, Finland; [Venketasubramanian, N.] Raffles Hosp, Neurosci Ctr, Singapore, Singapore; [Violante, Francesco S.] Univ Bologna, Bologna, Italy; [Vlassov, Vasiliy V.] Higher Sch Econ, Moscow, Russia; [Wagner, Gregory R.] Natl Inst Occupat Safety & Hlth, Washington, DC USA; [Waller, Stephen G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Chen, Wanqing] Chinese Acad Med Sci, Inst Canc, Beijing 100021, Peoples R China; [Warouw, Tati S.] Minist Hlth Indonesia, NIHRD, Jakarta, Indonesia; [Weichenthal, Scott] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Wang Wenzhi] Beijing Neurosurg Inst, Beijing, Peoples R China; [Werdecker, Andrea] Inst Med Sociol & Social Med, Marburg, Germany; [Westerman, Ronny] Fed Inst Populat Res, Wiesbaden, Germany; [Westerman, Ronny] German Natl Cohort Consortium, Heidelberg, Germany; [Wilkinson, James D.] Wayne State Univ, Detroit, MI USA; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Xu, Gelin] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Lijing L.] Duke Kunshan Univ, Kunshan, Peoples R China; [Yano, Yuichiro] Jichi Med Sch, Simotsuke, Tochigi, Japan; [Yip, Paul] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan; [Yoon, Seok-Jun] Korea Univ, Seoul, South Korea; [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA; [Yu, Chuanhua] Sch Publ Hlth, Wuhan, Peoples R China; [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Peoples R China; [Zaki, Maysaa El Sayed] Mansoura Fac Med, Mansoura, Egypt; [Zhao, Yong] Chongqing Med Univ, Chongqing, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Imperial College London; Imperial College London; Hacettepe University; Hacettepe University; Egyptian Knowledge Bank (EKB); Cairo University; Mekelle University; CHU Limoges; University of Southern California; Harvard University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of London; University College London; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Birzeit University; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Universidad de Extremadura; Tufts University; Tufts University; International Centre for Diarrhoeal Disease Research (ICDDR); Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Oxford; University of Oxford; Universite de Lorraine; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Ministry of Health - Saudi Arabia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universidad de Cartagena; University of Groningen; University of Groningen; Bahir Dar University; Ahmadu Bello University; Kurdistan University of Medical Sciences; University of London; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; Uppsala University; Dalarna University; University of Belgrade; Mashhad University Medical Science; Instituto Nacional de Salud Publica; Kwame Nkrumah University Science & Technology; Public Health Agency of Canada; Sri Ramachandra Institute of Higher Education & Research; University of Birmingham; University of Auckland; University of Auckland; University of Gothenburg; Pontificia Universidad Javeriana; Stanford University; Stanford University; University of Oxford; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Yale University; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Universidade de Sao Paulo; New York University; New York University; New York University; University of London; King's College London; Addis Ababa University; Addis Ababa University; University of Birmingham; University of Otago; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Aga Khan University; Aga Khan University; Moscow State University of Medicine & Dentistry; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; University of Sydney; University of Sydney; Ministry of Health - Turkey; Ministry of Health - Turkey; Tel Aviv University; Sackler Faculty of Medicine; The World Bank; University of New South Wales Sydney; Brien Holden Vision Institute; University of New South Wales Sydney; University of New South Wales Sydney; Anglia Ruskin University; Georgetown University; Danube University Krems; University of Cambridge; University of Trnava; University of Trnava; University System of Ohio; Ohio State University; University of Arizona; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Leicester; Cabrini Health; Monash University; Monash University; Monash University; Monash University; University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University College Station; University of Calgary; University of Oklahoma System; University of Oklahoma Health Sciences Center; Telethon Kids Institute; University of Western Australia; Universidad Autonoma Metropolitana - Mexico; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Perugia; Universidad Nacional de Colombia; University Diego Portales; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia; National Taiwan University; University of Queensland; University of Queensland; University of Queensland; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Cambridge; University of Copenhagen; Bispebjerg Hospital; Cyprus University of Technology; University of Salerno; Universidad de la Republica, Uruguay; Murdoch Children's Research Institute; University of Southampton; University of California System; University of California San Diego; Mayo Clinic; University of Otago; University of Otago; University of Otago; Massey University; Walden University; Public Health Foundation of India; Guy's & St Thomas' NHS Foundation Trust; Public Health England; Carol Davila University of Medicine & Pharmacy; Griffith University; Griffith University; US Department of Veterans Affairs; University of Brighton; University of Sussex; Icahn School of Medicine at Mount Sinai; African Medical & Research Foundation (AMREF); University of Peradeniya; University of Liverpool; University of Liverpool; Hospital of Santa Creu i Sant Pau; Medical University Varna; University of Rochester; University of Western Australia; Russian Academy of Sciences; Federal Center of Theoretical & Applied Sociology - FCTAS; Institute of Social & Economic Studies of Population; Ministry of Health of the Russian Federation; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of the Philippines System; University of the Philippines Manila; Auckland University of Technology; Auckland University of Technology; Boston University; National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine; University of Edinburgh; James Cook University; Hassan II University Hospital Center of Fez; Wageningen University & Research; Agence de Medecine Preventive; CHU Dijon Bourgogne; University of Massachusetts System; University of Massachusetts Boston; University of British Columbia; University of British Columbia; Tokyo Women's Medical University; Fortis Escorts Hospital; Brandeis University; Arabian Gulf University; Sun Yat Sen University; Sun Yat Sen University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Yeshiva University; Albert Einstein College of Medicine; University of London; London School of Hygiene & Tropical Medicine; Baylor College of Medicine; Central South University; George Washington University; Qatar University; Aarhus University; National Institute for Health Development - Estonia; University of Tokyo; University of Tokyo; University of Tokyo; American Cancer Society; George Mason University; Yonsei University; Yonsei University Health System; Tianjin Center for Disease Control & Prevention; Ruprecht Karls University Heidelberg; Fudan University; Fudan University; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Case Western Reserve University; Case Western Reserve University Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; National Center for Disease Control & Public Health - Georgia; South African Medical Research Council; University of Cape Town; University of Cape Town; University of Cape Town; Jordan University of Science & Technology; Health Services Academy; United Arab Emirates University; Seoul National University (SNU); Universidade Federal do Rio Grande do Sul; Northeastern University; Soonchunhyang University; University of Canberra; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); National Cerebral & Cardiovascular Center - Japan; National Institute of Health Research & Development (NIHRD); Oregon Health & Science University; Universite de Montreal; Erasmus University Rotterdam; Erasmus MC; Arkansas State University; University of Adelaide; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uppsala University; Nova Southeastern University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Shandong First Medical University & Shandong Academy of Medical Sciences; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Emory University; Rollins School Public Health; Emory University; Turning Point Alcohol & Drug Centre - Australia; Universita degli Studi di Bari Aldo Moro; University of Bristol; American Cancer Society; Australian National University; Aintree University Hospitals NHS Foundation Trust; Swansea University; Ministry of Health-Singapore; National University of Singapore; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Tehran University of Medical Sciences; University of London; Queen Mary University London; University of Pennsylvania; University of Pennsylvania; UERM Memorial Medical Center; Icahn School of Medicine at Mount Sinai; University of Sydney; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Mekelle University; Jefferson University; University of Helsinki; Helsinki University Central Hospital; Ifakara Health Institute; Pacific Institute for Research & Evaluation (PIRE); Curtin University; University of Ottawa; Universiti Kebangsaan Malaysia; Salahaddin University; University of Papua New Guinea; IRCCS Burlo Garofolo; University of North Texas System; University of North Texas Denton; Iran University of Medical Sciences; National Center for Child Health & Development - Japan; University of Crete; University of Crete; Egerton University; Philipps University Marburg; Okinawa Chubu Central Hospital; University of Kwazulu Natal; ASST Papa Giovanni XXIII; Suraj Eye Institute; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; University of Oslo; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deakin University; University of Bergen; University of Bergen; Queensland University of Technology (QUT); Lund University; Makerere University; Kyung Hee University; Teikyo University; Fundacion Jimenez Diaz; Sungkyunkwan University (SKKU); Universidade do Porto; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Flinders University South Australia; Aalborg University; University of Witwatersrand; Shanghai Jiao Tong University; Emory University; McGill University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Hamad Medical Corporation; University of Missouri System; University of Missouri Columbia; Egyptian Knowledge Bank (EKB); Suez Canal University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Universidade Federal de Minas Gerais; Pompeu Fabra University; Ulm University; Ann & Robert H. Lurie Children's Hospital of Chicago; Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute; Muhimbili University of Health & Allied Sciences; Queensland Centre for Mental Health Research; Case Western Reserve University; Chicago Medical School; Marshall University; Universidade Federal de Santa Catarina (UFSC); University of Alabama System; University of Alabama Birmingham; Stellenbosch University; An Najah National University; Tufts Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tachikawa Hospital; Finnish Institute of Occupational Health; Washington State University; Northumbria University; University of Edinburgh; Reykjavik University; International Institute for Population Sciences; Dartmouth College; Stavanger University Hospital; Ministry of Health of the Russian Federation; Western University (University of Western Ontario); Universiti Tunku Abdul Rahman (UTAR); University Hospital Attikon; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Alexandra Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Northwestern University; University of California System; University of California Irvine; University of Illinois System; University of Illinois Urbana-Champaign; Chaim Sheba Medical Center; Tel Aviv University; Westchester Medical Center; Trimbos Institute; Memorial University Newfoundland; University of Virginia; King Fahad Medical City; CGIAR; Worldfish; Aristotle University of Thessaloniki; Universidade do Sul de Santa Catarina; Johns Hopkins University; Hanoi Medical University; Rigshospitalet; University of Copenhagen; Cleveland Clinic Foundation; African Population & Health Research Centre; Netherlands National Institute for Public Health & the Environment; Maastricht University; UKK Institute; Raffles Hospital; University of Bologna; HSE University (National Research University Higher School of Economics); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Uniformed Services University of the Health Sciences - USA; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Ministry of Health - Indonesia; National Institute of Health Research & Development (NIHRD); Health Canada; Beijing Neurosurgical Institute; Wayne State University; Royal Cornwall Hospital; Nanjing University; Duke Kunshan University; University of Hong Kong; National Center for Neurology & Psychiatry - Japan; Korea University; Jackson State University; Wuhan University; Egyptian Knowledge Bank (EKB); Mansoura University; Chongqing Medical University	Murray, CJL (corresponding author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.		Chowdhury, Rajiv/AHB-1253-2022; Zheng, Yingfeng/CAE-9225-2022; Ermakov, Sergey/G-1709-2016; Kim, Yun Jin/AAE-8281-2019; Bensenor, Isabela Judith Martins/L-3306-2017; Pandian, Jeyaraj Durai/AAV-5591-2020; Alsharif, Ubai/C-6527-2017; Lalloo, Ratilal/O-5624-2014; Zaki, Maysaa El Sayed/C-1522-2013; Kieling, Christian/U-3905-2019; Fra.Paleo, Urbano/B-8088-2016; wang, lili/HDL-7210-2022; Tediosi, Fabrizio/AAD-4805-2022; Marzan, Melvin/AAP-8443-2020; Alvarez, Elena/S-1068-2019; Alvis-Guzman, Nelson/D-4913-2013; KUMAR, ANIL/ACD-8340-2022; Ding, Eric L./K-1118-2019; Bennett, Derrick/AFL-9254-2022; Narayan, K.M. Venkat/J-9819-2012; Mukaigawara, Mitsuru/L-2144-2016; Bennett, Derrick/AAH-1220-2022; Nyakarahuka, Luke/W-8164-2019; Balakrishnan, Kalpana/B-6653-2015; Bedi, Neeraj/AGR-0606-2022; Naohiro, Yonemoto/Y-3761-2019; McGrath, John Joseph/G-5493-2010; Undurraga, Eduardo/I-3739-2014; Geleijnse, Johanna Marianna M/B-5749-2012; Naldi, Luigi/AFM-8982-2022; alla, francois/D-2295-2014; Traebert, Jefferson/R-8699-2016; Truelsen, Thomas/AAY-1549-2020; Prabhakaran, Dorairaj/B-4147-2011; CT, Sreeramareddy/I-1203-2019; Kuipers, Ernst J/H-3293-2019; Medina, Catalina/AAT-6316-2020; Davis, Adrian C/E-6022-2015; assadi, reza/AAI-1124-2021; Pesudovs, Konrad/T-9403-2019; Fahimifar, Sepideh/M-5303-2019; Defo, Barthelemy Kuate/I-4818-2017; Gething, Peter/GQR-1884-2022; Zonies, David/B-6497-2011; Satpathy, Maheswar/J-3135-2017; Tanne, David/F-2560-2010; Resnikoff, Serge/N-2355-2019; Abu-Raddad, Laith J/AAY-1441-2020; Ärnlöv, Johan/AAF-2746-2019; Bedi, Neeraj/H-2838-2019; Salomon, Joshua A/D-3898-2009; Amini, Heresh/B-3076-2010; Santos, Itamar S/K-7055-2012; Stein, Dan/A-1752-2008; Scarborough, Peter/ABD-6111-2021; Beghi, Ettore/AAA-7426-2020; Gona, Philimon/K-1477-2019; Norheim, Ole Frithjof/AAC-8771-2020; Kinfu, Yohannes/AAC-8054-2020; Carabin, Helene/B-7600-2016; Hay, Simon Iain/F-8967-2015; Melaku, Yohannes Adama/S-2451-2019; Brenner, Hermann/ABE-6383-2020; Søreide, Kjetil/A-9797-2010; Nyakarahuka, Luke/AGH-2432-2022; Richardus, Jan Hendrik/AAE-1278-2021; Singh, Jasvinder/R-6172-2019; Catalá-López, Ferrán/N-6018-2018; Deribe, Kebede/K-7055-2019; Bicer, Burcu Kucuk/G-4922-2017; Badawi, Alaa/ABC-1300-2021; Díaz-Torné, César/AAG-2419-2020; Lopez, Alan/AAA-2734-2022; Tonelli, Marcello/B-3028-2009; Gething, Peter/ABD-2110-2020; CASO, VALERIA/AAC-5156-2022; Zaki, Maysaa El Sayed/H-3049-2019; Franklin, Richard Charles/H-1731-2012; Lopez, Alan D/F-1487-2010; Trillini, Matias/ABA-7075-2020; Sepanlou, Sadaf G/H-9343-2016; Jacobsen, Kathryn H./B-5857-2008; Refaat, Amany/AAA-8470-2021; Amare, Azmeraw T./B-9487-2018; Rojas-Rueda, David/AAK-2184-2020; Buchbinder, Rachelle/G-2952-2011; Thrift, Amanda/I-6251-2012; Hamadeh, Randah R./AAE-9720-2020; Takahashi, Ken/AAX-7705-2020; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Liu, Yang/AAA-7224-2019; Khan, Prof Dr Ejaz/GNP-1245-2022; Juel, Knud/C-8916-2013; Neupane, Sudan Prasad/C-8056-2011; Brazinova, Alexandra/C-4265-2016; Matzopoulos, Richard/AAL-9965-2021; A, Naheed/AHB-2940-2022; ABBASOGLU OZGOREN, AYSE/I-8707-2013; Bose, Dipan/GRS-0467-2022; Salomon, Joshua/S-1929-2019; Charlson, Fiona J/F-5290-2011; Tillmann, Taavi/R-6026-2016; Zhao, Yong/Z-3231-2019; Lortet-Tieulent, Joannie/AAE-9099-2019; Giussani, Giorgia/E-8057-2017; Bikbov, Boris/I-4594-2013; Castro, Ruben E/J-1948-2015; Degenhardt, Louisa J/D-4515-2012; , Bennett/O-7998-2019; Kemp, Andrew Haddon/C-7984-2012; Mckee, Martin/E-6673-2018; Weiderpass, Elisabete/AAP-2747-2021; Quistberg, D Alex/P-3538-2019; Haro, Josep Maria/D-1423-2011; Perico, Norberto/ABH-3222-2020; Crump, John A./AAZ-6412-2020; van Os, Jim/C-2113-2014; Lozano, Rafael/T-5352-2018; Murray, Joseph/Z-6274-2019; ortiz, alberto/Y-7582-2018; Heydarpour, Pouria/J-7330-2019; Banerjee, Amitava/D-4381-2014; Leung, Ricky/P-3702-2015; Lotufo, Paulo/A-9843-2008; Schöttker, Ben/F-8183-2014; Aboyans, Victor/AAN-8308-2020; Memish, Ziad Ahmed/AEJ-9424-2022; Feigin, Valery/AAF-2313-2019; Terkawi, Abdullah Suleiman/AAC-1113-2019; Dokova, Klara/N-2448-2016; Knibbs, Luke/C-7865-2012; Antonio, Carl Abelardo/AAP-4280-2020; Heredia-Pi, Ileana Beatriz/L-4247-2019; Poenaru, Dan/S-2562-2017; A, Naheed/AHB-2941-2022; Ukwaja, Kingsley N./A-7794-2013; Benzian, Habib/AAN-5866-2020; Ronfani, Luca/B-6668-2013; van Os, Jim/V-8884-2019; Zheng, Yingfeng/AAE-2983-2022; Montico, Marcella/B-5290-2013; LOGROSCINO, GIANCARLO/K-5148-2016; Pereira, David/M-9286-2013; Scott, James G/D-5900-2012; Kivipelto, Miia/AAS-3557-2021; Wagner, Gregory R/B-1014-2009; Tediosi, Fabrizio/ABC-7880-2020; Patten, Scott/B-4434-2011; McKee, Marc D/E-2187-2011; Kengne, Andre Pascal/ABB-3696-2020; Brenner, Hermann/B-4627-2017; Meretoja, Atte/H-6531-2019; Naidoo, Kovin Shunmugam/AAF-5914-2020; Coffeng, Luc/AAL-6631-2021; Majdan, Marek/K-5017-2012; Karch, André/D-6973-2017; Asghar, Rana Jawad/AAF-7634-2021; Adsuar, Jose C/C-6558-2008; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; assadi, reza/AAT-6629-2020; Whiteford, Harvey A/A-4840-2009; Karthikeyan, Ganesan/D-5767-2012; Papachristou, Christina/AAR-2187-2021; Hankey, Graeme J/H-4968-2014; Foigt, Nataliya/AAU-5229-2020; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Girelli, Domenico/B-1183-2008; Charlson, Fiona/R-8963-2019; Khader, Yousef/AAE-9620-2019; Mokdad, Ali H./AAD-1232-2022; Lunevicius, Raimundas/B-2528-2018; Olusanya, Bolajoko O./F-4504-2012; Anderson, Hugh R/A-7417-2016; Malekzadeh, Reza/U-1382-2017; Deribe, Kebede/I-5422-2019; Carapetis, Jonathan R/H-8933-2014; Boothapati, Anil Kumar/HHS-1813-2022; wang, lin/HHM-2225-2022; Sposato, Luciano A/D-7782-2012; Hossain, Mazeda/AAL-3202-2020; Husseini, Abdullatif/E-8377-2015; PACELLA, ROSANA E./F-2774-2010; Ribeiro, Ana Cristina/HHN-7466-2022; Bell, Michelle/Y-4608-2018; Newton, Charles RJC/B-7578-2014; Thurston, George/ABB-1359-2021; Naldi, Luigi/K-6343-2016; Mozaffarian, Dariush/ABC-2822-2020; Crump, John A./AAZ-6289-2020; RUIZ, FERNANDO PEREZ/X-1980-2019; Rana, Saleem M/Y-9791-2018; Soshnikov, Sergey/R-7352-2016; Ortblad, Katrina/ABF-9070-2020; Khan, Gulfaraz/AAC-2859-2022; Schneider, Ione J.C./J-8762-2013; Oh, In Hwan/AAI-9070-2020; Phillips, Michael Robert/AAE-7585-2021; Schwebel, David/GXH-9944-2022; Soshnikov, Sergey/AAG-9739-2020; PEREZ-RUIZ, FERNANDO/E-4844-2012; Castañeda-Orjuela, Carlos/N-2601-2017; Bolliger, Ian W/C-4207-2016; Waller, Stephen/AAI-1787-2020; Rahimi, Kazem/AAA-4250-2022; Santos, Itamar/M-2208-2019; Soshnikov, Sergey/AAV-8566-2020; Rahimi, Kazem/Q-1279-2015; Pourmalek, Farshad/A-8188-2010; Monasta, Lorenzo/B-1388-2012; Kaul, Anil/B-2075-2016; Moradi-Lakeh, Maziar/ABC-9793-2021; Higashi, Hideki/D-3797-2011; wang, lin/GSE-3040-2022; Weiderpass, Elisabete/M-4029-2016; Nolte, Sandra/B-7498-2008; Brugha, Traolach/T-9326-2019; Li, Yichong/A-3559-2019; Ferrari, Alize J/G-1746-2011; Kan, Haidong/AGU-0328-2022; Khan, Ejaz A/B-9340-2016; Giussani, Giorgia/AAA-8029-2020; Knudsen, Ann Kristin/AAB-2465-2019; Alsharif, Ubai/AAK-2088-2021; Brayne, Carol/AAA-4285-2020; GANKPE, GBETOHO FORTUNE/GLT-4476-2022; Patton, George C/B-5246-2013; Shiri, Rahman/ABB-1780-2021; Ribeiro, Antonio L/C-2707-2009; Bernabe, Eduardo/R-3441-2017; Vlassov, Valentin/F-4720-2013; Refaat, Amany/K-5419-2016; Beyene, Tariku J/A-6875-2017; Erskine, Holly/K-5244-2012; Lansingh, Van/C-8672-2018; Remuzzi, Giuseppe/V-9766-2017; Vlassov, Vasiliy/B-4036-2014; Leasher, Janet/B-8889-2016; Davitoiu, Dragos/P-9703-2017; Cirillo, Massimo/G-5480-2018	Zheng, Yingfeng/0000-0002-0914-7864; Ermakov, Sergey/0000-0003-1072-1162; Kim, Yun Jin/0000-0001-8853-6587; Alsharif, Ubai/0000-0002-4024-3950; Lalloo, Ratilal/0000-0001-5822-1269; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Kieling, Christian/0000-0001-7691-4149; Fra.Paleo, Urbano/0000-0001-6192-7684; Tediosi, Fabrizio/0000-0001-8671-9400; Marzan, Melvin/0000-0003-2696-7335; Alvarez, Elena/0000-0002-9679-2721; Alvis-Guzman, Nelson/0000-0001-9458-864X; Ding, Eric L./0000-0002-5881-8097; Bennett, Derrick/0000-0002-9170-8447; Narayan, K.M. Venkat/0000-0001-8621-5405; Mukaigawara, Mitsuru/0000-0001-6530-2083; Bennett, Derrick/0000-0002-9170-8447; Nyakarahuka, Luke/0000-0002-2944-9157; Balakrishnan, Kalpana/0000-0002-5905-1801; Bedi, Neeraj/0000-0003-4709-8423; McGrath, John Joseph/0000-0002-4792-6068; Undurraga, Eduardo/0000-0002-4425-1253; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Naldi, Luigi/0000-0002-3160-2835; Prabhakaran, Dorairaj/0000-0002-3172-834X; CT, Sreeramareddy/0000-0002-5693-7631; Kuipers, Ernst J/0000-0002-0633-3098; Davis, Adrian C/0000-0001-7134-7528; Pesudovs, Konrad/0000-0002-6322-9369; Defo, Barthelemy Kuate/0000-0002-6589-0564; Gething, Peter/0000-0001-6759-5449; Satpathy, Maheswar/0000-0003-3521-4781; Tanne, David/0000-0002-6699-2220; Resnikoff, Serge/0000-0002-5866-4446; Abu-Raddad, Laith J/0000-0003-0790-0506; Ärnlöv, Johan/0000-0002-6933-4637; Bedi, Neeraj/0000-0003-4709-8423; Salomon, Joshua A/0000-0003-3929-5515; Amini, Heresh/0000-0002-4825-1322; Santos, Itamar S/0000-0003-3212-8466; Stein, Dan/0000-0001-7218-7810; Scarborough, Peter/0000-0002-2378-2944; Beghi, Ettore/0000-0003-2542-0469; Norheim, Ole Frithjof/0000-0002-5748-5956; Kinfu, Yohannes/0000-0001-9607-6891; Hay, Simon Iain/0000-0002-0611-7272; Melaku, Yohannes Adama/0000-0002-3051-7313; Brenner, Hermann/0000-0002-6129-1572; Søreide, Kjetil/0000-0001-7594-4354; Nyakarahuka, Luke/0000-0002-2944-9157; Richardus, Jan Hendrik/0000-0003-0564-6313; Singh, Jasvinder/0000-0003-3485-0006; Catalá-López, Ferrán/0000-0002-3833-9312; Bicer, Burcu Kucuk/0000-0002-5615-264X; Díaz-Torné, César/0000-0001-6275-7699; Tonelli, Marcello/0000-0002-0846-3187; CASO, VALERIA/0000-0002-2020-8891; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Franklin, Richard Charles/0000-0003-1864-4552; Lopez, Alan D/0000-0001-5818-6512; Trillini, Matias/0000-0003-1859-1729; Sepanlou, Sadaf G/0000-0002-3669-5129; Jacobsen, Kathryn H./0000-0002-4198-6246; Amare, Azmeraw T./0000-0002-7940-0335; Rojas-Rueda, David/0000-0001-5854-2484; Buchbinder, Rachelle/0000-0002-0597-0933; Thrift, Amanda/0000-0001-8533-4170; Hamadeh, Randah R./0000-0002-4205-1354; Takahashi, Ken/0000-0002-7310-2257; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Liu, Yang/0000-0001-5477-2186; Khan, Prof Dr Ejaz/0000-0002-7072-8035; Brazinova, Alexandra/0000-0003-0625-256X; Matzopoulos, Richard/0000-0001-9063-6210; A, Naheed/0000-0002-6016-5603; ABBASOGLU OZGOREN, AYSE/0000-0002-6106-4839; Salomon, Joshua/0000-0003-3929-5515; Charlson, Fiona J/0000-0003-2876-5040; Tillmann, Taavi/0000-0002-8428-3719; Zhao, Yong/0000-0001-9290-109X; Lortet-Tieulent, Joannie/0000-0002-8816-7475; Giussani, Giorgia/0000-0003-2460-3095; Bikbov, Boris/0000-0002-1925-7506; Castro, Ruben E/0000-0002-7289-9081; Degenhardt, Louisa J/0000-0002-8513-2218; Kemp, Andrew Haddon/0000-0003-1146-3791; Mckee, Martin/0000-0002-0121-9683; Weiderpass, Elisabete/0000-0003-2237-0128; Quistberg, D Alex/0000-0001-9730-2686; Haro, Josep Maria/0000-0002-3984-277X; Perico, Norberto/0000-0002-3147-4327; Crump, John A./0000-0002-4529-102X; Lozano, Rafael/0000-0002-7356-8823; Murray, Joseph/0000-0002-5511-3454; ortiz, alberto/0000-0002-9805-9523; Heydarpour, Pouria/0000-0001-5644-7555; Banerjee, Amitava/0000-0001-8741-3411; Leung, Ricky/0000-0002-2852-6771; Lotufo, Paulo/0000-0002-4856-8450; Schöttker, Ben/0000-0002-1217-4521; Memish, Ziad Ahmed/0000-0002-5099-0714; Terkawi, Abdullah Suleiman/0000-0001-8734-2748; Antonio, Carl Abelardo/0000-0001-7476-0553; Heredia-Pi, Ileana Beatriz/0000-0002-9998-9239; Poenaru, Dan/0000-0002-6267-6140; A, Naheed/0000-0002-6016-5603; Ukwaja, Kingsley N./0000-0002-1974-8735; Benzian, Habib/0000-0003-3692-4849; Ronfani, Luca/0000-0001-5710-3914; van Os, Jim/0000-0002-7245-1586; Montico, Marcella/0000-0003-0377-8232; LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Pereira, David/0000-0003-0384-7592; Scott, James G/0000-0002-0744-0688; Patten, Scott/0000-0001-9871-4041; McKee, Marc D/0000-0001-8349-965X; Brenner, Hermann/0000-0002-6129-1572; Meretoja, Atte/0000-0001-6433-1931; Coffeng, Luc/0000-0002-4425-2264; Majdan, Marek/0000-0001-8037-742X; Karch, André/0000-0003-3014-8543; Adsuar, Jose C/0000-0001-7203-3168; Whiteford, Harvey A/0000-0003-4667-6623; Karthikeyan, Ganesan/0000-0002-2073-2917; Hankey, Graeme J/0000-0002-6044-7328; Foigt, Nataliya/0000-0002-3613-5965; Girelli, Domenico/0000-0001-9684-1899; Charlson, Fiona/0000-0003-2876-5040; Khader, Yousef/0000-0002-7830-6857; Mokdad, Ali H./0000-0002-4994-3339; Lunevicius, Raimundas/0000-0003-3295-0142; Olusanya, Bolajoko O./0000-0002-3826-0583; Malekzadeh, Reza/0000-0002-9820-6335; Deribe, Kebede/0000-0002-8526-6996; Carapetis, Jonathan R/0000-0002-1182-9792; Sposato, Luciano A/0000-0001-6425-9343; Hossain, Mazeda/0000-0002-1878-8145; Husseini, Abdullatif/0000-0001-8767-5956; PACELLA, ROSANA E./0000-0002-9742-1957; Ribeiro, Ana Cristina/0000-0002-0493-8376; Bell, Michelle/0000-0002-3965-1359; Newton, Charles RJC/0000-0002-6999-5507; Naldi, Luigi/0000-0002-3160-2835; Crump, John A./0000-0002-4529-102X; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Rana, Saleem M/0000-0001-6479-9235; Soshnikov, Sergey/0000-0002-6983-7066; Ortblad, Katrina/0000-0002-5675-8836; Khan, Gulfaraz/0000-0001-6836-1783; Schneider, Ione J.C./0000-0001-6339-7832; Oh, In Hwan/0000-0002-5450-9887; Phillips, Michael Robert/0000-0002-5973-2439; Soshnikov, Sergey/0000-0002-6983-7066; Castañeda-Orjuela, Carlos/0000-0002-8735-6223; Bolliger, Ian W/0000-0001-8055-297X; Santos, Itamar/0000-0003-3212-8466; Rahimi, Kazem/0000-0002-4807-4610; Pourmalek, Farshad/0000-0002-2134-0771; Monasta, Lorenzo/0000-0001-7774-548X; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Higashi, Hideki/0000-0002-5534-0905; Weiderpass, Elisabete/0000-0003-2237-0128; Nolte, Sandra/0000-0001-6185-9423; Brugha, Traolach/0000-0002-9786-9591; Li, Yichong/0000-0003-3842-475X; Ferrari, Alize J/0000-0002-7863-9117; Khan, Ejaz A/0000-0002-7072-8035; Giussani, Giorgia/0000-0003-2460-3095; Alsharif, Ubai/0000-0002-4024-3950; Brayne, Carol/0000-0001-5307-663X; GANKPE, GBETOHO FORTUNE/0000-0002-1242-9686; Patton, George C/0000-0001-5039-8326; Shiri, Rahman/0000-0002-9312-3100; Ribeiro, Antonio L/0000-0002-2740-0042; Bernabe, Eduardo/0000-0002-1858-3713; Vlassov, Valentin/0000-0003-2845-2992; Thomson, Blake/0000-0002-6433-0338; Stroumpoulis, Konstantinos/0000-0003-3234-3772; Mori, Rintaro/0000-0001-7656-6156; Colquhoun, Samantha/0000-0002-6750-1147; Kim, Daniel/0000-0001-8907-6420; Derrett, Sarah/0000-0003-2867-0498; Refaat, Amany/0000-0002-0501-6146; Rothenbacher, Dietrich/0000-0002-3563-2791; Pandian, Jeyaraj/0000-0003-0028-1968; Ohkubo, Takayoshi/0000-0002-3283-8196; Farzadfar, Farshad/0000-0001-8288-4046; Lucas, Robyn/0000-0003-2736-3541; del Pozo Cruz, Borja/0000-0002-9728-1317; Shibuya, Kenji/0000-0003-2528-7530; CHANG, JUNG-CHEN/0000-0001-8651-2602; Ackerman, Ilana/0000-0002-6028-1612; Al Asfoor, Deena/0000-0002-7973-1935; Boufous, Soufiane/0000-0002-5686-1729; Xu, Gelin/0000-0002-6194-0341; Sindi, Shireen/0000-0002-3786-0552; shishani, kawkab/0000-0002-7792-6456; Duber, Herbert/0000-0002-5077-3170; Benjet, Corina/0000-0002-4569-6094; Abd-Allah, Foad/0000-0001-8308-5756; Servan-Mori, Edson/0000-0001-9820-8325; Topouzis, Fotis/0000-0002-8966-537X; Dargan, Paul/0000-0002-3433-9622; Moturi, Wilkister Nyaora/0000-0001-6620-4856; Jeemon, Panniyammakal/0000-0003-4172-4307; Beyene, Tariku J/0000-0002-7474-1966; Gouda, Hebe/0000-0002-5709-4509; Coates, Matthew/0000-0002-8474-4992; Levitz, Carly/0000-0003-3094-411X; Knibbs, Luke/0000-0002-0399-2370; Ruhago, George Mugambage/0000-0001-7469-7822; Pullan, Rachel/0000-0001-9844-1362; Sunguya, Bruno/0000-0003-3625-0725; Ye, Pengpeng/0000-0002-2924-1436; Gabbe, Belinda/0000-0001-7096-7688; Erskine, Holly/0000-0003-3119-9211; Hotez, Peter/0000-0001-8770-1042; Lyons, Ronan/0000-0001-5225-000X; Aboyans, Victor/0000-0002-0322-9818; Mhimbira, Francis/0000-0001-8989-6832; Gibney, Katherine/0000-0001-5851-5339; Woolf, Anthony/0000-0001-8482-8056; Briggs, Adam/0000-0002-2314-1039; Kengne, Andre Pascal/0000-0002-5183-131X; Meaney, Peter/0000-0001-9898-6928; Blyth, Fiona/0000-0003-1128-6756; Dandona, Rakhi/0000-0003-0926-788X; Feigin, Valery L./0000-0002-6372-1740; Khang, Young-Ho/0000-0002-9585-8266; Assadi, Reza/0000-0002-5016-2994; Jha, Vivekanand/0000-0002-8015-9470; Neupane, Sudan Prasad/0000-0002-7389-4178; Juel, Knud/0000-0002-4134-1173; Chen, Honglei/0000-0003-3446-7779; Barrero, Lope/0000-0003-1503-0264; Blosser, Christopher/0000-0001-8368-6682; Reddy, K Srinath/0000-0003-3416-3548; WILKINSON, JAMES/0000-0003-1945-5622; Seedat, Soraya/0000-0002-5118-786X; Knudsen, Ann Kristin/0000-0002-1218-798X; Colistro, Valentina/0000-0002-5727-4980; , Borja/0000-0003-3944-2212; Cooper, Leslie/0000-0003-1002-3313; Cavlin, Alanur/0000-0001-9714-9984; Te Ao, Braden/0000-0002-1050-200X; Sahraian, Mohammad Ali/0000-0002-3224-8807; Islami, Farhad/0000-0002-7357-5994; Innos, Kaire/0000-0003-0120-2213; Esteghamati, Alireza/0000-0001-5114-3982; Lind, Margaret/0000-0002-1572-4074; Mackay, Mark/0000-0002-3787-1112; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Pearce, Neil/0000-0002-9938-7852; Cooper, Cyrus/0000-0003-3510-0709; Lansingh, Van/0000-0002-0090-4195; Stanaway, Jeffrey/0000-0003-2209-8478; Achoki, Tom/0000-0001-6309-8904; Remuzzi, Giuseppe/0000-0002-6194-3446; alla, francois/0000-0002-5793-7190; Roberts, Allen/0000-0003-3660-6330; Vlassov, Vasiliy/0000-0001-5203-549X; Hoek, Hans/0000-0001-6353-5465; Leasher, Janet/0000-0002-8779-5162; Qato, Dima/0000-0001-5411-6998; Pope, Daniel/0000-0003-2694-5478; FARAON, EMERITO JOSE A./0000-0001-6157-5930; Davitoiu, Dragos/0000-0002-4493-6754; Mitchell, Philip/0000-0002-7954-5235; Ademi, Zanfina/0000-0002-0625-3522; Shiue, Ivy/0000-0003-1788-3009; Razavi, Homie/0000-0002-2658-6930; Roy, Nobhojit/0000-0003-2022-7416; Christensen, Hanne/0000-0002-7472-3194; Buckle, Geoffrey/0000-0001-7721-0397; Endres, Matthias/0000-0001-6520-3720; Taylor, Hugh/0000-0002-9437-784X; Tenkorang, Eric/0000-0001-6127-3799; Yoon, Seok-Jun/0000-0003-3297-0071; Nisar, Muhammad Imran/0000-0002-2378-4720; Goto, Atsushi/0000-0003-0669-654X; Dokova, Klara/0000-0002-0164-4903; Budke, Christine/0000-0002-4750-0905; Piel, Frederic B./0000-0001-8131-7728; Lallukka, Tea/0000-0003-3841-3129; Miller, Ted/0000-0002-0958-2639; Cirillo, Massimo/0000-0002-6409-3504; Tabb Dina, Karen/0000-0002-4722-9502; van Gool, Coen H/0000-0001-7170-0563; Singh, Abhishek/0000-0001-6263-4410; Felson, David/0000-0002-2668-2447; Dherani, Mukesh/0000-0002-3055-9636; Jarvis, Deborah/0000-0002-1753-3896; Abubakar, Ibrahim/0000-0002-0370-1430; Bhala, Neeraj/0000-0003-2502-1177	Bill AMP; Melinda Gates Foundation; Graduate School of Medical Sciences, University Medical Center Groningen (UMCG); National Health and Medical Research Council; National Natural Sciences Foundation of China; German National Cohort Consortium; Brien Holden Vision Institute; National Health and Medical Research Council Public Health (Australian) Early Career Fellowship; Wellcome Trust Fellowship in Public Health and Tropical Medicine [099876]; National Natural Science Foundation for Young Scholars of China [81200051]; Research Fund for the Doctoral Program of Higher Education of China [20110071120060]; Science Foundation for Young Scholars in Zhongshan Hospital [2012ZSQN04]; Scientific Project for Fudan University [20520133474]; Australian National Health and Medical Research Council Senior Principal Research Fellow; Swiss National Science Foundation [PBBSP3-146869, P300P3-154634]; Korean Health Technology RAMP;D Project (Ministry of Health AMP; Welfare, Republic of Korea) [HI13C0729]; CGIAR Research Program on Aquatic Agricultural Systems; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/K006525/1, MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, RP-PG-0407-10184, CDF-2013-06-012, ACF-2011-13-012, NF-SI-0510-10060, NF-SI-0611-10084] Funding Source: researchfish; MRC [MR/K006525/1, MR/L003120/1] Funding Source: UKRI	Bill AMP; Melinda Gates Foundation(CGIAR); Graduate School of Medical Sciences, University Medical Center Groningen (UMCG); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); German National Cohort Consortium; Brien Holden Vision Institute; National Health and Medical Research Council Public Health (Australian) Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust Fellowship in Public Health and Tropical Medicine(Wellcome Trust); National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Foundation for Young Scholars in Zhongshan Hospital; Scientific Project for Fudan University; Australian National Health and Medical Research Council Senior Principal Research Fellow(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Korean Health Technology RAMP;D Project (Ministry of Health AMP; Welfare, Republic of Korea); CGIAR Research Program on Aquatic Agricultural Systems(CGIAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Bill & Melinda Gates Foundation.r On behalf of the GBD 2010 Genitourinary Diseases Expert Group, GR, NoP, and BB would like to acknowledge that their activities within the GBD 2013 have been made on the behalf of the International Society of Nephrology (ISN). ATA received institutional support and grants from the Graduate School of Medical Sciences, University Medical Center Groningen (UMCG). JM has received support from the National Health and Medical Research Council. LLY is also supported by the National Natural Sciences Foundation of China. UOM would like to acknowledge his funding by the German National Cohort Consortium. RB was provided funding support by the Brien Holden Vision Institute. INA would like to acknowledge her funding support from the National Health and Medical Research Council Public Health (Australian) Early Career Fellowship. KD is supported by a Wellcome Trust Fellowship in Public Health and Tropical Medicine (grant number 099876). The funding sources had no role in the writing of the manuscript or the decision to submit it for publication. JS was supported by the National Natural Science Foundation for Young Scholars of China, (number 81200051); Research Fund for the Doctoral Program of Higher Education of China (number 20110071120060); Science Foundation for Young Scholars in Zhongshan Hospital (number 2012ZSQN04); and the Scientific Project for Fudan University (number 20520133474). RB is funded by an Australian National Health and Medical Research Council Senior Principal Research Fellow. TF is grateful to the Swiss National Science Foundation for an Early and an Advanced Postdoc Mobility fellowship (project numbers PBBSP3-146869 and P300P3-154634). SJY and IHO received funding for their work in a grant from the Korean Health Technology R&D Project (Ministry of Health & Welfare, Republic of Korea; grant number HI13C0729). ALT-L was supported by the CGIAR Research Program on Aquatic Agricultural Systems.	Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Alliance NCD, 2013, HLTH PLAN HLTH PEOPL; Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085; Bergstrom G, 2015, INT J CARDIOL, V182, P141, DOI 10.1016/j.ijcard.2014.12.060; Bloom DE, 2007, INT J EPIDEMIOL, V36, P498, DOI 10.1093/ije/dym079; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Capingana DP, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-732; Carolina MS, 2003, SOC SCI MED, V57, P539, DOI 10.1016/S0277-9536(02)00379-9; Caselli G., 2002, GENUS, P9; Catala-Lopez F, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-34; Chang P, 2014, VASC MED, V19, P289, DOI 10.1177/1358863X14535475; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Dorsey ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007015; Flaxman A, 2014, INTEGRATED METAREGRE; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Frenk J, 1991, Health Transit Rev, V1, P21; Gelman A, 2005, ANN STAT, V33, P1, DOI 10.1214/009053604000001048; Gennaro V, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-19; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Hill K, 2007, INT J EPIDEMIOL, V36, P374, DOI 10.1093/ije/dyl257; Hofmarcher Maria M., 1998, Croatian Medical Journal, V39, P241; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Jolliffe I., 2005, PRINCIPAL COMPONENT; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P26, DOI 10.1080/14034950701355668; Keyhani S, 2010, AM J PUBLIC HEALTH, V100, P1075, DOI 10.2105/AJPH.2009.178491; King G, 2004, AM POLIT SCI REV, V98, P191, DOI 10.1017/S000305540400108X; Luengo-Fernandez R, 2012, EUR J NEUROL, V19, P149, DOI 10.1111/j.1468-1331.2011.03500.x; Mackenbach JP, 2013, INT J EPIDEMIOL, V42, P1100, DOI 10.1093/ije/dyt122; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; MARMOT MG, 1984, LANCET, V1, P1003; McMichael AJ, 2004, LANCET, V363, P1155, DOI 10.1016/S0140-6736(04)15902-3; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Pinter L, 2014, SUSTAINABLE DEV GO 2; Preston SH, 2007, INT J EPIDEMIOL, V36, P484, DOI 10.1093/ije/dym075; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Rivera JA, 2002, PUBLIC HEALTH NUTR, V5, P113, DOI 10.1079/PHN2001282; Rivera-Andrade A, 2014, PROG CARDIOVASC DIS, V57, P276, DOI 10.1016/j.pcad.2014.09.004; Robine J-M, 1993, CALCULATION HLTH EXP; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Salomon JA, 2009, AM J EPIDEMIOL, V170, P343, DOI 10.1093/aje/kwp144; Santosa A, 2014, GLOBAL HEALTH ACTION, V7, P56, DOI 10.3402/gha.v7.23574; Smallman-Raynor M, 1999, HEALTH PLACE, V5, P209, DOI 10.1016/S1353-8292(99)00010-6; Specialist Health Service, 2019, TB PREV CONTR PNG RE; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang JY, 2014, INT J CARDIOL, V172, P82, DOI 10.1016/j.ijcard.2013.12.082; World Health Organization (WHO), 2009, 2008 2013 ACT PLAN; Wu WH, 2013, AM J RESP CRIT CARE, V187, P303, DOI 10.1164/rccm.201207-1290OC; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	59	1174	1237	19	997	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2145	2191		10.1016/S0140-6736(15)61340-X	http://dx.doi.org/10.1016/S0140-6736(15)61340-X			47	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8YW	26321261	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000365992600030
J	Meisel, A; Smith, CJ				Meisel, Andreas; Smith, Craig J.			Prevention of stroke-associated pneumonia: where next?	LANCET			English	Editorial Material							DIAGNOSIS		[Meisel, Andreas] Charite, NeuroCure Clin Res Ctr, Ctr Stroke Res Berlin, Dept Neurol, D-10117 Berlin, Germany; [Smith, Craig J.] Salford Royal Hosp NHS Fdn Trust, Ctr Stroke & Vasc Res, Salford, Lancs, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Salford Royal NHS Foundation Trust; Salford Royal Hospital	Meisel, A (corresponding author), Charite, NeuroCure Clin Res Ctr, Ctr Stroke Res Berlin, Dept Neurol, D-10117 Berlin, Germany.	andreas.meisel@charite.de		Smith, Craig James/0000-0002-9078-9919; Meisel, Andreas/0000-0001-7233-5342				Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Harms H, 2012, J NEUROL NEUROSUR PS, V83, P1225, DOI 10.1136/jnnp-2012-302194; Hetze S, 2013, J CEREBR BLOOD F MET, V33, P846, DOI 10.1038/jcbfm.2013.6; Kalra L, 2015, LANCET, V386, P1835, DOI 10.1016/S0140-6736(15)00126-9; Khaja AM, 2007, LANCET, V369, P319, DOI 10.1016/S0140-6736(07)60154-8; Kishore AK, 2015, STROKE, V46, P1202, DOI 10.1161/STROKEAHA.114.007843; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Meisel C, 2011, NEW ENGL J MED, V365, P2134, DOI 10.1056/NEJMcibr1112454; Osler W, 1998, PRINCIPLES PRACTICE, P109; Smith CJ, 2015, STROKE, V46, P2335, DOI 10.1161/STROKEAHA.115.009617; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Westendorp WF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub2	14	14	16	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1802	1804		10.1016/S0140-6736(15)00127-0	http://dx.doi.org/10.1016/S0140-6736(15)00127-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26343837				2022-12-28	WOS:000364194700011
J	Du, J; Lu, W; Wu, SP; Cheng, YF; Gouaux, E				Du, Juan; Lu, Wei; Wu, Shenping; Cheng, Yifan; Gouaux, Eric			Glycine receptor mechanism elucidated by electron cryo-microscopy	NATURE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; ANTAGONIST-BINDING; GATING MECHANISM; ANION PERMEATION; LOOP; DESENSITIZATION; AGONIST; INHIBITION	The strychnine-sensitive glycine receptor (GlyR) mediates inhibitory synaptic transmission in the spinal cord and brainstem and is linked to neurological disorders, including autism and hyperekplexia. Understanding of molecular mechanisms and pharmacology of glycine receptors has been hindered by a lack of high-resolution structures. Here we report electron cryo-microscopy structures of the zebrafish alpha 1 GlyR with strychnine, glycine, or glycine and ivermectin (glycine/ivermectin). Strychnine arrests the receptor in an antagonist-bound closed ion channel state, glycine stabilizes the receptor in an agonist-bound open channel state, and the glycine/ivermectin complex adopts a potentially desensitized or partially open state. Relative to the glycine-bound state, strychnine expands the agonist-binding pocket via outward movement of the C loop, promotes rearrangement of the extracellular and transmembrane domain 'wrist' interface, and leads to rotation of the transmembrane domain towards the pore axis, occluding the ion conduction pathway. These structures illuminate the GlyR mechanism and define a rubric to interpret structures of Cys-loop receptors.	[Du, Juan; Lu, Wei; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Wu, Shenping; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Cheng, Yifan/0000-0001-9535-0369	National Institute of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Z. H. Yu, N. Grigorieff, J. Cruz and C. Hong (Janelia Campus), C. Arthur (FEI) and M. Braunfeld (UCSF) for assistance with microscope operation, data collection and for comments, and to R. Stites, M. Hakanson and A. Trzynka (OHSU) for computational support. We acknowledge the support of R. Goodman and J. Gray. Microscopy at Oregon Health & Science University (OHSU) was performed at the Multiscale Microscopy Core (MMC) with technical support from the OHSU-FEI Living Lab, Intel and the OHSU Center for Spatial Systems Biomedicine (OCSSB). We thank L. Vaskalis for help with illustrations and H. Owen for proofreading. R. Hibbs is gratefully acknowledged for pre-screening the GlyR constructs and D. P. Claxton for optimizing the constructs. We thank Gouaux and Baconguis laboratory members for discussions. This work was supported by the National Institute of Health (E.G). E.G. is an investigator with the Howard Hughes Medical Institute.	Akabas MH, 2013, P NATL ACAD SCI USA, V110, P16700, DOI 10.1073/pnas.1316157110; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; APRISON M. H., 1965, LIFE SCI, V4, P2075, DOI 10.1016/0024-3205(65)90325-5; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bode A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-2; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Cecchini M, 2015, NEUROPHARMACOLOGY, V96, P137, DOI 10.1016/j.neuropharm.2014.12.006; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CURTIS DR, 1967, NATURE, V215, P1502, DOI 10.1038/2151502a0; CURTIS DR, 1968, EXP BRAIN RES, V5, P235; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FATIMASHAD K, 1993, P ROY SOC B-BIOL SCI, V253, P69, DOI 10.1098/rspb.1993.0083; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; GRAHAM D, 1983, EUR J BIOCHEM, V131, P519, DOI 10.1111/j.1432-1033.1983.tb07292.x; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Huang S, 2013, BIOCHEM J, V454, P303, DOI 10.1042/BJ20130636; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Kinde MN, 2015, STRUCTURE, V23, P995, DOI 10.1016/j.str.2015.03.017; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lynagh T, 2010, J BIOL CHEM, V285, P14890, DOI 10.1074/jbc.M110.107789; Lynch JW, 2006, CURR OPIN INVEST DR, V7, P48; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; MARVIZON JCG, 1986, MOL PHARMACOL, V30, P590; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Moraga-Cid G, 2015, P NATL ACAD SCI USA, V112, P2865, DOI 10.1073/pnas.1417864112; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Purohit P, 2013, J GEN PHYSIOL, V141, P467, DOI 10.1085/jgp.201210946; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; RAJENDRA S, 1995, TRENDS NEUROSCI, V18, P80; RUIZGOMEZ A, 1990, BIOCHEMISTRY-US, V29, P7033, DOI 10.1021/bi00482a012; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VANDENBERG RJ, 1992, NEURON, V9, P491, DOI 10.1016/0896-6273(92)90186-H; WERMAN R, 1967, NATURE, V214, P681, DOI 10.1038/214681a0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832; Yu RL, 2014, BIOCHEMISTRY-US, V53, P6041, DOI 10.1021/bi500815f	65	281	284	11	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2015	526	7572					224	+		10.1038/nature14853	http://dx.doi.org/10.1038/nature14853			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9GV	26344198	Green Accepted			2022-12-28	WOS:000362399000040
J	Ye, X; Tam, WL; Shibue, T; Kaygusuz, Y; Reinhardt, F; Eaton, EN; Weinberg, RA				Ye, Xin; Tam, Wai Leong; Shibue, Tsukasa; Kaygusuz, Yasemin; Reinhardt, Ferenc; Eaton, Elinor Ng; Weinberg, Robert A.			Distinct EMT programs control normal mammary stem cells and tumour-initiating cells	NATURE			English	Article							BRCA1; POPULATIONS; TRANSITIONS; PROGENITORS; INDUCTION; INVASION; MUTATION; TARGET	Tumour-initiating cells (TICs) are responsible for metastatic dissemination and clinical relapse in a variety of cancers(1,2). Analogies between TICs and normal tissue stem cells have led to the proposal that activation of the normal stem-cell program within a tissue serves as the major mechanism for generating TICs3-7. Supporting this notion, we and others previously established that the Slug epithelial-to-mesenchymal transition-inducing transcription factor (EMT-TF), a member of the Snail family, serves as a master regulator of the gland-reconstituting activity of normal mammary stem cells, and that forced expression of Slug in collaboration with Sox9 in breast cancer cells can efficiently induce entrance into the TIC state(8). However, these earlier studies focused on xenograft models with cultured cell lines and involved ectopic expression of EMT-TFs, often at non-physiological levels. Using genetically engineered knock-in reporter mouse lines, here we show that normal gland-reconstituting mammary stem cells(9-11) residing in the basal layer of the mammary epithelium and breast TICs originating in the luminal layer exploit the paralogous EMT-TFs Slug and Snail, respectively, which induce distinct EMT programs. Broadly, our findings suggest that the seemingly similar stem-cell programs operating in TICs and normal stem cells of the corresponding normal tissue are likely to differ significantly in their details.	[Ye, Xin; Tam, Wai Leong; Shibue, Tsukasa; Kaygusuz, Yasemin; Reinhardt, Ferenc; Eaton, Elinor Ng; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tam, Wai Leong] Genome Inst Singapore, Singapore 138672, Singapore; [Tam, Wai Leong] Canc Sci Inst Singapore, Singapore 117599, Singapore; [Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ye, X (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	xye@wi.mit.edu; weinberg@wi.mit.edu	Tam, Wai Leong/P-1497-2019	Tam, Wai Leong/0000-0003-2365-5264	National Research Foundation, Singapore [NRF-NRFF2015-04]; Breast Cancer Research Foundation; Samuel Waxman Cancer Research Foundation; Ludwig Center for Molecular Oncology at MIT; National Cancer Institute [P01-CA080111, R01-CA078461, U01-CA184897, K99-CA194160]; Wilshire Charitable Foundation/Andria and Paul Heafy Postdoctoral Fellowship; Mattina R. Proctor Foundation; Helen Hay Whitney Foundation; NATIONAL CANCER INSTITUTE [K99CA194160, P01CA080111, R01CA078461, U01CA184897] Funding Source: NIH RePORTER	National Research Foundation, Singapore(National Research Foundation, Singapore); Breast Cancer Research Foundation; Samuel Waxman Cancer Research Foundation; Ludwig Center for Molecular Oncology at MIT; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wilshire Charitable Foundation/Andria and Paul Heafy Postdoctoral Fellowship; Mattina R. Proctor Foundation; Helen Hay Whitney Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The pBl.1 and pBl.3 murine PyMT tumour cell lines, from which pBl.1G and pBl.3G were derived, were gifts from the Harold L. Moses laboratory. We thank G. Bell for helping analysing the ChIP-seq data. We thank R. Bronson for help assessing the histopathology of the murine tumours. We thank A. Lambert and S. Thiagalingam for providing the MCF10A-Ras and MCF10A-Ras-C cells. We thank W. Israelsen and M. Vander Heiden for providing the MMTV-cre; p53<SUP>+/-</SUP>; BRCA1<SUP>fl/fl</SUP> murine mammary tumour samples. We thank the Keck Microscopy Facility at the Whitehead Institute for microscopy assistance and the Koch Institute Swanson Biotechnology Center (SBC) for technical support, especially the Histology and ES cell and Transgenics Cores. R. A. W. is an American Cancer Society and Ludwig Foundation professor. W.L.T. is supported by the National Research Foundation, Singapore (NRF-NRFF2015-04). This research was supported by the Breast Cancer Research Foundation, the Samuel Waxman Cancer Research Foundation, the Ludwig Center for Molecular Oncology at MIT, National Cancer Institute Program P01-CA080111, R01-CA078461, U01-CA184897 (to R.A.W.), K99-CA194160 (to X.Y.), the Wilshire Charitable Foundation/Andria and Paul Heafy Postdoctoral Fellowship (to X.Y.), the Mattina R. Proctor Foundation, and the Helen Hay Whitney Foundation (to X.Y.).	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Papageorgis P, 2010, CANCER RES, V70, P968, DOI 10.1158/0008-5472.CAN-09-1872; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Siebzehnrubl FA, 2013, EMBO MOL MED, V5, P1196, DOI 10.1002/emmm.201302827; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran HD, 2014, CANCER RES, V74, P6330, DOI 10.1158/0008-5472.CAN-14-0923; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	35	470	484	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					256	+		10.1038/nature14897	http://dx.doi.org/10.1038/nature14897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26331542	Green Submitted, Green Accepted			2022-12-28	WOS:000360927400040
J	Brady, AC; Dillon, PA				Brady, Ann-Christina; Dillon, Patrick A.			Gastric Pneumatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brady, Ann-Christina; Dillon, Patrick A.] Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Brady, AC (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	dillonp@wustl.edu	Brady, Ann-Christina/AAK-4745-2020						0	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					954	954		10.1056/NEJMicm1411051	http://dx.doi.org/10.1056/NEJMicm1411051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2OB	26332550				2022-12-28	WOS:000360439500011
J	Shah, R				Shah, Rupal			10-MINUTE CONSULTATION Assessing the risk of diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bridge Lane Grp Practice, London SW11 3AD, England		Shah, R (corresponding author), Bridge Lane Grp Practice, London SW11 3AD, England.	rupal.shah7@nhs.net		Shah, Rupal/0000-0001-9079-0971				National Institute for Health and Care Excellence, MAN OV OB AD LIF WEI	1	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2015	351								h4525	10.1136/bmj.h4525	http://dx.doi.org/10.1136/bmj.h4525			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9JX	26338017				2022-12-28	WOS:000360931900002
J	Blumenthal, DM; Orav, EJ; Jena, AB; Dudzinski, DM; Le, ST; Jha, AK				Blumenthal, Daniel M.; Orav, E. John; Jena, Anupam B.; Dudzinski, David M.; Le, Sidney T.; Jha, Ashish K.			Access, quality, and costs of care at physician owned hospitals in the United States: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY REVASCULARIZATION; SPECIALTY HOSPITALS; CARDIAC HOSPITALS; ASSOCIATION; OWNERSHIP; MORTALITY; TOO	OBJECTIVE To compare physician owned hospitals (POHs) with non-POHs on metrics around patient populations, quality of care, costs, and payments. DESIGN Observational study. SETTING Acute care hospitals in 95 hospital referral regions in the United States, 2010. PARTICIPANTS 2186 US acute care hospitals (219 POHs and 1967 non-POHs). MAIN OUTCOME MEASURES Proportions of patients using Medicaid and those from ethnic and racial minority groups; hospital performance on patient experience metrics, care processes, risk adjusted 30 day mortality, and readmission rates; costs of care; care payments; and Medicare market share. RESULTS The 219 POHs were more often small (<100 beds), for profit, and in urban areas. 120 of these POHs were general (non-specialty) hospitals. Compared with patients from non-POHs, those from POHs were younger (77.4 v 78.4 years, P<0.001), less likely to be admitted through an emergency department (23.2% v. 29.0%, P<0.001), equally likely to be black (5.1% v 5.5%, P=0.85) or to use Medicaid (14.9% v 15.4%, P=0.75), and had similar numbers of chronic diseases and predicted mortality scores. POHs and non-POHs performed similarly on patient experience scores, processes of care, risk adjusted 30 day mortality, 30 day readmission rates, costs, and payments for acute myocardial infarction, congestive heart failure, and pneumonia. CONCLUSION Although POHs may treat slightly healthier patients, they do not seem to systematically select more profitable or less disadvantaged patients or to provide lower value care.	[Blumenthal, Daniel M.; Dudzinski, David M.] Massachusetts Gen Hosp, Dept Internal Med, Div Cardiol, Boston, MA 02114 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Le, Sidney T.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health	Blumenthal, DM (corresponding author), Massachusetts Gen Hosp, Dept Internal Med, Div Cardiol, Boston, MA 02114 USA.	dblumenthal1@mgh.harvard.edu			Department of Health Policy and Management at the T H Chan School of Public Health at Harvard University; Office of the Director, National Institutes of Health early independence award [1DP5OD017897-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Department of Health Policy and Management at the T H Chan School of Public Health at Harvard University; Office of the Director, National Institutes of Health early independence award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded using internal resources from the Department of Health Policy and Management at the T H Chan School of Public Health at Harvard University. ABJ reports funding from the Office of the Director, National Institutes of Health early independence award (grant 1DP5OD017897-01).	Alharthi MS, 2010, EUR J ECHOCARDIOGR, V11, DOI 10.1093/ejechocard/jeq052; Anderson JH, 2011, WEEKLY STANDARD; [Anonymous], 2006, REP C PHYS OWN SPEC; [Anonymous], 2008, PHYS OWN SPEC HOSP A; [Anonymous], 2006, REC REG PHYS OWN SPE, P3; [Anonymous], 2006, REP C INCR VAL MED, P1; Bogue RJ, 2007, HOSP GOVERNANCE LATI, P1; Burns LR, 2014, INDIA'S HEALTHCARE INDUSTRY: INNOVATION IN DELIVERY, FINANCING, AND MANUFACTURING, P1, DOI 10.1017/CBO9781107360242; Carey K, 2008, HEALTH SERV RES, V43, P1869, DOI 10.1111/j.1475-6773.2008.00881.x; Cole Cristie M, 2013, Virtual Mentor, V15, P150, DOI 10.1001/virtualmentor.2013.15.2.hlaw1-1302; Cram P, 2005, NEW ENGL J MED, V352, P1454, DOI 10.1056/NEJMsa042325; Cram P, 2007, JAMA-J AM MED ASSOC, V297, P998, DOI 10.1001/jama.297.9.998; Cram P, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-155; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Greenwald L, 2006, HEALTH AFFAIR, V25, P106, DOI 10.1377/hlthaff.25.1.106; Hadley J., 2005, HLTH AFFAIRS WEB EXC, VW5, P491; Hahn HF, 2010, J HLTH CARE COMPLIAN, P63; Hollingsworth JM, 2010, HEALTH AFFAIR, V29, P683, DOI 10.1377/hlthaff.2008.0567; Jandorf L, 2005, J URBAN HEALTH, V82, P216, DOI 10.1093/jurban/jti046; Jha AK, 2009, HEALTH AFFAIR, V28, P897, DOI 10.1377/hlthaff.28.3.897; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Kliff S, 2011, CONSTRUCTION STOPS P; Kocher KE, 2013, MED CARE, V51, P689, DOI 10.1097/MLR.0b013e3182992c7b; Lu X, 2009, CLIN ORTHOP RELAT R, V467, P2577, DOI 10.1007/s11999-009-0855-1; Lynk WJ, 2002, HEALTH AFFAIR, V21, P215, DOI 10.1377/hlthaff.21.4.215; McCrum ML, 2013, JAMA INTERN MED, V173, P1351, DOI 10.1001/jamainternmed.2013.7049; Millard WB, 2006, ANN EMERG MED, V48, P144, DOI 10.1016/j.annemergmed.2006.06.020; Mitchell J. M., 2005, EFFECTS PHYS OWNED W, VW5, P481; MITCHELL JM, 1995, J HEALTH ECON, V14, P263, DOI 10.1016/0167-6296(95)00003-Z; Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962; O'Neill L, 2012, HEALTH AFFAIR, V31, P806, DOI 10.1377/hlthaff.2011.0624; Silva C, 2010, AM MED NEWS; Stensland J, 2006, HEALTH AFFAIR, V25, P119, DOI 10.1377/hlthaff.25.1.119; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; Wennberg J., 1999, QUALITY MED CARE US	35	14	14	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2015	351								h4466	10.1136/bmj.h4466	http://dx.doi.org/10.1136/bmj.h4466			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9JT	26333819	Green Published, hybrid			2022-12-28	WOS:000360931400002
J	Eggener, SE; Cifu, AS; Nabhan, C				Eggener, Scott E.; Cifu, Adam S.; Nabhan, Chadi			Prostate Cancer Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								MAJOR RECOMMENDATIONS The USPSTF recommends against PSA-based screening for prostate cancer due to moderate or high certainty that the test has no net benefit or the harms outweigh the benefits (grade D). The AUA recommends shared decision making for men aged 55 to 69 years; for men electing to be screened, an interval of 2 years or more may be preferable to annual screening. The AUA recommends against PSA screening in men younger than 40 years, against routine screening between ages 40 and 54 years for men at average risk, and against routine screening in men older than 70 years or any man with less than a 10- to 15-year life expectancy.	[Eggener, Scott E.] Univ Chicago, Dept Surg, Urol Sect, Chicago, IL 60637 USA; [Cifu, Adam S.] Univ Chicago, Dept Med, Gen Internal Med Sect, Chicago, IL 60637 USA; [Nabhan, Chadi] Univ Chicago, Dept Med, Sect Hematol & Oncol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Eggener, SE (corresponding author), Univ Chicago, Dept Surg, Urol Sect, 5841 S Maryland Ave,Mail Code 6038, Chicago, IL 60637 USA.	seggener@uchicago.edu						Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Efstathiou JA, 2006, UROLOGY, V68, P342, DOI 10.1016/j.urology.2006.02.030; Etzioni R, 2008, CANCER CAUSE CONTROL, V19, P175, DOI 10.1007/s10552-007-9083-8; Ilic D, 2011, BJU INT, V107, P882, DOI 10.1111/j.1464-410X.2010.10032.x; Loeb S, 2011, J UROLOGY, V186, P1830, DOI 10.1016/j.juro.2011.06.057; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208	10	26	26	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					825	826		10.1001/jama.2015.8033	http://dx.doi.org/10.1001/jama.2015.8033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305653				2022-12-28	WOS:000360017200023
J	Chevalier, B				Chevalier, Bernard			In-stent restenosis treatment: quest for the best device	LANCET			English	Editorial Material							ELUTING STENTS; BARE-METAL; NEOATHEROSCLEROSIS; BALLOON; TRIAL		Inst Cardiovasc Paris Sud, Ramsay Gen Sante, F-91300 Massy, France	UDICE-French Research Universities; Universite Paris Saclay	Chevalier, B (corresponding author), Inst Cardiovasc Paris Sud, Ramsay Gen Sante, F-91300 Massy, France.	bchevali@aol.com	Chevalier, Bernard/AAU-2855-2021					Alfonso F, 2015, J AM COLL CARDIOL, V66, P23, DOI 10.1016/j.jacc.2015.04.063; Alfonso F, 2014, J AM COLL CARDIOL, V63, P1378, DOI 10.1016/j.jacc.2013.12.006; Balakrishnan B, 2005, CIRCULATION, V111, P2958, DOI 10.1161/CIRCULATIONAHA.104.512475; Chevalier B, 2012, J INTERV CARDIOL, V25, P586, DOI 10.1111/j.1540-8183.2012.00769.x; Cipriani A, 2008, ANN INTERN MED, V159, P103; Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436; Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P9, DOI 10.1161/CIRCINTERVENTIONS.110.940320; Lee JM, 2015, JACC-CARDIOVASC INTE, V8, P382, DOI 10.1016/j.jcin.2014.09.023; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Siontis GCM, 2015, LANCET, V386, P655, DOI 10.1016/S0140-6736(15)60657-2; Taniwaki M, 2014, J AM COLL CARDIOL, V63, P1617, DOI 10.1016/j.jacc.2013.12.036; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	14	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					627	628		10.1016/S0140-6736(15)60939-4	http://dx.doi.org/10.1016/S0140-6736(15)60939-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26334140				2022-12-28	WOS:000359849200007
J	Keating, C				Keating, Conrad			The art of medicine The social history of ISIS-2: trial and tribulation	LANCET			English	Editorial Material									Wellcome Unit Hist Med, Oxford OX2 6PE, England		Keating, C (corresponding author), Wellcome Unit Hist Med, Oxford OX2 6PE, England.	conrad.keating@wuhmo.ox.ac.uk							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					E2	E3		10.1016/S0140-6736(15)61504-5	http://dx.doi.org/10.1016/S0140-6736(15)61504-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP4KA	26334163				2022-12-28	WOS:000359849200001
J	Connor, JP; Haber, PS; Hall, WD				Connor, Jason P.; Haber, Paul S.; Hall, Wayne D.			Alcohol use disorders	LANCET			English	Review							SUBSTANCE USE DISORDERS; COGNITIVE-BEHAVIORAL THERAPY; GENOME-WIDE ASSOCIATION; DOUBLE-BLIND; WERNICKES ENCEPHALOPATHY; IDENTIFICATION TEST; DEPENDENT PATIENTS; BRIEF INTERVENTION; MENTAL-DISORDERS; CONSUMPTION	Alcohol use disorders are common in developed countries, where alcohol is cheap, readily available, and heavily promoted. Common, mild disorders often remit in young adulthood, but more severe disorders can become chronic and need long-term medical and psychological management. Doctors are uniquely placed to opportunistically assess and manage alcohol use disorders, but in practice diagnosis and treatment are often delayed. Brief behavioural intervention is effective in primary care for hazardous drinkers and individuals with mild disorders. Brief interventions could also encourage early entry to treatment for people with more-severe illness who are underdiagnosed and undertreated. Sustained abstinence is the optimum outcome for severe disorder. The stigma that discourages treatment seeking needs to be reduced, and pragmatic approaches adopted for patients who initially reject abstinence as a goal. To engage people in one or more psychological and pharmacological treatments of equivalent effectiveness is more important than to advocate a specific treatment. A key research priority is to improve the diagnosis and treatment of most affected people who have comorbid mental and other drug use disorders.	[Connor, Jason P.; Hall, Wayne D.] Univ Queensland, Ctr Youth Subst Abuse Res, Brisbane, Qld 4029, Australia; [Connor, Jason P.] Univ Queensland, Discipline Psychiat, Brisbane, Qld 4029, Australia; [Haber, Paul S.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Haber, Paul S.] Sydney Local Hlth Dist, Drug Hlth Serv, Sydney, NSW, Australia; [Hall, Wayne D.] Kings Coll London, Addict Dept, London WC2R 2LS, England	University of Queensland; University of Queensland; University of Sydney; University of London; King's College London	Hall, WD (corresponding author), Univ Queensland, Ctr Youth Subst Abuse Res, Brisbane, Qld 4029, Australia.	w.hall@uq.edu.au	Hall, Wayne/A-3283-2008; Connor, Jason/F-7040-2010	Hall, Wayne/0000-0003-1984-0096; Connor, Jason/0000-0002-7020-1196	National Health and Medical Research Council of Australia Career Development Fellowship [1031909]	National Health and Medical Research Council of Australia Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	JPC is supported by a National Health and Medical Research Council of Australia Career Development Fellowship (1031909). PSH is a member of the International Advisory Committee for Lundbeck (nalmefene) and holds no shares or any financial interests. He has previously been a consultant for Alphapharm (acamprosate). WDH declares no competing interests.	Addolorato G, 2007, LANCET, V370, P1915, DOI 10.1016/S0140-6736(07)61814-5; Agrawal A, 2008, ADDICTION, V103, P1069, DOI 10.1111/j.1360-0443.2008.02213.x; Allen JP, 1997, J STUD ALCOHOL, V58, P7; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; American Psychological Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596, 10.5771/0943-7444-2017-8-668]; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Babor T.F., 2010, ALCOHOL NO ORDINARY, DOI 10.1093/acprof:oso/9780199551149.001.0001; Bertholet N, 2014, ALCOHOL ALCOHOLISM, V49, P423, DOI 10.1093/alcalc/agu016; Bradley KA, 2014, JAMA-J AM MED ASSOC, V311, P1861, DOI 10.1001/jama.2014.3629; Calver LA, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-14; Chartier KG, 2010, CHILD ADOL PSYCH CL, V19, P493, DOI 10.1016/j.chc.2010.03.004; Cohen E, 2007, DRUG ALCOHOL DEPEN, V86, P214, DOI 10.1016/j.drugalcdep.2006.06.008; Conigrave KM, 2003, ADDICTION, V98, P31, DOI 10.1046/j.1359-6357.2003.00581.x; Conigrave KM, 2002, ALCOHOL CLIN EXP RES, V26, P332, DOI 10.1097/00000374-200203000-00005; Connor JP, 2011, ALCOHOL ALCOHOLISM, V46, P161, DOI 10.1093/alcalc/agr004; Connor JP, 2014, CURR OPIN PSYCHIATR, V27, P269, DOI 10.1097/YCO.0000000000000069; Danielsson AK, 2014, ADDICT BEHAV, V39, P1846, DOI 10.1016/j.addbeh.2014.06.007; Danielsson J, 2014, WORLD J GASTROENTERO, V20, P11743, DOI 10.3748/wjg.v20.i33.11743; Darke S, 2014, DRUG ALCOHOL REV, V33, P109, DOI 10.1111/dar.12108; Day E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004033.pub3; DeVido JJ, 2012, CURR PSYCHIAT REP, V14, P610, DOI 10.1007/s11920-012-0314-7; Dhalla S, 2007, CLIN INVEST MED, V30, P33, DOI 10.25011/cim.v30i1.447; Drobes DJ, 2001, INT HDB ALCOHOL DEPE, P281; Dutra L, 2008, AM J PSYCHIAT, V165, P179, DOI 10.1176/appi.ajp.2007.06111851; Esser MB, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140329; Feeney GFX, 2006, ALCOHOL ALCOHOLISM, V41, P321, DOI 10.1093/alcalc/agl007; Feeney GFX, ADDICTION M IN PRESS; Ferri M, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005032.PUB2; Garfield JBB, 2014, AUST NZ J PSYCHIAT, V48, P36, DOI 10.1177/0004867413508455; Gaume J, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00108; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Gudin JA, 2013, POSTGRAD MED, V125, P115, DOI 10.3810/pgm.2013.07.2684; Haber P, 2009, GUIDELINES TREATMENT; Hall W, 1999, UNMET NEED PSYCHIAT, P290; Hall W, 2009, ADDICT BEHAV, V34, P526, DOI 10.1016/j.addbeh.2009.03.010; Hartzler B, 2012, DRUG ALCOHOL DEPEN, V122, P1, DOI 10.1016/j.drugalcdep.2011.11.011; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Hasin DS, 2013, AM J PSYCHIAT, V170, P834, DOI 10.1176/appi.ajp.2013.12060782; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Heather N, 2008, ADDICTION, V103, P228, DOI 10.1111/j.1360-0443.2007.02060.x; Heather N, 2014, ADDICTION, V109, P1059, DOI 10.1111/add.12443; HELZER JE, 1985, NEW ENGL J MED, V312, P1678, DOI 10.1056/NEJM198506273122605; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hillemacher T, 2011, ALCOHOL ALCOHOLISM, V46, P224, DOI 10.1093/alcalc/agr026; Hobbs JDJ, 2011, AM J ADDICTION, V20, P319, DOI 10.1111/j.1521-0391.2011.00140.x; Hunt GE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001088.pub3; Iovieno N, 2011, J CLIN PSYCHIAT, V72, P1144, DOI 10.4088/JCP.10m06217; Johnson BA, 2010, AM J PSYCHIAT, V167, P630, DOI 10.1176/appi.ajp.2010.08101500; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; Jorgensen CH, 2011, ALCOHOL CLIN EXP RES, V35, P1749, DOI 10.1111/j.1530-0277.2011.01523.x; Kavanagh DJ, 2010, HDB CLIN PSYCHOL COM, P902; Kerr WC, 2012, DRUG ALCOHOL REV, V31, P200, DOI 10.1111/j.1465-3362.2011.00374.x; Kessler RC, 2011, TXB PSYCHIAT EPIDEMI; Keyes KM, 2010, AM J EPIDEMIOL, V172, P1364, DOI 10.1093/aje/kwq304; Kiefer F, 2003, ARCH GEN PSYCHIAT, V60, P92, DOI 10.1001/archpsyc.60.1.92; Kirshenbaum AP, 2009, J SUBST ABUSE TREAT, V36, P8, DOI 10.1016/j.jsat.2008.04.001; Koob George F, 2014, Handb Clin Neurol, V125, P33, DOI 10.1016/B978-0-444-62619-6.00003-3; Koob GF, 2008, NEUROBIOLOGY ALCOHOL; Kranzler HR, 2014, AM J PSYCHIAT, V171, P445, DOI 10.1176/appi.ajp.2013.13081014; Lane J, 2008, SEX TRANSM INFECT, V84, P524, DOI 10.1136/sti.2008.032482; Laramee P, 2014, BMJ OPEN, V4; Lejoyeux M, 2011, ALCOHOL ALCOHOLISM, V46, P61, DOI 10.1093/alcalc/agq077; Lev-Ran S, 2012, CAN J PSYCHIAT, V57, P342, DOI 10.1177/070674371205700603; Li DW, 2012, HUM GENET, V131, P725, DOI 10.1007/s00439-011-1116-4; Litten RZ, 2013, J ADDICT MED, V7, P277, DOI 10.1097/ADM.0b013e31829623f4; Litten RZ, 2012, ADDICT BIOL, V17, P513, DOI 10.1111/j.1369-1600.2012.00454.x; Litten RZ, 2010, ALCOHOL CLIN EXP RES, V34, P955, DOI 10.1111/j.1530-0277.2010.01170.x; Lubman DI, 2010, INT REV PSYCHIATR, V22, P191, DOI 10.3109/09540261003689958; Magill M, 2009, J STUD ALCOHOL DRUGS, V70, P516, DOI 10.15288/jsad.2009.70.516; Magnusson A, 2010, ALCOHOL, V44, P131, DOI 10.1016/j.alcohol.2010.01.001; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS67; Marchi KC, 2014, WORLD J CARDIOL, V6, P283, DOI 10.4330/wjc.v6.i5.283; Marlatt GA, 2010, ANNU REV CLIN PSYCHO, V6, P591, DOI 10.1146/annurev.clinpsy.121208.131438; Martin GW, 2012, CAN J PSYCHIAT, V57, P350, DOI 10.1177/070674371205700604; Martin T., 2010, OPEN ADDICT J, V3, P92, DOI [10.2174/1874941001003020092, DOI 10.2174/1874941001003010092]; Mason BJ, 2012, ALCOHOL CLIN EXP RES, V36, P497, DOI 10.1111/j.1530-0277.2011.01616.x; Mattick RP, 1996, LANCET, V347, P97, DOI 10.1016/S0140-6736(96)90215-9; McCambridge J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000413; McKee SA, 2013, ANNU REV CLIN PSYCHO, V9, P649, DOI 10.1146/annurev-clinpsy-050212-185549; Mdege ND, 2013, DRUG ALCOHOL DEPEN, V131, P1, DOI 10.1016/j.drugalcdep.2013.01.023; Miller P, 2009, EVIDENCE BASED ADDIC, P233; Miller WR, 2001, J STUD ALCOHOL, V62, P211, DOI 10.15288/jsa.2001.62.211; Miller WR, 2002, ADDICTION, V97, P265, DOI 10.1046/j.1360-0443.2002.00019.x; Miller WR, 2013, MOTIVATIONAL INTERVI, V3rd; Mitchell AJ, 2012, BRIT J PSYCHIAT, V201, P93, DOI 10.1192/bjp.bp.110.091199; Monahan SC, 1996, ADDICTION, V91, P787, DOI 10.1046/j.1360-0443.1996.9167876.x; Moyer A, 2002, J SUBST ABUSE TREAT, V23, P247, DOI 10.1016/S0740-5472(02)00264-7; Mueser KT, 2001, INT HDB ALCOHOL DEPE; Murthy P, 2012, CURR OPIN PSYCHIATR, V25, P194, DOI 10.1097/YCO.0b013e328351a3e0; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nilsen P, 2008, J SUBST ABUSE TREAT, V35, P184, DOI 10.1016/j.jsat.2007.09.008; O'Donnell A, 2014, ALCOHOL ALCOHOLISM, V49, P66, DOI 10.1093/alcalc/agt170; O'Keefe JH, 2014, MAYO CLIN PROC, V89, P382, DOI 10.1016/j.mayocp.2013.11.005; Olfson E, 2012, ALCOHOL CLIN EXP RES, V36, P2086, DOI 10.1111/j.1530-0277.2012.01843.x; Palmer RHC, 2012, DRUG ALCOHOL DEPEN, V125, P179, DOI 10.1016/j.drugalcdep.2012.07.005; Pennay A, 2011, J SUBST ABUSE TREAT, V41, P363, DOI 10.1016/j.jsat.2011.05.004; Perry EC, 2014, CNS DRUGS, V28, P401, DOI 10.1007/s40263-014-0163-5; Rehm J, 2008, INT J METH PSYCH RES, V17, P141, DOI 10.1002/mpr.259; Rehm J, 2015, EUR ADDICT RES, V21, P6, DOI 10.1159/000365284; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Ries R, 2009, J HEPATOL; Roerecke M, 2014, INT J EPIDEMIOL, V43, P906, DOI 10.1093/ije/dyu018; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001867.pub3; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004332.pub2; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schabelman E, 2012, J EMERG MED, V42, P488, DOI 10.1016/j.jemermed.2011.05.076; Schomerus G, 2013, PSYCHIAT RES, V209, P665, DOI 10.1016/j.psychres.2013.02.006; Schomerus G, 2011, ALCOHOL ALCOHOLISM, V46, P105, DOI 10.1093/alcalc/agq089; Schuckit MA, 2014, NEW ENGL J MED, V371, P2109, DOI 10.1056/NEJMra1407298; Sechi G, 2007, LANCET NEUROL, V6, P442, DOI 10.1016/S1474-4422(07)70104-7; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Sinclair J, 2014, EUR ADDICT RES, V20, P209, DOI 10.1159/000357865; Siva N, 2015, LANCET, V386, P121, DOI 10.1016/S0140-6736(15)61228-4; Skinner MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087366; Smith LA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005338.pub2; Stewart S, 2012, CLIN MED, V12, P266, DOI 10.7861/clinmedicine.12-3-266; Sturgess JE, 2011, ADDICT BIOL, V16, P357, DOI 10.1111/j.1369-1600.2010.00287.x; Thomson AD, 2009, PRACT GASTROENTEROL, V33, P21; van Amsterdam J, 2013, J PSYCHOPHARMACOL, V27, P987, DOI 10.1177/0269881113495320; van den Brink W, 2014, J PSYCHOPHARMACOL, V28, P733, DOI 10.1177/0269881114527362; Verrill C, 2009, ADDICTION, V104, P768, DOI 10.1111/j.1360-0443.2009.02521.x; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; White A, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1479; White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x; Whitfield JB, 2013, ALCOHOL CLIN EXP RES, V37, P575, DOI 10.1111/acer.12015; Witkiewitz K, 2014, J STUD ALCOHOL DRUGS, V75, P415, DOI 10.15288/jsad.2014.75.415; WODAK AD, 1983, BMJ-BRIT MED J, V287, P1420, DOI 10.1136/bmj.287.6403.1420; World Health Organization, 1992, ICD 10 CLASS MENT BE, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; World Health Organization, MAN SUSBST AB; Young RM, 2011, J SUBST ABUSE TREAT, V40, P18, DOI 10.1016/j.jsat.2010.08.003; Zelner I, 2013, J POPUL THER CLIN PH, V20, pE201	136	217	219	3	80	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					988	998		10.1016/S0140-6736(15)00122-1	http://dx.doi.org/10.1016/S0140-6736(15)00122-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26343838				2022-12-28	WOS:000371644200032
J	Nash, IS				Nash, Ira S.			Why Physicians Hate "Patient Satisfaction" but Shouldn't	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE		[Nash, Ira S.] North Shore LIJ Hlth Syst, Manhasset, NY 11030 USA	Northwell Health	Nash, IS (corresponding author), North Shore LIJ Hlth Syst, 600 Community Dr,Suite 302, Manhasset, NY 11030 USA.	inash@nshs.edu						Centers for Medicare and Medicaid Services, HOSP VAL BAS PURCH; Centers for Medicare & Medicaid Services, SURV PAT EXP HCAHPS; Centers for Medicare & Medicaid Services, 2015, HOSP COMP STAR RAT F; Centers for Medicare & Medicaid Services, 2014, PHYS COMP OV WHAT AR; Centers for Medicare & Medicaid Services, 2015, VAL BAS PAYM MOD; Derksen F, 2013, BRIT J GEN PRACT, V63, DOI [10.3399/bjgpbjgp13X660814, 10.3399/bjgp13X660814]; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Sacks GD, 2015, JAMA SURG, V150, P858, DOI 10.1001/jamasurg.2015.1108	9	10	10	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					792	U301		10.7326/M15-1087	http://dx.doi.org/10.7326/M15-1087			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26344665				2022-12-28	WOS:000365746400023
J	Sedgwick, P; Greenwood, N				Sedgwick, Philip; Greenwood, Nan			Understanding the Hawthorne effect	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sedgwick, Philip] Univ London, Inst Med & Biomed Educ, London, England; [Greenwood, Nan] Univ Kingston, Fac Hlth Social Care & Educ, Kingston Upon Thames, Surrey, England; [Greenwood, Nan] Univ London, London, England	University of London; Kingston University; University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h267; Smith JE, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2988	2	213	215	0	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2015	351								h4672	10.1136/bmj.h4672	http://dx.doi.org/10.1136/bmj.h4672			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9KB	26341898	Green Accepted			2022-12-28	WOS:000360932300002
J	Deng, B				Deng, Boer			Motion studies: See how they run	NATURE			English	Editorial Material								Software tools that track how animals move are helping researchers to do everything from diagnosing neurological conditions to illuminating evolution.											0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					145	146		10.1038/525145a	http://dx.doi.org/10.1038/525145a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26333469	Bronze			2022-12-28	WOS:000360594100045
J	Vita, N; Platsaki, S; Basle, A; Allen, SJ; Paterson, NG; Crombie, AT; Murrell, JC; Waldron, KJ; Dennison, C				Vita, Nicolas; Platsaki, Semeli; Basle, Arnaud; Allen, Stephen J.; Paterson, Neil G.; Crombie, Andrew T.; Murrell, J. Colin; Waldron, Kevin J.; Dennison, Christopher			A four-helix bundle stores copper for methane oxidation	NATURE			English	Article							ELLMANS REAGENT; BINDING; PROTEINS; AFFINITY; METAL; MONOOXYGENASE; METHANOBACTIN; TRAFFICKING; MECHANISMS; EXPRESSION	Methane-oxidizing bacteria (methanotrophs) require large quantities of copper for the membrane-bound (particulate) methane monooxygenase(1,2). Certain methanotrophs are also able to switch to using the iron-containing soluble methane monooxygenase to catalyse methane oxidation, with this switchover regulated by copper(3,4). Methane monooxygenases are nature's primary biological mechanism for suppressing atmospheric levels of methane, a potent greenhouse gas. Furthermore, methanotrophs and methane monooxygenases have enormous potential in bioremediation and for biotransformations producing bulk and fine chemicals, and in bioenergy, particularly considering increased methane availability from renewable sources and hydraulic fracturing of shale rock(5,6). Here we discover and characterize a novel copper storage protein (Csp1) from the methanotroph Methylosinus trichosporium OB3b that is exported from the cytosol, and stores copper for particulate methane monooxygenase. Csp1 is a tetramer of four-helix bundles with each monomer binding up to 13 Cu(I) ions in a previously unseen manner via mainly Cys residues that point into the core of the bundle. Csp1 is the first example of a protein that stores a metal within an established protein-folding motif. This work provides a detailed insight into how methanotrophs accumulate copper for the oxidation of methane. Understanding this process is essential if the wide-ranging biotechnological applications of methanotrophs are to be realized. Cytosolic homologues of Csp1 are present in diverse bacteria, thus challenging the dogma that such organisms do not use copper in this location.	[Vita, Nicolas; Platsaki, Semeli; Basle, Arnaud; Allen, Stephen J.; Waldron, Kevin J.; Dennison, Christopher] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Paterson, Neil G.] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Crombie, Andrew T.; Murrell, J. Colin] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Newcastle University - UK; Diamond Light Source; University of East Anglia	Dennison, C (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	christopher.dennison@ncl.ac.uk	Waldron, Kevin/J-2368-2016; Crombie, Andrew/C-9167-2012; Murrell, John C/B-1443-2012; Waldron, Kevin John/HHM-8983-2022	Waldron, Kevin/0000-0002-5577-7357; Waldron, Kevin John/0000-0002-5577-7357; Dennison, Christopher/0000-0001-8665-052X; Crombie, Andrew/0000-0002-8577-2602; Basle, Arnaud/0000-0002-4899-3086; Paterson, Neil/0000-0003-4292-6971	Biotechnology and Biological Sciences Research Council [BB/K008439/1]; Newcastle University; Sir Henry Dale Fellowship - Wellcome Trust; Royal Society [098375/Z/12/Z]; Biotechnology and Biological Sciences Research Council [BB/F012713/1] Funding Source: researchfish; Natural Environment Research Council [NER/A/S/2002/00876, NE/E016855/1] Funding Source: researchfish; BBSRC [BB/F012713/1, BB/K008439/1] Funding Source: UKRI; NERC [NE/E016855/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University; Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank staff of the Diamond Light Source for help with diffraction data collection, J. Gray for performing mass spectrometry studies, the School of Civil Engineering and Geosciences and D. Graham for access to facilities at the very start of this work, A. Badarau for discussions about determining Cu(I) affinities and S. J. Firbank for structural modelling at the initial stages of this project. This work was supported by Biotechnology and Biological Sciences Research Council (grant BB/K008439/1 to C.D. and K.J.W.) and Newcastle University (part funding of a PhD studentship for S.P.). K.J.W. was supported by a Sir Henry Dale Fellowship funded by the Wellcome Trust and the Royal Society (098375/Z/12/Z).	Allen S, 2013, DALTON T, V42, P3233, DOI 10.1039/c2dt32166a; Allen S, 2012, BIOCHEMISTRY-US, V51, P1439, DOI 10.1021/bi201370r; Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Badarau A, 2011, P NATL ACAD SCI USA, V108, P13007, DOI 10.1073/pnas.1101448108; Badarau A, 2011, J AM CHEM SOC, V133, P2983, DOI 10.1021/ja1091547; Badarau A, 2010, BIOCHEMISTRY-US, V49, P7798, DOI 10.1021/bi101064w; Bagchi P, 2013, J AM CHEM SOC, V135, P18549, DOI 10.1021/ja408827d; Balasubramanian R, 2011, J BIOL CHEM, V286, P37313, DOI 10.1074/jbc.M111.284984; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Brusseau GA, 1990, BIODEGRADATION, V1, P19, DOI 10.1007/BF00117048; Calderone V, 2005, P NATL ACAD SCI USA, V102, P51, DOI 10.1073/pnas.0408254101; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cobine PA, 2002, BIOCHEMISTRY-US, V41, P5822, DOI 10.1021/bi025515c; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; DAVIES SL, 1970, J GEN MICROBIOL, V61, P227, DOI 10.1099/00221287-61-2-227; El Ghazouani A, 2012, P NATL ACAD SCI USA, V109, P8400, DOI 10.1073/pnas.1112921109; El Ghazouani A, 2011, INORG CHEM, V50, P1378, DOI 10.1021/ic101965j; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Haynes CA, 2014, NAT CHEM BIOL, V10, P331, DOI 10.1038/nchembio.1509; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Jiang H, 2010, BIOCHEM ENG J, V49, P277, DOI 10.1016/j.bej.2010.01.003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Kharenko OA, 2005, J AM CHEM SOC, V127, P7678, DOI 10.1021/ja042757m; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murrell JC, 2000, TRENDS MICROBIOL, V8, P221, DOI 10.1016/S0966-842X(00)01739-X; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; POUNTNEY DL, 1994, BIOCHEMISTRY-US, V33, P9699, DOI 10.1021/bi00198a040; REED WM, 1980, J BACTERIOL, V141, P908, DOI 10.1128/JB.141.2.908-913.1980; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Semrau JD, 2013, ENVIRON MICROBIOL, V15, P3077, DOI 10.1111/1462-2920.12150; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stafford GP, 2003, MICROBIOL-SGM, V149, P1771, DOI 10.1099/mic.0.26060-0; Stein LY, 2010, J BACTERIOL, V192, P6497, DOI 10.1128/JB.01144-10; Sutherland DEK, 2011, METALLOMICS, V3, P444, DOI 10.1039/c0mt00102c; Theil EC, 2011, CURR OPIN CHEM BIOL, V15, P304, DOI 10.1016/j.cbpa.2011.01.004; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Xiao ZG, 2008, INORG CHEM, V47, P4338, DOI 10.1021/ic702440e; Xie F, 2010, J INORG BIOCHEM, V104, P261, DOI 10.1016/j.jinorgbio.2009.12.005	57	61	61	2	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					140	+		10.1038/nature14854	http://dx.doi.org/10.1038/nature14854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26308900	Green Accepted			2022-12-28	WOS:000360594100041
J	Yusuf, A; Vadhwana, B; Mohite, U; Collins, C				Yusuf, Abdulkani; Vadhwana, Bhamini; Mohite, Ujjwala; Collins, Carole			CASE REVIEW A premenopausal woman with abdominal discomfort and iron deficiency anaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CELIAC-DISEASE; DIAGNOSIS; ASSOCIATION; GUIDELINES; MANAGEMENT		[Yusuf, Abdulkani] Chelsea & Westminster Hosp, Dept Gastroenterol, London, England; [Vadhwana, Bhamini] North Middlesex Univ Hosp, Dept Surg, London, England; [Mohite, Ujjwala] West Middlesex Univ Hosp, Dept Pathol, London, England; [Collins, Carole] West Middlesex Univ Hosp, Dept Gastroenterol, Histopathol, London, England	Imperial College London	Yusuf, A (corresponding author), Chelsea & Westminster Hosp, Dept Gastroenterol, London, England.	AYusufabdyus12@gmail.com						[Anonymous], 2008, WORLDW PREV AN 1993; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Harper JW, 2007, AM J HEMATOL, V82, P996, DOI 10.1002/ajh.20996; Hernandez Lincoln, 2006, Curr Gastroenterol Rep, V8, P383, DOI 10.1007/s11894-006-0023-7; Hopper AD, 2007, BRIT MED J, V335, P558, DOI 10.1136/bmj.39316.442338.AD; Kupper C, 2005, GASTROENTEROLOGY, V128, pS121, DOI 10.1053/j.gastro.2005.02.024; Liu K, 2012, EUR J GASTROEN HEPAT, V24, P109, DOI 10.1097/MEG.0b013e32834f3140; Ludvigsson JF, 2014, GUT, V63, P1210, DOI 10.1136/gutjnl-2013-306578; Mooney P. D., 2014, BMJ, V348; National Institute for Health and Care Excellence, 2009, COEL DIS REC ASS COE; Osazuwa F, 2011, N AM J MED SCI, V3, P30, DOI 10.4297/najms.2011.330; Presutti J, 2007, AM FAM PHYSICIAN, V76, P1795; Rodrigo L, 2006, WORLD J GASTROENTERO, V12, P6585, DOI 10.3748/wjg.v12.i41.6585; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Short MW, 2013, AM FAM PHYSICIAN, V87, P98; Steele R, 2011, POSTGRAD MED J, V87, P19, DOI 10.1136/pgmj.2008.075838; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C	19	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2015	351								h4664	10.1136/bmj.h4664	http://dx.doi.org/10.1136/bmj.h4664			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9JX	26338052				2022-12-28	WOS:000360931900010
J	Jurecic, A				Jurecic, Ann			The art of medicine No protocol for grief	LANCET			English	Editorial Material									Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Jurecic, A (corresponding author), Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA.	ann.jurecic@rutgers.edu							0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					848	849		10.1016/S0140-6736(15)00053-7	http://dx.doi.org/10.1016/S0140-6736(15)00053-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0MJ	26335869	Bronze			2022-12-28	WOS:000360290000014
J	Hoyt, JM; Schmidt, VA; Tondreau, AM; Chirik, PJ				Hoyt, Jordan M.; Schmidt, Valerie A.; Tondreau, Aaron M.; Chirik, Paul J.			Iron-catalyzed intermolecular [2+2] cycloadditions of unactivated alkenes	SCIENCE			English	Article							ELECTRONIC-STRUCTURE; PHOTOCYCLOADDITIONS; ELUCIDATION	Cycloadditions, such as the [4+2] Diels-Alder reaction to form six-membered rings, are among the most powerful and widely used methods in synthetic chemistry. The analogous [2+2] alkene cycloaddition to synthesize cyclobutanes is kinetically accessible by photochemical methods, but the substrate scope and functional group tolerance are limited. Here, we report iron-catalyzed intermolecular [2+2] cycloaddition of unactivated alkenes and cross cycloaddition of alkenes and dienes as regio- and stereoselective routes to cyclobutanes. Through rational ligand design, development of this base metal-catalyzed method expands the chemical space accessible from abundant hydrocarbon feedstocks.	[Hoyt, Jordan M.; Schmidt, Valerie A.; Tondreau, Aaron M.; Chirik, Paul J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University	Chirik, PJ (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	pchirik@princeton.edu		Tondreau, Aaron/0000-0003-0440-5497	Firmenich; NIH [F32 GM109594]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM109594] Funding Source: NIH RePORTER	Firmenich; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by Firmenich. V.A.S. thanks the NIH for a Ruth L. Kirschstein National Research Award (F32 GM109594).	Bach T, 2002, EUR J ORG CHEM, V2002, P645, DOI 10.1002/1099-0690(200202)2002:4<645::AID-EJOC645>3.0.CO;2-A; Behr A, 2009, CHEMSUSCHEM, V2, P1072, DOI 10.1002/cssc.200900186; Bouwkamp MW, 2006, J AM CHEM SOC, V128, P13340, DOI 10.1021/ja064711u; Brimioulle R, 2013, SCIENCE, V342, P840, DOI 10.1126/science.1244809; Collman J. P., 1987, PRINCIPLES APPL ORGA, P495; Diels O, 1928, LIEBIGS ANN CHEM, V460, P98; Du JN, 2014, SCIENCE, V344, P392, DOI 10.1126/science.1251511; DZHEMILEV UM, 1994, RUSS CHEM B+, V43, P252, DOI 10.1007/BF00695821; Fringuelli F., 2002, DIELS ALDER REACTION; HEIMBACH P, 1973, ANGEW CHEM INT EDIT, V12, P975, DOI 10.1002/anie.197309751; Hoyt JM, 2013, J AM CHEM SOC, V135, P4862, DOI 10.1021/ja400895j; Jones D. S. J., 2006, HDB PETROLEUM PROCES, P389; Lee-Ruff E, 2003, CHEM REV, V103, P1449, DOI 10.1021/cr010013a; Matar S., 1991, CHEM PETROCHEMICAL P; McGuinness DS, 2011, CHEM REV, V111, P2321, DOI 10.1021/cr100217q; Rappoport Z., 2005, CHEM CYCLOBUTANES, P281; Russell SK, 2011, J AM CHEM SOC, V133, P8858, DOI 10.1021/ja202992p; SALOMON RG, 1974, J AM CHEM SOC, V96, P1145, DOI 10.1021/ja00811a031; Schmidt VA, 2015, J AM CHEM SOC, V137, P7903, DOI 10.1021/jacs.5b04034; Trovitch RJ, 2008, J AM CHEM SOC, V130, P11631, DOI 10.1021/ja803296f; WINKLER JD, 1995, CHEM REV, V95, P2003, DOI 10.1021/cr00038a010; WOODWARD RB, 1969, ANGEW CHEM INT EDIT, V8, P781, DOI 10.1002/anie.196907811; ZIMMERMAN H, 2009, ULLMANNS ENCY IND CH	23	135	135	3	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					960	963		10.1126/science.aac7440	http://dx.doi.org/10.1126/science.aac7440			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315433				2022-12-28	WOS:000360646800049
J	Lea, AM; Ryan, MJ				Lea, Amanda M.; Ryan, Michael J.			SEXUAL SELECTION Irrationality in mate choice revealed by tungara frogs	SCIENCE			English	Article							MATING SIGNALS; PREFERENCE; DOMINANCE; ECONOMICS; ABSOLUTE; DECISION; UTILITY; SPACE	Mate choice models derive from traditional microeconomic decision theory and assume that individuals maximize their Darwinian fitness by making economically rational decisions. Rational choices exhibit regularity, whereby the relative strength of preferences between options remains stable when additional options are presented. We tested female frogs with three simulated males who differed in relative call attractiveness and call rate. In binary choice tests, females' preferences favored stimulus caller B over caller A; however, with the addition of an inferior "decoy" C, females reversed their preferences and chose A over B. These results show that the relative valuation of mates is not independent of inferior alternatives in the choice set and therefore cannot be explained with the rational choice models currently used in sexual selection theory.	[Lea, Amanda M.; Ryan, Michael J.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Ryan, Michael J.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian Tropical Research Institute	Lea, AM (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	alea@utexas.edu			NSF [1120031]	NSF(National Science Foundation (NSF))	We thank the Autoridad Nacional del Ambiente for permission to do field work in Panama; the Smithsonian Tropical Research Institute for logistical support; M. Still, S. Beckett, and A. Smejdir for assistance; and M. Jennions and an anonymous reviewer for helpful suggestions on the manuscript. M.J.R. thanks M. Bateson for early conversations on decoys. This study was supported by NSF Integrative Organismal Systems grant 1120031 to M.J.R., R. Taylor, and R. Page and an NSF Predoctoral Fellowship to A.M.L. Procedures were approved by the Institutional Animal Care and Use Committees at The University of Texas at Austin and the Smithsonian Tropical Research Institute (AUP 2011-0825-2014-02). Experimental data are provided in the supplementary materials.	Akre KL, 2011, SCIENCE, V333, P751, DOI 10.1126/science.1205623; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; ARIELY D, 1995, ORGAN BEHAV HUM DEC, V63, P223, DOI 10.1006/obhd.1995.1075; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Birnbaum MH, 1999, ORGAN BEHAV HUM DEC, V77, P44, DOI 10.1006/obhd.1998.2816; Callander S, 2013, BEHAV ECOL, V24, P730, DOI 10.1093/beheco/ars208; COOPER WS, 1987, PSYCHOL REV, V94, P395, DOI 10.1037/0033-295X.94.4.395; COOPER WS, 1989, BIOL PHILOS, V4, P457, DOI 10.1007/BF00162590; Dechaume-Moncharmont FX, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-69; Gasparini C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3072; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kirkpatrick M, 2006, ANIM BEHAV, V71, P1215, DOI 10.1016/j.anbehav.2005.11.010; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; Orr HA, 2007, EVOLUTION, V61, P2997, DOI 10.1111/j.1558-5646.2007.00237.x; Pettibone JC, 2007, J BEHAV DECIS MAKING, V20, P323, DOI 10.1002/bdm.557; Reaney LT, 2009, ANIM BEHAV, V77, P139, DOI 10.1016/j.anbehav.2008.09.019; Ryan Michael J., 2011, P185; Ryan MJ, 2003, EVOLUTION, V57, P2608, DOI 10.1111/j.0014-3820.2003.tb01503.x; Schulz AW, 2013, PHILOS SOC SCI, V43, P46, DOI 10.1177/0048393112463336; Trimmer PC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0858; Tsetsos K, 2010, PSYCHOL REV, V117, P1275, DOI 10.1037/a0020580; TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750	24	71	73	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					964	966		10.1126/science.aab2012	http://dx.doi.org/10.1126/science.aab2012			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315434				2022-12-28	WOS:000360646800050
J	Hermanowicz, A; Debek, W				Hermanowicz, Adam; Debek, Wojciech			Single Bubble - Pyloric Atresia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hermanowicz, Adam; Debek, Wojciech] Med Univ Bialystok, Bialystok, Poland	Medical University of Bialystok	Hermanowicz, A (corresponding author), Med Univ Bialystok, Bialystok, Poland.	ahermanowicz@-wp.pl	Dębek, Wojciech/S-8168-2018; Hermanowicz, ahermanowicz/T-3500-2018	Dębek, Wojciech/0000-0001-6023-8510; Hermanowicz, ahermanowicz/0000-0002-5723-6941					0	1	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					863	863		10.1056/NEJMicm1411375	http://dx.doi.org/10.1056/NEJMicm1411375			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP8VC	26308687				2022-12-28	WOS:000360171700012
J	van Nunen, LX; Zimmermann, FM; Tonino, PAL; Barbato, E; Baumbach, A; Engstrom, T; Klauss, V; MacCarthy, PA; Manoharan, G; Oldroyd, KG; Lee, PNV; van't Veer, M; Fearon, WF; De Bruyne, B; Pijls, NHJ				van Nunen, Lokien X.; Zimmermann, Frederik M.; Tonino, Pim A. L.; Barbato, Emanuele; Baumbach, Andreas; Engstrom, Thomas; Klauss, Volker; MacCarthy, Philip A.; Manoharan, Ganesh; Oldroyd, Keith G.; Lee, Peter N. Ver; van't Veer, Marcel; Fearon, William F.; De Bruyne, Bernard; Pijls, Nico H. J.		FAME Study Investigators	Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial	LANCET			English	Article							OUTCOMES UTILIZING REVASCULARIZATION; PACLITAXEL-ELUTING STENTS; MEDICAL THERAPY; PROGNOSTIC VALUE; GUIDED PCI; INTERVENTION; RISK	Background In the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) study, fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) improved outcome compared with angiography-guided PCI for up to 2 years of follow-up. The aim in this study was to investigate whether the favourable clinical outcome with the FFR-guided PCI in the FAME study persisted over a 5-year follow-up. Methods The FAME study was a multicentre trial done in Belgium, Denmark, Germany, the Netherlands, Sweden, the UK, and the USA. Patients (aged >= 18 years) with multivessel coronary artery disease were randomly assigned to undergo angiography-guided PCI or FFR-guided PCI. Before randomisation, stenoses requiring PCI were identified on the angiogram. Patients allocated to angiography-guided PCI had revascularisation of all identified stenoses. Patients allocated to FFR-guided PCI had FFR measurements of all stenotic arteries and PCI was done only if FFR was 0.80 or less. No one was masked to treatment assignment. The primary endpoint was major adverse cardiac events at 1 year, and the data for the 5-year follow-up are reported here. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00267774. Findings After 5 years, major adverse cardiac events occurred in 31% of patients (154 of 496) in the angiography-guided group versus 28% (143 of 509 patients) in the FFR-guided group (relative risk 0.91, 95% CI 0.75-1.10; p=0.31). The number of stents placed per patient was significantly higher in the angiography-guided group than in the FFR-guided group (mean 2.7 [SD 1.2] vs 1.9 [1.3], p<0.0001). Interpretation The results confirm the long-term safety of FFR-guided PCI in patients with multivessel disease. A strategy of FFR-guided PCI resulted in a significant decrease of major adverse cardiac events for up to 2 years after the index procedure. From 2 years to 5 years, the risks for both groups developed similarly. This clinical outcome in the FFR-guided group was achieved with a lower number of stented arteries and less resource use. These results indicate that FFR guidance of multivessel PCI should be the standard of care in most patients.	[van Nunen, Lokien X.; Zimmermann, Frederik M.; Tonino, Pim A. L.; van't Veer, Marcel; Pijls, Nico H. J.] Catharina Hosp, Dept Cardiol, NL-5623 EJ Eindhoven, Netherlands; [van Nunen, Lokien X.; Zimmermann, Frederik M.; Tonino, Pim A. L.; van't Veer, Marcel; Pijls, Nico H. J.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Barbato, Emanuele; De Bruyne, Bernard] Onze Lieve Vrouw Hosp, Cardiovasc Ctr Aalst, Aalst, Belgium; [Barbato, Emanuele] Univ Naples Federico II, Dept Adv Biomed Sci, Div Cardiol, Naples, Italy; [Baumbach, Andreas] Univ Hosp Bristol NHS Fdn Trust, Bristol Heart Inst, Bristol, Avon, England; [Engstrom, Thomas] Univ Copenhagen, Rigshosp, Ctr Heart, DK-2100 Copenhagen, Denmark; [Klauss, Volker] Univ Hosp, Med Poliklin, Munich, Germany; [MacCarthy, Philip A.] Kings Coll Hosp London, London, England; [Manoharan, Ganesh] Royal Victoria Hosp, Ctr Heart, Belfast BT12 6BA, Antrim, North Ireland; [Oldroyd, Keith G.] Golden Jubilee Natl Hosp, Glasgow, Lanark, Scotland; [Lee, Peter N. Ver] Northeast Cardiol Associates, Bangor, ME USA; [Lee, Peter N. Ver] Eastern Maine Med Ctr, Bangor, ME USA; [Fearon, William F.] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Fearon, William F.] Palo Alto VA Hlth Care Syst, Stanford, CA USA	Catharina Hospital; Eindhoven University of Technology; Cardiovascular Center Aalst; University of Naples Federico II; University of Bristol; Rigshospitalet; University of Copenhagen; University of Munich; King's College Hospital NHS Foundation Trust; King's College Hospital; Golden Jubilee Hospital; Eastern Maine Medical Center; Stanford University	Pijls, NHJ (corresponding author), Catharina Hosp, Dept Cardiol, Michelangelolaan 2, NL-5623 EJ Eindhoven, Netherlands.	nico.pijls@inter.nl.net	Oldroyd, Keith G/C-2281-2014; van nunen, Lokien/GLU-5691-2022	Oldroyd, Keith G/0000-0002-7842-3463; van nunen, Lokien/0000-0003-4650-5381; Barbato, Emanuele/0000-0002-0050-5178; Engstrom, Thomas/0000-0001-5436-9194	St Jude Medical; Heart Foundation; Medtronic; Radi Medical Systems (St Jude Medical); Stichting Vrienden van het Hart Zuidoost Brabant (Heart Foundation)	St Jude Medical(St. Jude Medical); Heart Foundation; Medtronic(Medtronic); Radi Medical Systems (St Jude Medical); Stichting Vrienden van het Hart Zuidoost Brabant (Heart Foundation)	St Jude Medical, Friends of the Heart Foundation, and Medtronic.; Radi Medical Systems (St Jude Medical), Stichting Vrienden van het Hart Zuidoost Brabant (Friends of the Heart Foundation), and Medtronic provided funding for the study.	Dangas GD, 2013, JACC-CARDIOVASC INTE, V6, P914, DOI 10.1016/j.jcin.2013.05.005; De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Fearon WF, 2007, AM HEART J, V154, P632, DOI 10.1016/j.ahj.2007.06.012; Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hachamovitch R, 1998, CIRCULATION, V97, P535; Hachamovitch R, 2011, EUR HEART J, V32, P1012, DOI 10.1093/eurheartj/ehq500; Li J, 2013, EUR HEART J, V34, P1375, DOI 10.1093/eurheartj/eht005; Mancini GBJ, 2014, JACC-CARDIOVASC INTE, V7, P195, DOI 10.1016/j.jcin.2013.10.017; Nam CW, 2011, J AM COLL CARDIOL, V58, P1211, DOI 10.1016/j.jacc.2011.06.020; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012; Ragosta M, 2007, AM J CARDIOL, V99, P896, DOI 10.1016/j.amjcard.2006.11.035; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004; Silber S, 2011, LANCET, V377, P1241, DOI 10.1016/S0140-6736(11)60395-4; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	22	327	335	1	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1853	1860		10.1016/S0140-6736(15)00057-4	http://dx.doi.org/10.1016/S0140-6736(15)00057-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26333474				2022-12-28	WOS:000364194700036
J	Viale, L; Allotey, J; Cheong-See, F; Arroyo-Manzano, D; Mccorry, D; Bagary, M; Mignini, L; Khan, KS; Zamora, J; Thangaratinam, S				Viale, Luz; Allotey, John; Cheong-See, Fiona; Arroyo-Manzano, David; Mccorry, Dougall; Bagary, Manny; Mignini, Luciano; Khan, Khalid S.; Zamora, Javier; Thangaratinam, Shakila		EBM CONNECT Collaboration	Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis	LANCET			English	Article							ANTIEPILEPTIC DRUGS; WOMEN; COMPLICATIONS; DELIVERY; SEIZURES; EXPOSURE; RISK	Background Antenatal care of women with epilepsy is varied. The association of epilepsy and antiepileptic drug exposure with pregnancy outcomes needs to be quantified to guide management. We did a systematic review and meta-analysis to investigate the association between epilepsy and reproductive outcomes, with or without exposure to antiepileptic drugs. Methods We searched MEDLINE, Embase, Cochrane, AMED, and CINAHL between Jan 1, 1990, and Jan 21, 2015, with no language or regional restrictions, for observational studies of pregnant women with epilepsy, which assessed the risk of obstetric complications in the antenatal, intrapartum, or postnatal period, and any neonatal complications. We used the Newcastle-Ottawa Scale to assess the methodological quality of the included studies, risk of bias in the selection and comparability of cohorts, and outcome. We assessed the odds of maternal and fetal complications (excluding congenital malformations) by comparing pregnant women with and without epilepsy and undertook subgroup analysis based on antiepileptic drug exposure in women with epilepsy. We summarised the association as odds ratio (OR; 95% CI) using random effects meta-analysis. The PROSPERO ID of this Systematic Review's protocol is CRD42014007547. Findings Of 7050 citations identified, 38 studies from low-income and high-income countries met our inclusion criteria (39 articles including 2 837 325 pregnancies). Women with epilepsy versus those without (2 809 984 pregnancies) had increased odds of spontaneous miscarriage (OR 1.54, 95% CI 1.02-2.32; I-2=67%), antepartum haemorrhage (1.49, 1.01-2.20; I-2=37%), post-partum haemorrhage (1.29, 1.13-1.49; I-2=41%), hypertensive disorders (1.37, 1.21-1.55; I-2=23%), induction of labour (1.67, 1.31-2.11; I-2=64%), caesarean section (1.40, 1.23-1.58; I-2=66%), any preterm birth (<37 weeks of gestation; 1.16, 1.01-1.34; I-2=64%), and fetal growth restriction (1.26, 1.20-1.33; I-2=1%). The odds of early preterm birth, gestational diabetes, fetal death or stillbirth, perinatal death, or admission to neonatal intensive care unit did not differ between women with epilepsy and those without the disorder. Interpretation A small but significant association of epilepsy, exposure to antiepileptic drugs, and adverse outcomes exists in pregnancy. This increased risk should be taken into account when counselling women with epilepsy.	[Viale, Luz; Mignini, Luciano] Ctr Rosarino Estudios Perinatales, Rosario, Santa Fe, Argentina; [Allotey, John; Cheong-See, Fiona; Khan, Khalid S.; Zamora, Javier; Thangaratinam, Shakila] Queen Mary Univ London, Barts & London Sch Med & Dent, Womens Hlth Res Unit, London, England; [Arroyo-Manzano, David; Zamora, Javier] Hosp Ramon & Cajal, E-28034 Madrid, Spain; [Mccorry, Dougall] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Bagary, Manny] Birmingham & Solihull Mental Hlth Fdn Trust, Birmingham, W Midlands, England; [Khan, Khalid S.; Thangaratinam, Shakila] Queen Mary Univ London, Multidisciplinary Evidence Synth Hub, London, England; [Zamora, Javier] CIBER Epidemiol & Publ Hlth, Madrid, Spain	University of London; Queen Mary University London; Hospital Universitario Ramon y Cajal; University of Birmingham; University of London; Queen Mary University London; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Zamora, J (corresponding author), Hosp Univ Ramon & Cajal, Madrid 28034, Spain.	javier.zamora@hrc.es	Thangaratinam, Shakila/AAP-3724-2021; Khan, Khalid S/AAT-8824-2020; Zamora, Javier/B-1722-2009; Zamora, Javier/AEO-0608-2022	Thangaratinam, Shakila/0000-0002-4254-460X; Khan, Khalid S/0000-0001-5084-7312; Zamora, Javier/0000-0003-4901-588X; Zamora, Javier/0000-0003-4901-588X; Cheong-See, Fiona/0000-0002-7688-0492; Meads, Catherine/0000-0002-2368-0665; von Dadelszen, Peter/0000-0003-4136-3070; Arroyo-Manzano, David/0000-0002-9210-7002	EBM CONNECT Collaboration; European Union [247613, 101377]; Canadian Institutes of Health Research	EBM CONNECT Collaboration; European Union(European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	EBM CONNECT Collaboration.; We received funding from the European Union made available to the EBM CONNECT Collaboration through its Seventh Framework Programme, Marie Curie Actions, International Staff Exchange Scheme (proposal number 101377; grant agreement number 247613), which contributed to LV's travel to the UK. EBM CONNECT Canadian Collaborators received funding from the Canadian Institutes of Health Research.	Al Bunyan M, 1999, SEIZURE-EUR J EPILEP, V8, P26, DOI 10.1053/seiz.1998.0239; [Anonymous], 2012, REV MAN US GUID VERS; Bech BH, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5159; Borthen I, 2011, BJOG-INT J OBSTET GY, V118, P956, DOI 10.1111/j.1471-0528.2011.03004.x; Borthen I, 2010, BJOG-INT J OBSTET GY, V117, P1537, DOI 10.1111/j.1471-0528.2010.02694.x; Borthen I, 2009, BJOG-INT J OBSTET GY, V116, P1736, DOI 10.1111/j.1471-0528.2009.02354.x; Borthen I, 2012, CURR OPIN OBSTET GYN, V24, P78, DOI 10.1097/GCO.0b013e32834feb6a; Cassina M, 2013, REPROD TOXICOL, V39, P50, DOI 10.1016/j.reprotox.2013.04.002; Chen YH, 2009, ARCH NEUROL-CHICAGO, V66, P979, DOI 10.1001/archneurol.2009.142; Delmis J, 1991, Jugosl Ginekol Perinatol, V31, P23; Edey S, 2014, EPILEPSIA, V55, pE72, DOI 10.1111/epi.12621; Endo S, 2004, EPILEPSIA, V45, P42, DOI 10.1111/j.0013-9580.2004.458009.x; Fairgrieve SD, 2000, BRIT MED J, V321, P674, DOI 10.1136/bmj.321.7262.674; Goel P, 2005, INTERNET J GYNECOL O, V5; Harden CL, 2009, NEUROLOGY, V73, P126, DOI 10.1212/WNL.0b013e3181a6b2f8; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hunt S, 2006, NEUROLOGY, V67, P1876, DOI 10.1212/01.wnl.0000244491.48937.55; Hvas CL, 2000, BRIT J OBSTET GYNAEC, V107, P896, DOI 10.1111/j.1471-0528.2000.tb11089.x; Jadhav SV, 2013, INDIAN MED GAZETTE; Katz O, 2006, J MATERN-FETAL NEO M, V19, P21, DOI 10.1080/14767050500434096; Kilic D, 2014, EPILEPSIA, V55, P1714, DOI 10.1111/epi.12758; Klein A, 2013, EPILEPSY CURR, V13, P429; Kulaga S, 2010, PHARMACOEPIDEM DR S, V19, pS45; Laskowska M, 2001, GYNECOL OBSTET INVES, V51, P99, DOI 10.1159/000052902; Laskowska Marzena, 2002, Ginekol Pol, V73, P35; Lin HL, 2009, J NEUROL, V256, P1742, DOI 10.1007/s00415-009-5222-3; Barroso FVL, 2015, J MATERN-FETAL NEO M, V28, P1445, DOI 10.3109/14767058.2014.955006; Mawer G, 2010, SEIZURE-EUR J EPILEP, V19, P112, DOI 10.1016/j.seizure.2009.11.008; McPherson JA, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.048; Meador KJ, 2006, NEUROLOGY, V67, P407, DOI 10.1212/01.wnl.0000227919.81208.b2; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Morrell MJ, 2002, AM FAM PHYSICIAN, V66, P1489; Najafi Mohammad Reza, 2012, Adv Biomed Res, V1, P4, DOI 10.4103/2277-9175.94426; National Institute of Clinical Excellence, 2011, EP DIAGN MAN EP AD C; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Olafsson E, 1998, EPILEPSIA, V39, P887, DOI 10.1111/j.1528-1157.1998.tb01186.x; Richmond JR, 2004, AM J OBSTET GYNECOL, V190, P371, DOI 10.1016/j.ajog.2003.09.020; Sabers A, 1998, ACTA NEUROL SCAND, V97, P164; Saleh AM, 2008, SAUDI MED J, V29, P261; Sawhney H, 1996, INT J GYNECOL OBSTET, V54, P17, DOI 10.1016/0020-7292(96)02683-5; *SCOTT INT GUID NE, 2003, DIAGN MAN EP AD NAT; SONNEVELD SW, 1990, AUST NZ J OBSTET GYN, V30, P286, DOI 10.1111/j.1479-828X.1990.tb02012.x; StataCorp, 2013, STATA STAT SOFTW REL; STEEGERSTHEUNISSEN RPM, 1994, EPILEPSY RES, V18, P261, DOI 10.1016/0920-1211(94)90046-9; TANGANELLI P, 1992, NEUROLOGY, V42, P89; Thomas SV, 2009, SEIZURE-EUR J EPILEP, V18, P163, DOI 10.1016/j.seizure.2008.08.010; Vanya M, 2013, EUR J CONTRACEP REPR, V18, pS254; Veiby G, 2009, EPILEPSIA, V50, P2130, DOI 10.1111/j.1528-1167.2009.02147.x; Venturella A, 2012, AM J OBSTET GYNECOL, V206, pS152, DOI 10.1016/j.ajog.2011.10.338; Viale L, 2014, RISK ADVERSE PREGNAN; Viinikainen K, 2006, EPILEPSIA, V47, P186, DOI 10.1111/j.1528-1167.2006.00386.x; WATERS CH, 1994, ARCH NEUROL-CHICAGO, V51, P250, DOI 10.1001/archneur.1994.00540150044014; Wells G, 2000, P 3 S SYST REV BAS S	53	135	142	1	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1845	1852		10.1016/S0140-6736(15)00045-8	http://dx.doi.org/10.1016/S0140-6736(15)00045-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26318519	Green Submitted			2022-12-28	WOS:000364194700035
J	Ding, K; Gulec, A; Johnson, AM; Schweitzer, NM; Stucky, GD; Marks, LD; Stair, PC				Ding, Kunlun; Gulec, Ahmet; Johnson, Alexis M.; Schweitzer, Neil M.; Stucky, Galen D.; Marks, Laurence D.; Stair, Peter C.			Identification of active sites in CO oxidation and water-gas shift over supported Pt catalysts	SCIENCE			English	Article							CARBON-MONOXIDE OXIDATION; INFRARED-SPECTRA; TEMPERATURE; PLATINUM; SINGLE; GOLD; FTIR; ATOM; ADSORPTION; PT/AL2O3	Identification and characterization of catalytic active sites are the prerequisites for an atomic-level understanding of the catalytic mechanism and rational design of high-performance heterogeneous catalysts. Indirect evidence in recent reports suggests that platinum (Pt) single atoms are exceptionally active catalytic sites. We demonstrate that infrared spectroscopy can be a fast and convenient characterization method with which to directly distinguish and quantify Pt single atoms from nanoparticles. In addition, we directly observe that only Pt nanoparticles show activity for carbon monoxide (CO) oxidation and water-gas shift at low temperatures, whereas Pt single atoms behave as spectators. The lack of catalytic activity of Pt single atoms can be partly attributed to the strong binding of CO molecules.	[Ding, Kunlun; Johnson, Alexis M.; Stair, Peter C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Gulec, Ahmet; Marks, Laurence D.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Schweitzer, Neil M.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Stucky, Galen D.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Stair, Peter C.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA	Northwestern University; Northwestern University; Northwestern University; University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Argonne National Laboratory	Stair, PC (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	pstair@northwestern.edu	Ding, Kunlun/D-3292-2012; Schweitzer, Neil/Q-3501-2017; Marks, Laurence/B-7527-2009	Schweitzer, Neil/0000-0002-8284-6944; Gulec, Ahmet/0000-0003-0729-7997	U.S. National Science Foundation [CHE-1058835]; Northwestern University Institute for Catalysis in Energy Processes (ICEP) [DOE DE-FG02-03-ER15457]; National Science Foundation [DMR-0959470]; Materials Research and Engineering Center program at the Materials Research Center [NSF DMR-1121262]; International Institute for Nanotechnology (IIN); Keck Foundation; state of Illinois through the IIN	U.S. National Science Foundation(National Science Foundation (NSF)); Northwestern University Institute for Catalysis in Energy Processes (ICEP); National Science Foundation(National Science Foundation (NSF)); Materials Research and Engineering Center program at the Materials Research Center; International Institute for Nanotechnology (IIN); Keck Foundation(W.M. Keck Foundation); state of Illinois through the IIN	We acknowledge funding from the U.S. National Science Foundation CHE-1058835 (K.D., A.M.J., and P.C.S.) and the Northwestern University Institute for Catalysis in Energy Processes (ICEP) on grant DOE DE-FG02-03-ER15457 (K.D., A.G., N.M.S., L.D.M., and P.C.S.). This work made use of the JEOL JEM-ARM200CF in the Electron Microscopy Service [Research Resources Center, University of Illinois at Chicago (UIC)]. The acquisition of the UIC JEOL JEM-ARM200CF was supported by a MRI-R2 grant from the National Science Foundation [DMR-0959470]. This work also made use of the Electron Probe Instrumentation Center (EPIC) facility and Keck-II facility of Northwestern University's Atomic and Nanoscale Characterization Experimental Center (NUANCE), which has received support from the Materials Research and Engineering Center program (NSF DMR-1121262) at the Materials Research Center; the International Institute for Nanotechnology (IIN); the Keck Foundation; and the state of Illinois, through the IIN. We acknowledge useful discussion with W. Wu (Northwestern University) regarding the infrared data interpretation. All data and images are available in the body of the paper or as supplementary materials.	Allian AD, 2011, J AM CHEM SOC, V133, P4498, DOI 10.1021/ja110073u; ANDERSON JA, 1992, J CHEM SOC FARADAY T, V88, P1197, DOI 10.1039/ft9928801197; Boccuzzi F, 1996, J PHYS CHEM-US, V100, P3625, DOI 10.1021/jp952259n; Chakarova K, 2005, MICROPOR MESOPOR MAT, V81, P305, DOI 10.1016/j.micromeso.2005.01.033; CROSSLEY A, 1977, SURF SCI, V68, P528, DOI 10.1016/0039-6028(77)90245-X; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Gracia FJ, 2003, J CATAL, V220, P382, DOI 10.1016/S0021-9517(03)00296-3; Green IX, 2011, SCIENCE, V333, P736, DOI 10.1126/science.1207272; Heiz U, 1999, J AM CHEM SOC, V121, P3214, DOI 10.1021/ja983616l; HERZ RK, 1984, APPL SURF SCI, V19, P373, DOI 10.1016/0378-5963(84)90074-6; Herzing AA, 2008, SCIENCE, V321, P1331, DOI 10.1126/science.1159639; Kaden WE, 2009, SCIENCE, V326, P826, DOI 10.1126/science.1180297; Kaspar J, 2003, CATAL TODAY, V77, P419, DOI 10.1016/S0920-5861(02)00384-X; Kistler JD, 2014, ANGEW CHEM INT EDIT, V53, P8904, DOI 10.1002/anie.201403353; Korotkikh O, 2000, CATAL TODAY, V62, P249, DOI 10.1016/S0920-5861(00)00426-0; Kuriyama M, 2007, J CATAL, V252, P39, DOI 10.1016/j.jcat.2007.09.001; LOEWENSTEIN W, 1954, AM MINERAL, V39, P92; Moses-DeBusk M, 2013, J AM CHEM SOC, V135, P12634, DOI 10.1021/ja401847c; OLSEN CW, 1988, SURF SCI, V201, P444, DOI 10.1016/0039-6028(88)90496-7; Pavlenko N, 2001, SURF SCI, V489, P29, DOI 10.1016/S0039-6028(01)01180-3; Pazmino JH, 2012, J CATAL, V286, P279, DOI 10.1016/j.jcat.2011.11.017; Pedrero C, 2005, J CATAL, V233, P242, DOI 10.1016/j.jcat.2005.04.005; Peterson EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5885; Pigos JM, 2007, APPL CATAL A-GEN, V319, P47, DOI 10.1016/j.apcata.2006.11.014; Qiao BT, 2011, NAT CHEM, V3, P634, DOI [10.1038/nchem.1095, 10.1038/NCHEM.1095]; Ratnasamy C, 2009, CATAL REV, V51, P325, DOI 10.1080/01614940903048661; Tibiletti D, 2005, J PHYS CHEM B, V109, P22553, DOI 10.1021/jp054576s; Visser T, 2005, J PHYS CHEM B, V109, P3822, DOI 10.1021/jp044767f; Xu Q, 2002, COORDIN CHEM REV, V231, P83, DOI 10.1016/S0010-8545(02)00115-7; Yang C., 1957, J PHYS CHEM-US, V61, P1504; Yang M, 2014, SCIENCE, V346, P1498, DOI 10.1126/science.1260526; YATES JT, 1979, J CHEM PHYS, V70, P1219, DOI 10.1063/1.437603; Zaera F, 2014, CHEM SOC REV, V43, P7624, DOI 10.1039/c3cs60374a; Zhai YP, 2010, SCIENCE, V329, P1633, DOI 10.1126/science.1192449; Zhu XL, 2011, J CATAL, V278, P123, DOI 10.1016/j.jcat.2010.11.023; Zhu XL, 2009, CATAL LETT, V129, P135, DOI 10.1007/s10562-008-9799-4	36	690	698	89	1214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					189	192		10.1126/science.aac6368	http://dx.doi.org/10.1126/science.aac6368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26338796	Bronze			2022-12-28	WOS:000362405600034
J	Hsu, TYT; Simon, LM; Neill, NJ; Marcotte, R; Sayad, A; Bland, CS; Echeverria, GV; Sun, TT; Kurley, SJ; Tyagi, S; Karlin, KL; Dominguez-Vidana, R; Hartman, JD; Renwick, A; Scorsone, K; Bernardi, RJ; Skinner, SO; Jain, A; Orellana, M; Lagisetti, C; Golding, I; Jung, SY; Neilson, JR; Zhang, XHF; Cooper, TA; Webb, TR; Neel, BG; Shaw, CA; Westbrook, TF				Hsu, Tiffany Y. -T.; Simon, Lukas M.; Neill, Nicholas J.; Marcotte, Richard; Sayad, Azin; Bland, Christopher S.; Echeverria, Gloria V.; Sun, Tingting; Kurley, Sarah J.; Tyagi, Siddhartha; Karlin, Kristen L.; Dominguez-Vidana, Rocio; Hartman, Jessica D.; Renwick, Alexander; Scorsone, Kathleen; Bernardi, Ronald J.; Skinner, Samuel O.; Jain, Antrix; Orellana, Mayra; Lagisetti, Chandraiah; Golding, Ido; Jung, Sung Y.; Neilson, Joel R.; Zhang, Xiang H-F.; Cooper, Thomas A.; Webb, Thomas R.; Neel, Benjamin G.; Shaw, Chad A.; Westbrook, Thomas F.			The spliceosome is a therapeutic vulnerability in MYC-driven cancer	NATURE			English	Article							C-MYC; BREAST-CANCER; GENE; PROTEIN; CELLS; TRANSCRIPTION; PRINCIPLES; INITIATION; GROWTH	MYC (also known as c-MYC) overexpression or hyperactivation is one of the most common drivers of human cancer. Despite intensive study, the MYC oncogene remains recalcitrant to therapeutic inhibition. MYC is a transcription factor, and many of its protumorigenic functions have been attributed to its ability to regulate gene expression programs(1-3). Notably, oncogenic MYC activation has also been shown to increase total RNA and protein production in many tissue and disease contexts(4-7). While such increases in RNA and protein production may endow cancer cells with pro-tumour hallmarks, this increase in synthesis may also generate new or heightened burden on MYC-driven cancer cells to process these macromolecules properly(8). Here we discover that the spliceosome is a new target of oncogenic stress in MYC-driven cancers. We identify BUD31 as a MYC-synthetic lethal gene in human mammary epithelial cells, and demonstrate that BUD31 is a component of the core spliceosome required for its assembly and catalytic activity. Core spliceosomal factors (such as SF3B1 and U2AF1) associated with BUD31 are also required to tolerate oncogenic MYC. Notably, MYC hyperactivation induces an increase in total precursor messenger RNA synthesis, suggesting an increased burden on the core spliceosome to process pre-mRNA. In contrast to normal cells, partial inhibition of the spliceosome in MYC-hyperactivated cells leads to global intron retention, widespread defects in pre-mRNA maturation, and deregulation of many essential cell processes. Notably, genetic or pharmacological inhibition of the spliceosome in vivo impairs survival, tumorigenicity and metastatic proclivity of MYC-dependent breast cancers. Collectively, these data suggest that oncogenic MYC confers a collateral stress on splicing, and that components of the spliceosome may be therapeutic entry points for aggressive MYC-driven cancers.	[Hsu, Tiffany Y. -T.; Neill, Nicholas J.; Bland, Christopher S.; Sun, Tingting; Kurley, Sarah J.; Tyagi, Siddhartha; Karlin, Kristen L.; Dominguez-Vidana, Rocio; Skinner, Samuel O.; Jain, Antrix; Orellana, Mayra; Golding, Ido; Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Hsu, Tiffany Y. -T.; Dominguez-Vidana, Rocio; Neilson, Joel R.; Westbrook, Thomas F.] Baylor Coll Med, Interdept Program Mol & Biomed Sci, Houston, TX 77030 USA; [Hsu, Tiffany Y. -T.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Hsu, Tiffany Y. -T.; Simon, Lukas M.; Neill, Nicholas J.; Bland, Christopher S.; Sun, Tingting; Kurley, Sarah J.; Tyagi, Siddhartha; Karlin, Kristen L.; Dominguez-Vidana, Rocio; Hartman, Jessica D.; Renwick, Alexander; Orellana, Mayra; Shaw, Chad A.; Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Marcotte, Richard; Sayad, Azin] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2C4, Canada; [Echeverria, Gloria V.; Neilson, Joel R.; Cooper, Thomas A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Echeverria, Gloria V.; Cooper, Thomas A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Echeverria, Gloria V.; Cooper, Thomas A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Scorsone, Kathleen; Bernardi, Ronald J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Skinner, Samuel O.; Golding, Ido] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Lagisetti, Chandraiah] SRI Int, Ctr Chem Biol, Biosci Div, Menlo Pk, CA 94025 USA; [Zhang, Xiang H-F.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Neel, Benjamin G.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 2J7, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; SRI International; Baylor College of Medicine; University of Toronto	Westbrook, TF (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	thomasw@bcm.edu	Jain, Antrix/AEB-7319-2022; Vidana, Rocio Dominguez/A-1153-2009; Tyagi, siddhartha/J-1838-2019	Jain, Antrix/0000-0002-2815-3645; Vidana, Rocio Dominguez/0000-0003-3855-5178; , SIDDHARTHA/0000-0001-5543-4787; Jung, Sung Yun/0000-0003-1521-7977; Neilson, Joel R./0000-0002-3408-608X; Kurley, Sarah/0000-0002-4127-1443; Simon, Lukas/0000-0001-6148-8861; Neill, Nicholas/0000-0003-4205-3488; Echeverria, Gloria/0000-0002-3772-9298; Zhang, Xiang/0000-0002-5674-8670; Hartman, Jessica/0000-0003-1578-3389	NIH [NCI 1F30CA180447, 1R01CA178039-01, U54-CA149196]; CPRIT [RP101499, RP120583]; Gillson Longenbaugh Foundation; Alex's Lemonade Stand Foundation; Susan G. Komen for the Cure [KG090355]; DOD Breast Cancer Research Program [BC120604];  [NCI P30CA125123]; Direct For Mathematical & Physical Scien [1147498] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA178039, U54CA149196, R01CA140474, F30CA180447, R21CA185769] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837, R25GM056929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Gillson Longenbaugh Foundation; Alex's Lemonade Stand Foundation; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); DOD Breast Cancer Research Program(United States Department of Defense); ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank J. Rosen, S. Butler, K. Neugebauer, M. Moore, S. Elledge, T. Davoli, members of T.F.W., C.A.S. and T.A.C. laboratories for comments, and P. Yu for bioinformatics support. The authors also acknowledge the joint participation by Adrienne Helis Melvin Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with Baylor College of Medicine for cancer research. The Dan L. Duncan Cancer Center Shared Resources was supported by the NCI P30CA125123 Center Grant and provided technical assistance including Cell-Based Assay Screening Service (D. Liu), Genomic and RNA Profiling Resource (L. White), Biostatistics & Informatics Shared Resource (S. Hilsenbeck), Cytometry and Cell Sorting (J. Sederstrom; P30 AI036211 and S10 RR024574), and the Proteomics and Metabolomics Core Facility (Cancer Prevention and Research Institute of Texas, RP12009). T.Y.-T.H. was supported by NIH pre-doctoral fellowship (NCI 1F30CA180447) and CPRIT training grant (RP101499). M.O. and R.J.B. were supported by The Gillson Longenbaugh Foundation. R.J.B. was supported by Alex's Lemonade Stand Foundation. T.F.W. was supported by CPRIT (RP120583), the Susan G. Komen for the Cure (KG090355), the NIH (1R01CA178039-01 and U54-CA149196) and the DOD Breast Cancer Research Program (BC120604).	Adler AS, 2014, GENE DEV, V28, P1068, DOI 10.1101/gad.237206.113; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Cunningham JT, 2014, CELL, V157, P1088, DOI 10.1016/j.cell.2014.03.052; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Echeverria GV, 2014, NUCLEIC ACIDS RES, V42, P1893, DOI 10.1093/nar/gkt1020; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; Lagisetti C, 2013, J MED CHEM, V56, P10033, DOI 10.1021/jm401370h; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin CJ, 2012, CELL REPORTS, V1, P325, DOI 10.1016/j.celrep.2012.02.010; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Masciadri B, 2004, BIOCHEM BIOPH RES CO, V320, P1342, DOI 10.1016/j.bbrc.2004.05.228; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mezquita P, 2005, ONCOGENE, V24, P889, DOI 10.1038/sj.onc.1208251; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sabo A, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014191; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; ZAPP ML, 1989, NUCLEIC ACIDS RES, V17, P2655, DOI 10.1093/nar/17.7.2655	39	284	301	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					384	+		10.1038/nature14985	http://dx.doi.org/10.1038/nature14985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26331541	Green Accepted			2022-12-28	WOS:000361297900045
J	Mou, Y; Yu, JY; Wannier, TM; Guo, CL; Mayo, SL				Mou, Yun; Yu, Jiun-Yann; Wannier, Timothy M.; Guo, Chin-Lin; Mayo, Stephen L.			Computational design of co-assembling protein-DNA nanowires	NATURE			English	Article							BINDING-SPECIFICITY; STABILITY	Biomolecular self-assemblies are of great interest to nanotechnologists because of their functional versatility and their biocompatibility(1). Over the past decade, sophisticated single-component nanostructures composed exclusively of nucleic acids(2-5), peptides(6-8) and proteins(9-15) have been reported, and these nanostructures have been used in a wide range of applications, from drug delivery(16) to molecular computing(17). Despite these successes, the development of hybrid co-assemblies of nucleic acids and proteins has remained elusive. Here we use computational protein design to create a protein-DNA co-assembling nanomaterial whose assembly is driven via non-covalent interactions. To achieve this, a homodimerization interface is engineered onto the Drosophila Engrailed homeodomain (ENH), allowing the dimerized protein complex to bind to two double-stranded DNA (dsDNA) molecules. By varying the arrangement of protein-binding sites on the dsDNA, an irregular bulk nanoparticle or a nanowire with single-molecule width can be spontaneously formed by mixing the protein and dsDNA building blocks. We characterize the protein-DNA nanowire using fluorescence microscopy, atomic force microscopy and X-ray crystallography, confirming that the nanowire is formed via the proposed mechanism. This work lays the foundation for the development of new classes of protein-DNA hybrid materials. Further applications can be explored by incorporating DNA origami, DNA aptamers and/or peptide epitopes into the protein-DNA framework presented here.	[Mou, Yun; Mayo, Stephen L.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Yu, Jiun-Yann; Wannier, Timothy M.; Mayo, Stephen L.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Guo, Chin-Lin] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Mou, Y (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	mouung@caltech.edu; steve@mayo.caltech.edu	Guo, Chin-Lin/AAP-9999-2021; Wannier, Timothy/ABD-5479-2020; Mou, Yun/O-1080-2018	Guo, Chin-Lin/0000-0002-8055-9482; Mou, Yun/0000-0001-5423-9031; Wannier, Timothy/0000-0002-4165-4751	Defense Advanced Research Projects Agency Protein Design Processes Program, a National Security Science and Engineering Faculty Fellowship (NSSEFF) [N00244-09-1-0011, N00244-09-1-0082]; Gordon and Betty Moore Foundation [GBMF2809]; Gordon and Betty Moore Foundation; Department of Energy; National Institutes of Health	Defense Advanced Research Projects Agency Protein Design Processes Program, a National Security Science and Engineering Faculty Fellowship (NSSEFF); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Defense Advanced Research Projects Agency Protein Design Processes Program, a National Security Science and Engineering Faculty Fellowship (NSSEFF N00244-09-1-0011, N00244-09-1-0082), and the Gordon and Betty Moore Foundation through grant GBMF2809 to the Caltech Programmable Molecular Technology Initiative. We would like to acknowledge the Gordon and Betty Moore Foundation for support of the Molecular Observatory at Caltech, and the Department of Energy and National Institutes of Health for supporting the Stanford Synchrotron Radiation Lightsource. We thank J. Kaiser, J. Hoy and P. Nikolovski at the Caltech Molecular Observatory for assistance in crystal screening and crystallographic data collection. Y.M. thanks L.-C. Ho for her encouragement and literature research in the crystallographic work. Y.M. thanks T.J. Zwang for assistance with AFM measurements. Y.M. thanks X. Zhang and S. Yan for the useful discussion. We are grateful to J. Kostecki and M. Ary for assistance with the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen BD, 2006, J COMPUT CHEM, V27, P1071, DOI 10.1002/jcc.20420; Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/nnano.2014.58, 10.1038/NNANO.2014.58]; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Chang M, 2011, ACS NANO, V5, P6156, DOI 10.1021/nn200693a; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Draganescu A, 1998, J MOL BIOL, V276, P529, DOI 10.1006/jmbi.1997.1567; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Guerrero L, 2005, J AM CHEM SOC, V127, P15624, DOI 10.1021/ja0550428; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Huang PS, 2005, J COMPUT CHEM, V26, P1222, DOI 10.1002/jcc.20252; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Marshall SA, 2002, J MOL BIOL, V316, P189, DOI 10.1006/jmbi.2001.5326; Mou Y, 2015, P NATL ACAD SCI USA, V112, P10714, DOI 10.1073/pnas.1505072112; Mou Y, 2015, J MOL BIOL, V427, P2697, DOI 10.1016/j.jmb.2015.06.006; Niemeyer CM, 2002, CHEMBIOCHEM, V3, P242, DOI 10.1002/1439-7633(20020301)3:2/3<242::AID-CBIC242>3.0.CO;2-F; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shah PS, 2007, J MOL BIOL, V372, P1, DOI 10.1016/j.jmb.2007.06.032; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Thomson AR, 2014, SCIENCE, V346, P485, DOI 10.1126/science.1257452; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Wilner OI, 2009, NANO LETT, V9, P2040, DOI 10.1021/nl900302z; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	40	58	59	5	254	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					230	+		10.1038/nature14874	http://dx.doi.org/10.1038/nature14874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26331548				2022-12-28	WOS:000360927400034
J	Pentland, A				Pentland, Alex			ECONOMICS Simple market models fail the test	NATURE			English	Editorial Material									MIT, Connect Sci & Human Dynam Labs, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Pentland, A (corresponding author), MIT, Connect Sci & Human Dynam Labs, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pentland@mit.edu						[Anonymous], 2014, SOCIAL PHYS SOCIAL N; Braha D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048596; Krause SM, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012815; Naim M., 2013, END POWER BOARDROOMS; Pan W., 2013, MIT SLOAN MANAGE REV, V54, P54404; World Economic Forum, 2014, OUTL GLOB AG 2015	6	5	5	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					190	191		10.1038/nature15215	http://dx.doi.org/10.1038/nature15215			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9IM	26331547				2022-12-28	WOS:000360927400020
J	Schumacher, MA; Tonthat, NK; Lee, J; Rodriguez-Castaneda, FA; Chinnam, NB; Kalliomaa-Sanford, AK; Ng, IW; Barge, MT; Shaw, PLR; Barilla, D				Schumacher, Maria A.; Tonthat, Nam K.; Lee, Jeehyun; Rodriguez-Castaneda, Fernando A.; Chinnam, Naga Babu; Kalliomaa-Sanford, Anne K.; Ng, Irene W.; Barge, Madhuri T.; Shaw, Porsha L. R.; Barilla, Daniela			DNA SEGREGATION Structures of archaeal DNA segregation machinery reveal bacterial and eukaryotic linkages	SCIENCE			English	Article							CHROMOSOME SEGREGATION; PLASMID; MECHANISM; BINDING; PROTEIN; ORIGIN	Although recent studies have provided a wealth of information about archaeal biology, nothing is known about the molecular basis of DNA segregation in these organisms. Here, we unveil the machinery and assembly mechanism of the archaeal Sulfolobus pNOB8 partition system. This system uses three proteins: ParA; an atypical ParB adaptor; and a centromere-binding component, AspA. AspA utilizes a spreading mechanism to create a DNA superhelix onto which ParB assembles. This supercomplex links to the ParA motor, which contains a bacteria-like Walker motif. The C domain of ParB harbors structural similarity to CenpA, which dictates eukaryotic segregation. Thus, this archaeal system combines bacteria-like and eukarya-like components, which suggests the possible conservation of DNA segregation principles across the three domains of life.	[Schumacher, Maria A.; Tonthat, Nam K.; Lee, Jeehyun; Chinnam, Naga Babu; Shaw, Porsha L. R.] Duke Univ, Dept Biochem, Sch Med, Durham, NC 27710 USA; [Rodriguez-Castaneda, Fernando A.; Kalliomaa-Sanford, Anne K.; Ng, Irene W.; Barge, Madhuri T.; Barilla, Daniela] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Duke University; University of York - UK	Schumacher, MA (corresponding author), Duke Univ, Dept Biochem, Sch Med, 243 Nanaline H Duke,Box 3711, Durham, NC 27710 USA.	maria.schumacher@duke.edu; daniela.barilla@york.ac.uk	chinnam, Nagababu/AFS-2420-2022; Chinnam, Nagababu/ABF-5512-2021	chinnam, Nagababu/0000-0001-8925-5365; Chinnam, Nagababu/0000-0001-8925-5365; Shaw, Porsha/0000-0003-3754-5330; Barilla, Daniela/0000-0002-3486-7492	NIH [GM074815]; UK Biotechnology and Biological Sciences Research Council [BB/F012004/1]; Leverhulme Trust [RPG-245]; DOE Office of Biological and Environmental Research; MINOS at National Center for Biotechnology Information, NIH [R01-GM105404]; BBSRC [BB/F012004/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F012004/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115563, R01GM074815, R01GM105404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); MINOS at National Center for Biotechnology Information, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM074815 (M.A.S) and UK Biotechnology and Biological Sciences Research Council (BB/F012004/1) and Leverhulme Trust (RPG-245) grants (D.B.). SAXS and crystallographic data were collected at the Advanced Light Source (ALS). ALS is a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Office of Basic Energy Sciences, U.S. Department of Energy (DOE), through the Integrated Diffraction Analysis Technologies program, supported by the DOE Office of Biological and Environmental Research. Additional support comes from MINOS at National Center for Biotechnology Information, NIH (R01-GM105404). We thank Q. She for the kind gift of the Sulfolobus NOB8H2 strain and N. Matamala for initial contributions to the project. Coordinates and structure factors have been deposited with the Protein Data Bank, accession numbers 4RS7, 4RS8, 4RSB, 4RSF, 4RU7 and 4RU8.	Bernad R, 2009, EXP CELL RES, V315, P3233, DOI 10.1016/j.yexcr.2009.07.023; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Fibriansah G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048015; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gordon GS, 2000, ANNU REV MICROBIOL, V54, P681, DOI 10.1146/annurev.micro.54.1.681; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Henikoff S, 2012, CHROMOSOMA, V121, P341, DOI 10.1007/s00412-012-0372-y; Hui MP, 2010, P NATL ACAD SCI USA, V107, P4590, DOI 10.1073/pnas.0913060107; Kalliomaa-Sanford AK, 2012, P NATL ACAD SCI USA, V109, P3754, DOI 10.1073/pnas.1113384109; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; McInerney JO, 2014, NAT REV MICROBIOL, V12, P449, DOI 10.1038/nrmicro3271; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pinto UM, 2012, NAT REV MICROBIOL, V10, P755, DOI 10.1038/nrmicro2882; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2012, J BIOL CHEM, V287, P26146, DOI 10.1074/jbc.M112.373696; Schumacher MA, 2012, CURR OPIN STRUC BIOL, V22, P72, DOI 10.1016/j.sbi.2011.11.001; She QX, 1998, EXTREMOPHILES, V2, P417, DOI 10.1007/s007920050087; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Svergun DI, 2000, J APPL CRYSTALLOGR, V33, P530, DOI 10.1107/S0021889800001370; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Valdivia MM, 2009, CURR GENOMICS, V10, P326, DOI 10.2174/138920209788920985; Vecchiarelli AG, 2014, P NATL ACAD SCI USA, V111, P4880, DOI 10.1073/pnas.1401025111; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779	30	31	31	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1120	1124		10.1126/science.aaa9046	http://dx.doi.org/10.1126/science.aaa9046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339031	Green Accepted			2022-12-28	WOS:000360628900046
J	Fox, BW; Tibbetts, RS				Fox, Bennett W.; Tibbetts, Randal S.			NEURODEGENERATION Problems at the nuclear pore	NATURE			English	Editorial Material							C9ORF72 REPEAT EXPANSIONS; HEXANUCLEOTIDE REPEAT; GGGGCC REPEAT; RNA FOCI; ALS; PROTEINS	Expansion of a repetitive DNA sequence is associated with neurodegeneration. Three studies identify genes involved in nuclear import and export that can mediate the toxicity this expansion causes. See Article P.56 & Letter P.129	[Fox, Bennett W.; Tibbetts, Randal S.] Univ Wisconsin, Dept Human Oncol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fox, BW (corresponding author), Univ Wisconsin, Dept Human Oncol, Madison, WI 53706 USA.	rstibbetts@facstaff.wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008505] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008505] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Gomez-Deza J, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0218-y; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Jovicic A., 2015, NATURE NEUROSCI; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Simone R, 2015, FEBS LETT, V589, P1653, DOI 10.1016/j.febslet.2015.05.003; Su ZM, 2014, NEURON, V83, P1043, DOI 10.1016/j.neuron.2014.07.041; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	20	9	10	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					36	37		10.1038/nature15208	http://dx.doi.org/10.1038/nature15208			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26308896				2022-12-28	WOS:000360594100016
J	Kaina, N; Lemoult, F; Fink, M; Lerosey, G				Kaina, Nadege; Lemoult, Fabrice; Fink, Mathias; Lerosey, Geoffroy			Negative refractive index and acoustic superlens from multiple scattering in single negative metamaterials	NATURE			English	Article							SYMMETRY-BREAKING; WAVES	Metamaterials, man-made composite media structured on a scale much smaller than a wavelength, offer surprising possibilities for engineering the propagation of waves(1-6). One of the most interesting of these is the ability to achieve superlensing-that is, to focus or image beyond the diffraction limit(7). This originates from the left-handed behaviour-the property of refracting waves negatively-that is typical of negative index metamaterials(8-10). Yet reaching this goal requires the design of 'double negative' metamaterials, which act simultaneously on the permittivity and permeability in electromagnetics(11,12), or on the density and compressibility in acoustics; this generally implies the use of two different kinds of building blocks(13,14) or specific particles presenting multiple overlapping resonances(15-17). Such a requirement limits the applicability of double negative metamaterials, and has, for example, hampered any demonstration of subwavelength focusing using left-handed acoustic metamaterials(18). Here we show that these strict conditions can be largely relaxed by relying on media that consist of only one type of single resonant unit cell. Specifically, we show with a simple yet general semi-analytical model that judiciously breaking the symmetry of a single negative metamaterial is sufficient to turn it into a double negative one. We then demonstrate that this occurs solely because of multiple scattering of waves off the metamaterial resonant elements, a phenomenon often disregarded in these media owing to their subwavelength patterning. We apply our approach to acoustics and verify through numerical simulations that it allows the realization of negative index acoustic metamaterials based on Helmholtz resonators only. Finally, we demonstrate the operation of a negative index acoustic superlens, achieving subwavelength focusing and imaging with spot width and resolution 7 and 3.5 times better than the diffraction limit, respectively. Our findings have profound implications for the physics of metamaterials, highlighting the role of their subwavelength crystalline structure, and hence entering the realm of metamaterial crystals. This widens the scope of possibilities for designing composite media with novel properties in a much simpler way than has been possible so far.	[Kaina, Nadege; Lemoult, Fabrice; Fink, Mathias; Lerosey, Geoffroy] ESPCI ParisTech, Inst Langevin, F-75005 Paris, France; [Kaina, Nadege; Lemoult, Fabrice; Fink, Mathias; Lerosey, Geoffroy] CNRS, UMR 7587, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Lerosey, G (corresponding author), ESPCI ParisTech, Inst Langevin, 1 Rue Jussieu, F-75005 Paris, France.	geoffroy.lerosey@espci.fr	Fink, Mathias/M-9437-2016	Fink, Mathias/0000-0002-8494-7562; Lemoult, Fabrice/0000-0001-9757-0760	LABEX WIFI (Laboratory of Excellence within the French Program "Investments for the Future") [ANR-10-LABX-24, ANR-10-IDEX-0001-02 PSL*]; Agence Nationale de la Recherche [ANR-13-JS09-0001-01]; French "Direction Generale de l'Armement"	LABEX WIFI (Laboratory of Excellence within the French Program "Investments for the Future"); Agence Nationale de la Recherche(French National Research Agency (ANR)); French "Direction Generale de l'Armement"(French National Research Agency (ANR))	We thank A. Lagendijk for sharing his knowledge of multiple scattering techniques. This work was supported by LABEX WIFI (Laboratory of Excellence within the French Program "Investments for the Future") grants ANR-10-LABX-24 and ANR-10-IDEX-0001-02 PSL*, and by Agence Nationale de la Recherche grant ANR-13-JS09-0001-01. N.K. acknowledges funding from the French "Direction Generale de l'Armement".	Belov PA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.193105; Brunet T, 2015, NAT MATER, V14, P384, DOI [10.1038/NMAT4164, 10.1038/nmat4164]; Christ A, 2008, NANO LETT, V8, P2171, DOI 10.1021/nl0805559; Craster RV, 2012, ACOUSTIC METAMATERIA, V166; de Vries P, 1998, REV MOD PHYS, V70, P447, DOI 10.1103/RevModPhys.70.447; Deymier PA, 2013, SPRINGER SERIES SOLI; Engheta N., 2006, METAMATERIALS PHYS E, DOI 10.1002/0471784192.; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Fokin V, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144302; Guenneau S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/399; Kaina N, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801308; Kante B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2161; Lee SH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.054301; Lemoult F, 2013, NAT PHYS, V9, P55, DOI [10.1038/nphys2480, 10.1038/NPHYS2480]; Lemoult F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.064301; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Li J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.055602; Liang Z., 2013, SCI REP, V3, P1; Liu ZY, 2000, SCIENCE, V289, P1734, DOI 10.1126/science.289.5485.1734; Notomi M, 2000, PHYS REV B, V62, P10696, DOI 10.1103/PhysRevB.62.10696; Papasimakis N, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.253903; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; Sukhovich A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.154301; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Xie YB, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.175501; Yariv A., 1984, OPTICAL WAVES CRYSTA, V5; Zhang S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.194301; Zhu J, 2011, NAT PHYS, V7, P52, DOI 10.1038/NPHYS1804; Zhu R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6510	34	377	384	32	484	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					77	+		10.1038/nature14678	http://dx.doi.org/10.1038/nature14678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26333466				2022-12-28	WOS:000360594100028
J	Davison, J; Moora, M; Opik, M; Adholeya, A; Ainsaar, L; Ba, A; Burla, S; Diedhiou, AG; Hiiesalu, I; Jairus, T; Johnson, NC; Kane, A; Koorem, K; Kochar, M; Ndiaye, C; Partel, M; Reier, U; Saks, U; Singh, R; Vasar, M; Zobel, M				Davison, J.; Moora, M.; Oepik, M.; Adholeya, A.; Ainsaar, L.; Ba, A.; Burla, S.; Diedhiou, A. G.; Hiiesalu, I.; Jairus, T.; Johnson, N. C.; Kane, A.; Koorem, K.; Kochar, M.; Ndiaye, C.; Paertel, M.; Reier, Ue.; Saks, Ue.; Singh, R.; Vasar, M.; Zobel, M.			Global assessment of arbuscular mycorrhizal fungus diversity reveals very low endemism	SCIENCE			English	Article							COMMUNITY COMPOSITION; PLANT DIVERSITY; DISPERSAL; PATTERNS; ENVIRONMENT; GRADIENTS; DRIVERS	The global biogeography of microorganisms remains largely unknown, in contrast to the well-studied diversity patterns of macroorganisms. We used arbuscular mycorrhizal (AM) fungus DNA from 1014 plant-root samples collected worldwide to determine the global distribution of these plant symbionts. We found that AM fungal communities reflected local environmental conditions and the spatial distance between sites. However, despite AM fungi apparently possessing limited dispersal ability, we found 93% of taxa on multiple continents and 34% on all six continents surveyed. This contrasts with the high spatial turnover of other fungal taxa and with the endemism displayed by plants at the global scale. We suggest that the biogeography of AM fungi is driven by unexpectedly efficient dispersal, probably via both abiotic and biotic vectors, including humans.	[Davison, J.; Moora, M.; Oepik, M.; Ainsaar, L.; Hiiesalu, I.; Jairus, T.; Koorem, K.; Paertel, M.; Reier, Ue.; Saks, Ue.; Vasar, M.; Zobel, M.] Univ Tartu, Inst Ecol & Earth Sci, Lai 40, EE-51005 Tartu, Estonia; [Adholeya, A.; Burla, S.] India Habitat Ctr, Ctr Mycorrhizal Res, Energy & Resources Inst TERI, New Delhi 110003, India; [Ba, A.] Univ Antilles, Lab Symbioses Trop & Mediterraneennes, Lab Biol & Physiol Vegetales, Fac Sci Exactes & Nat,UMR 113, Pointe A Pitre 97159, Guadeloupe, France; [Diedhiou, A. G.; Kane, A.; Ndiaye, C.] UCAD, Inst Rech Dev, Inst Senegalais Rech Agr, Lab Commun Microbiol,Dept Biol Vegetale, Dakar, Senegal; [Hiiesalu, I.] Czech Acad Sci, Inst Bot, Trebon 37901, Czech Republic; [Johnson, N. C.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Koorem, K.] Netherlands Inst Ecol, NL-6708 PB Wageningen, Netherlands; [Kochar, M.; Singh, R.] India Habitat Ctr, TERI, Biotechnol & Management Bioresources Div, TERI Deakin Nano Biotechnol Ctr, New Delhi 110003, India	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; TERI University; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite des Antilles; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Northern Arizona University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Davison, J (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Lai 40, EE-51005 Tartu, Estonia.	john.davison@ut.ee; mari.moora@ut.ee; martin.zobel@ut.ee	Öpik, Maarja/A-1765-2008; Ainsaar, Leho/U-6039-2018; Johnson, Nancy C/G-7830-2011; Pärtel, Meelis/D-5493-2012; Moora, Mari/D-1961-2009; Zobel, Martin/H-1336-2015; KNAW, NIOO-KNAW/A-4320-2012	Öpik, Maarja/0000-0001-8025-7460; Pärtel, Meelis/0000-0002-5874-0138; Moora, Mari/0000-0002-4819-7506; Zobel, Martin/0000-0001-7957-6704; KNAW, NIOO-KNAW/0000-0002-3835-159X; Hiiesalu, Inga/0000-0002-5457-2376; DIEDHIOU, Abdala Gamby/0000-0002-1790-6883; Ainsaar, Leho/0000-0002-0347-9577; BURLA, SASHIDHAR/0000-0002-3676-4809; Koorem, Kadri/0000-0002-3376-9372; Kochar, Mandira/0000-0002-8835-9629	Estonian Science Foundation [9050, 9157]; Estonian Research council [IUT-20-28, IUT-20-29]; European Regional Development Fund (Frontiers in Biodiversity Research Centre of Excellence); U.S. NSF [DEB-0842327]; Estonian Science Foundation [9050, 9157]; Estonian Research council [IUT-20-28, IUT-20-29]; European Regional Development Fund (Frontiers in Biodiversity Research Centre of Excellence); U.S. NSF [DEB-0842327]	Estonian Science Foundation; Estonian Research council(Estonian Research Council); European Regional Development Fund (Frontiers in Biodiversity Research Centre of Excellence); U.S. NSF(National Science Foundation (NSF)); Estonian Science Foundation; Estonian Research council(Estonian Research Council); European Regional Development Fund (Frontiers in Biodiversity Research Centre of Excellence); U.S. NSF(National Science Foundation (NSF))	This research was funded by grants from the Estonian Science Foundation (9050 and 9157), the Estonian Research council (IUT-20-28 and IUT-20-29), the European Regional Development Fund (Frontiers in Biodiversity Research Centre of Excellence), and the U.S. NSF (DEB-0842327 to N.C.J.). We are grateful to colleagues who offered local support and contributed to fieldwork: J. D. Bever, C. Birnbaum, H. Bruelheide, J. J. Cantero, J. Cole, E. Corcket, M. Diallo, K. J. Esler, E. Facelli, J. M. Facelli, L. Gotzenberger, R. Johnson, J. M. Kalwij, A. Koppel, M. E. Leal, J. Liira, E. Louisanna, E. Marcon, E. Mayemba, H. Moora, J. Morgan, V. Neshataeva, J. Paal, A. K. Pandey, C. Phosri, J. N. Price, S. Polme, J. Propster, G. Sharma, K. Shukla, R. Singh, H. Schimann, M. Semchenko, G. Sharma, R. Singh, S. Sitawan, K. Sukla, A. Zobel, E. Vanatoa, and W. Wei. We thank I. A. Dickie for useful comments on the manuscript. All the raw and filtered data are available either in the supplementary materials or from the European Nucleotide Archive (raw data: data set PRJEB9764; representative read set: accession numbers LN615280-LN623520).	Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bonfante P, 2008, TRENDS PLANT SCI, V13, P492, DOI 10.1016/j.tplants.2008.07.001; Bredenkamp GJ, 2002, PLANT ECOL, V163, P209, DOI 10.1023/A:1020957807971; Chagnon PL, 2013, TRENDS PLANT SCI, V18, P484, DOI 10.1016/j.tplants.2013.05.001; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Egan C, 2014, FUNGAL ECOL, V12, P26, DOI 10.1016/j.funeco.2014.06.004; Glassman SI, 2015, NEW PHYTOL, V205, P1619, DOI 10.1111/nph.13240; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Harner MJ, 2011, AQUAT SCI, V73, P35, DOI 10.1007/s00027-010-0157-4; Hazard C, 2013, ISME J, V7, P498, DOI 10.1038/ismej.2012.127; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Heywood V. H., 2007, FLOWERING PLANT FAMI; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kivlin SN, 2014, FUNGAL ECOL, V12, P14, DOI 10.1016/j.funeco.2014.04.004; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; KOSKE RE, 1990, AM J BOT, V77, P466, DOI 10.2307/2444380; Lekberg Y, 2014, NEW PHYTOL, V202, P1101, DOI 10.1111/nph.12758; Lekberg Y, 2011, ECOLOGY, V92, P1292, DOI 10.1890/10-1516.1; Mangan SA, 2002, OECOLOGIA, V131, P587, DOI 10.1007/s00442-002-0907-7; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; MCILVEEN WD, 1976, CAN J BOT, V54, P1486, DOI 10.1139/b76-161; Meiser A, 2014, NEW PHYTOL, V201, P623, DOI 10.1111/nph.12532; Metz J, 2010, J ECOL, V98, P697, DOI 10.1111/j.1365-2745.2010.01652.x; MORTON JB, 1995, CAN J BOT, V73, pS25, DOI 10.1139/b95-221; Opik M, 2014, BOTANY, V92, P135, DOI 10.1139/cjb-2013-0110; Opik M, 2013, MYCORRHIZA, V23, P411, DOI 10.1007/s00572-013-0482-2; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Rosendahl S, 2009, MOL ECOL, V18, P4316, DOI 10.1111/j.1365-294X.2009.04359.x; Schettino A, 2005, GEOPHYS J INT, V163, P727, DOI 10.1111/j.1365-246X.2005.02638.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Varga S, 2015, MYCORRHIZA, V25, P335, DOI 10.1007/s00572-014-0613-4; Veresoglou SD, 2014, PLANT SOIL, V377, P395, DOI 10.1007/s11104-013-2008-2; WARNER NJ, 1987, MYCOLOGIA, V79, P721, DOI 10.2307/3807824; Wilson JB, 2012, J VEG SCI, V23, P796, DOI 10.1111/j.1654-1103.2012.01400.x	40	478	503	45	474	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					970	973		10.1126/science.aab1161	http://dx.doi.org/10.1126/science.aab1161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315436				2022-12-28	WOS:000360646800052
J	Smith, MW; Baran, PS				Smith, Myles W.; Baran, Phil S.			As simple as [2+2]	SCIENCE			English	Editorial Material							CATALYSTS; IRON		[Smith, Myles W.; Baran, Phil S.] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Smith, MW (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	pbaran@scripps.edu						Carruthers W., 1990, CYCLOADDITION REACTI; HEIMBACH P, 1973, ANGEW CHEM INT EDIT, V12, P975, DOI 10.1002/anie.197309751; Hoyt JM, 2015, SCIENCE, V349, P960, DOI 10.1126/science.aac7440; Lee-Ruff E, 2003, CHEM REV, V103, P1449, DOI 10.1021/cr010013a; Nicolaou KC, 2002, ANGEW CHEM INT EDIT, V41, P1668, DOI 10.1002/1521-3773(20020517)41:10<1668::AID-ANIE1668>3.0.CO;2-Z; Small BL, 1998, J AM CHEM SOC, V120, P4049, DOI 10.1021/ja9802100	6	9	9	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					925	926		10.1126/science.aac9883	http://dx.doi.org/10.1126/science.aac9883			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315420				2022-12-28	WOS:000360646800020
J	Ganapathi, L; Somers, M				Ganapathi, Lakshmi; Somers, Michael			A Child with Gross Hematuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ganapathi, Lakshmi; Somers, Michael] Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ganapathi, L (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.	lakshmi.ganapathi@childrens.harvard.edu							0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					E11	E11		10.1056/NEJMicm1410250	http://dx.doi.org/10.1056/NEJMicm1410250			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP8VC	26308700				2022-12-28	WOS:000360171700001
J	Losh, JS; van Hoof, A				Losh, Jillian S.; van Hoof, Ambro			Gateway Arch to the RNA Exosome	CELL			English	Editorial Material							TRAMP COMPLEX; REVEALS	The RNA exosome degrades many different RNAs. Thoms et al. now fill an important gap in our understanding of how the exosome recognizes distinct subsets of target RNAs.	[Losh, Jillian S.; van Hoof, Ambro] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Losh, Jillian S.; van Hoof, Ambro] Univ Texas Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	van Hoof, A (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, 6431 Fannin St,MSB 1-212, Houston, TX 77030 USA.	ambro.van.hoof@uth.tmc.edu		van Hoof, Ambro/0000-0002-7800-9764; Losh, Jillian/0000-0003-4648-6512	NIGMS NIH HHS [R01 GM099790] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099790] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Falk S, 2014, MOL CELL, V55, P856, DOI 10.1016/j.molcel.2014.07.020; Liu JJ, 2014, NAT STRUCT MOL BIOL, V21, P95, DOI 10.1038/nsmb.2736; Losh JS, 2015, NUCLEIC ACIDS RES, V43, P1848, DOI 10.1093/nar/gkv005; Makino DL, 2015, NATURE, V524, P54, DOI 10.1038/nature14865; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107	9	4	5	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					940	941		10.1016/j.cell.2015.08.013	http://dx.doi.org/10.1016/j.cell.2015.08.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317461	Bronze			2022-12-28	WOS:000360589900004
J	Thoms, M; Thomson, E; Bassler, J; Gnadig, M; Griesel, S; Hurt, E				Thoms, Matthias; Thomson, Emma; Bassler, Jochen; Gnaedig, Maren; Griesel, Sabine; Hurt, Ed			The Exosome Is Recruited to RNA Substrates through Specific Adaptor Proteins	CELL			English	Article							PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; CRYSTAL-STRUCTURE; QUALITY-CONTROL; NUCLEAR EXPORT; MESSENGER-RNAS; BINDING-SITES; YEAST; COMPLEX	The exosome regulates the processing, degradation, and surveillance of a plethora of RNA species. However, little is known about how the exosome recognizes and is recruited to its diverse substrates. We report the identification of adaptor proteins that recruit the exosome-associated helicase, Mtr4, to unique RNA substrates. Nop53, the yeast homolog of the tumor suppressor PICT1, targets Mtr4 to pre-ribosomal particles for exosome-mediated processing, while a second adaptor Utp18 recruits Mtr4 to cleaved rRNA fragments destined for degradation by the exosome. Both Nop53 and Utp18 contain the same consensus motif, through which they dock to the "arch'' domain of Mtr4 and target it to specific substrates. These findings show that the exosome employs a general mechanism of recruitment to defined substrates and that this process is regulated through adaptor proteins.	[Thoms, Matthias; Thomson, Emma; Bassler, Jochen; Gnaedig, Maren; Griesel, Sabine; Hurt, Ed] Heidelberg Univ, Biochem Zentrum, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hurt, E (corresponding author), Heidelberg Univ, Biochem Zentrum, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019; Baßler, Jochen/AAC-5336-2021	Ed Hurt, Dr./0000-0002-4535-8255; Baßler, Jochen/0000-0002-7441-7867; Thoms, Matthias/0000-0001-8084-6097	Deutsche Forschungsgemeinschaft (DFG) [HU363/10-5, HU363/12-1, BA2316/1-4, GRK1188]; DFG [HU363/10-5, HU363/12-1, BA2316/1-4]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We are grateful to D. Tollervey (anti-Mtr4), J.R. Warner (anti-Rpl3), B. Stillman (anti-Nop7), A.W. Johnson (anti-Nmd3), E. Tosta (anti-Nsa3), M. Remacha (anti-Rsa4), M. Fromont-Racine (anti-Nog1, anti-Nsa2, and anti-Rlp24) and M. Seedorf (anti-Rpl35) for the kind gift of antibodies. We would also like to thank Dieter Kressler for sharing the pFA6A-FTpA-natNT2 plasmid, along with Martina Kallas and Bettina Bradatsch for performing the Utp18 yeast two-hybrid screen. We thank David Ibberson at the Cell Networks Deep Sequencing Core Facility for performing MiSeq sequencing. This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG) (HU363/10-5, HU363/12-1, and BA2316/1-4) (to E.H. and J.B.), and M.T. was funded by a grant from (GRK1188). M.T. was funded within GRK1188 of the Deutsche Forschungsgemeinschaft (DFG). This work was funded by grants from the DFG (HU363/10-5, HU363/12-1, and BA2316/1-4) (to E.H. and J.B.).	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BELTRAME M, 1992, EMBO J, V11, P1531, DOI 10.1002/j.1460-2075.1992.tb05198.x; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Cote CA, 2002, RNA, V8, P786, DOI 10.1017/S1355838202023063; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Falk S, 2014, MOL CELL, V55, P856, DOI 10.1016/j.molcel.2014.07.020; Granato DC, 2005, FEBS J, V272, P4450, DOI 10.1111/j.1742-4658.2005.04861.x; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Halbach F, 2012, RNA, V18, P124, DOI 10.1261/rna.029553.111; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; Jakob S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032552; James P, 1996, GENETICS, V144, P1425; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Klauer AA, 2013, NUCLEIC ACIDS RES, V41, P533, DOI 10.1093/nar/gks1013; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebaron S, 2009, EMBO J, V28, P3808, DOI 10.1038/emboj.2009.335; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee NN, 2013, CELL, V155, P1061, DOI 10.1016/j.cell.2013.10.027; Leidig C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4491; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Sloan KE, 2014, RNA, V20, P540, DOI 10.1261/rna.043471.113; Smith JS, 2000, GENE CHROMOSOME CANC, V29, P16, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1007>3.3.CO;2-9; Takahashi S, 2003, EMBO J, V22, P3951, DOI 10.1093/emboj/cdg374; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thomson E, 2005, RNA, V11, P1215, DOI 10.1261/rna.2720205; Thomson E, 2010, MOL CELL BIOL, V30, P976, DOI 10.1128/MCB.01359-09; TOLLERVEY D, 1987, EMBO J, V6, P469, DOI 10.1002/j.1460-2075.1987.tb04777.x; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	49	126	128	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1029	1038		10.1016/j.cell.2015.07.060	http://dx.doi.org/10.1016/j.cell.2015.07.060			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317469	Bronze			2022-12-28	WOS:000360589900013
J	Watts, G				Watts, Geoff			Marcia Stefanick: women's west coast initiatives lead to wisdom	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					733	733		10.1016/S0140-6736(15)61529-X	http://dx.doi.org/10.1016/S0140-6736(15)61529-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LR	26333964				2022-12-28	WOS:000360287900012
J	Lane, R				Lane, Richard			Salim Yusuf: global leader in cardiovascular disease research	LANCET			English	Biographical-Item																		YUSUF S, PUBLICATION LIST	1	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					645	645		10.1016/S0140-6736(15)61492-1	http://dx.doi.org/10.1016/S0140-6736(15)61492-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26334148				2022-12-28	WOS:000359849200020
J	Piccolo, R; Giustino, G; Mehran, R; Windecker, S				Piccolo, Raffaele; Giustino, Gennaro; Mehran, Roxana; Windecker, Stephan			Stable coronary artery disease: revascularisation and invasive strategies	LANCET			English	Article							FRACTIONAL FLOW RESERVE; DUAL ANTIPLATELET THERAPY; BYPASS GRAFT-SURGERY; LONG-TERM SURVIVAL; ELUTING STENT IMPLANTATION; INTERNAL THORACIC ARTERY; 5-YEAR FOLLOW-UP; OFF-PUMP; ON-PUMP; MEDICAL THERAPY	Stable coronary artery disease is the most common clinical manifestation of ischaemic heart disease and a leading cause of mortality worldwide. Myocardial revascularisation is a mainstay in the treatment of symptomatic patients or those with ischaemia-producing coronary lesions, and reduces ischaemia to a greater extent than medical treatment. Documentation of ischaemia and plaque burden is fundamental in the risk stratification of patients with stable coronary artery disease, and several invasive and non-invasive techniques are available (eg, fractional flow reserve or intravascular ultrasound) or being validated (eg, instantaneous wave-free ratio and optical coherence tomography). The use of new-generation drug-eluting stents and arterial conduits greatly improve clinical outcome in patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). PCI is feasible, safe, and effective in many patients with stable coronary artery disease who remain symptomatic despite medical treatment. In patients with multivessel and left main coronary artery disease, the decision between PCI or CABG is guided by the local Heart Team (team of different cardiovascular specialists, including non-invasive and invasive cardiologists, and cardiac surgeons), who carefully judge the possible benefits and risks inherent to PCI and CABG. In specific subsets, such as patients with diabetes and advanced, multivessel coronary artery disease, CABG remains the standard of care in view of improved protection against recurrent ischaemic adverse events.	[Piccolo, Raffaele; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Giustino, Gennaro; Mehran, Roxana] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA	University of Bern; University Hospital of Bern; Icahn School of Medicine at Mount Sinai	Mehran, R (corresponding author), Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, Box 1030, New York, NY 10029 USA.	Roxana.Mehran@mountsinai.org	Mehran, Roxana/ABF-4160-2021; Piccolo, Raffaele/AAA-7871-2019; Giustino, Gennaro/F-3866-2017; Piccolo, Raffaele/U-4297-2017	Piccolo, Raffaele/0000-0002-3124-9912; Giustino, Gennaro/0000-0002-5400-9516	Italian Society of Cardiology; Umberto Veronesi Foundation; Abbott Laboratories; Biotronik; Boston Scientific; Edwards Lifesciences; Medtronic; Medicines Company; St Jude; AstraZeneca; Eli Lilly; Bayer; Biosensors	Italian Society of Cardiology; Umberto Veronesi Foundation(Fondazione Umberto Veronesi); Abbott Laboratories(Abbott Laboratories); Biotronik; Boston Scientific(Boston Scientific); Edwards Lifesciences; Medtronic(Medtronic); Medicines Company; St Jude(St. Jude Medical); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Bayer(Bayer AG); Biosensors	RP reports research grants from the Italian Society of Cardiology and the Umberto Veronesi Foundation. RM reports grants from The Medicines Company, Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, AstraZeneca, Janssen Pharmaceuticals; and reports personal fees from Watermark Research Partners, Abbott Laboratories, AstraZeneca, Boston Scientific, Covidien, CSL Behring, Janssen Pharmaceuticals, Merck and Co, Sanofi-Aventis, The Medicines Company, Bayer, Osprey Medical Inc, Platform Q, and Regardo Bioscience, outside the submitted work. RM has equity in Elixir Medical Corporation and Claret Medical Inc. SW reports institutional research grants from Abbott Laboratories, Biotronik, Boston Scientific, Edwards Lifesciences, Medtronic, Medicines Company, and St Jude; and reports speaker's fees from AstraZeneca, Eli Lilly, Abbott Laboratories, Biotronik, Boston Scientific, Bayer, Edwards Lifesciences, Medtronic, and Biosensors. GG declares no competing interests.	Abrams J, 2005, NEW ENGL J MED, V352, P2524, DOI 10.1056/NEJMcp042317; Bangalore S, 2015, NEW ENGL J MED, V372, P1213, DOI 10.1056/NEJMoa1412168; Bangalore S, 2013, CIRCULATION, V127, P769, DOI 10.1161/CIRCULATIONAHA.112.131961; Bax JJ, 2014, EUR HEART J, V35, P2627, DOI 10.1093/eurheartj/ehu256; Bech GJW, 2001, CIRCULATION, V103, P2928, DOI 10.1161/01.CIR.103.24.2928; Belkacemi A, 2013, INT J CARDIOL, V168, P4209, DOI 10.1016/j.ijcard.2013.07.178; Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038; Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; Capodanno D, 2011, J AM COLL CARDIOL, V58, P1426, DOI 10.1016/j.jacc.2011.07.005; Dai CY, 2013, ANN THORAC SURG, V95, P1938, DOI 10.1016/j.athoracsur.2012.12.038; De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Deb S, 2013, JAMA-J AM MED ASSOC, V310, P2086, DOI 10.1001/jama.2013.281718; Deo SV, 2013, J CARDIAC SURG, V28, P109, DOI 10.1111/jocs.12074; Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563; Diegeler A, 2013, NEW ENGL J MED, V368, P1189, DOI 10.1056/NEJMoa1211666; Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C; Elmariah S, 2015, LANCET, V385, P792, DOI 10.1016/S0140-6736(14)62052-3; EMOND M, 1994, CIRCULATION, V90, P2645, DOI 10.1161/01.CIR.90.6.2645; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Farooq V, 2013, CIRCULATION, V128, P141, DOI 10.1161/CIRCULATIONAHA.113.001803; Farooq V, 2013, LANCET, V381, P639, DOI 10.1016/S0140-6736(13)60108-7; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Garcia S, 2013, J AM COLL CARDIOL, V62, P1421, DOI 10.1016/j.jacc.2013.05.033; Gasior M, 2014, JACC-CARDIOVASC INTE, V7, P1277, DOI 10.1016/j.jcin.2014.05.025; Genereux P, 2015, EUROINTERVENTION, V11, P634, DOI 10.4244/EIJY14M10_05; Giustino G, 2015, J AM COLL CARDIOL, V65, P1298, DOI 10.1016/j.jacc.2015.01.039; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Hakeem A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000354; Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6; Head SJ, 2013, EUR HEART J, V34, P2862, DOI 10.1093/eurheartj/eht330; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Itagaki S, 2013, HEART, V99, P849, DOI 10.1136/heartjnl-2013-303672; Johnson NP, 2014, J AM COLL CARDIOL, V64, P1641, DOI 10.1016/j.jacc.2014.07.973; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kim JB, 2014, J AM COLL CARDIOL, V63, P2280, DOI 10.1016/j.jacc.2014.02.584; Kulik A, 2015, CIRCULATION, V131, P927, DOI 10.1161/CIR.0000000000000182; Lamy A, 2013, NEW ENGL J MED, V368, P1179, DOI 10.1056/NEJMoa1301228; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Maniar HS, 2002, J THORAC CARDIOV SUR, V123, P45, DOI 10.1067/mtc.2002.118686; Mauri L, 2015, NEW ENGL J MED, V372, P1373, DOI 10.1056/NEJMc1501195; Mehran R, 2015, J AM COLL CARDIOL, V65, P1103, DOI 10.1016/j.jacc.2015.01.024; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Mintz GS, 2014, J AM COLL CARDIOL, V64, P207, DOI 10.1016/j.jacc.2014.01.015; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689; Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nascimento BR, 2014, CATHETER CARDIO INTE, V84, P377, DOI 10.1002/ccd.25047; Niccoli G, 2013, JACC-CARDIOVASC IMAG, V6, P1108, DOI 10.1016/j.jcmg.2013.05.004; Nocerino AG, 2013, AM J CARDIOL, V112, P1576, DOI 10.1016/j.amjcard.2013.07.017; Opie LH, 2006, LANCET, V367, P69, DOI 10.1016/S0140-6736(06)67927-0; Palmerini T, 2015, J AM COLL CARDIOL, V65, P1092, DOI 10.1016/j.jacc.2014.12.046; Palmerini T, 2012, J AM COLL CARDIOL, V60, P798, DOI 10.1016/j.jacc.2011.10.912; Panoulas VF, 2015, J AM COLL CARDIOL, V65, P85, DOI 10.1016/j.jacc.2014.04.093; Park SJ, 2015, NEW ENGL J MED, V372, P1204, DOI 10.1056/NEJMoa1415447; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Pfisterer ME, 2010, LANCET, V375, P763, DOI 10.1016/S0140-6736(10)60168-7; Piccolo R, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002223; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Reith S, 2013, HEART, V99, P700, DOI 10.1136/heartjnl-2013-303616; Rodriguez A, 2001, J AM COLL CARDIOL, V37, P51, DOI 10.1016/S0735-1097(00)01052-4; Roy P, 2008, EUR HEART J, V29, P1851, DOI 10.1093/eurheartj/ehn249; Ruttmann E, 2011, CIRCULATION, V124, P1321, DOI 10.1161/CIRCULATIONAHA.111.030536; Sen S, 2013, J AM COLL CARDIOL, V61, P1409, DOI 10.1016/j.jacc.2013.01.034; Sen S, 2012, J AM COLL CARDIOL, V59, P1392, DOI 10.1016/j.jacc.2011.11.003; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Shaw LJ, 2014, JACC-CARDIOVASC IMAG, V7, P593, DOI 10.1016/j.jcmg.2013.10.021; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Sianos Georgios, 2005, EuroIntervention, V1, P219; Sigwart U, 2002, LANCET, V360, P965; Simoons ML, 2010, EUR HEART J, V31, P530, DOI 10.1093/eurheartj/ehp605; Smith PK, 2014, NEW ENGL J MED, V371, P2178, DOI 10.1056/NEJMoa1410490; Stefanini GG, 2013, LANCET, V382, P1879, DOI 10.1016/S0140-6736(13)61782-1; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Taggart DP, 2010, EUR HEART J, V31, P2470, DOI 10.1093/eurheartj/ehq318; Tatoulis J, 2011, ANN THORAC SURG, V92, P9, DOI 10.1016/j.athoracsur.2011.03.099; Tobis J, 2007, J AM COLL CARDIOL, V49, P839, DOI 10.1016/j.jacc.2006.10.055; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333; van der Zee S, 2009, NAT REV CARDIOL, V6, P580, DOI 10.1038/nrcardio.2009.121; Verma S, 2013, LANCET DIABETES ENDO, V1, P317, DOI 10.1016/S2213-8587(13)70089-5; Vranckx P, 2015, EUROINTERVENTION, V11, P171, DOI 10.4244/EIJV11I2A31; Waksman R, 2013, J AM COLL CARDIOL, V61, P917, DOI 10.1016/j.jacc.2012.12.012; Weintraub William S, 2008, N Engl J Med, V359, P677, DOI 10.1056/NEJMoa072771; Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Windecker S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3859; Yi GJ, 2014, CIRCULATION, V130, P539, DOI 10.1161/CIRCULATIONAHA.113.004255	97	116	127	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					702	713		10.1016/S0140-6736(15)61220-X	http://dx.doi.org/10.1016/S0140-6736(15)61220-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26334162				2022-12-28	WOS:000359849200037
J	Verma, AM; Patel, M; Aslam, MI; Jameson, J; Pringle, JH; Wurm, P; Singh, B				Verma, Ajay M.; Patel, Maleene; Aslam, Muhammad Imran; Jameson, John; Pringle, James Howard; Wurm, Peter; Singh, Baljit			Circulating plasma microRNAs as a screening method for detection of colorectal adenomas	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Verma, Ajay M.; Aslam, Muhammad Imran; Jameson, John; Wurm, Peter; Singh, Baljit] Univ Leicester, Univ Hosp Leicester, Leicester, Leics, England; [Patel, Maleene; Pringle, James Howard] Univ Leicester, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester		ajaymarkverma@gmail.com	Aslam, Muhammad/GRS-8220-2022; Verma, Ajay/J-6380-2014	Aslam, Muhammad/0000-0002-6071-5468; Verma, Ajay/0000-0002-6432-3357					0	39	39	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			100	100		10.1016/S0140-6736(15)60415-9	http://dx.doi.org/10.1016/S0140-6736(15)60415-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312830				2022-12-28	WOS:000360570500100
J	Rosenbaum, L				Rosenbaum, Lisa			Scoring No Goal - Further Adventures in Transparency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; ASSOCIATION; OUTCOMES											Birkmeyer JD, 2013, NEW ENGL J MED, V369, P1434, DOI 10.1056/NEJMsa1300625; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Shih T, 2015, ANN SURG, V261, P920, DOI 10.1097/SLA.0000000000001032; Waldo SW, 2015, J AM COLL CARDIOL, V65, P1119, DOI 10.1016/j.jacc.2015.01.008	4	18	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1385	1388		10.1056/NEJMp1510094	http://dx.doi.org/10.1056/NEJMp1510094			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8XI	26332360				2022-12-28	WOS:000362372800001
J	Stockbridge, RB; Kolmakova-Partensky, L; Shane, T; Koide, A; Koide, S; Miller, C; Newstead, S				Stockbridge, Randy B.; Kolmakova-Partensky, Ludmila; Shane, Tania; Koide, Akiko; Koide, Shohei; Miller, Christopher; Newstead, Simon			Crystal structures of a double-barrelled fluoride ion channel	NATURE			English	Article							RESISTANCE; SELECTIVITY; PROTEINS; EMRE; EVOLUTION	To contend with hazards posed by environmental fluoride, microorganisms export this anion through F--specific ion channels of the Fluc family(1-4). Since the recent discovery of Fluc channels, numerous idiosyncratic features of these proteins have been unearthed, including strong selectivity for F- over Cl- and dual-topology dimeric assembly(5,6). To understand the chemical basis for F- permeation and how the antiparallel subunits convene to form a F--selective pore, here we solve the crystal structures of two bacterial Fluc homologues in complex with three different monobody inhibitors, with and without F- present, to a maximum resolution of 2.1 angstrom. The structures reveal a surprising 'double-barrelled' channel architecture in which two F- ion pathways span the membrane, and the dual-topology arrangement includes a centrally coordinated cation, most likely Na+center dot F- selectivity is proposed to arise from the very narrow pores and an unusual anion coordination that exploits the quadrupolar edges of conserved phenylalanine rings.	[Stockbridge, Randy B.; Kolmakova-Partensky, Ludmila; Shane, Tania; Miller, Christopher] Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA; [Koide, Akiko; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Miller, Christopher] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QU, England; [Newstead, Simon] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Brandeis University; Howard Hughes Medical Institute; University of Chicago; University of Oxford; University of Oxford	Newstead, S (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	simon.newstead@bioch.ox.ac.uk		Stockbridge, Randy/0000-0001-8848-3032; Koide, Shohei/0000-0001-5473-4358; Newstead, Simon/0000-0001-7432-2270	Wellcome Trust [102890/Z/13/Z]; National Institutes of Health (NIH) [RO1-GM107023, U54-GM087519]; NIH [K99-GM-111767]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107023, K99GM111767, U54GM087519] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Parker for critically reading the manuscript; to D. Turman, A. Lajoie, M. Pham, and K. Piasta for pilot experiments; to S. Strobel for sharing results of unpublished experiments; and to B. Foxman for help with the Cambridge Structural Database. This work was supported in part by a Wellcome Trust Investigator Award 102890/Z/13/Z and National Institutes of Health (NIH) grants RO1-GM107023 and U54-GM087519. R.B.S. was supported by NIH grant K99-GM-111767. C.M. is grateful to F. Ashcroft and Lincoln College, Oxford, for hosting a Newton-Abraham Visiting Professorship.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adamek Ewa, 2005, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V51, P69; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Brammer AE, 2014, J GEN PHYSIOL, V144, P129, DOI 10.1085/jgp.201411225; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dickson VK, 2014, NATURE, V516, P213, DOI 10.1038/nature13913; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Ji CH, 2014, J GEN PHYSIOL, V144, P257, DOI 10.1085/jgp.201411243; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Lev B., 2013, ENCY METALLOPROTEINS, P2112, DOI DOI 10.1007/978-1-4614-1533-6_242; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith KD, 2015, J BIOL CHEM, V290, P19874, DOI 10.1074/jbc.M115.651976; Stockbridge RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6120; Stockbridge RB, 2013, ELIFE, V2, DOI 10.7554/eLife.01084; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; Turman DL, 2015, P NATL ACAD SCI USA, V112, P5697, DOI 10.1073/pnas.1505301112; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Varma S, 2008, J MOL BIOL, V376, P13, DOI 10.1016/j.jmb.2007.11.059; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308	41	76	76	7	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					548	+		10.1038/nature14981	http://dx.doi.org/10.1038/nature14981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26344196	Green Accepted			2022-12-28	WOS:000361599900056
J	Chen, DL; Savidge, T				Chen, Deliang; Savidge, Tor			Comment on "Extreme electric fields power catalysis in the active site of ketosteroid isomerase"	SCIENCE			English	Editorial Material								Fried et al. (Reports, 19 December 2014, p. 1510) demonstrate electric field-dependent acceleration of biological catalysis using ketosteroid isomerase as a prototypic example. These findings were not extended to aqueous solution because water by itself has field fluctuations that are too large and fast to provide a catalytic effect. Given physiological context, when water electrostatic interactions are considered, electric fields play a less important role in the catalysis.	[Chen, Deliang] Gannan Normal Univ, Jiangxi Key Lab Organo Pharmaceut Chem, Nanchang 341000, Jiangxi, Peoples R China; [Savidge, Tor] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Savidge, Tor] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Gannan Normal University; Baylor College of Medicine; Baylor College of Medicine	Savidge, T (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	tor.savidge@bcm.edu		Fried, Stephen/0000-0003-2494-2193	National Science Foundation of China [21473041]; National Institutes of Health [AI100914, DK096323, P30 DK56338, UL1TR000071]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R21DK096323] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Science Foundation of China (21473041) and AI100914, DK096323, P30 DK56338, and Clinical and Translational Science Award UL1TR000071 from the National Institutes of Health.	Cannon WR, 1998, J BIOL CHEM, V273, P26257, DOI 10.1074/jbc.273.41.26257; Fried SD, 2014, SCIENCE, V346, P1510, DOI 10.1126/science.1259802; Ha NC, 2000, J BIOL CHEM, V275, P41100, DOI 10.1074/jbc.M007561200; Kraut DA, 2010, P NATL ACAD SCI USA, V107, P1960, DOI 10.1073/pnas.0911168107; Reichardt C., 2003, SOLVENTS SOLVENT EFF, V3rd; Ruben EA, 2013, BIOCHEMISTRY-US, V52, P1074, DOI 10.1021/bi301348x	6	6	6	6	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251								10.1126/science.aab0095	http://dx.doi.org/10.1126/science.aab0095			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315427	Green Accepted			2022-12-28	WOS:000360646800034
J	Teague, BP; Weiss, R				Teague, Brian P.; Weiss, Ron			Synthetic communities, the sum of parts	SCIENCE			English	Editorial Material									[Teague, Brian P.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Teague, BP (corresponding author), MIT, Dept Biol Engn, NE47-223, Cambridge, MA 02139 USA.	rweiss@mit.edu		/0000-0002-9833-2817				Bacchus W, 2013, METAB ENG, V16, P33, DOI 10.1016/j.ymben.2012.12.001; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Chen Y, 2015, SCIENCE, V349, P986, DOI 10.1126/science.aaa3794; Evans JM, 2013, J ENDOCRINOL, V218, pR37, DOI 10.1530/JOE-13-0131; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Khakhar A, 2016, ACS SYNTH BIOL, V5, P279, DOI 10.1021/acssynbio.5b00064; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Shong J, 2012, CURR OPIN BIOTECH, V23, P798, DOI 10.1016/j.copbio.2012.02.001; Slusarczyk AL, 2012, NAT REV GENET, V13, P406, DOI 10.1038/nrg3227; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Xavier JB, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.16; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782	15	15	16	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					924	925		10.1126/science.aad0876	http://dx.doi.org/10.1126/science.aad0876			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315419	Green Published			2022-12-28	WOS:000360646800019
J	Burgess, RC; Misteli, T				Burgess, Rebecca C.; Misteli, Tom			Not All DDRs Are Created Equal: Non-Canonical DNA Damage Responses	CELL			English	Review							DOUBLE-STRAND BREAKS; ACTIVATION; CHROMATIN; REPLICATION; MITOSIS; COMPLEX; STRESS; REPAIR; ATM	It is commonly assumed that there is a single canonical DNA damage response (DDR) that protects cells from various types of double-strand breaks and that its activation occurs via recognition of DNA ends by the DDR machinery. Recent work suggests that both assumptions may be oversimplifications. Here, we discuss several variations of the DDR in which the pathway is activated by diverse cellular events and/or generates distinct signaling outcomes. The existence of multiple non-canonical DDRs provides insights into how DNA damage is sensed and suggests a highly modular organization of the DDR.	[Burgess, Rebecca C.; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Burgess, Rebecca C.] Stevenson Univ, Sch Sci, Dept Biol Sci, Stevenson, MD 21153 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Burgess, RC (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	rburgess@stevenson.edu; mistelit@mail.nih.gov			Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We apologize to the large number of authors whose work we could not cite due to space constraints. Thanks to Marc Raley for help with the figure. Work in the Misteli laboratory is supported by the Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research.	Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bruhn C, 2014, CELL REP, V6, P182, DOI 10.1016/j.celrep.2013.12.018; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046; Lee DH, 2014, MOL CELL, V54, P512, DOI 10.1016/j.molcel.2014.03.020; Luftig MA, 2014, ANNU REV VIROL, V1, P605, DOI 10.1146/annurev-virology-031413-085548; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Olcina MM, 2013, MOL CELL, V52, P758, DOI 10.1016/j.molcel.2013.10.019; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Shah GA, 2015, CELL, V162, P987, DOI 10.1016/j.cell.2015.07.058; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001	18	42	43	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					944	947		10.1016/j.cell.2015.08.006	http://dx.doi.org/10.1016/j.cell.2015.08.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317463	Green Accepted, Bronze			2022-12-28	WOS:000360589900006
J	Galie, N; Barbera, JA; Frost, AE; Ghofrani, HA; Hoeper, MM; McLaughlin, VV; Peacock, AJ; Simonneau, G; Vachiery, JL; Grunig, E; Oudiz, RJ; Vonk-Noordegraaf, A; White, RJ; Blair, C; Gillies, H; Miller, KL; Harris, JHN; Langley, J; Rubin, LJ				Galie, N.; Barbera, J. A.; Frost, A. E.; Ghofrani, H-A.; Hoeper, M. M.; McLaughlin, V. V.; Peacock, A. J.; Simonneau, G.; Vachiery, J-L.; Gruenig, E.; Oudiz, R. J.; Vonk-Noordegraaf, A.; White, R. J.; Blair, C.; Gillies, H.; Miller, K. L.; Harris, J. H. N.; Langley, J.; Rubin, L. J.		Ambition Investigators	Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-FAILURE; COMBINATION THERAPY; INHALED ILOPROST; DOUBLE-BLIND; BOSENTAN; EPOPROSTENOL; DIAGNOSIS; SURVIVAL; TRIAL	BACKGROUND Data on the effect of initial combination therapy with ambrisentan and tadalafil on long-term outcomes in patients with pulmonary arterial hypertension are scarce. METHODS In this event-driven, double-blind study, we randomly assigned, in a 2: 1: 1 ratio, participants with World Health Organization functional class II or III symptoms of pulmonary arterial hypertension who had not previously received treatment to receive initial combination therapy with 10 mg of ambrisentan plus 40 mg of tadalafil (combination-therapy group), 10 mg of ambrisentan plus placebo (ambrisentan-monotherapy group), or 40 mg of tadalafil plus placebo (tadalafil-monotherapy group), all administered once daily. The primary end point in a time-to-event analysis was the first event of clinical failure, which was defined as the first occurrence of a composite of death, hospitalization for worsening pulmonary arterial hypertension, disease progression, or unsatisfactory long-term clinical response. RESULTS The primary analysis included 500 participants; 253 were assigned to the combination-therapy group, 126 to the ambrisentan-monotherapy group, and 121 to the tadalafil-monotherapy group. A primary end-point event occurred in 18%, 34%, and 28% of the participants in these groups, respectively, and in 31% of the pooled-monotherapy group (the two monotherapy groups combined). The hazard ratio for the primary end point in the combination-therapy group versus the pooled-monotherapy group was 0.50 (95% confidence interval [CI], 0.35 to 0.72; P<0.001). At week 24, the combination-therapy group had greater reductions from baseline in N-terminal pro-brain natriuretic peptide levels than did the pooled-monotherapy group (mean change, -67.2% vs. -50.4%; P<0.001), as well as a higher percentage of patients with a satisfactory clinical response (39% vs. 29%; odds ratio, 1.56 [95% CI, 1.05 to 2.32]; P = 0.03) and a greater improvement in the 6-minute walk distance (median change from baseline, 48.98 m vs. 23.80 m; P<0.001). The adverse events that occurred more frequently in the combination-therapy group than in either monotherapy group included peripheral edema, headache, nasal congestion, and anemia. CONCLUSIONS Among participants with pulmonary arterial hypertension who had not received previous treatment, initial combination therapy with ambrisentan and tadalafil resulted in a significantly lower risk of clinical-failure events than the risk with ambrisentan or tadalafil monotherapy.	[Galie, N.] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Barbera, J. A.] Hosp Clin Barcelona, Inst Invest Biomed August Pi Sunyer, Barcelona, Spain; [Barbera, J. A.] Univ Barcelona, Barcelona, Spain; [Barbera, J. A.] Biomed Res Networking Ctr Resp Dis, Madrid, Spain; [Frost, A. E.] Baylor Coll Med, Houston, TX 77030 USA; [Ghofrani, H-A.] Univ Giessen, D-35390 Giessen, Germany; [Ghofrani, H-A.] Marburg Lung Ctr, Giessen, Germany; [Hoeper, M. M.] Hannover Med Sch, Hannover, Germany; [Hoeper, M. M.] German Ctr Lung Res, Hannover, Germany; [Gruenig, E.] Univ Heidelberg Hosp, Thoraxklin, Heidelberg, Germany; [McLaughlin, V. V.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Peacock, A. J.] Reg Heart & Lung Ctr, Glasgow, Lanark, Scotland; [Harris, J. H. N.; Langley, J.] GlaxoSmithKline, Uxbridge, Middx, England; [Simonneau, G.] Univ Paris 11, Fac Med, Orsay, France; [Simonneau, G.] Ctr Chirurg Marie Lannelongue, Lab Excellence Rech Medicament & Innovat,Serv Pne, INSERM Unite Mixte Rech S 999,Dept Hosp Univ Thor, Hop Bicetre,AP HP,Ctr Reference Hypertens Pulm Se, Le Plessis Robinson, France; [Vachiery, J-L.] Univ Brussels, Hop Erasme, Brussels, Belgium; [Oudiz, R. J.] UCLA Med Ctr, Angeles Biomed Res Inst, Torrance, CA USA; [Blair, C.; Gillies, H.; Miller, K. L.] Angeles Biomed Res Inst, UCLA Med Ctr, Foster City, CA USA; [Rubin, L. J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Vonk-Noordegraaf, A.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [White, R. J.] Univ Rochester, Rochester, NY USA	University of Bologna; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Baylor College of Medicine; Justus Liebig University Giessen; Hannover Medical School; Ruprecht Karls University Heidelberg; University of Michigan System; University of Michigan; GlaxoSmithKline; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Libre de Bruxelles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California San Diego; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Rochester	Galie, N (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.		Vachiery, Jean-Luc/ABC-6631-2021; Ghofrani, Ardeschir/AAD-5293-2020; Weder, Max/AAO-4265-2021; Söderberg, Stefan/AAG-3881-2019; Simonneau, Gerald/ABE-6614-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022; Galie, Nazzareno/F-7004-2014; Vizza, Carmine Dario/AAC-5540-2020; Reynaud-Gaubert, Martine LM/P-6958-2016; Hoeper, Marius C/Z-1546-2019	Ghofrani, Ardeschir/0000-0002-2029-4419; Söderberg, Stefan/0000-0001-9225-1306; Galie, Nazzareno/0000-0003-4271-8670; Vizza, Carmine Dario/0000-0002-3540-4983; Hoeper, Marius C/0000-0001-9086-2293; vonk noordegraaf, anton/0000-0002-4057-758X; Frachon, Irene/0000-0001-6666-9709; de Groote, Pascal/0000-0002-6211-0147; Hubbert, Laila/0000-0002-6578-8826; Selimovic, Nedim/0000-0001-8189-412X; Harris, Julia/0000-0002-9111-047X	Gilead Sciences; GlaxoSmithKline	Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline)	Funded by Gilead Sciences and GlaxoSmithKline; AMBITION ClinicalTrials.gov number, NCT01178073.	Arif SA, 2011, CLIN THER, V33, P993, DOI 10.1016/j.clinthera.2011.06.008; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Campo A, 2011, EUR RESPIR J, V38, P359, DOI 10.1183/09031936.00148310; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Ghofrani HA, 2014, EUR RESPIR REV, V23, P469, DOI 10.1183/09059180.00007314; Ghofrani HA, 2013, NEW ENGL J MED, V369, P330, DOI 10.1056/NEJMoa1209655; Haddad F, 2011, CIRC-HEART FAIL, V4, P692, DOI 10.1161/CIRCHEARTFAILURE.110.949933; Hoeper MM, 2006, EUR RESPIR J, V28, P691, DOI 10.1183/09031936.06.00057906; Humbert M, 2004, EUR RESPIR J, V24, P353, DOI 10.1183/09031936.04.00028404; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Kemp K, 2012, J HEART LUNG TRANSPL, V31, P150, DOI 10.1016/j.healun.2011.11.002; MAHLER DA, 1994, MED SCI SPORT EXER, V26, P1078; McLaughlin VV, 2006, AM J RESP CRIT CARE, V174, P1257, DOI 10.1164/rccm.200603-358OC; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Simonneau G, 2008, ANN INTERN MED, V149, P521, DOI 10.7326/0003-4819-149-8-200810210-00004; Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313; Spence R, 2009, J PHARM SCI-US, V98, P4962, DOI 10.1002/jps.21789; Sztrymf B, 2010, EUR RESPIR J, V35, P1286, DOI 10.1183/09031936.00070209; Vatter H, 2006, CARDIOVASC DRUG REV, V24, P63, DOI 10.1111/j.1527-3466.2006.00063.x	25	650	673	1	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					834	844		10.1056/NEJMoa1413687	http://dx.doi.org/10.1056/NEJMoa1413687			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP8VC	26308684	Green Published, Bronze			2022-12-28	WOS:000360171700009
J	Le, P; Rothberg, MB				Phuc Le; Rothberg, Michael B.			Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years	ANNALS OF INTERNAL MEDICINE			English	Article							POSTHERPETIC NEURALGIA; TERM PERSISTENCE; OLDER-ADULTS; VARICELLA; EFFICACY; PREVENTION; ACYCLOVIR; RECOMMENDATIONS; POPULATION; ENGLAND	Background: Each year, herpes zoster (HZ) affects 1 million U.S. adults, many of whom develop postherpetic neuralgia (PHN). Zoster vaccine is licensed for persons aged 50 years or older, but its cost-effectiveness for those aged 50 to 59 years is unknown. Objective: To estimate the cost-effectiveness of HZ vaccine versus no vaccination. Design: Markov model. Data Sources: Medical literature. Target Population: Adults aged 50 years. Time Horizon: Lifetime. Perspective: Societal. Intervention: HZ vaccine. Outcome Measures: Number of HZ and PHN cases prevented and incremental cost per quality-adjusted life-year (QALY) saved. Results of Base-Case Analysis: For every 1000 persons receiving the vaccine at age 50 years, 25 HZ cases and 1 PHN case could be prevented. The incremental cost-effectiveness ratio (ICER) for HZ vaccine versus no vaccine was $323 456 per QALY. Results of Sensitivity Analysis: In deterministic and scenario sensitivity analyses, the only variables that produced an ICER less than $100 000 per QALY were vaccine cost (at a value of $80) and the rate at which efficacy wanes. In probabilistic sensitivity analysis, the mean ICER was $500 754 per QALY (95% CI, $93 510 to $1 691 211 per QALY). At a willingness-to-pay threshold of $100 000 per QALY, the probability that vaccination would be cost-effective was 3%. Limitation: Long-term effectiveness data for HZ vaccine are lacking for 50-year-old adults. Conclusion: Herpes zoster vaccine for persons aged 50 years does not seem to represent good value according to generally accepted standards. Our findings support the decision of the Advisory Committee on Immunization Practices not to recommend the vaccine for adults in this age group.	[Phuc Le; Rothberg, Michael B.] Cleveland Clin, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Le, P (corresponding author), Cleveland Clin, Ctr Value Based Care Res, Inst Med, 9500 Euclid Ave,Mail Code G10, Cleveland, OH 44195 USA.	lep@ccf.org						Agency for Healthcare Research and Quality, 2014, HEALTHC COST UT PROJ; Arias Elizabeth, 2014, Natl Vital Stat Rep, V63, P1; Bresse X, 2013, EXPERT REV PHARM OUT, V13, P393, DOI [10.1586/ERP.13.19, 10.1586/erp.13.19]; Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Brisson M, 2007, CLIN INFECT DIS, V45, P1527, DOI 10.1086/523011; Brown MM, 2001, OPHTHALMOLOGY, V108, P643, DOI 10.1016/S0161-6420(00)00635-7; Bureau of Labor Statistics, 2014, MAY 2014 NAT OCC EMP; Bureau of Labor Statistics, 2015, US WEEKL EARN WAG SA; Bureau of Labor Statistics, 2014, MED CAR COMP CONS PR; Centers for Disease Control and Prevention, 2014, AD VACC PRIC LIST; Centers for Disease Control and Prevention. CDC WONDER, 2014, CDCP SER, V20; Centers for Medicare & Medicaid Services, 2014, PHYS FEE SCHED; Chen N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006866.pub3; COBO LM, 1986, OPHTHALMOLOGY, V93, P763; Colin J, 2000, OPHTHALMOLOGY, V107, P1507, DOI 10.1016/S0161-6420(00)00222-0; Coplan PM, 2004, J PAIN, V5, P344, DOI 10.1016/j.jpain.2004.06.001; de Boer PT, 2013, VACCINE, V31, P1276, DOI 10.1016/j.vaccine.2012.12.067; Drolet M, 2012, VACCINE, V30, P2047, DOI 10.1016/j.vaccine.2012.01.045; Edmunds WJ, 2001, VACCINE, V19, P3076, DOI 10.1016/S0264-410X(01)00044-5; Galil K, 1997, ARCH INTERN MED, V157, P1209, DOI 10.1001/archinte.157.11.1209; Hales CM, 2014, MMWR-MORBID MORTAL W, V63; Hales CM, 2013, ANN INTERN MED, V159, P739, DOI 10.7326/0003-4819-159-11-201312030-00006; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Helgason S, 2000, BRIT MED J, V321, P794, DOI 10.1136/bmj.321.7264.794; Hornberger J, 2006, ANN INTERN MED, V145, P317, DOI 10.7326/0003-4819-145-5-200609050-00004; Jackson LA, 2008, CLIN INFECT DIS, V47, P754, DOI 10.1086/591132; Johnson RW, 2010, EXPERT REV VACCINES, V9, P21, DOI 10.1586/ERV.10.30; Katz J, 2004, CLIN INFECT DIS, V39, P342, DOI 10.1086/421942; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; Kawai K, 2014, VACCINE, V32, P1645, DOI 10.1016/j.vaccine.2014.01.058; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1; Moore Lee, 2010, Cost Eff Resour Alloc, V8, P7, DOI 10.1186/1478-7547-8-7; Morrison VA, 2015, CLIN INFECT DIS, V60, P900, DOI 10.1093/cid/ciu918; Murakami S, 1997, ANN NEUROL, V41, P353, DOI 10.1002/ana.410410310; Najafzadeh M, 2009, PHARMACOECONOMICS, V27, P991, DOI 10.2165/11314010-000000000-00000; Opstelten W, 2002, FAM PRACT, V19, P471, DOI 10.1093/fampra/19.5.471; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; [Population Division U. S. Census Bureau], 2014, ANN EST RES POP SING; Rimland D, 2010, CLIN INFECT DIS, V50, P1000, DOI 10.1086/651078; Rothberg MB, 2007, CLIN INFECT DIS, V44, P1280, DOI 10.1086/514342; Schmader KE, 2012, CLIN INFECT DIS, V55, P1320, DOI 10.1093/cid/cis638; Schmader KE, 2012, CLIN INFECT DIS, V54, P922, DOI 10.1093/cid/cir970; Singhal Puneet K, 2011, J Med Econ, V14, P639, DOI 10.3111/13696998.2011.607482; Summerfield AQ, 2002, ARCH OTOLARYNGOL, V128, P1255, DOI 10.1001/archotol.128.11.1255; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Tseng HF, 2011, JAMA-J AM MED ASSOC, V305, P160, DOI 10.1001/jama.2010.1983; Ultsch B, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-359; US Census Bureau, 2021, TOP RAC; van Hoek AJ, 2009, VACCINE, V27, P1454, DOI 10.1016/j.vaccine.2008.12.024; van Lier A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-237; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Yawn BP, 2011, MAYO CLIN PROC, V86, P88, DOI 10.4065/mcp.2010.0618	53	40	40	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2015	163	7					489	+		10.7326/M15-0093	http://dx.doi.org/10.7326/M15-0093			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0OQ	26344036				2022-12-28	WOS:000362496400002
J	Draaisma, D				Draaisma, Douwe			Oliver Sacks (1933-2015) Neurologist who made house calls OBITUARY	NATURE			English	Biographical-Item									Univ Groningen, Hist Psychol, NL-9700 AB Groningen, Netherlands	University of Groningen	Draaisma, D (corresponding author), Univ Groningen, Hist Psychol, NL-9700 AB Groningen, Netherlands.	d.draaisma@rug.nl						SACKS OW, PUBLICATION LIST	1	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					188	188		10.1038/525188a	http://dx.doi.org/10.1038/525188a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26331535	Bronze, Green Submitted			2022-12-28	WOS:000360927400019
J	McKee, M				McKee, Martin			Is the UK government right that seven day working in hospitals would save 6000 lives a year? The claim turned out to come from a single study that shows nothing so simple	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKee, Martin] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), London Sch Hyg & Trop Med, London, England.	martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018	Mckee, Martin/0000-0002-0121-9683				Appleby J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d566; Bray BD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001705; Cunningham SA, 2008, SOC SCI MED, V67, P1784, DOI 10.1016/j.socscimed.2008.09.044; Department of Health, 2015, HIGH RISK DEATH ASS; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; Hunt Jeremy, 2015, BBC NEWS; Laughlin A, 2007, J GERONTOL NURS, V33, P20, DOI 10.3928/00989134-20070901-04; Meacock R, 2015, HEALTH ECON, V24, P907, DOI 10.1002/hec.3207; Morris S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4757; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Smith M., 2015, DAILY MIRROR; Triggle N, 2015, BBC NEWS; UK Statistics Authority (, 2009, COD PRACT OFF STAT; Wolff A, 2015, J ROY SOC MED, V108, P259, DOI 10.1177/0141076814566260	15	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2015	351								h4723	10.1136/bmj.h4723	http://dx.doi.org/10.1136/bmj.h4723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VJ1XN	26342818	Green Accepted			2022-12-28	WOS:000550693600004
J	Govindarajan, A; Urbach, DR; Kumar, M; Li, Q; Murray, BJ; Juurlink, D; Kennedy, E; Gagliardi, A; Sutradhar, R; Baxter, NN				Govindarajan, Anand; Urbach, David R.; Kumar, Matthew; Li, Qi; Murray, Brian J.; Juurlink, David; Kennedy, Erin; Gagliardi, Anna; Sutradhar, Rinku; Baxter, Nancy N.			Outcomes of Daytime Procedures Performed by Attending Surgeons after Night Work	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SLEEP-DEPRIVATION; SURGICAL-PROCEDURES; COMPLICATIONS; RESIDENTS; ALCOHOL; FATIGUE; SAFETY	BACKGROUND Sleep loss in attending physicians has an unclear effect on patient outcomes. In this study, we examined the effect of medical care provided by physicians after midnight on the outcomes of their scheduled elective procedures performed during the day. METHODS We conducted a population-based, retrospective, matched-cohort study in Ontario, Canada. Patients undergoing 1 of 12 elective daytime procedures performed by a physician who had treated patients from midnight to 7 a.m. were matched in a 1: 1 ratio to patients undergoing the same procedure by the same physician on a day when the physician had not treated patients after midnight. Outcomes included death, readmission, complications, length of stay, and procedure duration. We used generalized estimating equations to compare outcomes between patient groups. RESULTS We included 38,978 patients, treated by 1448 physicians, in the study, of whom 40.6% were treated at an academic center. We found no significant difference in the primary outcome (death, readmission, or complication) between patients who underwent a daytime procedure performed by a physician who had provided patient care after midnight and those who underwent a procedure performed by a physician who had not treated patients after midnight (22.2% and 22.4%, respectively; P = 0.66; adjusted odds ratio, 0.99; 95% confidence interval, 0.95 to 1.03). We also found no significant difference in outcomes after stratification for academic versus nonacademic center, physician's age, or type of procedure. Secondary analyses revealed no significant difference between patient groups in length of stay or procedure duration. CONCLUSIONS Overall, the risks of adverse outcomes of elective daytime procedures were similar whether or not the physician had provided medical services the previous night.	[Govindarajan, Anand; Urbach, David R.; Kumar, Matthew; Li, Qi; Juurlink, David; Sutradhar, Rinku; Baxter, Nancy N.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Govindarajan, Anand; Kennedy, Erin] Univ Toronto, Mt Sinai Hosp, Dept Surg, Toronto, ON, Canada; [Gagliardi, Anna] Univ Toronto, Univ Hlth Network, Dept Surg, Toronto, ON, Canada; [Murray, Brian J.] Univ Toronto, Div Neurol, Dept Med, Toronto, ON, Canada; [Baxter, Nancy N.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Baxter, Nancy N.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Govindarajan, A (corresponding author), Univ Toronto, Mt Sinai Hosp, 600 Univ Ave,Suite 1220, Toronto, ON M5G 1X5, Canada.	agovindarajan@mtsinai.on.ca	Murray, Brian/E-6786-2016; Baxter, Nancy N/E-7020-2015	Murray, Brian/0000-0001-5085-0909; Baxter, Nancy N/0000-0003-4793-4620	University of Toronto	University of Toronto(University of Toronto)	Funded by the University of Toronto Dean's Fund and others.	Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Chu MWA, 2011, ARCH SURG-CHICAGO, V146, P1080, DOI 10.1001/archsurg.2011.121; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Ellman PI, 2004, ANN THORAC SURG, V78, P906, DOI 10.1016/j.athoracsur.2004.04.006; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Nurok M, 2010, NEW ENGL J MED, V363, P2577, DOI 10.1056/NEJMp1007901; Olson EJ, 2009, CHEST, V136, P1389, DOI 10.1378/chest.08-1952; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Redelmeier DA, 2008, J CLIN EPIDEMIOL, V61, P882, DOI 10.1016/j.jclinepi.2007.10.015; Reid RJ, 2002, HEALTH SERV RES, V37, P1345, DOI 10.1111/1475-6773.01029; Reid RJ, 2001, MED CARE, V39, P86, DOI 10.1097/00005650-200101000-00010; Rothschild JM, 2009, JAMA-J AM MED ASSOC, V302, P1565, DOI 10.1001/jama.2009.1423; Schieman C, 2008, AM J SURG, V195, P684, DOI 10.1016/j.amjsurg.2008.01.009; Sharpe JP, 2013, J AM COLL SURGEONS, V216, P791, DOI 10.1016/j.jamcollsurg.2012.12.005; Uchal M, 2005, AM J SURG, V189, P753, DOI 10.1016/j.amjsurg.2005.03.021; Urbach DR, 2014, NEW ENGL J MED, V370, P1029, DOI 10.1056/NEJMsa1308261; Vinden C, 2013, JAMA-J AM MED ASSOC, V310, P1837, DOI 10.1001/jama.2013.280372; Wilhelm BJ, 2009, INT J PSYCHOPHYSIOL, V72, P307, DOI 10.1016/j.ijpsycho.2009.01.008; Wilkins R., 2004, NEIGHBOURHOOD INCOME; Williams J.I., 1996, PATTERNS HLTH CARE O, V2nd, P339	22	70	72	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					845	853		10.1056/NEJMsa1415994	http://dx.doi.org/10.1056/NEJMsa1415994			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP8VC	26308685	Bronze			2022-12-28	WOS:000360171700010
J	Klco, JM; Miller, CA; Griffith, M; Petti, A; Spencer, DH; Ketkar-Kulkarni, S; Wartman, LD; Christopher, M; Lamprecht, TL; Helton, NM; Duncavage, EJ; Payton, JE; Baty, J; Heath, SE; Griffith, OL; Shen, D; Hundal, J; Chang, GS; Fulton, R; O'Laughlin, M; Fronick, C; Magrini, V; Demeter, RT; Larson, DE; Kulkarni, S; Ozenberger, BA; Welch, JS; Walter, MJ; Graubert, TA; Westervelt, P; Radich, JP; Link, DC; Mardis, ER; DiPersio, JF; Wilson, RK; Ley, TJ				Klco, Jeffery M.; Miller, Christopher A.; Griffith, Malachi; Petti, Allegra; Spencer, David H.; Ketkar-Kulkarni, Shamika; Wartman, Lukas D.; Christopher, Matthew; Lamprecht, Tamara L.; Helton, Nicole M.; Duncavage, Eric J.; Payton, Jacqueline E.; Baty, Jack; Heath, Sharon E.; Griffith, Obi L.; Shen, Dong; Hundal, Jasreet; Chang, Gue Su; Fulton, Robert; O'Laughlin, Michelle; Fronick, Catrina; Magrini, Vincent; Demeter, Ryan T.; Larson, David E.; Kulkarni, Shashikant; Ozenberger, Bradley A.; Welch, John S.; Walter, Matthew J.; Graubert, Timothy A.; Westervelt, Peter; Radich, Jerald P.; Link, Daniel C.; Mardis, Elaine R.; DiPersio, John F.; Wilson, Richard K.; Ley, Timothy J.			Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMAL RESIDUAL DISEASE; COOPERATIVE-ONCOLOGY-GROUP; COMPLETE REMISSION; ADULT PATIENTS; CLONAL HEMATOPOIESIS; CYTOGENETIC ABNORMALITIES; PROGNOSTIC IMPACT; STEM-CELLS; RELAPSE; CANCER	IMPORTANCE Tests that predict outcomes for patients with acute myeloid leukemia (AML) are imprecise, especially for those with intermediate risk AML. OBJECTIVES To determine whether genomic approaches can provide novel prognostic information for adult patients with de novo AML. DESIGN, SETTING, AND PARTICIPANTS Whole-genome or exome sequencing was performed on samples obtained at disease presentation from 71 patients with AML (mean age, 50.8 years) treated with standard induction chemotherapy at a single site starting in March 2002, with follow-up through January 2015. In addition, deep digital sequencing was performed on paired diagnosis and remission samples from 50 patients (including 32 with intermediate-risk AML), approximately 30 days after successful induction therapy. Twenty-five of the 50 were from the cohort of 71 patients, and 25 were new, additional cases. EXPOSURES Whole-genome or exome sequencing and targeted deep sequencing. Risk of identification based on genetic data. MAIN OUTCOMES AND MEASURES Mutation patterns (including clearance of leukemia-associated variants after chemotherapy) and their association with event-free survival and overall survival. RESULTS Analysis of comprehensive genomic data from the 71 patients did not improve outcome assessment over current standard-of-care metrics. In an analysis of 50 patients with both presentation and documented remission samples, 24 (48%) had persistent leukemia-associated mutations in at least 5% of bone marrow cells at remission. The 24 with persistent mutations had significantly reduced event-free and overall survival vs the 26 who cleared all mutations. Patients with intermediate cytogenetic risk profiles had similar findings. [GRAPHICS] CONCLUSIONS AND RELEVANCE The detection of persistent leukemia-associated mutations in at least 5% of bone marrow cells in day 30 remission samples was associated with a significantly increased risk of relapse, and reduced overall survival. These data suggest that this genomic approach may improve risk stratification for patients with AML.	[Klco, Jeffery M.; Spencer, David H.; Duncavage, Eric J.; Payton, Jacqueline E.; Kulkarni, Shashikant] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Klco, Jeffery M.; Lamprecht, Tamara L.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Miller, Christopher A.; Griffith, Malachi; Petti, Allegra; Ketkar-Kulkarni, Shamika; Griffith, Obi L.; Shen, Dong; Hundal, Jasreet; Chang, Gue Su; Fulton, Robert; O'Laughlin, Michelle; Fronick, Catrina; Magrini, Vincent; Demeter, Ryan T.; Larson, David E.; Ozenberger, Bradley A.; Mardis, Elaine R.; Wilson, Richard K.; Ley, Timothy J.] Washington Univ, McDonnell Genome Inst, St Louis, MO USA; [Miller, Christopher A.; Petti, Allegra; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Med, Div Genom & Bioinformat, St Louis, MO USA; [Griffith, Malachi; Wartman, Lukas D.; Fulton, Robert; Magrini, Vincent; Larson, David E.; Kulkarni, Shashikant; Mardis, Elaine R.; Wilson, Richard K.; Ley, Timothy J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Ketkar-Kulkarni, Shamika; Christopher, Matthew; Lamprecht, Tamara L.; Helton, Nicole M.; Heath, Sharon E.; Griffith, Obi L.; Ozenberger, Bradley A.; Welch, John S.; Walter, Matthew J.; Graubert, Timothy A.; Westervelt, Peter; Link, Daniel C.; DiPersio, John F.; Ley, Timothy J.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Baty, Jack] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Shen, Dong] Medimmune AstraZeneca, Gaithersburg, MD USA; [Kulkarni, Shashikant] Washington Univ, Dept Pediat, Div Hematol Oncol, St Louis, MO 63130 USA; [Graubert, Timothy A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Radich, Jerald P.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Washington University (WUSTL); St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); AstraZeneca; Medimmune; Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Fred Hutchinson Cancer Center	Ley, TJ (corresponding author), Washington Univ, Sch Med, 660 South Euclid Ave,Campus Box 8007, St Louis, MO 63110 USA.	timley@wustl.edu	Wilson, Richard K./AAF-4139-2019; Magrini, Vincent/AAT-5830-2020; Walter, Matthew J/S-7758-2018; Griffith, Malachi/P-1285-2014; Klco, Jeffery/M-9717-2018; Miller, Christopher A./A-1060-2009; Mardis, Elaine/W-2202-2019; Griffith, Obi/P-1286-2014	Wilson, Richard K./0000-0002-1992-1358; Magrini, Vincent/0000-0002-2019-4872; Griffith, Malachi/0000-0002-6388-446X; Klco, Jeffery/0000-0003-2961-6960; Miller, Christopher A./0000-0003-4266-6700; Griffith, Obi/0000-0002-0843-4271; Larson, David/0000-0001-7934-5906; Westover, Tamara/0000-0002-1000-6698	National Institutes of Health [KO8 HL116605, PO1 CA101937, U54 HG003079]; Barnes-Jewish Hospital Foundation [00335-0505-02]; National Cancer Institute Cancer Center [P30CA91842]; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [P01CA018029, P01CA101937, K08CA166229, P50CA171963, P30CA091842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087107, K08HL116605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants KO8 HL116605 (Dr Klco), PO1 CA101937 (Dr Ley), and U54 HG003079 (Dr Wilson) from the National Institutes of Health and grant 00335-0505-02 (Dr Ley) from the Barnes-Jewish Hospital Foundation. Technical assistance was provided by the Alvin J. Siteman Cancer Center Tissue Procurement Core, the High Speed Cell Sorting Core, and the Molecular and Genomic Analysis Core at Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, Missouri, which are all supported by grant P30CA91842 from the National Cancer Institute Cancer Center. Dr Klco reports holding a Career Award for Medical Scientists from the Burroughs Wellcome Fund.	Breems DA, 2005, J CLIN ONCOL, V23, P1969, DOI 10.1200/JCO.2005.06.027; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Chen XY, 2015, J CLIN ONCOL, V33, P1258, DOI 10.1200/JCO.2014.58.3518; Chen YM, 2011, J CLIN ONCOL, V29, P2507, DOI 10.1200/JCO.2010.34.2873; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cheson BD, 2004, J CLIN ONCOL, V22, P576; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Hourigan CS, 2013, NAT REV CLIN ONCOL, V10, P460, DOI 10.1038/nrclinonc.2013.100; Inaba H, 2012, J CLIN ONCOL, V30, P3625, DOI 10.1200/JCO.2011.41.5323; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kihara R, 2014, LEUKEMIA, V28, P1586, DOI 10.1038/leu.2014.55; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Loken MR, 2012, BLOOD, V120, P1581, DOI 10.1182/blood-2012-02-408336; Marcucci G, 2004, J CLIN ONCOL, V22, P2410, DOI 10.1200/JCO.2004.03.023; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Paietta E, 2012, HEMATOL-AM SOC HEMAT, P35, DOI 10.1182/asheducation-2012.1.35; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Ploen GG, 2014, BRIT J HAEMATOL, V167, P478, DOI 10.1111/bjh.13062; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ravandi F, 2010, BLOOD, V116, P5818, DOI 10.1182/blood-2010-07-296392; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowe JM, 2010, CANCER-AM CANCER SOC, V116, P5012, DOI 10.1002/cncr.25263; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Terwijn M, 2013, J CLIN ONCOL, V31, P3889, DOI 10.1200/JCO.2012.45.9628; Walter RB, 2011, J CLIN ONCOL, V29, P4417, DOI 10.1200/JCO.2011.35.7525; Walter RB, 2010, J CLIN ONCOL, V28, P1766, DOI 10.1200/JCO.2009.25.1066; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733	34	238	244	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					811	822		10.1001/jama.2015.9643	http://dx.doi.org/10.1001/jama.2015.9643			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305651	Green Accepted, Bronze			2022-12-28	WOS:000360017200021
J	Prinja, S; Jagnoor, J; Chauhan, AS; Aggarwal, S; Ivers, R				Prinja, Shankar; Jagnoor, Jagnoor; Chauhan, Akashdeep S.; Aggarwal, Sameer; Ivers, Rebecca			Estimation of the economic burden of injury in north India: a prospective cohort study	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Prinja, Shankar] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Jagnoor, Jagnoor; Ivers, Rebecca] George Inst Global Hlth, Sydney, NSW, Australia; [Jagnoor, Jagnoor] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney, NSW 2006, Australia; [Chauhan, Akashdeep S.] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Aggarwal, Sameer] Post Grad Inst Med Educ & Res, Dept Orthopaed, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; George Institute for Global Health; University of Sydney; University of Sydney; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh		shankarprinja@gmail.com		Ivers, Rebecca/0000-0003-3448-662X; jagnoor, Jagnoor/0000-0002-5276-9095; Chauhan, Akashdeep Singh/0000-0001-6791-2221					0	16	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			57	57		10.1016/S0140-6736(15)60852-2	http://dx.doi.org/10.1016/S0140-6736(15)60852-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313107				2022-12-28	WOS:000360573400058
J	Rocco, P; Gellad, WF; Donohue, JM				Rocco, Philip; Gellad, Walid F.; Donohue, Julie M.			Modernizing Medicaid Managed Care Can States Meet the Data Challenges?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rocco, Philip; Donohue, Julie M.] Univ Pittsburgh, Hlth Policy Inst, Sch Hlth Sci, Pittsburgh, PA 15261 USA; [Gellad, Walid F.] Vet Affairs Pittsburgh Hlth Care Syst, Ctr Hlth Equity Res & Promot, Pittsburgh, PA USA; [Gellad, Walid F.] Univ Pittsburgh, Sch Med, Div Gen Internal Med, Pittsburgh, PA 15261 USA; [Donohue, Julie M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rocco, P (corresponding author), Univ Pittsburgh, Hlth Policy Inst, 3550 Terrace St,S310-1, Pittsburgh, PA 15261 USA.	pbr8@pitt.edu		Rocco, Philip/0000-0001-5971-7039; Donohue, Julie/0000-0003-2418-6017				Altman D, 2015, JAMA-J AM MED ASSOC, V314, P384, DOI 10.1001/jama.2015.7811; Bindman AB, 2015, JAMA-J AM MED ASSOC, V314, P345, DOI 10.1001/jama.2015.8209; Byrd V., 2011, COLLECTING USING REP; Centers for Medicare and Medicaid Services, MED ADV ENC DAT MIN; Centers for Medicare and Medicaid Services, RE TRANSF MED STAT I; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Gnadinger T, NEW HLTH POLICY BRIE; Office of Inspector General, NOT ALL STAT REP MED; Porter J, 2015, ALL PAYER CLAIMS DAT	9	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1559	1560		10.1001/jama.2015.10979	http://dx.doi.org/10.1001/jama.2015.10979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26322564				2022-12-28	WOS:000363028500011
J	Wheeler, DB; Zoncu, R; Root, DE; Sabatini, DM; Sawyers, CL				Wheeler, Douglas B.; Zoncu, Roberto; Root, David E.; Sabatini, David M.; Sawyers, Charles L.			Identification of an oncogenic RAB protein	SCIENCE			English	Article							RECEPTOR TRAFFICKING; EXCHANGE FACTORS; DENN DOMAIN; KINASE; MUTATIONS; CANCER; ACTIVATION; AKT/PKB; PATHWAY; GROWTH	In a short hairpin RNA screen for genes that affect AKT phosphorylation, we identified the RAB35 small guanosine triphosphatase (GTPase)-a protein previously implicated in endomembrane trafficking-as a regulator of the phosphatidylinositol 3'-OH kinase (PI3K) pathway. Depletion of RAB35 suppresses AKT phosphorylation in response to growth factors, whereas expression of a dominant active GTPase-deficient mutant of RAB35 constitutively activates the PI3K/AKT pathway. RAB35 functions downstream of growth factor receptors and upstream of PDK1 and mTORC2 and copurifies with PI3K in immunoprecipitation assays. Two somatic RAB35 mutations found in human tumors generate alleles that constitutively activate PI3K/AKT signaling, suppress apoptosis, and transform cells in a PI3K-dependent manner. Furthermore, oncogenic RAB35 is sufficient to drive platelet-derived growth factor receptor a to LAMP2-positive endomembranes in the absence of ligand, suggesting that there may be latent oncogenic potential in dysregulated endomembrane trafficking.	[Wheeler, Douglas B.; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Wheeler, Douglas B.] Rockefeller Univ, Weill Cornell, Sloan Kettering Triinst, MD PhD Program, New York, NY 10021 USA; [Wheeler, Douglas B.; Root, David E.; Sabatini, David M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zoncu, Roberto] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Sabatini, David M.; Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	sabatini@wi.mit.edu; sawyersc@mskcc.org	Sawyers, Charles/G-5327-2016	/0000-0002-1446-7256	Starr Cancer Consortium Award [I2-A117]; Department of Defense Prostate Cancer Research Program via the Office of the Congressionally Directed Medical Research Programs Predoctoral Prostate Cancer Training Award [PC094483]; NIH Medical Scientist Training Program [GM07739]; Glenn Foundation for Medical Research; NIH Director's New Innovator Award [1DP2CA195761-01]; Pew-Stewart Scholarship for Cancer Research; NIH [CA103866, AI47389, CA155169, CA092629]; NATIONAL CANCER INSTITUTE [R01CA193837, R01CA103866, P50CA092629, P30CA008748, R01CA155169, R01CA129105, DP2CA195761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Starr Cancer Consortium Award; Department of Defense Prostate Cancer Research Program via the Office of the Congressionally Directed Medical Research Programs Predoctoral Prostate Cancer Training Award; NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew-Stewart Scholarship for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all of the members of the Sabatini and Sawyers laboratories for critical readings of this manuscript and helpful discussions. We also thank N. D. Novikov, M. A. Domser, K. C. Wood, D. J. Spencer, T. R. Peterson, C. Thoreen, S. Kinkel, M. J. Evans, R. Bose, P. Watson, O. S. Andersen, S. C. Blanchard, T. E. McGraw, N. Rosen, and A. Smogorzewska for helpful discussions; S. Silver for assistance with the RNAi screens; V. Boyko and Y. Romin of the MSKCC Molecular Cytology Core Facility for assistance with confocal microscopy; A. Kazlauskas for helpful discussions about PDGFR biology; and the late A. Hall for helpful input about GTPase biology. Funds for the RNAi screen were provided by the Starr Cancer Consortium Award I2-A117. D.B.W. was supported by the Department of Defense Prostate Cancer Research Program via the Office of the Congressionally Directed Medical Research Programs Predoctoral Prostate Cancer Training Award PC094483, as well as by NIH Medical Scientist Training Program grant GM07739. R.Z. was supported by the Glenn Foundation for Medical Research, the NIH Director's New Innovator Award 1DP2CA195761-01, and the Pew-Stewart Scholarship for Cancer Research. This work was partially supported by NIH grants CA103866 and AI47389 (to D.M.S.) and CA155169 and CA092629 (to C.L.S.). Data from the RNAi screen described in this manuscript can be found in the supplementary materials.	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Chamberlain MD, 2010, CELL SIGNAL, V22, P1562, DOI 10.1016/j.cellsig.2010.05.025; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; Chua CEL, 2010, FEBS LETT, V584, P1, DOI 10.1016/j.febslet.2009.11.051; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Dai J, 2013, CLIN CANCER RES, V19, P6935, DOI 10.1158/1078-0432.CCR-13-1266; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Heinrich MC, 2012, CLIN CANCER RES, V18, P4375, DOI 10.1158/1078-0432.CCR-12-0625; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Kermorgant S, 2004, EMBO J, V23, P3721, DOI 10.1038/sj.emboj.7600396; Lewis NL, 2009, J CLIN ONCOL, V27, P5262, DOI 10.1200/JCO.2009.21.8487; Marat AL, 2012, MOL BIOL CELL, V23, P163, DOI 10.1091/mbc.E11-05-0474; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Tyner JW, 2009, BLOOD, V113, P1749, DOI 10.1182/blood-2008-04-152157; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	35	87	90	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2015	350	6257					211	217		10.1126/science.aaa4903	http://dx.doi.org/10.1126/science.aaa4903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS9JB	26338797	Green Accepted, Green Submitted			2022-12-28	WOS:000362405600040
J	Merila, J				Merila, Juha			EVOLUTIONARY BIOLOGY Perplexing effects of phenotypic plasticity	NATURE			English	Editorial Material									Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland	University of Helsinki	Merila, J (corresponding author), Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland.	juha.merila@helsinki.fi	Merila, Juha/A-4061-2008	Merila, Juha/0000-0001-9614-0072				Ancel LW, 2000, THEOR POPUL BIOL, V58, P307, DOI 10.1006/tpbi.2000.1484; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Ghalambor CK, 2015, NATURE, V525, P372, DOI 10.1038/nature15256; Paenke I, 2007, AM NAT, V170, pE47, DOI 10.1086/518952; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Schaum CE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1486; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; WADDINGTON C, 1961, ADV GENET, V10, P257, DOI 10.1016/S0065-2660(08)60119-4; West-Eberhard Mary Jane, 2003, pi	10	7	7	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					326	327		10.1038/nature15214	http://dx.doi.org/10.1038/nature15214			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26331543				2022-12-28	WOS:000361297900030
J	Johnson, PTJ; De Roode, JC; Fenton, A				Johnson, Pieter T. J.; De Roode, Jacobus C.; Fenton, Andy			Why infectious disease research needs community ecology	SCIENCE			English	Review							POPULATION-DYNAMICS; PHYLOGENETIC STRUCTURE; GLOBAL HEALTH; HOST; TRANSMISSION; WILDLIFE; PARASITES; METACOMMUNITY; BIODIVERSITY; DIVERSITY	Infectious diseases often emerge from interactions among multiple species and across nested levels of biological organization. Threats as diverse as Ebola virus, human malaria, and bat white-nose syndrome illustrate the need for a mechanistic understanding of the ecological interactions underlying emerging infections. We describe how recent advances in community ecology can be adopted to address contemporary challenges in disease research. These analytical tools can identify the factors governing complex assemblages of multiple hosts, parasites, and vectors, and reveal how processes link across scales from individual hosts to regions. They can also determine the drivers of heterogeneities among individuals, species, and regions to aid targeting of control strategies. We provide examples where these principles have enhanced disease management and illustrate how they can be further extended.	[Johnson, Pieter T. J.] Univ Colorado, Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [De Roode, Jacobus C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Fenton, Andy] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	University of Colorado System; University of Colorado Boulder; Emory University; University of Liverpool	Johnson, PTJ (corresponding author), Univ Colorado, Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	pieter.johnson@colorado.edu	Fenton, Andy/B-5972-2009	Fenton, Andy/0000-0002-7676-917X; JOHNSON, PIETER/0000-0002-7997-5390	NSF/NIH/USDA DEB [131223]; NSF [DEB-1149308, DEB-1257160]; NIH [R01GM109499, R01GM109501]; UK Natural Environment Research Council [NE/G006830/1, NE/I024038/1]; NERC [NE/I026367/1, NE/I024038/1, NE/G006830/1, NE/G007349/1] Funding Source: UKRI; Natural Environment Research Council [NE/I024038/1, NE/G007349/1, NE/I026367/1, NE/G006830/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109501, R01GM109499] Funding Source: NIH RePORTER	NSF/NIH/USDA DEB; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For discussions and feedback helpful in shaping the manuscript, we thank S. Altizer, D. Calhoun, G. Devevey, I. Doron, S. Haas, K. Hoang, B. Hoye, M. Joseph, J. Koprivnikar, T. McDevitt-Galles, J. Mihaljevic, A. Pedersen, O. Petchey, A. Pierce, D. Preston, Y. Springer, W. Stutz, L. Tao, S. White, and members of the Macroecology of Infectious Disease Research Coordination Network (funded by NSF/NIH/USDA DEB 131223). Supported by NSF grant DEB-1149308 and NIH grant R01GM109499 (P.T.J.J.), NSF grant DEB-1257160 and NIH grant R01GM109501 (J.C.d.R.), and UK Natural Environment Research Council grants NE/G006830/1 and NE/I024038/1 (A.F.).	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Al-Tawfiq JA, 2014, TRENDS MICROBIOL, V22, P573, DOI 10.1016/j.tim.2014.08.001; Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; [Anonymous], 2014, PREDICT SUCC YELL FE; Blackwell AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1671; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Calabrese JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029215; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chesson P, 2012, ECOL COMPLEX, V10, P52, DOI 10.1016/j.ecocom.2011.11.002; Cirtwill AR, 2015, J ANIM ECOL, V84, P734, DOI 10.1111/1365-2656.12323; Civitello DJ, 2015, P NATL ACAD SCI USA, V112, P8667, DOI 10.1073/pnas.1506279112; Dallas T, 2014, OIKOS, V123, P866, DOI 10.1111/oik.00707; Davis S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1004; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Drake JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002056; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Drury KLS, 2008, OIKOS, V117, P182, DOI 10.1111/j.2007.0030-1299.16081.x; Dunn RR, 2010, P ROY SOC B-BIOL SCI, V277, P2587, DOI 10.1098/rspb.2010.0340; Durbin AP, 2013, VIROLOGY, V439, P34, DOI 10.1016/j.virol.2013.01.018; Rabinovich JE, 2011, MEM I OSWALDO CRUZ, V106, P479, DOI 10.1590/S0074-02762011000400016; Ezenwa VO, 2015, SCIENCE, V347, P175, DOI 10.1126/science.1261714; Fenton A, 2013, PARASITOLOGY, V140, P1119, DOI 10.1017/S0031182013000590; Fenton A, 2010, PARASITOLOGY, V137, P1027, DOI 10.1017/S0031182009991788; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Franco AO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101699; Gibson AK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001142; Gilbert L, 2001, J ANIM ECOL, V70, P1053, DOI 10.1046/j.0021-8790.2001.00558.x; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Grear DA, 2009, ECOL LETT, V12, P528, DOI 10.1111/j.1461-0248.2009.01306.x; Griffiths EC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2286; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112; Harms G, 2002, TROP MED INT HEALTH, V7, P479, DOI 10.1046/j.1365-3156.2002.00893.x; Henipavirus Ecology Research Group (HERG), 2006, P186; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Holt Robert D., 2006, P6; Hudson P. J., 2008, INFECT DIS EC EFF, P347; Jasny B, 2014, SCIENCE, V345, P1256, DOI 10.1126/science.345.6202.1256; Johnson PTJ, 2015, ECOL LETT, V18, P1119, DOI 10.1111/ele.12479; Johnson PTJ, 2013, P NATL ACAD SCI USA, V110, P16916, DOI 10.1073/pnas.1310557110; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kaabi B, 2013, BIOSYSTEMS, V114, P253, DOI 10.1016/j.biosystems.2013.10.003; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Knowles SCL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0598; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Langwig KE, 2015, FRONT ECOL ENVIRON, V13, P195, DOI 10.1890/140241; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lembo T, 2008, J APPL ECOL, V45, P1246, DOI 10.1111/j.1365-2664.2008.01468.x; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mahl P, 2014, VET RES, V45, DOI 10.1186/s13567-014-0077-8; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Messenger AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089055; Mihaljevic JR, 2012, TRENDS ECOL EVOL, V27, P323, DOI 10.1016/j.tree.2012.01.011; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Parker IM, 2015, NATURE, V520, P542, DOI 10.1038/nature14372; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pedersen AB, 2015, TRENDS PARASITOL, V31, P200, DOI 10.1016/j.pt.2015.02.004; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; Poisot T, 2012, ECOL LETT, V15, P1353, DOI 10.1111/ele.12002; Poulin R, 2010, TRENDS PARASITOL, V26, P492, DOI 10.1016/j.pt.2010.05.008; Presley SJ, 2010, OIKOS, V119, P908, DOI 10.1111/j.1600-0706.2010.18544.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Rudge JW, 2013, P NATL ACAD SCI USA, V110, P11457, DOI 10.1073/pnas.1221509110; Rynkiewicz EC, 2015, TRENDS PARASITOL, V31, P212, DOI 10.1016/j.pt.2015.02.005; Schindler DW, 1998, ECOSYSTEMS, V1, P323, DOI 10.1007/s100219900026; Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241; Seabloom EW, 2015, ECOL LETT, V18, P401, DOI 10.1111/ele.12418; Sepulveda J, 2014, SCIENCE, V345, P1275, DOI 10.1126/science.1257099; Shen Z, 2004, EMERG INFECT DIS, V10, P256, DOI 10.3201/eid1002.030732; Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950; Stiasny K, 2007, PLOS PATHOG, V3, P191, DOI 10.1371/journal.ppat.0030020; Streicker DG, 2013, ECOL LETT, V16, P975, DOI 10.1111/ele.12122; Stutz WE, 2014, AM NAT, V183, P810, DOI 10.1086/676005; Susi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6975; Suzan G, 2015, ECOL EVOL, V5, P865, DOI 10.1002/ece3.1404; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Voss JD, 2007, MICROB ECOL, V54, P730, DOI 10.1007/s00248-007-9234-1; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Wood CL, 2013, TRENDS ECOL EVOL, V28, P239, DOI 10.1016/j.tree.2012.10.011; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; World Health Organization, 2014, TOP 10 CAUS DEATH; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	104	246	252	11	420	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252							1259504	10.1126/science.1259504	http://dx.doi.org/10.1126/science.1259504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339035	Green Accepted			2022-12-28	WOS:000360628900032
J	van Ginneken, E				van Ginneken, Ewout			INTERNATIONAL HEALTH CARE SYSTEMS Perennial Health Care Reform - The Long Dutch Quest for Cost Control and Quality Improvement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Davis K., 2014, UPDATE MIRROR MIRROR; Organization for Economic Cooperation and Development, 2014, HLTH GLANC EUR 2014; van den Berg MJ, 2015, DUTCH HLTH CARE PERF; Van Dijk CE, 2013, KENNISVRAAG RUIMTE S; van Ginneken E, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1383	5	11	11	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					885	889		10.1056/NEJMp1410422	http://dx.doi.org/10.1056/NEJMp1410422			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ2OB	26332544	Bronze			2022-12-28	WOS:000360439500002
J	Rudmik, L; Soler, ZM				Rudmik, Luke; Soler, Zachary M.			Medical Therapies for Adult Chronic Sinusitis A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TASTE RECEPTOR T2R38; TOPICAL AMPHOTERICIN-B; CHRONIC RHINOSINUSITIS; NASAL POLYPOSIS; LONG-TERM; MACROLIDE THERAPY; STEROID-THERAPY; ORAL STEROIDS; DOUBLE-BLIND; ANTI-IGE	IMPORTANCE Chronic sinusitis is a common inflammatory condition defined by persistent symptomatic inflammation of the sinonasal cavities lasting longer than 3 months. It accounts for 1% to 2% of total physician encounters and is associated with large health care expenditures. Appropriate use of medical therapies for chronic sinusitis is necessary to optimize patient quality of life (QOL) and daily functioning and minimize the risk of acute inflammatory exacerbations. OBJECTIVE To summarize the highest-quality evidence on medical therapies for adult chronic sinusitis and provide an evidence-based approach to assist in optimizing patient care. EVIDENCE REVIEW A systematic review searched Ovid MEDLINE (1947-January 30, 2015), EMBASE, and Cochrane Databases. The search was limited to randomized clinical trials (RCTs), systematic reviews, and meta-analyses. Evidence was categorized into maintenance and intermittent or rescue therapies and reported based on the presence or absence of nasal polyps. FINDINGS Twenty-nine studies met inclusion criteria: 12 meta-analyses (>60 RCTs), 13 systematic reviews, and 4 RCTs that were not included in any of the meta-analyses. Saline irrigation improved symptom scores compared with no treatment (standardized mean difference [SMD], 1.42 [95% CI, 1.01 to 1.84]; a positive SMD indicates improvement). Topical corticosteroid therapy improved overall symptom scores (SMD, -0.46 [95% CI, -0.65 to -0.27]; a negative SMD indicates improvement), improved polyp scores (SMD, -0.73 [95% CI, -1.0 to -0.46]; a negative SMD indicates improvement), and reduced polyp recurrence after surgery (relative risk, 0.59 [95% CI, 0.45 to 0.79]). Systemic corticosteroids and oral doxycycline (both for 3 weeks) reduced polyp size compared with placebo for 3 months after treatment (P <.001). Leukotriene antagonists improved nasal symptoms compared with placebo in patients with nasal polyps (P <.01). Macrolide antibiotic for 3 months was associated with improved QOL at a single time point (24 weeks after therapy) compared with placebo for patients without polyps (SMD, -0.43 [95% CI, -0.82 to -0.05]). CONCLUSIONS AND RELEVANCE Evidence supports daily high-volume saline irrigation with topical corticosteroid therapy as a first-line therapy for chronic sinusitis. A short course of systemic corticosteroids (1-3 weeks), short course of doxycycline (3 weeks), or a leukotriene antagonist may be considered in patients with nasal polyps. A prolonged course (3 months) of macrolide antibiotic may be considered for patients without polyps.	[Rudmik, Luke] Univ Calgary, Dept Surg, Div Otolaryngol Head & Neck Surg, Calgary, AB T2T 5C7, Canada; [Soler, Zachary M.] Med Univ S Carolina, Div Rhinol & Sinus Surg, Dept Otolaryngol Head & Neck Surg, Charleston, SC USA	University of Calgary; Medical University of South Carolina	Rudmik, L (corresponding author), Univ Calgary, Dept Surg, Div Otolaryngol Head & Neck Surg, Richmond Rd Diagnost & Treatment Ctr, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada.	lukerudmik@gmail.com			National Institutes of Health; National Institute on Deafness and Other Communication Disorders; Brainlab; Olympus	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Brainlab; Olympus	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Soler reports receiving consulting fees from Brainlab and Olympus and receiving grant support from the National Institutes of Health and the National Institute on Deafness and Other Communication Disorders. No other disclosures were reported.	Adappa ND, 2014, INT FORUM ALLERGY RH, V4, P3, DOI 10.1002/alr.21253; Adappa ND, 2013, INT FORUM ALLERGY RH, V3, P184, DOI 10.1002/alr.21140; Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Alt JA, 2013, INT FORUM ALLERGY RH, V3, P941, DOI 10.1002/alr.21217; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; [Anonymous], 2008, Drugs R D, V9, P125; [Anonymous], SECT 2 TOOLS METH CR; Bachert C, 2012, J INTERN MED, V272, P133, DOI 10.1111/j.1365-2796.2012.02559.x; Bassiouni A, 2012, LARYNGOSCOPE, V122, P225, DOI 10.1002/lary.22374; Bhattacharyya N, 2003, AM J RHINOL, V17, P27, DOI 10.1177/194589240301700106; Bhattacharyya N, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000224508.59725.19; Bhattacharyya N, 2011, ANN OTO RHINOL LARYN, V120, P423, DOI 10.1177/000348941112000701; Braun H, 2003, LARYNGOSCOPE, V113, P264, DOI 10.1097/00005537-200302000-00013; Cervin A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0416-2; Chang TW, 2006, J ALLERGY CLIN IMMUN, V117, P1203, DOI 10.1016/j.jaci.2006.04.005; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; de Loos DAED, 2013, LARYNGOSCOPE, V123, P57, DOI 10.1002/lary.23671; Dellamonica P, 1994, Ann Otolaryngol Chir Cervicofac, V111, P217; Desrosiers M, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-2; DeYoung K, 2014, AM J RHINOL ALLERGY, V28, P145, DOI 10.2500/ajra.2014.28.4019; Dykewicz M.S., 2010, J ALLERGY CLIN IMMUN, V567, P125; Fandino M, 2013, AM J RHINOL ALLERGY, V27, pE146, DOI 10.2500/ajra.2013.27.3950; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gevaert P, 2006, J ALLERGY CLIN IMMUN, V118, P1133, DOI 10.1016/j.jaci.2006.05.031; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Halawi AM, 2013, ALLERGY ASTHMA PROC, V34, P328, DOI 10.2500/aap.2013.34.3675; Harvey R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006394; Harvey RJ, 2009, IMMUNOL ALLERGY CLIN, V29, P689, DOI 10.1016/j.iac.2009.07.006; Hellings PW, 2013, ALLERGY, V68, P1, DOI 10.1111/all.12040; Hessler JL, 2007, AM J RHINOL, V21, P10, DOI 10.2500/ajr.2007.21.2960; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hsu J, 2013, J ALLERGY CLIN IMMUN, V131, P977, DOI 10.1016/j.jaci.2013.01.028; Huck W, 1993, Arch Fam Med, V2, P497, DOI 10.1001/archfami.2.5.497; IFI Claims Patent Services, METH MAT TREAT PREV; Ikeda Katsuhisa, 1995, Rhinology (Utrecht), V33, P162; Isaacs S, 2011, INT FORUM ALLERGY RH, V1, P250, DOI 10.1002/alr.20056; Jervis-Bardy J, 2012, LARYNGOSCOPE, V122, P2148, DOI 10.1002/lary.23486; Joe SA, 2008, OTOLARYNG HEAD NECK, V139, P340, DOI 10.1016/j.otohns.2008.05.628; Kalish L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006549.pub2; Kalish LH, 2009, OTOLARYNG HEAD NECK, V141, P674, DOI 10.1016/j.otohns.2009.08.006; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Lal D, 2011, INT FORUM ALLERGY RH, V1, P136, DOI 10.1002/alr.20024; Lal D, 2009, AM J RHINOL ALLERGY, V23, P396, DOI 10.2500/ajra.2009.23.3334; Lanza DC, 2006, ANN OTO RHINOL LARYN, V115, P27; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Lee RJ, 2015, CURR OPIN ALLERGY CL, V15, P14, DOI 10.1097/ACI.0000000000000120; LEGENT F, 1994, CHEMOTHERAPY, V40, P8, DOI 10.1159/000239310; Lim M, 2008, AM J RHINOL, V22, P381, DOI 10.2500/ajr.2008.22.3189; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Martinez-Devesa P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005232.pub3; Mattos JL, 2011, INT FORUM ALLERGY RH, V1, P3, DOI 10.1002/alr.20003; Mostafa BE, 2005, ORL-J OTO-RHIN-LARYN, V67, P148, DOI 10.1159/000086016; Ocampo CJ, 2013, J ALLER CL IMM-PRACT, V1, P205, DOI 10.1016/j.jaip.2012.12.001; Ocampo CJ, 2013, ALLERGY ASTHMA PROC, V34, P132, DOI 10.2500/aap.2013.34.3636; Ocampo CJ, 2013, J ALLERGY CLIN IMMUN, V1, P212; Oxford Centre for Evidence Based Medicine, LEV OF EV; Parnham MJ, 2014, PHARMACOL THERAPEUT, V143, P225, DOI 10.1016/j.pharmthera.2014.03.003; Patel AM, 2013, ANN INTERN MED, V158, P869, DOI 10.7326/0003-4819-158-12-201306180-00004; Pauli C, 2007, LARYNGO RHINO OTOL, V86, P282, DOI 10.1055/s-2007-966094; Pinto JM, 2010, RHINOLOGY, V48, P318, DOI [10.4193/Rhin09.144, 10.4193/Rhino09.144]; Piromchai P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008233.pub2; Poetker DM, 2013, INT FORUM ALLERGY RH, V3, P104, DOI 10.1002/alr.21072; Poetker DM, 2010, OTOLARYNG CLIN N AM, V43, P753, DOI 10.1016/j.otc.2010.04.003; Ponikau JU, 1999, MAYO CLIN PROC, V74, P877, DOI 10.4065/74.9.877; Pynnonen MA, 2007, ARCH OTOLARYNGOL, V133, P1115, DOI 10.1001/archotol.133.11.1115; Pynnonen MA, 2013, OTOLARYNG HEAD NECK, V148, P366, DOI 10.1177/0194599812470427; Reiter J, 2013, ALLERGY, V68, P1040, DOI 10.1111/all.12199; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Rudmik L, HIGH VOLUME SINONASA; Rudmik L, 2014, LARYNGOSCOPE, V124, P2007, DOI 10.1002/lary.24630; Rudmik L, 2013, INT FORUM ALLERGY RH, V3, P281, DOI 10.1002/alr.21096; Rudmik L, 2012, LARYNGOSCOPE, V122, P1431, DOI 10.1002/lary.23259; Rudmik L, 2012, CURR OPIN OTOLARYNGO, V20, P29, DOI 10.1097/MOO.0b013e32834dfb3d; Rudmik L, 2011, CURR ALLERGY ASTHM R, V11, P247, DOI 10.1007/s11882-010-0175-2; Sacks PL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008263.pub2; Scadding GK, 2008, CLIN EXP ALLERGY, V38, P260, DOI 10.1111/j.1365-2222.2007.02889.x; Schaper C, 2011, J INVEST ALLERG CLIN, V21, P51; Smith KA, 2015, LARYNGOSCOPE, V125, P1547, DOI 10.1002/lary.25180; Snidvongs K, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009274.pub2, 10.1002/14651858.CD009274]; Soler ZM, 2008, AM J RHINOL, V22, P297, DOI 10.2500/ajr.2008.22.3172; Soler ZM, 2013, INT FORUM ALLERGY RH, V3, P31, DOI 10.1002/alr.21064; Soler ZM, 2009, LARYNGOSCOPE, V119, P2083, DOI 10.1002/lary.20739; Stewart RA, 2008, OTOLARYNG HEAD NECK, V139, P682, DOI 10.1016/j.otohns.2008.07.010; Subramanian HN, 2002, AM J RHINOL, V16, P303, DOI 10.1177/194589240201600605; Tan BK, 2013, AM J RESP CRIT CARE, V188, P1275, DOI 10.1164/rccm.201308-1500ED; Thomas WW, 2013, INT FORUM ALLERGY RH, V3, P691, DOI 10.1002/alr.21172; Vaidyanathan S, 2011, ANN INTERN MED, V154, P293, DOI 10.7326/0003-4819-154-5-201103010-00003; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; van den Berg JWG, 2014, OTOLARYNG HEAD NECK, V150, P16, DOI 10.1177/0194599813510885; van Drunen CM, 2009, IMMUNOL ALLERGY CLIN, V29, P621, DOI 10.1016/j.iac.2009.07.003; Van Zele T, 2010, J ALLERGY CLIN IMMUN, V125, P1069, DOI 10.1016/j.jaci.2010.02.020; Videler WJ, 2011, ALLERGY, V66, P1457, DOI 10.1111/j.1398-9995.2011.02693.x; Vuralkan E, 2012, THER ADV RESPIR DIS, V6, P5, DOI 10.1177/1753465811427577; Wallwork B, 2006, LARYNGOSCOPE, V116, P189, DOI 10.1097/01.mlg.0000191560.53555.08; Wang TQ, 2015, EUR ARCH OTO-RHINO-L, V272, P1923, DOI 10.1007/s00405-014-3269-y; Wei CC, 2013, LARYNGOSCOPE, V123, P2347, DOI 10.1002/lary.24066; Wentzel JL, 2013, AM J RHINOL ALLERGY, V27, P482, DOI 10.2500/ajra.2013.27.3976; Westphal JF, 2000, BRIT J CLIN PHARMACO, V50, P285, DOI 10.1046/j.1365-2125.2000.00261.x; Wilson KF, 2014, INT FORUM ALLERGY RH, V4, P93, DOI 10.1002/alr.21258; Yasui N, 1996, CLIN PHARMACOL THER, V59, P514, DOI 10.1016/S0009-9236(96)90179-4; Yoon BN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/813610	102	96	107	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					926	939		10.1001/jama.2015.7544	http://dx.doi.org/10.1001/jama.2015.7544			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325561				2022-12-28	WOS:000360392100019
J	Aarts, AA; Anderson, JE; Anderson, CJ; Attridge, PR; Attwood, A; Axt, J; Babel, M; Bahnik, S; Baranski, E; Barnett-Cowan, M; Bartmess, E; Beer, J; Bell, R; Bentley, H; Beyan, L; Binion, G; Borsboom, D; Bosch, A; Bosco, FA; Bowman, SD; Brandt, MJ; Braswell, E; Brohmer, H; Brown, BT; Brown, K; Bruning, J; Calhoun-Sauls, A; Callahan, SP; Chagnon, E; Chandler, J; Chartier, CR; Cheung, F; Christopherson, CD; Cillessen, L; Clay, R; Cleary, H; Cloud, MD; Cohn, M; Cohoon, J; Columbus, S; Cordes, A; Costantini, G; Alvarez, LDC; Cremata, E; Crusius, J; DeCoster, J; DeGaetano, MA; Della Penna, N; den Bezemer, B; Deserno, MK; Devitt, O; Dewitte, L; Dobolyi, DG; Dodson, GT; Donnellan, MB; Donohue, R; Dore, RA; Dorrough, A; Dreber, A; Dugas, M; Dunn, EW; Easey, K; Eboigbe, S; Eggleston, C; Embley, J; Epskamp, S; Errington, TM; Estel, V; Farach, FJ; Feather, J; Fedor, A; Fernandez-Castilla, B; Fiedler, S; Field, JG; Fitneva, SA; Flagan, T; Forest, AL; Forsell, E; Foster, JD; Frank, MC; Frazier, RS; Fuchs, H; Gable, P; Galak, J; Galliani, EM; Gampa, A; Garcia, S; Gazarian, D; Gilbert, E; Giner-Sorolla, R; Glockner, A; Goellner, L; Goh, JX; Goldberg, R; Goodbourn, PT; Gordon-McKeon, S; Gorges, B; Gorges, J; Goss, J; Graham, J; Grange, JA; Gray, J; Hartgerink, C; Hartshorne, J; Hasselman, F; Hayes, T; Heikensten, E; Henninger, F; Hodsoll, J; Holubar, T; Hoogendoorn, G; Humphries, DJ; Hung, COY; Immelman, N; Irsik, VC; Jahn, G; Jakel, F; Jekel, M; Johannesson, M; Johnson, LG; Johnson, DJ; Johnson, KM; Johnston, WJ; Jonas, K; Joy-Gaba, JA; Kappes, HB; Kelso, K; Kidwell, MC; Kim, SK; Kirkhart, M; Kleinberg, B; Knezevic, G; Kolorz, FM; Kossakowski, JJ; Krause, RW; Krijnen, J; Kuhlmann, T; Kunkels, YK; Kyc, MM; Lai, CK; Laique, A; Lakens, D; Lane, KA; Lassetter, B; Lazarevic, LB; LeBel, EP; Lee, KJ; Lee, M; Lemm, K; Levitan, CA; Lewis, M; Lin, L; Lin, S; Lippold, M; Loureiro, D; Luteijn, I; Mackinnon, S; Mainard, HN; Marigold, DC; Martin, DP; Martinez, T; Masicampo, EJ; Matacotta, J; Mathur, M; May, M; Mechin, N; Mehta, P; Meixner, J; Melinger, A; Miller, JK; Miller, M; Moore, K; Moschl, M; Motyl, M; Muller, SM; Munafo, M; Neijenhuijs, KI; Nervi, T; Nicolas, G; Nilsonne, G; Nosek, BA; Nuijten, MB; Olsson, C; Osborne, C; Ostkamp, L; Pavel, M; Penton-Voak, IS; Perna, O; Pernet, C; Perugini, M; Pipitone, RN; Pitts, M; Plessow, F; Prenoveau, JM; Rahal, RM; Ratliff, KA; Reinhard, D; Renkewitz, F; Ricker, AA; Rigney, A; Rivers, AM; Roebke, M; Rutchick, AM; Ryan, RS; Sahin, O; Saide, A; Sandstrom, GM; Santos, D; Saxe, R; Schlegelmilch, R; Schmidt, K; Scholz, S; Seibel, L; Selterman, DF; Shaki, S; Simpson, WB; Sinclair, HC; Skorinko, JLM; Slowik, A; Snyder, JS; Soderberg, C; Sonnleitner, C; Spencer, N; Spies, JR; Steegen, S; Stieger, S; Strohminger, N; Sullivan, GB; Talhelm, T; Tapia, M; te Dorsthorst, A; Thomae, M; Thomas, SL; Tio, P; Traets, F; Tsang, S; Tuerlinckx, F; Turchan, P; Valasek, M; van 't Veer, AE; Van Aert, R; van Assen, M; van Bork, R; van de Ven, M; van den Bergh, D; van der Hulst, M; van Dooren, R; van Doorn, J; van Renswoude, DR; van Rijn, H; Vanpaemel, W; Echeverria, AV; Vazquez, M; Velez, N; Vermue, M; Verschoor, M; Vianello, M; Voracek, M; Vuu, G; Wagenmakers, EJ; Weerdmeester, J; Welsh, A; Westgate, EC; Wissink, J; Wood, M; Woods, A; Wright, E; Wu, S; Zeelenberg, M; Zuni, K				Aarts, Alexander A.; Anderson, Joanna E.; Anderson, Christopher J.; Attridge, Peter R.; Attwood, Angela; Axt, Jordan; Babel, Molly; Bahnik, Stepan; Baranski, Erica; Barnett-Cowan, Michael; Bartmess, Elizabeth; Beer, Jennifer; Bell, Raoul; Bentley, Heather; Beyan, Leah; Binion, Grace; Borsboom, Denny; Bosch, Annick; Bosco, Frank A.; Bowman, Sara D.; Brandt, Mark J.; Braswell, Erin; Brohmer, Hilmar; Brown, Benjamin T.; Brown, Kristina; Bruening, Jovita; Calhoun-Sauls, Ann; Callahan, Shannon P.; Chagnon, Elizabeth; Chandler, Jesse; Chartier, Christopher R.; Cheung, Felix; Christopherson, Cody D.; Cillessen, Linda; Clay, Russ; Cleary, Hayley; Cloud, Mark D.; Cohn, Michael; Cohoon, Johanna; Columbus, Simon; Cordes, Andreas; Costantini, Giulio; Alvarez, Leslie D. Cramblet; Cremata, Ed; Crusius, Jan; DeCoster, Jamie; DeGaetano, Michelle A.; Della Penna, Nicolas; den Bezemer, Bobby; Deserno, Marie K.; Devitt, Olivia; Dewitte, Laura; Dobolyi, David G.; Dodson, Geneva T.; Donnellan, M. Brent; Donohue, Ryan; Dore, Rebecca A.; Dorrough, Angela; Dreber, Anna; Dugas, Michelle; Dunn, Elizabeth W.; Easey, Kayleigh; Eboigbe, Sylvia; Eggleston, Casey; Embley, Jo; Epskamp, Sacha; Errington, Timothy M.; Estel, Vivien; Farach, Frank J.; Feather, Jenelle; Fedor, Anna; Fernandez-Castilla, Belen; Fiedler, Susann; Field, James G.; Fitneva, Stanka A.; Flagan, Taru; Forest, Amanda L.; Forsell, Eskil; Foster, Joshua D.; Frank, Michael C.; Frazier, Rebecca S.; Fuchs, Heather; Gable, Philip; Galak, Jeff; Galliani, Elisa Maria; Gampa, Anup; Garcia, Sara; Gazarian, Douglas; Gilbert, Elizabeth; Giner-Sorolla, Roger; Gloeckner, Andreas; Goellner, Lars; Goh, Jin X.; Goldberg, Rebecca; Goodbourn, Patrick T.; Gordon-McKeon, Shauna; Gorges, Bryan; Gorges, Jessie; Goss, Justin; Graham, Jesse; Grange, James A.; Gray, Jeremy; Hartgerink, Chris; Hartshorne, Joshua; Hasselman, Fred; Hayes, Timothy; Heikensten, Emma; Henninger, Felix; Hodsoll, John; Holubar, Taylor; Hoogendoorn, Gea; Humphries, Denise J.; Hung, Cathy O. -Y.; Immelman, Nathali; Irsik, Vanessa C.; Jahn, Georg; Jaekel, Frank; Jekel, Marc; Johannesson, Magnus; Johnson, Larissa G.; Johnson, David J.; Johnson, Kate M.; Johnston, William J.; Jonas, Kai; Joy-Gaba, Jennifer A.; Kappes, Heather Barry; Kelso, Kim; Kidwell, Mallory C.; Kim, Seung Kyung; Kirkhart, Matthew; Kleinberg, Bennett; Knezevic, Goran; Kolorz, Franziska Maria; Kossakowski, Jolanda J.; Krause, Robert Wilhelm; Krijnen, Job; Kuhlmann, Tim; Kunkels, Yoram K.; Kyc, Megan M.; Lai, Calvin K.; Laique, Aamir; Lakens, Daniel; Lane, Kristin A.; Lassetter, Bethany; Lazarevic, Ljiljana B.; LeBel, Etienne P.; Lee, Key Jung; Lee, Minha; Lemm, Kristi; Levitan, Carmel A.; Lewis, Melissa; Lin, Lin; Lin, Stephanie; Lippold, Matthias; Loureiro, Darren; Luteijn, Ilse; Mackinnon, Sean; Mainard, Heather N.; Marigold, Denise C.; Martin, Daniel P.; Martinez, Tylar; Masicampo, E. J.; Matacotta, Josh; Mathur, Maya; May, Michael; Mechin, Nicole; Mehta, Pranjal; Meixner, Johannes; Melinger, Alissa; Miller, Jeremy K.; Miller, Mallorie; Moore, Katherine; Moeschl, Marcus; Motyl, Matt; Mueller, Stephanie M.; Munafo, Marcus; Neijenhuijs, Koen I.; Nervi, Taylor; Nicolas, Gandalf; Nilsonne, Gustav; Nosek, Brian A.; Nuijten, Michele B.; Olsson, Catherine; Osborne, Colleen; Ostkamp, Lutz; Pavel, Misha; Penton-Voak, Ian S.; Perna, Olivia; Pernet, Cyril; Perugini, Marco; Pipitone, R. Nathan; Pitts, Michael; Plessow, Franziska; Prenoveau, Jason M.; Rahal, Rima-Maria; Ratliff, Kate A.; Reinhard, David; Renkewitz, Frank; Ricker, Ashley A.; Rigney, Anastasia; Rivers, Andrew M.; Roebke, Mark; Rutchick, Abraham M.; Ryan, Robert S.; Sahin, Onur; Saide, Anondah; Sandstrom, Gillian M.; Santos, David; Saxe, Rebecca; Schlegelmilch, Rene; Schmidt, Kathleen; Scholz, Sabine; Seibel, Larissa; Selterman, Dylan Faulkner; Shaki, Samuel; Simpson, William B.; Sinclair, H. Colleen; Skorinko, Jeanine L. M.; Slowik, Agnieszka; Snyder, Joel S.; Soderberg, Courtney; Sonnleitner, Carina; Spencer, Nick; Spies, Jeffrey R.; Steegen, Sara; Stieger, Stefan; Strohminger, Nina; Sullivan, Gavin B.; Talhelm, Thomas; Tapia, Megan; te Dorsthorst, Anniek; Thomae, Manuela; Thomas, Sarah L.; Tio, Pia; Traets, Frits; Tsang, Steve; Tuerlinckx, Francis; Turchan, Paul; Valasek, Milan; van 't Veer, Anna E.; Van Aert, Robbie; van Assen, Marcel; van Bork, Riet; van de Ven, Mathijs; van den Bergh, Don; van der Hulst, Marije; van Dooren, Roel; van Doorn, Johnny; van Renswoude, Daan R.; van Rijn, Hedderik; Vanpaemel, Wolf; Echeverria, Alejandro Vasquez; Vazquez, Melissa; Velez, Natalia; Vermue, Marieke; Verschoor, Mark; Vianello, Michelangelo; Voracek, Martin; Vuu, Gina; Wagenmakers, Eric-Jan; Weerdmeester, Joanneke; Welsh, Ashlee; Westgate, Erin C.; Wissink, Joeri; Wood, Michael; Woods, Andy; Wright, Emily; Wu, Sining; Zeelenberg, Marcel; Zuni, Kellylynn		Open Sci Collaboration	Estimating the reproducibility of psychological science	SCIENCE			English	Article							REPLICABILITY; REPLICATION; PUBLICATION; INCENTIVES; PREVALENCE; TRUTH; POWER	Reproducibility is a defining feature of science, but the extent to which it characterizes current research is unknown. We conducted replications of 100 experimental and correlational studies published in three psychology journals using high-powered designs and original materials when available. Replication effects were half the magnitude of original effects, representing a substantial decline. Ninety-seven percent of original studies had statistically significant results. Thirty-six percent of replications had statistically significant results; 47% of original effect sizes were in the 95% confidence interval of the replication effect size; 39% of effects were subjectively rated to have replicated the original result; and if no bias in original results is assumed, combining original and replication results left 68% with statistically significant effects. Correlational tests suggest that replication success was better predicted by the strength of original evidence than by characteristics of the original and replication teams.	[Aarts, Alexander A.] Open Sci Collaborat, Nuenen, Netherlands; [Anderson, Joanna E.] Def Res & Dev Canada, Ottawa, ON, Canada; [Anderson, Christopher J.] Southern New Hampshire Univ, Dept Psychol, Schenectady, NY 12305 USA; [Attridge, Peter R.] Mercer Sch Med, Macon, GA 31207 USA; [Attridge, Peter R.; Bentley, Heather; Beyan, Leah; Binion, Grace; Brown, Benjamin T.; Brown, Kristina; DeGaetano, Michelle A.; Devitt, Olivia; Eboigbe, Sylvia; Humphries, Denise J.; Mainard, Heather N.; Vazquez, Melissa] Georgia Gwinnett Coll, Lawrenceville, GA 30043 USA; [Attwood, Angela; Easey, Kayleigh; Munafo, Marcus; Penton-Voak, Ian S.; Woods, Andy] Univ Bristol, Sch Expt Psychol, Bristol BS8 1TH, Avon, England; [Axt, Jordan; DeCoster, Jamie; Dobolyi, David G.; Dodson, Geneva T.; Dore, Rebecca A.; Eggleston, Casey; Frazier, Rebecca S.; Gampa, Anup; Gilbert, Elizabeth; Lai, Calvin K.; Lee, Minha; Martin, Daniel P.; Nosek, Brian A.; Osborne, Colleen; Reinhard, David; Simpson, William B.; Talhelm, Thomas; Thomas, Sarah L.; Vuu, Gina; Westgate, Erin C.] Univ Virginia, Charlottesville, VA 22904 USA; [Babel, Molly; Dunn, Elizabeth W.; Sandstrom, Gillian M.] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; [Bahnik, Stepan] Univ Wurzburg, Dept Psychol 2, D-97070 Wurzburg, Germany; [Baranski, Erica; Ricker, Ashley A.; Saide, Anondah] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Barnett-Cowan, Michael] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Bartmess, Elizabeth; Cohn, Michael] Univ Calif San Francisco, San Francisco, CA 94118 USA; [Beer, Jennifer; Flagan, Taru; Rigney, Anastasia] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Bell, Raoul] Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany; [Binion, Grace; Mehta, Pranjal] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Borsboom, Denny; Columbus, Simon; den Bezemer, Bobby; Deserno, Marie K.; Epskamp, Sacha; Jonas, Kai; Kleinberg, Bennett; Kossakowski, Jolanda J.; Kunkels, Yoram K.; Rahal, Rima-Maria; Sahin, Onur; Tio, Pia; van Bork, Riet; van den Bergh, Don; van Renswoude, Daan R.; Wagenmakers, Eric-Jan] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Bosch, Annick; Cillessen, Linda; Hasselman, Fred; Kolorz, Franziska Maria; Krause, Robert Wilhelm; Luteijn, Ilse; Neijenhuijs, Koen I.; Seibel, Larissa; te Dorsthorst, Anniek; van de Ven, Mathijs; van der Hulst, Marije; van Dooren, Roel; Vermue, Marieke; Weerdmeester, Joanneke] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Bosco, Frank A.; Cleary, Hayley; Field, James G.; Joy-Gaba, Jennifer A.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Bowman, Sara D.; Braswell, Erin; Cohoon, Johanna; Errington, Timothy M.; Gorges, Bryan; Gorges, Jessie; Kidwell, Mallory C.; Nosek, Brian A.; Soderberg, Courtney; Spies, Jeffrey R.] Ctr Open Sci, Charlottesville, VA 22902 USA; [Brandt, Mark J.; Brohmer, Hilmar; Hartgerink, Chris; Hoogendoorn, Gea; Krijnen, Job; Nuijten, Michele B.; van 't Veer, Anna E.; Van Aert, Robbie; van Assen, Marcel; Verschoor, Mark; Wissink, Joeri; Zeelenberg, Marcel] Tilburg Univ, Dept Social Psychol, NL-5000 LE Tilburg, Netherlands; [Bruening, Jovita; Meixner, Johannes] Humboldt Univ, D-10099 Berlin, Germany; [Bruening, Jovita] Charite, D-13353 Berlin, Germany; [Calhoun-Sauls, Ann] Belmont Abbey Coll, Belmont, NC 28012 USA; [Callahan, Shannon P.; Rivers, Andrew M.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Chagnon, Elizabeth; Dugas, Michelle; Loureiro, Darren; Selterman, Dylan Faulkner] Univ Maryland, Washington, DC 20012 USA; [Chandler, Jesse] Univ Michigan, Inst Social Res, Ann Arbor, MI 48104 USA; [Chandler, Jesse] Math Policy Res, Washington, DC 20002 USA; [Chartier, Christopher R.; Nervi, Taylor; Perna, Olivia] Ashland Univ, Ashland, OH 44805 USA; [Cheung, Felix; Gray, Jeremy; Johnson, David J.] Michigan State Univ, E Lansing, MI 48824 USA; [Cheung, Felix; Hung, Cathy O. -Y.; Lin, Lin] Univ Hong Kong, Dept Psychol, Pok Fu Lam, Hong Kong, Peoples R China; [Christopherson, Cody D.] Southern Oregon Univ, Dept Psychol, Ashland, OR 97520 USA; [Clay, Russ] CUNY Coll Staten Isl, Staten Isl, NY 10314 USA; [Cloud, Mark D.; Kyc, Megan M.] Lock Haven Univ, Dept Psychol, Lock Haven, PA 17745 USA; [Cordes, Andreas; Gloeckner, Andreas; Jekel, Marc; Lippold, Matthias] Univ Gottingen, D-37073 Gottingen, Germany; [Costantini, Giulio; Perugini, Marco] Univ Milano Bicocca, Milan, Italy; [Alvarez, Leslie D. Cramblet; Kelso, Kim; Martinez, Tylar; Pipitone, R. Nathan; Spencer, Nick; Tapia, Megan; Welsh, Ashlee; Wright, Emily; Zuni, Kellylynn] Adams State Univ, Dept Psychol, Alamosa, CO 81101 USA; [Cremata, Ed; Graham, Jesse; Hayes, Timothy; Johnson, Kate M.] Univ So Calif, Los Angeles, CA 90089 USA; [Crusius, Jan; Fuchs, Heather] Univ Cologne, D-50931 Cologne, Germany; [Della Penna, Nicolas] Australian Natl Univ, Canberra, ACT, Australia; [Dewitte, Laura; Steegen, Sara; Traets, Frits; Tuerlinckx, Francis; van Doorn, Johnny; Vanpaemel, Wolf] Univ Leuven, Leuven, Belgium; [Donnellan, M. Brent] Texas A&M Univ, College Stn, TX 77845 USA; [Donohue, Ryan; Moore, Katherine] Elmhurst Coll, Elmhurst, IL 60126 USA; [Dorrough, Angela; Goellner, Lars] Univ Siegen, Dept Social Psychol, D-57068 Siegen, Germany; [Dorrough, Angela; Fiedler, Susann; Gloeckner, Andreas; Henninger, Felix; May, Michael; Rahal, Rima-Maria; Schlegelmilch, Rene] Max Planck Inst Res Collect Goods, Bonn, Germany; [Dreber, Anna; Forsell, Eskil; Heikensten, Emma; Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [Embley, Jo; Giner-Sorolla, Roger] Univ Kent, Sch Psychol, Canterbury, Kent, England; [Estel, Vivien; Mueller, Stephanie M.; Renkewitz, Frank; Schlegelmilch, Rene] Univ Erfurt, Erfurt, Germany; [Farach, Frank J.] Univ Washington, Seattle, WA 98195 USA; [Farach, Frank J.] Prometheus Res, New Haven, CT 06510 USA; [Feather, Jenelle; Hartshorne, Joshua; Olsson, Catherine; Saxe, Rebecca] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Fedor, Anna] Parmenides Ctr Study Thinking, Munich, Germany; [Fernandez-Castilla, Belen] Univ Complutense Madrid, Madrid, Spain; [Fitneva, Stanka A.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Forest, Amanda L.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Foster, Joshua D.] Univ S Alabama, Dept Psychol, Mobile, AL 36688 USA; [Frank, Michael C.; Holubar, Taylor; Kim, Seung Kyung; Lee, Key Jung; Lin, Stephanie; Mathur, Maya; Velez, Natalia] Stanford Univ, Stanford, CA 94305 USA; [Gable, Philip; Mechin, Nicole] Univ Alabama, Dept Psychol, Tuscaloosa, AL 35487 USA; [Galak, Jeff] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Galliani, Elisa Maria; Vianello, Michelangelo] Univ Padua, Appl Psychol Unit, Dept FISPPA, Padua, Italy; [Garcia, Sara] Univ Nacl Asuncion, Asuncion, Paraguay; [Gazarian, Douglas; Lane, Kristin A.] Bard Coll, Providence, RI 02906 USA; [Goh, Jin X.; Pavel, Misha] Northeastern Univ, Boston, MA 02115 USA; [Goldberg, Rebecca; Miller, Mallorie; Sinclair, H. Colleen; Wu, Sining] Mississippi State Univ, Dept Counseling & Educ Psychol, Mississippi State, MS 39762 USA; [Goodbourn, Patrick T.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Gordon-McKeon, Shauna] Hampshire Coll, Amherst, MA 01002 USA; [Goss, Justin] Colorado State Univ, Pueblo, CO 81001 USA; [Grange, James A.] Keele Univ, Sch Psychol, Keele ST5 5BG, Staffs, England; [Hasselman, Fred] Inst Behav Sci, Nijmegen, Netherlands; [Henninger, Felix] Univ Koblenz Landau, Landau, Germany; [Hodsoll, John] IHR Biomed Res Ctr Mental Hlth, Inst Psychiat Psychol & Neurosci, Dept Biostat, London, England; [Hodsoll, John] Kings Coll London, Maudsley NHS Fdn Trust, London, England; [Immelman, Nathali; Thomae, Manuela; Wood, Michael] Univ Winchester, Dept Psychol, Winchester, Hants, England; [Irsik, Vanessa C.; Snyder, Joel S.] Univ Nevada, Las Vegas, NV 89154 USA; [Jahn, Georg] Med Univ Lubeck, Inst Multimedia & Interact Syst, D-23538 Lubeck, Germany; [Jaekel, Frank; Ostkamp, Lutz] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany; [Johnson, Larissa G.] Univ Birmingham, Northampton NN1 3NB, Northants, England; [Johnston, William J.] Univ Chicago, Chicago, IL 60615 USA; [Kappes, Heather Barry] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England; [Kirkhart, Matthew; Prenoveau, Jason M.] Loyola Univ, Baltimore, MD 21210 USA; [Kleinberg, Bennett] UCL, Dept Secur & Crime Sci, London WC1H 9EZ, England; [Knezevic, Goran; Lazarevic, Ljiljana B.] Univ Belgrade, Dept Psychol, Belgrade, Serbia; [Kuhlmann, Tim; Stieger, Stefan] Univ Konstanz, Dept Psychol, Constance, Germany; [Laique, Aamir] Open Sci Collaborat, Saratoga, CA USA; [Lakens, Daniel] Eindhoven Univ Technol, Sch Innovat Sci, NL-5600 MB Eindhoven, Netherlands; [Lassetter, Bethany] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [LeBel, Etienne P.] Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada; [Lemm, Kristi] Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA; [Levitan, Carmel A.] Occidental Coll, Dept Cognit Sci, Los Angeles, CA 90041 USA; [Lewis, Melissa; Pitts, Michael] Reed Coll, Dept Psychol, Portland, OR 97202 USA; [Mackinnon, Sean] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [Marigold, Denise C.] Univ Waterloo, Renison Univ Coll, Waterloo, ON N2L 3G4, Canada; [Masicampo, E. J.] Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA; [Matacotta, Josh] Calif State Univ Fullerton, Counseling & Psychol Serv, Fullerton, CA 92831 USA; [May, Michael] Univ Bonn, Bonn, Germany; [Meixner, Johannes] Univ Potsdam, Potsdam, Germany; [Melinger, Alissa] Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland; [Miller, Jeremy K.] Willamette Univ, Salem, OR 97301 USA; [Moore, Katherine] Arcadia Univ, Glenside, PA 19038 USA; [Moeschl, Marcus; Plessow, Franziska] Tech Univ Dresden, D-01062 Dresden, Germany; [Motyl, Matt] Univ Illinois, Dept Psychol, Chicago, IL 60607 USA; [Nicolas, Gandalf] William & Mary, Williamsburg, VA 23185 USA; [Nilsonne, Gustav] Stockholm Univ, S-10691 Stockholm, Sweden; [Nilsonne, Gustav] Karolinska Inst, Stockholm, Sweden; [Olsson, Catherine] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Pernet, Cyril; Valasek, Milan] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Plessow, Franziska] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Ratliff, Kate A.] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Roebke, Mark] Wright State Univ, Dept Psychol, Dayton, OH 45435 USA; [Rutchick, Abraham M.] Calif State Univ Northridge, Northridge, CA 91330 USA; [Ryan, Robert S.] Kutztown Univ Penn, Kutztown, PA 19530 USA; [Santos, David] Univ Autonoma Madrid, Dept Psychol, Madrid, Spain; [Santos, David] IE Business Sch, Madrid, Spain; [Schmidt, Kathleen] Univ Virginias Coll Wise, Dept Social Sci, Wise, VA 24230 USA; [Scholz, Sabine; van Rijn, Hedderik] Univ Groningen, Groningen, Netherlands; [Shaki, Samuel] Ariel Univ, Dept Behav Sci, IL-40700 Ariel, Israel; [Skorinko, Jeanine L. M.] Worcester Polytech Inst, Dept Social Sci, Worcester, MA 01609 USA; [Slowik, Agnieszka; Sonnleitner, Carina; Voracek, Martin] Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria; [Strohminger, Nina] Duke Univ, Durham, NC 27708 USA; [Sullivan, Gavin B.] Coventry Univ, Ctr Res Psychol Behav & Achievement, Coventry CV1 5FB, W Midlands, England; [Thomae, Manuela] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Tsang, Steve] City Univ Hong Kong, Kln, Hong Kong, Peoples R China; [Turchan, Paul] Jacksonville State Univ, Jacksonville, FL 32211 USA; [van 't Veer, Anna E.] TIBER, Tilburg, Netherlands; [Echeverria, Alejandro Vasquez] Univ Republ Uruguay, Montevideo 11200, Uruguay; [Woods, Andy] Univ Oxford, Oxford, England	Defence Research & Development Canada; University System of Georgia; Georgia Gwinnett College; University of Bristol; University of Virginia; University of British Columbia; University of Wurzburg; University of California System; University of California Riverside; University of Waterloo; University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; Heinrich Heine University Dusseldorf; University of Oregon; University of Amsterdam; Radboud University Nijmegen; Virginia Commonwealth University; Tilburg University; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Davis; University of Michigan System; University of Michigan; Mathematica; Ashland University; Michigan State University; University of Hong Kong; City University of New York (CUNY) System; College of Staten Island (CUNY); Pennsylvania State System of Higher Education (PASSHE); Lock Haven University; University of Gottingen; University of Milano-Bicocca; University of Southern California; University of Cologne; Australian National University; KU Leuven; Texas A&M University System; Texas A&M University College Station; Universitat Siegen; Max Planck Society; Stockholm School of Economics; University of Kent; University of Erfurt; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Complutense University of Madrid; Queens University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of South Alabama; Stanford University; University of Alabama System; University of Alabama Tuscaloosa; Carnegie Mellon University; University of Padua; Universidad Nacional de Asuncion; Northeastern University; Mississippi State University; University of Sydney; Colorado State University; Keele University; University of Koblenz & Landau; South London & Maudsley NHS Trust; University of London; King's College London; University of Winchester; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Lubeck; University Osnabruck; University of Birmingham; University of Chicago; University of London; London School Economics & Political Science; Loyola University Maryland; University of London; University College London; University of Belgrade; University of Konstanz; Eindhoven University of Technology; University of Iowa; Western University (University of Western Ontario); Western Washington University; Occidental College; Reed College - Oregon; Dalhousie University; University of Waterloo; Wake Forest University; California State University System; California State University Fullerton; University of Bonn; University of Potsdam; University of Dundee; Willamette University; Technische Universitat Dresden; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Stockholm University; Karolinska Institutet; New York University; University of Edinburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; State University System of Florida; University of Florida; University System of Ohio; Wright State University Dayton; California State University System; California State University Northridge; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania; Autonomous University of Madrid; IE University; University of Virginia; University of Groningen; Ariel University; Worcester Polytechnic Institute; University of Vienna; Duke University; Coventry University; Open University - UK; City University of Hong Kong; Universidad de la Republica, Uruguay; University of Oxford	Nosek, BA (corresponding author), Univ Virginia, Charlottesville, VA 22904 USA.	nosek@virginia.edu	Sullivan, Gavin Brent/W-4876-2019; Shaki, Samuel/X-3701-2019; Santos, David/M-2420-2019; Jekel, Marc/L-1651-2018; Gazarian, Douglas/AAN-7641-2021; Rahal, Rima-Maria/ACP-8470-2022; Matacotta, Joshua J./J-9203-2015; Meixner, Johannes M/GZK-3202-2022; Crusius, Jan/AAE-8311-2019; Ryan, Robert/GXF-0280-2022; Epskamp, Sacha/I-4515-2019; Costantini, Giulio/F-3829-2018; Columbus, Simon/K-3327-2019; Cillessen, Linda/V-7208-2017; Sahin, Onur/AAY-8831-2020; Hasselman, Fred/P-2479-2019; Perugini, Marco/AAD-5880-2019; Johannesson, Magnus/E-9680-2011; Fernández-Castilla, Belén/AAA-6035-2021; Cheung, Felix/R-1726-2018; Lakens, Daniël/K-3831-2015; Glöckner, Andreas/B-8897-2011; Knezevic, Goran D/G-6420-2019; Santos, David/L-7145-2018; Thomae, Manuela/AAL-8601-2020; Attwood, Angela S/F-7071-2011; Prenoveau, Jason/N-2097-2019; Nuijten, Michèle B./N-2483-2014; Wagenmakers, Eric-Jan/AAH-7065-2019; DeCoster, Jamie/ABB-7592-2021; Lin, Stephanie/V-3480-2019; Cleary, Hayley/L-6458-2019; Schlegelmilch, René/HGA-2564-2022; Fedor, Anna/B-8984-2009; Vásquez-Echeverría, Alejandro/AAW-4557-2020; Kossakowski, Jolanda/N-3587-2015; Vianello, Michelangelo/G-8919-2013; Stieger, Stefan/G-2572-2012; Pernet, Cyril R./A-9237-2008; Christopherson, Cody/W-4107-2019; Sullivan, Gavin Brent/P-7885-2019; Snyder, Joel S/B-4675-2008; Moore, Katherine Sledge/B-8445-2009; Lazarevic, Ljiljana B./L-8779-2016; Tio, Pia/H-3987-2016; Westgate, Erin/T-5190-2019; Munafo, Marcus/AAE-2306-2020; Dewitte, Laura/ABC-9575-2020; Jonas, Kai/AAB-3120-2021; Voracek, Martin/S-5865-2016; Jahn, Georg/G-8931-2013; Hasselman, Fred/C-5603-2011; vanpaemel, wolf/AAC-9834-2022; Plessow, Franziska/AAE-8754-2019; Hartgerink, Chris/H-6623-2013; Motyl, Matt/G-6480-2016; van Rijn, Hedderik/L-3685-2014	Sullivan, Gavin Brent/0000-0003-0146-5953; Shaki, Samuel/0000-0002-2340-5401; Santos, David/0000-0001-9786-5219; Jekel, Marc/0000-0002-9146-0306; Rahal, Rima-Maria/0000-0002-1404-0471; Matacotta, Joshua J./0000-0002-0192-5254; Crusius, Jan/0000-0002-9403-6084; Costantini, Giulio/0000-0001-6610-5452; Columbus, Simon/0000-0003-1546-955X; Cillessen, Linda/0000-0003-2030-8646; Sahin, Onur/0000-0002-7433-0155; Hasselman, Fred/0000-0003-1384-8361; Perugini, Marco/0000-0002-4864-6623; Johannesson, Magnus/0000-0001-8759-6393; Cheung, Felix/0000-0002-7826-7405; Lakens, Daniël/0000-0002-0247-239X; Glöckner, Andreas/0000-0002-7766-4791; Knezevic, Goran D/0000-0001-8951-3774; Santos, David/0000-0001-9786-5219; Attwood, Angela S/0000-0003-3696-4349; Nuijten, Michèle B./0000-0002-1468-8585; Wagenmakers, Eric-Jan/0000-0003-1596-1034; Lin, Stephanie/0000-0003-0334-6595; Cleary, Hayley/0000-0002-0859-7134; Schlegelmilch, René/0000-0003-0285-5291; Fedor, Anna/0000-0003-2290-2323; Kossakowski, Jolanda/0000-0002-6946-1732; Vianello, Michelangelo/0000-0002-1530-1469; Stieger, Stefan/0000-0002-7784-6624; Pernet, Cyril R./0000-0003-4010-4632; Christopherson, Cody/0000-0002-0461-0135; Snyder, Joel S/0000-0002-5565-3063; Moore, Katherine Sledge/0000-0001-7982-1140; Lazarevic, Ljiljana B./0000-0003-1629-3699; Tio, Pia/0000-0001-8984-491X; Westgate, Erin/0000-0002-9116-6246; Munafo, Marcus/0000-0002-4049-993X; Dewitte, Laura/0000-0002-8383-6801; Jonas, Kai/0000-0001-6607-1993; Voracek, Martin/0000-0001-6109-6155; Jahn, Georg/0000-0002-4940-3404; Hasselman, Fred/0000-0003-1384-8361; vanpaemel, wolf/0000-0002-5855-3885; Wood, Michael/0000-0002-9277-1878; Forest, Amanda/0000-0003-1042-6112; Nicolas, Gandalf/0000-0001-8215-1758; Fernandez-Castilla, Belen/0000-0002-3451-0637; tuerlinckx, francis/0000-0002-1775-7654; Bell, Raoul/0000-0002-0592-0362; Bowman, Sara/0000-0002-5741-8868; Mehta, Pranjal/0000-0001-7570-7404; /0000-0003-2377-1791; Hartgerink, Chris/0000-0003-1050-6809; Brandt, Mark/0000-0002-7185-7031; Field, James/0000-0001-8487-6648; Schmidt, Kathleen/0000-0002-9946-5953; Motyl, Matt/0000-0002-7190-0802; Gazarian, Douglas/0000-0002-4186-5006; Soderberg, Courtney/0000-0003-1227-7042; DeCoster, Jamie/0000-0001-9751-6051; Brohmer, Hilmar/0000-0001-7763-4229; Borsboom, Denny/0000-0001-9720-4162; Zeelenberg, Marcel/0000-0002-7100-4223; Frank, Michael/0000-0002-7551-4378; Ryan, Robert/0000-0002-7900-3778; Penton-Voak, Ian/0000-0003-4232-0953; Farach, Frank/0000-0002-2145-0145; Dorrough, Angela/0000-0002-5645-949X; Garcia, Sara/0000-0003-0395-1250; van Assen, Marcel/0000-0002-7517-6081; van 't Veer, Anna/0000-0002-2733-1841; Melinger, Alissa/0000-0003-0129-1068; Goodbourn, Patrick/0000-0001-7899-7355; Moschl, Marcus/0000-0002-4823-3474; Nosek, Brian/0000-0001-6797-5476; Bahnik, Stepan/0000-0002-0579-6808; Sandstrom, Gillian/0000-0002-0549-9600; Grange, James/0000-0002-8352-8390; Kleinberg, Bennett/0000-0003-1658-9086; Levitan, Carmel/0000-0001-5403-444X; van Doorn, Johnny/0000-0003-0270-096X; Cohoon, Johanna/0000-0002-3352-9766; Lane, Kristin/0000-0002-7895-2744; van Rijn, Hedderik/0000-0002-0461-9850; Neijenhuijs, Koen/0000-0002-6664-3514; Bosco, Frank/0000-0002-3497-4335; Errington, Tim/0000-0002-4959-5143; Galak, Jeff/0000-0003-1166-8842; Mackinnon, Sean/0000-0003-0921-9589; Renkewitz, Frank/0000-0001-8072-6802; Hartshorne, Joshua/0000-0003-1240-3598; Ricker, Ashley/0000-0002-5549-2247	Center for Open Science; Laura and John Arnold Foundation; Medical Research Council [MC_UU_12013/6] Funding Source: researchfish; MRC [MC_UU_12013/6] Funding Source: UKRI	Center for Open Science; Laura and John Arnold Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	In addition to the coauthors of this manuscript, there were many volunteers who contributed to project success. We thank D. Acup, J. Anderson, S. Anzellotti, R. Araujo, J. D. Arnal, T. Bates, R. Battleday, R. Bauchwitz, M. Bernstein, B. Blohowiak, M. Boffo, E. Bruneau, B. Chabot-Hanowell, J. Chan, P. Chu, A. Dalla Rosa, B. Deen, P. DiGiacomo, C. Dogulu, N. Dufour, C. Fitzgerald, A. Foote, A. Garcia, E. Garcia, C. Gautreau, L. Germine, T. Gill, L. Goldberg, S. D. Goldinger, H. Gweon, D. Haile, K. Hart, F. Hjorth, J. Hoenig, A. Innes-Ker, B. Jansen, R. Jersakova, Y. Jie, Z. Kaldy, W. K. Vong, A. Kenney, J. Kingston, J. Koster-Hale, A. Lam, R. LeDonne, D. Lumian, E. Luong, S. Man-pui, J. Martin, A. Mauk, T. McElroy, K. McRae, T. Miller, K. Moser, M. Mullarkey, A. R. Munoz, J. Ong, C. Parks, D. S. Pate, D. Patron, H. J. M. Pennings, M. Penuliar, A. Pfammatter, J. P. Shanoltz, E. Stevenson, E. Pichler, H. Raudszus, H. Richardson, N. Rothstein, T. Scherndl, S. Schrager, S. Shah, Y. S. Tai, A. Skerry, M. Steinberg, J. Stoeterau, H. Tibboel, A. Tooley, A. Tullett, C. Vaccaro, E. Vergauwe, A. Watanabe, I. Weiss, M. H. White II, P. Whitehead, C. Widmann, D. K. Williams, K. M. Williams, and H. Yi. Also, we thank the authors of the original research that was the subject of replication in this project. These authors were generous with their time, materials, and advice for improving the quality of each replication and identifying the strengths and limits of the outcomes. The authors of this work are listed alphabetically. This project was supported by the Center for Open Science and the Laura and John Arnold Foundation. The authors declare no financial conflict of interest with the reported research.	Alexander A, 2012, PERSPECT PSYCHOL SCI, V7, P657, DOI 10.1177/1745691612462588; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Braver SL, 2014, PERSPECT PSYCHOL SCI, V9, P333, DOI 10.1177/1745691614529796; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; Errington TM, 2014, ELIFE, V3, DOI 10.7554/eLife.04333; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; Fisher RA, 1925, P CAMB PHILOS SOC, V22, P700, DOI 10.1017/S0305004100009580; GREENWALD AG, 1975, PSYCHOL BULL, V82, P1, DOI 10.1037/h0076157; Hartshorne JK, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00008; Hempel C., 1948, PHILOS SCI, V15, P135, DOI DOI 10.1086/286983; HEMPEL CG, 1968, PHILOS SCI, V35, P116, DOI 10.1086/288197; Howard GS, 2009, REV GEN PSYCHOL, V13, P116, DOI 10.1037/a0015468; Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; LAKATOS I, 1970, CRITICISM GROWTH KNO; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lehrer J., 2010, NEW YORKER, V13, P229; McNutt M, 2014, SCIENCE, V343, P231, DOI 10.1126/science.1250475; Meehl P. E., 1990, PSYCHOL INQ, V1, P108, DOI DOI 10.1207/S15327965PLI0102_1; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Nosek BA, 2014, SOC PSYCHOL-GERMANY, V45, P137, DOI 10.1027/1864-9335/a000192; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; O.S. Collaboration, 2013, IMPLEMENTING REPRODU, DOI [10.2139/ssrn.2195999, DOI 10.2139/SSRN.2195999]; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rozin P, 2009, PERSPECT PSYCHOL SCI, V4, P435, DOI 10.1111/j.1745-6924.2009.01151.x; Salmon W. C., 1999, INTRO PHILOS SCI, P7; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03	37	3180	3194	37	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251							aac4716	10.1126/science.aac4716	http://dx.doi.org/10.1126/science.aac4716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ5LW	26315443	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000360646800042
J	Lin, X; Fauque, B; Behnia, K				Lin, Xiao; Fauque, Benoit; Behnia, Kamran			Scalable T-2 resistivity in a small single-component Fermi surface	SCIENCE			English	Article							ELECTRON-ELECTRON SCATTERING; KADOWAKI-WOODS RATIO; TEMPERATURE DEPENDENCE; HEAVY-FERMION; COEFFICIENTS; RESISTANCE	Scattering among electrons generates a distinct contribution to electrical resistivity that follows a quadratic temperature (T) dependence. In strongly correlated electron systems, the prefactor A of this T-2 resistivity scales with the magnitude of the electronic specific heat, gamma. Here we show that one can change the magnitude of A by four orders of magnitude in metallic strontium titanate (SrTiO3) by tuning the concentration of the carriers and, consequently, the Fermi energy. The T-2 behavior persists in the single-band dilute limit despite the absence of two known mechanisms for T-2 behavior: distinct electron reservoirs and Umklapp processes. The results highlight the absence of a microscopic theory for momentum decay through electron-electron scattering in various Fermi liquids.	[Lin, Xiao; Fauque, Benoit; Behnia, Kamran] UPMC, Ecole Super Phys & Chim Ind, Lab Phys & Etud Mat, CNRS, 10 Rue Vauquelin, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite	Behnia, K (corresponding author), UPMC, Ecole Super Phys & Chim Ind, Lab Phys & Etud Mat, CNRS, 10 Rue Vauquelin, F-75005 Paris, France.	kamran.behnia@espci.fr	Behnia, Kamran/AHC-5765-2022	Behnia, Kamran/0000-0001-8997-5645	Agence Nationale de Recherche through SUPERFIELD; Agence Nationale de Recherche through QUANTUM LIMIT; Ile de France region	Agence Nationale de Recherche through SUPERFIELD(French National Research Agency (ANR)); Agence Nationale de Recherche through QUANTUM LIMIT(French National Research Agency (ANR)); Ile de France region(Region Ile-de-France)	We thank H. Maebashi, D. Maslov, and K. Miyake for stimulating discussions. This work was supported by Agence Nationale de Recherche through the SUPERFIELD and QUANTUM LIMIT projects and by a grant from the Ile de France region.	Allen SJ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.045114; Baber WG, 1937, PROC R SOC LON SER-A, V158, P0383, DOI 10.1098/rspa.1937.0027; Barisic N, 2013, P NATL ACAD SCI USA, V110, P12235, DOI 10.1073/pnas.1301989110; Chang J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057005; Efetov DK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.256805; HARTMAN R, 1969, PHYS REV, V181, P1070, DOI 10.1103/PhysRev.181.1070; Hussey NE, 2005, J PHYS SOC JPN, V74, P1107, DOI 10.1143/JPSJ.74.1107; Joynt R, 2002, REV MOD PHYS, V74, P235, DOI 10.1103/RevModPhys.74.235; KADOWAKI K, 1986, SOLID STATE COMMUN, V58, P507, DOI 10.1016/0038-1098(86)90785-4; KATZ MJ, 1965, PHYS REV LETT, V15, P828, DOI 10.1103/PhysRevLett.15.828; LAWRENCE WE, 1973, PHYS REV B, V7, P2317, DOI 10.1103/PhysRevB.7.2317; LeBoeuf D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054506; Lin X, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.207002; Lin X, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021002; MACDONALD AH, 1980, PHYS REV LETT, V44, P489, DOI 10.1103/PhysRevLett.44.489; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; Maebashi H, 1998, J PHYS SOC JPN, V67, P242, DOI 10.1143/JPSJ.67.242; MIYAKE K, 1989, SOLID STATE COMMUN, V71, P1149, DOI 10.1016/0038-1098(89)90729-1; MORELLI DT, 1984, PHYS REV B, V30, P1080, DOI 10.1103/PhysRevB.30.1080; Mott N.F., 1990, METAL INSULATOR TRAN, V2nd, P72; Nakamae S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.100502; Okuda T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.113104; Pal HK, 2012, LITH J PHYS, V52, P142; Paul I, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224418; RICE MJ, 1968, PHYS REV LETT, V20, P1439, DOI 10.1103/PhysRevLett.20.1439; Spinelli A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.155110; THOMPSON AH, 1975, PHYS REV LETT, V35, P1786, DOI 10.1103/PhysRevLett.35.1786; van der Marel D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.205111; Verma A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.216601; YAMADA K, 1986, PROG THEOR PHYS, V76, P621, DOI 10.1143/PTP.76.621	31	92	92	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					945	948		10.1126/science.aaa8655	http://dx.doi.org/10.1126/science.aaa8655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315430	Green Submitted			2022-12-28	WOS:000360646800045
J	Sedgwick, P; Joekes, K				Sedgwick, Philip; Joekes, Katherine			Interpreting hazard ratios	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sedgwick, Philip; Joekes, Katherine] St Georges Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England	St Georges University London	Sedgwick, P (corresponding author), St Georges Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2011, BMJ-BRIT MED J, V343, pd4890; Sedgwick Philip, 2014, BMJ, V349, pg5608, DOI 10.1136/bmj.g5608; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7118; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4960; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	5	6	6	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2015	351								h4631	10.1136/bmj.h4631	http://dx.doi.org/10.1136/bmj.h4631			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2NX	26318794				2022-12-28	WOS:000360439100013
J	[Anonymous]				[Anonymous]			The House: Its Unique Problems in Hygiene (Reprinted from JAMA., vol 65, pg 802-803, 1915)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1914, YB USDA, P339; Kinne Helen, 1914, SHELTER AND CLOTHING, P15; 1915, JAMA, V65, P802	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					839	839		10.1001/jama.2014.11944	http://dx.doi.org/10.1001/jama.2014.11944			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305664				2022-12-28	WOS:000360017200031
J	Jubb, A; Young, R; Bickmore, W; Hume, D				Jubb, Alasdair; Young, Robert; Bickmore, Wendy; Hume, David			Divergent transcriptional activation by glucocorticoids in mouse and human macrophages	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Jubb, Alasdair; Hume, David] Univ Edinburgh, Roslin Inst, Edinburgh EH4 2XU, Midlothian, Scotland; [Jubb, Alasdair; Young, Robert; Bickmore, Wendy] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh		alasdair.jubb@ed.ac.uk			MRC [MC_PC_U127527202] Funding Source: UKRI; Medical Research Council [MC_PC_U127527202] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			54	54		10.1016/S0140-6736(15)60369-5	http://dx.doi.org/10.1016/S0140-6736(15)60369-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312876	Bronze			2022-12-28	WOS:000360570500054
J	van der Klaauw, A; Keogh, J; Henning, E; Stephenson, C; Trowse, VM; Fletcher, P; Farooqi, S				van der Klaauw, Agatha; Keogh, Julia; Henning, Elana; Stephenson, Cheryl; Trowse, Victoria M.; Fletcher, Paul; Farooqi, Sadaf			Role of melanocortin signalling in the preference for dietary macronutrients in human beings	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[van der Klaauw, Agatha; Keogh, Julia; Henning, Elana; Stephenson, Cheryl; Trowse, Victoria M.; Farooqi, Sadaf] Univ Cambridge, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Cambridge CB2 0QQ, England; [Fletcher, Paul] Univ Cambridge, Dept Psychiat, Cambridge CB2 0QQ, England	University of Cambridge; University of Cambridge		av330@medschl.cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Fletcher, Paul/F-5380-2011	O'Rahilly, Stephen/0000-0003-2199-4449; van der Klaauw, Agatha/0000-0001-6971-8828; Farooqi, Sadaf/0000-0001-7609-3504; Fletcher, Paul/0000-0001-8257-1517	Wellcome Trust [099038] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			12	12		10.1016/S0140-6736(15)60327-0	http://dx.doi.org/10.1016/S0140-6736(15)60327-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312834	Green Accepted			2022-12-28	WOS:000360570500012
J	Rehm, J; Room, R				Rehm, Juergen; Room, Robin			Cultural specificity in alcohol use disorders	LANCET			English	Editorial Material							SUBSTANCE USE; DEPENDENCE		[Rehm, Juergen] Mental Hlth Res Inst, Ctr Addict & Mental Hlth & Campbell Family, Toronto, ON M5S 2S1, Canada; [Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Med Sci, Toronto, ON, Canada; [Rehm, Juergen] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany; [Room, Robin] Ctr Alcohol Policy Res, Fitzroy, Vic, Australia; [Room, Robin] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Room, Robin] Stockholm Univ, Ctr Social Res Alcohol & Drugs, Stockholm, Sweden	University of Toronto; University of Toronto; Technische Universitat Dresden; University of Melbourne; Stockholm University	Rehm, J (corresponding author), Mental Hlth Res Inst, Ctr Addict & Mental Hlth & Campbell Family, Toronto, ON M5S 2S1, Canada.; Rehm, J (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Med Sci, Toronto, ON, Canada.; Rehm, J (corresponding author), Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada.; Rehm, J (corresponding author), Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany.	jtrehm@gmail.com						Connor JP, 2016, LANCET, V387, P988, DOI 10.1016/S0140-6736(15)00122-1; Nutt DJ, 2014, J PSYCHOPHARMACOL, V28, P3, DOI 10.1177/0269881113512038; Rehm J, 2014, ALCOHOL ALCOHOLISM, V49, P118, DOI 10.1093/alcalc/agt171; Rehm J, 2013, ALCOHOL ALCOHOLISM, V48, P633, DOI 10.1093/alcalc/agt127; Rehm J, 2015, ANN FAM MED, V13, P28, DOI 10.1370/afm.1742; Rehm J, 2015, EUR ADDICT RES, V21, P6, DOI 10.1159/000365284; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Room R, 1998, ADDICT RES, V6, P131, DOI 10.3109/16066359808993296; Room R, 1998, DRUG ALCOHOL REV, V17, P305, DOI 10.1080/09595239800187141; Room R, 2006, ADDICTION, V101, P31, DOI 10.1111/j.1360-0443.2006.01597.x; Schmidt L, 1999, J STUD ALCOHOL, V60, P448, DOI 10.15288/jsa.1999.60.448; Ustun B, 1997, DRUG ALCOHOL DEPEN, V47, P161, DOI 10.1016/S0376-8716(97)00087-2; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	13	10	10	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2022	399	10327					E7	E8		10.1016/S0140-6736(15)00122-1	http://dx.doi.org/10.1016/S0140-6736(15)00122-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZJ4WT	26343842				2022-12-28	WOS:000762307100001
J	Ribas, A				Ribas, Antoni			Releasing the Brakes on Cancer Immunotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							T-CELLS		[Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Ribas, A (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA.							HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; MCINTYRE BW, 1983, CELL, V34, P739, DOI 10.1016/0092-8674(83)90530-5; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943	5	169	181	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1490	1492		10.1056/NEJMp1510079	http://dx.doi.org/10.1056/NEJMp1510079			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26348216				2022-12-28	WOS:000362880300004
J	Valgimigli, M; Frigoli, E; Leonardi, S; Rothenbuhler, M; Gagnor, A; Calabro, P; Garducci, S; Rubartelli, P; Briguori, C; Ando, G; Repetto, A; Limbruno, U; Garbo, R; Sganzerla, P; Russo, F; Lupi, A; Cortese, B; Ausiello, A; Ierna, S; Esposito, G; Presbitero, P; Santarelli, A; Sardella, G; Varbella, F; Tresoldi, S; de Cesare, N; Rigattieri, S; Zingarelli, A; Tosi, P; van 't Hof, A; Boccuzzi, G; Omerovic, E; Sabate, M; Heg, D; Juni, P; Vranckx, P				Valgimigli, M.; Frigoli, E.; Leonardi, S.; Rothenbuehler, M.; Gagnor, A.; Calabro, P.; Garducci, S.; Rubartelli, P.; Briguori, C.; Ando, G.; Repetto, A.; Limbruno, U.; Garbo, R.; Sganzerla, P.; Russo, F.; Lupi, A.; Cortese, B.; Ausiello, A.; Ierna, S.; Esposito, G.; Presbitero, P.; Santarelli, A.; Sardella, G.; Varbella, F.; Tresoldi, S.; de Cesare, N.; Rigattieri, S.; Zingarelli, A.; Tosi, P.; van 't Hof, A.; Boccuzzi, G.; Omerovic, E.; Sabate, M.; Heg, D.; Jueni, P.; Vranckx, P.		MATRIX Investigators	Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITORS; ACUTE MYOCARDIAL-INFARCTION; INTERVENTION; DEFINITION	BACKGROUND Conflicting evidence exists on the efficacy and safety of bivalirudin administered as part of percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome. METHODS We randomly assigned 7213 patients with an acute coronary syndrome for whom PCI was anticipated to receive either bivalirudin or unfractionated heparin. Patients in the bivalirudin group were subsequently randomly assigned to receive or not to receive a post-PCI bivalirudin infusion. Primary outcomes for the comparison between bivalirudin and heparin were the occurrence of major adverse cardiovascular events (a composite of death, myocardial infarction, or stroke) and net adverse clinical events (a composite of major bleeding or a major adverse cardiovascular event). The primary outcome for the comparison of a post-PCI bivalirudin infusion with no post-PCI infusion was a composite of urgent target-vessel revascularization, definite stent thrombosis, or net adverse clinical events. RESULTS The rate of major adverse cardiovascular events was not significantly lower with bivalirudin than with heparin (10.3% and 10.9%, respectively; relative risk, 0.94; 95% confidence interval [CI], 0.81 to 1.09; P = 0.44), nor was the rate of net adverse clinical events (11.2% and 12.4%, respectively; relative risk, 0.89; 95% CI, 0.78 to 1.03; P = 0.12). Post-PCI bivalirudin infusion, as compared with no infusion, did not significantly decrease the rate of urgent target-vessel revascularization, definite stent thrombosis, or net adverse clinical events (11.0% and 11.9%, respectively; relative risk, 0.91; 95% CI, 0.74 to 1.11; P = 0.34). CONCLUSIONS In patients with an acute coronary syndrome, the rates of major adverse cardiovascular events and net adverse clinical events were not significantly lower with bivalirudin than with unfractionated heparin. The rate of the composite of urgent target-vessel revascularization, definite stent thrombosis, or net adverse clinical events was not significantly lower with a post-PCI bivalirudin infusion than with no post-PCI infusion. (Funded by the Medicines Company and Terumo Medical; MATRIX ClinicalTrials.gov number, NCT01433627.)	[Valgimigli, M.] Univ Hosp Bern, Swiss Cardiovasc Ctr Bern, CH-3010 Bern, Switzerland; [Rothenbuehler, M.; Heg, D.] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Rothenbuehler, M.; Heg, D.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Jueni, P.] Univ Bern, Inst Primary Hlth Care, Bern, Switzerland; [Valgimigli, M.] Erasmus MC, Thoraxctr, Rotterdam, Netherlands; [van 't Hof, A.] Isala Klin, Zwolle, Netherlands; [Frigoli, E.] EUSTRATEGY Assoc, Forli, Italy; [Leonardi, S.; Repetto, A.] Fdn IRCCS Policlin San Matteo, Dipartimento CardioToracoVascolare, Unita Operat Complessa Cardiol, Pavia, Italy; [Gagnor, A.; Varbella, F.] Osped Riuniti Rivoli, Cardiol Unit, Turin, Italy; [Garbo, R.; Boccuzzi, G.] San Giovanni Bosco Hosp, Turin, Italy; [Calabro, P.] Univ Naples 2, Dept Cardiothorac Sci, Div Cardiol, Naples, Italy; [Esposito, G.] Univ Naples Federico II, Div Cardiol, Dept Adv Biomed Sci, Naples, Italy; [Briguori, C.] Clin Mediterranea, Naples, Italy; [Garducci, S.] Azienda Osped Osped Civile Vimercate, Desio, Italy; [Rubartelli, P.] ASL3 Osped Villa Scassi, Dept Cardiol, Genoa, Italy; [Zingarelli, A.] IRCCS Azienda Osped Univ San Martino, Genoa, Italy; [Ando, G.] Univ Messina, Azienda Osped Univ Policlin Gaetano Martino, Messina, Italy; [Limbruno, U.] ASL 9 Grosseto, Unit Operat Cardiol, Grosseto, Italy; [Sganzerla, P.] Azienda Osped Osped Treviglio Caravaggio, Treviglio, Italy; [Russo, F.] Azienda Osped St Anna, Como, Italy; [Lupi, A.] Univ Hosp Maggiore della Carita, Novara, Italy; [Cortese, B.] Osped Fatebenefratelli, Milan, Italy; [Ausiello, A.] Casa Cura Villa Verde, Taranto, Italy; [Ierna, S.] Osped Sirai Carbonia, Carbonia, Italy; [Presbitero, P.] IRCCS Humanitas, Rozzano, Italy; [Santarelli, A.] Infermi Hosp, Cardiovasc Dept, Rimini, Italy; [Sardella, G.] Univ Roma La Sapienza, Policlin Umberto 1, I-00185 Rome, Italy; [Rigattieri, S.] Sandro Pertini Hosp Rome, Intervent Cardiol Unit, Rome, Italy; [Tresoldi, S.] Azienda Osped Osped Desio, Desio, Italy; [de Cesare, N.] Policlin San Marco, Zingonia, Italy; [Tosi, P.] Mater Salutis Hosp, Legnago, Italy; [Omerovic, E.] Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden; [Sabate, M.] Univ Barcelona, Thorax Inst, Dept Cardiol, Hosp Clin, Barcelona, Spain; [Vranckx, P.] Jessa Ziekenhuis, Hartctr Hasselt, Dept Cardiol & Crit Care Med, Hasselt, Belgium	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; Erasmus University Rotterdam; Erasmus MC; Isala Clinics; IRCCS Fondazione San Matteo; Universita della Campania Vanvitelli; University of Naples Federico II; Mediterranean Clinic; University of Genoa; IRCCS AOU San Martino IST; University of Messina; Ospedale di Treviglio-Caravaggio; Ospedale Sant'Anna di Como; University of Eastern Piedmont Amedeo Avogadro; IRCCS Humanitas Research Hospital; Hospital of Rimini; Sapienza University Rome; University Hospital Sapienza Rome; Ospedale Sandro Pertini; ULSS 9 Scaligera; Ospedale Mater Salutis di Legnago; Sahlgrenska University Hospital; University of Barcelona; Hospital Clinic de Barcelona	Valgimigli, M (corresponding author), Univ Hosp Bern, Swiss Cardiovasc Ctr Bern, CH-3010 Bern, Switzerland.	marco.valgimigli@insel.ch	Romagnoli, Enrico/M-7725-2017; Portolan, Monica/E-5577-2016; Sabate, Manel/AAX-7245-2021; Valgimigli, Marco/AAE-9103-2019; Cortese, Bernardo/M-4374-2016; Andò, Giuseppe/E-6368-2015; BOCCUZZI, GIACOMO/C-2265-2019; Leonardi, Sergio/K-4334-2018; limbruno, ugo/GPG-3729-2022; Limbruno, Ugo/ACC-3935-2022; Calabro, Paolo/AAC-2704-2022; Lupi, Alessandro/AAH-8299-2020; VARBELLA, FERDINANDO/AAA-9428-2019; Diletti, Roberto/P-2214-2014; Leonardi, Sergio/AAK-1490-2020; Rigattieri, Stefano/AAL-9063-2020; Juni, Peter/Q-8700-2016; De Caterina, Raffaele/K-3857-2016; De+Servi, Stefano/AAT-2631-2021; Esposito, Giovanni/F-2880-2010	Romagnoli, Enrico/0000-0003-1611-7708; Portolan, Monica/0000-0002-1785-2854; Valgimigli, Marco/0000-0002-4353-7110; Cortese, Bernardo/0000-0002-5808-7810; Andò, Giuseppe/0000-0001-5552-6382; BOCCUZZI, GIACOMO/0000-0003-4220-758X; Leonardi, Sergio/0000-0002-4800-6132; limbruno, ugo/0000-0002-1538-2967; Lupi, Alessandro/0000-0003-3644-0449; VARBELLA, FERDINANDO/0000-0002-8213-359X; Leonardi, Sergio/0000-0002-4800-6132; Rigattieri, Stefano/0000-0001-5116-2737; Juni, Peter/0000-0002-5985-0670; De Caterina, Raffaele/0000-0003-1637-574X; Esposito, Giovanni/0000-0003-0565-7127; Sabate Tenas, Manel/0000-0002-2316-3705; calabro, paolo/0000-0002-5018-830X; Santarelli, Andrea/0000-0001-7575-6118; Mazzarotto, Pietro/0000-0003-3183-1141; Costa, Francesco/0000-0002-3097-2834; Heg, Dik/0000-0002-8766-7945; GOMEZ HOSPITAL, JOAN ANTONI/0000-0002-3249-3095; Zingarelli, Antonio/0000-0002-8240-2622; Rothenbuhler, Martina/0000-0001-8009-4104	Medicines Company; Terumo Medical	Medicines Company; Terumo Medical	Funded by the Medicines Company and Terumo Medical; MATRIX ClinicalTrials.gov number, NCT01433627.	Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Berger PB, 2014, LANCET, V384, P1824, DOI 10.1016/S0140-6736(14)61041-2; Cortese B, 2014, EUROINTERVENTION, V10, pT64, DOI 10.4244/EIJV10STA11; Han YL, 2015, JAMA-J AM MED ASSOC, V313, P1336, DOI 10.1001/jama.2015.2323; Huber K, 2014, AM HEART J, V168, P611, DOI 10.1016/j.ahj.2014.06.014; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Montalescot G, 2014, NEW ENGL J MED, V371, P1016, DOI 10.1056/NEJMoa1407024; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Navarese EP, 2015, JACC-CARDIOVASC INTE, V8, P201, DOI 10.1016/j.jcin.2014.10.003; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Stone GW, 2015, J AM COLL CARDIOL, V65, P27, DOI 10.1016/j.jacc.2014.10.029; Subherwal S, 2012, J AM COLL CARDIOL, V59, P1861, DOI 10.1016/j.jacc.2011.12.045; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Valgimigli M, 2014, AM HEART J, V168; Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6; Valgimigli M, 2014, J CARDIOVASC TRANSL, V7, P101, DOI 10.1007/s12265-013-9537-1	22	271	284	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					997	1009		10.1056/NEJMoa1507854	http://dx.doi.org/10.1056/NEJMoa1507854			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9TV	26324049	Green Published, Bronze			2022-12-28	WOS:000360959000005
J	Wagner, G; Kaberger, T; Olai, S; Oppenheimer, M; Rittenhouse, K; Sterner, T				Wagner, Gernot; Kaberger, Tomas; Olai, Susanna; Oppenheimer, Michael; Rittenhouse, Katherine; Sterner, Thomas			Energy policy: Push renewables to spur carbon pricing	NATURE			English	Editorial Material									[Wagner, Gernot; Rittenhouse, Katherine] Environm Def Fund, Boston, MA 02108 USA; [Wagner, Gernot] Columbia Univ, Int & Publ Affairs, New York, NY USA; [Kaberger, Tomas] Chalmers Univ Technol, Ind Energy Policy, S-41296 Gothenburg, Sweden; [Olai, Susanna; Sterner, Thomas] Univ Gothenburg, Gothenburg, Sweden; [Oppenheimer, Michael] Princeton Univ, Woodrow Wilson Sch, Geosci & Int Affairs, Princeton, NJ 08544 USA; [Oppenheimer, Michael] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Sterner, Thomas] Environm Def Fund, New York, NY USA	Environmental Defense Fund; Columbia University; Chalmers University of Technology; University of Gothenburg; Princeton University; Princeton University; Environmental Defense Fund	Wagner, G (corresponding author), Environm Def Fund, Boston, MA 02108 USA.	gernot@gwagner.com	Sterner, Thomas/AGZ-2537-2022	Wagner, Gernot/0000-0001-6059-0688; Oppenheimer, Michael/0000-0002-9708-5914				Darghouth N. R., 2015, NET METERING MARKET; Mathews JA, 2014, NATURE, V513, P166, DOI 10.1038/513166a; MIT Energy Initiative, 2015, FUT SOL EN; Prentiss Mara, 2015, ENERGY REVOLUTION PH; Searchinger TD, 2009, SCIENCE, V326, P527, DOI 10.1126/science.1178797; Trancik JE, 2014, NATURE, V507, P300, DOI 10.1038/507300a; van Benthem A, 2008, ENERG J, V29, P131; Wagner G., 2015, CLIMATE SHOCK EC CON, DOI [10.1515/9781400865475, DOI 10.1515/9781400865475]	8	31	31	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					27	29		10.1038/525027a	http://dx.doi.org/10.1038/525027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4SE	26333455	Bronze			2022-12-28	WOS:000360594100011
J	Chou, R; Hashimoto, R; Friedly, J; Fu, RW; Bougatsos, C; Dana, T; Sullivan, SD; Jarvik, J				Chou, Roger; Hashimoto, Robin; Friedly, Janna; Fu, Rongwei; Bougatsos, Christina; Dana, Tracy; Sullivan, Sean D.; Jarvik, Jeffrey			Epidural Corticosteroid Injections for Radiculopathy and Spinal Stenosis A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							LOW-BACK-PAIN; LUMBAR RADICULAR PAIN; MANAGING CHRONIC PAIN; DOUBLE-BLIND TRIAL; STEROID INJECTIONS; DISC HERNIATION; TRANSFORAMINAL INJECTION; NERVE-ROOT; PERIRADICULAR INFILTRATION; HEALTH-CARE	Background: Use of epidural corticosteroid injections is increasing. Purpose: To review evidence on the benefits and harms of epidural corticosteroid injections in adults with radicular low back pain or spinal stenosis of any duration. Data Sources: Ovid MEDLINE (through May 2015), Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, prior systematic reviews, and reference lists. Study Selection: Randomized trials of epidural corticosteroid injections versus placebo interventions, or that compared epidural injection techniques, corticosteroids, or doses. Data Extraction: Dual extraction and quality assessment of individual studies, which were used to determine the overall strength of evidence (SOE). Data Synthesis: 30 placebo-controlled trials evaluated epidural corticosteroid injections for radiculopathy, and 8 trials were done for spinal stenosis. For radiculopathy, epidural corticosteroids were associated with greater immediate-term reduction in pain (weighted mean difference on a scale of 0 to 100, -7.55 [95% CI, -11.4 to -3.74]; SOE, moderate), function (standardized mean difference after exclusion of an outlier trial, -0.33 [CI, -0.56 to -0.09]; SOE, low), and short-term surgery risk (relative risk, 0.62 [CI, 0.41 to 0.92]; SOE, low). Effects were below predefined minimum clinically important difference thresholds, and there were no longer-term benefits. Limited evidence showed no clear effects of technical factors, patient characteristics, or comparator interventions on estimates. There were no clear effects of epidural corticosteroid injections for spinal stenosis (SOE, low to moderate). Serious harms were rare, but harms reporting was suboptimal (SOE, low). Limitations: The review was restricted to English-language studies. Some meta-analyses were based on small numbers of trials (particularly for spinal stenosis), and most trials had methodological shortcomings. Conclusion: Epidural corticosteroid injections for radiculopathy were associated with immediate reductions in pain and function. However, benefits were small and not sustained, and there was no effect on long-term surgery risk. Limited evidence suggested no effectiveness for spinal stenosis.	Pacific Northwest Evidence Based Practice Ctr, Portland, OR USA; [Chou, Roger] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Spectrum Res, Tacoma, WA USA; Comparat Effectiveness Cost & Outcomes Res Ctr, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu	Jarvik, Jeffrey/AAL-4292-2021	Chou, Roger/0000-0001-9889-8610	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Ackerman WE, 2007, ANESTH ANALG, V104, P1217, DOI 10.1213/01.ane.0000260307.16555.7f; Agency for Healthcare Research and Quality, 2013, AHRQ PUBL; Ahadian FM, 2011, REGION ANESTH PAIN M, V36, P572, DOI 10.1097/AAP.0b013e318232e843; American Academy of Neurology, 2007, AAN SUMM EV BAS GUID; [Anonymous], ESIB0813 AG HEALTHC; Arden NK, 2005, RHEUMATOLOGY, V44, P1399, DOI 10.1093/rheumatology/kei028; Becker C, 2007, SPINE, V32, P1803, DOI 10.1097/BRS.0b013e3181076514; Beliveau P, 1971, Rheumatol Phys Med, V11, P40, DOI 10.1093/rheumatology/11.1.40; Benoist M, 2012, EUR SPINE J, V21, P204, DOI 10.1007/s00586-011-2007-z; Benyamin RM, 2012, PAIN PHYSICIAN, V15, pE363; Bicket MC, 2013, ANESTHESIOLOGY, V119, P907, DOI 10.1097/ALN.0b013e31829c2ddd; BREIVIK H, 1976, ADV PAIN RES THER, V1, P927; Buchner M, 2000, CLIN ORTHOP RELAT R, P149; BUSH K, 1991, SPINE, V16, P572, DOI 10.1097/00007632-199105000-00015; Candido KD, 2008, ANESTH ANALG, V106, P638, DOI 10.1213/ane.0b013e3181605e9b; Candido KD, 2013, PAIN PHYSICIAN, V16, P497; Carette S, 1997, NEW ENGL J MED, V336, P1634, DOI 10.1056/NEJM199706053362303; Choi HJ, 2013, INT J TECHNOL ASSESS, V29, P244, DOI 10.1017/S0266462313000342; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2009, SPINE, V34, P1078, DOI 10.1097/BRS.0b013e3181a103b1; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Cocelli LP, 2009, J MUSCULOSKELET PAIN, V17, P281, DOI 10.1080/10582450903088070; Cohen SP, 2012, ANN INTERN MED, V156, P551, DOI [10.7326/0003-4819-156-8-201204170-00397, 10.7326/0003-4819-156-8-201204170-00002]; Cohen SP, 2012, ARCH INTERN MED, V172, P134, DOI 10.1001/archinternmed.2011.593; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; CUCKLER JM, 1985, J BONE JOINT SURG AM, V67A, P63, DOI 10.2106/00004623-198567010-00009; Datta Rashmi, 2011, Med J Armed Forces India, V67, P25, DOI 10.1016/S0377-1237(11)80007-9; Dean DD, 2014, SOUTH MED J, V107, P528, DOI 10.14423/SMJ.0000000000000144; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; DILKE TFW, 1973, BRIT MED J, V2, P635, DOI 10.1136/bmj.2.5867.635; Edwards SJ, 2009, INT J CLIN PRACT, V63, P841, DOI 10.1111/j.1742-1241.2009.02072.x; EL ZAHAAR MS, 1991, J NEUROL ORTH MED S, V12, P181; Epstein Nancy E, 2013, Surg Neurol Int, V4, pS74, DOI 10.4103/2152-7806.109446; Friedly J, 2007, SPINE, V32, P1754, DOI 10.1097/BRS.0b013e3180b9f96e; Friedly JL, 2014, NEW ENGL J MED, V371, P11, DOI 10.1056/NEJMoa1313265; Fukusaki M, 1998, CLIN J PAIN, V14, P148, DOI 10.1097/00002508-199806000-00010; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Ghahreman A, 2011, PAIN MED, V12, P871, DOI 10.1111/j.1526-4637.2011.01116.x; Ghahreman A, 2010, PAIN MED, V11, P1149, DOI 10.1111/j.1526-4637.2010.00908.x; Ghai B, 2014, PAIN PHYSICIAN, V17, P277; Ghai B, 2013, ANESTH ANALG, V117, P219, DOI 10.1213/ANE.0b013e3182910a15; Gharibo CG, 2011, PAIN PHYSICIAN, V14, P499; Habib G, 2013, J CLIN ANESTH, V25, P629, DOI 10.1016/j.jclinane.2013.07.002; Hashimoto R, 2011, HLTH TECHNOLOGY ASSE; HELLIWELL M, 1985, BRIT J CLIN PRACT, V39, P228; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huda N, 2010, J CLIN DIAGN RES, V4, P2842; Iversen T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5278; Jeong HS, 2007, RADIOLOGY, V245, P584, DOI 10.1148/radiol.2452062007; Kang SS, 2011, PAIN PHYSICIAN, V14, P361; Karppinen J, 2001, SPINE, V26, P1059, DOI 10.1097/00007632-200105010-00015; Karppinen J, 2001, SPINE, V26, P2587, DOI 10.1097/00007632-200112010-00013; Kennedy DJ, 2014, PAIN MED, V15, P548, DOI 10.1111/pme.12325; Kim D, 2011, CLIN J PAIN, V27, P518, DOI 10.1097/AJP.0b013e31820c53e0; KLENERMAN L, 1984, BRIT J RHEUMATOL, V23, P35; Koc Z, 2009, SPINE, V34, P985, DOI 10.1097/BRS.0b013e31819c0a6b; Kolsi I, 2000, JOINT BONE SPINE, V67, P113; Kraemer J, 1997, Eur Spine J, V6, P357, DOI 10.1007/BF01142687; Kreiner DS, 2014, SPINE J, V14, P180, DOI 10.1016/j.spinee.2013.08.003; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; MacVicar J, 2013, PAIN MED, V14, P14, DOI 10.1111/j.1526-4637.2012.01508.x; Manchikanti L, 2014, PAIN PHYSICIAN, V17, pE489; Manchikanti L, 2014, PAIN PHYSICIAN, V17, pE61; Manchikanti L, 2013, PAIN PRACT, V13, P547, DOI 10.1111/papr.12023; Manchikanti Laxmaiah, 2013, Pain Physician, V16, pS49; Manchikanti L, 2012, PAIN PHYSICIAN, V15, P371; Manchikanti L, 2012, PAIN PHYSICIAN, V15, P273; Manchikanti L, 2012, J SPINAL DISORD TECH, V25, P226, DOI 10.1097/BSD.0b013e3182160068; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pE199; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pE143; Manchikanti L, 2012, PAIN PHYSICIAN, V15, P131; Manchikanti L, 2012, PAIN PHYSICIAN, V15, P51; Manchikanti L, 2011, SPINE, V36, P1897, DOI 10.1097/BRS.0b013e31823294f2; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P317; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P343; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P801; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P833; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; MATHEWS JA, 1987, BRIT J RHEUMATOL, V26, P416; McCahon RA, 2011, ANAESTHESIA, V66, P595, DOI 10.1111/j.1365-2044.2011.06764.x; McGrath JM, 2011, PAIN MED, V12, P726, DOI 10.1111/j.1526-4637.2011.01077.x; Nam HS, 2011, ANN REHABIL MED-ARM, V35, P514, DOI 10.5535/arm.2011.35.4.514; Ng L, 2005, SPINE, V30, P857, DOI 10.1097/01.brs.0000158878.93445.a0; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Owlia M. B., 2007, SMJ Singapore Medical Journal, V48, P241; Pacific Northwest Evidence-based Practice Center; Agency for Healthcare Research and Quality, 2014, SYST REV PROT PAIN M; Park CH, 2010, PAIN MED, V11, P1654, DOI 10.1111/j.1526-4637.2010.00941.x; Park Y, 2013, AM J PHYS MED REHAB, V92, P575, DOI 10.1097/PHM.0b013e318292356b; Parr AT, 2012, PAIN PHYSICIAN, V15, pE159; Pinto RZ, 2012, ANN INTERN MED, V157, P865, DOI 10.7326/0003-4819-157-12-201212180-00564; Price C, 2005, HEALTH TECHNOL ASSES, V9, P1; Quraishi NA, 2012, EUR SPINE J, V21, P214, DOI 10.1007/s00586-011-2008-y; Rados I, 2013, EUR NEUROL, V69, P27, DOI 10.1159/000338265; Rados I, 2011, PAIN MED, V12, P1316, DOI 10.1111/j.1526-4637.2011.01213.x; RIDLEY MG, 1988, BRIT J RHEUMATOL, V27, P295; Riew KD, 2006, J BONE JOINT SURG AM, V88A, P1722, DOI 10.2106/JBJS.E.00278; Riew KD, 2000, J BONE JOINT SURG AM, V82A, P1589, DOI 10.2106/00004623-200011000-00012; Roberts ST, 2009, PM&R, V1, P657, DOI 10.1016/j.pmrj.2009.04.008; ROGERS P, 1992, Pain Clinic, V5, P67; Sayegh FE, 2009, SPINE, V34, P1441, DOI 10.1097/BRS.0b013e3181a4804a; Shamliyan TA, 2014, PHYS MED REH CLIN N, V25, P471, DOI 10.1016/j.pmr.2014.02.001; Smith RM, 2013, NEW ENGL J MED, V369, P1598, DOI 10.1056/NEJMoa1213978; SNOEK W, 1977, ACTA ORTHOP SCAND, V48, P635, DOI 10.3109/17453677708994810; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Tafazal S, 2009, EUR SPINE J, V18, P1220, DOI 10.1007/s00586-009-1000-2; Thomas E, 2003, CLIN RHEUMATOL, V22, P299, DOI 10.1007/s10067-003-0736-z; U.S. Food and Drug Administration, 2014, NOV 24 25 2014 M AN; Valat JP, 2003, ANN RHEUM DIS, V62, P639, DOI 10.1136/ard.62.7.639; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003; Wilson-MacDonald J, 2005, J BONE JOINT SURG BR, V87B, P352, DOI 10.1302/0301-620X.87B3.15338	112	129	135	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2015	163	5					373	U133		10.7326/M15-0934	http://dx.doi.org/10.7326/M15-0934			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0OM	26302454				2022-12-28	WOS:000360296000009
J	Newgard, CD; Lewis, RJ				Newgard, Craig D.; Lewis, Roger J.			Missing Data How to Best Account for What Is Not Known	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADVANCED STATISTICS; CLINICAL-RESEARCH		[Newgard, Craig D.] Oregon Hlth & Sci Univ, Dept Emergency Med, Ctr Policy & Res Emergency Med, 3181 SW Sam Jackson Pk Rd,Mail Code CR-114, Portland, OR 97239 USA; [Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Lewis, Roger J.] Los Angeles Biomed Res Inst, Torrance, CA USA; [Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Oregon Health & Science University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Newgard, CD (corresponding author), Oregon Hlth & Sci Univ, Dept Emergency Med, Ctr Policy & Res Emergency Med, 3181 SW Sam Jackson Pk Rd,Mail Code CR-114, Portland, OR 97239 USA.	newgardc@ohsu.edu						Bakris GL, 2015, JAMA-J AM MED ASSOC, V314, P884, DOI 10.1001/jama.2015.10081; Haukoos JS, 2007, ACAD EMERG MED, V14, P662, DOI 10.1197/j.aem.2006.11.037; Little R.J.A., 2002, STAT ANAL MISSING DA; Newgard CD, 2007, ACAD EMERG MED, V14, P669, DOI 10.1197/j.aem.2006.11.038; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER	5	104	105	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					940	941		10.1001/jama.2015.10516	http://dx.doi.org/10.1001/jama.2015.10516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325562				2022-12-28	WOS:000360392100020
J	Sheehan, R; Hassiotis, A; Walters, K; Osborn, D; Strydom, A; Horsfall, L				Sheehan, Rory; Hassiotis, Angela; Walters, Kate; Osborn, David; Strydom, Andre; Horsfall, Laura			Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; RISK MARKERS; ADULTS; PREVALENCE; MEDICATION; TRENDS; RETARDATION; DISORDERS; HEALTH; PRESCRIPTION	Objectives To describe the incidence of recorded mental illness and challenging behaviour in people with intellectual disability in UK primary care and to explore the prescription of psychotropic drugs in this group. Design Cohort study. Setting 571 general practices contributing data to The Health Improvement Network clinical database. Participants 33 016 adults (58% male) with intellectual disability who contributed 211 793 person years' data. Main outcome measures Existing and new records of mental illness, challenging behaviour, and psychotropic drug prescription. Results 21% (7065) of the cohort had a record of mental illness at study entry, 25% (8300) had a record of challenging behaviour, and 49% (16 242) had a record of prescription of psychotropic drugs. During follow-up, the rate of new cases of mental illness in people without a history at cohort entry was 262 (95% confidence interval 254 to 271) per 10 000 person years and the rate of challenging behaviour was 239 (231 to 247) per 10 000 person years. The rate of new psychotropic drug prescription in those without a previous history of psychotropic drug treatment was 518 (503 to 533) per 10 000 person years. Rates of new recording of severe mental illness declined by 5% (95% confidence interval 3% to 7%) per year(P<0.001), and new prescriptions of antipsychotics declined by 4% (3% to 5%) per year P<0.001) between 1999 and 2013. New prescriptions of mood stabilisers also decreased significantly. The rate of new antipsychotic prescribing was significantly higher in people with challenging behaviour (incidence rate ratio 2.08, 95% confidence interval 1.90 to 2.27; P<0.001), autism (1.79, 1.56 to 2.04; P<0.001), and dementia (1.42, 1.12 to 1.81; P<0.003) and in those of older age, after control for other sociodemographic factors and comorbidity. Conclusions The proportion of people with intellectual disability who have been treated with psychotropic drugs far exceeds the proportion with recorded mental illness. Antipsychotics are often prescribed to people without recorded severe mental illness but who have a record of challenging behaviour. The findings suggest that changes are needed in the prescribing of psychotropics for people with intellectual disability. More evidence is needed of the efficacy and safety of psychotropic drugs in this group, particularly when they are used for challenging behaviour.	[Sheehan, Rory; Hassiotis, Angela; Osborn, David; Strydom, Andre] UCL, Div Psychiat, London W1T 7NF, England; [Walters, Kate; Horsfall, Laura] UCL, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England	University of London; University College London; University of London; University College London	Sheehan, R (corresponding author), UCL, Div Psychiat, London W1T 7NF, England.	r.sheehan@ucl.ac.uk	; Osborn PhD FRCPsych, David/B-8165-2009	Strydom, Andre/0000-0002-2502-6704; Walters, Kate/0000-0003-2173-2430; Osborn PhD FRCPsych, David/0000-0003-2519-1539; Hassiotis, Angela/0000-0002-9800-3909	Baily Thomas Charitable Fund [518669]; UK National Institute for Health Research [RP-DG-0611-10003]; National Institute for Health Research [ACF-2014-18-028] Funding Source: researchfish	Baily Thomas Charitable Fund; UK National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work received funding from the Baily Thomas Charitable Fund (grant 518669) and the UK National Institute for Health Research (grant RP-DG-0611-10003). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bourke Alison, 2004, Inform Prim Care, V12, P171; Brylewski J, 1999, J INTELL DISABIL RES, V43, P504, DOI 10.1046/j.1365-2788.1999.00234.x; BRYLEWSKI J, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000377.PUB2; Buckles J, 2013, J MENT HEALTH RES IN, V6, P181, DOI 10.1080/19315864.2011.651682; Buszewicz M, 2014, LANCET PSYCHIAT, V1, P522, DOI 10.1016/S2215-0366(14)00079-0; Cooper SA, 2007, PSYCHOL MED, V37, P873, DOI 10.1017/S0033291707009968; Cooper SA, 2007, BRIT J PSYCHIAT, V190, P27, DOI 10.1192/bjp.bp.106.022483; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Davies L, 2013, RES DEV DISABIL, V34, P764, DOI 10.1016/j.ridd.2012.10.004; de Kuijper G, 2010, J INTELL DISABIL RES, V54, P659, DOI 10.1111/j.1365-2788.2010.01275.x; de Winter CF, 2011, J INTELL DISABIL RES, V55, P675, DOI 10.1111/j.1365-2788.2011.01390.x; Deb S, 2009, WORLD PSYCHIATRY, V8, P181; Department of Health, 2012, TRANSF CAR NAT RESP; Emerson E, 2001, RES DEV DISABIL, V22, P77, DOI 10.1016/S0891-4222(00)00061-5; Felce D, 2009, J INTELL DISABIL RES, V53, P243, DOI 10.1111/j.1365-2788.2008.01131.x; Glover G, 2014, BRIT J PSYCHIAT, V205, P6, DOI 10.1192/bjp.bp.113.141267; Hardoon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082365; Heslop P, 2014, LANCET, V383, P889, DOI 10.1016/S0140-6736(13)62026-7; Holden B, 2004, RES DEV DISABIL, V25, P509, DOI 10.1016/j.ridd.2004.03.004; Holden B, 2003, RES DEV DISABIL, V24, P323, DOI 10.1016/S0891-4222(03)00060-X; Holden B, 2006, RES DEV DISABIL, V27, P456, DOI 10.1016/j.ridd.2005.06.001; Horsfall L, 2013, PHARMACOEPIDEM DR S, V22, P64, DOI 10.1002/pds.3368; Hsu SW, 2014, RES DEV DISABIL, V35, P364, DOI 10.1016/j.ridd.2013.11.011; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Lennox N, 2005, J INTELL DISABIL RES, V49, P296, DOI 10.1111/j.1365-2788.2005.00618.x; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; Lundqvist LO, 2013, RES DEV DISABIL, V34, P1346, DOI 10.1016/j.ridd.2013.01.010; MACKENBACH JP, 1988, HEALTH POLICY, V10, P207, DOI 10.1016/0168-8510(88)90006-1; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Marston L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006135; Matson JL, 2000, RES DEV DISABIL, V21, P263, DOI 10.1016/S0891-4222(00)00042-1; Matson JL, 2010, RES DEV DISABIL, V31, P1570, DOI 10.1016/j.ridd.2010.05.005; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; McClintock K, 2003, J INTELL DISABIL RES, V47, P405, DOI 10.1046/j.1365-2788.2003.00517.x; Molyneux P, 1999, J APPL RES INTELLECT, V12, P46, DOI 10.1111/j.1468-3148.1999.tb00049.x; Morgan VA, 2008, BRIT J PSYCHIAT, V193, P364, DOI 10.1192/bjp.bp.107.044461; National Institute for Health and Care Excellence (NICE), 2015, CHALL BEH LEARN DIS; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; Richards M, 2001, BRIT J PSYCHIAT, V179, P523, DOI 10.1192/bjp.179.6.523; Sawyer A, 2014, RES AUTISM SPECT DIS, V8, P803, DOI 10.1016/j.rasd.2014.03.021; Stephenson CP, 2013, AUST NZ J PSYCHIAT, V47, P74, DOI 10.1177/0004867412466595; Strydom A, 2007, BRIT J PSYCHIAT, V191, P150, DOI 10.1192/bjp.bp.106.028845; Tsiouris JA, 2010, J INTELL DISABIL RES, V54, P1, DOI 10.1111/j.1365-2788.2009.01232.x; Tsiouris JA, 2013, J AUTISM DEV DISORD, V43, P719, DOI 10.1007/s10803-012-1617-6; Tyrer Peter, 2014, BMJ, V349, pg4323, DOI 10.1136/bmj.g4323; Walters K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041670	51	177	177	0	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2015	351								h4326	10.1136/bmj.h4326	http://dx.doi.org/10.1136/bmj.h4326			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ9JQ	26330451	Green Published, hybrid			2022-12-28	WOS:000360931100001
J	Yang, YQ; Haigentz, M; Welch, M				Yang, Yuanquan; Haigentz, Missak, Jr.; Welch, Mary			Diplopia and Ataxia in a Heavy Smoker	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EFNS TASK-FORCE; PARANEOPLASTIC SYNDROMES; AUTOANTIBODY		[Yang, Yuanquan; Welch, Mary] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Haigentz, Missak, Jr.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Oncol, Bronx, NY 10467 USA; [Welch, Mary] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Welch, M (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol, 111 E 210th St, Bronx, NY 10467 USA.	mawelch@montefiore.org		Haigentz, Missak/0000-0002-3610-2266				BUDDESTEFFEN C, 1988, ANN NEUROL, V23, P528, DOI 10.1002/ana.410230518; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; Darnell RB, 2011, CONT NEUROLOGY SERIE, P70; Galvin R, 2010, EUR J NEUROL, V17, P1408, DOI 10.1111/j.1468-1331.2010.03153.x; McKeon A, 2010, ARCH NEUROL-CHICAGO, V67, P322, DOI 10.1001/archneurol.2009.336; Nishimoto Y, 2004, J NEUROIMMUNOL, V148, P200, DOI 10.1016/j.jneuroim.2003.11.017; Pittock SJ, 2003, ANN NEUROL, V53, P580, DOI 10.1002/ana.10518; Psimaras D, 2010, J NEUROL NEUROSUR PS, V81, P42, DOI 10.1136/jnnp.2008.159483; Titulaer MJ, 2011, EUR J NEUROL, V18, P19, DOI 10.1111/j.1468-1331.2010.03220.x; Vedeler CA, 2006, EUR J NEUROL, V13, P682, DOI 10.1111/j.1468-1331.2006.01266.x	10	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					942	943		10.1001/jama.2015.8617	http://dx.doi.org/10.1001/jama.2015.8617			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325563				2022-12-28	WOS:000360392100021
J	Tedersoo, L; Bahram, M; Polme, S; Anslan, S; Riit, T; Koljalg, U; Nilsson, RH; Hildebrand, F; Abarenkov, K				Tedersoo, Leho; Bahram, Mohammad; Polme, Sergei; Anslan, Sten; Riit, Taavi; Koljalg, Urmas; Nilsson, R. Henrik; Hildebrand, Falk; Abarenkov, Kessy			Response to Comment on "Global diversity and geography of soil fungi"	SCIENCE			English	Editorial Material								Schadt and Rosling (Technical Comment, 26 June 2015, p. 1438) argue that primer-template mismatches neglected the fungal class Archaeorhizomycetes in a global soil survey. Amplicon-based metabarcoding of nine barcode-primer pair combinations and polymerase chain reaction (PCR)-free shotgun metagenomics revealed that barcode and primer choice and PCR bias drive the diversity and composition of microorganisms in general, but the Archaeorhizomycetes were little affected in the global study. We urge that careful choice of DNA markers and primers is essential for ecological studies using high-throughput sequencing for identification.	[Tedersoo, Leho; Polme, Sergei; Abarenkov, Kessy] Univ Tartu, Nat Hist Museum, EE-50090 Tartu, Estonia; [Bahram, Mohammad; Anslan, Sten; Riit, Taavi; Koljalg, Urmas] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Bahram, Mohammad] Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden; [Nilsson, R. Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Hildebrand, Falk] European Mol Biol Lab, D-69012 Heidelberg, Germany	University of Tartu; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Uppsala University; University of Gothenburg; European Molecular Biology Laboratory (EMBL)	Tedersoo, L (corresponding author), Univ Tartu, Nat Hist Museum, Ulikooli 18, EE-50090 Tartu, Estonia.	leho.tedersoo@ut.ee	Kõljalg, Urmas/AAM-7828-2020; Kõljalg, Urmas/H-6925-2015; Tedersoo, Leho/ABE-7452-2020; Nilsson, R. Henrik/A-6062-2009; Bahram, Mohammad/A-9766-2010; Abarenkov, Kessy/H-9611-2015; Hildebrand, Falk/K-1914-2014	Kõljalg, Urmas/0000-0002-5171-1668; Nilsson, R. Henrik/0000-0002-8052-0107; Bahram, Mohammad/0000-0002-9539-3307; Abarenkov, Kessy/0000-0001-5526-4845; Hildebrand, Falk/0000-0002-0078-8948				Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Menkis A, 2014, FUNGAL BIOL-UK, V118, P943, DOI 10.1016/j.funbio.2014.08.005; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Schadt CW, 2015, SCIENCE, V348, DOI 10.1126/science.aaa4269; Tedersoo L, 2015, MYCOKEYS, P1, DOI 10.3897/mycokeys.10.4852; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Tedersoo L, 2013, FUNGAL BIOL REV, V27, P83, DOI 10.1016/j.fbr.2013.09.001	11	26	28	6	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251								10.1126/science.aaa5594	http://dx.doi.org/10.1126/science.aaa5594			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315429				2022-12-28	WOS:000360646800036
J	AghaKouchak, A; Feldman, D; Hoerling, M; Huxman, T; Lund, J				AghaKouchak, Amir; Feldman, David; Hoerling, Martin; Huxman, Travis; Lund, Jay			Water and climate: Recognize anthropogenic drought	NATURE			English	Editorial Material									[AghaKouchak, Amir] Univ Calif Irvine, Ctr Hydrol & Remote Sensing, Irvine, CA 92697 USA; [Feldman, David] Univ Calif Irvine, Dept Planning Policy & Design, Irvine, CA USA; [Hoerling, Martin] NOAA, Earth Syst Res Lab, Boulder, CO USA; [Huxman, Travis] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Lund, Jay] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Irvine; University of California System; University of California Davis	AghaKouchak, A (corresponding author), Univ Calif Irvine, Ctr Hydrol & Remote Sensing, Irvine, CA 92697 USA.	amir.a@uci.edu		AghaKouchak, Amir/0000-0003-4689-8357	Directorate For Geosciences [1316536] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Aghakouchak A, 2014, SCIENCE, V343, P1430, DOI 10.1126/science.343.6178.1430; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Diaz HF, 2015, J CLIMATE, V28, P4637, DOI 10.1175/JCLI-D-14-00774.1; Howitt R. J., 2014, EC ANAL 2014 DROUGHT; Hwan J. L., 2015, RIVER RES APPL; Lund J. R., 2015, P WORLD ENV WAT RES, P2073; Power ME, 2015, COPEIA, V103, P200, DOI 10.1643/CE-14-086; Shukla S, 2015, GEOPHYS RES LETT, V42, P4384, DOI 10.1002/2015GL063666; Stott PA, 2014, B AM METEOROL SOC, V95, pS1	10	206	209	3	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					409	411		10.1038/524409a	http://dx.doi.org/10.1038/524409a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LN	26310750	Bronze			2022-12-28	WOS:000360069300014
J	Marx, V				Marx, Vivien			THE DNA OF A NATION	NATURE			English	Editorial Material																		Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0	5	52	52	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					503	505		10.1038/524503a	http://dx.doi.org/10.1038/524503a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LN	26310768	Bronze			2022-12-28	WOS:000360069300046
J	Khosla, R; Say, L; Temmerman, M				Khosla, Rajat; Say, Lale; Temmerman, Marleen			Sexual health, human rights, and law	LANCET			English	Editorial Material									[Khosla, Rajat; Say, Lale; Temmerman, Marleen] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland	World Health Organization	Khosla, R (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	khoslar@who.int	, lalesay/AAG-1912-2021		World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2011, PREVALENCE INCIDENCE; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; UN General Assembly, 1994, PROGR ACT INT C POP; UNAIDS, 2013, REP GLOB AIDS EP 201; UNFPA, 2014, FRAM OF ACT; WHO, 1975, WHO TECHN REP SER, V572; WHO, 2014, REPR HLTH STRAT ACC; WHO, 2010, DEV SEX HLTH PROGR R; World Health Organization, 2015, OPERATIONAL FRAMEWOR; World Health Organization, 2006, DEF SEX HLTH REP TEC	11	14	14	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					725	726		10.1016/S0140-6736(15)61449-0	http://dx.doi.org/10.1016/S0140-6736(15)61449-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LR	26333959				2022-12-28	WOS:000360287900009
J	Cahill, TJ; Prendergast, BD				Cahill, Thomas J.; Prendergast, Bernard D.			Infective endocarditis	LANCET			English	Review							BLOOD-STREAM INFECTIONS; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; COAGULASE-NEGATIVE STAPHYLOCOCCI; PROSTHETIC VALVE ENDOCARDITIS; INTERNATIONAL COLLABORATION; ANTIBIOTIC-PROPHYLAXIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CARDIOVERTER-DEFIBRILLATORS; RISK-FACTORS; FIBRONECTIN-BINDING	Infective endocarditis occurs worldwide, and is defined by infection of a native or prosthetic heart valve, the endocardial surface, or an indwelling cardiac device. The causes and epidemiology of the disease have evolved in recent decades with a doubling of the average patient age and an increased prevalence in patients with indwelling cardiac devices. The microbiology of the disease has also changed, and staphylococci, most often associated with health-care contact and invasive procedures, have overtaken streptococci as the most common cause of the disease. Although novel diagnostic and therapeutic strategies have emerged, 1 year mortality has not improved and remains at 30%, which is worse than for many cancers. Logistical barriers and an absence of randomised trials hinder clinical management, and longstanding controversies such as use of antibiotic prophylaxis remain unresolved. In this Seminar, we discuss clinical practice, controversies, and strategies needed to target this potentially devastating disease.	[Cahill, Thomas J.] Oxford Univ Hosp, Dept Cardiol, Oxford, England; [Prendergast, Bernard D.] St Thomas Hosp, Dept Cardiol, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	Prendergast, BD (corresponding author), St Thomas Hosp, Dept Cardiol, London SE1 7EH, England.	bernard.prendergast@gstt.nhs.uk		Cahill, Thomas/0000-0003-4318-5618	Oxford Partnership Comprehensive Biomedical Research Centre; UK Department of Health's National Institute for Health Research Biomedical Research Centres	Oxford Partnership Comprehensive Biomedical Research Centre; UK Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR))	The work of BDP has been supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The views expressed in this Seminar are his and not necessarily those of the Department of Health. The authors are grateful to Dr Andrew Kelion, Dr Jim Newton, and Dr Nik Sabharwal for assistance with images.	AGNIHOTRI AK, 1995, J THORAC CARDIOV SUR, V110, P1708, DOI 10.1016/S0022-5223(95)70035-8; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Alonso-Valle H, 2010, J THORAC CARDIOV SUR, V139, P887, DOI 10.1016/j.jtcvs.2009.05.042; Ammerlaan HSM, 2013, CLIN INFECT DIS, V56, P798, DOI 10.1093/cid/cis1006; Anguera I, 2005, EUR HEART J, V26, P288, DOI 10.1093/eurheartj/ehi034; Arvay A, 1988, Eur J Cardiothorac Surg, V2, P340; Asopa S, 2007, EUR J CARDIO-THORAC, V32, P696, DOI 10.1016/j.ejcts.2007.07.029; Athan E, 2012, JAMA-J AM MED ASSOC, V307, P1727, DOI 10.1001/jama.2012.497; Baddley JW, 2008, EUR J CLIN MICROBIOL, V27, P519, DOI 10.1007/s10096-008-0466-x; Baddour LM, 2012, NEW ENGL J MED, V367, P842, DOI 10.1056/NEJMcp1107675; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Bosshard PP, 2003, CLIN INFECT DIS, V37, P167, DOI 10.1086/375592; Brinkman CL, 2013, J CLIN MICROBIOL, V51, P2040, DOI 10.1128/JCM.00304-13; Brouqui P, 2001, CLIN MICROBIOL REV, V14, P177, DOI 10.1128/CMR.14.1.177-207.2001; Bruun NE, 2014, EUR HEART J, V35, P624, DOI 10.1093/eurheartj/eht274; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chambers J, 2014, HEART, V100, P524, DOI 10.1136/heartjnl-2013-304354; Chambers JB, 2011, J ROY SOC MED, V104, P138, DOI 10.1258/jrsm.2011.100356; Chirillo F, 2013, AM J CARDIOL, V112, P1171, DOI 10.1016/j.amjcard.2013.05.060; Chirouze C, 2015, CLIN INFECT DIS, V60, P741, DOI 10.1093/cid/ciu871; Chu VH, 2009, HEART, V95, P570, DOI 10.1136/hrt.2008.152975; Chu VH, 2004, CLIN INFECT DIS, V39, P1527, DOI 10.1086/424878; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Chu VH, 2015, CIRCULATION, V131, P131, DOI 10.1161/CIRCULATIONAHA.114.012461; Cockerill FR, 2004, CLIN INFECT DIS, V38, P1724, DOI 10.1086/421087; Cosgrove SE, 2009, CLIN INFECT DIS, V48, P713, DOI 10.1086/597031; CROFT CH, 1983, AM J CARDIOL, V51, P1650, DOI 10.1016/0002-9149(83)90203-5; DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203; Das M, 1997, ANNU REV MED, V48, P25, DOI 10.1146/annurev.med.48.1.25; Day MD, 2009, CIRCULATION, V119, P865, DOI 10.1161/CIRCULATIONAHA.108.798751; Dayer MJ, 2015, LANCET, V385, P1219, DOI 10.1016/S0140-6736(14)62007-9; De Castro S, 2000, CLIN INFECT DIS, V30, P825, DOI 10.1086/313762; de Oliveira JC, 2009, CIRC-ARRHYTHMIA ELEC, V2, P29, DOI 10.1161/CIRCEP.108.795906; de Sa DDC, 2010, MAYO CLIN PROC, V85, P422, DOI 10.4065/mcp.2009.0585; Dickerman SA, 2007, AM HEART J, V154, P1086, DOI 10.1016/j.ahj.2007.07.023; Dundar C, 2011, J AM SOC ECHOCARDIOG, V24, P803, DOI 10.1016/j.echo.2011.03.001; Durante-Mangoni E, 2008, ARCH INTERN MED, V168, P2095, DOI 10.1001/archinte.168.19.2095; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Duval X, 2010, ANN INTERN MED, V152, P497, DOI 10.7326/0003-4819-152-8-201004200-00006; Edwards AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043046; Fagman E, 2012, EUR RADIOL, V22, P2407, DOI 10.1007/s00330-012-2491-5; Fernandez-Hidalgo N, 2012, CLIN MICROBIOL INFEC, V18, pE522, DOI 10.1111/1469-0691.12033; Feuchtner GM, 2009, J AM COLL CARDIOL, V53, P436, DOI 10.1016/j.jacc.2008.01.077; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fournier PE, 2010, CLIN INFECT DIS, V51, P131, DOI 10.1086/653675; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Fowler VG, 1997, J AM COLL CARDIOL, V30, P1072, DOI 10.1016/S0735-1097(97)00250-7; Geissdorfer W, 2012, J CLIN MICROBIOL, V50, P216, DOI 10.1128/JCM.05531-11; Goldenberger D, 1997, J CLIN MICROBIOL, V35, P2733, DOI 10.1128/JCM.35.11.2733-2739.1997; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033; Habib G, 2008, PROG CARDIOVASC DIS, V50, P274, DOI 10.1016/j.pcad.2007.10.007; Habib G, 2010, EUR J ECHOCARDIOGR, V11, P202, DOI 10.1093/ejechocard/jeq004; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Heiro M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-49; Heldman AW, 1996, AM J MED, V101, P68, DOI 10.1016/S0002-9343(96)00070-8; Hess A, 2013, AM J NEURORADIOL, V34, P1579, DOI 10.3174/ajnr.A3582; Hill EE, 2007, EUR HEART J, V28, P196, DOI 10.1093/eurheartj/ehl427; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Joseph JP, 2013, J ANTIMICROB CHEMOTH, V68, P444, DOI 10.1093/jac/dks408; Kaiser SP, 2007, ANN THORAC SURG, V83, P30, DOI 10.1016/j.athoracsur.2006.07.037; Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Lalani T, 2013, JAMA INTERN MED, V173, P1495, DOI 10.1001/jamainternmed.2013.8203; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Lockhart PB, 2009, J AM DENT ASSOC, V140, P1238, DOI 10.14219/jada.archive.2009.0046; Lopez J, 2007, EUR HEART J, V28, P760, DOI 10.1093/eurheartj/ehl486; LOWRANCE JH, 1990, J CLIN INVEST, V86, P7, DOI 10.1172/JCI114717; Lyytikainen O, 2005, EUR J CLIN MICROBIOL, V24, P399, DOI 10.1007/s10096-005-1345-3; Malhotra A, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0464-9; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Martin-Davila P, 2005, AM HEART J, V150, P1099, DOI 10.1016/j.ahj.2005.02.009; Martinez-Selles M, 2008, MAYO CLIN PROC, V83, P1213, DOI 10.4065/83.11.1213; Meine TJ, 2001, AM HEART J, V142, P280, DOI 10.1067/mhj.2001.116964; Miller SE, 2012, CURR OPIN INFECT DIS, V25, P412, DOI 10.1097/QCO.0b013e328355e4da; Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020; Morris CD, 1998, JAMA-J AM MED ASSOC, V279, P599, DOI 10.1001/jama.279.8.599; MUGGE A, 1989, J AM COLL CARDIOL, V14, P631; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Narducci ML, 2013, J AM COLL CARDIOL, V61, P1398, DOI 10.1016/j.jacc.2012.12.041; Nigo M, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0431-z; Olmos C, 2013, EUR HEART J, V34, P1999, DOI 10.1093/eurheartj/ehs336; Osler W, 1885, Br Med J, V1, P577; Pasquali SK, 2012, AM HEART J, V163, P894, DOI 10.1016/j.ahj.2012.03.002; Pazos-Lopez Pablo, 2014, JACC Cardiovasc Imaging, V7, P896, DOI 10.1016/j.jcmg.2014.05.009; Perez-Vazquez A, 2000, ARCH INTERN MED, V160, P1185, DOI 10.1001/archinte.160.8.1185; Peters PJ, 2006, LANCET INFECT DIS, V6, P742, DOI 10.1016/S1473-3099(06)70631-4; Petti CA, 2006, J CLIN MICROBIOL, V44, P257, DOI 10.1128/JCM.44.1.257-259.2006; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; Prendergast BD, 2006, HEART, V92, P879, DOI 10.1136/hrt.2005.067256; Prendergast BD, 2004, HEART, V90, P611, DOI 10.1136/hrt.2003.029850; Prendergast BD, 2010, CIRCULATION, V121, P1141, DOI 10.1161/CIRCULATIONAHA.108.773598; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Rabkin DG, 2012, ANN THORAC SURG, V93, P51, DOI 10.1016/j.athoracsur.2011.08.016; RICHARDSON JV, 1978, CIRCULATION, V58, P589, DOI 10.1161/01.CIR.58.4.589; Richey R, 2008, BMJ-BRIT MED J, V336, P770, DOI 10.1136/bmj.39510.423148.AD; Riedel S, 2008, J CLIN MICROBIOL, V46, P1381, DOI 10.1128/JCM.02033-07; Rushani D, 2013, CIRCULATION, V128, P1412, DOI 10.1161/CIRCULATIONAHA.113.001827; Saby L, 2013, J AM COLL CARDIOL, V61, P2374, DOI 10.1016/j.jacc.2013.01.092; Sandoe JAT, 2015, J ANTIMICROB CHEMOTH, V70, P325, DOI 10.1093/jac/dku383; Sarrazin JF, 2012, J AM COLL CARDIOL, V59, P1616, DOI 10.1016/j.jacc.2011.11.059; Seckeler Michael D, 2011, Clin Epidemiol, V3, P67, DOI 10.2147/CLEP.S12977; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Sen Yew H, 2012, CURR INFECT DIS REP, V14, DOI 10.1007/s11908-012-0265-5; Servy A, 2014, JAMA DERMATOL, V150, P494, DOI 10.1001/jamadermatol.2013.8727; Shiue AB, 2010, AM J CARDIOL, V106, P1011, DOI 10.1016/j.amjcard.2010.05.034; Silverman ME, 2007, AM J CARDIOL, V100, P1802, DOI 10.1016/j.amjcard.2007.07.034; Sy RW, 2011, EUR HEART J, V32, P2016, DOI 10.1093/eurheartj/ehp085; Thompson KA, 2011, AM J CARDIOL, V107, P100, DOI 10.1016/j.amjcard.2010.08.051; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392; Thuny F, 2005, CIRCULATION, V112, P69, DOI 10.1161/CIRCULATIONAHA.104.493155; Tornos P, 2011, CURR PROB CARDIOLOGY, V36, P175, DOI 10.1016/j.cpcardiol.2011.03.004; Valente AM, 2005, PEDIATRICS, V115, pE15, DOI 10.1542/peds.2004-1152; Veloso TR, 2013, INFECT IMMUN, V81, P697, DOI 10.1128/IAI.01030-12; Victor F, 1999, HEART, V81, P82, DOI 10.1136/hrt.81.1.82; Vieira MLC, 2004, HEART, V90, P1020, DOI 10.1136/hrt.2003.025585; Viganego F, 2012, AM J CARDIOL, V109, P1466, DOI 10.1016/j.amjcard.2012.01.360; Vilacosta I, 2002, J AM COLL CARDIOL, V39, P1489, DOI 10.1016/S0735-1097(02)01790-4; Voigt A, 2006, J AM COLL CARDIOL, V48, P590, DOI 10.1016/j.jacc.2006.05.016; Vondracek M, 2011, J INFECTION, V62, P472, DOI 10.1016/j.jinf.2011.04.010; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Werdan K, 2014, NAT REV CARDIOL, V11, P35, DOI 10.1038/nrcardio.2013.174; Widmer Eleonora, 2006, Curr Infect Dis Rep, V8, P271, DOI 10.1007/s11908-006-0071-z	130	448	473	3	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					882	893		10.1016/S0140-6736(15)00067-7	http://dx.doi.org/10.1016/S0140-6736(15)00067-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE9RA	26341945				2022-12-28	WOS:000370974400033
J	des Georges, A; Dhote, V; Kuhn, L; Hellen, CUT; Pestova, TV; Frank, J; Hashem, Y				des Georges, Amedee; Dhote, Vidya; Kuhn, Lauriane; Hellen, Christopher U. T.; Pestova, Tatyana V.; Frank, Joachim; Hashem, Yaser			Structure of mammalian eIF3 in the context of the 43S preinitiation complex	NATURE			English	Article							EUKARYOTIC TRANSLATION INITIATION; MESSENGER-RNA RECRUITMENT; PARTICLE ELECTRON CRYOMICROSCOPY; CRYOELECTRON MICROSCOPY; RECOGNITION MOTIF; 26S PROTEASOME; MOLECULAR-DYNAMICS; RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; COP9 SIGNALOSOME	During eukaryotic translation initiation, 43S complexes, comprising a 40S ribosomal subunit, initiator transfer RNA and initiation factors (eIF) 2, 3, 1 and 1A, attach to the 59-terminal region of messenger RNA and scan along it to the initiation codon. Scanning on structured mRNAs also requires the DExH-box protein DHX29. Mammalian eIF3 contains 13 subunits and participates in nearly all steps of translation initiation. Eight subunits having PCI (proteasome, COP9 signalosome, eIF3) or MPN (Mpr1, Pad1, amino-terminal) domains constitute the structural core of eIF3, to which five peripheral subunits are flexibly linked. Here we present a cryo-electron microscopy structure of eIF3 in the context of the DHX29-bound 43S complex, showing the PCI/MPN core at,6 angstrom resolution. It reveals the organization of the individual subunits and their interactions with components of the 43S complex. We were able to build near-complete polyalanine-level models of the eIF3 PCI/MPN core and of two peripheral subunits. The implications for understanding mRNA ribosomal attachment and scanning are discussed.	[des Georges, Amedee; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, HHMI, New York, NY 10032 USA; [Dhote, Vidya; Hellen, Christopher U. T.; Pestova, Tatyana V.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Kuhn, Lauriane] CNRS, Prote Platform Strasbourg Esplanade, F-67084 Strasbourg, France; [Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; [Hashem, Yaser] Univ Strasbourg, CNRS, Architecture & React ARN, F-67084 Strasbourg, France	Columbia University; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Columbia University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pestova, TV (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	Tatyana.Pestova@downstate.edu; jf2192@cumc.columbia.edu; y.hashem@ibmc-cnrs.unistra.fr	Georges, Amédée des/C-3588-2014	Georges, Amédée des/0000-0002-9704-3781; Kuhn, Lauriane/0000-0002-2637-1024	HHMI; NIH [R01 GM29169, R01 GM59660]; French National Research Agency as part of the Investments for the future program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059660, R01GM029169] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French National Research Agency as part of the Investments for the future program(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. A. Grassucci for helping collect the electron microscopy images, H. Kao for help with computations, and the proteomic platform Strasbourg-Esplanade for conducting the nano-LS-MS/MS analysis. This work was supported by both HHMI and NIH R01 GM29169 (to J.F.) and NIH R01 GM59660 (to T.V.P.). This work has been published under the framework of the LABEX: ANR-10-LABX-0036_NETRNA and benefits from funding from the state managed by the French National Research Agency as part of the Investments for the future program (to Y.H.).	Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Aylett CHS, 2015, NAT STRUCT MOL BIOL, V22, P269, DOI 10.1038/nsmb.2963; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chiu WL, 2010, MOL CELL BIOL, V30, P4415, DOI 10.1128/MCB.00280-10; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Dhote V, 2012, P NATL ACAD SCI USA, V109, pE3150, DOI 10.1073/pnas.1208014109; Dong ZZ, 2013, J BIOL CHEM, V288, P27951, DOI 10.1074/jbc.M113.483164; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Ellisdon Andrew M, 2012, Bioarchitecture, V2, P118, DOI 10.4161/bioa.21131; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hashem Y, 2013, NATURE, V503, P539, DOI 10.1038/nature12658; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Khoshnevis S, 2014, NUCLEIC ACIDS RES, V42, P4123, DOI 10.1093/nar/gkt1369; Kouba T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040464; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lange H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004564; Langlois R, 2014, J STRUCT BIOL, V186, P1, DOI 10.1016/j.jsb.2014.03.001; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Liu Y, 2014, STRUCTURE, V22, P923, DOI 10.1016/j.str.2014.03.010; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Rezende AM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1175; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmitt E, 2012, NAT STRUCT MOL BIOL, V19, P450, DOI 10.1038/nsmb.2259; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Thiele H, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-141; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Valasek L, 1999, J BIOL CHEM, V274, P27567, DOI 10.1074/jbc.274.39.27567; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; WAGENKNECHT T, 1988, J MOL BIOL, V203, P753, DOI 10.1016/0022-2836(88)90207-0; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Yu YP, 2011, NUCLEIC ACIDS RES, V39, P4851, DOI 10.1093/nar/gkr045; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	68	142	143	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2015	525	7570					491	+		10.1038/nature14891	http://dx.doi.org/10.1038/nature14891			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8KI	26344199	Green Accepted			2022-12-28	WOS:000361599900044
J	Smith, JM				Smith, Jeanette M.			Yukon Tim Zuck	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		NEWLANDS A, 2007, CANADIAN PAINTINGS P, V346	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					976	977		10.1001/jama.2014.11965	http://dx.doi.org/10.1001/jama.2014.11965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348737				2022-12-28	WOS:000360840700027
J	Sylvester, J				Sylvester, James			CASE REVIEW An atypical cause of respiratory failure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PNEUMOCYSTIS-CARINII-PNEUMONIA; JIROVECII PNEUMONIA; MANAGEMENT		Doncaster Royal Infirm, Dept Crit Care, Doncaster DN2 5LT, England		Sylvester, J (corresponding author), Doncaster Royal Infirm, Dept Crit Care, Doncaster DN2 5LT, England.	sylvesterj@doctors.org.uk						Amini B, PNEUMOCYSTIS PNEUMON; Bennett NJ, 2013, MEDSCAPE; Castro JG, 2010, HIV AIDS-RES PALLIAT, V2, P123; Helweg-Larsen J, 2009, J ANTIMICROB CHEMOTH, V64, P1282, DOI 10.1093/jac/dkp372; KUHLMAN JE, 1990, RADIOLOGY, V175, P711, DOI 10.1148/radiology.175.3.2343118; Morris A, 2014, BMJ BEST PRACTICE; Seaton A, 2000, SCIENCE, V2, P1361; Thomas FC, 2015, UPTODATE; Vilar FJ, 1999, BRIT J CLIN PHARMACO, V47, P605, DOI 10.1046/j.1365-2125.1999.00966.x; Wilkin A, 1999, AM FAM PHYSICIAN, V60, P1699; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2015	351								h4682	10.1136/bmj.h4682	http://dx.doi.org/10.1136/bmj.h4682			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9KB	26341246				2022-12-28	WOS:000360932300003
J	Maraka, S; Kennel, KA				Maraka, Spyridoula; Kennel, Kurt A.			Bisphosphonates for the prevention and treatment of osteoporosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BONE TURNOVER MARKERS; INTRAVENOUS IBANDRONATE INJECTIONS; FRACTURE RISK REDUCTION; ZOLEDRONIC ACID; POSTMENOPAUSAL OSTEOPOROSIS; VERTEBRAL FRACTURES; HIP FRACTURE; ORAL BISPHOSPHONATES; RANDOMIZED-TRIAL; MINERAL DENSITY	Osteoporosis is a systemic skeletal disorder characterized by bone loss, which leads to impaired bone strength and an increased risk of fractures. Two million fractures are attributed to osteoporosis annually in the United States and they are associated with serious morbidity and mortality. Bisphosphonates reduce the risk of fracture by suppressing bone resorption and increasing bone strength, and they have been widely used for the prevention and treatment of osteoporosis. However, the use of these drugs for the management of osteoporosis remains a clinical challenge. There are several important considerations including appropriate patient selection, pretreatment evaluation, potential adverse effects, patient preferences, and adherence. This review will discuss the evidence informing the clinical strategy for using bisphosphonates in patients with osteoporosis and those at high risk of fracture, focusing on the benefits and risks of treatment. We will also consider issues related to the monitoring and duration of treatment.	[Maraka, Spyridoula; Kennel, Kurt A.] Mayo Clin, Div Endocrinol Diabet Nutr & Metab, Rochester, MN 55905 USA	Mayo Clinic	Kennel, KA (corresponding author), Mayo Clin, Div Endocrinol Diabet Nutr & Metab, Rochester, MN 55905 USA.	kennel.kurt@mayo.edu		Maraka, Spyridoula/0000-0001-7259-132X				Abraham A, 2013, CLIN OBSTET GYNECOL, V56, P722, DOI 10.1097/GRF.0b013e3182a8ae55; Allen MR, 2011, BONE, V49, P56, DOI 10.1016/j.bone.2010.10.159; Andrici J, 2012, ALIMENT PHARM THER, V36, P708, DOI 10.1111/apt.12041; Bauer DC, 2004, J BONE MINER RES, V19, P1250, DOI 10.1359/JBMR.040512; Bauer DC, 2000, ARCH INTERN MED, V160, P517, DOI 10.1001/archinte.160.4.517; Bauer DC, 2014, JAMA INTERN MED, V174, P1126, DOI 10.1001/jamainternmed.2014.1232; Black DM, 2012, NEW ENGL J MED, V366, P2051, DOI 10.1056/NEJMp1202623; Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; BLACK DM, 2007, NEW ENGL J MED, V356, P1809, DOI [DOI 10.1056/NEJMOA067312, 10.1056/NEJMoa067312]; Boonen S, 2012, NEW ENGL J MED, V367, P1714, DOI 10.1056/NEJMoa1204061; Boonen S, 2012, J BONE MINER RES, V27, P963, DOI 10.1002/jbmr.1570; Burch J, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18110; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Chang KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081124; Chapurlat RD, 2005, OSTEOPOROSIS INT, V16, P842, DOI 10.1007/s00198-004-1770-7; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Chopin F, 2012, JOINT BONE SPINE, V79, P26, DOI 10.1016/j.jbspin.2011.05.004; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; Clowes JA, 2004, J CLIN ENDOCR METAB, V89, P1117, DOI 10.1210/jc.2003-030501; Colon-Emeric C, 2011, OSTEOPOROSIS INT, V22, P2329, DOI 10.1007/s00198-010-1473-1; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Cosman F, 2011, J BONE MINER RES, V26, P503, DOI 10.1002/jbmr.238; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; Crandall CJ, 2014, ANN INTERN MED, V161, P711, DOI 10.7326/M14-0317; Cremers SCLM, 2005, CLIN PHARMACOKINET, V44, P551, DOI 10.2165/00003088-200544060-00001; Cremers S, 2011, BONE, V49, P42, DOI 10.1016/j.bone.2011.01.014; Crilly RG, 2014, OSTEOPOROSIS INT, V25, P205, DOI 10.1007/s00198-013-2453-z; Cryer B, 2002, MAYO CLIN PROC, V77, P1031, DOI 10.4065/77.10.1031; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Dell RM, 2012, J BONE MINER RES, V27, P2544, DOI 10.1002/jbmr.1719; Delmas PD, 2007, J CLIN ENDOCR METAB, V92, P1296, DOI 10.1210/jc.2006-1526; Delmas PD, 2006, ARTHRITIS RHEUM-US, V54, P1838, DOI 10.1002/art.21918; Diez-Perez A, 2012, OSTEOPOROSIS INT, V23, P2769, DOI 10.1007/s00198-012-2093-8; Donaldson MG, 2012, J BONE MINER RES, V27, P1804, DOI 10.1002/jbmr.1625; Eastell R, 2000, OSTEOPOROSIS INT, V11, P331, DOI 10.1007/s001980070122; Eastell R, 2003, J BONE MINER RES, V18, P1051, DOI 10.1359/jbmr.2003.18.6.1051; Eisman JA, 2008, J RHEUMATOL, V35, P488; Ensrud KE, 2004, J BONE MINER RES, V19, P1259, DOI 10.1359/JBMR.040326; Filleul O, 2010, J CANCER RES CLIN, V136, P1117, DOI 10.1007/s00432-010-0907-7; Food and Drug Administration, 2013, UPD SAF REV FOLL OCT; Food and Drug Administration, 2011, BACKGR DOC M ADV COM; Food and Drug Administration, 2011, FDA DRUG SAF COMM NE; Fraunfelder FW, 2003, NEW ENGL J MED, V348, P1187, DOI 10.1056/NEJM200303203481225; Funck-Brentano T, 2011, SEMIN ARTHRITIS RHEU, V41, P157, DOI 10.1016/j.semarthrit.2011.01.005; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Gleeson T, 2009, OSTEOPOROSIS INT, V20, P2127, DOI 10.1007/s00198-009-0976-0; Gong HS, 2012, J BONE JOINT SURG AM, V94A, P1729, DOI 10.2106/JBJS.K.01434; Gralow JR, 2013, J NATL COMPR CANC NE, V11, pS1; Grbic JT, 2010, J AM DENT ASSOC, V141, P1365, DOI 10.14219/jada.archive.2010.0082; Grey A, 2012, BONE, V50, P1389, DOI 10.1016/j.bone.2012.03.016; Harrington JT, 2004, CALCIFIED TISSUE INT, V74, P129, DOI 10.1007/s00223-003-0042-4; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Hellstein JW, 2011, J AM DENT ASSOC, V142, P1243, DOI 10.14219/jada.archive.2011.0108; Hiligsmann M, 2013, OSTEOPOROSIS INT, V24, P2907, DOI 10.1007/s00198-013-2364-z; Imaz I, 2010, OSTEOPOROSIS INT, V21, P1943, DOI 10.1007/s00198-009-1134-4; Jansen JP, 2011, SEMIN ARTHRITIS RHEU, V40, P275, DOI 10.1016/j.semarthrit.2010.06.001; Jarvinen TLN, 2014, CAN MED ASSOC J, V186, P165, DOI 10.1503/cmaj.121874; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Kanis JA, 2011, OSTEOPOROSIS INT, V22, P2395, DOI 10.1007/s00198-011-1713-z; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P475, DOI 10.1007/s00198-004-1698-y; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P229, DOI 10.1007/s00198-004-1811-2; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027; Kim SW, 2005, ENDOCR J, V52, P667, DOI 10.1507/endocrj.52.667; Kim TY, 2012, J BONE JOINT SURG BR, V94B, P956, DOI 10.1302/0301-620X.94B7.29079; Leslie WD, 2014, OSTEOPOROSIS INT, V25, P2271, DOI 10.1007/s00198-014-2761-y; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lin TC, 2014, OSTEOPOROSIS INT, V25, P1503, DOI 10.1007/s00198-014-2624-6; Loke YK, 2009, DRUG SAFETY, V32, P219, DOI 10.2165/00002018-200932030-00004; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; McCloskey EV, 2009, OSTEOPOROSIS INT, V20, P811, DOI 10.1007/s00198-008-0786-9; McClung M, 2009, OBSTET GYNECOL, V114, P999, DOI 10.1097/AOG.0b013e3181bdce0a; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; McHorney CA, 2011, HEALTH EXPECT, V14, P307, DOI 10.1111/j.1369-7625.2010.00619.x; Miller PD, 2012, OSTEOPOROSIS INT, V23, P1747, DOI 10.1007/s00198-011-1773-0; Miller PD, 2008, CURR MED RES OPIN, V24, P107, DOI 10.1185/030079907X253681; Miller PD, 2011, BONE, V49, P77, DOI 10.1016/j.bone.2010.12.024; Miller PD, 2010, CALCIFIED TISSUE INT, V87, P305, DOI 10.1007/s00223-010-9403-y; Miller PD, 2010, J WOMENS HEALTH, V19, P665, DOI 10.1089/jwh.2010.1945; Montori VM, 2011, AM J MED, V124, P549, DOI 10.1016/j.amjmed.2011.01.013; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P1871, DOI 10.1210/jc.2011-3060; Nelson HD, 2010, ANN INTERN MED, V153, P99, DOI 10.7326/0003-4819-153-2-201007200-00262; Nieves JW, 2010, OSTEOPOROSIS INT, V21, P399, DOI 10.1007/s00198-009-0962-6; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Ott SM, 2001, J CLIN ENDOCR METAB, V86, P1835, DOI 10.1210/jc.86.4.1835; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; PAPAPOULOS SE, 1986, BONE MINER, V1, P69; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Patel DV, 2015, OSTEOPOROSIS INT, V26, P499, DOI 10.1007/s00198-014-2872-5; Perazella MA, 2008, KIDNEY INT, V74, P1385, DOI 10.1038/ki.2008.356; Pitts CJD, 2011, MAYO CLIN PROC, V86, P338, DOI 10.4065/mcp.2010.0636; Rabenda V, 2008, OSTEOPOROSIS INT, V19, P811, DOI 10.1007/s00198-007-0506-x; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Reid DM, 2008, CANCER TREAT REV, V34, pS3, DOI 10.1016/j.ctrv.2008.03.007; Reid DM, 2009, LANCET, V373, P1253, DOI 10.1016/S0140-6736(09)60250-6; Reid IR, 2010, J CLIN ENDOCR METAB, V95, P4380, DOI 10.1210/jc.2010-0597; Rizzoli R, 2015, NAT REV RHEUMATOL, V11, P98, DOI 10.1038/nrrheum.2014.188; Ross S, 2011, VALUE HEALTH, V14, P571, DOI 10.1016/j.jval.2010.11.010; Roux C, 2004, CURR MED RES OPIN, V20, P433, DOI 10.1185/030079903125003125; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; Sambrook PN, 2012, BONE, V50, P289, DOI 10.1016/j.bone.2011.10.024; Schafer AL, 2010, OSTEOPOROSIS INT, V21, P439, DOI 10.1007/s00198-009-0974-2; Schilcher J, 2014, NEW ENGL J MED, V371, P974, DOI 10.1056/NEJMc1403799; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11; Seeman E, 2009, OSTEOPOROSIS INT, V20, P187, DOI 10.1007/s00198-008-0813-x; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Silva BC, 2014, J BONE MINER RES, V29, P518, DOI 10.1002/jbmr.2176; Solomon DH, 2013, OSTEOPOROSIS INT, V24, P237, DOI 10.1007/s00198-012-2042-6; Solomon DH, 2014, J BONE MINER RES, V29, P1929, DOI 10.1002/jbmr.2202; Stein EM, 2011, J CLIN ENDOCR METAB, V96, P3457, DOI 10.1210/jc.2011-1448; Sun K, 2013, OSTEOPOROSIS INT, V24, P279, DOI 10.1007/s00198-012-2158-8; Tadrous M, 2014, OSTEOPOROSIS INT, V25, P1225, DOI 10.1007/s00198-013-2576-2; Tannenbaum C, 2002, J CLIN ENDOCR METAB, V87, P4431, DOI 10.1210/jc.2002-020275; Ulmner M, 2014, J ORAL MAXIL SURG, V72, P76, DOI 10.1016/j.joms.2013.06.221; Wang Z, 2011, J BONE MINER RES, V26, P553, DOI 10.1002/jbmr.233; Wark JD, 2012, OSTEOPOROSIS INT, V23, P503, DOI 10.1007/s00198-011-1563-8; Watts NB, 2008, OSTEOPOROSIS INT, V19, P365, DOI 10.1007/s00198-007-0460-7; Watts NB, 2005, J BONE MINER RES, V20, P2097, DOI 10.1359/JBMR.050814; Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Wysowski DK, 2005, ARCH INTERN MED, V165, P346, DOI 10.1001/archinte.165.3.346-b; Xue DT, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-45	133	98	106	0	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2015	351								h3783	10.1136/bmj.h3783	http://dx.doi.org/10.1136/bmj.h3783			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9JT	26333528				2022-12-28	WOS:000360931400001
J	Sundar, S; Neal, RD; Kehoe, S				Sundar, Sudha; Neal, Richard D.; Kehoe, Sean			Diagnosis of ovarian cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PRIMARY-CARE; COLLABORATIVE TRIAL; ADNEXAL MASSES; WOMEN; RISK; SYMPTOMS; PATIENT; ULTRASOUND; SURVIVAL; MUTATION		[Sundar, Sudha; Kehoe, Sean] Sandwell & West Birmingham Hosp NHS Trust, Pan Birmingham Gynaecol Canc Ctr, Birmingham, W Midlands, England; [Sundar, Sudha; Kehoe, Sean] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Neal, Richard D.] Bangor Univ, North Wales Ctr Primary Care Res, Bangor, Gwynedd, Wales	University of Birmingham; Bangor University	Sundar, S (corresponding author), Sandwell & West Birmingham Hosp NHS Trust, Pan Birmingham Gynaecol Canc Ctr, Birmingham, W Midlands, England.	s.s.sundar@bham.ac.uk		Sundar, Sudha/0000-0002-5843-3015				Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Andersen MR, 2014, OBSTET GYNECOL, V123, P73, DOI 10.1097/AOG.0000000000000051; [Anonymous], 2011, GREEN TOP GUID 62 MA; Candido-dos-Reis FJ, 2015, CLIN CANCER RES, V21, P652, DOI 10.1158/1078-0432.CCR-14-2497; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Ferlay J., 2013, IARC CANCERBASE; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gilbert L, 2012, LANCET ONCOL, V13, P285, DOI 10.1016/S1470-2045(11)70333-3; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Hamilton W, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2998; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952; Lim AW, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0200-y; Lowe KA, 2013, GYNECOL ONCOL, V130, P107, DOI 10.1016/j.ygyno.2013.03.026; Lyratzopoulos G, 2015, BRIT J CANCER, V112, pS35, DOI 10.1038/bjc.2015.40; Lyratzopoulos G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7400; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; Manchanda R, 2012, BJOG-INT J OBSTET GY, V119, P527, DOI 10.1111/j.1471-0528.2011.03257.x; Manchanda R, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju380; Manchanda R, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju379; Maringe C, 2012, GYNECOL ONCOL, V127, P75, DOI 10.1016/j.ygyno.2012.06.033; McAlpine JN, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.003; Menon U, 2015, J CLIN ONCOL, V33, P2062, DOI 10.1200/JCO.2014.59.4945; Moss EL, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-8; National Institute for Health and Care Excellence, 2011, REC IN MAN OV CANC C; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Ness RB, 1999, JNCI-J NATL CANCER I, V91, P1459, DOI 10.1093/jnci/91.17.1459; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Pitts MK, 2011, AUST NZ J OBSTET GYN, V51, P71, DOI 10.1111/j.1479-828X.2010.01284.x; Rai N, 2015, EUR J OBSTET GYN R B, V187, P64, DOI 10.1016/j.ejogrb.2015.02.011; Rosenthal AN, 2012, INT J GYNECOL CANCER, V22, pS27, DOI 10.1097/IGC.0b013e318251cc3f; Royal College of Obstetricians and Gynaecologists, 2015, 48 ROYAL COLL OBST G; Sharma A, 2012, BJOG-INT J OBSTET GY, V119, P207, DOI 10.1111/j.1471-0528.2011.03038.x; Sharma A, 2007, YB OBSTET GYNAECOLOG, P159; Sundar S, 2010, OBSTET GYNAECOLOGY E; Timmerman D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6839; Valentin L, 2013, ULTRASOUND OBST GYN, V41, P80, DOI 10.1002/uog.12308; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wheatley G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3954	39	62	65	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2015	351								h4443	10.1136/bmj.h4443	http://dx.doi.org/10.1136/bmj.h4443			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9JQ	26328593	Green Published			2022-12-28	WOS:000360931100003
J	Tammimies, K; Marshall, CR; Walker, S; Kaur, G; Thiruvahindrapuram, B; Lionel, AC; Yuen, RKC; Uddin, M; Roberts, W; Weksberg, R; Woodbury-Smith, M; Zwaigenbaum, L; Anagnostou, E; Wang, ZZ; Wei, J; Howe, JL; Gazzellone, MJ; Lau, L; Sung, WWL; Whitten, K; Vardy, C; Crosbie, V; Tsang, B; D'Abate, L; Tong, WWL; Luscombe, S; Doyle, T; Carter, MT; Szatmari, P; Stuckless, S; Merico, D; Stavropoulos, DJ; Scherer, SW; Fernandez, BA				Tammimies, Kristiina; Marshall, Christian R.; Walker, Susan; Kaur, Gaganjot; Thiruvahindrapuram, Bhooma; Lionel, Anath C.; Yuen, Ryan K. C.; Uddin, Mohammed; Roberts, Wendy; Weksberg, Rosanna; Woodbury-Smith, Marc; Zwaigenbaum, Lonnie; Anagnostou, Evdokia; Wang, Zhuozhi; Wei, John; Howe, Jennifer L.; Gazzellone, Matthew J.; Lau, Lynette; Sung, Wilson W. L.; Whitten, Kathy; Vardy, Cathy; Crosbie, Victoria; Tsang, Brian; D'Abate, Lia; Tong, Winnie W. L.; Luscombe, Sandra; Doyle, Tyna; Carter, Melissa T.; Szatmari, Peter; Stuckless, Susan; Merico, Daniele; Stavropoulos, Dimitri J.; Scherer, Stephen W.; Fernandez, Bridget A.			Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COPY NUMBER VARIATION; DE-NOVO; MEDICAL GENETICS; AMERICAN-COLLEGE; MUTATIONS; TCF12; INDIVIDUALS; GUIDELINES; STANDARDS; VARIANTS	IMPORTANCE The use of genome-wide tests to provide molecular diagnosis for individuals with autism spectrum disorder (ASD) requires more study. OBJECTIVE To perform chromosomal microarray analysis (CMA) and whole-exome sequencing (WES) in a heterogeneous group of children with ASD to determine the molecular diagnostic yield of these tests in a sample typical of a developmental pediatric clinic. DESIGN, SETTING, AND PARTICIPANTS The sample consisted of 258 consecutively ascertained unrelated children with ASD who underwent detailed assessments to define morphology scores based on the presence of major congenital abnormalities and minor physical anomalies. The children were recruited between 2008 and 2013 in Newfoundland and Labrador, Canada. The probands were stratified into 3 groups of increasing morphological severity: essential, equivocal, and complex (scores of 0-3, 4-5, and >= 6). EXPOSURES All probands underwent CMA, with WES performed for 95 proband-parent trios. MAIN OUTCOMES AND MEASURES The overall molecular diagnostic yield for CMA and WES in a population-based ASD sample stratified in 3 phenotypic groups. RESULTS Of 258 probands, 24 (9.3%, 95% CI, 6.1%-13.5%) received a molecular diagnosis from CMA and 8 of 95 (8.4%, 95% CI, 3.7%-15.9%) from WES. The yields were statistically different between the morphological groups. Among the children who underwent both CMA and WES testing, the estimated proportion with an identifiable genetic etiology was 15.8% (95% CI, 9.1%-24.7%; 15/95 children). This included 2 children who received molecular diagnoses from both tests. The combined yield was significantly higher in the complex group when compared with the essential group (pairwise comparison, P =.002). [Graphics] CONCLUSIONS AND RELEVANCE Among a heterogeneous sample of children with ASD, the molecular diagnostic yields of CMA and WES were comparable, and the combined molecular diagnostic yield was higher in children with more complex morphological phenotypes in comparison with the children in the essential category. If replicated in additional populations, these findings may inform appropriate selection of molecular diagnostic testing for children affected by ASD.	[Tammimies, Kristiina; Marshall, Christian R.; Walker, Susan; Kaur, Gaganjot; Thiruvahindrapuram, Bhooma; Lionel, Anath C.; Yuen, Ryan K. C.; Uddin, Mohammed; Wang, Zhuozhi; Wei, John; Howe, Jennifer L.; Gazzellone, Matthew J.; Lau, Lynette; Sung, Wilson W. L.; Tsang, Brian; D'Abate, Lia; Tong, Winnie W. L.; Merico, Daniele; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Program Genet & Genome Biol, Toronto, ON M5G OA4, Canada; [Tammimies, Kristiina] Karolinska Inst, Ctr Neurodev Disorders KIND, Pediat Neuropsychiat Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Marshall, Christian R.; Lau, Lynette; Stavropoulos, Dimitri J.] Hosp Sick Children, Dept Pediat Lab Med, Genome Diagnost, Toronto, ON M5G OA4, Canada; [Roberts, Wendy] Hosp Sick Children, Autism Res Unit, Toronto, ON M5G OA4, Canada; [Weksberg, Rosanna] Hosp Sick Children, Dept Pediat, Toronto, ON M5G OA4, Canada; [Weksberg, Rosanna] Hosp Sick Children, Genome Biol Program, Toronto, ON M5G OA4, Canada; [Weksberg, Rosanna] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Woodbury-Smith, Marc] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Anagnostou, Evdokia] Bloorview Res Inst, Toronto, ON, Canada; [Whitten, Kathy; Fernandez, Bridget A.] Eastern Hlth, Prov Med Genet Program, St John, NF, Canada; [Vardy, Cathy; Crosbie, Victoria; Luscombe, Sandra; Doyle, Tyna] Eastern Hlth, Child Hlth Program, St John, NF, Canada; [Carter, Melissa T.] Hosp Sick Children, Div Clin & Metab Genet, Dept Pediat, Toronto, ON M5G OA4, Canada; [Szatmari, Peter] Univ Toronto, Hosp Sick Children, Ctr Addict & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Vardy, Cathy; Crosbie, Victoria; Doyle, Tyna] Mem Univ Newfoundland, Discipline Pediat, St John, NF, Canada; [Stuckless, Susan; Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Genet, St John, NF, Canada; [Stuckless, Susan; Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Med, St John, NF, Canada; [Stavropoulos, Dimitri J.] Hosp Sick Children, Cytogenet Lab, Dept Pediat Lab Med, Toronto, ON M5G OA4, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Karolinska Institutet; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McMaster University; University of Alberta; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Hospital for Sick Children (SickKids); Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, Peter Gilgan Ctr Res & Learning, 686 Bay St, Toronto, ON M5G OA4, Canada.	stephen.scherer@sickkids.ca	Scherer, Stephen W./B-3785-2013; Yuen, Ryan K. C./J-4876-2012	Scherer, Stephen W./0000-0002-8326-1999; Yuen, Ryan K. C./0000-0001-7273-4968; Uddin, Mohammed/0000-0001-6867-5803; Tammimies, Kristiina/0000-0002-8324-4697; Woodbury-Smith, Marc/0000-0002-0593-8917; Sung, Wilson/0000-0002-4703-5118; Merico, Daniele/0000-0002-3728-4401	Autism Speaks; Autism Speaks Canada; NeuroDevNet; Canadian Institute for Advanced Research; University of Toronto McLaughlin Centre; Genome Canada; Ontario Genomics Institute; government of Ontario; Canadian Institutes of Health Research; Ontario Brain Institute; Hospital for Sick Children Foundation; Janeway Research Foundation; Swedish Research Council	Autism Speaks; Autism Speaks Canada; NeuroDevNet; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); University of Toronto McLaughlin Centre; Genome Canada(Genome Canada); Ontario Genomics Institute; government of Ontario; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Brain Institute; Hospital for Sick Children Foundation; Janeway Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Autism Speaks (Drs Scherer and Yuen), Autism Speaks Canada (Dr Scherer), NeuroDevNet (Dr Scherer), the Canadian Institute for Advanced Research (Dr Scherer), the University of Toronto McLaughlin Centre (Dr Scherer), Genome Canada and Ontario Genomics Institute (Dr Scherer), the government of Ontario (Drs Scherer and Szatmari), the Canadian Institutes of Health Research (Drs Scherer and Szatmari), the Ontario Brain Institute (Drs Anagnostou and Scherer), The Hospital for Sick Children Foundation (Dr Scherer), and the Janeway Research Foundation (Dr Fernandez). Dr Tammimies holds a fellowship from the Swedish Research Council.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anagnostou E, 2014, CAN MED ASSOC J, V186, P509, DOI 10.1503/cmaj.121756; Baker E, 2015, PEDIATR CLIN N AM, V62, P607, DOI 10.1016/j.pcl.2015.03.003; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Centers for Disease Control and Prevention (CDC), 2010, PREV AUT SPECTR DIS; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; di Rocco F, 2014, EUR J HUM GENET, V22, P1413, DOI 10.1038/ejhg.2014.57; Gazzellone MJ, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-34; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Hall Judith G., 2007, HDB PHYS MEASUREMENT; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lionel AC, 2014, HUM MOL GENET, V23, P2752, DOI 10.1093/hmg/ddt669; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Liu XQ, 2008, BIOL PSYCHIAT, V64, P561, DOI 10.1016/j.biopsych.2008.05.023; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Manouilenko Irina, 2014, Autism Res Treat, V2014, P743482, DOI 10.1155/2014/743482; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Marshall CR, 2012, METHODS MOL BIOL, V838, P115, DOI 10.1007/978-1-61779-507-7_5; McGrew SG, 2012, J AUTISM DEV DISORD, V42, P1582, DOI 10.1007/s10803-011-1398-3; Miles JH, 2005, AM J MED GENET A, V135A, P171, DOI 10.1002/ajmg.a.30590; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Narcisa V, 2013, CLIN PEDIATR, V52, P139, DOI 10.1177/0009922812466583; Ozgen HM, 2010, MOL PSYCHIATR, V15, P300, DOI 10.1038/mp.2008.75; Paumard-Hernandez B, 2015, EUR J HUM GENET, V23, P907, DOI 10.1038/ejhg.2014.205; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Piven J, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-30; Pyott SM, 2013, AM J HUM GENET, V92, P590, DOI 10.1016/j.ajhg.2013.02.009; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson EB, 2014, P NATL ACAD SCI USA, V111, P15161, DOI 10.1073/pnas.1409204111; Rosti RO, 2014, DEV MED CHILD NEUROL, V56, P12, DOI 10.1111/dmcn.12278; Scherer SW, 2011, HUM GENET, V130, P123, DOI 10.1007/s00439-011-1037-2; Sharma VP, 2013, NAT GENET, V45, P304, DOI 10.1038/ng.2531; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Trottier M, 2013, J AUTISM DEV DISORD, V43, P556, DOI 10.1007/s10803-012-1592-y; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; Wong VCN, 2014, J AUTISM DEV DISORD, V44, P9, DOI 10.1007/s10803-013-1846-3; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792	49	241	243	2	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					895	903		10.1001/jama.2015.10078	http://dx.doi.org/10.1001/jama.2015.10078			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325558	Bronze			2022-12-28	WOS:000360392100016
J	Amstad, E; Gopinadhan, M; Holtze, C; Osuji, CO; Brenner, MP; Spaepen, F; Weitz, DA				Amstad, Esther; Gopinadhan, Manesh; Holtze, Christian; Osuji, Chinedum O.; Brenner, Michael P.; Spaepen, Frans; Weitz, David A.			Production of amorphous nanoparticles by supersonic spray-drying with a microfluidic nebulator	SCIENCE			English	Article							CEFUROXIME AXETIL NANOPARTICLES; WATER-SOLUBLE DRUGS; BIOAVAILABILITY; STABILIZATION; DRYER; ENHANCEMENT; PARTICLES; STABILITY; DESIGN; ENERGY	Amorphous nanoparticles (a-NPs) have physicochemical properties distinctly different from those of the corresponding bulk crystals; for example, their solubility is much higher. However, many materials have a high propensity to crystallize and are difficult to formulate in an amorphous structure without stabilizers. We fabricated a microfluidic nebulator that can produce amorphous NPs from a wide range of materials, even including pure table salt (NaCl). By using supersonic air flow, the nebulator produces drops that are so small that they dry before crystal nuclei can form. The small size of the resulting spray-dried a-NPs limits the probability of crystal nucleation in any given particle during storage. The kinetic stability of the a-NPs-on the order of months-is advantageous for hydrophobic drug molecules.	[Amstad, Esther; Brenner, Michael P.; Spaepen, Frans; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Amstad, Esther] Ecole Polytech Fed Lausanne, Inst Mat, Lausanne, Switzerland; [Gopinadhan, Manesh; Osuji, Chinedum O.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT USA; [Holtze, Christian] BASF SE, D-67056 Ludwigshafen, Germany; [Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Yale University; BASF; Harvard University	Weitz, DA (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	weitz@seas.harvard.edu	Amstad, Esther/O-3587-2016	Amstad, Esther/0000-0002-9491-1010; Osuji, Chinedum/0000-0003-0261-3065; Gopinadhan, Manesh/0000-0001-8452-6613	BASF SE; NSF [DMR-1310266, DMS-1411694, ECS-0335765]; Harvard MRSEC [DMR-1420570]; Direct For Mathematical & Physical Scien [1310266] Funding Source: National Science Foundation	BASF SE(BASF); NSF(National Science Foundation (NSF)); Harvard MRSEC(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge support from BASF SE, NSF grants DMR-1310266 and DMS-1411694, and Harvard MRSEC grant DMR-1420570. M.P.B. is an investigator of the Simons Foundation. Part of this work was performed at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network, supported by NSF award no. ECS-0335765. CNS is part of Harvard University. We thank D. C. Bell for acquiring the EDS images and L. R. Arriaga and D. M. Aubrecht for helpful discussions. Patent applications have been filed to cover the nebulator device (PCT/US2013/060522) and the production of a-NPs (PCT/US2014/062785). Additional data discussed in the main text are available in the supplementary materials. E.A. conducted the experiments; M.G. performed the SAXS experiments and analysis; E.A., F.S., and D.A.W. did the calculations and wrote the paper; and all the authors contributed to the design and analysis of the experiments.	Arpagaus C, 2012, DRY TECHNOL, V30, P1113, DOI 10.1080/07373937.2012.686949; Burki K, 2011, INT J PHARMACEUT, V408, P248, DOI 10.1016/j.ijpharm.2011.02.012; Dhumal RS, 2008, EUR J PHARM BIOPHARM, V70, P109, DOI 10.1016/j.ejpb.2008.04.001; Greer AL, 2015, NAT MATER, V14, P542, DOI 10.1038/nmat4292; Guo P, 2013, NANOMEDICINE-UK, V8, P333, DOI [10.2217/NNM.12.119, 10.2217/nnm.12.119]; Hancock BC, 2000, PHARM RES-DORDR, V17, P397, DOI 10.1023/A:1007516718048; Harsha S, 2013, DRUG DES DEV THER, V7, P1027, DOI 10.2147/DDDT.S39956; Harsha Sree N, 2015, Drug Des Devel Ther, V9, P273, DOI 10.2147/DDDT.S66654; Kawabata Y, 2011, INT J PHARMACEUT, V420, P1, DOI 10.1016/j.ijpharm.2011.08.032; Kelton K. F, 2010, NUCL CONDENSED MATTE; Kesisoglou F, 2007, ADV DRUG DELIVER REV, V59, P631, DOI 10.1016/j.addr.2007.05.003; Kim JS, 2008, INT J PHARMACEUT, V359, P211, DOI 10.1016/j.ijpharm.2008.04.006; KIM YW, 1989, ACTA METALL MATER, V37, P247, DOI 10.1016/0001-6160(89)90283-6; Laitinen R, 2013, INT J PHARMACEUT, V453, P65, DOI 10.1016/j.ijpharm.2012.04.066; Landstrom L, 2004, J APPL PHYS, V95, P4408, DOI 10.1063/1.1667596; Law D, 2003, J PHARM SCI-US, V92, P505, DOI 10.1002/jps.10324; Li XA, 2010, J CONTROL RELEASE, V147, P304, DOI 10.1016/j.jconrel.2010.07.113; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Lu PJ, 2008, NATURE, V453, P499, DOI 10.1038/nature06931; Martena V, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0934-1; Matteucci ME, 2007, MOL PHARMACEUT, V4, P782, DOI 10.1021/mp0700211; Matteucci ME, 2006, LANGMUIR, V22, P8951, DOI 10.1021/la061122t; Nahtigal IG, 2009, J PHYS CHEM B, V113, P14681, DOI 10.1021/jp9039572; Ng YC, 2013, EUR J PHARM BIOPHARM, V84, P555, DOI 10.1016/j.ejpb.2013.01.008; Overhoff KA, 2007, EUR J PHARM BIOPHARM, V65, P57, DOI 10.1016/j.ejpb.2006.07.012; PAGE JH, 1995, PHYS REV E, V52, P2763, DOI 10.1103/PhysRevE.52.2763; Rotem A, 2012, LAB CHIP, V12, P4263, DOI 10.1039/c2lc40546f; Tavakoli AH, 2013, J PHYS CHEM C, V117, P17123, DOI 10.1021/jp405820g; Thiele J, 2011, LAB CHIP, V11, P2362, DOI 10.1039/c1lc20298g; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yang W, 2008, INT J PHARMACEUT, V361, P177, DOI 10.1016/j.ijpharm.2008.05.003; Yu L, 2011, MATER CHEM PHYS, V130, P361, DOI 10.1016/j.matchemphys.2011.06.049; Zhu WZ, 2010, INT J PHARMACEUT, V395, P260, DOI 10.1016/j.ijpharm.2010.05.018	34	87	90	6	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					956	960		10.1126/science.aac9582	http://dx.doi.org/10.1126/science.aac9582			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315432				2022-12-28	WOS:000360646800048
J	Zheng, MH; Shi, KQ; Chen, YP				Zheng, Ming-Hua; Shi, Ke-Qing; Chen, Yong-Ping			Skin lesion in a critically ill man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCRUB TYPHUS; ORIENTIA-TSUTSUGAMUSHI; CLINICAL PROFILE; DIAGNOSIS; RISK; PCR; PREDICTORS; HUMANS; ASSAY		[Zheng, Ming-Hua; Shi, Ke-Qing; Chen, Yong-Ping] Wenzhou Med Univ, Affiliated Hosp 1, Dept Infect & Liver Dis, Liver Res Ctr, Wenzhou 325000, Peoples R China	Wenzhou Medical University	Zheng, MH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Infect & Liver Dis, Liver Res Ctr, Wenzhou 325000, Peoples R China.	zhengmh@wmu.edu.cn	Shi, Keqing/GZK-5146-2022; Shi, KeQing/A-3411-2009; Zheng, Ming-Hua/H-5584-2019	Shi, Keqing/0000-0002-5070-3834; Shi, KeQing/0000-0002-5070-3834; Zheng, Ming-Hua/0000-0003-4984-2631				AMANO K, 1992, ACTA VIROL, V36, P67; Blacksell SD, 2007, CLIN INFECT DIS, V44, P391, DOI 10.1086/510585; Chang K, 2014, J MICROBIOL IMMUNOL; Chrispal A, 2010, TROP DOCT, V40, P129, DOI 10.1258/td.2010.090452; Fournier PE, 2008, CLIN MICROBIOL INFEC, V14, P168, DOI 10.1111/j.1469-0691.2007.01889.x; Isaac R, 2004, CLIN INFECT DIS, V39, P1395, DOI 10.1086/424748; Janardhanan J, 2014, DIAGN MICR INFEC DIS, V79, P7, DOI 10.1016/j.diagmicrobio.2013.11.030; Jang WJ, 2003, CLIN DIAGN LAB IMMUN, V10, P394, DOI 10.1128/CDLI.10.3.394-398.2003; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kim DM, 2007, AM J TROP MED HYG, V76, P806; Kim DM, 2011, J CLIN MICROBIOL, V49, P607, DOI 10.1128/JCM.01216-09; Kim DM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-108; LANGE WR, 1992, AM FAM PHYSICIAN, V45, P1161; Lee CS, 2009, AM J TROP MED HYG, V81, P484, DOI 10.4269/ajtmh.2009.81.484; Paris DH, 2009, CLIN MICROBIOL INFEC, V15, P488, DOI 10.1111/j.1469-0691.2008.02671.x; Park SW, 2011, AM J TROP MED HYG, V85, P924, DOI 10.4269/ajtmh.2011.11-0134; Parola P, 2008, EMERG INFECT DIS, V14, P1483, DOI 10.3201/eid1409.071259; Prakash JAJ, 2006, TROP DOCT, V36, P212, DOI 10.1258/004947506778604715; Rajapakse S, 2012, ASIAN PAC J TROP MED, V5, P261, DOI 10.1016/S1995-7645(12)60036-4; ROBINSON DM, 1976, AM J TROP MED HYG, V25, P900, DOI 10.4269/ajtmh.1976.25.900; Sirisanthana V, 2003, PEDIATR INFECT DIS J, V22, P341, DOI 10.1097/00006454-200304000-00010; Sriwongpan P, 2014, RISK MANAG HEALTHC P, V7, P11, DOI [10.2147/RMHP.S55305, 10.2147/RMHP.S52470]; Varghese GM, 2014, INT J INFECT DIS, V23, P39, DOI 10.1016/j.ijid.2014.02.009; Watt G, 2003, CURR OPIN INFECT DIS, V16, P429, DOI 10.1097/00001432-200310000-00009; Watthanaworawit W, 2013, AM J TROP MED HYG, V89, P308, DOI 10.4269/ajtmh.12-0600; Zhang WY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002493	26	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2015	351								h4570	10.1136/bmj.h4570	http://dx.doi.org/10.1136/bmj.h4570			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2NX	26318374				2022-12-28	WOS:000360439100007
J	Yoneda, H; Inubushi, Y; Nagamine, K; Michine, Y; Ohashi, H; Yumoto, H; Yamauchi, K; Mimura, H; Kitamura, H; Katayama, T; Ishikawa, T; Yabashi, M				Yoneda, Hitoki; Inubushi, Yuichi; Nagamine, Kazunori; Michine, Yurina; Ohashi, Haruhiko; Yumoto, Hirokatsu; Yamauchi, Kazuto; Mimura, Hidekazu; Kitamura, Hikaru; Katayama, Tetsuo; Ishikawa, Tetsuya; Yabashi, Makina			Atomic inner-shell laser at 1.5-angstrom wavelength pumped by an X-ray free-electron laser	NATURE			English	Article							EMISSION; PLASMA; ABSORPTION	Since the invention of the first lasers in the visible-light region, research has aimed to produce short-wavelength lasers that generate coherent X-rays(1,2); the shorter the wavelength, the better the imaging resolution of the laser and the shorter the pulse duration, leading to better temporal resolution in probe measurements. Recently, free-electron lasers based on self-amplified spontaneous emission(3,4) have made it possible to generate a hard-X-ray laser (that is, the photon energy is of the order of ten kiloelectronvolts) in anngstrom-wavelength regime(5,6), enabling advances in fields from ultrafast X-ray spectrosopy to X-ray quantum optics. An atomic laser based on neon atoms and pumped by a soft-X-ray (that is, a photon energy of less than one kiloelectronvolt) free-electron laser has been achieved at a wavelength of 14 nanometres7. Here, we use a copper target and report a hard-X-ray inner-shell atomic laser operating at a wavelength of 1.5 angstroms. X-ray free-electron laser pulses with an intensity of about 10(19) watts per square centimetre(7,8) tuned to the copper K-absorption edge produced sufficient population inversion to generate strong amplified spontaneous emission on the copper Ka lines. Furthermore, we operated the X-ray free-electron laser source in a two-colour mode(9), with one colour tuned for pumping and the other for the seed (starting) light for the laser.	[Yoneda, Hitoki; Nagamine, Kazunori; Michine, Yurina] Univ Electrocommun, Inst Laser Sci, Chofu, Tokyo 1828585, Japan; [Yoneda, Hitoki; Inubushi, Yuichi; Ohashi, Haruhiko; Yamauchi, Kazuto; Mimura, Hidekazu; Ishikawa, Tetsuya; Yabashi, Makina] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Inubushi, Yuichi; Ohashi, Haruhiko; Yumoto, Hirokatsu; Katayama, Tetsuo] Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795198, Japan; [Yamauchi, Kazuto] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Mimura, Hidekazu] Univ Tokyo, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Kitamura, Hikaru] Kyoto Univ, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan	University of Electro-Communications - Japan; RIKEN; Japan Synchrotron Radiation Research Institute; Osaka University; University of Tokyo; Kyoto University	Yoneda, H (corresponding author), Univ Electrocommun, Inst Laser Sci, Chofu, Tokyo 1828585, Japan.	yoneda@ils.uec.ac.jp	Ishikawa, Tetsuya/I-4775-2012; Yabashi, Makina/A-2832-2015	Ishikawa, Tetsuya/0000-0002-6906-9909; Yabashi, Makina/0000-0002-2472-1684; Inubushi, Yuichi/0000-0003-1608-3819	Photon Frontier Network Program; Global COE Program 'Center of Excellence for Atomically Controlled Fabrication Technology' from the Ministry of Education, Sports, Culture, Science and Technology, Japan (MEXT);  [2012B8014];  [2013A8013];  [2013B8020];  [2014A8008];  [25247093];  [23226004]; Grants-in-Aid for Scientific Research [23226004] Funding Source: KAKEN	Photon Frontier Network Program; Global COE Program 'Center of Excellence for Atomically Controlled Fabrication Technology' from the Ministry of Education, Sports, Culture, Science and Technology, Japan (MEXT); ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The experiment was performed at SACLA with the approval of JASRI and the program review committee (grant numbers 2012B8014, 2013A8013, 2013B8020, 2014A8008). We acknowledge the supporting members of the SACLA facility. This research was partially supported by Grant-in-Aids for Scientific Research (A) (25247093) and (S) (23226004), by the Photon Frontier Network Program and by the Global COE Program 'Center of Excellence for Atomically Controlled Fabrication Technology' from the Ministry of Education, Sports, Culture, Science and Technology, Japan (MEXT).	Beye M, 2013, NATURE, V501, P191, DOI 10.1038/nature12449; BONIFACIO R, 1984, OPT COMMUN, V50, P373, DOI 10.1016/0030-4018(84)90105-6; Cho BI, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.245003; Ciricosta O, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.065002; DEUTSCH M, 1995, PHYS REV A, V51, P283, DOI 10.1103/PhysRevA.51.283; DEUTSCH M, 1982, PHYS REV B, V26, P5558, DOI 10.1103/PhysRevB.26.5558; DUGUAY MA, 1967, APPL PHYS LETT, V10, P350, DOI 10.1063/1.1728208; Elton R., 1990, XRAY LASERS; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Glover TE, 2012, NATURE, V488, P603, DOI 10.1038/nature11340; Hara T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3919; Inubushi Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.144801; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Kameshima T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867668; KAPTEYN HC, 1986, PHYS REV LETT, V57, P2939, DOI 10.1103/PhysRevLett.57.2939; Kondratenko A. M., 1980, PART ACCEL, V10, P207; MATTHEWS DL, 1985, PHYS REV LETT, V54, P110, DOI 10.1103/PhysRevLett.54.110; Mimura H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4539; Rackstraw DS, 2014, HIGH ENERG DENS PHYS, V11, P59, DOI 10.1016/j.hedp.2014.02.003; Rohringer N, 2012, NATURE, V481, P488, DOI 10.1038/nature10721; Shwartz S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.163901; SUCKEWER S, 1985, PHYS REV LETT, V55, P1753, DOI 10.1103/PhysRevLett.55.1753; Suckewer S, 2009, LASER PHYS LETT, V6, P411, DOI 10.1002/lapl.200910023; Tamasaku K, 2014, NAT PHOTONICS, V8, P313, DOI [10.1038/NPHOTON.2014.10, 10.1038/nphoton.2014.10]; Tono K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083035; Vinko SM, 2012, NATURE, V482, P59, DOI 10.1038/nature10746; Yoneda H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6080; Young L, 2010, NATURE, V466, P56, DOI 10.1038/nature09177	28	95	95	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					446	+		10.1038/nature14894	http://dx.doi.org/10.1038/nature14894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26310765				2022-12-28	WOS:000360069300033
J	Cunningham, AS				Cunningham, Allan S.			PERSONAL VIEW Vaccine mandates in the US are doing more harm than good	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												crabarbicus62@gmail.com						Busby C, 2015, CD HOWE I COMMENTARY; Centers for Disease Control and Prevention, ROT VACC ROTASHIELD; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P549; Crowcroft NS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h308; Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P741; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Gostin LO, 2015, JAMA-J AM MED ASSOC, V313, P1099, DOI 10.1001/jama.2015.1518; HILL AB, 1950, BRIT MED J, V2, pU6; Orenstein WA, 2004, J INFECT DIS, V189, pS1, DOI 10.1086/377693; Rhode Island Department of Health, 2014, SUMM IMM REQ CHANG; Skowronski DM, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.4.21022; Worboys Michael, 2007, BMJ, V334 Suppl 1, ps19, DOI 10.1136/bmj.39045.558889.94	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2015	351								h4576	10.1136/bmj.h4576	http://dx.doi.org/10.1136/bmj.h4576			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2NJ	26311688				2022-12-28	WOS:000360437600002
J	Bolkan, HA; Hagander, L; von Schreeb, J; Bash-Taqi, D; Kamara, TB; Salvesen, O; Wibe, A				Bolkan, Hakon A.; Hagander, Lars; von Schreeb, Johan; Bash-Taqi, Donald; Kamara, Thaim B.; Salvesen, Oyvind; Wibe, Arne			Who is performing surgery in low-income settings: a countrywide inventory of the surgical workforce distribution and scope of practice in Sierra Leone	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Bolkan, Hakon A.; Salvesen, Oyvind; Wibe, Arne] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Bolkan, Hakon A.; Wibe, Arne] CapaCare, Trondheim, Norway; [Bolkan, Hakon A.; Wibe, Arne] Univ Trondheim Hosp, Dept Surg, St Olavs Hosp, Trondheim, Norway; [Hagander, Lars] Lund Univ, Childrens Hosp, Fac Med, Dept Clin Sci Paediat Surg & Global Paediat, Lund, Sweden; [von Schreeb, Johan] Karolinska Inst, Hlth Syst & Policy Res Grp, Stockholm, Sweden; [Bash-Taqi, Donald] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Kamara, Thaim B.] Connaught Hosp, Dept Surg, Freetown, Sierra Leone	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Lund University; Karolinska Institutet; Ministry of Health & Sanitation Sierra Leone; Connaught Hospital		hakon.bolkan@capacare.org							0	5	5	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			44	44		10.1016/S0140-6736(15)60839-X	http://dx.doi.org/10.1016/S0140-6736(15)60839-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313093	Bronze			2022-12-28	WOS:000360573400045
J	Jackson, T; Thomas, S; Stabile, V; Han, X; Shotwell, M; McQueen, K				Jackson, Tracy; Thomas, Sarah; Stabile, Victoria; Han, Xue; Shotwell, Matthew; McQueen, Kelly			Prevalence of chronic pain in low-income and middle-income countries: a systematic review and meta-analysis	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Jackson, Tracy; McQueen, Kelly] Vanderbilt Univ, Anesthesiol, Nashville, TN 37204 USA; [Han, Xue; Shotwell, Matthew] Vanderbilt Univ, Sch Med, Nashville, TN 37204 USA; [Thomas, Sarah] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Stabile, Victoria] Operat Smile Int, Virginia Beach, VA USA	Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center		tracy.jackson@vanderbilt.edu							0	95	106	1	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			10	10		10.1016/S0140-6736(15)60805-4	http://dx.doi.org/10.1016/S0140-6736(15)60805-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313056	Bronze			2022-12-28	WOS:000360573400011
J	Bhandari, S; Gupta, P; Quinn, P; Sandhu, J; Hakimi, A; Jones, D; Ng, L				Bhandari, Sanjay; Gupta, Pankaj; Quinn, Paulene; Sandhu, Jatinderpal; Hakimi, Amirmansoor; Jones, Donald; Ng, Leong			Pleiotropic effects of statins in hypercholesterolaemia: a prospective observational study using a lipoproteomic based approach	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Bhandari, Sanjay; Gupta, Pankaj; Quinn, Paulene; Sandhu, Jatinderpal; Hakimi, Amirmansoor; Jones, Donald; Ng, Leong] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Bhandari, Sanjay; Quinn, Paulene; Sandhu, Jatinderpal; Hakimi, Amirmansoor; Jones, Donald; Ng, Leong] Univ Leicester, NIHR Leicester Cardiovasc Biomed Res Unit, Glenfi eld Hosp, Leicester LE3 9QP, Leics, England; [Gupta, Pankaj] Univ Hosp Leicester NHS Trust, Dept Chem Pathol, Leicester, Leics, England; [Jones, Donald] Univ Leicester, Dept Canc Studies & Mol Med, Leicester Royal Infirm, Leicester LE3 9QP, Leics, England	University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester		sanjay1bhandari@hotmail.com	Jones, Donald/Y-6803-2019	Jones, Donald/0000-0001-6583-870X; Ng, Leong/0000-0002-6553-5749					0	18	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			21	21		10.1016/S0140-6736(15)60336-1	http://dx.doi.org/10.1016/S0140-6736(15)60336-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312843	Bronze			2022-12-28	WOS:000360570500021
J	Shaikh, S; Noshirwani, A; West, N; Perry, S; Jayne, D				Shaikh, Shafaque; Noshirwani, Arish; West, Nicholas; Perry, Sarah; Jayne, David			Can macrophages within the microenvironment of locally invasive rectal cancers predict response to radiotherapy?	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Shaikh, Shafaque; Noshirwani, Arish; West, Nicholas; Perry, Sarah; Jayne, David] Univ Leeds, Leeds LS9 7TF, W Yorkshire, England	University of Leeds		s.shaikh@leeds.ac.uk	Shaikh, Shafaque/L-2230-2016	Shaikh, Shafaque/0000-0002-4536-9595; West, Nicholas/0000-0002-0346-6709	National Institute for Health Research [CL-2010-02-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	15	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			87	87		10.1016/S0140-6736(15)60402-0	http://dx.doi.org/10.1016/S0140-6736(15)60402-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312909				2022-12-28	WOS:000360570500087
J	Elledge, SJ				Elledge, Stephen J.			The DNA Damage Response-Self-awareness for DNA The 2015 Albert Lasker Basic Medical Research Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELLS		[Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, NRB, 77 Ave Louis Pasteur,Room 158D, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu						Cerbonil C, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00508; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Janion C, 2008, INT J BIOL SCI, V4, P338; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193	7	11	12	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1111	1112		10.1001/jama.2015.10387	http://dx.doi.org/10.1001/jama.2015.10387			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26348099	Bronze			2022-12-28	WOS:000361284500010
J	Bever, GS; Lyson, TR; Field, DJ; Bhullar, BAS				Bever, G. S.; Lyson, Tyler R.; Field, Daniel J.; Bhullar, Bhart-Anjan S.			Evolutionary origin of the turtle skull	NATURE			English	Article							PERMIAN REPTILE; PHYLOGENY; PALEOECOLOGY; INSIGHTS	Transitional fossils informing the origin of turtles are among the most sought-after discoveries in palaeontology(1-5). Despite strong genomic evidence indicating that turtles evolved from within the diapsid radiation (which includes all other living reptiles(6,7)), evidence of the inferred transformation between an ancestral turtle with an open, diapsid skull to the closed, anapsid condition of modern turtles remains elusive. Here we use high-resolution computed tomography and a novel character/taxon matrix to study the skull of Eunotosaurus africanus, a 260-million-year-old fossil reptile from the Karoo Basin of South Africa, whose distinctive post-cranial skeleton shares many unique features with the shelled body plan of turtles(2-4). Scepticism regarding the status of Eunotosaurus as the earliest stem turtle arises from the possibility that these shell-related features are the products of evolutionary convergence. Our phylogenetic analyses indicate strong cranial support for Eunotosaurus as a critical transitional form in turtle evolution, thus fortifying a 40-million-year extension to the turtle stem and moving the ecological context of its origin back onto land(8,9). Furthermore, we find unexpected evidence that Eunotosaurus is a diapsid reptile in the process of becoming secondarily anapsid. This is important because categorizing the skull based on the number of openings in the complex of dermal bone covering the adductor chamber has long held sway in amniote systematics(10), and still represents a common organizational scheme for teaching the evolutionary history of the group. These discoveries allow us to articulate a detailed and testable hypothesis of fenestral closure represents a crucially important link in a chain that will eventually lead to consilience in reptile systematics, paving the way for synthetic studies of amniote evolution and development.	[Bever, G. S.] New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Bever, G. S.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Bever, G. S.; Lyson, Tyler R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Lyson, Tyler R.] Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO 80205 USA; [Field, Daniel J.; Bhullar, Bhart-Anjan S.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Field, Daniel J.; Bhullar, Bhart-Anjan S.] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA; [Bhullar, Bhart-Anjan S.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	New York Institute Technology; American Museum of Natural History (AMNH); University of Witwatersrand; Yale University; Yale University; University of Chicago	Bever, GS (corresponding author), New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA.	gbever@nyit.edu		Field, Daniel/0000-0002-1786-0352	Division Of Earth Sciences [1258878] Funding Source: National Science Foundation; Division Of Environmental Biology [1500798] Funding Source: National Science Foundation	Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Bever GS, 2011, EVOL DEV, V13, P269, DOI 10.1111/j.1525-142X.2011.00478.x; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Bhullar Bhart-Anjan S., 2009, Breviora, V518, P1, DOI 10.3099/0006-9698-518.1.1; Bickelmann C, 2009, CAN J EARTH SCI, V46, P651, DOI 10.1139/E09-038; COX CB, 1969, B BRIT MUS NAT HIST, V18, P165; Cundall David, 2008, Contributions to Herpetology, V23, P349; Day M, 2013, S AFR J SCI, V109, P68, DOI 10.1590/sajs.2013/20120030; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Field DJ, 2014, EVOL DEV, V16, P189, DOI 10.1111/ede.12081; GAFFNEY ES, 1990, B AM MUS NAT HIST, P5; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gow Chris E., 1997, Palaeontologia Africana, V34, P33; Joyce WG, 2004, P ROY SOC B-BIOL SCI, V271, P1, DOI 10.1098/rspb.2003.2523; KEYSER AW, 1981, S AFR J SCI, V77, P417; Lee MSY, 2013, J EVOLUTION BIOL, V26, P2729, DOI 10.1111/jeb.12268; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Lyson TR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6211; Lyson TR, 2013, EVOL DEV, V15, P317, DOI 10.1111/ede.12041; Lyson TR, 2013, CURR BIOL, V23, P1113, DOI 10.1016/j.cub.2013.05.003; Lyson TR, 2010, BIOL LETTERS, V6, P830, DOI 10.1098/rsbl.2010.0371; M?ller J., 2004, RECENT ADV ORIGIN EA, P379; Maisano JA, 2002, J VERTEBR PALEONTOL, V22, P268, DOI 10.1671/0272-4634(2002)022[0268:TFOSEA]2.0.CO;2; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Muller J, 2003, NATURWISSENSCHAFTEN, V90, P473, DOI 10.1007/s00114-003-0461-0; Pineiro G, 2012, CR PALEVOL, V11, P379, DOI 10.1016/j.crpv.2012.02.001; Reisz R. R., 1981, DIAPSID REPTILE PENN; Reisz RR, 2011, P ROY SOC B-BIOL SCI, V278, P3731, DOI 10.1098/rspb.2011.0439; RIEPPEL O, 1987, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V195, P101; Romer A, 1956, OSTEOLOGY REPTILES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheyer TM, 2007, P ROY SOC B-BIOL SCI, V274, P1885, DOI 10.1098/rspb.2007.0499; Schoch RR, 2015, NATURE, V523, P584, DOI 10.1038/nature14472; Tsuji LA, 2009, FOSS REC, V12, P71, DOI 10.1002/mmng.200800011; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; Werneburg I, 2012, J EXP ZOOL PART B, V318B, P235, DOI 10.1002/jez.b.22450	37	65	65	2	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					239	+		10.1038/nature14900	http://dx.doi.org/10.1038/nature14900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26331544				2022-12-28	WOS:000360927400036
J	Kiermaier, E; Sixt, M				Kiermaier, E.; Sixt, M.			Fragmented communication between immune cells	SCIENCE			English	Editorial Material							NEUTROPHILS; INNATE		[Kiermaier, E.; Sixt, M.] Inst Sci & Technol Austria IST Austria, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Kiermaier, E (corresponding author), Inst Sci & Technol Austria IST Austria, A-3400 Klosterneuburg, Austria.	sixt@ist.ac.at		Kiermaier, Eva/0000-0001-6165-5738; Sixt, Michael/0000-0002-6620-9179				Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062	6	3	3	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1055	1056		10.1126/science.aad0867	http://dx.doi.org/10.1126/science.aad0867			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339015				2022-12-28	WOS:000360628900020
J	Kuzmina, M; Herbig, M; Ponge, D; Sandlobes, S; Raabe, D				Kuzmina, M.; Herbig, M.; Ponge, D.; Sandloebes, S.; Raabe, D.			Linear complexions: Confined chemical and structural states at dislocations	SCIENCE			English	Article							ATOM-PROBE TOMOGRAPHY; TRANSMISSION ELECTRON-MICROSCOPY; GRAIN-BOUNDARY TRANSITIONS; PHASE-TRANSFORMATION; SEGREGATION; NUCLEATION; ALLOYS; PRECIPITATION; MARTENSITE; INTERFACES	For 5000 years, metals have been mankind's most essential materials owing to their ductility and strength. Linear defects called dislocations carry atomic shear steps, enabling their formability. We report chemical and structural states confined at dislocations. In a body-centered cubic Fe-9 atomic percent Mn alloy, we found Mn segregation at dislocation cores during heating, followed by formation of face-centered cubic regions but no further growth. The regions are in equilibrium with the matrix and remain confined to the dislocation cores with coherent interfaces. The phenomenon resembles interface-stabilized structural states called complexions. A cubic meter of strained alloy contains up to a light year of dislocation length, suggesting that linear complexions could provide opportunities to nanostructure alloys via segregation and confined structural states.	[Kuzmina, M.; Herbig, M.; Ponge, D.; Sandloebes, S.; Raabe, D.] Max Planck Inst Eisenforsch GmbH, D-40237 Dusseldorf, Germany	Max Planck Society	Raabe, D (corresponding author), Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, D-40237 Dusseldorf, Germany.	raabe@mpie.de	Herbig, Michael/O-1063-2013; Raabe, Dierk/A-6470-2009	Herbig, Michael/0000-0001-9561-6139; Raabe, Dierk/0000-0003-0194-6124	European Union under European Research Council; German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)] [SFB 761]	European Union under European Research Council; German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)](German Research Foundation (DFG))	The authors gratefully acknowledge funding by the European Union, provided under the 7th Framework Programme through the European Research Council Advanced Grant SMARTMET. M.H. is grateful to the German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)] for funding through SFB 761 "Steel Ab Initio." Data are available in the main text and the supplementary materials.	Arslan I, 2008, ULTRAMICROSCOPY, V108, P1579, DOI 10.1016/j.ultramic.2008.05.008; Baram M, 2011, SCIENCE, V332, P206, DOI 10.1126/science.1201596; BULLOUGH R, 1956, P PHYS SOC LOND B, V69, P1276, DOI 10.1088/0370-1301/69/12/311; CAHN JW, 1957, ACTA METALL MATER, V5, P169, DOI 10.1016/0001-6160(57)90021-4; Cantwell PR, 2014, ACTA MATER, V62, P1, DOI 10.1016/j.actamat.2013.07.037; Dillon SJ, 2007, ACTA MATER, V55, P6208, DOI 10.1016/j.actamat.2007.07.029; Dillon SJ, 2007, ACTA MATER, V55, P5247, DOI 10.1016/j.actamat.2007.04.051; Easterling K. E., 1975, ACTA METALL, V24, P333; Frolov T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.255502; Frolov T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2919; Furuhara T, 2001, MAT SCI ENG A-STRUCT, V312, P145, DOI 10.1016/S0921-5093(00)01904-3; Guo W, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.035501; Harmer MP, 2011, SCIENCE, V332, P182, DOI 10.1126/science.1204204; Hellman OC, 2000, MICROSC MICROANAL, V6, P437, DOI 10.1007/s100050010051; Herbig M, 2015, ULTRAMICROSCOPY, V153, P32, DOI 10.1016/j.ultramic.2015.02.003; Herbig M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.126103; Kaplan WD, 2013, J MATER SCI, V48, P5681, DOI 10.1007/s10853-013-7462-y; Kirchheim R, 2007, ACTA MATER, V55, P5129, DOI 10.1016/j.actamat.2007.05.047; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Lejcek P, 2010, SPRINGER SER MATER S, V136, P1, DOI 10.1007/978-3-642-12505-8; McLean D, 1957, GRAIN BOUNDARIES MET; Nag S, 2012, ACTA MATER, V60, P6247, DOI 10.1016/j.actamat.2012.07.033; Nakada N, 2011, ISIJ INT, V51, P299, DOI 10.2355/isijinternational.51.299; Raabe D, 2014, CURR OPIN SOLID ST M, V18, P253, DOI 10.1016/j.cossms.2014.06.002; Raabe D, 2013, ACTA MATER, V61, P6132, DOI 10.1016/j.actamat.2013.06.055; Rigutti L, 2014, NANO LETT, V14, P107, DOI 10.1021/nl4034768; SEAH MP, 1975, SURF SCI, V53, P168, DOI 10.1016/0039-6028(75)90124-7; Tang M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024102; Tang M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.075502	29	187	194	9	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1080	1083		10.1126/science.aab2633	http://dx.doi.org/10.1126/science.aab2633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339026				2022-12-28	WOS:000360628900037
J	Ziff, OJ; Lane, DA; Samra, M; Griffith, M; Kirchhof, P; Lip, GYH; Steeds, RP; Townend, J; Kotecha, D				Ziff, Oliver J.; Lane, Deirdre A.; Samra, Monica; Griffith, Michael; Kirchhof, Paulus; Lip, Gregory Y. H.; Steeds, Richard P.; Townend, Jonathan; Kotecha, Dipak			Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-FAILURE PATIENTS; PERMANENT ATRIAL-FIBRILLATION; SUBARACHNOID-ANEURYSM-TRIAL; ACUTE MYOCARDIAL-INFARCTION; ALL-CAUSE MORTALITY; TASK-FORCE; PROGNOSTIC-SIGNIFICANCE; ENDOVASCULAR-COILING; EUROPEAN-SOCIETY; PROPENSITY SCORE	OBJECTIVE To clarify the impact of digoxin on death and clinical outcomes across all observational and randomised controlled trials, accounting for study designs and methods. DATA SOURCES AND STUDY SELECTION Comprehensive literature search of Medline, Embase, the Cochrane Library, reference lists, and ongoing studies according to a prospectively registered design (PROSPERO: CRD42014010783), including all studies published from 1960 to July 2014 that examined treatment with digoxin compared with control (placebo or no treatment). DATA EXTRACTION AND SYNTHESIS Unadjusted and adjusted data pooled according to study design, analysis method, and risk of bias. MAIN OUTCOME MEASURES Primary outcome (all cause mortality) and secondary outcomes (including admission to hospital) were meta-analysed with random effects modelling. RESULTS 52 studies were systematically reviewed, comprising 621 845 patients. Digoxin users were 2.4 years older than control (weighted difference 95% confidence interval 1.3 to 3.6), with lower ejection fraction (33% v 42%), more diabetes, and greater use of diuretics and anti-arrhythmic drugs. Meta-analysis included 75 study analyses, with a combined total of 4 006 210 patient years of follow-up. Compared with control, the pooled risk ratio for death with digoxin was 1.76 in unadjusted analyses (1.57 to 1.97), 1.61 in adjusted analyses (1.31 to 1.97), 1.18 in propensity matched studies (1.09 to 1.26), and 0.99 in randomised controlled trials (0.93 to 1.05). Meta-regression confirmed that baseline differences between treatment groups had a significant impact on mortality associated with digoxin, including markers of heart failure severity such as use of diuretics (P=0.004). Studies with better methods and lower risk of bias were more likely to report a neutral association of digoxin with mortality (P<0.001). Across all study types, digoxin led to a small but significant reduction in all cause hospital admission (risk ratio 0.92, 0.89 to 0.95; P<0.001; n=29 525). CONCLUSIONS Digoxin is associated with a neutral effect on mortality in randomised trials and a lower rate of admissions to hospital across all study types. Regardless of statistical analysis, prescription biases limit the value of observational data.	[Ziff, Oliver J.; Lane, Deirdre A.; Kirchhof, Paulus; Lip, Gregory Y. H.; Townend, Jonathan; Kotecha, Dipak] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Ziff, Oliver J.; Samra, Monica] Royal Free London NHS Fdn Trust, London, England; [Lane, Deirdre A.; Kirchhof, Paulus; Lip, Gregory Y. H.; Kotecha, Dipak] City Hosp, Sandwell & West Birmingham NHS Trust, Birmingham, W Midlands, England; [Griffith, Michael; Steeds, Richard P.; Townend, Jonathan; Kotecha, Dipak] Univ Hosp Birmingham NHS Trust, Birmingham, W Midlands, England; [Kotecha, Dipak] Monash Univ, Monash Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia	University of Birmingham; University of London; University College London; Royal Free London NHS Foundation Trust; University of Birmingham; Monash University	Kotecha, D (corresponding author), Univ Birmingham, Sch Med, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England.	2TTd.kotecha@bham.ac.uk	Lane, Deirdre/AAX-1866-2020; Ziff, Oliver/AAA-9157-2020; Kirchhof, Paulus/AAT-7074-2021; Kotecha, Dipak/Q-2827-2016; Ziff, Oliver/HCI-3886-2022	Lane, Deirdre/0000-0002-5604-9378; Ziff, Oliver/0000-0002-1504-7245; Kirchhof, Paulus/0000-0002-1881-0197; Kotecha, Dipak/0000-0002-2570-9812; Ziff, Oliver/0000-0002-1504-7245; Ziff, Monica/0000-0002-7094-2779; Steeds, Richard/0000-0001-5687-2535; Townend, Jonathan/0000-0002-5881-5806	Arthur Thompson Trust, University of Birmingham; National Institute for Health Research [CL-2012-09-001] Funding Source: researchfish	Arthur Thompson Trust, University of Birmingham; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by a grant from the Arthur Thompson Trust, University of Birmingham.	Adams Kirkwood F Jr, 2005, J Am Coll Cardiol, V46, P497; Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; Ahmed A, 2006, EUR J HEART FAIL, V8, P409, DOI 10.1016/j.ejheart.2005.10.002; Ahmed A, 2008, INT J CARDIOL, V123, P138, DOI 10.1016/j.ijcard.2006.12.001; Ahmed A, 2007, J GERONTOL A-BIOL, V62, P323, DOI 10.1093/gerona/62.3.323; Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; Ahmed A, 2014, AM J MED, V127, P61, DOI 10.1016/j.amjmed.2013.08.027; Allen LA, 2014, CIRCULATION, V65, P2691; Andrey JL, 2011, INT J CLIN PRACT, V65, P1250, DOI 10.1111/j.1742-1241.2011.02771.x; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Banerjee AK, 1996, INT J CARDIOL, V55, P9, DOI 10.1016/0167-5273(96)02580-6; Bavishi C, 2015, INT J CARDIOL, V188, P99, DOI 10.1016/j.ijcard.2015.04.031; BIGGER JT, 1985, AM J CARDIOL, V55, P623, DOI 10.1016/0002-9149(85)90125-0; BLACKWOOD R, 1990, CLIN PHARMACOL THER, V48, P325, DOI 10.1038/clpt.1990.156; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Butler Javed, 2010, Congest Heart Fail, V16, P191, DOI 10.1111/j.1751-7133.2010.00161.x; BYINGTON R, 1985, J AM COLL CARDIOL, V6, P976, DOI 10.1016/S0735-1097(85)80297-7; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Garcia-Rubira JC, 2014, INTERN EMERG MED, V9, P759, DOI 10.1007/s11739-013-1032-9; Casiglia E, 1998, JPN HEART J, V39, P639; Centre of Cardiovascular Sciences; University of Birmingham, 2015, RAT CONTR THER EV PE; Chan KE, 2010, J AM SOC NEPHROL, V21, P1550, DOI 10.1681/ASN.2009101047; Chao TF, 2014, CAN J CARDIOL, V30, P1190, DOI 10.1016/j.cjca.2014.05.009; Chiang CE, 2012, CIRC-ARRHYTHMIA ELEC, V5, P632, DOI 10.1161/CIRCEP.112.970749; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhaliwal AS, 2008, AM J CARDIOL, V102, P1356, DOI 10.1016/j.amjcard.2008.07.014; DIBIANCO R, 1989, NEW ENGL J MED, V320, P677, DOI 10.1056/NEJM198903163201101; Digitalis Subcommittee of the Multicenter Post-Infarction Research Group, 1987, Cardiovasc Drugs Ther, V1, P125; Domanski M, 2005, J CARD FAIL, V11, P83, DOI 10.1016/j.cardfail.2004.07.002; Eichhorn EJ, 2000, AM J CARDIOL, V86, P1032, DOI 10.1016/S0002-9149(00)01146-2; Eisenstein EL, 2006, J CARD FAIL, V12, P336, DOI 10.1016/j.cardfail.2006.04.002; Elkayam U, 1998, CARDIOLOGY, V89, P38, DOI 10.1159/000047278; Fauchier L, 2009, AM J CARDIOL, V103, P248, DOI 10.1016/j.amjcard.2008.09.064; Flahavan EM, 2014, BJU INT, V113, P236, DOI 10.1111/bju.12287; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Flory JH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000888; Freeman JV, 2015, CIRC-ARRHYTHMIA ELEC, V8, P49, DOI 10.1161/CIRCEP.114.002292; Freeman JV, 2013, CIRC-CARDIOVASC QUAL, V6, P525, DOI 10.1161/CIRCOUTCOMES.111.000079; Friberg L, 2010, HEART, V96, P275, DOI 10.1136/hrt.2009.175786; Gamst J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006486; Georgiopoulou VV, 2009, CIRC-HEART FAIL, V2, P90, DOI 10.1161/CIRCHEARTFAILURE.108.807032; Ghali JK, 2004, J CARD FAIL, V10, P452, DOI 10.1016/j.cardfail.2004.02.008; Gheorghiade M, 2013, EUR HEART J, V34, P1489, DOI 10.1093/eurheartj/eht120; Gjesdal K, 2008, HEART, V94, P191, DOI 10.1136/hrt.2006.108399; Goldberger ZD, 2014, JAMA INTERN MED, V174, P151, DOI 10.1001/jamainternmed.2013.10432; GOLDSTEIN RE, 1991, CIRCULATION, V83, P52, DOI 10.1161/01.CIR.83.1.52; GOLDSTEIN S, 1988, JAMA-J AM MED ASSOC, V259, P539; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hallberg P, 2007, EUR J CLIN PHARMACOL, V63, P959, DOI 10.1007/s00228-007-0346-9; Hannover Medical School German Federal Ministry of Education and Research, 2014, DIG IMPR OUTC PAT AD; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Hashim T, 2014, AM J MED, V127, P132, DOI 10.1016/j.amjmed.2013.08.006; Haynes K, 2008, CLIN PHARMACOL THER, V84, P90, DOI 10.1038/sj.clpt.6100458; Hernan MA, 2004, J EPIDEMIOL COMMUN H, V58, P265, DOI 10.1136/jech.2002.006361; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Hohnloser SH, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1019, DOI 10.1161/CIRCEP.114.002046; Hood WB, 2004, J CARD FAIL, V10, P155, DOI 10.1016/j.cardfail.2003.12.005; Hussain Z, 2006, J CARD FAIL, V12, P343, DOI 10.1016/j.cardfail.2006.02.005; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Jorge E, 2013, REV PORT CARDIOL, V32, P303, DOI 10.1016/j.repc.2012.11.007; Kim SY, 2013, J CLIN EPIDEMIOL, V66, P408, DOI 10.1016/j.jclinepi.2012.09.016; KOBER L, 1994, EUR HEART J, V15, P382, DOI 10.1093/oxfordjournals.eurheartj.a060507; Kotecha D, 2014, IMPACT DIGOXIN DEATH; Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8; Kotecha D, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-7; LEOR J, 1995, CARDIOVASC DRUG THER, V9, P609, DOI 10.1007/BF00878094; Lindsay SJ, 1999, LANCET, V354, P1003, DOI 10.1016/S0140-6736(99)03815-5; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; MADSEN EB, 1984, J AM COLL CARDIOL, V3, P681, DOI 10.1016/S0735-1097(84)80243-0; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; Mamas MA, 2009, EUR J HEART FAIL, V11, P676, DOI 10.1093/eurjhf/hfp085; MANTEL N, 1959, J NATL CANCER I, V22, P719; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Meyer P, 2008, AM J CARDIOL, V102, P1681, DOI 10.1016/j.amjcard.2008.05.068; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; MOLSTAD P, 1991, EUR HEART J, V12, P65, DOI 10.1093/oxfordjournals.eurheartj.a059827; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; MOSS AJ, 1981, CIRCULATION, V64, P1150, DOI 10.1161/01.CIR.64.6.1150; Mulder BA, 2014, HEART RHYTHM, V11, P1543, DOI 10.1016/j.hrthm.2014.06.007; MULLER JE, 1986, NEW ENGL J MED, V314, P265, DOI 10.1056/NEJM198601303140501; Murphy SA, 2013, EUR HEART J, V34, P1465, DOI 10.1093/eurheartj/eht087; NICE, 2014, ATRIAL FIBRILLATION; Okin PM, 2015, J HYPERTENS, V33, P1480, DOI 10.1097/HJH.0000000000000559; Pastori D, 2015, INT J CARDIOL, V180, P1, DOI 10.1016/j.ijcard.2014.11.112; Patel NJ, 2013, INT J CARDIOL, V169, pE84, DOI 10.1016/j.ijcard.2013.10.040; Pearl J., 2009, UNDERSTANDING PROPEN; Perry G, 1997, NEW ENGL J MED, V336, P525; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Reicher-Reiss H, 1999, INT J CARDIOL, V68, P137, DOI 10.1016/S0167-5273(98)00364-7; Rodriguez-Manero M, 2014, REV ESP CARDIOL, V67, P890, DOI 10.1016/j.rec.2014.01.014; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB., 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; RYAN TJ, 1983, CIRCULATION, V67, P735, DOI 10.1161/01.CIR.67.4.735; Ryttlefors M, 2008, STROKE, V39, P2720, DOI 10.1161/STROKEAHA.107.506030; Shah M, 2014, AM J CARDIOL, V114, P401, DOI 10.1016/j.amjcard.2014.05.013; Shrier I, 2007, AM J EPIDEMIOL, V166, P1203, DOI 10.1093/aje/kwm189; Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Turakhia MP, 2014, J AM COLL CARDIOL, V64, P660, DOI 10.1016/j.jacc.2014.03.060; Vamos M, 2015, EUR HEART J, V36, P1831, DOI 10.1093/eurheartj/ehv143; VANVELDHUISEN DJ, 1993, J AM COLL CARDIOL, V22, P1564, DOI 10.1016/0735-1097(93)90579-P; VONOLSHAUSEN KE, 1988, LANCET, V1, P489; WARD RE, 1995, J AM COLL CARDIOL, V26, P93, DOI 10.1016/0735-1097(95)00140-U; Washam JB, 2015, LANCET, V385, P2363, DOI 10.1016/S0140-6736(14)61836-5; Whitbeck MG, 2013, EUR HEART J, V34, P1481, DOI 10.1093/eurheartj/ehs348; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zakeri R, 2013, CIRCULATION, V128, P1085, DOI 10.1161/CIRCULATIONAHA.113.001475; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	111	188	200	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2015	351								h4451	10.1136/bmj.h4451	http://dx.doi.org/10.1136/bmj.h4451			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3XK	26321114	hybrid, Green Published			2022-12-28	WOS:000377715700001
J	Lee, JY; Terakawa, T; Qi, Z; Steinfeld, JB; Redding, S; Kwon, Y; Gaines, WA; Zhao, W; Sung, P; Greene, EC				Lee, Ja Yil; Terakawa, Tsuyoshi; Qi, Zhi; Steinfeld, Justin B.; Redding, Sy; Kwon, YoungHo; Gaines, William A.; Zhao, Weixing; Sung, Patrick; Greene, Eric C.			Base triplet stepping by the Rad51/RecA family of recombinases	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; STRAND EXCHANGE; HOMOLOGOUS RECOMBINATION; MEIOTIC RECOMBINATION; DNA; REPAIR; FILAMENTS; YEAST; DMC1	DNA strand exchange plays a central role in genetic recombination across all kingdoms of life, but the physical basis for these reactions remains poorly defined. Using single-molecule imaging, we found that bacterial RecA and eukaryotic Rad51 and Dmc1 all stabilize strand exchange intermediates in precise three-nucleotide steps. Each step coincides with an energetic signature (0.3 kBT) that is conserved from bacteria to humans. Triplet recognition is strictly dependent on correct Watson-Crick pairing. Rad51, RecA, and Dmc1 can all step over mismatches, but only Dmc1 can stabilize mismatched triplets. This finding provides insight into why eukaryotes have evolved a meiosis-specific recombinase. We propose that canonical Watson-Crick base triplets serve as the fundamental unit of pairing interactions during DNA recombination.	[Lee, Ja Yil; Terakawa, Tsuyoshi; Qi, Zhi; Steinfeld, Justin B.; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Terakawa, Tsuyoshi] Kyoto Univ, Dept Biophys, Sakyo Ku, Kyoto, Japan; [Redding, Sy] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Kwon, YoungHo; Gaines, William A.; Zhao, Weixing; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Greene, Eric C.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Kyoto University; Columbia University; Yale University; Columbia University; Howard Hughes Medical Institute	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	ecg2108@cumc.columbia.edu	LEE, JA YIL/S-2207-2016; oxRNA, oxDNA //V-1335-2019	LEE, JA YIL/0000-0002-5726-9022; Redding, Sy/0000-0003-3463-7985; zhao, weixing/0000-0001-5746-3696	NIH [GM074739, RO1ES015252, CA146940]; NSF [MCB-1154511]; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [R01CA146940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367, R01GM074739] Funding Source: NIH RePORTER; Direct For Biological Sciences [1154511] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Rothstein, L. Symington, H. Klein, M. Lichten, M. Gottesman, J. Dworkin, D. Duzdevich, and other members of the Greene and Sung laboratories for comments on the manuscript. Supported by NIH grants GM074739 (E.C.G.), RO1ES015252 (P.S.), and CA146940 (E.C.G. and P.S.); NSF grant MCB-1154511 (E.C.G.); and a Japan Society for the Promotion of Science fellowship (T.T.). E.C.G. is an HHMI Early Career Scientist. The data described in this manuscript are archived in the laboratory of E.C.G. in the Department of Biochemistry and Molecular Biophysics, Columbia University.	Bianco P R, 1998, Front Biosci, V3, pD570; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Chen WL, 1999, GENETICS, V151, P1299; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Danilowicz C, 2014, NUCLEIC ACIDS RES, V42, P526, DOI 10.1093/nar/gkt867; Doye JPK, 2013, PHYS CHEM CHEM PHYS, V15, P20395, DOI 10.1039/c3cp53545b; Evans E, 2000, MOL CELL, V5, P789, DOI 10.1016/S1097-2765(00)80319-6; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kowalczykowski SC, 2008, NATURE, V453, P463, DOI 10.1038/453463a; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Ragunathan K, 2011, STRUCTURE, V19, P1064, DOI 10.1016/j.str.2011.06.009; SELVA EM, 1995, GENETICS, V139, P1175; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454	19	105	107	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					977	981		10.1126/science.aab2666	http://dx.doi.org/10.1126/science.aab2666			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315438	Green Accepted			2022-12-28	WOS:000360646800054
J	Dascenco, D; Erfurth, ML; Izadifar, A; Song, MM; Sachse, S; Bortnick, R; Urwyler, O; Petrovic, M; Ayaz, D; He, HH; Kise, Y; Thomas, F; Kidd, T; Schmucker, D				Dascenco, Dan; Erfurth, Maria-Luise; Izadifar, Azadeh; Song, Minmin; Sachse, Sonja; Bortnick, Rachel; Urwyler, Olivier; Petrovic, Milan; Ayaz, Derya; He, Haihuai; Kise, Yoshiaki; Thomas, Franziska; Kidd, Thomas; Schmucker, Dietmar			Slit and Receptor Tyrosine Phosphatase 69D Confer Spatial Specificity to Axon Branching via Dscam1	CELL			English	Article							DROSOPHILA-DSCAM; MOLECULAR DIVERSITY; SENSORY NEURONS; SELF-AVOIDANCE; PROTEIN; GUIDANCE; MIDLINE; REPELLENT; ISOFORMS; NEURITES	Axonal branching contributes substantially to neuronal circuit complexity. Studies in Drosophila have shown that loss of Dscam1 receptor diversity can fully block axon branching in mechanosensory neurons. Here we report that cell-autonomous loss of the receptor tyrosine phosphatase 69D (RPTP69D) and loss of midline-localized Slit inhibit formation of specific axon collaterals through modulation of Dscam1 activity. Genetic and biochemical data support a model in which direct binding of Slit to Dscam1 enhances the interaction of Dscam1 with RPTP69D, stimulating Dscam1 dephosphorylation. Single-growth-cone imaging reveals that Slit/RPTP69D are not required for general branch initiation but instead promote the extension of specific axon collaterals. Hence, although regulation of intrinsic Dscam1-Dscam1 isoform interactions is essential for formation of all mechanosensory-axon branches, the local ligand-induced alterations of Dscam1 phosphorylation in distinct growth-cone compartments enable the spatial specificity of axon collateral formation.	[Dascenco, Dan; Erfurth, Maria-Luise; Izadifar, Azadeh; Sachse, Sonja; Urwyler, Olivier; Petrovic, Milan; Ayaz, Derya; He, Haihuai; Kise, Yoshiaki; Schmucker, Dietmar] VIB, Neuronal Wiring Lab, B-3000 Leuven, Belgium; [Dascenco, Dan; Erfurth, Maria-Luise; Izadifar, Azadeh; Sachse, Sonja; Urwyler, Olivier; Petrovic, Milan; Kise, Yoshiaki; Schmucker, Dietmar] Univ Leuven, Sch Med, Dept Oncol, B-3000 Leuven, Belgium; [Erfurth, Maria-Luise] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Song, Minmin; Kidd, Thomas] Univ Nevada, Biol MS 314, Reno, NV 89557 USA; [Sachse, Sonja] Free Univ Berlin, Dept Biol Chem & Pharm, D-14195 Berlin, Germany; [Bortnick, Rachel; Thomas, Franziska] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA	Flanders Institute for Biotechnology (VIB); KU Leuven; University of Kiel; Nevada System of Higher Education (NSHE); University of Nevada Reno; Free University of Berlin; Harvard University; Dana-Farber Cancer Institute	Schmucker, D (corresponding author), VIB, Neuronal Wiring Lab, Herestr 49, B-3000 Leuven, Belgium.	dietmar.schmucker@vib-kuleuven.be	Kidd, Thomas/AAT-9993-2020	Sachse, Sonja/0000-0001-9467-4986; Urwyler, Olivier/0000-0001-8334-8667; Dascenco, Dan/0000-0002-4629-8266; Kidd, Thomas/0000-0001-7190-4208	NIH [2RO1NS046747-05A1, 2P40OD010949-10A1]; FWO [G059611N, G078913N, G077013N]; BELSPO IUAP VII-20 "WIBRAIN''; VIB funding; Boehringer Ingelheim Fonds; EMBO; JSPS; SNSF; NSF [IOS-1052555]; National Center for Research Resources [P20RR016464, 5P20RR024210]; NIGM from the NIH [8 P20 GM103554]; DSHB; HFSP; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024210, P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046747] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1052555] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FWO(FWO); BELSPO IUAP VII-20 "WIBRAIN''; VIB funding; Boehringer Ingelheim Fonds(Boehringer Ingelheim); EMBO(European Molecular Biology Organization (EMBO)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SNSF(Swiss National Science Foundation (SNSF)); NSF(National Science Foundation (NSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGM from the NIH; DSHB; HFSP(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NIH (2RO1NS046747-05A1) (D.S.); FWO (G059611N) (D.S.); FWO (G078913N) (D.S.); FWO (G077013N) (D.S.); BELSPO IUAP VII-20 "WIBRAIN'' (D.S.); VIB funding; and fellowships of FWO (D.D.), Boehringer Ingelheim Fonds (M.-L.E. and S.S.), EMBO (M.P.), JSPS & HFSP (Y.K.), and SNSF (O.U.). The work of T.K. and M.S. was supported by NSF (IOS-1052555), the National Center for Research Resources (P20RR016464, 5P20RR024210), and the NIGM (8 P20 GM103554) from the NIH. We thank Tineke Breynaert for technical help (cell culture). We thank members of the lab, Paul Garrity (Brandeis University), Fritz Rathjen (MDC, Berlin), Bassem Hassan, Matthew Holt, and Georg Halder (VIB) for critical reading, discussions, and insightful comments. We would like to thank the Clemens, Bashaw, Dickson, Zinn, Suzuki, Treisman, Lee, Hassan, Kidd, and Bogdan labs for fly stocks, antibodies, and plasmids. For cell lines and antibodies, we thank the DGRC, supported by NIH grant 2P40OD010949-10A1, and the DSHB, created by the NICHD of the NIH and maintained by the university of Iowa.	Berger J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000085; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Campbell DS, 2007, NEURON, V55, P231, DOI 10.1016/j.neuron.2007.06.034; Chedotal A, 2007, ADV EXP MED BIOL, V621, P65, DOI 10.1007/978-0-387-76715-4_5; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Desai C, 2003, GENETICS, V164, P575; Evans TA, 2010, CURR OPIN NEUROBIOL, V20, P79, DOI 10.1016/j.conb.2009.12.006; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GHYSEN A, 1978, NATURE, V274, P869, DOI 10.1038/274869a0; Hao JC, 2010, DEV CELL, V18, P950, DOI 10.1016/j.devcel.2010.02.019; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; He HH, 2014, SCIENCE, V344, P1182, DOI 10.1126/science.1251852; Hofmeyer K, 2009, P NATL ACAD SCI USA, V106, P19399, DOI 10.1073/pnas.0903961106; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kim JH, 2013, NEURON, V78, P827, DOI 10.1016/j.neuron.2013.05.020; Kise Y, 2013, CURR OPIN NEUROBIOL, V23, P983, DOI 10.1016/j.conb.2013.09.011; Kurusu M, 2008, MOL CELL NEUROSCI, V38, P53, DOI 10.1016/j.mcn.2008.01.015; Liu Y, 2005, J NEUROSCI, V25, P10556, DOI 10.1523/JNEUROSCI.2710-05.2005; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; Muda M, 2002, BIOCHEM J, V366, P73, DOI 10.1042/BJ20020298; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Purohit AA, 2012, J BIOL CHEM, V287, P27126, DOI 10.1074/jbc.M112.340174; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; ROBERTS A, 1983, J EMBRYOL EXP MORPH, V75, P31; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Selner NG, 2014, BIOCHEMISTRY-US, V53, P397, DOI 10.1021/bi401223r; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Sun Q, 2000, DEVELOPMENT, V127, P801; Sun W, 2013, EMBO J, V32, P2029, DOI 10.1038/emboj.2013.144; Tayler TD, 2004, DEVELOPMENT, V131, P5935, DOI 10.1242/dev.01465; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yeo SY, 2004, MECH DEVELOP, V121, P315, DOI 10.1016/j.mod.2004.03.006; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	46	43	43	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1140	1154		10.1016/j.cell.2015.08.003	http://dx.doi.org/10.1016/j.cell.2015.08.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317474	Green Accepted, Bronze			2022-12-28	WOS:000360589900022
J	Hoyler, M; Hagander, L; Gillies, R; Riviello, R; Chu, K; Bergstrom, S; Meara, JG				Hoyler, Marguerite; Hagander, Lars; Gillies, Rowan; Riviello, Robert; Chu, Kathryn; Bergstrom, Staffan; Meara, John G.			Surgical care by non-surgeons in low-income and middle-income countries: a systematic review	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Hoyler, Marguerite] Columbia Univ, Dept Surg, New York Presbyterian Hosp, New York, NY USA; [Hoyler, Marguerite; Hagander, Lars; Gillies, Rowan; Riviello, Robert; Meara, John G.] Harvard Univ, Sch Med, Program Global Surg & Social Change, Boston, MA 02115 USA; [Hagander, Lars] Lund Univ, Fac Med, Dept Clin Sci Lund, Int Pediat & Pediat Surg, Lund, Sweden; [Bergstrom, Staffan] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth, Stockholm, Sweden; [Hoyler, Marguerite; Hagander, Lars; Riviello, Robert; Chu, Kathryn] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Gillies, Rowan; Meara, John G.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA	Columbia University; NewYork-Presbyterian Hospital; Harvard University; Harvard Medical School; Lund University; Karolinska Institutet; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital		hoylerm@gmail.com							0	35	35	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			42	42		10.1016/S0140-6736(15)60837-6	http://dx.doi.org/10.1016/S0140-6736(15)60837-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313091				2022-12-28	WOS:000360573400043
J	Megaw, R; Mellough, C; Wright, A; Lako, M; Ffrench-Constant, C				Megaw, Roly; Mellough, Carla; Wright, Alan; Lako, Majlinda; Ffrench-Constant, Charles			Use of induced pluripotent stem-cell technology to understand photoreceptor cytoskeletal dynamics in retinitis pigmentosa	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Megaw, Roly; Ffrench-Constant, Charles] Univ Edinburgh, Scottish Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Mellough, Carla; Lako, Majlinda] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wright, Alan] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh EH16 4UU, Midlothian, Scotland	University of Edinburgh; Newcastle University - UK; University of Edinburgh		rolymegaw@ed.ac.uk		Mellough, Carla/0000-0003-3685-6516; Megaw, Roly/0000-0001-5605-4540	BBSRC [BB/E012841/1] Funding Source: UKRI; MRC [G0802545] Funding Source: UKRI; Fight for Sight [1870, 1456/57] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/E012841/1] Funding Source: Medline; Medical Research Council [G0301182] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fight for Sight; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			69	69		10.1016/S0140-6736(15)60384-1	http://dx.doi.org/10.1016/S0140-6736(15)60384-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312891				2022-12-28	WOS:000360570500069
J	Schwahn, BC; Van Spronsen, FJ; Belaidi, AA; Bowhay, S; Christodoulou, J; Derks, TG; Hennermann, JB; Jameson, E; Konig, K; McGregor, TL; Font-Montgomery, E; Santamaria-Araujo, JA; Santra, S; Vaidya, M; Vierzig, A; Wassmer, E; Weis, I; Wong, FY; Veldman, A; Schwarz, G				Schwahn, Bernd C.; Van Spronsen, Francjan J.; Belaidi, Abdel A.; Bowhay, Stephen; Christodoulou, John; Derks, Terry G.; Hennermann, Julia B.; Jameson, Elisabeth; Koenig, Kai; McGregor, Tracy L.; Font-Montgomery, Esperanza; Santamaria-Araujo, Jose A.; Santra, Saikat; Vaidya, Mamta; Vierzig, Anne; Wassmer, Evangeline; Weis, Ilona; Wong, Flora Y.; Veldman, Alex; Schwarz, Guenter			Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study	LANCET			English	Article							GENOMIC STRUCTURE; GENES MOCS1; MUTATIONS; BIOSYNTHESIS; FEATURES; URINE	Background Molybdenum cofactor deficiency (MoCD) is characterised by early, rapidly progressive postnatal encephalopathy and intractable seizures, leading to severe disability and early death. Previous treatment attempts have been unsuccessful. After a pioneering single treatment we now report the outcome of the complete first cohort of patients receiving substitution treatment with cyclic pyranopterin monophosphate (cPMP), a biosynthetic precursor of the cofactor. Methods In this observational prospective cohort study, newborn babies with clinical and biochemical evidence of MoCD were admitted to a compassionate-use programme at the request of their treating physicians. Intravenous cPMP (80-320 mu g/kg per day) was started in neonates diagnosed with MoCD (type A and type B) following a standardised protocol. We prospectively monitored safety and efficacy in all patients exposed to cPMP. Findings Between June 6, 2008, and Jan 9, 2013, intravenous cPMP was started in 16 neonates diagnosed with MoCD (11 type A and five type B) and continued in eight type A patients for up to 5 years. We observed no drug-related serious adverse events after more than 6000 doses. The disease biomarkers urinary S-sulphocysteine, xanthine, and urate returned to almost normal concentrations in all type A patients within 2 days, and remained normal for up to 5 years on continued cPMP substitution. Eight patients with type A disease rapidly improved under treatment and convulsions were either completely suppressed or substantially reduced. Three patients treated early remain seizure free and show near-normal long-term development. We detected no biochemical or clinical response in patients with type B disease. Interpretation cPMP substitution is the first effective therapy for patients with MoCD type A and has a favourable safety profile. Restoration of molybdenum cofactor-dependent enzyme activities results in a greatly improved neurodevelopmental outcome when started sufficiently early. The possibility of MoCD type A needs to be urgently explored in every encephalopathic neonate to avoid any delay in appropriate cPMP substitution, and to maximise treatment benefit.	[Schwahn, Bernd C.; Bowhay, Stephen] NHS Greater Glasgow & Clyde, Royal Hosp Sick Children, Glasgow, Lanark, Scotland; [Van Spronsen, Francjan J.; Derks, Terry G.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands; [Belaidi, Abdel A.; Schwarz, Guenter] Univ Cologne, Ctr Mol Med Cologne, Dept Chem, Inst Biochem,CECAD Cologne, D-50931 Cologne, Germany; [Vierzig, Anne] Univ Cologne, Paediat Intens Care, Univ Childrens Hosp, D-50931 Cologne, Germany; [Belaidi, Abdel A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Christodoulou, John] Univ Sydney, Western Sydney Genet Program, Childrens Hosp Westmead, Sydney, NSW 2006, Australia; [Christodoulou, John] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Christodoulou, John] Univ Sydney, Discipline Genet Med, Sydney, NSW 2006, Australia; [Hennermann, Julia B.] Johannes Gutenberg Univ Mainz, Villa Metab, Ctr Pediat & Adolescent Med, Univ Med Ctr, D-55122 Mainz, Germany; [Schwahn, Bernd C.; Jameson, Elisabeth] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Willink Biochem Genet Unit, Manchester, Lancs, England; [Koenig, Kai] Mercy Hosp Women, Dept Pediat, Melbourne, Vic, Australia; [McGregor, Tracy L.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [McGregor, Tracy L.] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Font-Montgomery, Esperanza] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Santamaria-Araujo, Jose A.; Veldman, Alex; Schwarz, Guenter] Orphatec Colbourne Pharmaceut, Niederkassel, Germany; [Santra, Saikat; Wassmer, Evangeline] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Vaidya, Mamta] Barts Hlth NHS Trust, Royal London Hosp, Paediat Intens Care, London, England; [Weis, Ilona] Gemeinschaftsklinikum Koblenz Mayen, Childrens Hosp, Kemperhof, Koblenz, Germany; [Wong, Flora Y.; Veldman, Alex] Monash Univ, Monash Newborn, Monash Med Ctr, Ritchie Ctr,Hudson Inst Med Res, Melbourne, Vic 3004, Australia; [Wong, Flora Y.; Veldman, Alex] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia	University of Glasgow; University of Groningen; University of Cologne; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; University of Sydney; University of Sydney; Johannes Gutenberg University of Mainz; University of Manchester; Vanderbilt University; Vanderbilt University; Children's Hospital of Wisconsin; University of Birmingham; Barts Health NHS Trust; Royal London Hospital; Hudson Institute of Medical Research; Monash University; Monash University	Schwahn, BC (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Willink Biochem Genet Unit, St Marys Hosp, Manchester M13 9WL, Lancs, England.	bernd.schwahn@cmft.nhs.uk	Wassmer, Evangeline/K-5467-2019; Christodoulou, John/M-3628-2019; Derks, Terry G. J./AGT-9822-2022; Belaidi, Abdel Ali/T-7593-2017; Schwarz, Guenter/ABE-9643-2021	Christodoulou, John/0000-0002-8431-0641; Derks, Terry G. J./0000-0002-7259-1095; Belaidi, Abdel Ali/0000-0003-0792-8728; Schwarz, Guenter/0000-0002-2118-9338; Santra, Saikat/0000-0002-7497-3556	German Ministry of Education and Research; Orphatec/Colbourne Pharmaceuticals	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Orphatec/Colbourne Pharmaceuticals	German Ministry of Education and Research; Orphatec/Colbourne Pharmaceuticals.	Arslanoglu S, 2001, BRAIN DEV-JPN, V23, P815, DOI 10.1016/S0387-7604(01)00316-3; Bayley N., 2019, BAYLEY SCALES INFANT; Belaidi AA, 2012, JIMD REP, V5, P35, DOI 10.1007/8904_2011_89; Carmi-Nawi N, 2011, J CHILD NEUROL, V26, P460, DOI 10.1177/0883073810383017; Hitzert MM, 2012, PEDIATRICS, V130, pE1005, DOI 10.1542/peds.2011-3330; Johnson JL., 2001, METABOLIC MOL BASES, P3163; Leimkuhler S, 2005, HUM GENET, V117, P565, DOI 10.1007/s00439-005-1341-9; MIZE C, 1995, J INHERIT METAB DIS, V18, P283, DOI 10.1007/BF00710416; Per H, 2007, BRAIN DEV-JPN, V29, P365, DOI 10.1016/j.braindev.2006.10.007; Pitt JJ, 2002, CLIN CHEM, V48, P1970; Reiss J, 2003, HUM MUTAT, V21, P569, DOI 10.1002/humu.10223; Reiss J, 1998, HUM GENET, V103, P639, DOI 10.1007/s004390050884; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Reiss J, 2011, HUM MUTAT, V32, P10, DOI 10.1002/humu.21390; Santamaria-Araujo JA, 2004, J BIOL CHEM, V279, P15994, DOI 10.1074/jbc.M311815200; Santamaria-Araujo JA, 2012, J BIOL INORG CHEM, V17, P113, DOI 10.1007/s00775-011-0835-2; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 2004, HUM MOL GENET, V13, P1249, DOI 10.1093/hmg/ddh136; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sie SD, 2010, J INHERIT METAB DIS, V33, pS401, DOI 10.1007/s10545-010-9198-z; Veldman A, 2011, J CHILD NEUROL, V26, P1059, DOI 10.1177/0883073811415851; Veldman A, 2010, PEDIATRICS, V125, pE1249, DOI 10.1542/peds.2009-2192; Vijayakumar K, 2011, PEDIATR NEUROL, V45, P246, DOI 10.1016/j.pediatrneurol.2011.06.006	23	76	80	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1955	1963		10.1016/S0140-6736(15)00124-5	http://dx.doi.org/10.1016/S0140-6736(15)00124-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PI	26343839				2022-12-28	WOS:000364763200030
J	Endler, A; Kesten, C; Schneider, R; Zhang, Y; Ivakov, A; Froehlich, A; Funke, N; Persson, S				Endler, Anne; Kesten, Christopher; Schneider, Rene; Zhang, Yi; Ivakov, Alexander; Froehlich, Anja; Funke, Norma; Persson, Staffan			A Mechanism for Sustained Cellulose Synthesis during Salt Stress	CELL			English	Article							CORTICAL MICROTUBULE ARRAYS; SYNTHASE COMPLEXES; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; ABIOTIC STRESS; DATA SETS; PROTEIN; TOLERANCE; CELLS; IDENTIFICATION	Abiotic stress, such as salinity, drought, and cold, causes detrimental yield losses for all major plant crop species. Understanding mechanisms that improve plants' ability to produce biomass, which largely is constituted by the plant cell wall, is therefore of upmost importance for agricultural activities. Cellulose is a principal component of the cell wall and is synthesized by microtubule-guided cellulose synthase enzymes at the plasma membrane. Here, we identified two components of the cellulose synthase complex, which we call companion of cellulose synthase (CC) proteins. The cytoplasmic tails of these membrane proteins bind to microtubules and promote microtubule dynamics. This activity supports microtubule organization, cellulose synthase localization at the plasma membrane, and renders seedlings less sensitive to stress. Our findings offer a mechanistic model for how two molecular components, the CC proteins, sustain microtubule organization and cellulose synthase localization and thus aid plant biomass production during salt stress.	[Endler, Anne; Kesten, Christopher; Schneider, Rene; Zhang, Yi; Ivakov, Alexander; Froehlich, Anja; Funke, Norma; Persson, Staffan] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Endler, Anne] Targenomix GmbH, D-14476 Potsdam, Germany; [Kesten, Christopher; Persson, Staffan] Univ Melbourne, Sch Biosci, Parkville, Vic 3010, Australia	Max Planck Society; University of Melbourne	Persson, S (corresponding author), Max Planck Inst Mol Plant Physiol, Muhlenberg 1, D-14476 Potsdam, Germany.	staffan.persson@unimelb.edu.au	Kesten, Christopher/AAK-4542-2020; Persson, Staffan/S-8399-2016; Schneider, René/CAI-0366-2022	Persson, Staffan/0000-0002-6377-5132; Schneider, René/0000-0003-3951-9742; Zhang, Yi/0000-0002-0745-3497; Kesten, Christopher/0000-0003-0794-2415	Max-Planck Gesellschaft; IMPRS fellowship via the MPG; DFG [PE1642/6-1]; ARC [DP150103495]	Max-Planck Gesellschaft(Max Planck Society); IMPRS fellowship via the MPG; DFG(German Research Foundation (DFG)); ARC(Australian Research Council)	D. melanogaster kinesin-1 heavy chain (DmKHC) was kindly provided by Prof. Stefan Diez, B CUBE, Dresden (Germany). Vector pETM11-SUMO3GFP was kindly provided by Dr. Huseyin Besir, European Molecular Biology Laboratory, Heidelberg (Germany). We thank Drs. Clara Sanchez-Rodriguez and Heather McFarlane for useful comments, Dr. Martin Bringmann for help in cloning the truncated CC1 protein, and Drs. Luisa Trindade and Nasim Mansoori for aid with split-ubiquitin assays. Protein preparation was done in cooperation with Martina Leidert and Anne Diehl (FMP Berlin Germany) with vector kindly provided by Patrick Loll (Drexel University Philadelphia, USA). The authors are grateful to the Max-Planck Gesellschaft for funding. C.K. was funded from an IMPRS fellowship via the MPG. Part of the research was funded through the DFG grant PE1642/6-1 and the ARC grant DP150103495.	Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Fujita M, 2011, PLANT J, V66, P915, DOI 10.1111/j.1365-313X.2011.04552.x; Fujita S, 2013, CURR BIOL, V23, P1969, DOI 10.1016/j.cub.2013.08.006; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Komis G, 2002, PLANT CELL PHYSIOL, V43, P911, DOI 10.1093/pcp/pcf114; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; Li SD, 2012, P NATL ACAD SCI USA, V109, P185, DOI 10.1073/pnas.1118560109; Lindeboom JJ, 2013, PLANT PHYSIOL, V161, P1189, DOI 10.1104/pp.112.204057; McFarlane HE, 2014, ANNU REV PLANT BIOL, V65, P69, DOI 10.1146/annurev-arplant-050213-040240; MOREJOHN LC, 1987, PLANTA, V172, P252, DOI 10.1007/BF00394595; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; MUELLER SC, 1980, J CELL BIOL, V84, P315, DOI 10.1083/jcb.84.2.315; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; Naoi K, 2004, PLANT CELL, V16, P1841, DOI 10.1105/tpc.021865; Nick P, 2013, PLANT J, V75, P309, DOI 10.1111/tpj.12102; Nitzsche B, 2010, METHOD CELL BIOL, V95, P247, DOI 10.1016/S0091-679X(10)95014-0; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Sampathkumar A, 2013, PLANT PHYSIOL, V162, P675, DOI 10.1104/pp.113.215277; Sanchez-Rodriguez C, 2012, PLANT CELL, V24, P589, DOI 10.1105/tpc.111.094672; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Wang C, 2007, PLANT CELL PHYSIOL, V48, P1534, DOI 10.1093/pcp/pcm123; Wang SH, 2011, PLANT CELL, V23, P3412, DOI 10.1105/tpc.111.089920; Wicker-Planquart C, 2004, PLANT J, V39, P126, DOI 10.1111/j.1365-313X.2004.02115.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhong RQ, 2002, PLANT CELL, V14, P3101, DOI 10.1105/tpc.005801; Zhu JH, 2010, PLANT J, V63, P128, DOI 10.1111/j.1365-313X.2010.04227.x	48	169	180	11	134	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1353	1364		10.1016/j.cell.2015.08.028	http://dx.doi.org/10.1016/j.cell.2015.08.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26343580	Bronze			2022-12-28	WOS:000361247900023
J	Baker, RW; Jeffrey, PD; Zick, M; Phillips, BP; Wickner, WT; Hughson, FM				Baker, Richard W.; Jeffrey, Philip D.; Zick, Michael; Phillips, Ben P.; Wickner, William T.; Hughson, Frederick M.			MEMBRANE FUSION A direct role for the Sec1/Munc18-family protein Vps33 as a template for SNARE assembly	SCIENCE			English	Article							STRUCTURAL BASIS; HOPS COMPLEX; DOMAIN 3A; MUNC18-1; BINDS; YEAST; RECRUITMENT; CHAPERONES; REVEALS; VAM7	Fusion of intracellular transport vesicles requires soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) and Sec1/Munc18-family (SM) proteins. Membrane-bridging SNARE complexes are critical for fusion, but their spontaneous assembly is inefficient and may require SM proteins in vivo. We report x-ray structures of Vps33, the SM subunit of the yeast homotypic fusion and vacuole protein-sorting (HOPS) complex, bound to two individual SNAREs. The two SNAREs, one from each membrane, are held in the correct orientation and register for subsequent complex assembly. Vps33 and potentially other SM proteins could thus act as templates for generating partially zipped SNARE assembly intermediates. HOPS was essential to mediate SNARE complex assembly at physiological SNARE concentrations. Thus, Vps33 appears to catalyze SNARE complex assembly through specific SNARE motif recognition.	[Baker, Richard W.; Jeffrey, Philip D.; Phillips, Ben P.; Hughson, Frederick M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Zick, Michael; Wickner, William T.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	Princeton University; Dartmouth College	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu	Baker, Richard/N-1428-2016	Baker, Richard/0000-0003-1136-6000; Jeffrey, Philip/0000-0002-4351-5341	NIH [GM071574, GM23377]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071574, R37GM023377, T32GM007388, R01GM023377] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Robinson and the staff of National Synchrotron Light Source beamline X29 for assistance with data collection and A. Merz, M. Rose, and members of our laboratories for reagents, discussion, and critical comments on the manuscript. This work was funded by NIH (GM071574 to F.M.H. and GM23377 to W.T.W.) and a predoctoral fellowship from NSF (R.W.B.). The atomic coordinates and structure factors are deposited in the Protein Data Bank with accession codes 5BV1 (Vps33/Vps16), 5BUZ (Vps33/Vps16/Vam3), and 5BV0 (Vps33/Vps16/Nyv1).	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067409; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Graham SC, 2013, P NATL ACAD SCI USA, V110, P13345, DOI 10.1073/pnas.1307074110; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Li YJ, 2007, FEBS LETT, V581, P5698, DOI 10.1016/j.febslet.2007.11.033; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Parisotto D, 2014, J BIOL CHEM, V289, P9639, DOI 10.1074/jbc.M113.514273; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zick M, 2013, MOL BIOL CELL, V24, P3746, DOI 10.1091/mbc.E13-07-0419; Zucchi PC, 2011, MOL BIOL CELL, V22, P4635, DOI 10.1091/mbc.E11-08-0680	30	177	179	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1111	1114		10.1126/science.aac7906	http://dx.doi.org/10.1126/science.aac7906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339030	Green Accepted			2022-12-28	WOS:000360628900044
J	Nielsen, J				Nielsen, Jens			Yeast cell factories on the horizon	SCIENCE			English	Editorial Material							PRECURSOR		[Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, SE-41296 Gothenburg, Sweden; [Nielsen, Jens] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, DK-2970 Horsholm, Denmark; [Nielsen, Jens] Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden	Chalmers University of Technology; Novo Nordisk Foundation; Technical University of Denmark; Royal Institute of Technology	Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, SE-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Nielsen, Jens/Q-1347-2017	Nielsen, Jens/0000-0002-9955-6003	Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Yeast Cell Factories] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability		Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Krivoruchko A, 2015, CURR OPIN BIOTECH, V35, P7, DOI 10.1016/j.copbio.2014.12.004; Nielsen J, 2014, MBIO, V5, DOI 10.1128/mBio.02153-14; Nielsen J, 2013, CURR OPIN BIOTECH, V24, P398, DOI 10.1016/j.copbio.2013.03.023; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Scalcinati G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-117; Szczebara FM, 2003, NAT BIOTECHNOL, V21, P143, DOI 10.1038/nbt775; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109	9	47	55	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1050	1051		10.1126/science.aad2081	http://dx.doi.org/10.1126/science.aad2081			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339012				2022-12-28	WOS:000360628900017
J	Segre, JA				Segre, Julia A.			Microbial growth dynamics and human disease	SCIENCE			English	Editorial Material							IDENTIFICATION		NHGRI, Microbial Genom Sect, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Segre, JA (corresponding author), NHGRI, Microbial Genom Sect, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA.	jsegre@nhgri.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Harcombe WR, 2014, CELL REP, V7, P1104, DOI 10.1016/j.celrep.2014.03.070; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kang DZ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2009; Korem T, 2015, SCIENCE, V349, P1101, DOI 10.1126/science.aac4812; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Manor O, 2014, CELL METAB, V20, P742, DOI 10.1016/j.cmet.2014.07.021; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Xu J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r27	13	14	15	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1058	1059		10.1126/science.aad0781	http://dx.doi.org/10.1126/science.aad0781			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339017				2022-12-28	WOS:000360628900022
J	Kay, M				Kay, Meera			CORRUPTION IN MEDICINE The unethical revenue targets that India's corporate hospitals set their doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Edacherian S, 2014, FROST SULLIVAN  0214; Francis PA, 2015, PHARMABIZ       0429; Gadre A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h826; Iyer M, 2015, TIMES INDIA; Nagarajan R, 2015, TIMES INDIA; Nagarajan R, 2013, TIMES INDIA; Pandya Sunil K, 2014, Indian J Med Ethics, V11, P68; Travasso C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4740	8	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2015	351								h4312	10.1136/bmj.h4312	http://dx.doi.org/10.1136/bmj.h4312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9JX	26337575				2022-12-28	WOS:000360931900001
J	Marchetti, MC				Marchetti, M. Cristina			SOFT MATTER Frictionless fluids from bacterial teamwork	NATURE			English	Editorial Material								By increasing the sensitivity of an established technique, researchers have shown that swimming bacteria can make frictionless fluids - with potential applications in areas such as microfluidics.	[Marchetti, M. Cristina] Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA; [Marchetti, M. Cristina] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA	Syracuse University; Syracuse University	Marchetti, MC (corresponding author), Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA.	mcmarche@syr.edu			Division Of Materials Research [1305184] Funding Source: National Science Foundation	Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Einstein A, 1906, ANN PHYS-BERLIN, V19, P289, DOI 10.1002/andp.19063240204; Gachelin J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.268103; Giomi L, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051908; Haines BM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041922; Hatwalne Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118101; Liverpool TB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.268101; Lopez HM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.028301; Rafai S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.098102; Ryan SD, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.050904; Saintillan D, 2010, EXP MECH, V50, P1275, DOI 10.1007/s11340-009-9267-0; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Sokolov A, 2010, P NATL ACAD SCI USA, V107, P969, DOI 10.1073/pnas.0913015107; Sokolov A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.148101	14	12	12	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					37	39		10.1038/525037a	http://dx.doi.org/10.1038/525037a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26333462				2022-12-28	WOS:000360594100017
J	Oldfield, BJ				Oldfield, Benjamin J.			Invisible Colleagues	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sch Med, Dept Med & Pediat, Baltimore, MD 21218 USA	Johns Hopkins University	Oldfield, BJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med & Pediat, Baltimore, MD 21218 USA.			Oldfield, Benjamin/0000-0003-1708-803X				[Anonymous], 2014, YEAR 2014 HOSP WAG S	1	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					792	793		10.1056/NEJMp1506873	http://dx.doi.org/10.1056/NEJMp1506873			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP8VC	26308683	Bronze			2022-12-28	WOS:000360171700005
J	Sink, KM; Espeland, MA; Castro, CM; Church, T; Cohen, R; Dodson, JA; Guralnik, J; Hendrie, HC; Jennings, J; Katula, J; Lopez, OL; McDermott, MM; Pahor, M; Reid, KF; Rushing, J; Verghese, J; Rapp, S; Williamson, JD				Sink, Kaycee M.; Espeland, Mark A.; Castro, Cynthia M.; Church, Timothy; Cohen, Ron; Dodson, John A.; Guralnik, Jack; Hendrie, Hugh C.; Jennings, Janine; Katula, Jeffery; Lopez, Oscar L.; McDermott, Mary M.; Pahor, Marco; Reid, Kieran F.; Rushing, Julia; Verghese, Joe; Rapp, Stephen; Williamson, Jeff D.		LIFE Study Investigators	Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults The LIFE Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; STYLE INTERVENTIONS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; AEROBIC EXERCISE; DISEASE; RECOMMENDATIONS; INDEPENDENCE; PERFORMANCE; ELDERS	IMPORTANCE Epidemiological evidence suggests that physical activity benefits cognition, but results from randomized trials are limited and mixed. OBJECTIVE To determine whether a 24-month physical activity program results in better cognitive function, lower risk of mild cognitive impairment (MCI) or dementia, or both, compared with a health education program. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial, the Lifestyle Interventions and Independence for Elders (LIFE) study, enrolled 1635 community-living participants at 8 US centers from February 2010 until December 2011. Participants were sedentary adults aged 70 to 89 years who were at risk for mobility disability but able to walk 400 m. INTERVENTIONS A structured, moderate-intensity physical activity program (n = 818) that included walking, resistance training, and flexibility exercises or a health education program (n = 817) of educational workshops and upper-extremity stretching. MAIN OUTCOMES AND MEASURES Prespecified secondary outcomes of the LIFE study included cognitive function measured by the Digit Symbol Coding (DSC) task subtest of the Wechsler Adult Intelligence Scale (score range: 0-133; higher scores indicate better function) and the revised Hopkins Verbal Learning Test (HVLT-R; 12-item word list recall task) assessed in 1476 participants (90.3%). Tertiary outcomes included global and executive cognitive function and incident MCI or dementia at 24 months. RESULTS At 24 months, DSC task and HVLT-R scores (adjusted for clinic site, sex, and baseline values) were not different between groups. The mean DSC task scores were 46.26 points for the physical activity group vs 46.28 for the health education group (mean difference, -0.01 points [95% CI, -0.80 to 0.77 points], P = .97). The mean HVLT-R delayed recall scores were 7.22 for the physical activity group vs 7.25 for the health education group (mean difference, -0.03 words [95% CI, -0.29 to 0.24 words], P = .84). No differences for any other cognitive or composite measures were observed. Participants in the physical activity group who were 80 years or older (n = 307) and those with poorer baseline physical performance (n = 328) had better changes in executive function composite scores compared with the health education group (P = .01 for interaction for both comparisons). Incident MCI or dementia occurred in 98 participants (13.2%) in the physical activity group and 91 participants (12.1%) in the health education group (odds ratio, 1.08 [95% CI, 0.80 to 1.46]). CONCLUSIONS AND RELEVANCE Among sedentary older adults, a 24-month moderate-intensity physical activity program compared with a health education program did not result in improvements in global or domain-specific cognitive function.	[Sink, Kaycee M.; Williamson, Jeff D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Gerontol & Geriatr Med, Winston Salem, NC 27157 USA; [Espeland, Mark A.; Rushing, Julia] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Castro, Cynthia M.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA; [Church, Timothy] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Cohen, Ron; Pahor, Marco] Univ Florida, Coll Med, Gainesville, FL USA; [Dodson, John A.] NYU, Dept Med, Sch Med, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Guralnik, Jack] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Div Gerontol, Baltimore, MD 21201 USA; [Hendrie, Hugh C.] Indiana Univ, Dept Psychiat, Indianapolis, IN 46204 USA; [Hendrie, Hugh C.] Indiana Univ, Ctr Aging Res, Indianapolis, IN 46204 USA; [Jennings, Janine] Wake Forest Univ, Dept Psychol, Winston Salem, NC 27157 USA; [Katula, Jeffery] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27157 USA; [Lopez, Oscar L.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Lopez, Oscar L.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [McDermott, Mary M.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Reid, Kieran F.] Tufts Univ, Nutr Exercise Physiol & Sarcopenia Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Verghese, Joe] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Verghese, Joe] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Rapp, Stephen] Wake Forest Univ, Bowman Gray Sch Med, Dept Psychiat, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Stanford University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; State University System of Florida; University of Florida; New York University; University System of Maryland; University of Maryland Baltimore; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Wake Forest University; Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; Tufts University; United States Department of Agriculture (USDA); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Wake Forest University; Wake Forest Baptist Medical Center	Sink, KM (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Sticht Ctr Aging, One Med Ctr Blvd, Winston Salem, NC 27157 USA.	kmsink@wakehealth.edu	Sink, Kaycee/AAY-5920-2020; Buford, Thomas W/B-1111-2011; Katula, Jeffrey Alan/K-5905-2013; Stafford, Randall/F-3974-2017; Newman, Anne B./C-6408-2013	Buford, Thomas W/0000-0002-9541-4358; Katula, Jeffrey Alan/0000-0003-2009-2443; Sink, Kaycee/0000-0001-9608-3856; Glynn, Nancy/0000-0003-2265-0162; Spring, Bonnie/0000-0003-0692-9868; Leeuwenburgh, Christiaan/0000-0003-0826-4257; Pepine, Carl/0000-0002-6011-681X; Gill, Thomas/0000-0002-6450-0368; Marsiske, Michael/0000-0001-5973-2116; Handberg, Eileen/0000-0002-7805-9577; Castro Sweet, Cynthia/0000-0001-6860-4095; Stafford, Randall/0000-0003-1805-1271; Kaplan, Robert/0000-0003-4837-5330; Vaz Fragoso, Carlos/0000-0002-7045-3334; Newman, Anne B./0000-0002-0106-1150; King, Abby/0000-0002-7949-8811	National Institutes of Health, National Institute on Aging [UO1 AG22376]; National Heart, Lung, and Blood Institute [3U01AG022376-05A2S]; National Institute on Aging, National Institutes of Health; Pepper Older Americans Independence Centers: Boston, Massachusetts [1P30AG031679]; Pepper Older Americans Independence Centers: Florida [1 P30 AG028740]; Pepper Older Americans Independence Centers: Pittsburgh, Pennsylvania [P30 AG024827]; Pepper Older Americans Independence Centers: Wake Forest University [1 P30 AG21332]; Pepper Older Americans Independence Centers: Yale University [P30AG021342]; US Department of Agriculture [58-1950-7-707]; NATIONAL INSTITUTE ON AGING [P30AG021342, U01AG022376, P30AG021332, P30AG031679, P30AG024827, P30AG028740] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pepper Older Americans Independence Centers: Boston, Massachusetts; Pepper Older Americans Independence Centers: Florida; Pepper Older Americans Independence Centers: Pittsburgh, Pennsylvania; Pepper Older Americans Independence Centers: Wake Forest University; Pepper Older Americans Independence Centers: Yale University; US Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Lifestyle Interventions and Independence for Elders (LIFE) study was funded by cooperative agreement UO1 AG22376 from the National Institutes of Health, National Institute on Aging and 3U01AG022376-05A2S from the National Heart, Lung, and Blood Institute; and sponsored in part by the Intramural Research Program, National Institute on Aging, National Institutes of Health. This research was also supported by the following grants awarded to Claude D. Pepper Older Americans Independence Centers: Boston, Massachusetts (1P30AG031679), Florida (1 P30 AG028740), Pittsburgh, Pennsylvania (P30 AG024827), Wake Forest University (1 P30 AG21332), and Yale University (P30AG021342). Dr Reid's contribution was partially supported by the US Department of Agriculture under agreement 58-1950-7-707.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Barnes DE, 2013, JAMA INTERN MED, V173, P797, DOI 10.1001/jamainternmed.2013.189; Brandt J, 2001, HOPKINS VERBAL LEARN; Burdette JH, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00023; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Coelho FGD, 2013, ARCH GERONTOL GERIAT, V56, P10, DOI 10.1016/j.archger.2012.06.003; Denkinger MD, 2012, Z GERONTOL GERIATR, V45, P11, DOI 10.1007/s00391-011-0262-6; Erickson KI, 2014, NEUROBIOL AGING, V35, pS20, DOI 10.1016/j.neurobiolaging.2014.03.034; Erickson Kirk I, 2013, Dialogues Clin Neurosci, V15, P99; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Espeland MA, 2014, J GERONTOL A-BIOL, V69, P1101, DOI 10.1093/gerona/glu031; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123; Goodglass H., 1983, BOSTON NAMING TEST; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Legault C, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-27; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Reitan RM, 1992, TRAIL MAKING TEST MA; Rejeski WJ, 2005, CONTEMP CLIN TRIALS, V26, P141, DOI 10.1016/j.cct.2004.12.005; Robertson DA, 2014, J AM GERIATR SOC, V62, P2118, DOI 10.1111/jgs.13111; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Sink KM, 2014, CLIN INTERV AGING, V9, P1425, DOI 10.2147/CIA.S65381; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Snowden M, 2011, J AM GERIATR SOC, V59, P704, DOI 10.1111/j.1532-5415.2011.03323.x; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stewart AL, 2001, J GERONTOL A-BIOL, V56, pM465, DOI 10.1093/gerona/56.8.M465; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wechsler D., 1997, WAIS 3 MANUAL; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Williamson JD, 2009, J GERONTOL A-BIOL, V64, P688, DOI 10.1093/gerona/glp014; Yuan Y, 2011, J STAT SOFTW, V45, P1	40	227	240	16	178	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					781	790		10.1001/jama.2015.9617	http://dx.doi.org/10.1001/jama.2015.9617			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP6SA	26305648	Green Accepted, Bronze			2022-12-28	WOS:000360017200018
J	Ali, J; Bolton, E; Saeb-Parsy, K; Bradley, JA; Pettigrew, G				Ali, Jason; Bolton, Eleanor; Saeb-Parsy, Kourosh; Bradley, J. Andrew; Pettigrew, Gavin			Targeting indirect pathway CD4 T-cell alloresponses in the prevention of chronic transplant rejection	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Ali, Jason; Bolton, Eleanor; Saeb-Parsy, Kourosh; Bradley, J. Andrew; Pettigrew, Gavin] Univ Cambridge, Dept Surg, Cambridge CB2 0QQ, England	University of Cambridge		ja297@cam.ac.uk		Bolton, Eleanor/0000-0002-7253-6045; Saeb-Parsy, Kourosh/0000-0002-0633-3696	British Heart Foundation [PG/10/002/28143] Funding Source: Medline	British Heart Foundation(British Heart Foundation)			0	5	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			17	17		10.1016/S0140-6736(15)60332-4	http://dx.doi.org/10.1016/S0140-6736(15)60332-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312839				2022-12-28	WOS:000360570500017
J	Brown, C; Esterhazy, D; Sarde, A; Pullabhatla, V; London, M; Arno, M; de Rinaldis, E; Mucida, D; Lord, G; Noelle, R				Brown, Chrysothemis; Esterhazy, Daria; Sarde, Aurelien; Pullabhatla, Venu; London, Mariya; Arno, Matthew; de Rinaldis, Emanuele; Mucida, Daniel; Lord, Graham; Noelle, Randolph			Role of retinoic acid in the stability of the T-helper-type 1 lineage and implications for autoimmunity	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Brown, Chrysothemis; Sarde, Aurelien; Lord, Graham; Noelle, Randolph] Kings Coll London, Div Transplantat Immunol & Mucosal Biol, London SE1 9RT, England; [Esterhazy, Daria; London, Mariya; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10021 USA; [Pullabhatla, Venu; de Rinaldis, Emanuele] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Pullabhatla, Venu; de Rinaldis, Emanuele] Kings Coll London, London SE1 9RT, England; [Arno, Matthew] Kings Coll London, Genom Ctr, London SE1 9RT, England	University of London; King's College London; Rockefeller University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London		chrysothemis.brown@kcl.ac.uk	Abraham, Sabu/E-1144-2019	Abraham, Sabu/0000-0002-0916-5827; Lord, Graham/0000-0003-2069-4743	Medical Research Council [MR/M003493/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			25	25						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312847	Bronze			2022-12-28	WOS:000360570500025
J	Cowie, MR; Woehrle, H; Wegscheider, K; Angermann, C; d'Ortho, MP; Erdmann, E; Levy, P; Simonds, AK; Somers, VK; Zannad, F; Teschler, H				Cowie, Martin R.; Woehrle, Holger; Wegscheider, Karl; Angermann, Christiane; d'Ortho, Marie-Pia; Erdmann, Erland; Levy, Patrick; Simonds, Anita K.; Somers, Virend K.; Zannad, Faiez; Teschler, Helmut			Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; CHEYNE-STOKES RESPIRATION; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; DYSFUNCTION; MORTALITY; MULTICENTER; TRIAL	BACKGROUND Central sleep apnea is associated with poor prognosis and death in patients with heart failure. Adaptive servo-ventilation is a therapy that uses a noninvasive ventilator to treat central sleep apnea by delivering servo-controlled inspiratory pressure support on top of expiratory positive airway pressure. We investigated the effects of adaptive servo-ventilation in patients who had heart failure with reduced ejection fraction and predominantly central sleep apnea. METHODS We randomly assigned 1325 patients with a left ventricular ejection fraction of 45% or less, an apnea-hypopnea index (AHI) of 15 or more events (occurrences of apnea or hypopnea) per hour, and a predominance of central events to receive guideline-based medical treatment with adaptive servo-ventilation or guideline-based medical treatment alone (control). The primary end point in the time-to-event analysis was the first event of death from any cause, lifesaving cardiovascular intervention (cardiac transplantation, implantation of a ventricular assist device, resuscitation after sudden cardiac arrest, or appropriate lifesaving shock), or unplanned hospitalization for worsening heart failure. RESULTS In the adaptive servo-ventilation group, the mean AHI at 12 months was 6.6 events per hour. The incidence of the primary end point did not differ significantly between the adaptive servo-ventilation group and the control group (54.1% and 50.8%, respectively; hazard ratio, 1.13; 95% confidence interval [CI], 0.97 to 1.31; P = 0.10). All-cause mortality and cardiovascular mortality were significantly higher in the adaptive servo-ventilation group than in the control group (hazard ratio for death from any cause, 1.28; 95% CI, 1.06 to 1.55; P = 0.01; and hazard ratio for cardiovascular death, 1.34; 95% CI, 1.09 to 1.65; P = 0.006). CONCLUSIONS Adaptive servo-ventilation had no significant effect on the primary end point in patients who had heart failure with reduced ejection fraction and predominantly central sleep apnea, but all-cause and cardiovascular mortality were both increased with this therapy.	[Cowie, Martin R.] Univ London Imperial Coll Sci Technol & Med, London SW3 6LY, England; [Simonds, Anita K.] Royal Brompton Hosp, London, England; [Woehrle, Holger] ResMed Germany, ResMed Sci Ctr, Martinsried, Germany; [Woehrle, Holger] Resp Ctr Ulm, Sleep & Ventilat Ctr Blaubeuren, Ulm, Germany; [Wegscheider, Karl] Univ Med Ctr Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Angermann, Christiane] Univ Hosp, Dept Med 1, Wurzburg, Germany; [Angermann, Christiane] Univ Hosp, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Angermann, Christiane] Univ Wurzburg, D-97070 Wurzburg, Germany; [Erdmann, Erland] Univ Cologne, Ctr Heart, D-50931 Cologne, Germany; [Teschler, Helmut] Univ Duisburg Essen, Univ Hosp Essen, West German Lung Ctr, Ruhrlandklin,Dept Pneumol, Essen, Germany; [d'Ortho, Marie-Pia] Univ Paris Diderot, Sorbonne Paris Cite, Hop Bichat,Explorat Fonct, AP HP,Dept Hosp Univ Fight Inflammat & Remodeling, Paris, France; [Levy, Patrick] CHU Grenoble, F-38043 Grenoble, France; [Zannad, Faiez] Univ Lorraine, CHU Nancy, INSERM, Nancy, France; [Somers, Virend K.] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Imperial College London; Royal Brompton Hospital; ResMed; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Mayo Clinic	Cowie, MR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Cardiol, Dovehouse St, London SW3 6LY, England.	m.cowie@imperial.ac.uk	Zannad, Faiez/K-4649-2019; Cowie, Martin R/AAQ-2818-2020; LEVY, Patrick/AAX-2802-2020	Cowie, Martin R/0000-0001-7457-2552; LEVY, Patrick/0000-0003-3174-7935	ResMed; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065176] Funding Source: NIH RePORTER	ResMed; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by ResMed and others; SERVE-HF ClinicalTrials.gov number, NCT00733343.	Acosta B, 2000, CHEST, V118, P1004, DOI 10.1378/chest.118.4.1004; Arzt M, 2007, CIRCULATION, V115, P3173, DOI 10.1161/CIRCULATIONAHA.106.683482; Bitter T, 2011, EUR HEART J, V32, P61, DOI 10.1093/eurheartj/ehq327; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; BRADLEY TD, 1992, AM REV RESPIR DIS, V145, P377, DOI 10.1164/ajrccm/145.2_Pt_1.377; Cowie MR, 2013, EUR J HEART FAIL, V15, P937, DOI 10.1093/eurjhf/hft051; DEHOYOS A, 1995, CLIN SCI, V88, P173, DOI 10.1042/cs0880173; GRACE MP, 1982, CRIT CARE MED, V10, P358, DOI 10.1097/00003246-198206000-00002; Gray AJ, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13330; Hastings PC, 2010, INT J CARDIOL, V139, P17, DOI 10.1016/j.ijcard.2008.08.022; Javaheri S, 2007, J AM COLL CARDIOL, V49, P2028, DOI 10.1016/j.jacc.2007.01.084; Kasai T, 2012, CIRCULATION, V126, P1495, DOI 10.1161/CIRCULATIONAHA.111.070813; Lenique F, 1997, AM J RESP CRIT CARE, V155, P500, DOI 10.1164/ajrccm.155.2.9032185; Levy P, 2007, SLEEP MED CLIN, V2, P615, DOI 10.1016/j.jsmc.2007.08.001; Momomura S, 2015, CIRC J, V79, P981, DOI 10.1253/circj.CJ-15-0221; Nakamura S, 2015, CLIN RES CARDIOL, V104, P208, DOI 10.1007/s00392-014-0774-3; Naughton MT, 2012, THORAX, V67, P357, DOI 10.1136/thoraxjnl-2011-200927; Oldenburg O, 2008, EUR J HEART FAIL, V10, P581, DOI 10.1016/j.ejheart.2008.04.007; Oldenburg O, 2007, EUR J HEART FAIL, V9, P251, DOI 10.1016/j.ejheart.2006.08.003; Oldenburg O, 2009, SLEEP MED, V10, P726, DOI 10.1016/j.sleep.2008.08.004; Philip-Joet F, 1999, RESPIRATION, V66, P136, DOI 10.1159/000029355; Sharma BK, 2012, CHEST, V142, P1211, DOI 10.1378/chest.12-0815; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Takama N, 2012, CIRC J, V76, P661, DOI 10.1253/circj.CJ-11-0299; Teschler H, 2001, AM J RESP CRIT CARE, V164, P614, DOI 10.1164/ajrccm.164.4.9908114; Yumino D, 2009, HEART, V95, P819, DOI 10.1136/hrt.2008.160952	26	601	627	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1095	1105		10.1056/NEJMoa1506459	http://dx.doi.org/10.1056/NEJMoa1506459			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR7UG	26323938	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000361556400005
J	Hunter-Schaedle, K				Hunter-Schaedle, Kim			When science fails a scientist	SCIENCE			English	Editorial Material									Hosp Psychiat, Austen Riggs Ctr, Stockbridge, MA 01262 USA		Hunter-Schaedle, K (corresponding author), Hosp Psychiat, Austen Riggs Ctr, Stockbridge, MA 01262 USA.	SciCareerEditor@aaas.org							0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1134	1134		10.1126/science.349.6252.1134	http://dx.doi.org/10.1126/science.349.6252.1134			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339032				2022-12-28	WOS:000360628900047
J	Lim, K; Hyun, YM; Lambert-Emo, K; Capece, T; Bae, S; Miller, R; Topham, DJ; Kim, M				Lim, Kihong; Hyun, Young-Min; Lambert-Emo, Kris; Capece, Tara; Bae, Seyeon; Miller, Richard; Topham, David J.; Kim, Minsoo			Neutrophil trails guide influenza-specific CD8(+) T cells in the airways	SCIENCE			English	Article							CHEMOKINE RECEPTORS; MIGRATION; IMMUNITY; INNATE; EXTRAVASATION; INFLAMMATION; RECRUITMENT; ACTIVATION; MECHANISMS; CHEMOTAXIS	During viral infections, chemokines guide activated effector T cells to infection sites. However, the cells responsible for producing these chemokines and how such chemokines recruit T cells are unknown. Here, we show that the early recruitment of neutrophils into influenza-infected trachea is essential for CD8(+) T cell-mediated immune protection in mice. We observed that migrating neutrophils leave behind long-lasting trails that are enriched in the chemokine CXCL12. Experiments with granulocyte-specific CXCL12 conditionally depleted mice and a CXCR4 antagonist revealed that CXCL12 derived from neutrophil trails is critical for virus-specific CD8(+) T cell recruitment and effector functions. Collectively, these results suggest that neutrophils deposit long-lasting, chemokine-containing trails, which may provide both chemotactic and haptotactic cues for efficient CD8(+) T cell migration and localization in influenza-infected tissues.	[Lim, Kihong; Hyun, Young-Min; Lambert-Emo, Kris; Capece, Tara; Bae, Seyeon; Topham, David J.; Kim, Minsoo] Univ Rochester, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14627 USA; [Miller, Richard] Northwestern Univ, Dept Pharmacol, Chicago, IL 60611 USA	University of Rochester; Northwestern University	Kim, M (corresponding author), Univ Rochester, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14627 USA.	minsoo_kim@urmc.rochester.edu		Capece, Tara/0000-0001-9282-0273; Hyun, Young-Min/0000-0002-0567-2039	NIH [HL087088, AI102851, HHSN272201400005C]; WCU Neurocytomics Program grant; Seoul National University Graduate School, Seoul, South Korea; American Heart Association [11SDG7520018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI112257, P01AI102851] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WCU Neurocytomics Program grant; Seoul National University Graduate School, Seoul, South Korea; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Gaylo, Y. Xu, B. Walling, J. Wong, N. Laniewski, H. Yang, and U. Sivagnanalingam for their technical assistance and comments on manuscript, and thank S. Morrison for CXCL12<SUP>DsRed</SUP> mouse. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. K.L. conducted most of the experiments and performed most of the statistical analysis of the data; Y.-M.H. and K.L.-E. designed the mouse trachea IV-TPM protocol and Y.-M.H. performed in vivo imaging and helped in the data analysis; K.L.-E., T.C., and S. B. helped in the virus infection and mouse T cell preparations. T.C. performed the transwell assay. R.M. provided CXCL12-mRFP expressing mice. D.J.T. designed the influenza-infection model of mouse trachea. M.K. conceived, designed, and directed the study. K.L. and M.K. wrote the manuscript with suggestions from all authors. This project was financially supported through grants from the NIH (HL087088 to M.K. and AI102851 to M.K. and D.J.T., and HHSN272201400005C to D.J.T.), WCU Neurocytomics Program grant, Seoul National University Graduate School, Seoul, South Korea to M. K., and the American Heart Association (11SDG7520018 to Y-M.H.). The authors have no conflicting financial interests.	Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Chakrabarti S, 2005, EXP LUNG RES, V31, P599, DOI 10.1080/019021490944232; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; de Oca RM, 2000, INFECT IMMUN, V68, P1746, DOI 10.1128/IAI.68.3.1746-1751.2000; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Engeman T, 2004, J LEUKOCYTE BIOL, V76, P941, DOI 10.1189/jlb.0304193; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gehad A, 2012, J IMMUNOL, V189, P337, DOI 10.4049/jimmunol.1102315; Gomperts BN, 2006, J IMMUNOL, V176, P1916, DOI 10.4049/jimmunol.176.3.1916; Grabie N, 2003, AM J PATHOL, V163, P2413, DOI 10.1016/S0002-9440(10)63596-1; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Hudak S, 2002, J IMMUNOL, V169, P1189, DOI 10.4049/jimmunol.169.3.1189; Hyun YM, 2012, J EXP MED, V209, P1349, DOI 10.1084/jem.20111426; Kriebel PW, 2008, J CELL BIOL, V183, P949, DOI 10.1083/jcb.200808105; Kucia M, 2004, J MOL HISTOL, V35, P233; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Majumdar R, 2014, CURR OPIN CELL BIOL, V30, P33, DOI 10.1016/j.ceb.2014.05.010; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mithal DS, 2013, GLIA, V61, P1288, DOI 10.1002/glia.22515; Mueller SN, 2013, IMMUNOL CELL BIOL, V91, P290, DOI 10.1038/icb.2012.75; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Pluskota E, 2008, BLOOD, V112, P2327, DOI 10.1182/blood-2007-12-127183; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; Soehnlein O, 2009, THROMB HAEMOSTASIS, V102, P198, DOI 10.1160/TH08-11-0720; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Tamura Y, 1998, J MED CHEM, V41, P640, DOI 10.1021/jm9707582; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Ward SG, 2009, BIOCHEM J, V418, P13, DOI 10.1042/BJ20081969; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456	51	245	252	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252							aaa4352	10.1126/science.aaa4352	http://dx.doi.org/10.1126/science.aaa4352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339033	Green Accepted			2022-12-28	WOS:000360628900034
J	Abdalla, M; Sax, PE; Mostaghimi, A; Miller, AL; Loscalzo, J				Abdalla, Marwah; Sax, Paul E.; Mostaghimi, Arash; Miller, Amy Leigh; Loscalzo, Joseph			On the Nose	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLASTOMYCOSIS; DIAGNOSIS; ANTIGEN		[Abdalla, Marwah] Columbia Univ, Med Ctr, Dept Med, Div Cardiol, New York, NY USA; [Sax, Paul E.; Mostaghimi, Arash; Miller, Amy Leigh; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Mostaghimi, Arash] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Mostaghimi, Arash] Harvard Univ, Sch Med, Boston, MA USA	Columbia University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021	Mostaghimi, Arash/0000-0002-6084-5617				Bariola JR, 2011, DIAGN MICR INFEC DIS, V69, P187, DOI 10.1016/j.diagmicrobio.2010.09.015; Chapman SW, 2008, CLIN INFECT DIS, V46, P1801, DOI 10.1086/588300; Durkin M, 2004, J CLIN MICROBIOL, V42, P4873, DOI 10.1128/JCM.42.10.4873-4875.2004; Fang W, 2007, RADIOGRAPHICS, V27, P641, DOI 10.1148/rg.273065122; Kralt D, 2009, MYCOPATHOLOGIA, V167, P115, DOI 10.1007/s11046-008-9163-7; Mason AR, 2008, INT J DERMATOL, V47, P824, DOI 10.1111/j.1365-4632.2008.03732.x; McKinnell JA, 2009, CLIN CHEST MED, V30, P227, DOI 10.1016/j.ccm.2009.02.003; MEDOFF G, 1991, HOSP PRACT, V26, P41; PAPPAS PG, 1993, MEDICINE, V72, P311, DOI 10.1097/00005792-199309000-00003	9	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					955	961		10.1056/NEJMcps1315433	http://dx.doi.org/10.1056/NEJMcps1315433			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2OB	26332551	Green Published			2022-12-28	WOS:000360439500012
J	Di Noia, JM				Di Noia, Javier M.			MOLECULAR BIOLOGY Unequal opportunity during class switching	NATURE			English	Editorial Material							BREAKS; RECOMBINATION; MECHANISMS; REPAIR	The DNA breakage-and-repair mechanism that generates antibodies of different classes has, in theory, a 50% chance of occurring correctly. But this recombination turns out to be heavily biased towards productive events. See Letter P.134	[Di Noia, Javier M.] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Di Noia, Javier M.] Univ Montreal, Dept Med, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Di Noia, JM (corresponding author), Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	javier.di.noia@ircm.qc.ca	Di Noia, Javier Marcelo/D-2285-2012	Di Noia, Javier Marcelo/0000-0003-2896-0321				Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Bonaud A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8613; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Daniel JA, 2013, MOL CELL, V50, P309, DOI 10.1016/j.molcel.2013.04.017; Dong JC, 2015, NATURE, V525, P134, DOI 10.1038/nature14970; Helmink BA, 2012, ANNU REV IMMUNOL, V30, P175, DOI 10.1146/annurev-immunol-030409-101320; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Stavnezer J, 2014, J IMMUNOL, V193, P5370, DOI 10.4049/jimmunol.1401849; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003	10	3	3	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					44	45		10.1038/nature15209	http://dx.doi.org/10.1038/nature15209			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26308892				2022-12-28	WOS:000360594100022
J	Becker, TW; Lowry, AR; Faccenna, C; Schmandt, B; Borsa, A; Yu, CQ				Becker, Thorsten W.; Lowry, Anthony R.; Faccenna, Claudio; Schmandt, Brandon; Borsa, Adrian; Yu, Chunquan			Western US intermountain seismicity caused by changes in upper mantle flow	NATURE			English	Article							DYNAMIC TOPOGRAPHY; UNITED-STATES; TRAVEL-TIMES; LITHOSPHERE; CRUSTAL; CONVECTION; APENNINES; ELEVATION; VISCOSITY; SUPPORT	Understanding the causes of intraplate earthquakes is challenging, as it requires extending plate tectonic theory to the dynamics of continental deformation. Seismicity in the western United States away from the plate boundary is clustered along a meandering, north-south trending 'intermountain' belt(1). This zone coincides with a transition from thin, actively deforming to thicker, less tectonically active crust and lithosphere. Although such structural gradients have been invoked to explain seismicity localization(2,3), the underlying cause of seismicity remains unclear. Here we show results fromimproved mantle flowmodels that reveal a relationship between seismicity and the rate change of 'dynamic topography' (that is, vertical normal stress from mantle flow). The associated predictive skill is greater than that of any of the other forcings we examined. Wesuggest that active mantle flow is amajor contributor to seismogenic intraplate deformation, while gravitational potential energy variations have a minor role. Seismicity localization should occur where convective changes in vertical normal stress are modulated by lithospheric strength heterogeneities. Our results on deformation processes appear consistent with findings from other mobile belts(4), and imply that mantle flow plays a significant and quantifiable part in shaping topography, tectonics, and seismic hazard within intraplate settings.	[Becker, Thorsten W.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Lowry, Anthony R.] Utah State Univ, Dept Geol, Logan, UT 84322 USA; [Faccenna, Claudio] Univ Roma Tre, Dept Sci, I-00146 Rome, Italy; [Schmandt, Brandon] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Borsa, Adrian] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Yu, Chunquan] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of Southern California; Utah System of Higher Education; Utah State University; Italfarmaco; Roma Tre University; University of New Mexico; University of California System; University of California San Diego; Scripps Institution of Oceanography; Massachusetts Institute of Technology (MIT)	Becker, TW (corresponding author), Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	twb@usc.edu	Yu, Chunquan/AAL-8099-2021; Borsa, Adrian/AAH-2158-2019; Lowry, Anthony R/F-8158-2012; Yu, Chunquan/AAL-8098-2021; Becker, Thorsten W/ABF-7643-2021	Yu, Chunquan/0000-0001-8681-8572; Lowry, Anthony R/0000-0001-6023-3090; Yu, Chunquan/0000-0001-8681-8572; Becker, Thorsten W/0000-0002-5656-4564; Borsa, Adrian/0000-0002-9939-1480	National Science Foundation (NSF) [EAR-0350028, EAR-0732947]; NSF/US Geological Survey Southern California Earthquake Center;  [EAR-1215720];  [EAR-1215757];  [EAR-0955909];  [EAR-1358622]; Directorate For Geosciences [0955909] Funding Source: National Science Foundation; Division Of Earth Sciences [1261833, 1358622] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF/US Geological Survey Southern California Earthquake Center; ; ; ; ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank C. Kreemer for publishing his geodetic strain-rate models in electronic form, and C. Conrad for comments. All figures were created with Generic Mapping Tools<SUP>28</SUP>. Some analysis was based on data services provided by the Plate Boundary Observatory operated by UNAVCO for EarthScope and supported by the National Science Foundation (NSF; EAR-0350028 and EAR-0732947). T.W.B. was partially supported by NSF/US Geological Survey Southern California Earthquake Center, as well as EAR-1215720 and EAR-1215757. A.R.L. was supported by EAR-0955909 and EAR-1358622.	ARTYUSHKOV EV, 1973, J GEOPHYS RES, V78, P7675, DOI 10.1029/JB078i032p07675; Auer L, 2014, J GEOPHYS RES-SOL EA, V119, P3006, DOI 10.1002/2013JB010773; Becker TW, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003977; Becker TW, 2014, EARTH PLANET SC LETT, V402, P234, DOI 10.1016/j.epsl.2013.10.012; BIRD P, 1991, J GEOPHYS RES-SOLID, V96, P10275, DOI 10.1029/91JB00370; Borsa AA, 2014, SCIENCE, V345, P1587, DOI 10.1126/science.1260279; Braun J, 2010, NAT GEOSCI, V3, P825, DOI 10.1038/NGEO1020; Burov E, 2005, GEOPHYS J INT, V161, P469, DOI 10.1111/j.1365-246X.2005.02588.x; Conrad CP, 2009, LITHOSPHERE-US, V1, P110, DOI 10.1130/L32.1; D'Agostino N, 1999, TERRA NOVA, V11, P234; Ekstrom G, 2005, PHYS EARTH PLANET IN, V148, P327, DOI 10.1016/j.pepi.2004.09.006; Engdahl ER, 1998, B SEISMOL SOC AM, V88, P722; Faccenna C, 2014, REV GEOPHYS, V52, P283, DOI 10.1002/2013RG000444; Faccenna C, 2014, EARTH PLANET SC LETT, V407, P163, DOI 10.1016/j.epsl.2014.09.027; Faccenna C, 2010, NATURE, V465, P602, DOI 10.1038/nature09064; Fay NP, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001988; Flesch LM, 2000, SCIENCE, V287, P834, DOI 10.1126/science.287.5454.834; Forte AM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027895; Forte AM, 2010, TECTONOPHYSICS, V481, P3, DOI 10.1016/j.tecto.2009.06.010; Ghosh A, 2013, GEOPHYS J INT, V194, P651, DOI 10.1093/gji/ggt151; Gurnis M., 2000, GEOCHEM GEOPHY GEOSY, V1, DOI DOI 10.1029/1999GC000035; Herrmann RB, 2011, B SEISMOL SOC AM, V101, P2609, DOI 10.1785/0120110095; Humphreys ED, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000181; James DE, 2011, EARTH PLANET SC LETT, V311, P124, DOI 10.1016/j.epsl.2011.09.007; Jones CH, 1996, NATURE, V381, P37, DOI 10.1038/381037a0; Kreemer C, 2014, GEOCHEM GEOPHY GEOSY, V15, P3849, DOI 10.1002/2014GC005407; Levander A., 2012, GEOCHEM GEOPHY GEOSY, V13, P1525; Levandowski W, 2014, J GEOPHYS RES-SOL EA, V119, P2375, DOI 10.1002/2013JB010607; Liu LJ, 2010, GEOLOGY, V38, P663, DOI 10.1130/G30624.1; Lou XT, 2014, EARTH PLANET SC LETT, V402, P6, DOI 10.1016/j.epsl.2013.11.056; Lowry AR, 2011, NATURE, V471, P353, DOI 10.1038/nature09912; Lowry AR, 2000, J GEOPHYS RES-SOL EA, V105, P23371, DOI 10.1029/2000JB900182; LOWRY AR, 1995, J GEOPHYS RES-SOL EA, V100, P17947, DOI 10.1029/95JB00747; MOLCHAN GM, 1992, J GEOPHYS RES-SOL EA, V97, P4823, DOI 10.1029/91JB03095; MORESI LN, 1995, PHYS FLUIDS, V7, P2154, DOI 10.1063/1.868465; Moucha R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039778; NCEDC, 2014, NO CAL EARTHQ DAT CT; Obrebski M, 2011, GEOPHYS J INT, V185, P1003, DOI 10.1111/j.1365-246X.2011.04990.x; Perry HKC, 2003, GEOPHYS J INT, V154, P279, DOI 10.1046/j.1365-246X.2003.01961.x; RICHARDS MA, 1984, J GEOPHYS RES, V89, P5987, DOI 10.1029/JB089iB07p05987; Schmandt B, 2014, GEOPHYS RES LETT, V41, P6342, DOI 10.1002/2014GL061231; Schmandt B, 2014, SCIENCE, V344, P1265, DOI [10.1126/science.1253358, 10.1126/science.1253258]; Schmandt B, 2010, EARTH PLANET SC LETT, V297, P435, DOI 10.1016/j.epsl.2010.06.047; Serpelloni E, 2013, J GEOPHYS RES-SOL EA, V118, P6003, DOI 10.1002/2013JB010102; Shen WS, 2013, J GEOPHYS RES-SOL EA, V118, P4325, DOI 10.1002/jgrb.50321; van Wijk JW, 2010, GEOLOGY, V38, P611, DOI 10.1130/G31031.1; Wessel P., 1998, EOS T AM GEOPHYS UN, V79, P579, DOI [10.1029/98EO00426, DOI 10.1029/98EO00426, DOI 10.1029/98E000426]; Zechar JD, 2008, GEOPHYS J INT, V172, P715, DOI 10.1111/j.1365-246X.2007.03676.x; Zhong SJ, 2000, J GEOPHYS RES-SOL EA, V105, P11063, DOI 10.1029/2000JB900003	49	35	38	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					458	+		10.1038/nature14867	http://dx.doi.org/10.1038/nature14867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26310767				2022-12-28	WOS:000360069300036
J	Turner, MS				Turner, Michael S.			Yoichiro Nambu (1921-2015) Visionary theorist who shaped modern particle physics.	NATURE			English	Biographical-Item									[Turner, Michael S.] Univ Chicago, Astron & Astrophys, Chicago, IL 60637 USA; [Turner, Michael S.] Univ Chicago, Phys, Chicago, IL 60637 USA; [Turner, Michael S.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Turner, MS (corresponding author), Univ Chicago, Astron & Astrophys, Chicago, IL 60637 USA.	mturner@kicp.uchicago.edu							0	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					416	416		10.1038/524416a	http://dx.doi.org/10.1038/524416a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26310759	Bronze			2022-12-28	WOS:000360069300022
J	Angus, DC				Angus, Derek C.			Fusing Randomized Trials With Big Data The Key to Self-learning Health Care Systems?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-TRIAL		Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Angus, DC (corresponding author), Univ Pittsburgh, Dept Crit Care Med, 3550 Terrace St,614 Scaife Hall, Pittsburgh, PA 15261 USA.	angusdc@upmc.edu	Angus, Derek C/E-9671-2012					Berry SM, 2015, JAMA-J AM MED ASSOC, V313, P1619, DOI 10.1001/jama.2015.2316; Fiore LD, 2011, CLIN TRIALS, V8, P183, DOI [10.1177/1740774510395635, 10.1177/1740774511398368]; Longford NT, 1999, STAT MED, V18, P1467, DOI 10.1002/(SICI)1097-0258(19990630)18:12<1467::AID-SIM149>3.0.CO;2-H; Noto MJ, 2015, JAMA-J AM MED ASSOC, V313, P369, DOI 10.1001/jama.2014.18400; Platform for European Preparedness Against (Re-) emerging Epidemics (PREPARE), PRACTICE C AD RAND T; Titiunik R, 2015, PS-POLIT SCI POLIT, V48, P75, DOI 10.1017/S1049096514001772	6	109	113	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					767	768		10.1001/jama.2015.7762	http://dx.doi.org/10.1001/jama.2015.7762			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305643				2022-12-28	WOS:000360017200011
J	Byass, P				Byass, Peter			A transition towards a healthier global population?	LANCET			English	Editorial Material							EPIDEMIOLOGIC TRANSITION		[Byass, Peter] Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res, S-90187 Umea, Sweden	Umea University	Byass, P (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res, S-90187 Umea, Sweden.	peter.byass@umu.se						Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Santosa A, 2014, GLOBAL HEALTH ACTION, V7, P56, DOI 10.3402/gha.v7.23574; Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25362; United Nations, 2015, OUTCOME DOCUMENT OF; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6	8	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 28	2015	386	10009					2121	+		10.1016/S0140-6736(15)61476-3	http://dx.doi.org/10.1016/S0140-6736(15)61476-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX8YW	26318267				2022-12-28	WOS:000365992600009
J	Jaacks, LM; Ali, MK; Bartlett, J; Bloomfield, GS; Checkley, W; Gaziano, TA; Heimburger, DC; Kishore, SP; Kohler, RE; Lipska, KJ; Manders, O; Ngaruiya, C; Peck, R; Pena, MB; Watkins, DA; Siegel, KR; Narayan, KMV				Jaacks, Lindsay M.; Ali, Mohammed K.; Bartlett, John; Bloomfield, Gerald S.; Checkley, William; Gaziano, Thomas A.; Heimburger, Douglas C.; Kishore, Sandeep P.; Kohler, Racquel E.; Lipska, Kasia J.; Manders, Olivia; Ngaruiya, Christine; Peck, Robert; Pena, Melissa Burroughs; Watkins, David A.; Siegel, Karen R.; Narayan, K. M. Venkat			Global Noncommunicable Disease Research: Opportunities and Challenges	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEALTH; SCIENCE		Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Duke Univ, Duke Global Hlth Inst, Durham, NC USA; Duke Univ, Duke Clin Res Inst, Durham, NC USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Gaziano, Thomas A.] Brigham & Womens Hosp, Boston, MA 02115 USA; Young Profess Chron Dis Network, Boston, MA USA; Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Kishore, Sandeep P.; Lipska, Kasia J.; Ngaruiya, Christine] Yale Univ, Sch Med, New Haven, CT 06510 USA; [Kohler, Racquel E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Peck, Robert] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY 10065 USA; [Ngaruiya, Christine] Yale Univ, Sch Med, New Haven, CT 06519 USA; [Watkins, David A.] Univ Washington, Seattle, WA 98104 USA	Emory University; Rollins School Public Health; Duke University; Duke University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Brigham & Women's Hospital; Vanderbilt University; Yale University; University of North Carolina; University of North Carolina Chapel Hill; Cornell University; Yale University; University of Washington; University of Washington Seattle	Jaacks, LM (corresponding author), Rollins Sch Publ Hlth, Claudia Nance Rollins Bldg 7040-I,1518 Clifton Rd, Atlanta, GA 30307 USA.	ljaacks@emory.edu	Narayan, K.M. Venkat/J-9819-2012; Watkins, David/ABC-3783-2020; Ali, Mohammed K/N-9833-2013	Narayan, K.M. Venkat/0000-0001-8621-5405; Watkins, David/0000-0001-6341-9595; Manders, Olivia/0000-0002-2113-1558; Checkley, William/0000-0003-1106-8812; Peck, Robert/0000-0002-4526-2480; Ali, Mohammed/0000-0001-7266-2503; Bloomfield, Gerald/0000-0002-7176-1611; Jaacks, Lindsay/0000-0002-7791-5167	FIC NIH HHS [R25 TW009337] Funding Source: Medline; NCI NIH HHS [R25 CA116339] Funding Source: Medline; NIA NIH HHS [K23 AG048359] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA116339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG048359] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Collins FS, 2015, JAMA-J AM MED ASSOC, V313, P131, DOI 10.1001/jama.2014.16736; Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Heimburger DC, 2014, AM J TROP MED HYG, V91, P219, DOI 10.4269/ajtmh.13-0741; Lamptey P, 2012, GLOB HEART, V7, P67, DOI 10.1016/j.gheart.2012.01.010; Merson MH, 2014, NEW ENGL J MED, V370, P1676, DOI 10.1056/NEJMp1401124; National Heart Lung and Blood Institute, 2012, NIH PUBLICATION, V12-7486; Syed SB, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-36; Thompson MJ, 2003, ACAD MED, V78, P342, DOI 10.1097/00001888-200303000-00023; Varmus H, 2002, LANCET, V360, pS1, DOI 10.1016/S0140-6736(02)11796-X; Vermund SH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008684	10	13	14	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2015	163	9					712	+		10.7326/M15-1068	http://dx.doi.org/10.7326/M15-1068			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX3PF	26301624	Green Accepted			2022-12-28	WOS:000365610600008
J	Zelenay, S; van der Veen, AG; Bottcher, JP; Snelgrove, KJ; Rogers, N; Acton, SE; Chakravarty, P; Girotti, MR; Marais, R; Quezada, SA; Sahai, E; Sousa, CRE				Zelenay, Santiago; van der Veen, Annemarthe G.; Boettcher, Jan P.; Snelgrove, Kathryn J.; Rogers, Neil; Acton, Sophie E.; Chakravarty, Probir; Girotti, Maria Romina; Marais, Richard; Quezada, Sergio A.; Sahai, Erik; Reis e Sousa, Caetano			Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity	CELL			English	Article							I INTERFERON; MALIGNANT-MELANOMA; COX-2 EXPRESSION; DENDRITIC CELLS; CANCER; INFLAMMATION; RESPONSES; REVEALS; INHIBITION; MECHANISM	The mechanisms by which melanoma and other cancer cells evade anti-tumor immunity remain incompletely understood. Here, we show that the growth of tumors formed by mutant Braf(V600E) mouse melanoma cells in an immunocompetent host requires their production of prostaglandin E2, which suppresses immunity and fuels tumor-promoting inflammation. Genetic ablation of cyclooxygenases (COX) or prostaglandin E synthases in Braf(V600E) mouse melanoma cells, as well as in Nras(G12D) melanoma or in breast or colorectal cancer cells, renders them susceptible to immune control and provokes a shift in the tumor inflammatory profile toward classic anti-cancer immune pathways. This mouse COX-dependent inflammatory signature is remarkably conserved in human cutaneous melanoma biopsies, arguing for COX activity as a driver of immune suppression across species. Pre-clinical data demonstrate that inhibition of COX synergizes with anti-PD-1 blockade in inducing eradication of tumors, implying that COX inhibitors could be useful adjuvants for immune-based therapies in cancer patients.	[Zelenay, Santiago; van der Veen, Annemarthe G.; Boettcher, Jan P.; Snelgrove, Kathryn J.; Rogers, Neil; Acton, Sophie E.; Reis e Sousa, Caetano] Lincolns Inn Fields Lab, Francis Crick Inst, Immunobiol Lab, London WC2A 3LY, England; [Chakravarty, Probir] Lincolns Inn Fields Lab, Francis Crick Inst, Bioinformat, London WC2A 3LY, England; [Girotti, Maria Romina; Marais, Richard] Univ Manchester, Canc Res UK Manchester Inst, Mol Oncol Grp, Manchester M20 4BX, Lancs, England; [Quezada, Sergio A.] UCL, Inst Canc, Dept Res Haematol, Canc Immunol Unit, London WC1E 6DD, England; [Sahai, Erik] Lincolns Inn Fields Lab, Francis Crick Inst, Tumor Cell Biol Lab, London WC2A 3LY, England	Francis Crick Institute; Francis Crick Institute; Cancer Research UK; University of Manchester; University of London; University College London; Francis Crick Institute	Zelenay, S (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Canc Inflammat & Immun Grp, Manchester M20 4BX, Lancs, England.	santiago.zelenay@cruk.manchester.ac.uk; caetano@crick.ac.uk	Reis e Sousa, Caetano/ABD-7322-2021; Acton, Sophie/G-9784-2012; Quezada, Sergio/ABF-6466-2020	Reis e Sousa, Caetano/0000-0001-7392-2119; Acton, Sophie/0000-0003-2704-716X; Quezada, Sergio/0000-0002-9763-1700; chakravarty, probir/0000-0003-1146-8824; Zelenay, Santiago/0000-0002-6865-3978; Sahai, Erik/0000-0002-3932-5086; Bottcher, Jan/0000-0002-8163-8107; Rogers, Neil/0000-0001-8977-7585	Cancer Research UK; Francis Crick Institute; European Research Council Advanced Researcher Grant; EMBO Long-Term Fellowship; Rubicon Fellowship from the Netherlands Organization for Scientific Research; Cancer Research UK [12100, 17240, 19279, 15689] Funding Source: researchfish; The Francis Crick Institute [10138, 10334, 10136, 10144, 10002] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Francis Crick Institute; European Research Council Advanced Researcher Grant(European Research Council (ERC)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Rubicon Fellowship from the Netherlands Organization for Scientific Research; Cancer Research UK(Cancer Research UK); The Francis Crick Institute	This work was funded by Cancer Research UK, The Francis Crick Institute, and a European Research Council Advanced Researcher Grant. A.G.V. was supported by an EMBO Long-Term Fellowship and a Rubicon Fellowship from the Netherlands Organization for Scientific Research. The authors are grateful to members of the Immunobiology Laboratory for assistance and helpful discussions.	Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Becker MR, 2009, MELANOMA RES, V19, P8, DOI 10.1097/CMR.0b013e32831d7f52; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Denkert C, 2001, CANCER RES, V61, P303; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Gamba CA, 2013, CANCER-AM CANCER SOC, V119, P1562, DOI 10.1002/cncr.27817; Gierach GL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2089; Goulet AC, 2003, CANCER BIOL THER, V2, P713; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Knight DA, 2013, J CLIN INVEST, V123, P1371, DOI 10.1172/JCI66236; Kuzbicki L, 2006, MELANOMA RES, V16, P29; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pedersen M, 2013, CANCER DISCOV, V3, P458, DOI 10.1158/2159-8290.CD-12-0464; Phan VT, 2013, P NATL ACAD SCI USA, V110, P6079, DOI 10.1073/pnas.1303302110; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tian WJ, 2010, EUR J CANCER PREV, V19, P288, DOI 10.1097/CEJ.0b013e328339648c; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wenzel J, 2005, AM J CLIN PATHOL, V124, P37, DOI 10.1309/4EJ9KL7CGDENWLE; Xu LH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008455	50	616	645	23	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1257	1270		10.1016/j.cell.2015.08.015	http://dx.doi.org/10.1016/j.cell.2015.08.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26343581	Green Published, hybrid			2022-12-28	WOS:000361247900016
J	Bauer, P; Thorpe, A; Brunet, G				Bauer, Peter; Thorpe, Alan; Brunet, Gilbert			The quiet revolution of numerical weather prediction	NATURE			English	Review							OPERATIONAL IMPLEMENTATION; RADIATIVE-TRANSFER; ASSIMILATION; CLIMATE; MODELS; PARAMETERIZATION; UNCERTAINTY; SKILL; RESOLUTION; CONVECTION	Advances in numerical weather prediction represent a quiet revolution because they have resulted from a steady accumulation of scientific knowledge and technological advances over many years that, with only a few exceptions, have not been associated with the aura of fundamental physics breakthroughs. Nonetheless, the impact of numerical weather prediction is among the greatest of any area of physical science. As a computational problem, global weather prediction is comparable to the simulation of the human brain and of the evolution of the early Universe, and it is performed every day at major operational centres across the world.	[Bauer, Peter; Thorpe, Alan] European Ctr Medium Range Weather Forecasts, Reading RG2 9AX, Berks, England; [Brunet, Gilbert] Environm Canada, Quebec City, PQ H9P 1J3, Canada	European Centre for Medium-Range Weather Forecasts (ECMWF); Environment & Climate Change Canada	Bauer, P (corresponding author), European Ctr Medium Range Weather Forecasts, Shinfield Pk, Reading RG2 9AX, Berks, England.	peter.bauer@ecmwf.int	Bauer, Peter/AAN-7317-2020	Bauer, Peter/0000-0002-3205-6055				Abbe C., 1901, MON WEATHER REV, V29, P551, DOI [DOI 10.1175/1520-0493(1901)29[551C:TPBOLW]2.0.CO;2, 10.1175/1520-0493(1901)29[551c:TPBOLW]2.0.CO;2]; [Anonymous], 2012, B AM METEOROL SOC, DOI DOI 10.1175/2011BAMS3224.1; Arakawa A, 2004, J CLIMATE, V17, P2493, DOI 10.1175/1520-0442(2004)017<2493:RATCPP>2.0.CO;2; Arakawa A, 1997, J METEOROL SOC JPN, V75, P155, DOI 10.2151/jmsj1965.75.1B_155; Baldwin MP, 2001, SCIENCE, V294, P581, DOI 10.1126/science.1063315; Barnston AG, 2012, B AM METEOROL SOC, V93, P631, DOI 10.1175/BAMS-D-11-00111.1; Bauer P, 2006, Q J ROY METEOR SOC, V132, P1259, DOI 10.1256/qj.05.153; Benoit R, 2000, MON WEATHER REV, V128, P1681, DOI 10.1175/1520-0493(2000)128<1681:TTUOCA>2.0.CO;2; Bjerkenes V., 1904, METEOROL Z, V21, P1, DOI DOI 10.1127/0941-2948/2009/416; BOLIN B, 1955, TELLUS, V7, P27, DOI 10.1111/j.2153-3490.1955.tb01139.x; Brunet G, 2010, B AM METEOROL SOC, V91, P1397, DOI 10.1175/2010BAMS3013.1; Buehner M, 2005, Q J ROY METEOR SOC, V131, P1013, DOI 10.1256/qj.04.15; Cardinali C, 2013, DATA ASSIMILATION AT, V2, P89; Chapnik B, 2006, Q J ROY METEOR SOC, V132, P543, DOI 10.1256/qj.04.102; Charney J.G., 1950, TELLUS, V2, P237, DOI [10.1111/j.2153-3490.1950.tb00336.x, DOI 10.3402/TELLUSA.V2I4.8607, 10.3402/tellusa.v2i4.8607]; Cloke HL, 2013, HYDROL PROCESS, V27, P1, DOI 10.1002/hyp.9679; Collard AD, 2010, Q J ROY METEOR SOC, V136, P2038, DOI 10.1002/qj.701; COURTIER P, 1994, Q J ROY METEOR SOC, V120, P1367, DOI 10.1256/smsqj.51911; Daley R., 1991, ATMOSPHERIC DATA ANA; Dole R, 2014, B AM METEOROL SOC, V95, P427, DOI 10.1175/BAMS-D-12-00069.1; Duc L, 2013, TELLUS A, V65, DOI 10.3402/tellusa.v65i0.18171; Dudhia J, 2014, ASIA-PAC J ATMOS SCI, V50, P121, DOI 10.1007/s13143-014-0031-8; Ehrendorfer M, 1997, METEOROL Z, V6, P147; EPSTEIN ES, 1969, TELLUS, V21, P739, DOI 10.1111/j.2153-3490.1969.tb00483.x; Evensen G, 2007, DATA ASSIMILATION EN; Ferro CAT, 2011, WEATHER FORECAST, V26, P699, DOI 10.1175/WAF-D-10-05030.1; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Frank WM, 2006, MON WEATHER REV, V134, P2397, DOI 10.1175/MWR3204.1; Gauthier P, 2001, MON WEATHER REV, V129, P2089, DOI 10.1175/1520-0493(2001)129<2089:IOTDFA>2.0.CO;2; Gauthier P, 2007, MON WEATHER REV, V135, P2339, DOI 10.1175/MWR3394.1; Gleckler PJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023061; Grenier H, 2001, MON WEATHER REV, V129, P357, DOI 10.1175/1520-0493(2001)129<0357:AMPPFL>2.0.CO;2; Holloway CE, 2013, J ATMOS SCI, V70, P1342, DOI 10.1175/JAS-D-12-0227.1; Horanyi A., 2014, Q J R METEOROL SOC; Hoskins B, 2013, Q J ROY METEOR SOC, V139, P573, DOI 10.1002/qj.1991; Hurrell J, 2009, B AM METEOROL SOC, V90, P1819, DOI 10.1175/2009BAMS2752.1; Inness PM, 2001, CLIM DYNAM, V17, P777, DOI 10.1007/s003820000148; Jakob C, 2010, B AM METEOROL SOC, V91, P869, DOI 10.1175/2009BAMS2898.1; Janiskova M., 2013, DATA ASSIMILATION AT, P251; Johnson C, 2009, MON WEATHER REV, V137, P1717, DOI 10.1175/2009MWR2715.1; Jung T, 2010, MON WEATHER REV, V138, P2434, DOI 10.1175/2010MWR3255.1; Kadowaki T., 2005, CAS JSC WGNE RES ACT, V34, P117; Kalnay E., 2003, ATMOSPHERIC MODELING, DOI DOI 10.1017/CBO9780511802270; Koster RD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041677; Lauritzen PH, 2012, Q J ROY METEOR SOC, V138, P906, DOI 10.1002/qj.986; Lawrence B., 2013, DATA HANDLING PATH E; Lazo JK, 2009, B AM METEOROL SOC, V90, P785, DOI 10.1175/2008BAMS2604.1; Leeuwen P. J. V., 2011, COMPUT FLUIDS; LEITH CE, 1974, MON WEATHER REV, V102, P409, DOI 10.1175/1520-0493(1974)102<0409:TSOMCF>2.0.CO;2; Lin H, 2009, MON WEATHER REV, V137, P2250, DOI 10.1175/2009MWR2831.1; Lin H, 2009, J CLIMATE, V22, P364, DOI 10.1175/2008JCLI2515.1; Lions J.-L., 1968, CONTROLE OPTIMAL SYS; LORENC AC, 1986, Q J ROY METEOR SOC, V112, P1177, DOI 10.1002/qj.49711247414; Lorenc AC, 2015, MON WEATHER REV, V143, P212, DOI 10.1175/MWR-D-14-00195.1; Lorenz EN, 2006, ANNU REV EARTH PL SC, V34, P37, DOI 10.1146/annurev.earth.34.083105.102317; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Lynch P, 2008, J COMPUT PHYS, V227, P3431, DOI 10.1016/j.jcp.2007.02.034; MacLachlan C, 2015, Q J ROY METEOR SOC, V141, P1072, DOI 10.1002/qj.2396; Magnusson L, 2013, MON WEATHER REV, V141, P3142, DOI 10.1175/MWR-D-12-00318.1; William PI, 2013, B AM METEOROL SOC, V94, P1007, DOI 10.1175/BAMS-D-12-00044.1; Martin GM, 2010, J CLIMATE, V23, P5933, DOI 10.1175/2010JCLI3541.1; Mollick E, 2006, IEEE ANN HIST COMPUT, V28, P62, DOI 10.1109/MAHC.2006.45; Molteni F, 2011, ECMWF TECHNICAL MEMO; Molteni F, 2006, PREDICTABILITY OF WEATHER AND CLIMATE, P365, DOI 10.1017/CBO9780511617652.015; Muller EH, 2014, Q J ROY METEOR SOC, V140, P2608, DOI 10.1002/qj.2327; Navon I. M., 2009, DATA ASSIMILATION AT, P21, DOI [10.1007/978-3-540-71056-1_2, DOI 10.1007/978-3-540-71056-1_2]; Palem K, 2013, ACM T EMBED COMPUT S, V12, DOI 10.1145/2465787.2465789; Palmer TN, 2012, Q J ROY METEOR SOC, V138, P841, DOI 10.1002/qj.1923; Phillips TJ, 2004, B AM METEOROL SOC, V85, P1903, DOI 10.1175/BAMS-85-12-1903; Poincare H., 1914, SCI METHOD; Rabier F, 2000, Q J ROY METEOR SOC, V126, P1143, DOI 10.1256/smsqj.56414; Randall D, 2003, B AM METEOROL SOC, V84, P1547, DOI 10.1175/BAMS-84-11-1547; Richardson L.F., 1922, WEATHER PREDICTION N, DOI DOI 10.1017/CBO9780511618291; ROBERT A, 1982, J METEOROL SOC JPN, V60, P319, DOI 10.2151/jmsj1965.60.1_319; Rodwell MJ, 2007, Q J ROY METEOR SOC, V133, P129, DOI 10.1002/qj.23; Rodwell MJ, 2010, Q J ROY METEOR SOC, V136, P1344, DOI 10.1002/qj.656; Saunders R, 1999, Q J ROY METEOR SOC, V125, P1407, DOI 10.1256/smsqj.55614; Scaife AA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023226; Shalf J, 2011, LECT NOTES COMPUT SC, V6449, P1, DOI 10.1007/978-3-642-19328-6_1; Shin HH, 2013, J ATMOS SCI, V70, P3248, DOI 10.1175/JAS-D-12-0290.1; Simmons AJ, 2002, Q J ROY METEOR SOC, V128, P647, DOI 10.1256/003590002321042135; Slingo J, 2011, PHILOS T R SOC A, V369, P4751, DOI 10.1098/rsta.2011.0161; Snik F, 2014, GEOPHYS RES LETT, V41, P7351, DOI 10.1002/2014GL061462; Staniforth A, 2002, MON WEATHER REV, V130, P3129, DOI 10.1175/1520-0493(2002)130<3129:ASCOFP>2.0.CO;2; Stensrud DJ, 2007, PARAMETERIZATION SCH; Teng HY, 2013, NAT GEOSCI, V6, P1056, DOI [10.1038/NGEO1988, 10.1038/ngeo1988]; THOMPSON PD, 1957, TELLUS, V9, P275, DOI 10.1111/j.2153-3490.1957.tb01885.x; Thorpe A., 2013, METEOROLOGY SECTION, P15; Trenberth KE, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018020; Watson PAG, 2015, J ATMOS SCI, V72, P236, DOI 10.1175/JAS-D-14-0252.1; Williams PD, 2005, PHILOS T R SOC A, V363, P2931, DOI 10.1098/rsta.2005.1676; Williamson DL, 2007, J METEOROL SOC JPN, V85B, P241, DOI 10.2151/jmsj.85B.241; World Meteorological Organization, 2015, 1156 WMO; Xu L, 2005, TELLUS A, V57, P546, DOI 10.1111/j.1600-0870.2005.00123.x; Yu H, 2013, WEATHER FORECAST, V28, P353, DOI 10.1175/WAF-D-11-00100.1; Zappa M, 2010, ATMOS SCI LETT, V11, P83, DOI 10.1002/asl.248; Zhang HL, 2010, ADV METEOROL, V2010, DOI 10.1155/2010/432160; Zhang Y, 2008, ATMOS CHEM PHYS, V8, P2895, DOI 10.5194/acp-8-2895-2008; Zhang Y, 2012, ATMOS ENVIRON, V60, P656, DOI 10.1016/j.atmosenv.2012.02.041	100	883	925	26	294	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					47	55		10.1038/nature14956	http://dx.doi.org/10.1038/nature14956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26333465				2022-12-28	WOS:000360594100023
J	Bakris, GL; Agarwal, R; Chan, JC; Cooper, ME; Gansevoort, RT; Haller, H; Remuzzi, G; Rossing, P; Schmieder, RE; Nowack, C; Kolkhof, P; Joseph, A; Pieper, A; Kimmeskamp-Kirschbaum, N; Ruilope, LM				Bakris, George L.; Agarwal, Rajiv; Chan, Juliana C.; Cooper, Mark E.; Gansevoort, Ron T.; Haller, Hermann; Remuzzi, Giuseppe; Rossing, Peter; Schmieder, Roland E.; Nowack, Christina; Kolkhof, Peter; Joseph, Amer; Pieper, Alexander; Kimmeskamp-Kirschbaum, Nina; Ruilope, Luis M.		Mineralocorticoid Receptor	Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINERALOCORTICOID RECEPTOR; BLOOD-PRESSURE; KIDNEY-DISEASE; BAY 94-8862; PROTEINURIA; ANTAGONIST; BLOCKADE; SPIRONOLACTONE; INHIBITION; MORBIDITY	IMPORTANCE Steroidal mineralocorticoid receptor antagonists, when added to a renin-angiotensin system blocker, further reduce proteinuria in patients with chronic kidney disease but may be underused because of a high risk of adverse events. OBJECTIVE To evaluate the safety and efficacy of different oral doses of the nonsteroidal mineralocorticoid receptor antagonist finerenone, given for 90 days to patients with diabetes and high or very high albuminuria who are receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, placebo-controlled, parallel-group study conducted at 148 sites in 23 countries. Patients were recruited from June 2013 to February 2014 and the study was completed in August 2014. Of 1501 screened patients, 823 were randomized and 821 received study drug. INTERVENTIONS Participants were randomly assigned to receive oral, once-daily finerenone (1.25mg/d, n = 96; 2.5mg/d, n = 92; 5mg/d, n = 100; 7.5mg/d, n = 97; 10mg/d, n = 98; 15mg/d, n = 125; and 25mg/d, n = 119) or matching placebo (n = 94) for 90 days. MAIN OUTCOMES AND MEASURES The primary outcome was the ratio of the urinary albumin-creatinine ratio (UACR) at day 90 vs at baseline. Safety end points were changes from baseline in serum potassium and estimated glomerular filtration rate. RESULTS The mean age of the participants was 64.2 years; 78% were male. At baseline, 36.7% of patients treated had very high albuminuria (UACR >= 300mg/g) and 40.0% had an estimated glomerular filtration rate of 60 mL/min/1.73m(2) or lower. Finerenone demonstrated a dose-dependent reduction in UACR. The primary outcome, the placebo-corrected mean ratio of the UACR at day 90 relative to baseline, was reduced in the finerenone 7.5-, 10-, 15-, and 20-mg/d groups (for 7.5mg/d, 0.79 [90% CI, 0.68-0.91; P =.004]; for 10mg/d, 0.76 [90% CI, 0.65-0.88; P =.001]; for 15mg/d, 0.67 [90% CI, 0.58-0.77; P<.001]; for 20mg/d, 0.62 [90% CI, 0.54-0.72; P <.001]). The prespecified secondary outcome of hyperkalemia leading to discontinuation was not observed in the placebo and finerenone 10-mg/d groups; incidences in the finerenone 7.5-, 15-, and 20-mg/d groups were 2.1%, 3.2%, and 1.7%, respectively. There were no differences in the incidence of the prespecified secondary outcome of an estimated glomerular filtration rate decrease of 30% or more or in incidences of adverse events and serious adverse events between the placebo and finerenone groups. CONCLUSIONS AND RELEVANCE Among patients with diabetic nephropathy, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of finerenone compared with placebo resulted in improvement in the urinary albumin-creatinine ratio. Further trials are needed to compare finerenone with other active medications.	[Bakris, George L.] Univ Chicago Med, Chicago, IL USA; [Agarwal, Rajiv] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA; [Agarwal, Rajiv] Indiana Univ, Indianapolis, IN 46204 USA; [Chan, Juliana C.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Cooper, Mark E.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Gansevoort, Ron T.] Univ Med Ctr Groeningen, Dept Nephrol, Groeningen, Netherlands; [Haller, Hermann] Hannover Med Sch, Dept Nephrol, Hannover, Germany; [Haller, Hermann] Hannover Med Sch, Dept Hypertens, Hannover, Germany; [Remuzzi, Giuseppe] Ist Ric Farmacol Mario Negri, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Unit Nephrol & Dialysis, Bergamo, Italy; [Rossing, Peter] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Rossing, Peter] Univ Copenhagen, Copenhagen, Denmark; [Rossing, Peter] Aarhus Univ, Aarhus, Denmark; [Schmieder, Roland E.] Univ Hosp Erlangen, Dept Hypertens & Nephrol, Erlangen, Germany; [Nowack, Christina] Bayer HealthCare, Global Clin Dev, Wuppertal, Germany; [Kolkhof, Peter] Bayer HealthCare, Global Drug Discovery, Heart Dis Res, Wuppertal, Germany; [Joseph, Amer] Bayer PLC, Global Clin Dev, Newbury, Berks, England; [Pieper, Alexander] MARCO GmbH & Co KG, Dusseldorf, Germany; [Kimmeskamp-Kirschbaum, Nina] Bayer HealthCare, Global Res & Dev Stat, Leverkusen, Germany; [Ruilope, Luis M.] Hosp 12 Octubre, Inst Invest & Hypertens Unit, E-28041 Madrid, Spain	US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Chinese University of Hong Kong; Baker Heart and Diabetes Institute; Hannover Medical School; Hannover Medical School; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII; Steno Diabetes Center; University of Copenhagen; Aarhus University; University of Erlangen Nuremberg; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer AG; Bayer Healthcare Pharmaceuticals; Hospital Universitario 12 de Octubre	Bakris, GL (corresponding author), Univ Chicago Med & Biol Sci, ASH Comprehens Hypertens Ctr, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.	gbakris@gmail.com	Schaper, Nicolaas C/E-7112-2014; De Cosmo, Salvatore/J-7420-2016; Del Prato, Stefano/K-3405-2016; rossing, peter/AAH-7879-2021; Cooper, Mark/AAC-5326-2020; Agarwal, Rajiv/H-3454-2019; Chan, Juliana/B-7918-2016; rossing, peter/AAZ-3415-2021; Remuzzi, Giuseppe/V-9766-2017	De Cosmo, Salvatore/0000-0001-8787-8286; Del Prato, Stefano/0000-0002-5388-0270; Agarwal, Rajiv/0000-0001-8355-7100; Chan, Juliana/0000-0003-1325-1194; rossing, peter/0000-0002-1531-4294; schaper, nicolaas/0000-0002-2128-8029; Sunder-Plassmann, Gere/0000-0002-9253-9921; Ruilope, Luis M/0000-0001-6278-7951; Finnes, Trine Elisabeth/0000-0003-1102-8706; Remuzzi, Giuseppe/0000-0002-6194-3446	Bayer HealthCare AG	Bayer HealthCare AG(Bayer AGBayer Healthcare Pharmaceuticals)	This study was funded by Bayer HealthCare AG.	Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Bakris GL, 2011, MAYO CLIN PROC, V86, P444, DOI 10.4065/mcp.2010.0713; Bolignano D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007004.pub3; Bomback AS, 2008, AM J KIDNEY DIS, V51, P199, DOI 10.1053/j.ajkd.2007.10.040; Chrysostomou A, 2001, NEW ENGL J MED, V345, P925, DOI 10.1056/NEJM200109203451215; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; Epstein M, 2006, CLIN J AM SOC NEPHRO, V1, P940, DOI 10.2215/CJN.00240106; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Gomez-Sanchez EP, 2012, MOL CELL ENDOCRINOL, V350, P289, DOI 10.1016/j.mce.2011.05.005; Holtkamp FA, 2011, EUR HEART J, V32, P1493, DOI 10.1093/eurheartj/ehr017; Kolkhof P, 2014, J CARDIOVASC PHARM, V64, P69, DOI 10.1097/FJC.0000000000000091; Lazich L, 2014, SEMIN NEPHROL, V34, P333, DOI 10.1016/j.semnephrol.2014.04.008; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Mavrakanas TA, 2014, EUR J INTERN MED, V25, P173, DOI 10.1016/j.ejim.2013.11.007; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; Rossing K, 2005, DIABETES CARE, V28, P2106, DOI 10.2337/diacare.28.9.2106; Ruilope LM, 2014, AM J NEPHROL, V40, P572, DOI 10.1159/000371497; Schmieder R, 2014, DIABETOLOGIA, V57, P2019, DOI 10.1007/s00125-014-3330-9; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Tuttle KR, 2014, DIABETES CARE, V37, P2864, DOI 10.2337/dc14-1296; Yamout H, 2014, ADV CHRONIC KIDNEY D, V21, P281, DOI 10.1053/j.ackd.2014.03.005	25	371	385	7	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					884	894		10.1001/jama.2015.10081	http://dx.doi.org/10.1001/jama.2015.10081			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325557	Green Published, Bronze			2022-12-28	WOS:000360392100015
J	Patel, A; Lee, HO; Jawerth, L; Maharana, S; Jahnel, M; Hein, MY; Stoynov, S; Mahamid, J; Saha, S; Franzmann, TM; Pozniakovski, A; Poser, I; Maghelli, N; Royer, LA; Weigert, M; Myers, EW; Grill, S; Drechsel, D; Hyman, AA; Alberti, S				Patel, Avinash; Lee, Hyun O.; Jawerth, Louise; Maharana, Shovamayee; Jahnel, Marcus; Hein, Marco Y.; Stoynov, Stoyno; Mahamid, Julia; Saha, Shambaditya; Franzmann, Titus M.; Pozniakovski, Andrej; Poser, Ina; Maghelli, Nicola; Royer, Loic A.; Weigert, Martin; Myers, Eugene W.; Grill, Stephan; Drechsel, David; Hyman, Anthony A.; Alberti, Simon			A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-BINDING PROTEINS; PRION-LIKE DOMAINS; BEAM PLANE ILLUMINATION; CELL-FREE FORMATION; DNA-DAMAGE; STRESS GRANULES; NEURODEGENERATIVE DISEASES; POLYMERASE-II; SEPARATION	Many proteins contain disordered regions of low-sequence complexity, which cause aging-associated diseases because they are prone to aggregate. Here, we study FUS, a prion-like protein containing intrinsically disordered domains associated with the neurodegenerative disease ALS. We show that, in cells, FUS forms liquid compartments at sites of DNA damage and in the cytoplasm upon stress. We confirm this by reconstituting liquid FUS compartments in vitro. Using an in vitro "aging'' experiment, we demonstrate that liquid droplets of FUS protein convert with time from a liquid to an aggregated state, and this conversion is accelerated by patient-derived mutations. We conclude that the physiological role of FUS requires forming dynamic liquid-like compartments. We propose that liquid-like compartments carry the trade-off between functionality and risk of aggregation and that aberrant phase transitions within liquid-like compartments lie at the heart of ALS and, presumably, other age-related diseases.	[Patel, Avinash; Lee, Hyun O.; Jawerth, Louise; Maharana, Shovamayee; Jahnel, Marcus; Saha, Shambaditya; Franzmann, Titus M.; Pozniakovski, Andrej; Poser, Ina; Maghelli, Nicola; Royer, Loic A.; Weigert, Martin; Myers, Eugene W.; Grill, Stephan; Drechsel, David; Hyman, Anthony A.; Alberti, Simon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Jawerth, Louise] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Hein, Marco Y.] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Stoynov, Stoyno] Bulgarian Acad Sci, Inst Mol Biol, BU-1113 Sofia, Bulgaria; [Mahamid, Julia] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Bulgarian Academy of Sciences; Max Planck Society	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	hyman@mpi-cbg.de; alberti@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Royer, Loic/C-7593-2017; Alberti, Simon/ABB-8277-2021; Franzmann, Titus M/D-1962-2011; Grill, Stephan/D-9427-2012; Hein, Marco/C-2994-2014; Alberti, Simon/B-2822-2017	Hyman, Anthony A/0000-0003-3664-154X; Royer, Loic/0000-0002-9991-9724; Hein, Marco/0000-0002-9490-2261; Jahnel, Marcus/0000-0002-8355-277X; Weigert, Martin/0000-0002-7780-9057; Stoynov, Stoyno/0000-0002-7004-1081; Alberti, Simon/0000-0003-4017-6505; Lee, Hyun/0000-0003-0102-4795; Maghelli, Nicola/0000-0001-8450-8271; Maharana, Shovamayee/0000-0003-3909-9151; Franzmann, Titus/0000-0002-4281-7209; Saha, Shambaditya/0000-0003-4734-1307	Alexander von Humboldt Foundation [GRO/1156614 STP-2, USA/1153678 STP, INI/1155756 STP]; EMBO ALTF [608-2013, 1131-2011]; Human Frontier of Science [LT000685/2012-L]; NSF of Bulgaria [DFNI-B02/16]; German Federal Ministry of Research and Education [BMBF 031A359A MaxSynBio, 031A099]; MaxSynBio consortium; Federal Ministry of Education and Research of Germany; Max Planck Society	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EMBO ALTF; Human Frontier of Science; NSF of Bulgaria; German Federal Ministry of Research and Education; MaxSynBio consortium; Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society)	We thank the members of the S.A. and A.A.H. labs for helpful discussions; Barbara Borgonovo (Chromatography Facility) and Regis Lemaitre (Protein Expression and Purification Facility) for help with protein expression and purification; Benoit Lombardot for image analysis; Bert Nitzsche and Britta Schroth-Diez (Light Microscopy Facility) for help with light microscopy; and Annett Duemmler, Doris Richter, Marit Leuschner, and Andrea Ssykor for assistance with generating plasmids and BAC lines. We are grateful to Matthias Mann for support in determining the FUS concentration in HeLa cells and Wolfgang Baumeister for support with the cryo-EM experiments. We thank Suzanne Eaton, Andreas Hermann, Frank Julicher, Timothy J. Mitchison, and Christopher A. Weber for helpful discussions and/or comments on the manuscript. We thank Jiri Lukas for sharing data before publication. We gratefully acknowledge funding from the Alexander von Humboldt Foundation (GRO/1156614 STP-2 to A. Patel, USA/1153678 STP to S. Saha, and INI/1155756 STP to S.M.), EMBO ALTF (608-2013 to S. Saha and 1131-2011 to J.M.), Human Frontier of Science (LT000685/2012-L to J.M.), the NSF of Bulgaria (DFNI-B02/16 to S. Stoynov), and the German Federal Ministry of Research and Education (BMBF 031A359A MaxSynBio to T.M.F. and 031A099 to N.M., L.R., M.W., and E.W.M.). This work is partly funded by the MaxSynBio consortium, which is jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society.	Aggarwal S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001577; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Deng H, 2014, NAT REV NEUROL, V10, P337, DOI 10.1038/nrneurol.2014.78; Dumetz AC, 2008, BIOPHYS J, V94, P570, DOI 10.1529/biophysj.107.116152; Dutertre M, 2014, TRENDS BIOCHEM SCI, V39, P141, DOI 10.1016/j.tibs.2014.01.003; Galkin O, 2002, P NATL ACAD SCI USA, V99, P8479, DOI 10.1073/pnas.122055299; Galkin O, 2000, P NATL ACAD SCI USA, V97, P6277, DOI 10.1073/pnas.110000497; Gao L, 2014, NAT PROTOC, V9, P1083, DOI 10.1038/nprot.2014.087; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hubstenberger A, 2013, DEV CELL, V27, P161, DOI 10.1016/j.devcel.2013.09.024; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Hyman AA, 2011, DEV CELL, V21, P14, DOI 10.1016/j.devcel.2011.06.013; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lee CF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.088101; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lomakin A, 2003, P NATL ACAD SCI USA, V100, P10254, DOI 10.1073/pnas.1334069100; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; Mastrocola AS, 2013, J BIOL CHEM, V288, P24731, DOI 10.1074/jbc.M113.497974; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Nomura T, 2014, J BIOL CHEM, V289, P1192, DOI 10.1074/jbc.M113.516492; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Rulten SL, 2014, NUCLEIC ACIDS RES, V42, P307, DOI 10.1093/nar/gkt835; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P5211, DOI 10.1093/hmg/ddu243; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Toretsky JA, 2014, J CELL BIOL, V206, P579, DOI 10.1083/jcb.201404124; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vekilov PG, 2010, SOFT MATTER, V6, P5254, DOI 10.1039/c0sm00215a; Vekilov PG, 2004, CRYST GROWTH DES, V4, P671, DOI 10.1021/cg049977w; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x; Yang LQ, 2014, P NATL ACAD SCI USA, V111, P17809, DOI 10.1073/pnas.1414004111	59	1336	1345	28	300	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1066	1077		10.1016/j.cell.2015.07.047	http://dx.doi.org/10.1016/j.cell.2015.07.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317470	Bronze			2022-12-28	WOS:000360589900016
J	Shah, GA; O'Shea, CC				Shah, Govind A.; O'Shea, Clodagh C.			Viral and Cellular Genomes Activate Distinct DNA Damage Responses	CELL			English	Article							DOUBLE-STRAND BREAKS; ACUTE LYMPHOBLASTIC-LEUKEMIA; FATAL ADENOVIRUS HEPATITIS; ATM ACTIVATION; HISTONE H2AX; MRE11-RAD50-NBS1 COMPLEX; IONIZING-RADIATION; PROTEIN-KINASE; MRE11 COMPLEX; MRN COMPLEX	In response to cellular genome breaks, MRE11/RAD50/NBS1 (MRN) activates a global ATM DNA damage response (DDR) that prevents cellular replication. Here, we show that MRN-ATM also has critical functions in defending the cell against DNA viruses. We reveal temporally distinct responses to adenovirus genomes: a critical MRN-ATM DDR that must be inactivated by E1B-55K/E4-ORF3 viral onco-proteins and a global MRN-independent ATM DDR to viral nuclear domains that does not impact viral replication. We show that MRN binds to adenovirus genomes and activates a localized ATM response that specifically prevents viral DNA replication. In contrast to chromosomal breaks, ATM activation is not amplified by H2AX across megabases of chromatin to induce global signaling and replicative arrest. Thus, gamma H2AX foci discriminate "self'' and "non-self'' genomes and determine whether a localized anti-viral or global ATM response is appropriate. This provides an elegant mechanism to neutralize viral genomes without jeopardizing cellular viability.	[Shah, Govind A.; O'Shea, Clodagh C.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	O'Shea, CC (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	oshea@salk.edu			NCI [R01CA137094, P30CA014195]; Marshall Legacy Foundation; Leona M. and Harry B. Helmsley Charitable Trust grant [2012-PG-MED002]; William Scandling Trust; Price Family Foundation; Chapman Charitable Trust;  [T32 GM007240]; NATIONAL CANCER INSTITUTE [R01CA137094, R01CA178932, P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marshall Legacy Foundation; Leona M. and Harry B. Helmsley Charitable Trust grant; William Scandling Trust; Price Family Foundation; Chapman Charitable Trust; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tony Hunter, James Fitzpatrick, Mike Nunn, Nicola Allen, and members of the O'Shea laboratory for helpful comments. We thank James Smyth for important early work and optimizing antibodies, Christina Tribull for additional experiments and support, and Jamie Kasuboski and Carolyn O'Connor for technical assistance. This work was supported by R01CA137094 and P30CA014195 from NCI. C.C.O. is supported by the Marshall Legacy Foundation, The Leona M. and Harry B. Helmsley Charitable Trust grant number 2012-PG-MED002, the William Scandling Trust, and the Price Family Foundation. G.A.S. was supported by T32 GM007240 and the Chapman Charitable Trust.	Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; BENNETT CB, 1993, P NATL ACAD SCI USA, V90, P5613, DOI 10.1073/pnas.90.12.5613; Blackford AN, 2008, J VIROL, V82, P7640, DOI 10.1128/JVI.00170-08; BOYER GS, 1957, J EXP MED, V105, P195, DOI 10.1084/jem.105.3.195; Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; Carson CT, 2009, EMBO J, V28, P652, DOI 10.1038/emboj.2009.15; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; CHALLBERG MD, 1979, P NATL ACAD SCI USA, V76, P655, DOI 10.1073/pnas.76.2.655; Cheng CY, 2013, J VIROL, V87, P6232, DOI 10.1128/JVI.00384-13; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cleaver J. E., 2011, NAT REV CANCER, V87, P1230; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Foote KM, 2013, J MED CHEM, V56, P2125, DOI 10.1021/jm301859s; Forrester NA, 2011, J VIROL, V85, P2201, DOI 10.1128/JVI.01748-10; Gasser S, 2006, CANCER RES, V66, P3959, DOI 10.1158/0008-5472.CAN-05-4603; Gautam D, 2013, J VIROL, V87, P8687, DOI 10.1128/JVI.00376-13; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hendrix RW, 1999, CURR BIOL, V9, pR914, DOI 10.1016/S0960-9822(00)80103-7; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hough R, 2005, J PEDIAT HEMATOL ONC, V27, P67, DOI 10.1097/01.mph.0000153958.95486.6f; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johnson L, 2002, CANCER CELL, V1, P325, DOI 10.1016/S1535-6108(02)00060-0; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Komatsu T, 2012, J VIROL, V86, P6701, DOI 10.1128/JVI.00380-12; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee YJ, 2014, J CLIN MICROBIOL, V52, P350, DOI 10.1128/JCM.01893-13; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Mathew SS, 2007, VIROLOGY, V365, P346, DOI 10.1016/j.virol.2007.03.049; Mathew SS, 2008, VIROLOGY, V374, P11, DOI 10.1016/j.virol.2007.12.034; Mboko WP, 2012, J VIROL, V86, P6899, DOI 10.1128/JVI.07119-11; Nichols GJ, 2009, J VIROL, V83, P5987, DOI 10.1128/JVI.00091-09; O'Shea CC, 2005, ONCOGENE, V24, P7640, DOI 10.1038/sj.onc.1209047; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; Ou HD, 2012, CELL, V151, P304, DOI 10.1016/j.cell.2012.08.035; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; POMBO A, 1994, EMBO J, V13, P5075, DOI 10.1002/j.1460-2075.1994.tb06837.x; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; REKOSH DMK, 1977, CELL, V11, P283, DOI 10.1016/0092-8674(77)90045-9; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Singhal G, 2013, J VIROL, V87, P8767, DOI 10.1128/JVI.00879-13; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Steiner I, 2008, PEDIATR BLOOD CANCER, V50, P647, DOI 10.1002/pbc.21120; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Suram A, 2014, AGING CELL, V13, P780, DOI 10.1111/acel.12246; THOMAS GP, 1980, CELL, V22, P523; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	65	59	61	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					987	1002		10.1016/j.cell.2015.07.058	http://dx.doi.org/10.1016/j.cell.2015.07.058			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317467	Green Accepted, Bronze			2022-12-28	WOS:000360589900010
J	Di Mario, C; Rosser, G				Di Mario, Carlo; Rosser, Gareth			Open questions for non-infarct-related arteries in STEMI	LANCET			English	Editorial Material							STENOSIS SEVERITY; RANDOMIZED-TRIAL; CORONARY		[Di Mario, Carlo] Royal Brompton Hosp, Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, London SW11 1DY, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW11 1DY, England	Royal Brompton Hospital; Imperial College London	Di Mario, C (corresponding author), Royal Brompton Hosp, Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, London SW11 1DY, England.	c.dimario@rbht.nhs.uk	Di Mario, Carlo/K-5185-2018	Di Mario, Carlo/0000-0002-4461-2055				American College of Cardiology, 2014, AM COLL CARD UPD HEA; Bainey Kevin R, 2014, Am Heart J, V167, P1, DOI 10.1016/j.ahj.2013.09.018; Cavender MA, 2009, AM J CARDIOL, V104, P507, DOI 10.1016/j.amjcard.2009.04.016; Engstrom T, 2015, LANCET; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Hanratty CG, 2002, J AM COLL CARDIOL, V40, P911, DOI 10.1016/S0735-1097(02)02049-1; Ntalianis A, 2010, JACC-CARDIOVASC INTE, V3, P1274, DOI 10.1016/j.jcin.2010.08.025; Sen S, 2012, J AM COLL CARDIOL, V59, P1392, DOI 10.1016/j.jacc.2011.11.003; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; van der Schaaf RJ, 2010, AM J CARDIOL, V105, P955, DOI 10.1016/j.amjcard.2009.11.014; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520	12	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					630	632		10.1016/S0140-6736(15)60856-X	http://dx.doi.org/10.1016/S0140-6736(15)60856-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26347917				2022-12-28	WOS:000359849200009
J	Lee, N				Lee, Naomi			Health Challenges 2040 Health of the UK population in 2040	LANCET			English	Editorial Material									Lancet, London EC2Y 5AS, England		Lee, N (corresponding author), Lancet, London EC2Y 5AS, England.			O'Flaherty, Martin/0000-0001-8944-4131					0	1	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					643	643		10.1016/S0140-6736(15)61491-X	http://dx.doi.org/10.1016/S0140-6736(15)61491-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP4KA	26334147	Bronze			2022-12-28	WOS:000359849200016
J	Ng-Kamstra, JS; Greenberg, SLM; Kotagal, M; Palmqvist, CL; Lai, FYX; Bollam, R; Meara, JG; Gruen, RL				Ng-Kamstra, Joshua S.; Greenberg, Sarah L. M.; Kotagal, Meera; Palmqvist, Charlotta L.; Lai, Francis Y. X.; Bollam, Rishitha; Meara, John G.; Gruen, Russell L.			Use and definitions of perioperative mortality rates in low-income and middle-income countries: a systematic review	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Ng-Kamstra, Joshua S.; Greenberg, Sarah L. M.; Meara, John G.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Meara, John G.] Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA; [Ng-Kamstra, Joshua S.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Greenberg, Sarah L. M.] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Kotagal, Meera] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Palmqvist, Charlotta L.; Lai, Francis Y. X.; Gruen, Russell L.] Alfred Hosp, Melbourne, Vic, Australia; [Palmqvist, Charlotta L.; Lai, Francis Y. X.; Gruen, Russell L.] Monash Univ, Melbourne, Vic 3004, Australia; [Gruen, Russell L.] Nanyang Technol Univ, Singapore 639798, Singapore; [Palmqvist, Charlotta L.] Lund Univ, Fac Med, Lund, Sweden; [Bollam, Rishitha] Boston Univ, Sch Med, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Toronto; Medical College of Wisconsin; University of Washington; University of Washington Seattle; Florey Institute of Neuroscience & Mental Health; Monash University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Lund University; Boston University		rgruen@ntu.edu.sg	Ng, Joshua/S-2673-2019	Ng, Joshua/0000-0001-9335-2061	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK070555] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))			0	20	20	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			29	29		10.1016/S0140-6736(15)60824-8	http://dx.doi.org/10.1016/S0140-6736(15)60824-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313076				2022-12-28	WOS:000360573400030
J	Ng-Kamstra, JS; Arya, S; Chung, TE; Weston, B; Frankfurter, C; Gutnik, LA; Kreutzer, T; Riesel, JN; Meara, JG				Ng-Kamstra, Joshua S.; Arya, Sumedha; Chung, Timothy E.; Weston, Brad; Frankfurter, Claudia; Gutnik, Lily A.; Kreutzer, Tino; Riesel, Johanna N.; Meara, John G.			Mapping the playing field-a novel web-based strategy to identify non-governmental actors in global surgery	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Ng-Kamstra, Joshua S.; Riesel, Johanna N.; Meara, John G.] Harvard Univ, Program Global Surg & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Ng-Kamstra, Joshua S.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Arya, Sumedha; Chung, Timothy E.; Weston, Brad; Frankfurter, Claudia] Univ Toronto, Fac Med, Toronto, ON, Canada; [Riesel, Johanna N.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Kreutzer, Tino] Harvard Humanitarian Initiat, Boston, MA USA; [Meara, John G.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA; [Gutnik, Lily A.] Ctr Surg & Publ Hlth, Boston, MA USA; [Gutnik, Lily A.] UNC Project Malawi, Lilongwe, Malawi; [Gutnik, Lily A.] Montefiore Med Ctr, Dept Surg, Bronx, NY 10467 USA	Harvard University; University of Toronto; University of Toronto; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Boston Children's Hospital; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine		John.meara@childrens.harvard.edu	Gutnik, Lily/AAV-5256-2020; Ng, Joshua/S-2673-2019	Ng, Joshua/0000-0001-9335-2061; Gutnik, Lily/0000-0001-8674-7655					0	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			55	55		10.1016/S0140-6736(15)60850-9	http://dx.doi.org/10.1016/S0140-6736(15)60850-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313105	Bronze			2022-12-28	WOS:000360573400056
J	Purtle, J; Rich, JA; Fein, JA; James, T; Corbin, TJ				Purtle, Jonathan; Rich, John A.; Fein, Joel A.; James, Thea; Corbin, Theodore J.			Hospital-Based Violence Prevention: Progress and Opportunities	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERVENTION; INJURY; COHORT; DEATH		Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; Boston Univ, Sch Med, Boston, MA 02118 USA	Drexel University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Drexel University; Boston University	Purtle, J (corresponding author), Drexel Univ, Nesbitt Hall,3rd Floor,3215 Market St, Philadelphia, PA 19104 USA.	jpp46@drexel.edu	Rich, John/AAA-8521-2021					Cooper C, 2006, J TRAUMA, V61, P534, DOI 10.1097/01.ta.0000236576.81860.8c; Cunningham RM, 2015, JAMA PEDIATR, V169, P63, DOI 10.1001/jamapediatrics.2014.1900; James TL, 2014, ACAD EMERG MED, V21, P742, DOI 10.1111/acem.12409; Juillard C, 2015, J TRAUMA ACUTE CARE, V78, P252, DOI 10.1097/TA.0000000000000527; Purtle J, 2014, OXFORD TXB VIOLENCE; Purtle J, 2015, AM J PREV MED, V48, P162, DOI 10.1016/j.amepre.2014.08.030; Rowhani-Rahbar A, 2015, ANN INTERN MED, V162, P492, DOI 10.7326/M14-2362; Snider C, 2009, CAN J EMERG MED, V11, P161; van der Westhuizen C, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010839, DOI 10.1002/14651858.CD010839]; Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337	10	20	20	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 3	2015	163	9					715	+		10.7326/M15-0586	http://dx.doi.org/10.7326/M15-0586			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX3PF	26301734				2022-12-28	WOS:000365610600009
J	Shann, F; Lange, T				Shann, Frank; Lange, Theis			Bubble CPAP for pneumonia: perils of stopping trials early	LANCET			English	Editorial Material							RANDOMIZED CLINICAL-TRIALS; BENEFIT; EFFICACY		[Shann, Frank] Royal Childrens Hosp, Intens Care Unit, Parkville, Vic 3052, Australia; [Shann, Frank] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Lange, Theis] Univ Copenhagen, Fac Hlth & Med Sci, Sect Biostat, Copenhagen, Denmark	Royal Children's Hospital Melbourne; University of Melbourne; University of Copenhagen	Shann, F (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.	frank.shann@rch.org.au	Shann, Frank/C-9510-2011	Lange, Theis/0000-0001-6807-8347				Aber V, 1996, LANCET, V348, P283, DOI 10.1016/S0140-6736(96)05387-1; Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Andres AM, 1997, BIOMETRICAL J, V39, P935; Bassler D, 2008, J CLIN EPIDEMIOL, V61, P241, DOI 10.1016/j.jclinepi.2007.07.016; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Chisti MJ, 2015, LANCET; Duke T, 2014, PAEDIATR INT CHILD H, V34, P3, DOI 10.1179/2046905513Y.0000000102; Lechat P, 1999, LANCET, V353, P9; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Pocock S, 2005, AM HEART J, V149, P939, DOI 10.1016/j.ahj.2004.10.038; Pocock SJ, 2005, JAMA-J AM MED ASSOC, V294, P2228, DOI 10.1001/jama.294.17.2228; Wheatley K, 2003, CONTROL CLIN TRIALS, V24, P66, DOI 10.1016/S0197-2456(02)00273-8; Zannad F, 2012, CIRC-HEART FAIL, V5, P294, DOI 10.1161/CIRCHEARTFAILURE.111.965707	13	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1020	1022		10.1016/S0140-6736(15)60691-2	http://dx.doi.org/10.1016/S0140-6736(15)60691-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	26311458				2022-12-28	WOS:000361189200007
J	Cung, TT; Morel, O; Cayla, G; Rioufol, G; Garcia-Dorado, D; Angoulvant, D; Bonnefoy-Cudraz, E; Guerin, P; Elbaz, M; Delarche, N; Coste, P; Vanzetto, G; Metge, M; Aupetit, JF; Jouve, B; Motreff, P; Tron, C; Labeque, JN; Steg, PG; Cottin, Y; Range, G; Clerc, J; Claeys, MJ; Coussement, P; Prunier, F; Moulin, F; Roth, O; Belle, L; Dubois, P; Barragan, P; Gilard, M; Piot, C; Colin, P; De Poli, F; Morice, MC; Ider, O; Dubois-Rande, JL; Unterseeh, T; Le Breton, H; Beard, T; Blanchard, D; Grollier, G; Malquarti, V; Staat, P; Sudre, A; Elmer, E; Hansson, MJ; Bergerot, C; Boussaha, I; Jossan, C; Derumeaux, G; Mewton, N; Ovize, M				Cung, T. -T.; Morel, O.; Cayla, G.; Rioufol, G.; Garcia-Dorado, D.; Angoulvant, D.; Bonnefoy-Cudraz, E.; Guerin, P.; Elbaz, M.; Delarche, N.; Coste, P.; Vanzetto, G.; Metge, M.; Aupetit, J. -F.; Jouve, B.; Motreff, P.; Tron, C.; Labeque, J. -N.; Steg, P. G.; Cottin, Y.; Range, G.; Clerc, J.; Claeys, M. J.; Coussement, P.; Prunier, F.; Moulin, F.; Roth, O.; Belle, L.; Dubois, P.; Barragan, P.; Gilard, M.; Piot, C.; Colin, P.; De Poli, F.; Morice, M. -C.; Ider, O.; Dubois-Rande, J. -L.; Unterseeh, T.; Le Breton, H.; Beard, T.; Blanchard, D.; Grollier, G.; Malquarti, V.; Staat, P.; Sudre, A.; Elmer, E.; Hansson, M. J.; Bergerot, C.; Boussaha, I.; Jossan, C.; Derumeaux, G.; Mewton, N.; Ovize, M.			Cyclosporine before PCI in Patients with Acute Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION INJURY; HEART; ISCHEMIA; SIZE; PORE; CARDIOPROTECTION; ASPIRATION; INJECTION	BACKGROUND Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improve clinical outcomes and prevent adverse left ventricular remodeling. METHODS In a multicenter, double-blind, randomized trial, we assigned 970 patients with an acute anterior ST-segment elevation myocardial infarction (STEMI) who were undergoing percutaneous coronary intervention (PCI) within 12 hours after symptom onset and who had complete occlusion of the culprit coronary artery to receive a bolus injection of cyclosporine (administered intravenously at a dose of 2.5 mg per kilogram of body weight) or matching placebo before coronary recanalization. The primary outcome was a composite of death from any cause, worsening of heart failure during the initial hospitalization, rehospitalization for heart failure, or adverse left ventricular remodeling at 1 year. Adverse left ventricular remodeling was defined as an increase of 15% or more in the left ventricular end-diastolic volume. RESULTS A total of 395 patients in the cyclosporine group and 396 in the placebo group received the assigned study drug and had data that could be evaluated for the primary outcome at 1 year. The rate of the primary outcome was 59.0% in the cyclosporine group and 58.1% in the control group (odds ratio, 1.04; 95% confidence interval, 0.78 to 1.39; P = 0.77). Cyclosporine did not reduce the incidence of the separate clinical components of the primary outcome or other events, including recurrent infarction, unstable angina, and stroke. No significant difference in the safety profile was observed between the two treatment groups. CONCLUSIONS In patients with anterior STEMI who had been referred for primary PCI, intravenous cyclosporine did not result in better clinical outcomes than those with placebo and did not prevent adverse left ventricular remodeling at 1 year. (Funded by the French Ministry of Health and NeuroVive Pharmaceutical; CIRCUS ClinicalTrials.gov number, NCT01502774; EudraCT number, 2009-013713-99.)	[Cung, T. -T.] Ctr Hosp Univ CHU Arnaud de Villeneuve, Montpellier, France; [Piot, C.] Clin Millenaire, Montpellier, France; [Morel, O.] Nouvel Hop Civil, Hop Univ Strasbourg, Strasbourg, France; [Cayla, G.] CHU Nimes, Nimes, France; [Rioufol, G.; Bonnefoy-Cudraz, E.; Bergerot, C.; Boussaha, I.; Jossan, C.; Derumeaux, G.; Mewton, N.; Ovize, M.] Hop Cardiovasc & Pneumol Louis Pradel, Lyon, France; [Rioufol, G.; Bonnefoy-Cudraz, E.; Bergerot, C.; Boussaha, I.; Jossan, C.; Derumeaux, G.; Mewton, N.; Ovize, M.] Univ Lyon 1, F-69365 Lyon, France; [Aupetit, J. -F.] Ctr Hosp St Joseph & St Luc, Lyon, France; [Malquarti, V.] Clin Sauvegarde, Lyon, France; [Staat, P.] Clin Tonkin, Lyon, France; [Bergerot, C.; Boussaha, I.; Jossan, C.; Derumeaux, G.; Mewton, N.; Ovize, M.] Clin Invest Ctr & Explorat Fonct Cardiovasc, Lyon, France; [Angoulvant, D.] CHU Tours, Tours, France; [Blanchard, D.] Clin St Gatien, Tours, France; [Guerin, P.] Hop Guillaume & Rene Laennec, Nantes, France; [Elbaz, M.] CHU Rangueil, F-31054 Toulouse, France; [Delarche, N.] Ctr Hosp Pau, Pau, France; [Coste, P.] Hop Haut Leveque, Bordeaux, France; [Vanzetto, G.] CHU Grenoble, Hop A Michallon, F-38043 Grenoble, France; [Metge, M.] Hop Henri Duffau, Avignon, France; [Jouve, B.] Ctr Hosp Pays Aix, Aix En Provence, France; [Motreff, P.] Hop Gabriel Montpied, Clermont Ferrand, France; [Tron, C.] Hop Charles Nicolle, Rouen, France; [Labeque, J. -N.] Clin Fourcade, Bayonne, France; [Steg, P. G.] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Cottin, Y.] Hop Bocage, Dijon, France; [Range, G.] Ctr Hosp Gen, Chartres, France; [Clerc, J.] Ctr Hosp Compiegne, Compiegne, France; [Prunier, F.] CHU Angers, Angers, France; [Moulin, F.] CHU Nancy Brabois, Vandoeuvre Les Nancy, France; [Roth, O.] CHU Mulhouse, Mulhouse, France; [Ider, O.] Clin Diaconat, Mulhouse, France; [Belle, L.] Ctr Hosp Annecy, Annecy, France; [Barragan, P.] Polyclin Fleurs, Ollioules, France; [Gilard, M.] Hop La Cavale Blanche, Brest, France; [Colin, P.; De Poli, F.] Clin Esquirol, Agen, France; [Morice, M. -C.] Inst Jacques Cartier, Massy, France; [Dubois-Rande, J. -L.] Ctr Hosp Henri Mondor, Creteil, France; [Unterseeh, T.] Hop Claude Galien, Quincy Sous Senat, France; [Le Breton, H.] Hop Pontchaillou, Rennes, France; [Beard, T.] Clin Ormeau, Tarbes, France; [Grollier, G.] Hop Cote Nacre, Caen, France; [Sudre, A.] Hop Cardiol Calmette, Lille, France; [Garcia-Dorado, D.] Hosp Univ Vall dHebron, Barcelona, Spain; [Claeys, M. J.] Univ Antwerp Hosp, Edegem, Belgium; [Coussement, P.] Algemeen Ziekenhuis St Jan, Brugge, Belgium; [Dubois, P.] CHU Charleroi, Charleroi, Belgium; [Elmer, E.; Hansson, M. J.] Lund Univ, Dept Clin Sci, Lund, Sweden	Universite de Montpellier; CHU de Montpellier; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Montpellier; CHU de Nimes; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Tours; Nantes Universite; CHU de Nantes; CHU de Toulouse; Centre Hospitalier de Pau; CHU Bordeaux; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Clermont Ferrand; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Nancy; Centre Hospitalier Annecy Genevois; CHU Brest; Universite de Bretagne Occidentale; Jacques Cartier Private Hospital; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Rennes; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Lille - ISITE; CHU Lille; Hospital Universitari Vall d'Hebron; University of Antwerp; Lund University	Ovize, M (corresponding author), Clin Invest Ctr Lyon, 28 Ave Doyen Lepine, F-69677 Lyon, France.	michel.ovize@chu-lyon.fr	Claeys, Marc/ABH-8781-2020; Ovize, michel/AAL-9247-2020; Elmér, Eskil/F-9341-2014; Vanzetto, Gerald/M-5513-2014; Carmen, Team3/Y-7384-2019; Sudre, Arnaud/ABF-7614-2020; Angoulvant, Denis/Q-9743-2019; Hansson, Magnus/G-4486-2014; COTTIN, YVES/ABA-4622-2020; Le Breton, Herve/ABD-8171-2020; STEG, Philippe Gabriel/Z-1567-2019; DERUMEAUX, Genevieve A/T-2489-2018; Guerin, Patrice/L-6004-2015	Elmér, Eskil/0000-0001-7901-1826; Carmen, Team3/0000-0002-3614-0924; Angoulvant, Denis/0000-0003-0788-8092; Hansson, Magnus/0000-0002-0201-0638; DERUMEAUX, Genevieve A/0000-0003-1471-1631; Lab, Carmen/0000-0002-5935-3236; ELBAZ, Meyer/0000-0002-3520-7883; Claeys, Marc/0000-0002-6628-9543; STEG, Philippe Gabriel/0000-0001-6896-2941; Gilard, Martine/0000-0002-2794-7953; Piot, Christophe/0000-0001-7497-0294	French Ministry of Health; NeuroVive Pharmaceutical	French Ministry of Health; NeuroVive Pharmaceutical(Johnson & Johnson)	Funded by the French Ministry of Health and NeuroVive Pharmaceutical; CIRCUS ClinicalTrials.gov number, NCT01502774; EudraCT number, 2009-013713-99.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Chiari P, 2014, ANESTHESIOLOGY, V121, P232, DOI 10.1097/ALN.0000000000000331; Cohen MV, 2014, J CARDIOVASC PHARM T, V19, P179, DOI 10.1177/1074248413508465; CROMPTON M, 1990, BIOCHEM J, V266, P33, DOI 10.1042/bj2660033; De Paulis D, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0379-4; DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790; Ehinger KHJ, 2013, CLIN DRUG INVEST, V33, P25, DOI 10.1007/s40261-012-0029-x; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; Fox KAA, 2010, HEART, V96, P1095, DOI 10.1136/hrt.2009.190827; Garcia-Dorado D, 2014, INT J CARDIOL, V177, P935, DOI 10.1016/j.ijcard.2014.09.203; Ghaffari S, 2013, CARDIOVASC THER, V31, pE34, DOI 10.1111/1755-5922.12010; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Hausenloy DJ, 2014, HEART, V100, P544, DOI 10.1136/heartjnl-2013-304845; Hausenloy DJ, 2002, CARDIOVASC RES, V55, P534, DOI 10.1016/S0008-6363(02)00455-8; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Ibanez B, 2013, CIRCULATION, V128, P1495, DOI 10.1161/CIRCULATIONAHA.113.003653; Jolly SS, 2015, NEW ENGL J MED, V372, P1389, DOI 10.1056/NEJMoa1415098; Khan AR, 2014, AM HEART J, V168, P512, DOI 10.1016/j.ahj.2014.06.021; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Lim WY, 2012, BRIT J PHARMACOL, V165, P2034, DOI 10.1111/j.1476-5381.2011.01691.x; Mewton N, 2015, AM HEART J, V169, P758, DOI 10.1016/j.ahj.2015.02.020; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Ortiz-Perez JT, 2007, EUR HEART J, V28, P1750, DOI 10.1093/eurheartj/ehm212; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Puymirat E, 2014, AM J CARDIOL, V114, P1651, DOI 10.1016/j.amjcard.2014.08.039; Sanchez H, 2001, BRIT J PHARMACOL, V133, P781, DOI 10.1038/sj.bjp.0704129; Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011; Skyschally A, 2010, CARDIOVASC DRUG THER, V24, P85, DOI 10.1007/s10557-010-6219-y; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2012, JAMA-J AM MED ASSOC, V307, P1817, DOI 10.1001/jama.2012.421; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zalewski J, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0475-8	33	453	466	3	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2015	373	11					1021	1031		10.1056/NEJMoa1505489	http://dx.doi.org/10.1056/NEJMoa1505489			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9TV	26321103	Green Published, Bronze			2022-12-28	WOS:000360959000007
J	Kumar, S; Chawdhary, G; Moorthy, R				Kumar, Sonia; Chawdhary, Gaurav; Moorthy, Ram			CASE SCENARIO Bilateral neck lumps	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kumar, Sonia] Royal Berkshire Hosp, Dept Otorhinolaryngol, Reading RG1 5AN, Berks, England; [Chawdhary, Gaurav; Moorthy, Ram] Wexham Pk Hosp, ENT Dept, Slough SL2 4HL, Berks, England	Royal Berkshire Hospital	Kumar, S (corresponding author), Royal Berkshire Hosp, Dept Otorhinolaryngol, Reading RG1 5AN, Berks, England.	Soniakumar111@gmail.com	moorthy, Ram/AAI-3160-2020	moorthy, Ram/0000-0003-2620-7184					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2015	351								h4678	10.1136/bmj.h4678	http://dx.doi.org/10.1136/bmj.h4678			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4CL	26346022				2022-12-28	WOS:000361279300003
J	Macilwain, C				Macilwain, Colin			Rejection of GM crops is not a failure for science	NATURE			English	Editorial Material												cfmworldview@googlemail.com						2013, NATURE, V497, P24; 2014, NATURE, V508, P289	2	2	2	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					7	7		10.1038/525007a	http://dx.doi.org/10.1038/525007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4SE	26333435	Bronze			2022-12-28	WOS:000360594100003
J	Wolchok, JD				Wolchok, Jedd D.			PD-1 Blockers	CELL			English	Editorial Material									Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Wolchok, JD (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	wolchokj@mskcc.org			NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	94	100	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					937	937		10.1016/j.cell.2015.07.045	http://dx.doi.org/10.1016/j.cell.2015.07.045			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317459	Bronze			2022-12-28	WOS:000360589900002
J	Dempsey, TM				Dempsey, Timothy M.			The "Good Person" Sign	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Dempsey, TM (corresponding author), Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA.	tdempsey@ucdavis.edu	Dempsey, Timothy/O-5970-2019						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					773	773		10.1001/jama.2015.4890	http://dx.doi.org/10.1001/jama.2015.4890			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305644				2022-12-28	WOS:000360017200014
J	Fatemi, G; Kermani, TA				Fatemi, Gita; Kermani, Tanaz A.			Clinical Significance of a Positive Antinuclear Antibody Test	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEMIC-LUPUS-ERYTHEMATOSUS; UNITED-STATES; AUTOANTIBODIES; PREVALENCE	A 30-year-old woman presented to the rheumatology clinic after experiencing 2 months of fatigue and polyarthralgias of the wrists, hands, knees, and feet. She reported no joint swelling or morning stiffness. She previously saw her primary care physician who prescribed celecoxib (for joint pain) and ordered antinuclear antibody (ANA) testing, which was positive at a value of 1: 80 (Table). She was then referred to the rheumatology clinic. The patient reported no history of fever, weight loss, photosensitivity, malar rashes, skin thickening, oral or nasal ulcers, weakness, Raynaud phenomenon, sicca symptoms, chest pain, shortness of breath, or abdominal pain. She was not taking any medications because 2 weeks after starting celecoxib, her joint pain resolved and she discontinued use without recurrence of pain. The patient had no family history of autoimmune diseases. On examination,her vital signs, including blood pressure, were normal; and results of skin, thyroid, musculoskeletal, mucus membranes, cardiovascular, pulmonary, and neurologic examinations were all normal. Additional test results, which were obtained after her rheumatology visit, are presented in the Table.	[Fatemi, Gita; Kermani, Tanaz A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kermani, TA (corresponding author), 2020 Santa Monica Blvd,Ste 540, Santa Monica, CA 90404 USA.	tkermani@mednet.ucla.edu						Abeles AM, 2013, AM J MED, V126, P342, DOI 10.1016/j.amjmed.2012.09.014; Agmon-Levin N, 2014, ANN RHEUM DIS, V73, P17, DOI 10.1136/annrheumdis-2013-203863; Al Daabil M, 2014, INT J CLIN PRACT, V68, P1508, DOI 10.1111/ijcp.12466; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Jaskowski Troy D., 1996, American Journal of Clinical Pathology, V105, P468; Lazurova I, 2009, ANN NY ACAD SCI, V1173, P211, DOI 10.1111/j.1749-6632.2009.04809.x; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Solomon DH, 2002, ARTHRIT RHEUM-ARTHR, V47, P434, DOI 10.1002/art.10561; Walsh JP, 2010, J CLIN ENDOCR METAB, V95, P1095, DOI 10.1210/jc.2009-1977; Ward MM, 2004, J WOMENS HEALTH, V13, P713, DOI 10.1089/jwh.2004.13.713	10	1	1	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					827	828		10.1001/jama.2015.7649	http://dx.doi.org/10.1001/jama.2015.7649			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305654				2022-12-28	WOS:000360017200024
J	Engstrom, T; Kelbaek, H; Helqvist, S; Hofsten, DE; Klovgaard, L; Holmvang, L; Jorgensen, E; Pedersen, F; Saunamaki, K; Clemmensen, P; De Backer, O; Ravkilde, J; Tilsted, HH; Villadsen, AB; Aaroe, J; Jensen, SE; Raungaard, B; Kober, L				Engstrom, Thomas; Kelbaek, Henning; Helqvist, Steffen; Hofsten, Dan Eik; Klovgaard, Lene; Holmvang, Lene; Jorgensen, Erik; Pedersen, Frants; Saunamaki, Kari; Clemmensen, Peter; De Backer, Ole; Ravkilde, Jan; Tilsted, Hans-Henrik; Villadsen, Anton Boel; Aaroe, Jens; Jensen, Svend Eggert; Raungaard, Bent; Kober, Lars		DANAMI-3-PRIMULTI Investigators	Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; FRACTIONAL FLOW RESERVE; VESSEL; MANAGEMENT; MORTALITY; OUTCOMES; FOLLOW; IMPACT; TIME	Background Patients with acute ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease have a worse prognosis compared with individuals with single-vessel disease. We aimed to study the clinical outcome of patients with STEMI treated with fractional flow reserve (FFR)-guided complete revascularisation versus treatment of the infarct-related artery only. Methods We undertook an open-label, randomised controlled trial at two university hospitals in Denmark. Patients presenting with STEMI who had one or more clinically significant coronary stenosis in addition to the lesion in the infarct-related artery were included. After successful percutaneous coronary intervention (PCI) of the infarct-related artery, patients were randomly allocated (in a 1: 1 ratio) either no further invasive treatment or complete FFR-guided revascularisation before discharge. Randomisation was done electronically via a web-based system in permuted blocks of varying size by the clinician who did the primary PCI. All patients received best medical treatment. The primary endpoint was a composite of all-cause mortality, non-fatal reinfarction, and ischaemia-driven revascularisation of lesions in non-infarct-related arteries and was assessed when the last enrolled patient had been followed up for 1 year. Analysis was on an intention-to-treat basis. This trial is registered with ClinicalTrials.gov, number NCT01960933. Findings From March, 2011, to February, 2014, we enrolled 627 patients to the trial; 313 were allocated no further invasive treatment after primary PCI of the infarct-related artery only and 314 were assigned complete revascularisation guided by FFR values. Median follow-up was 27 months (range 12-44 months). Events comprising the primary endpoint were recorded in 68 (22%) patients who had PCI of the infarct-related artery only and in 40 (13%) patients who had complete revascularisation (hazard ratio 0.56, 95% CI 0.38-0.83; p=0.004). Interpretation In patients with STEMI and multivessel disease, complete revascularisation guided by FFR measurements significantly reduces the risk of future events compared with no further invasive intervention after primary PCI. This effect is driven by significantly fewer repeat revascularisations, because all-cause mortality and non-fatal reinfarction did not differ between groups. Thus, to avoid repeat revascularisation, patients can safely have all their lesions treated during the index admission. Future studies should clarify whether complete revascularisation should be done acutely during the index procedure or at later time and whether it has an effect on hard endpoints.	[Engstrom, Thomas; Kelbaek, Henning; Helqvist, Steffen; Hofsten, Dan Eik; Klovgaard, Lene; Holmvang, Lene; Jorgensen, Erik; Pedersen, Frants; Saunamaki, Kari; Clemmensen, Peter; De Backer, Ole; Kober, Lars] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Ravkilde, Jan; Tilsted, Hans-Henrik; Villadsen, Anton Boel; Aaroe, Jens; Jensen, Svend Eggert; Raungaard, Bent] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark	Rigshospitalet; University of Copenhagen; Aalborg University; Aalborg University Hospital	Kelbaek, H (corresponding author), Roskilde Hosp, Dept Cardiol, DK-4000 Roskilde, Denmark.	hkelbaek@dadlnet.dk	De Backer, Ole/AAQ-2369-2020	De Backer, Ole/0000-0002-9674-0278; Kober, Lars/0000-0002-6635-1466; Saunamaki, Kari/0000-0001-5953-5243; Engstrom, Thomas/0000-0001-5436-9194	Danish Agency for Science, Technology and Innovation; Danish Council for Strategic Research (EDITORS) [09-066994]	Danish Agency for Science, Technology and Innovation; Danish Council for Strategic Research (EDITORS)	Our trial was funded by the Danish Agency for Science, Technology and Innovation and the Danish Council for Strategic Research (EDITORS, grant 09-066994). We thank the patients who participated in our trial, our co-investigators and colleagues, staff at the participating centres, and our dedicated research nurses.	Bainey KR, 2014, AM HEART J, V167, P1, DOI 10.1016/j.ahj.2013.09.018; Bangalore S, 2011, AM J CARDIOL, V107, P1300, DOI 10.1016/j.amjcard.2010.12.039; Cavender MA, 2009, AM J CARDIOL, V104, P507, DOI 10.1016/j.amjcard.2009.04.016; Dambrink JHE, 2010, EUROINTERVENTION, V5, P968, DOI 10.4244/; De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758; Di Mario Carlo, 2004, Int J Cardiovasc Intervent, V6, P128; Glaser R, 2005, CIRCULATION, V111, P143, DOI 10.1161/01.CIR.0000150335.01285.12; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017; Hofsten DE, 2015, AM HEART J, V169, P613, DOI 10.1016/j.ahj.2015.02.004; Kelbaek H, 2008, J AM COLL CARDIOL, V51, P899, DOI 10.1016/j.jacc.2007.10.047; Kelly DJ, 2013, EUROINTERVENTION, V8, P1190, DOI 10.4244/EIJV8I10A183; Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071; Lonborg J, 2012, EUR HEART J, V33, P1491, DOI 10.1093/eurheartj/ehr309; MULLER DWM, 1991, AM HEART J, V121, P1042, DOI 10.1016/0002-8703(91)90661-Z; Ntalianis A, 2010, JACC-CARDIOVASC INTE, V3, P1274, DOI 10.1016/j.jcin.2010.08.025; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162; Rasoul S, 2009, CORONARY ARTERY DIS, V20, P415, DOI 10.1097/MCA.0b013e32832e5c4c; Sethi A, 2011, CATHETER CARDIO INTE, V77, P163, DOI 10.1002/ccd.22647; Sorajja P, 2007, EUR HEART J, V28, P1709, DOI 10.1093/eurheartj/ehm184; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	28	570	593	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					665	671		10.1016/S0140-6736(15)60648-1	http://dx.doi.org/10.1016/S0140-6736(15)60648-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26347918				2022-12-28	WOS:000359849200033
J	Keating, C				Keating, Conrad			The art of medicine The social history of ISIS-2: the early history	LANCET			English	Editorial Material									Wellcome Unit Hist Med, Oxford OX2 6PE, England		Keating, C (corresponding author), Wellcome Unit Hist Med, Oxford OX2 6PE, England.	conrad.keating@wuhmo.ox.ac.uk							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					646	647		10.1016/S0140-6736(15)61493-3	http://dx.doi.org/10.1016/S0140-6736(15)61493-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP4KA	26334149				2022-12-28	WOS:000359849200021
J	Keating, C				Keating, Conrad			The art of medicine The social history of ISIS-2: triumph and the path not taken	LANCET			English	Editorial Material									Wellcome Unit Hist Med, Oxford OX2 6PE, England		Keating, C (corresponding author), Wellcome Unit Hist Med, Oxford OX2 6PE, England.	conrad.keating@wuhmo.ox.ac.uk							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					E4	E5		10.1016/S0140-6736(15)61505-7	http://dx.doi.org/10.1016/S0140-6736(15)61505-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP4KA	26334164				2022-12-28	WOS:000359849200002
J	Olsen, MH; Spencer, S				Olsen, Michael Hecht; Spencer, Stuart			A global perspective on hypertension: a Lancet Commission	LANCET			English	Editorial Material									[Olsen, Michael Hecht] Odense Univ Hosp, Ctr Individualised Med Arterial Dis, Dept Endocrinol, Cardiovasc & Prevent Clin, DK-5000 Odense C, Denmark; [Spencer, Stuart] Lancet, London, England	University of Southern Denmark; Odense University Hospital	Olsen, MH (corresponding author), Odense Univ Hosp, Ctr Individualised Med Arterial Dis, Dept Endocrinol, Cardiovasc & Prevent Clin, DK-5000 Odense C, Denmark.	michael.olsen@dadlnet.dk	Olsen, Michael H/H-8176-2014	Olsen, Michael Hecht/0000-0003-2230-5780	Novo Nordisk Fonden [NNF13OC0003736] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Blacher J, 2010, J HUM HYPERTENS, V24, P19, DOI 10.1038/jhh.2009.34; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; World Health Organization, GLOB BRIEF HYP SIL K	7	14	18	3	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					637	638		10.1016/S0140-6736(15)61178-3	http://dx.doi.org/10.1016/S0140-6736(15)61178-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP4KA	26334143				2022-12-28	WOS:000359849200013
J	Zerhouni, YA; Abu-Bonsrah, N; Mehes, M; Goldstein, S; Buyske, J; Abdullah, F				Zerhouni, Yasmin A.; Abu-Bonsrah, Nancy; Mehes, Mira; Goldstein, Seth; Buyske, Jo; Abdullah, Fizan			General surgery education: a systematic review of training worldwide	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Zerhouni, Yasmin A.] Univ Calif East Bay, Dept Surg, Oakland, CA USA; [Abu-Bonsrah, Nancy] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; [Mehes, Mira; Goldstein, Seth; Abdullah, Fizan] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA; [Buyske, Jo] Amer Board Surg Philadelphia, Philadelphia, PA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine		fa@jhmi.edu							0	7	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			39	39		10.1016/S0140-6736(15)60834-0	http://dx.doi.org/10.1016/S0140-6736(15)60834-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313087	Bronze			2022-12-28	WOS:000360573400040
J	Bottomley, M; Harden, P; Wood, K				Bottomley, Matthew; Harden, Paul; Wood, Kathryn			CD57 expression in CD8 T cells and development of cutaneous squamous cell carcinoma in renal transplant recipients: a prospective cohort study	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Bottomley, Matthew; Harden, Paul] Univ Oxford, Oxford Transplant Ctr, Oxford Univ Hosp NHS Trust, Oxford OX3 9DU, England; [Bottomley, Matthew; Wood, Kathryn] Univ Oxford, Oxford OX3 9DU, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford		matthew.bottomley@nds.ox.ac.uk	Bottomley, Matthew/I-4260-2019	Bottomley, Matthew/0000-0001-5793-4777					0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			23	23		10.1016/S0140-6736(15)60338-5	http://dx.doi.org/10.1016/S0140-6736(15)60338-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312845	Bronze			2022-12-28	WOS:000360570500023
J	Mol, BJ; Roberts, CT; Thangaratinam, S; Magee, LA; de Groot, CJM; Hofmeyr, GJ				Mol, Ben W. J.; Roberts, Claire T.; Thangaratinam, Shakila; Magee, Laura A.; de Groot, Christianne J. M.; Hofmeyr, G. Justus			Pre-eclampsia	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; EARLY-PREGNANCY PREDICTION; LIFE-STYLE INTERVENTIONS; EARLY-ONSET PREECLAMPSIA; MIDDLE-INCOME COUNTRIES; ANTENATAL CARE PACKAGES; PLACENTAL GROWTH-FACTOR; LONG-TERM RISK; HLA-C GENES; HYPERTENSIVE DISORDERS	Pre-eclampsia affects 3-5% of pregnancies and is traditionally diagnosed by the combined presentation of high blood pressure and proteinuria. New definitions also include maternal organ dysfunction, such as renal insufficiency, liver involvement, neurological or haematological complications, uteroplacental dysfunction, or fetal growth restriction. When left untreated, pre-eclampsia can be lethal, and in low-resource settings, this disorder is one of the main causes of maternal and child mortality. In the absence of curative treatment, the management of pre-eclampsia involves stabilisation of the mother and fetus, followed by delivery at an optimal time. Although algorithms to predict pre-eclampsia are promising, they have yet to become validated. Simple preventive measures, such as low-dose aspirin, calcium, and diet and lifestyle interventions, show potential but small benefit. Because pre-eclampsia predisposes mothers to cardiovascular disease later in life, pregnancy is also a window for future health. A collaborative approach to discovery and assessment of the available treatments will hasten our understanding of pre-eclampsia and is an effort much needed by the women and babies affected by its complications.	[Mol, Ben W. J.; Roberts, Claire T.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA 5006, Australia; [Thangaratinam, Shakila] Queen Mary Univ London, Barts & London Sch Med & Dent, Womens Hlth Res Unit, London, England; [Magee, Laura A.] BC Womens Hosp & Hlth Ctr, Vancouver, BC, Canada; [de Groot, Christianne J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Hofmeyr, G. Justus] Univ Ft Hare, Univ Witwatersrand, Effect Care Res Unit, East London, South Africa; [Hofmeyr, G. Justus] Eastern Cape Dept Hlth, East London, South Africa	Robinson Research Institute; University of Adelaide; University of London; Queen Mary University London; Vrije Universiteit Amsterdam; University of Fort Hare; University of Witwatersrand	Mol, BJ (corresponding author), Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA 5006, Australia.	ben.mol@adelaide.edu.au	Thangaratinam, Shakila/AAP-3724-2021	Thangaratinam, Shakila/0000-0002-4254-460X; Roberts, Claire/0000-0002-9250-2192	Bill & Melinda Gates Foundation; University of British Columbia, a grantee of the Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of British Columbia, a grantee of the Bill & Melinda Gates Foundation	BWJM provides consultancy for ObsEva and has been an invited speaker on sponsored symposia and scientific meetings; all honoraria go to his institute. LAM was the principal investigator of the CHIPS trial and is a consultant to the PRE-EMPT project funded by the Bill & Melinda Gates Foundation. GJH is principal investigator for the Calcium and Pre-eclampsia Study funded by the University of British Columbia, a grantee of the Bill & Melinda Gates Foundation. CTR, ST, and CJMdG declare no competing interests.	Abalos E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Ahmed R, 2014, J AM COLL CARDIOL, V63, P1815, DOI 10.1016/j.jacc.2014.02.529; Alexander JM, 2006, OBSTET GYNECOL, V108, P826, DOI 10.1097/01.AOG.0000235721.88349.80; Alfirevic Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h217; Allen R, 2014, ACTA OBSTET GYN SCAN, V93, P973, DOI 10.1111/aogs.12467; Allen RE, 2014, EUR J OBSTET GYN R B, V182, P194, DOI 10.1016/j.ejogrb.2014.09.027; Althabe F, 2015, LANCET, V385, P629, DOI 10.1016/S0140-6736(14)61651-2; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; [Anonymous], 2015, Obstet Gynecol, V125, P521, DOI 10.1097/01.AOG.0000460762.59152.d7; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bain ES, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-195; BELIZAN JM, 1980, AM J CLIN NUTR, V33, P2202, DOI 10.1093/ajcn/33.10.2202; Berks D, 2013, BJOG-INT J OBSTET GY, V120, P924, DOI 10.1111/1471-0528.12191; Blom EA, 2010, BJOG-INT J OBSTET GY, V117, P1390, DOI 10.1111/j.1471-0528.2010.02660.x; Bramham K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2301; Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; Broekhuijsen K, 2015, LANCET, V385, P2492, DOI 10.1016/S0140-6736(14)61998-X; Brown MA, 2011, HYPERTENS PREGNANCY, V30, P188, DOI 10.3109/10641955.2010.507854; Brownfoot FC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006764.pub3; Burton GJ, 2014, PLACENTA, V35, P9, DOI 10.1016/j.placenta.2013.11.005; Buurma AJ, 2013, HUM REPROD UPDATE, V19, P289, DOI 10.1093/humupd/dms060; Chappell LC, 2013, CIRCULATION, V128, P2121, DOI 10.1161/CIRCULATIONAHA.113.003215; Conde-Agudelo A, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.020; Cormick Gabriela, 2014, BMC Res Notes, V7, P920, DOI 10.1186/1756-0500-7-920; Cusimano MC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.001; De Vries JIP, 2012, J THROMB HAEMOST, V10, P64, DOI 10.1111/j.1538-7836.2011.04553.x; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Dodd JM, 2013, COCHRANE DB SYST REV, V7; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Dorniak-Wall T, 2014, J HUM HYPERTENS, V28, P230, DOI 10.1038/jhh.2013.100; Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 2010, COCHRANE DB SYST REV, V8; Duley L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001449.pub3; Dunsmuir DT, 2014, IEEE J BIOMED HEALTH, V18, P1857, DOI 10.1109/JBHI.2014.2301156; Ephraim RKD, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0390-2; EPSTEIN FH, 1964, NEW ENGL J MED, V271, P391, DOI 10.1056/NEJM196408202710803; Everett TR, 2012, J MATERN-FETAL NEO M, V25, P50, DOI 10.3109/14767058.2011.557791; Firoz T, 2014, BJOG-INT J OBSTET GY, V121, P1210, DOI 10.1111/1471-0528.12737; Firoz T, 2014, BJOG, V121, P1220, DOI DOI 10.1111/1471-0528.12737; Firoz T, 2011, BEST PRACT RES CL OB, V25, P537, DOI 10.1016/j.bpobgyn.2011.04.002; Fong FM, 2014, AM J EPIDEMIOL, V180, P335, DOI 10.1093/aje/kwu151; Garg AX, 2015, NEW ENGL J MED, V372, P124, DOI 10.1056/NEJMoa1408932; Gillon TER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113715; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Goldenberg RL, 2015, ACTA OBSTET GYN SCAN, V94, P148, DOI 10.1111/aogs.12533; Goldenberg RL, 2011, INT J GYNECOL OBSTET, V113, P91, DOI 10.1016/j.ijgo.2011.01.002; Gyamfi-Bannerman C, 2012, OBSTET GYNECOL, V119, P555, DOI 10.1097/AOG.0b013e31824758f6; HABLI M, 2009, AM J OBSTET GYNECOL, V201, DOI DOI 10.1016/J.AJOG.2009.06.033; Hagmann H, 2012, CLIN CHEM, V58, P837, DOI 10.1373/clinchem.2011.169094; Hansen AR, 2010, J PEDIATR-US, V156, P532, DOI 10.1016/j.jpeds.2009.10.018; Heidrich MB, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-61; Hermes W, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.016; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hoedjes M, 2010, OBSTET GYNECOL SURV, V65, P631, DOI 10.1097/OGX.0b013e3182077f64; Hofmeyr GJ, 2007, BJOG-INT J OBSTET GY, V114, P933, DOI 10.1111/j.1471-0528.2007.01389.x; Hofmeyr GJ, 2014, BJOG-INT J OBSTET GY, V121, P951, DOI 10.1111/1471-0528.12613; Hofmeyr GJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub4; Hofmeyr GJ, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-20; Hofmeyr GJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub3; Hofmeyr GJ, PROTOCOL 11PRT 4028; Jacobs AK, 2005, CIRCULATION, V111, P383, DOI 10.1161/01.CIR.0000155289.62829.0F; Jebbink J, 2012, BBA-MOL BASIS DIS, V1822, P1960, DOI 10.1016/j.bbadis.2012.08.004; Jozwiak M, 2011, LANCET, V378, P2095, DOI 10.1016/S0140-6736(11)61484-0; Katz L, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-28; Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578; Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297; Kleinrouweler CE, 2012, BJOG-INT J OBSTET GY, V119, P778, DOI 10.1111/j.1471-0528.2012.03311.x; Koopmans CM, 2011, HYPERTENS PREGNANCY, V30, P433, DOI 10.3109/10641955.2010.506236; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Kvehaugen AS, 2011, HYPERTENSION, V58, P63, DOI 10.1161/HYPERTENSIONAHA.111.172387; Lakshmi BS, 2012, OBSTET MED, V5, P171, DOI 10.1258/om.2012.120010; Lalani S, 2013, J OBSTET GYNAECOL CA, V35, P215, DOI 10.1016/S1701-2163(15)30993-2; Laskin S, 2011, J OBSTET GYNAECOL CA, V33, P900, DOI 10.1016/S1701-2163(16)35015-0; Leslie K, 2011, BEST PRACT RES CL OB, V25, P343, DOI 10.1016/j.bpobgyn.2011.01.002; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Long W, 2015, PLACENTA, V36, P433, DOI 10.1016/j.placenta.2014.05.008; Lorenz RP, 2014, OBSTET GYNECOL, V124, P377, DOI 10.1097/AOG.0000000000000399; MacDonald SE, 2007, J OBSTET GYNAECOL CA, V29, P705, DOI 10.1016/S1701-2163(16)32601-9; Magee LA, 2005, AM J OBSTET GYNECOL, V193, P153, DOI 10.1016/j.ajog.2004.11.059; Magee LA, 2015, NEW ENGL J MED, V372, P407, DOI 10.1056/NEJMoa1404595; Magee LA, 2014, PREGNANCY HYPERTENS, V4, P105, DOI 10.1016/j.preghy.2014.01.003; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Makrides M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub2; Makrides M, 2014, COCHRANE DB SYST REV, V4; McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042; McDonald SD, 2010, AM J KIDNEY DIS, V55, P1026, DOI 10.1053/j.ajkd.2009.12.036; Meher S, 2007, COCHRANE DB SYST REV, V2; Mol B, 2013, AM J PERINAT, V30, P163, DOI 10.1055/s-0032-1322512; Morris RK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4342; Myatt L, 2013, BJOG-INT J OBSTET GY, V120, P1183, DOI 10.1111/1471-0528.12128; Nakimuli A, 2015, P NATL ACAD SCI USA, V112, P845, DOI 10.1073/pnas.1413453112; National Institute for Health and Clinical Excellence (NICE), 2011, NICE CLINICAL GUIDEL; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Nouwen E, 2012, HYPERTENS PREGNANCY, V31, P131, DOI 10.3109/10641955.2010.544799; Orbach H, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.011; Payne BA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001589; Poon LCY, 2009, HYPERTENSION, V53, P812, DOI 10.1161/HYPERTENSIONAHA.108.127977; Prick BW, 2015, EUR J OBSTET GYN R B, V185, P88, DOI 10.1016/j.ejogrb.2014.11.038; Rana S, 2014, HYPERTENSION, V63, P198, DOI 10.1161/HYPERTENSIONAHA.113.02293; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Rautio N, 2014, J WOMENS HEALTH, V23, P506, DOI 10.1089/jwh.2013.4520; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Rodger MA, 2014, LANCET, V384, P1673, DOI 10.1016/S0140-6736(14)60793-5; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Saleem S, 2014, B WORLD HEALTH ORGAN, V92, P605, DOI 10.2471/BLT.13.127464; Sattar N, 1997, OBSTET GYNECOL, V89, P403, DOI 10.1016/S0029-7844(96)00514-5; Saudan P, 2012, Pregnancy Hypertens, V2, P182, DOI 10.1016/j.preghy.2012.04.015; Smith JM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-34; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Spratling PM, 2014, JOGNN-J OBST GYN NEO, V43, P179, DOI 10.1111/1552-6909.12296; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Staines-Urias E, 2012, INT J EPIDEMIOL, V41, P1764, DOI 10.1093/ije/dys162; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Strand KM, 2013, BMJ-BRIT MED J, V347, pf4089, DOI DOI 10.1136/BMJ.F4089; Tajik P, 2012, BJOG-INT J OBSTET GY, V119, P1123, DOI 10.1111/j.1471-0528.2012.03405.x; Thangaratinam S, 2006, BJOG-INT J OBSTET GY, V113, P369, DOI 10.1111/j.1471-0528.2006.00908.x; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Thangaratinam S, 2011, ARCH DIS CHILD-FETAL, V96, P101, DOI DOI 10.1136/ADC.2011.300163.15; Thangaratinam S, 2011, ACTA OBSTET GYN SCAN, V90, P574, DOI 10.1111/j.1600-0412.2011.01112.x; Thangaratinam S, 2011, ACTA OBSTET GYN SCAN, V90, P564, DOI 10.1111/j.1600-0412.2011.01111.x; Thangaratinam S, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-10; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Turnbull DA, 2004, LANCET, V363, P1104, DOI 10.1016/S0140-6736(04)15893-5; Vadillo-Ortega F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2901; Veerbeek JHW, 2015, HYPERTENSION, V65, P600, DOI 10.1161/HYPERTENSIONAHA.114.04850; Velauthar L, 2014, ULTRASOUND OBST GYN, V43, P500, DOI 10.1002/uog.13275; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vermillion ST, 1999, AM J OBSTET GYNECOL, V181, P858, DOI 10.1016/S0002-9378(99)70314-5; Vigil-De Gracia P, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.016; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Vogel JP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-19; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7; Williams D, 2003, CURR OPIN OBSTET GYN, V15, P465, DOI 10.1097/00001703-200312000-00002; Williams PJ, 2011, BEST PRACT RES CL OB, V25, P405, DOI 10.1016/j.bpobgyn.2011.02.007; World Health Organization, 2011, WHO RECOMMENDATIONS; Woudstra DM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008148.pub2; Young B, 2012, HYPERTENS PREGNANCY, V31, P50, DOI 10.3109/10641955.2010.544955	139	707	775	17	182	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					999	1011		10.1016/S0140-6736(15)00070-7	http://dx.doi.org/10.1016/S0140-6736(15)00070-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26342729				2022-12-28	WOS:000371644200033
J	Rea, T; Eisenberg, M				Rea, Thomas; Eisenberg, Mickey			Sudden Cardiac Arrest: A Call to Action From the Institute of Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESUSCITATION; SURVIVAL				Rea, T (corresponding author), 401 5th Ave,Suite 1200, Seattle, WA 98104 USA.	rea123@u.washington.edu						[Anonymous], 2015, CIRCULATION, DOI DOI 10.1161/CIR.0000000000000152; [Anonymous], ABCS OF MEASURING; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Kragholm K, 2015, CIRCULATION, V131, P1682, DOI 10.1161/CIRCULATIONAHA.114.011366; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nolan JP, 2010, RESUSCITATION, V81, pE1, DOI 10.1016/j.resuscitation.2010.08.002; Rea TD, 2010, CIRCULATION, V121, P1134, DOI 10.1161/CIRCULATIONAHA.109.899799; Theophanous Christos, 2015, Ann Intern Med, V163, P238, DOI 10.7326/M15-0195	9	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					794	U304		10.7326/M15-1926	http://dx.doi.org/10.7326/M15-1926			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26343457				2022-12-28	WOS:000365746400024
J	Johnston, EJ; Rylott, EL; Beynon, E; Lorenz, A; Chechik, V; Bruce, NC				Johnston, Emily J.; Rylott, Elizabeth L.; Beynon, Emily; Lorenz, Astrid; Chechik, Victor; Bruce, Neil C.			Monodehydroascorbate reductase mediates TNT toxicity in plants	SCIENCE			English	Article							EXPLOSIVE 2,4,6-TRINITROTOLUENE; DETOXIFICATION; GLUTATHIONE; ACTIVATION; CATALYZES; ASCORBATE	The explosive 2,4,6-trinitrotoluene (TNT) is a highly toxic and persistent environmental pollutant. Due to the scale of affected areas, one of the most cost-effective and environmentally friendly means of removing explosives pollution could be the use of plants. However, mechanisms of TNT phytotoxicity have been elusive. Here, we reveal that phytotoxicity is caused by reduction of TNT in the mitochondria, forming a nitro radical that reacts with atmospheric oxygen, generating reactive superoxide. The reaction is catalyzed by monodehydroascorbate reductase 6 (MDHAR6), with Arabidopsis deficient in MDHAR6 displaying enhanced TNT tolerance. This discovery will contribute toward the remediation of contaminated sites. Moreover, in an environment of increasing herbicide resistance, with a shortage in new herbicide classes, our findings reveal MDHAR6 as a valuable plant-specific target.	[Johnston, Emily J.; Rylott, Elizabeth L.; Beynon, Emily; Lorenz, Astrid; Bruce, Neil C.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England; [Chechik, Victor] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Rylott, EL (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.	liz.rylott@york.ac.uk; neil.bruce@york.ac.uk	Rylott, Elizabeth L/A-6059-2012	Rylott, Elizabeth L/0000-0002-1609-414X; Bruce, Neil Charles/0000-0003-0398-2997; Johnston, Emily/0000-0003-0592-0992	Biotechnology and Biological Sciences Research Council; Burgess family; Garfield Weston Foundation; Strategic Environmental Research and Development Program of the U.S. Department of Defense; EPSRC [EP/H045031/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1098548] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H045031/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Burgess family; Garfield Weston Foundation; Strategic Environmental Research and Development Program of the U.S. Department of Defense; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors acknowledge the assistance of M. V. Budarina for technical support. E.J.J., E.B., and A.L. were supported by Ph.D. studentships from the Biotechnology and Biological Sciences Research Council, the Burgess family, and the Garfield Weston Foundation, respectively. This work was supported by funding from the Strategic Environmental Research and Development Program of the U.S. Department of Defense to E.L.R and N.C.B. The supplementary materials contain additional data.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARRIGONI O, 1981, FEBS LETT, V125, P242, DOI 10.1016/0014-5793(81)80729-6; Beynon ER, 2009, PLANT PHYSIOL, V151, P253, DOI 10.1104/pp.109.141598; Brentner LB, 2010, ENVIRON POLLUT, V158, P470, DOI 10.1016/j.envpol.2009.08.022; Clausen J, 2004, ENVIRON POLLUT, V129, P13, DOI 10.1016/j.envpol.2003.10.002; Duke SO, 2012, PEST MANAG SCI, V68, P505, DOI 10.1002/ps.2333; FINKELSTEIN E, 1982, MOL PHARMACOL, V21, P262; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gandia-Herrero F, 2008, PLANT J, V56, P963, DOI 10.1111/j.1365-313X.2008.03653.x; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Gunning V, 2014, PLANT PHYSIOL, V165, P854, DOI 10.1104/pp.114.237180; Heap, 2020, INT SURV HERB RES WE; HOSSAIN MA, 1985, J BIOL CHEM, V260, P2920; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jackson RG, 2007, P NATL ACAD SCI USA, V104, P16822, DOI 10.1073/pnas.0705110104; Jenkins TF, 2006, CHEMOSPHERE, V63, P1280, DOI 10.1016/j.chemosphere.2005.09.066; Kumagai Y, 2004, FREE RADICAL BIO MED, V37, P350, DOI 10.1016/j.freeradbiomed.2004.04.023; Kumagai Y, 2000, FEBS LETT, V478, P295, DOI 10.1016/S0014-5793(00)01841-X; Lisenbee CS, 2005, PLANT J, V43, P900, DOI 10.1111/j.1365-313X.2005.02503.x; Obara K, 2002, PLANT CELL PHYSIOL, V43, P697, DOI 10.1093/pcp/pcf103; PICHTEL J, 2012, APPL ENVIRON SOIL SC, V2012, DOI DOI 10.1155/2012/617236; Rylott EL, 2006, NAT BIOTECHNOL, V24, P216, DOI 10.1038/nbt1184; Rylott EL, 2011, CURR OPIN BIOTECH, V22, P434, DOI 10.1016/j.copbio.2010.10.014; Travis ER, 2008, ENVIRON POLLUT, V153, P119, DOI 10.1016/j.envpol.2007.07.015; Travis ER, 2007, ENVIRON SCI TECHNOL, V41, P5854, DOI 10.1021/es070507a; U.S. Agency for Toxic Substances and Disease Registry, 1995, ATSDR PUBL, V118-96-7; U. S. General Accountability Office Department of Defense Operational Ranges, 2004, GAO PUBL; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003	28	59	65	8	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1072	1075		10.1126/science.aab3472	http://dx.doi.org/10.1126/science.aab3472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339024	Green Accepted			2022-12-28	WOS:000360628900035
J	Kaplan, WD				Kaplan, Wayne D.			The mechanism of crystal deformation	SCIENCE			English	Editorial Material							INTERFACE		Technion Israel Inst Technol, Dept Mat Sci & Engn, Haifa, Israel	Technion Israel Institute of Technology	Kaplan, WD (corresponding author), Technion Israel Inst Technol, Dept Mat Sci & Engn, Haifa, Israel.	kaplan@technion.ac.il	Kaplan, Wayne D./C-9100-2011	Kaplan, Wayne D./0000-0001-9202-391X				Baram M, 2011, SCIENCE, V332, P206, DOI 10.1126/science.1201596; Dillon SJ, 2007, ACTA MATER, V55, P6208, DOI 10.1016/j.actamat.2007.07.029; GIBBS JW, 1961, SCIENTIFIC PAPERS J, V1, P219; Kaplan WD, 2013, J MATER SCI, V48, P5681, DOI 10.1007/s10853-013-7462-y; Kuzmina M, 2015, SCIENCE, V349, P1080, DOI 10.1126/science.aab2633; Lauritsen JV, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.076103; Luo J, 2011, SCIENCE, V333, P1730, DOI 10.1126/science.1208774; Nussbaum E, 2012, J MATER SCI, V47, P1647, DOI 10.1007/s10853-011-5707-1; Oh SH, 2005, SCIENCE, V310, P661, DOI 10.1126/science.1118611; Seidman DN, 2007, ANNU REV MATER RES, V37, P127, DOI 10.1146/annurev.matsci.37.052506.084200; Tang M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024102; Zhu GZ, 2012, NATURE, V490, P384, DOI 10.1038/nature11563	12	14	14	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1059	1060		10.1126/science.aac9623	http://dx.doi.org/10.1126/science.aac9623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339018				2022-12-28	WOS:000360628900023
J	Schuijs, MJ; Willart, MA; Vergote, K; Gras, D; Deswarte, K; Ege, MJ; Madeira, FB; Beyaert, R; van Loo, G; Bracher, F; von Mutius, E; Chanez, P; Lambrecht, BN; Hammad, H				Schuijs, Martijn J.; Willart, Monique A.; Vergote, Karl; Gras, Delphine; Deswarte, Kim; Ege, Markus J.; Madeira, Filipe Branco; Beyaert, Rudi; van Loo, Geert; Bracher, Franz; von Mutius, Erika; Chanez, Pascal; Lambrecht, Bart N.; Hammad, Hamida			ALLERGY Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells	SCIENCE			English	Article							NF-KAPPA-B; CHILDHOOD ASTHMA; AIRWAY INFLAMMATION; MITE ALLERGEN; ENZYME A20; EXPOSURE; RESPONSES; CHILDREN; IMMUNITY; ENVIRONMENT	Growing up on a dairy farm protects children from allergy, hay fever, and asthma. A mechanism linking exposure to this endotoxin (bacterial lipopolysaccharide)-rich environment with protection has remained elusive. Here we show that chronic exposure to low-dose endotoxin or farm dust protects mice from developing house dust mite (HDM)-induced asthma. Endotoxin reduced epithelial cell cytokines that activate dendritic cells (DCs), thus suppressing type 2 immunity to HDMs. Loss of the ubiquitin-modifying enzyme A20 in lung epithelium abolished the protective effect. A single-nucleotide polymorphism in the gene encoding A20 was associated with allergy and asthma risk in children growing up on farms. Thus, the farming environment protects from allergy by modifying the communication between barrier epithelial cells and DCs through A20 induction.	[Schuijs, Martijn J.; Willart, Monique A.; Vergote, Karl; Deswarte, Kim; Madeira, Filipe Branco; Lambrecht, Bart N.; Hammad, Hamida] VIB Inflammat Res Ctr, Immunoregulat Lab, Ghent, Belgium; [Schuijs, Martijn J.; Willart, Monique A.; Vergote, Karl; Deswarte, Kim; Madeira, Filipe Branco; Lambrecht, Bart N.; Hammad, Hamida] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium; [Gras, Delphine; Chanez, Pascal] Aix Marseille Univ, Assistance Publ Hop Marseille, Dept Resp Med, UMR INSERM U1067,CNRS 7333, Marseille, France; [Ege, Markus J.; von Mutius, Erika] Univ Munich, Dr von Hauner Childrens Hosp, D-81377 Munich, Germany; [Beyaert, Rudi; van Loo, Geert] VIB Inflammat Res Ctr, Unit Mol Signal Transduct, Ghent, Belgium; [Beyaert, Rudi; van Loo, Geert] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Bracher, Franz] Univ Munich, Dept Pharm, Ctr Drug Res, D-81377 Munich, Germany; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Munich; Flanders Institute for Biotechnology (VIB); Ghent University; University of Munich; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), VIB Inflammat Res Ctr, Immunoregulat Lab, Ghent, Belgium.	bart.lambrecht@ugent.be; hamida.hammad@ugent.be	Gras, Delphine/A-7062-2017; Hammad, Hamida/J-9391-2015; , van Loo Geert/AAD-1220-2019; Lambrecht, Bart N/K-2484-2014; Ege, Markus/C-1962-2012; van Loo, Geert/C-1505-2009; Gras, Delphine/AAP-7248-2020; Beyaert, Rudi/B-2589-2009	Hammad, Hamida/0000-0003-3762-8603; , van Loo Geert/0000-0002-8427-4775; Lambrecht, Bart N/0000-0003-4376-6834; Ege, Markus/0000-0001-6643-3923; Gras, Delphine/0000-0002-6630-2955; chanez, pascal/0000-0003-4059-0917; Beyaert, Rudi/0000-0002-5704-582X; von Mutius, Erika/0000-0002-8893-4515; Deswarte, Kim/0000-0002-9761-6973	European Union FP7 grant "MedALL" (Mechanisms in Development of Allergy); European Union Innovative Medicines Initiative grant "EUBIOPRED"; Flanders Organization for Scientific Research (FWO) program; European Research Council Consolidator grant; Ghent University Multidisciplinary Research Platform grant; ARARD; Fonds de Recherche en Sante Respiratoire; ANR "Mucocil"; European Union [GABRIEL: LSHB-CT-2006-018996, HERA: ERC2009-AdG_20090506_250268]; Gottfried-Wilhelm-Leibniz award from the German Research Council	European Union FP7 grant "MedALL" (Mechanisms in Development of Allergy); European Union Innovative Medicines Initiative grant "EUBIOPRED"; Flanders Organization for Scientific Research (FWO) program; European Research Council Consolidator grant(European Research Council (ERC)); Ghent University Multidisciplinary Research Platform grant; ARARD; Fonds de Recherche en Sante Respiratoire; ANR "Mucocil"(French National Research Agency (ANR)); European Union(European Commission); Gottfried-Wilhelm-Leibniz award from the German Research Council	The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. M.J.E. and E.v.M have filed patent applications (EP000002361632B1, EP000001964570B1, and US020080305089A1) that relate to identifying microorganisms and derived substances in farm dust that induce protection from several inflammatory diseases. This research was supported by European Union FP7 grant "MedALL" (Mechanisms in Development of Allergy) and by a European Union Innovative Medicines Initiative grant "EUBIOPRED." H.H. and B.N.L. are recipients of several Flanders Organization for Scientific Research (FWO) program grants. B.N.L. is a recipient of a European Research Council Consolidator grant and a Ghent University Multidisciplinary Research Platform grant (Group-ID). D.G. and P.C. are supported by grants from ARARD, Fonds de Recherche en Sante Respiratoire, and ANR "Mucocil." Population analyses were supported by two European Union research grants (GABRIEL: LSHB-CT-2006-018996, HERA: ERC2009-AdG_20090506_250268). E.v.M is supported by a Gottfried-Wilhelm-Leibniz award from the German Research Council. M.J.E. and E.v.M. are members of the German Center for Lung Research (DZL).	Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; El Bakkouri K, 2005, J BIOL CHEM, V280, P17938, DOI 10.1074/jbc.M413588200; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Kadota K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072551; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li XN, 2012, J ALLERGY CLIN IMMUN, V130, P861, DOI 10.1016/j.jaci.2012.04.041; Llop-Guevara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088714; McAlees JW, 2015, MUCOSAL IMMUNOL, V8, P863, DOI 10.1038/mi.2014.117; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Pearce N, 2013, LANCET RESP MED, V1, P96, DOI 10.1016/S2213-2600(13)70023-7; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Peters M, 2006, THORAX, V61, P134, DOI 10.1136/thx.2005.049403; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Simpson A, 2006, AM J RESP CRIT CARE, V174, P386, DOI 10.1164/rccm.200509-1380OC; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	33	374	390	10	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1106	1110		10.1126/science.aac6623	http://dx.doi.org/10.1126/science.aac6623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339029				2022-12-28	WOS:000360628900043
J	Cassel, CK; Kronick, R				Cassel, Christine K.; Kronick, Richard			Learning From the Past to Measure the Future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cassel, Christine K.] Natl Qual Forum, 1030 15th St NW,Ste 800, Washington, DC 20005 USA; [Kronick, Richard] Agcy Healthcare Res & Qual, US Dept Hlth & Human Serv, Washington, DC USA	Agency for Healthcare Research & Quality	Cassel, CK (corresponding author), Natl Qual Forum, 1030 15th St NW,Ste 800, Washington, DC 20005 USA.	cassel@qualityforum.org						[Anonymous], NAT STAT HEALTHC ASS; Austin JM, 2015, HEALTH AFFAIR, V34, P423, DOI 10.1377/hlthaff.2014.0201; Bipartisan Policy Center, TRANS VOL VAL CONS A; Blumenthal D, 2015, JAMA-J AM MED ASSOC, V313, P1901, DOI 10.1001/jama.2015.4862; Institute of Medicine, 2015, VIT SIGNS COR METR H; Krumholz HM, 2011, CIRCULATION, V124, P1038, DOI 10.1161/CIRCULATIONAHA.111.044107; President's Council of Advisors on Science and Technology, REP PRES BETT HTLH C	7	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					875	876		10.1001/jama.2015.9186	http://dx.doi.org/10.1001/jama.2015.9186			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325553				2022-12-28	WOS:000360392100011
J	Natarajan, A; Yabukarski, F; Lamba, V; Schwans, JP; Sunden, F; Herschlag, D				Natarajan, Aditya; Yabukarski, Filip; Lamba, Vandana; Schwans, Jason P.; Sunden, Fanny; Herschlag, Daniel			Comment on "Extreme electric fields power catalysis in the active site of ketosteroid isomerase"	SCIENCE			English	Editorial Material							3-OXO-DELTA-5-STEROID ISOMERASE; ENZYME; ENERGETICS	Fried et al. (Reports, 19 December 2014, p. 1510) demonstrated a strong correlation between reaction rate and the carbonyl stretching frequency of a product analog bound to ketosteroid isomerase oxyanion hole mutants and concluded that the active-site electric field provides 70% of catalysis. Alternative comparisons suggest a smaller contribution, relative to the corresponding solution reaction, and highlight the importance of atomic-level descriptions.	[Natarajan, Aditya; Yabukarski, Filip; Lamba, Vandana; Sunden, Fanny; Herschlag, Daniel] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Schwans, Jason P.] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA	Stanford University; California State University System; California State University Long Beach	Herschlag, D (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	herschla@stanford.edu						Blow D, 2000, STRUCT FOLD DES, V8, pR77, DOI 10.1016/S0969-2126(00)00125-8; Choi G, 2001, BIOCHEMISTRY-US, V40, P6828, DOI 10.1021/bi002767+; Fried SD, 2014, SCIENCE, V346, P1510, DOI 10.1126/science.1259802; HAWKINSON DC, 1991, BIOCHEMISTRY-US, V30, P10849, DOI 10.1021/bi00109a007; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Kraut DA, 2010, P NATL ACAD SCI USA, V107, P1960, DOI 10.1073/pnas.0911168107; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; POLLACK RM, 1986, BIOCHEMISTRY-US, V25, P1905, DOI 10.1021/bi00356a011	10	7	7	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251								10.1126/science.aab1584	http://dx.doi.org/10.1126/science.aab1584			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315426				2022-12-28	WOS:000360646800033
J	Lui, TH; Tam, KF				Lui, Tun Hing; Tam, Kwok Fai			An unusual case of a painful big toe	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lui, Tun Hing] North Dist Hosp, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Tam, Kwok Fai] North Dist Hosp, Dept Radiol, Hong Kong, Hong Kong, Peoples R China		Lui, TH (corresponding author), North Dist Hosp, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	luithderek@yahoo.co.uk						Cooper C, 2006, J BONE MINER RES, V21, pP3, DOI 10.1359/JBMR.06S201	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2015	351									10.1136/bmj.h4533	http://dx.doi.org/10.1136/bmj.h4533			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2NG	26306612				2022-12-28	WOS:000360437200001
J	Altman, DG				Altman, Douglas G.			ISIS and the emergence of large, simple trials	LANCET			English	Editorial Material							SOCIAL-HISTORY; MEDICINE; ART		Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England	University of Oxford	Altman, DG (corresponding author), Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England.	doug.altman@csm.ox.ac.uk			Cancer Research UK [16895] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V2, P57; Bland JM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3985; Campbell MJ, 2013, J ROY SOC MED, V106, P68, DOI 10.1177/0141076813477570; Hopewell S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c723; Keating C, 2015, LANCET, V386, P646, DOI 10.1016/S0140-6736(15)61493-3; Keating C, 2015, LANCET, V386, pE2, DOI 10.1016/S0140-6736(15)61504-5; Keating C, 2015, LANCET, V386, pE4, DOI 10.1016/S0140-6736(15)61505-7; MOSTELLER F, 1980, CONTROL CLIN TRIALS, V1, P37, DOI 10.1016/S0197-2456(80)80006-7; Peto R., 1978, BIOMEDICINE; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; Yusuf S, 2000, AM HEART J, V139, pS136, DOI 10.1016/S0002-8703(00)90061-9	12	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					636	637		10.1016/S0140-6736(15)61450-7	http://dx.doi.org/10.1016/S0140-6736(15)61450-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26334142				2022-12-28	WOS:000359849200012
J	Higgins, JPT; Welton, NJ				Higgins, Julian P. T.; Welton, Nicky J.			Network meta-analysis: a norm for comparative effectiveness?	LANCET			English	Editorial Material							MULTIPLE-TREATMENTS		[Higgins, Julian P. T.; Welton, Nicky J.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England	University of Bristol	Higgins, JPT (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England.	julian.higgins@bristol.ac.uk	Higgins, Julian PT/H-4008-2011	Higgins, Julian PT/0000-0002-8323-2514; Welton, Nicky/0000-0003-2198-3205	Medical Research Council [MR/K025643/1, G0802413] Funding Source: Medline; MRC [MR/K025643/1, G0802413] Funding Source: UKRI; National Institute for Health Research [NF-SI-0514-10114] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Dias S, 2013, MED DECIS MAKING, V33, P597, DOI 10.1177/0272989X13487604; Eddy DM, 1992, METAANALYSIS CONFIDE; Gleser L.J., 1994, HDB RES SYNTHESIS, P339, DOI DOI 10.7758/9781610448864.16; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Siontis GCM, 2015, LANCET, V386, P655, DOI 10.1016/S0140-6736(15)60657-2	12	73	73	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					628	630		10.1016/S0140-6736(15)61478-7	http://dx.doi.org/10.1016/S0140-6736(15)61478-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26334141	Green Submitted			2022-12-28	WOS:000359849200008
J	Singh, S; Loftus, EV				Singh, Siddharth; Loftus, Edward V., Jr.			Crohn's disease: REACT to save the gut	LANCET			English	Editorial Material							INFLAMMATORY BOWEL DISEASES; MANAGEMENT; TIME		[Singh, Siddharth; Loftus, Edward V., Jr.] Mayo Clin, Div Gastroenterol & Hepatol, Dept Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Loftus, EV (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Dept Internal Med, Rochester, MN 55905 USA.	loftus.edward@mayo.edu	Loftus, Edward V/E-8304-2011	Loftus, Edward V/0000-0001-7199-6851				Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Katz S, 2013, INFLAMM BOWEL DIS, V19, P2257, DOI 10.1097/MIB.0b013e31828c8536; Khanna R, 2015, LANCET, V386, P1825, DOI 10.1016/S0140-6736(15)00068-9; Marchetti M, 2013, EUR J HEALTH ECON, V14, P853, DOI 10.1007/s10198-012-0430-7; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Peyrin-Biroulet L, 2014, GUT, V63, P88, DOI 10.1136/gutjnl-2013-304984; Peyrin-Biroulet L, 2011, J CROHNS COLITIS, V5, P477, DOI 10.1016/j.crohns.2011.06.009; Vermeire S, 2013, GUT, V62, P1511, DOI 10.1136/gutjnl-2012-303958	12	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1800	1802		10.1016/S0140-6736(15)00069-0	http://dx.doi.org/10.1016/S0140-6736(15)00069-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26342730				2022-12-28	WOS:000364194700010
J	Than, M; Peacock, WF				Than, Martin; Peacock, William F.			Supraventricular tachycardia: back to basics	LANCET			English	Editorial Material									[Than, Martin] Christchurch Hosp, Canterbury 8011, New Zealand; [Peacock, William F.] Baylor Coll Med, Houston, TX 77030 USA	Christchurch Hospital New Zealand; Baylor College of Medicine	Than, M (corresponding author), Christchurch Hosp, Canterbury 8011, New Zealand.	martinthan@xtra.co.nz						Appelboam A, 2015, LANCET, V386, P1747, DOI 10.1016/S0140-6736(15)61485-4; Link MS, 2012, NEW ENGL J MED, V367, P1438, DOI 10.1056/NEJMcp1111259; Smith G, 2009, EMERG MED AUSTRALAS, V21, P449, DOI 10.1111/j.1742-6723.2009.01228.x; Smith GD, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009502.pub3	4	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1712	1712		10.1016/S0140-6736(15)61514-8	http://dx.doi.org/10.1016/S0140-6736(15)61514-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0WK	26314491	hybrid			2022-12-28	WOS:000363974200009
J	Elshenawy, MM; Jergic, S; Xu, ZQ; Sobhy, MA; Takahashi, M; Oakley, AJ; Dixon, NE; Hamdan, SM				Elshenawy, Mohamed M.; Jergic, Slobodan; Xu, Zhi-Qiang; Sobhy, Mohamed A.; Takahashi, Masateru; Oakley, Aaron J.; Dixon, Nicholas E.; Hamdan, Samir M.			Replisome speed determines the efficiency of the Tus-Ter replication termination barrier	NATURE			English	Article							ESCHERICHIA-COLI; DNA-REPLICATION; SINGLE-MOLECULE; CHROMOSOME-REPLICATION; POLAR ARREST; FORK TRAP; HELICASE; COMPLEX; PROTEIN; REFINEMENT	In all domains of life, DNA synthesis occurs bidirectionally from replication origins. Despite variable rates of replication fork progression, fork convergence often occurs at specific sites(1). Escherichia coli sets a 'replication fork trap' that allows the first arriving fork to enter but not to leave the terminus region(2-5). The trap is set by oppositely oriented Tus-bound Ter sites that block forks on approach fromonly one direction(3-7). However, the efficiency of fork blockage by Tus-Ter does not exceed 50% in vivo despite its apparent ability to almost permanently arrest replication forks in vitro(8,9). Here we use data from single-molecule DNA replication assays and structural studies to show that both polarity and fork-arrest efficiency are determined by a competition between rates of Tus displacement and rearrangement of Tus-Ter interactions that leads to blockage of slower moving replisomes by two distinct mechanisms. To our knowledge this is the first example where intrinsic differences in rates of individual replisomes have different biological outcomes.	[Elshenawy, Mohamed M.; Sobhy, Mohamed A.; Takahashi, Masateru; Hamdan, Samir M.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci Engn, Thuwal 23955, Saudi Arabia; [Jergic, Slobodan; Xu, Zhi-Qiang; Oakley, Aaron J.; Dixon, Nicholas E.] Illawarra Hlth & Med Res, Ctr Med & Mol Biosci, Wollongong, NSW 2522, Australia; [Jergic, Slobodan; Xu, Zhi-Qiang; Oakley, Aaron J.; Dixon, Nicholas E.] Univ Wollongong, Wollongong, NSW 2522, Australia	King Abdullah University of Science & Technology; University of Wollongong	Dixon, NE (corresponding author), Illawarra Hlth & Med Res, Ctr Med & Mol Biosci, Wollongong, NSW 2522, Australia.	nickd@uow.edu.au; samir.hamdan@kaust.edu.sa	Oakley, Aaron/A-9464-2013; Dixon, Nicholas E/A-1226-2008; Elshenawy, Mohamed/AAA-6812-2020	Oakley, Aaron/0000-0002-4764-014X; Dixon, Nicholas E/0000-0002-5958-6945; Hamdan, Samir/0000-0001-5192-1852; Elshenawy, Mohamed/0000-0002-8599-8388; Xu, Zhi-Qiang/0000-0002-5884-0569	King Abdullah University of Science and Technology; Faculty Initiated Collaborative Award; Australian Research Council [DP0877658, DP0984797, FT0990287]	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Faculty Initiated Collaborative Award; Australian Research Council(Australian Research Council)	We thank A. van Oijen for critical comments and the groups of N. Dekker and S. Patel for helpful discussions. This research was supported by the King Abdullah University of Science and Technology through core funding (to S.M.H.) and a Faculty Initiated Collaborative Award (to S.M.H. and N.E.D.), and by the Australian Research Council (DP0877658 to N.E.D. and A.J.O.; DP0984797 to N.E.D.), including an Australian Professorial Fellowship to N.E.D. and a Future Fellowship (FT0990287) to A.J.O. X-ray crystallographic data were collected at the Australian Synchrotron, Victoria, Australia.	[Anonymous], PYMOL MOL GRAPH SYST; Bastia D, 2008, P NATL ACAD SCI USA, V105, P12831, DOI 10.1073/pnas.0805898105; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; COSKUNARI FF, 1994, J BIOL CHEM, V269, P4027; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Dalgaard Jacob Z., 2009, V521, P35, DOI [10.1007/978-1-60327-817-5_3, 10.1007/978-1-60327-815-7_3]; Duggin IG, 2009, J MOL BIOL, V387, P532, DOI 10.1016/j.jmb.2009.02.027; Duggin IG, 2008, MOL MICROBIOL, V70, P1323, DOI 10.1111/j.1365-2958.2008.06500.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finkelstein IJ, 2013, ANNU REV BIOPHYS, V42, P241, DOI 10.1146/annurev-biophys-083012-130304; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; HILL TM, 1987, P NATL ACAD SCI USA, V84, P1754, DOI 10.1073/pnas.84.7.1754; Jergic S, 2013, EMBO J, V32, P1322, DOI 10.1038/emboj.2012.347; Kamada K, 1996, NATURE, V383, P598, DOI 10.1038/383598a0; Kaplan DL, 2009, MOL MICROBIOL, V72, P279, DOI 10.1111/j.1365-2958.2009.06656.x; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Moreau MJJ, 2012, MOL BIOSYST, V8, P2783, DOI 10.1039/c2mb25281c; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Oakley AJ, 2003, ACTA CRYSTALLOGR D, V59, P1192, DOI 10.1107/S0907444903009958; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey M, 2015, NUCLEIC ACIDS RES, V43, P5924, DOI 10.1093/nar/gkv527; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Tanner NA, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp006; Pham TM, 2013, MOL MICROBIOL, V90, P584, DOI 10.1111/mmi.12386; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valjavec-Gratian M, 2005, MOL MICROBIOL, V58, P758, DOI 10.1111/j.1365-2958.2005.04860.x; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106	36	29	29	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					394	+		10.1038/nature14866	http://dx.doi.org/10.1038/nature14866			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26322585				2022-12-28	WOS:000361297900047
J	Lai, F; Gardini, A; Zhang, AD; Shiekhattar, R				Lai, Fan; Gardini, Alessandro; Zhang, Anda; Shiekhattar, Ramin			Integrator mediates the biogenesis of enhancer RNAs	NATURE			English	Article							GENE-EXPRESSION; SUPER-ENHANCERS; POLYMERASE-II; CELL IDENTITY; TRANSCRIPTION; ACTIVATION; CHROMATIN; ARCHITECTURE; INITIATION; PROMOTERS	Integrator is a multi-subunit complex stably associated with the carboxy-terminal domain (CTD) of RNA polymerase II (RNAPII)(1). Integrator is endowed with a core catalytic RNA endonuclease activity, which is required for the 3'-end processing of non-polyadenylated, RNAPII-dependent, uridylate-rich, small nuclearRNAgenes(1). Here we examine the requirement of Integrator in the biogenesis of transcripts derived from distal regulatory elements (enhancers) involved in tissue-and temporal-specific regulation of gene expression in metazoans(2-5). Integrator is recruited to enhancers and super-enhancers in a stimulus-dependent manner. Functional depletion of Integrator subunits diminishes the signal-dependent induction of enhancer RNAs (eRNAs) and abrogates stimulus-induced enhancer-promoter chromatin looping. Global nuclear run-on and RNAPII profiling reveals a role for Integrator in 3'-end cleavage of eRNA primary transcripts leading to transcriptional termination. In the absence of Integrator, eRNAs remain bound to RNAPII and their primary transcripts accumulate. Notably, the induction of eRNAs and gene expression responsiveness requires the catalytic activity of Integrator complex. We propose a role for Integrator in biogenesis of eRNAs and enhancer function in metazoans.	[Lai, Fan; Gardini, Alessandro; Zhang, Anda; Shiekhattar, Ramin] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Human Genet, Miami, FL 33136 USA	University of Miami	Shiekhattar, R (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Human Genet, Biomed Res Bldg,Room 719,1501 NW 10th Ave, Miami, FL 33136 USA.	rshiekhattar@med.miami.edu	Lai, Fan/ABD-2862-2021	Zhang Quintero, Anda/0000-0003-2498-4836; Lai, Fan/0000-0002-0568-2616	University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center; National Institute of Health [R01GM078455, R01 GM105754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078455, R01GM105754] Funding Source: NIH RePORTER	University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank J.M. Marinis and M.A. Lazar for technical support for GRO-seq experiments. We thank D. Hu in A. Shilatifard's laboratory for performing the SEC ChIP-seq experiments. We thank the Oncogenomics core facility at Sylvester Comprehensive Cancer Center for performing high-throughput sequencing. We also thank Shiekhattar laboratory members and P.-J. Hamard for support and discussions. This work was supported by funds from University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center and grants R01GM078455 and R01 GM105754 (R.S.) from the National Institute of Health.	Albrecht TR, 2012, MOL CELL BIOL, V32, P1112, DOI 10.1128/MCB.06511-11; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Gardini A, 2014, MOL CELL, V56, P128, DOI 10.1016/j.molcel.2014.08.004; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Skaar JR, 2015, CELL RES, V25, P288, DOI 10.1038/cr.2015.19; Stadelmayer B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6531; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yamamoto J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5263; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287	31	168	173	4	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					399	+		10.1038/nature14906	http://dx.doi.org/10.1038/nature14906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26308897	Green Accepted			2022-12-28	WOS:000361297900048
J	Chang, CH; Qiu, J; O'Sullivan, D; Buck, MD; Noguchi, T; Curtis, JD; Chen, QY; Gindin, M; Gubin, MM; van der Windt, GJW; Tonc, E; Schreiber, RD; Pearce, EJ; Pearce, EL				Chang, Chih-Hao; Qiu, Jing; O'Sullivan, David; Buck, Michael D.; Noguchi, Takuro; Curtis, Jonathan D.; Chen, Qiongyu; Gindin, Mariel; Gubin, Matthew M.; van der Windt, Gerritje J. W.; Tonc, Elena; Schreiber, Robert D.; Pearce, Edward J.; Pearce, Erika L.			Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression	CELL			English	Article							T-CELL-ACTIVATION; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; IMMUNE-RESPONSE; PD-1; PROLIFERATION; MELANOMA; EXPRESSION; DIFFERENTIATION; EXHAUSTION	Failure of T cells to protect against cancer is thought to result from lack of antigen recognition, chronic activation, and/or suppression by other cells. Using a mouse sarcoma model, we show that glucose consumption by tumors metabolically restricts T cells, leading to their dampened mTOR activity, glycolytic capacity, and IFN-g production, thereby allowing tumor progression. We show that enhancing glycolysis in an antigenic "regressor'' tumor is sufficient to override the protective ability of T cells to control tumor growth. We also show that checkpoint blockade antibodies against CTLA-4, PD-1, and PD-L1, which are used clinically, restore glucose in tumor microenvironment, permitting T cell glycolysis and IFN-gamma production. Furthermore, we found that blocking PD-L1 directly on tumors dampens glycolysis by inhibiting mTOR activity and decreasing expression of glycolysis enzymes, reflecting a role for PD-L1 in tumor glucose utilization. Our results establish that tumor-imposed metabolic restrictions can mediate T cell hyporesponsiveness during cancer.	[Chang, Chih-Hao; Qiu, Jing; O'Sullivan, David; Buck, Michael D.; Noguchi, Takuro; Curtis, Jonathan D.; Chen, Qiongyu; Gindin, Mariel; Gubin, Matthew M.; van der Windt, Gerritje J. W.; Tonc, Elena; Schreiber, Robert D.; Pearce, Edward J.; Pearce, Erika L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Pearce, EL (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.	pearce@ie-freiburg.mpg.de	Noguchi, Takuro/AAW-9101-2020; Schreiber, Robert/Q-7550-2019	Gubin, Matthew/0000-0001-7443-2752; Schreiber, Robert/0000-0003-1590-2341; CHANG, CHIH-HAO/0000-0002-0139-7439; Buck, Michael/0000-0002-9611-1199	NIH [CA181125, AI091965, CA43059, CA141541, CA164062, AI032573]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease; CRI, WWWW Foundation; BMS; Irvington Fellowship; Netherlands Organisation for Scientific Research; NSF Graduate Research Fellowship [DGE-1143954]; NATIONAL CANCER INSTITUTE [R01CA164062, R01CA181125, R37CA043059, R01CA043059, U01CA141541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965, R01AI032573, R56AI032573] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease(Burroughs Wellcome Fund); CRI, WWWW Foundation; BMS(Bristol-Myers Squibb); Irvington Fellowship; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Shaw, C. Hsieh, H. Christofk, J. Cyster, Y. Feng, B. Edelson J. Lin, J. Hu, H. Yu, M. Colonna, A. Fuchs, G. Randolph, and L. Huang. This work was supported by grants from the NIH (CA181125, AI091965 to E.L.P.; CA43059, CA141541 to R.D.S.; CA164062, AI032573 to E.J.P.), The Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease (E.L.P.), CRI, WWWW Foundation, and BMS (R.D.S), Irvington Fellowship (M.M.G.), Netherlands Organisation for Scientific Research (G.J.W.v.d.W.), and NSF Graduate Research Fellowship DGE-1143954 (M.D.B.). Robert Schreiber is a cofounder of Igenica Biotherapeutics, and is a senior advisor to Jounce Therapeutics.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Anichini A, 2010, CANCER RES, V70, P8378, DOI 10.1158/0008-5472.CAN-10-2028; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Berghoff AS, 2015, NEURO-ONCOLOGY, V17, P1064, DOI 10.1093/neuonc/nou307; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Carlsson R., 2014, J IMMUNOL CLIN RES, V2, P1013; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; HATTEN ME, 1988, J NEUROSCI, V8, P1447; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Issazadeh-Navikas S, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27091; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kingwell Katie, 2013, Nat Rev Neurol, V9, P602, DOI 10.1038/nrneurol.2013.197; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Liu YW, 2013, J NEUROSCI, V33, P14231, DOI 10.1523/JNEUROSCI.5812-12.2013; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; O'Sullivan D, 2015, TRENDS IMMUNOL, V36, P71, DOI 10.1016/j.it.2014.12.004; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Parish IA, 2009, CURR OPIN IMMUNOL, V21, P291, DOI 10.1016/j.coi.2009.05.008; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pedicord VA, 2015, J IMMUNOL, V194, P2089, DOI 10.4049/jimmunol.1402390; Quezada SA, 2013, BRIT J CANCER, V108, P1560, DOI 10.1038/bjc.2013.117; Rao RR, 2010, CELL CYCLE, V9, P2996, DOI 10.4161/cc.9.15.12359; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vesely MD, 2013, ANN NY ACAD SCI, V1284, P1, DOI 10.1111/nyas.12105; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	58	1543	1603	35	406	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1229	1241		10.1016/j.cell.2015.08.016	http://dx.doi.org/10.1016/j.cell.2015.08.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26321679	Green Accepted, Bronze			2022-12-28	WOS:000361247900014
J	Crowley, JW; Katz, RF; Huybers, P; Langmuir, CH; Park, SH				Crowley, John W.; Katz, Richard F.; Huybers, Peter; Langmuir, Charles H.; Park, Sung-Hyun			Response to Comment on "Glacial cycles drive variations in the production of oceanic crust"	SCIENCE			English	Editorial Material								Goff comments that faulting is important for creation of abyssal hills and is the dominant process at slow-spreading ridges. We respond that faulting is indeed important but cannot alone explain the bathymetric signal predicted by our models and observed at the Australian-Antarctic Ridge. We show that for intermediate-to fast-spreading ridges, abyssal hill spacing is consistent with the periodicity of the obliquity cycle.	[Crowley, John W.; Katz, Richard F.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Crowley, John W.; Huybers, Peter; Langmuir, Charles H.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Park, Sung-Hyun] Korea Polar Res Inst, Div Polar Earth Syst Sci, Inchon, South Korea	University of Oxford; Harvard University; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Katz, RF (corresponding author), Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England.	richard.katz@earth.ox.ac.uk; shpark314@kopri.re.kr	Katz, Richard/D-3364-2009	Katz, Richard/0000-0001-8746-5430; Huybers, Peter/0000-0002-3734-8145; Crowley, John/0000-0001-8655-7907	Div Atmospheric & Geospace Sciences [1338832] Funding Source: National Science Foundation	Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Crowley JW, 2015, SCIENCE, V347, P1237, DOI 10.1126/science.1261508; GOFF JA, 1988, J GEOPHYS RES-SOLID, V93, P13589, DOI 10.1029/JB093iB11p13589; Goff JA, 2015, SCIENCE, V349, DOI 10.1126/science.aab2350; Ito G, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001970	4	3	3	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252								10.1126/science.aab3497	http://dx.doi.org/10.1126/science.aab3497			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339023	Bronze			2022-12-28	WOS:000360628900031
J	van der Zwaag, D; Meijer, EW				van der Zwaag, Daan; Meijer, E. W.			Fueling connections between chemistry and biology	SCIENCE			English	Editorial Material							MICROTUBULES; PATHWAY		[van der Zwaag, Daan; Meijer, E. W.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology	van der Zwaag, D (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands.	e.w.meijer@tue.nl	Meijer, E.W./K-7632-2013	Meijer, E.W./0000-0003-4126-7492; van der Zwaag, Daan/0000-0003-0320-8715				Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Boekhoven J, 2015, SCIENCE, V349, P1075, DOI 10.1126/science.aac6103; Boekhoven J, 2010, ANGEW CHEM INT EDIT, V49, P4825, DOI 10.1002/anie.201001511; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Hirose T, 2013, ANGEW CHEM INT EDIT, V52, P304, DOI 10.1002/anie.201205085; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; Jonkheijm P, 2006, SCIENCE, V313, P80, DOI 10.1126/science.1127884; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Korevaar PA, 2012, NATURE, V481, P492, DOI 10.1038/nature10720; Kumar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6793; Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l	12	13	13	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1056	1057		10.1126/science.aad0194	http://dx.doi.org/10.1126/science.aad0194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339016	Green Submitted			2022-12-28	WOS:000360628900021
J	Tefferi, A; Lasho, TL; Begna, KH; Patnaik, MM; Zblewski, DL; Finke, CM; Laborde, RR; Wassie, E; Schimek, L; Hanson, CA; Gangat, N; Wang, XL; Pardanani, A				Tefferi, Ayalew; Lasho, Terra L.; Begna, Kebede H.; Patnaik, Mrinal M.; Zblewski, Darci L.; Finke, Christy M.; Laborde, Rebecca R.; Wassie, Emnet; Schimek, Lauren; Hanson, Curtis A.; Gangat, Naseema; Wang, Xiaolin; Pardanani, Animesh			A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL WORKING GROUP; MYELOPROLIFERATIVE NEOPLASMS; TERMINAL TRANSFERASE; POLYCYTHEMIA-VERA; TETRAHYMENA; MUTATIONS; RNA; RUXOLITINIB; ASSOCIATION; SEQUENCE	BACKGROUND Current drugs for myeloproliferative neoplasm-associated myelofibrosis, including Janus kinase (JAK) inhibitors, do not induce complete or partial remissions. Imetelstat is a 13-mer lipid-conjugated oligonucleotide that targets the RNA template of human telomerase reverse transcriptase. METHODS We sought to obtain preliminary information on the therapeutic activity and safety of imetelstat in patients with high-risk or intermediate-2-risk myelofibrosis. Imetelstat was administered as a 2-hour intravenous infusion (starting dose, 9.4 mg per kilogram of body weight) every 1 to 3 weeks. The primary end point was the overall response rate, and the secondary end points were adverse events, spleen response, and independence from red-cell transfusions. RESULTS A total of 33 patients (median age, 67 years) met the eligibility criteria; 48% had received prior JAK inhibitor therapy. A complete or partial remission occurred in 7 patients (21%), with a median duration of response of 18 months (range, 13 to 20+) for complete responses and 10 months (range, 7 to 10+) for partial responses. Bone marrow fibrosis was reversed in all 4 patients who had a complete response, and a molecular response occurred in 3 of the 4 patients. Response rates were 27% among patients with a JAK2 mutation versus 0% among those without a JAK2 mutation (P = 0.30) and 32% among patients without an ASXL1 mutation versus 0% among those with an ASXL1 mutation (P = 0.07). The rate of complete response was 38% among patients with a mutation in SF3B1 or U2AF1 versus 4% among patients without a mutation in these genes (P = 0.04). Responses did not correlate with baseline telomere length. Treatment-related adverse events included grade 4 thrombocytopenia (in 18% of patients), grade 4 neutropenia (in 12%), grade 3 anemia (in 30%), and grade 1 or 2 elevation in levels of total bilirubin (in 12%), alkaline phosphatase (in 21%), and aspartate aminotransferase (in 27%). CONCLUSIONS Imetelstat was found to be active in patients with myelofibrosis but also had the potential to cause clinically significant myelosuppression. (Funded by Geron; ClinicalTrials. gov number, NCT01731951.)	[Tefferi, Ayalew; Lasho, Terra L.; Begna, Kebede H.; Zblewski, Darci L.; Finke, Christy M.; Laborde, Rebecca R.; Wassie, Emnet; Schimek, Lauren; Gangat, Naseema; Pardanani, Animesh] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA; [Hanson, Curtis A.] Mayo Clin, Dept Lab Med, Div Hematopathol, Rochester, MN 55905 USA; [Wang, Xiaolin] Biometr & Dev Operat, Menlo Pk, CA USA	Mayo Clinic; Mayo Clinic	Tefferi, A (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Div Hematol, 200 First St, Rochester, MN 55905 USA.	tefferi.ayalew@mayo.edu			Geron	Geron	Funded by Geron	Baerlocher GM, 2015, NEW ENGL J MED, V373, P920, DOI 10.1056/NEJMoa1503479; Barosi G, 2008, LEUKEMIA, V22, P437, DOI 10.1038/sj.leu.2404914; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; Broseus J, 2013, LEUKEMIA, V27, P1826, DOI 10.1038/leu.2013.120; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; Gangat N, 2011, J CLIN ONCOL, V29, P392, DOI 10.1200/JCO.2010.32.2446; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Kannan R, 2013, GENE DEV, V27, P627, DOI 10.1101/gad.212738.112; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Ouellette MM, 2011, J CELL MOL MED, V15, P1433, DOI 10.1111/j.1582-4934.2011.01279.x; Pardanani A, 2013, LEUKEMIA, V27, P1322, DOI 10.1038/leu.2013.71; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Roth A, 2010, RECENT RESULTS CANC, V184, P221, DOI 10.1007/978-3-642-01222-8_16; Ruella M, 2013, EXP HEMATOL, V41, P627, DOI 10.1016/j.exphem.2013.03.007; Spanoudakis E, 2011, LEUKEMIA RES, V35, P459, DOI 10.1016/j.leukres.2010.07.042; Tang W, 2012, NATURE, V484, P260, DOI 10.1038/nature10924; Tefferi A, 2014, LEUKEMIA, V28, P431, DOI 10.1038/leu.2013.286; Tefferi A, 2015, JAMA ONCOL, V1, P97, DOI 10.1001/jamaoncol.2015.89; Tefferi A, 2013, BLOOD, V122, P1395, DOI 10.1182/blood-2013-03-488098; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557	34	239	246	2	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					908	919		10.1056/NEJMoa1310523	http://dx.doi.org/10.1056/NEJMoa1310523			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2OB	26332545				2022-12-28	WOS:000360439500006
J	Kleopa, KA				Kleopa, Kleopas A.			Carpal Tunnel Syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK-FACTORS; SHORT-TERM; DIAGNOSIS; SONOGRAPHY; SURGERY; INTERVENTION; METAANALYSIS; PREDICTORS; SYMPTOMS; RELEASE							Kleopa, Kleopas/0000-0002-4103-8094				Alford J Winslow, 2004, Am J Orthop (Belle Mead NJ), V33, P397; [Anonymous], 2012, COCHRANE DB SYST REV; [Anonymous], 2004, J HAND SURG-AM; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Barcenilla A, 2012, RHEUMATOLOGY, V51, P250, DOI 10.1093/rheumatology/ker108; Benson LS, 2006, ARTHROSCOPY, V22, P919, DOI 10.1016/j.arthro.2006.05.008; BISCHOFF C, 1991, EUR NEUROL, V31, P33, DOI 10.1159/000116642; Bland JDP, 2000, MUSCLE NERVE, V23, P1280, DOI 10.1002/1097-4598(200008)23:8<1280::AID-MUS20>3.3.CO;2-P; Bland JDP, 2005, MUSCLE NERVE, V32, P527, DOI 10.1002/mus.20408; BUCHJAEGER N, 1994, J HAND SURG-BRIT EUR, V19B, P720, DOI 10.1016/0266-7681(94)90244-5; BURKE DT, 1994, ARCH PHYS MED REHAB, V75, P1241, DOI 10.1016/0003-9993(94)90012-4; Chow JCY, 2005, J HAND SURG-AM, V30A, P1242, DOI 10.1016/j.jhsa.2005.05.018; Claes F, 2013, AM J PHYS MED REHAB, V92, P1005, DOI 10.1097/PHM.0b013e31829b4bd8; COOK AC, 1995, J HAND SURG-BRIT EUR, V20B, P228, DOI 10.1016/S0266-7681(05)80057-9; CSEUZ KA, 1966, MAYO CLIN PROC, V41, P232; D'Arcy CA, 2000, JAMA-J AM MED ASSOC, V283, P3110, DOI 10.1001/jama.283.23.3110; DAWSON DM, 1993, NEW ENGL J MED, V329, P2013, DOI 10.1056/NEJM199312303292707; Descatha A, 2012, SEMIN ARTHRITIS RHEU, V41, P914, DOI 10.1016/j.semarthrit.2011.11.006; Garfinkel MS, 1998, JAMA-J AM MED ASSOC, V280, P1601, DOI 10.1001/jama.280.18.1601; GIRLANDA P, 1993, J NEUROL, V240, P187, DOI 10.1007/BF00857526; Graham B, 2008, J BONE JOINT SURG AM, V90A, P2587, DOI 10.2106/JBJS.G.01362; Graham RG, 2004, PLAST RECONSTR SURG, V113, P550, DOI 10.1097/01.PRS.0000101055.76543.C7; Gravlee JR, 2007, AM FAM PHYSICIAN, V75, P342; Hakim AJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P275, DOI 10.1002/art.10395; Harris-Adamson C, 2015, OCCUP ENVIRON MED, V72, P33, DOI 10.1136/oemed-2014-102378; Herbert R, 2000, AM J IND MED, V37, P62, DOI 10.1002/(SICI)1097-0274(200001)37:1<62::AID-AJIM6>3.0.CO;2-D; Incebiyik S, 2015, J BACK MUSCULOSKELET, V28, P221, DOI 10.3233/BMR-140507; Jablecki CK, 2002, NEUROLOGY, V58, P1589, DOI 10.1212/WNL.58.11.1589; Jarvik JG, 2009, LANCET, V374, P1074, DOI 10.1016/S0140-6736(09)61517-8; Jenkins Paul J, 2012, Hand (N Y), V7, P151, DOI 10.1007/s11552-012-9390-8; Jetzer T, 2003, J OCCUP ENVIRON MED, V45, P1312, DOI 10.1097/01.jom.0000099981.80004.c9; Jones NF, 2012, PLAST RECONSTR SURG, V129, P683, DOI 10.1097/PRS.0b013e3182402c37; KAPLAN SJ, 1990, J HAND SURG-BRIT EUR, V15B, P106, DOI 10.1016/0266-7681(90)90061-8; Kaymak B, 2008, ARCH PHYS MED REHAB, V89, P743, DOI 10.1016/j.apmr.2007.09.041; Keith MW, 2009, J AM ACAD ORTHOP SUR, V17, P397, DOI 10.5435/00124635-200906000-00008; Keith MW, 2009, J AM ACAD ORTHOP SUR, V17, P389, DOI 10.5435/00124635-200906000-00007; Kronlage SC, 2015, J HAND SURG-AM, V40, P438, DOI 10.1016/j.jhsa.2014.12.012; Kwon BC, 2008, J HAND SURG-AM, V33A, P65, DOI 10.1016/j.jhsa.2007.10.014; Lim PG, 2008, J HAND SURG-EUR VOL, V33E, P645, DOI 10.1177/1753193408093326; Lo JK, 2002, ARCH PHYS MED REHAB, V83, P598, DOI 10.1053/apmr.2002.32476; Marshall S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001554.pub2; Mondelli M, 2002, NEUROLOGY, V58, P289, DOI 10.1212/WNL.58.2.289; MURAKAMI T, 1994, NEUROLOGY, V44, P315, DOI 10.1212/WNL.44.2.315; Nakamichi K, 2005, MUSCLE NERVE, V32, P364, DOI 10.1002/mus.20363; Nathan PA, 2002, J HAND SURG-AM, V27A, P644, DOI 10.1053/jhsu.2002.34003; O'Connor D, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003219, DOI 10.1002/14651858.CD003219]; OMALLEY MJ, 1992, J HAND SURG-AM, V17A, P638, DOI 10.1016/0363-5023(92)90307-B; Padua L, 2001, NEUROLOGY, V56, P1459, DOI 10.1212/WNL.56.11.1459; Padua L, 1997, ITAL J NEUROL SCI, V18, P145, DOI 10.1007/BF02048482; Page MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009899; Racasan O, 2005, J HAND SURG-BRIT EUR, V30B, P412, DOI 10.1016/j.jhsb.2005.04.009; RADECKI P, 1994, MUSCLE NERVE, V17, P325, DOI 10.1002/mus.880170311; Rosecrance JC, 2002, AM J IND MED, V42, P107, DOI 10.1002/ajim.10093; Sayegh ET, 2015, CLIN ORTHOP RELAT R, V473, P1120, DOI 10.1007/s11999-014-3835-z; Shiri R, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-80; Solomon DH, 1999, J GEN INTERN MED, V14, P310, DOI 10.1046/j.1525-1497.1999.00340.x; Stevens JC, 1999, MUSCLE NERVE, V22, P1448, DOI 10.1002/(SICI)1097-4598(199910)22:10<1448::AID-MUS17>3.3.CO;2-P; Stoll C, 1998, CLIN GENET, V54, P345, DOI 10.1034/j.1399-0004.1998.5440414.x; Weber RA, 2005, ANN PLAS SURG, V54, P15, DOI 10.1097/01.sap.0000139566.23908.2c; Westropp N, 2012, COCHRANE DB SYST REV, V7; Zieske L, 2013, J HAND SURG-AM, V38A, P1530, DOI 10.1016/j.jhsa.2013.04.024	61	15	18	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2015	163	5							ITC1	10.7326/AITC201509010	http://dx.doi.org/10.7326/AITC201509010			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0OM	26322711				2022-12-28	WOS:000360296000003
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Blaming doctors won't reduce antibiotic overuse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Brookes-Howell L, 2014, FAM PRACT, V31, P102, DOI 10.1093/fampra/cmt052; Meikle J, 2015, GUARDIAN; National Institute for Health and Care Excellence, 2015, CALLS NHS CURB ANT P; NHS Choices, FEEL WEATH	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2015	351								h4697	10.1136/bmj.h4697	http://dx.doi.org/10.1136/bmj.h4697			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9JQ	26330400	Bronze			2022-12-28	WOS:000360931100012
J	Manoharan, VN				Manoharan, Vinothan N.			Colloidal matter: Packing, geometry, and entropy	SCIENCE			English	Review							HARD-SPHERES; NANOPARTICLE CLUSTERS; COMPLEX STRUCTURES; GLASS-TRANSITION; PHASE-TRANSITION; BROWNIAN-MOTION; CRYSTALS; LIQUIDS; PARTICLES; SUSPENSIONS	Colloidal particles with well-controlled shapes and interactions are an ideal experimental system for exploring how matter organizes itself. Like atoms and molecules, these particles form bulk phases such as liquids and crystals. But they are more than just crude analogs of atoms; they are a form of matter in their own right, with complex and interesting collective behavior not seen at the atomic scale. Their behavior is affected by geometrical or topological constraints, such as curved surfaces or the shapes of the particles. Because the interactions between the particles are often short-ranged, we can understand the effects of these constraints using geometrical concepts such as packing. The geometrical viewpoint gives us a window into how entropy affects not only the structure of matter, but also the dynamics of how it forms.	[Manoharan, Vinothan N.] Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Manoharan, Vinothan N.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Manoharan, VN (corresponding author), Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	vnm@seas.harvard.edu	Manoharan, Vinothan N/C-1292-2008	Manoharan, Vinothan N/0000-0003-0370-6095	National Science Foundation [DMR-1306410, DMR-1420570]; Division Of Materials Research [1306410] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	I thank P. Chaikin, D. Grier, D. Pine, M. Wyart, S. Glotzer, M. Holmes-Cerfon, J. Crocker, and P. Royall for helpful discussions. Research discussed from my own group is funded by the National Science Foundation through grant numbers DMR-1306410 and DMR-1420570.	Aarts DGAL, 2004, SCIENCE, V304, P847, DOI 10.1126/science.1097116; ALDER BJ, 1957, J CHEM PHYS, V27, P1208, DOI 10.1063/1.1743957; Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; Anderson VJ, 2002, NATURE, V416, P811, DOI 10.1038/416811a; Arkus N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.118303; Backofen R, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.025701; Bausch AR, 2003, SCIENCE, V299, P1716, DOI 10.1126/science.1081160; BERNAL JD, 1960, NATURE, V188, P910, DOI 10.1038/188910a0; Bianchi E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168301; Bowick MJ, 2009, ADV PHYS, V58, P449, DOI 10.1080/00018730903043166; Brambilla G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.085703; Brown R., 1828, PHILOS MAG, V4, P161, DOI [10.1080/14786442808674769, DOI 10.1080/14786442808674769]; Chakrabarty A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.160603; Charbonneau B, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4770498; Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Coxeter H. S. M., 1958, ILLINOIS J MATH, V2, P746; Damasceno PF, 2012, SCIENCE, V337, P453, DOI 10.1126/science.1220869; de Nijs B, 2015, NAT MATER, V14, P56, DOI [10.1038/NMAT4072, 10.1038/nmat4072]; Di Michele L, 2013, PHYS CHEM CHEM PHYS, V15, P3115, DOI 10.1039/c3cp43841d; DINSMORE AD, 1995, PHYS REV E, V52, P4045, DOI 10.1103/PhysRevE.52.4045; Dogic Z, 2006, CURR OPIN COLLOID IN, V11, P47, DOI 10.1016/j.cocis.2005.10.004; Doye JPK, 1997, J CHEM SOC FARADAY T, V93, P4233, DOI 10.1039/a706221d; Duguet E, 2011, CHEM SOC REV, V40, P941, DOI 10.1039/c0cs00048e; Edmond KV, 2012, P NATL ACAD SCI USA, V109, P17891, DOI 10.1073/pnas.1203328109; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Einstein TL, 2010, SCIENCE, V327, P423, DOI 10.1126/science.1184947; FINNEY JL, 1976, MATER SCI ENG, V23, P199, DOI 10.1016/0025-5416(76)90194-4; Florescu M, 2009, P NATL ACAD SCI USA, V106, P20658, DOI 10.1073/pnas.0907744106; Forster JD, 2010, ADV MATER, V22, P2939, DOI 10.1002/adma.200903693; Francois N, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.148001; FRANK FC, 1952, PROC R SOC LON SER-A, V215, P43, DOI 10.1098/rspa.1952.0194; Frenkel D, 1999, PHYSICA A, V263, P26, DOI 10.1016/S0378-4371(98)00501-9; FRENKEL D, 1988, NATURE, V332, P822, DOI 10.1038/332822a0; Frenkel D, 2006, SCOT GRAD SER, P19; Ganapathy R, 2010, SCIENCE, V327, P445, DOI 10.1126/science.1179947; Gasser U, 2003, J PHYS-CONDENS MAT, V15, pS375, DOI 10.1088/0953-8984/15/1/351; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Haji-Akbari A, 2009, NATURE, V462, P773, DOI 10.1038/nature08641; Hales S., 1727, VEGETABLE STATICKS A; Hales TC, 1997, DISCRETE COMPUT GEOM, V17, P1, DOI 10.1007/BF02770863; Hales TC, 1997, DISCRETE COMPUT GEOM, V18, P135, DOI 10.1007/PL00009312; Henzie J, 2013, P NATL ACAD SCI USA, V110, P6640, DOI 10.1073/pnas.1218616110; Holmes-Cerfon M, 2013, P NATL ACAD SCI USA, V110, pE5, DOI 10.1073/pnas.1211720110; Hoy RS, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051403; Hunter GL, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/6/066501; Irvine WTM, 2012, NAT MATER, V11, P948, DOI [10.1038/nmat3429, 10.1038/NMAT3429]; Irvine WTM, 2010, NATURE, V468, P947, DOI 10.1038/nature09620; Jenkins IC, 2014, P NATL ACAD SCI USA, V111, P4803, DOI 10.1073/pnas.1318012111; Karmakar S, 2014, ANNU REV CONDEN MA P, V5, P255, DOI 10.1146/annurev-conmatphys-031113-133848; Kegel WK, 2000, SCIENCE, V287, P290, DOI 10.1126/science.287.5451.290; Kleman M., 1979, J PHYS LETT-PARIS, V40, P569, DOI [10.1051/jphyslet:019790040021056900, DOI 10.1051/JPHYSLET:019790040021056900]; Kraft DJ, 2012, P NATL ACAD SCI USA, V109, P10787, DOI 10.1073/pnas.1116820109; Kruglova O, 2013, SOFT MATTER, V9, P9072, DOI 10.1039/c3sm50845e; Lacava J, 2012, NANO LETT, V12, P3279, DOI 10.1021/nl3013659; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; LINDSAY HM, 1982, J CHEM PHYS, V76, P3774, DOI 10.1063/1.443417; Lubensky TC, 1997, SOLID STATE COMMUN, V102, P187, DOI 10.1016/S0038-1098(96)00718-1; Luque A, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4712304; Malins A, 2013, FARADAY DISCUSS, V167, P405, DOI 10.1039/c3fd00078h; Malins A, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/42/425103; Mao XM, 2013, NAT MATER, V12, P217, DOI [10.1038/NMAT3496, 10.1038/nmat3496]; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Martinez A, 2014, NAT MATER, V13, P259, DOI [10.1038/NMAT3840, 10.1038/nmat3840]; Meng GN, 2014, SCIENCE, V343, P634, DOI 10.1126/science.1244827; Meng GN, 2010, SCIENCE, V327, P560, DOI 10.1126/science.1181263; Musevic I, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0266; NELSON DR, 1989, SOLID STATE PHYS, V42, P1; ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x; Perrin J, 1909, ANN CHIM PHYS, V18, P5; Poon W, 2004, SCIENCE, V304, P830, DOI 10.1126/science.1097964; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; PUSEY PN, 1987, PHYS REV LETT, V59, P2083, DOI 10.1103/PhysRevLett.59.2083; Reichert H, 2000, NATURE, V408, P839, DOI 10.1038/35048537; Rogers WB, 2011, P NATL ACAD SCI USA, V108, P15687, DOI 10.1073/pnas.1109853108; Royall CP, 2008, NAT MATER, V7, P556, DOI 10.1038/nmat2219; Royall CP, 2015, PHYS REP, V560, P1, DOI 10.1016/j.physrep.2014.11.004; Royall CP, 2015, J NON-CRYST SOLIDS, V407, P34, DOI 10.1016/j.jnoncrysol.2014.08.017; Russo J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00505; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Sacanna S, 2013, SOFT MATTER, V9, P8096, DOI 10.1039/c3sm50500f; Sacanna S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2694; SCHAEFER DW, 1975, PHYS REV LETT, V35, P1448, DOI 10.1103/PhysRevLett.35.1448; Schall P, 2006, NATURE, V440, P319, DOI 10.1038/nature04557; Schall P, 2004, SCIENCE, V305, P1944, DOI 10.1126/science.1102186; Senyuk B, 2013, NATURE, V493, P200, DOI 10.1038/nature11710; Smallenburg F, 2013, NAT PHYS, V9, P554, DOI [10.1038/nphys2693, 10.1038/NPHYS2693]; STILLINGER FH, 1984, SCIENCE, V225, P983, DOI 10.1126/science.225.4666.983; Thue A., 1892, FORHDL SKAND NATURFO, V14, P352; Tkalec U, 2011, SCIENCE, V333, P62, DOI 10.1126/science.1205705; Torquato S, 2000, PHYS REV LETT, V84, P2064, DOI 10.1103/PhysRevLett.84.2064; Turiv T, 2013, SCIENCE, V342, P1351, DOI 10.1126/science.1240591; van Anders G, 2014, P NATL ACAD SCI USA, V111, pE4812, DOI 10.1073/pnas.1418159111; van Meel JA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061110; Varilly P, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4748100; WALES DJ, 2004, ENERGY LANDSCAPES AP; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Wang ZR, 2012, SCIENCE, V338, P87, DOI 10.1126/science.1224763; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; WOOD WW, 1957, J CHEM PHYS, V27, P1207, DOI 10.1063/1.1743956; Wu KT, 2012, P NATL ACAD SCI USA, V109, P18731, DOI 10.1073/pnas.1207356109; Young KL, 2013, ANGEW CHEM INT EDIT, V52, P13980, DOI 10.1002/anie.201306009; Zhao K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.268301	104	297	300	17	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251							1253751	10.1126/science.1253751	http://dx.doi.org/10.1126/science.1253751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315444	Green Published			2022-12-28	WOS:000360646800040
J	Wollman, EE; Lei, CU; Weinstein, AJ; Suh, J; Kronwald, A; Marquardt, F; Clerk, AA; Schwab, KC				Wollman, E. E.; Lei, C. U.; Weinstein, A. J.; Suh, J.; Kronwald, A.; Marquardt, F.; Clerk, A. A.; Schwab, K. C.			Quantum squeezing of motion in a mechanical resonator	SCIENCE			English	Article							GROUND-STATE; FLUCTUATIONS; LIGHT; ATOM	According to quantum mechanics, a harmonic oscillator can never be completely at rest. Even in the ground state, its position will always have fluctuations, called the zero-point motion. Although the zero-point fluctuations are unavoidable, they can be manipulated. Using microwave frequency radiation pressure, we have manipulated the thermal fluctuations of a micrometer-scale mechanical resonator to produce a stationary quadrature-squeezed state with a minimum variance of 0.80 times that of the ground state. We also performed phase-sensitive, back-action evading measurements of a thermal state squeezed to 1.09 times the zero-point level. Our results are relevant to the quantum engineering of states of matter at large length scales, the study of decoherence of large quantum systems, and for the realization of ultrasensitive sensing of force and motion.	[Wollman, E. E.; Lei, C. U.; Weinstein, A. J.; Schwab, K. C.] CALTECH, Appl Phys, Pasadena, CA 91125 USA; [Suh, J.] Korea Res Inst Stand & Sci, Taejon 305340, South Korea; [Kronwald, A.; Marquardt, F.] Univ Erlangen Nurnberg, D-91058 Erlangen, Germany; [Marquardt, F.] Max Planck Inst Sci Light, D-91058 Erlangen, Germany; [Clerk, A. A.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada	California Institute of Technology; Korea Research Institute of Standards & Science (KRISS); University of Erlangen Nuremberg; Max Planck Society; McGill University	Schwab, KC (corresponding author), CALTECH, Appl Phys, Pasadena, CA 91125 USA.	schwab@caltech.edu	Marquardt, Florian/C-2533-2008	Marquardt, Florian/0000-0003-4566-1753; Suh, Junho/0000-0002-0112-0499; Wollman, Emma/0000-0002-5474-3745	Institute for Quantum Information and Matter, an NSF Physics Frontiers Center; Gordon and Betty Moore Foundation (NSF-IQIM) [1125565]; Defense Advanced Research Projects Agency (DARPA-QUANTUM) [HR0011-10-1-0066]; NSF (NSF-DMR) [1052647]; NSF (NSF-EEC) [0832819]; Semiconductor Research Corporation (SRC); Defense Advanced Research Project Agency (DARPA) through STARnet Center for Function Accelerated nanoMaterial Engineering (FAME); DARPA ORCHID program through AFOSR	Institute for Quantum Information and Matter, an NSF Physics Frontiers Center(National Science Foundation (NSF)); Gordon and Betty Moore Foundation (NSF-IQIM)(National Science Foundation (NSF)); Defense Advanced Research Projects Agency (DARPA-QUANTUM)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF (NSF-DMR)(National Science Foundation (NSF)); NSF (NSF-EEC); Semiconductor Research Corporation (SRC); Defense Advanced Research Project Agency (DARPA) through STARnet Center for Function Accelerated nanoMaterial Engineering (FAME)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DARPA ORCHID program through AFOSR	This work is supported by funding provided by the Institute for Quantum Information and Matter, an NSF Physics Frontiers Center with support of the Gordon and Betty Moore Foundation (NSF-IQIM 1125565), by the Defense Advanced Research Projects Agency (DARPA-QUANTUM HR0011-10-1-0066), by the NSF (NSF-DMR 1052647 and NSF-EEC 0832819), and by the Semiconductor Research Corporation (SRC) and Defense Advanced Research Project Agency (DARPA) through STARnet Center for Function Accelerated nanoMaterial Engineering (FAME). A.A.C., F.M., and A.K. acknowledge support from the DARPA ORCHID program through a grant from AFOSR, F.M. and A.K. from ITN cQOM and the ERC OPTOMECH, and A.A.C. from NSERC.	BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; CIRAC JI, 1993, PHYS REV LETT, V70, P556, DOI 10.1103/PhysRevLett.70.556; DUNN TJ, 1993, PHYS REV LETT, V70, P3388, DOI 10.1103/PhysRevLett.70.3388; Gao JS, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2906373; Garrett GA, 1997, SCIENCE, V275, P1638, DOI 10.1126/science.275.5306.1638; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; Jahne K, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063819; Kienzler D, 2015, SCIENCE, V347, P53, DOI 10.1126/science.1261033; KIM MS, 1989, PHYS REV A, V40, P2494, DOI 10.1103/PhysRevA.40.2494; Kronwald A, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.063833; Lecocq F, 2015, NAT PHYS, V11, P635, DOI [10.1038/NPHYS3365, 10.1038/nphys3365]; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Palomaki TA, 2013, SCIENCE, V342, P710, DOI 10.1126/science.1244563; Pontin A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.023601; Rabl P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205304; RUGAR D, 1991, PHYS REV LETT, V67, P699, DOI 10.1103/PhysRevLett.67.699; Ruskov R, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235407; SLUSHER RE, 1985, PHYS REV LETT, V55, P2409, DOI 10.1103/PhysRevLett.55.2409; Suh J, 2014, SCIENCE, V344, P1262, DOI 10.1126/science.1253258; Suh J, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816428; Szorkovszky A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.184301; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Vanner MR, 2011, P NATL ACAD SCI USA, V108, P16182, DOI 10.1073/pnas.1105098108; Vinante A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.207203; YURKE B, 1988, PHYS REV LETT, V60, P764, DOI 10.1103/PhysRevLett.60.764	27	415	417	9	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					952	955		10.1126/science.aac5138	http://dx.doi.org/10.1126/science.aac5138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315431	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000360646800047
J	Piot, P				Piot, Philippe			PARTICLE PHYSICS Positrons ride the wave	NATURE			English	Editorial Material							PLASMA; ELECTRONS; ACCELERATION		[Piot, Philippe] No Illinois Univ, Dept Phys, De Kalb, IL 60115 USA; [Piot, Philippe] Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA	Northern Illinois University; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory	Piot, P (corresponding author), No Illinois Univ, Dept Phys, De Kalb, IL 60115 USA.	ppiot@niu.edu						Blue BE, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.214801; Blumenfeld I, 2007, NATURE, V445, P741, DOI 10.1038/nature05538; CHEN P, 1985, PHYS REV LETT, V54, P693, DOI 10.1103/PhysRevLett.54.693; Corde S, 2015, NATURE, V524, P442, DOI 10.1038/nature14890; Joshi C, 2003, PHYS TODAY, V56, P47, DOI 10.1063/1.1595054; ROSENZWEIG JB, 1991, PHYS REV A, V44, pR6189, DOI 10.1103/PhysRevA.44.R6189	6	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					422	423		10.1038/524422a	http://dx.doi.org/10.1038/524422a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26310761	Green Submitted			2022-12-28	WOS:000360069300026
J	Sharma, D; Hayman, K; Stewart, BT; Dominguez, L; Trelles, M; Saqeb, S; Kasonga, C; Hangi, TK; Mupenda, J; Naseer, A; Wong, E; Kushner, AL				Sharma, Davina; Hayman, Kate; Stewart, Barclay T.; Dominguez, Lynette; Trelles, Miguel; Saqeb, Sanaulhaq; Kasonga, Cheride; Hangi, Theophile Kubuya; Mupenda, Jerome; Naseer, Aamer; Wong, Evan; Kushner, Adam L.			Care of surgical infections by Medecins Sans Frontieres Operations Centre Brussels in 2008-14	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Sharma, Davina; Hayman, Kate; Kushner, Adam L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Stewart, Barclay T.] Univ Washington, Seattle, WA 98195 USA; [Dominguez, Lynette; Trelles, Miguel; Saqeb, Sanaulhaq; Kasonga, Cheride; Hangi, Theophile Kubuya; Mupenda, Jerome; Naseer, Aamer] Med Sans Frontieres Operat Ctr Brussels, Surg Unit, Brussels, Belgium; [Saqeb, Sanaulhaq] Hosp Ahmad Sha Baba, Med Sans Frontieres, Kabul, Afghanistan; [Kasonga, Cheride] Gen Referral Hosp, Med Sans Frontieres, Niangara, DEM REP CONGO; [Hangi, Theophile Kubuya] Gen Referral Hosp, Med Sans Frontieres, Masis, DEM REP CONGO; [Mupenda, Jerome] Gen Referral Hosp, Med Sans Frontieres, Lubutu, DEM REP CONGO; [Naseer, Aamer] Dist Headquarters Hosp, Med Sans Frontieres, Timurgara, Lower Dir, Israel; [Wong, Evan] McGill Univ, Ctr Hlth, Ctr Global Surg, Montreal, PQ, Canada; [Kushner, Adam L.] SOS, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; McGill University		stewarb@uw.edu		Kushner, Adam/0000-0002-7797-4837; Hayman, Kaitlin (Kate)/0000-0003-3190-6406					0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			31	31		10.1016/S0140-6736(15)60826-1	http://dx.doi.org/10.1016/S0140-6736(15)60826-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313079	Bronze			2022-12-28	WOS:000360573400032
J	Elkommos, S; Richardson, MP; Schoene-Bake, JC; Marson, A; Elger, C; Weber, B; Keller, SS				Elkommos, Samia; Richardson, Mark P.; Schoene-Bake, Jan-Christoph; Marson, Anthony; Elger, Christian; Weber, Bernd; Keller, Simon S.			Presurgical entorhinal cortex volume and postoperative seizure outcome in temporal lobe epilepsy	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Elkommos, Samia; Marson, Anthony; Keller, Simon S.] Univ Liverpool, Dept Mol & Clin Pharmacol, Inst Translat Med, Liverpool L9 7AL, Merseyside, England; [Richardson, Mark P.; Keller, Simon S.] Kings Coll London, Dept Clin Neurosci, Inst Psychiat, London WC2R 2LS, England; [Schoene-Bake, Jan-Christoph; Elger, Christian; Weber, Bernd] Univ Bonn, Dept Epileptol, Bonn, Germany; [Schoene-Bake, Jan-Christoph; Elger, Christian; Weber, Bernd] Life & Brain Res Ctr, Dept Neurocognit Imaging, Bonn, Germany	University of Liverpool; University of London; King's College London; University of Bonn; University of Bonn		S.Elkommos@liverpool.ac.uk	Marson, Anthony/AAW-9776-2020; Richardson, Mark P/E-5385-2010; Weber, Bernd/H-5244-2012	Marson, Anthony/0000-0002-6861-8806; Richardson, Mark P/0000-0001-8925-3140; Weber, Bernd/0000-0002-7811-9605; Keller, Simon/0000-0001-5247-9795	Medical Research Council [MR/K023152/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			34	34						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312856				2022-12-28	WOS:000360570500034
J	Lipsitch, M; Esvelt, K; Inglesby, T				Lipsitch, Marc; Esvelt, Kevin; Inglesby, Thomas			Calls for Caution in Genome Engineering Should Be a Model for Similar Dialogue on Pandemic Pathogen Research	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lipsitch, Marc] Harvard Univ, TH Chan Sch Publ Hlth, Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Esvelt, Kevin] Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Inglesby, Thomas] UPMC Ctr Biosecur, Baltimore, MD 21202 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Lipsitch, M (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Epidemiol, 677 Huntington Ave,Kresge Bldg,Room 506G, Boston, MA 02115 USA.							Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Cambridge Working Group,, 2014, CAMBR WORK GROUP CON; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; InterAcademy Panel on International Issues, 2005, IOP STAT BIOS; Lipsitch M, 2014, MBIO, V5, DOI 10.1128/mBio.02366-14; Lipsitch M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001646; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Rey F, 2013, SCIENCE, V342, P311, DOI 10.1126/science.342.6156.311-a; Wain-Hobson S, 2013, NATURE, V495, P411, DOI 10.1038/495411a; White House Blog, 2014, DOING DIL ASS RISKS	10	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					790	U298		10.7326/M15-1048	http://dx.doi.org/10.7326/M15-1048			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX5MQ	26344802				2022-12-28	WOS:000365746400022
J	Xiong, J; Kushwaha, SK; Liang, T; Krizan, JW; Hirschberger, M; Wang, WD; Cava, RJ; Ong, NP				Xiong, Jun; Kushwaha, Satya K.; Liang, Tian; Krizan, Jason W.; Hirschberger, Max; Wang, Wudi; Cava, R. J.; Ong, N. P.			Evidence for the chiral anomaly in the Dirac semimetal Na3Bi	SCIENCE			English	Article							MAGNETORESISTANCE; CD3AS2	In a Dirac semimetal, each Dirac node is resolved into two Weyl nodes with opposite "handedness" or chirality. The two chiral populations do not mix. However, in parallel electric and magnetic fields (E parallel to B), charge is predicted to flow between the Weyl nodes, leading to negative magnetoresistance. This "axial" current is the chiral (Adler-Bell-Jackiw) anomaly investigated in quantum field theory. We report the observation of a large, negative longitudinal magnetoresistance in the Dirac semimetal Na3Bi. The negative magnetoresistance is acutely sensitive to deviations of the direction of B from E and is incompatible with conventional transport. By rotating E (as well as B), we show that it is consistent with the prediction of the chiral anomaly.	[Xiong, Jun; Liang, Tian; Hirschberger, Max; Wang, Wudi; Ong, N. P.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Kushwaha, Satya K.; Krizan, Jason W.; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University	Ong, NP (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	npo@princeton.edu	Ong, N. Phuan/Z-1626-2019; Liang, Tian/AAE-6777-2022; Kushwaha, Satya K./B-8287-2017; Hirschberger, Max/AAE-8003-2019	Liang, Tian/0000-0002-4332-2814; Kushwaha, Satya K./0000-0002-3169-969X; Hirschberger, Max/0000-0002-1780-1619; Ong, N. Phuan/0000-0001-7166-1058	Army Research Office [ARO W911NF-11-1-0379]; MURI [ARO W911NF-12-1-0461]; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4539]; NSF [DMR 1420541, DMR-1157490]; State of Florida; U.S. Department of Energy	Army Research Office; MURI(MURI); Gordon and Betty Moore Foundation's EPiQS Initiative; NSF(National Science Foundation (NSF)); State of Florida; U.S. Department of Energy(United States Department of Energy (DOE))	We thank B.A. Bernevig and Z. Wang for valuable discussions. Supported by Army Research Office grant ARO W911NF-11-1-0379, a MURI award for topological insulators (ARO W911NF-12-1-0461), and the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF4539 (N.P.O.). The growth and characterization of crystals were performed by S.K.K., J.W.K., and R.J.C. with support from NSF grant DMR 1420541. Some experiments were performed at the National High Magnetic Field Laboratory (NHMFL), which is supported by NSF Cooperative Agreement no. DMR-1157490, the State of Florida, and the U.S. Department of Energy; we thank E. S. Choi for assistance at NHMFL.	ADLER SL, 1969, PHYS REV, V177, P2426, DOI 10.1103/PhysRev.177.2426; Aji V, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.241101; Bell J. S., 1969, NUOVO CIMENTO A, V60, P4; Burkov AA, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.245157; Burkov AA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235126; Fang C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.266802; Hosur P, 2013, CR PHYS, V14, P857, DOI 10.1016/j.crhy.2013.10.010; Jeon S, 2014, NAT MATER, V13, P851, DOI 10.1038/nmat4023; Kim HJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.246603; Kushwaha SK, 2015, APL MATER, V3, DOI 10.1063/1.4908158; Liang T, 2015, NAT MATER, V14, P280, DOI 10.1038/nmat4143; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; NIELSEN HB, 1983, PHYS LETT B, V130, P389, DOI 10.1016/0370-2693(83)91529-0; Parameswaran SA, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031035; Peskin E. M., 1995, INTRO QUANTUM FIELD; Son DT, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.104412; TSIDILKO.IM, 1974, PHYS STATUS SOLIDI B, V64, P717, DOI 10.1002/pssb.2220640236; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang ZJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195320; Yang BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5898; Yang KY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075129; Young SM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140405	23	797	807	11	387	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2015	350	6259					413	416		10.1126/science.aac6089	http://dx.doi.org/10.1126/science.aac6089			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU0NG	26338798				2022-12-28	WOS:000363213400034
J	Schenker, Y; Arnold, R				Schenker, Yael; Arnold, Robert			The Next Era of Palliative Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schenker, Yael; Arnold, Robert] Univ Pittsburgh, Sect Palliat Care & Med Eth, Div Gen Internal Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schenker, Y (corresponding author), Univ Pittsburgh, Sect Palliat Care & Med Eth, Div Gen Internal Med, 230 McKee Pl,Ste 600, Pittsburgh, PA 15213 USA.	schenkery@upmc.edu			NCATS NIH HHS [KL2 TR000146, KL2TR000146] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Gelfman LP, 2013, J PALLIAT MED, V16, P125, DOI 10.1089/jpm.2012.0427; Institute of Medicine, 2014, DYING AM IMPR QUAL H; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Krumholz HM, 2015, JAMA-J AM MED ASSOC, V314, P355, DOI 10.1001/jama.2015.8035; Morrison R, 2011, STATE BY STATE REPOR; Murtagh FEM, 2014, PALLIATIVE MED, V28, P49, DOI 10.1177/0269216313489367; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Schenker Y, 2014, J ONCOL PRACT, V10, pE37, DOI 10.1200/JOP.2013.001130	8	59	60	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2015	314	15					1565	1566		10.1001/jama.2015.11217	http://dx.doi.org/10.1001/jama.2015.11217			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT7XK	26334719	Green Accepted			2022-12-28	WOS:000363028500014
J	Holyoake, T; Vetrie, D				Holyoake, Tessa; Vetrie, David			CANCER Repositioned to kill stem cells	NATURE			English	Editorial Material							PHILADELPHIA-CHROMOSOME; LEUKEMIA		[Holyoake, Tessa; Vetrie, David] Univ Glasgow, Inst Canc Sci, Glasgow G12 0ZD, Lanark, Scotland	University of Glasgow	Holyoake, T (corresponding author), Univ Glasgow, Inst Canc Sci, Glasgow G12 0ZD, Lanark, Scotland.	tessa.holyoake@glasgow.ac.uk; david.vetrie@glasgow.ac.uk		Vetrie, David/0000-0003-2075-4662				Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Pemovska T, 2015, NATURE, V519, P102, DOI 10.1038/nature14119; Prost S, 2008, J CLIN INVEST, V118, P1765, DOI 10.1172/JCI33037; Prost S, 2015, NATURE, V525, P380, DOI 10.1038/nature15248	7	4	4	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					328	329		10.1038/nature15213	http://dx.doi.org/10.1038/nature15213			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26331538	Green Accepted			2022-12-28	WOS:000361297900031
J	Prost, S; Relouzat, F; Spentchian, M; Ouzegdouh, Y; Saliba, J; Massonnet, G; Beressi, JP; Verhoeyen, E; Raggueneau, V; Maneglier, B; Castaigne, S; Chomienne, C; Chretien, S; Rousselot, P; Leboulch, P				Prost, Stephane; Relouzat, Francis; Spentchian, Marc; Ouzegdouh, Yasmine; Saliba, Joseph; Massonnet, Gerald; Beressi, Jean-Paul; Verhoeyen, Els; Raggueneau, Victoria; Maneglier, Benjamin; Castaigne, Sylvie; Chomienne, Christine; Chretien, Stany; Rousselot, Philippe; Leboulch, Philippe			Erosion of the chronic myeloid leukaemia stem cell pool by PPAR gamma agonists	NATURE			English	Article							IMATINIB; STAT5; PATHWAY; CITED2; HEMATOPOIESIS; HIF-1-ALPHA; INHIBITION; QUIESCENCE; ACTIVATION; RESISTANCE	Whether cancer is maintained by a small number of stem cells or is composed of proliferating cells with approximate phenotypic equivalency is a central question in cancer biology(1). In the stem cell hypothesis, relapse after treatment may occur by failure to eradicate cancer stem cells. Chronic myeloid leukaemia (CML) is quintessential to this hypothesis. CML is a myeloproliferative disorder that results from dysregulated tyrosine kinase activity of the fusion oncoprotein BCR-ABL(2). During the chronic phase, this sole genetic abnormality (chromosomal translocation Ph+: t(9;22)(q34;q11)) at the stem cell level causes increased proliferation of myeloid cells without loss of their capacity to differentiate. Without treatment, most patients progress to the blast phase when additional oncogenic mutations result in a fatal acute leukaemia made of proliferating immature cells. Imatinib mesylate and other tyrosine kinase inhibitors (TKIs) that target the kinase activity of BCR-ABL have improved patient survival markedly. However, fewer than 10% of patients reach the stage of complete molecular response (CMR), defined as the point when BCR-ABL transcripts become undetectable in blood cells(3). Failure to reach CMR results from the inability of TKIs to eradicate quiescent CML leukaemia stem cells (LSCs)(2-4). Here we show that the residual CML LSC pool can be gradually purged by the glitazones, antidiabetic drugs that are agonists of peroxisome proliferator-activated receptor-gamma (PPAR gamma). We found that activation of PPAR gamma by the glitazones decreases expression of STAT5 and its downstreamtargets HIF2 alpha(5) and CITED2(6), which are key guardians of the quiescence and stemness of CML LSCs. When pioglitazone was given temporarily to three CML patients in chronic residual disease in spite of continuous treatment with imatinib, all of them achieved sustained CMR, up to 4.7 years after withdrawal of pioglitazone. This suggests that clinically relevant cancer eradication may become a generally attainable goal by combination therapy that erodes the cancer stem cell pool.	[Prost, Stephane; Relouzat, Francis; Ouzegdouh, Yasmine; Saliba, Joseph; Chretien, Stany; Leboulch, Philippe] Inst Emerging Dis & Innovat Therapies iMETI, CEA, F-92265 Fontenay Aux Roses, France; [Spentchian, Marc] Hop Mignot, Dept Biol Med, F-78150 Le Chesnay, France; [Massonnet, Gerald; Chomienne, Christine; Rousselot, Philippe] Univ Paris Diderot, Hop St Louis,Inst Univ Hematol, UMR S 940, Unite Biol Cellulaire, F-75010 Paris, France; [Beressi, Jean-Paul] Hop Mignot, Serv Endocrinol & Diabetol, F-78150 Le Chesnay, France; [Verhoeyen, Els] Univ Lyon 1, CNRS, Int Ctr Infectiol Res,ENS Lyon, CIRI,EVIR Team,Inserm,U1111,UMR5308, F-69007 Lyon, France; [Verhoeyen, Els] INSERM, U895, Ctr Med Mol C3M, Equipe 3, F-06204 Nice, France; [Raggueneau, Victoria] Ctr Hosp Versailles, Lab Hematol, F-78150 Le Chesnay, France; [Maneglier, Benjamin] Ctr Hosp Versailles, Serv Biol Med, Unite Pharmacol, F-78150 Le Chesnay, France; [Castaigne, Sylvie; Chomienne, Christine; Rousselot, Philippe] Univ Versailles St Quentin En Yvelines, Serv Hematol & Oncol, Hop Mignot, F-78150 Le Chesnay, France; [Chretien, Stany] Inst Emerging Dis & Innovat Therapies iMETI, INSERM, F-92265 Fontenay Aux Roses, France; [Leboulch, Philippe] Brigham & Womens Hosp, Genet Div, Boston, MA 02115 USA; [Leboulch, Philippe] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Leboulch, Philippe] Ramathibodi Hosp, Hematol Div, Bangkok 10400, Thailand; [Leboulch, Philippe] Mahidol Univ, Bangkok 10400, Thailand	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier de Versailles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Mahidol University; Mahidol University	Prost, S (corresponding author), Inst Emerging Dis & Innovat Therapies iMETI, CEA, F-92265 Fontenay Aux Roses, France.	stephane.prost@cea.fr; pleboulch@rics.bwh.harvard.edu	PROST, Stephane/I-8362-2015; Chretien, Stany/M-5166-2018; Verhoeyen, Els/H-6360-2016; Verhoeyen, Els/AAW-4853-2021	PROST, Stephane/0000-0002-8567-8253; Verhoeyen, Els/0000-0001-9224-5491; CHOMIENNE, Christine/0000-0001-5513-5752; OUZEGDOUH MAMMASSE, Yasmine/0000-0001-6361-8885	Association Laurette Fugain, Paris, France; Association pour la Recherche sur le Cancer, Villejuif, France; Chaire industrielle de l'Agence Nationale pour la Recherche (ANR)	Association Laurette Fugain, Paris, France; Association pour la Recherche sur le Cancer, Villejuif, France(Fondation ARC pour la Recherche sur le Cancer); Chaire industrielle de l'Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	We thank C. Costa, V. Tran Chau, F. Goullieux, A. Krief, P. Raynal, C. Terre, S. Tabore and T. Andrieu for their experimental contributions. This work was supported by the Association Laurette Fugain, Paris, France, by the Association pour la Recherche sur le Cancer, Villejuif, France to S. P., P.R. and P.L. and by the Chaire industrielle de l'Agence Nationale pour la Recherche (ANR) to P.L.	Avagyan S, 2011, BLOOD, V118, P6078, DOI 10.1182/blood-2011-07-365080; Berria R, 2007, CLIN PHARMACOL THER, V82, P275, DOI 10.1038/sj.clpt.6100146; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Chomel JC, 2011, ONCOTARGET, V2, P713; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Davies GF, 2009, DRUG DES DEV THER, V3, P79; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Du JW, 2013, CURR OPIN HEMATOL, V20, P301, DOI 10.1097/MOH.0b013e3283606022; Du JW, 2012, BLOOD, V119, P2789, DOI 10.1182/blood-2011-10-387902; Fatrai S, 2011, BLOOD, V117, P3320, DOI 10.1182/blood-2010-08-303669; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kieslinger M, 2000, GENE DEV, V14, P232; Kominsky DJ, 2009, CLIN CANCER RES, V15, P3442, DOI 10.1158/1078-0432.CCR-08-3291; Koschmieder S, 2011, AM J BLOOD RES, V1, P65; Liu SH, 2014, MOL CANCER THER, V13, P1194, DOI 10.1158/1535-7163.MCT-13-0341; Lu DS, 2010, EUR J PHARMACOL, V636, P198, DOI 10.1016/j.ejphar.2010.03.010; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Pitulis N, 2009, ANTICANCER RES, V29, P2331; Prost S, 2008, J CLIN INVEST, V118, P1765, DOI 10.1172/JCI33037; Roth O, 2010, CLIN CHIM ACTA, V411, P140, DOI 10.1016/j.cca.2009.10.007; Rousselot P, 2012, ASH ANN M; Szanto A, 2005, MOL PHARMACOL, V67, P1935, DOI 10.1124/mol.104.006445; Wang LH, 2012, EXP HEMATOL, V40, P811, DOI 10.1016/j.exphem.2012.05.013; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Yuan HF, 2012, BLOOD, V119, P1904, DOI 10.1182/blood-2011-06-361691	36	201	206	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					380	+		10.1038/nature15248	http://dx.doi.org/10.1038/nature15248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26331539	Green Submitted			2022-12-28	WOS:000361297900044
J	Gilman, M; Hockenberry, JM; Adams, EK; Milstein, AS; Wilson, IB; Becker, ER				Gilman, Matlin; Hockenberry, Jason M.; Adams, E. Kathleen; Milstein, Arnold S.; Wilson, Ira B.; Becker, Edmund R.			The Financial Effect of Value-Based Purchasing and the Hospital Readmissions Reduction Program on Safety-Net Hospitals in 2014 A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; PERFORMANCE-MEASURES; HEART-FAILURE; MORTALITY-RATES; HEALTH-CARE; OUTCOMES; EXPERIENCE; CALIFORNIA; POLICY	Background: Medicare's value-based purchasing (VBP) and the Hospital Readmissions Reduction Program (HRRP) could disproportionately affect safety-net hospitals. Objective: To determine whether safety-net hospitals incur larger financial penalties than other hospitals under VBP and HRRP. Design: Cross-sectional analysis. Setting: United States in 2014. Participants: 3022 acute care hospitals participating in VBP and the HRRP. Measurements: Safety-net hospitals were defined as being in the top quartile of the Medicare disproportionate share hospital (DSH) patient percentage and Medicare uncompensated care (UCC) payments per bed. The differences in penalties in both total dollars and dollars per bed between safety-net hospitals and other hospitals were estimated with the use of bivariate and graphical regression methods. Results: Safety-net hospitals in the top quartile of each measure were more likely to be penalized under VBP than other hospitals (62.9% vs. 51.0% under the DSH definition and 60.3% vs. 51.5% under the UCC per-bed definition). This was also the case under the HRRP (80.8% vs. 69.0% and 81.9% vs. 68.7%, respectively). Safety-net hospitals also had larger payment penalties ($115 900 vs. $66 600 and $150 100 vs. $54 900, respectively). On a perbed basis, this translated to $436 versus $332 and $491 versus $314, respectively. Sensitivity analysis setting the cutoff at the top decile rather than the top quartile decile led to similar conclusions with somewhat larger differences between safety-net and other hospitals. The quadratic fit of the data indicated that the larger effect of these penalties is in the middle of the distribution of the DSH and UCC measures. Limitation: Only 2 measures of safety-net status were included in the analyses. Conclusion: Safety-net hospitals were disproportionately likely to be affected under VBP and the HRRP, but most incurred relatively small payment penalties in 2014.	[Gilman, Matlin; Hockenberry, Jason M.; Adams, E. Kathleen; Becker, Edmund R.] Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, 1518 Clifton Rd, Atlanta, GA 30322 USA; [Milstein, Arnold S.] Stanford Sch Med, Clin Excellence Res Ctr, Palo Alto, CA USA; [Wilson, Ira B.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA	Emory University; Rollins School Public Health; Stanford University; Brown University	Hockenberry, JM (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, 1518 Clifton Rd, Atlanta, GA 30322 USA.	jason.hockenberry@emory.edu	Wilson, Ira/F-9190-2016	Wilson, Ira/0000-0002-0246-738X; Gilman, Matlin/0000-0001-7432-4823	Patient-Centered Outcomes Research Institute	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI)	Patient-Centered Outcomes Research Institute.	Aaronson DS, 2013, J HEALTHC QUAL, V35, P15, DOI 10.1111/j.1945-1474.2011.00173.x; [Anonymous], 2013, FED REG, V78, P78; Berenson Robert A, 2013, TIMELY ANAL IMMED HL; Bernheim SM, 2012, 2012 MEASURES MAINTE; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Burgess JF, 2014, HEALTH ECON POLICY L, V9, P193, DOI 10.1017/S1744133113000340; Chatterjee P, 2012, ARCH INTERN MED, V172, P1204, DOI 10.1001/archinternmed.2012.3158; Conover M., 2012, HOSP WIDE ALL CAUSE; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Fonarow GC, 2009, JAMA-J AM MED ASSOC, V302, P792, DOI 10.1001/jama.2009.1180; Gilman M, 2014, HEALTH AFFAIR, V33, P1314, DOI 10.1377/hlthaff.2014.0138; Goldman LE, 2007, MED CARE, V45, P579, DOI 10.1097/MLR.0b013e318041f723; Gu Q, 2014, HEALTH SERV RES, V49, P818, DOI 10.1111/1475-6773.12150; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Hockenberry JM, 2013, MED CARE, V51, P13, DOI 10.1097/MLR.0b013e31825c2fec; Hockenberry JM, 2013, MED CARE, V51, P23, DOI 10.1097/MLR.0b013e3182785a5d; James J, 2013, HLTH AFF MILLWO 1112; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Jha AK, 2013, JAMA-J AM MED ASSOC, V309, P347, DOI 10.1001/jama.2012.196646; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Keyhani S, 2014, ANN INTERN MED, V161, P775, DOI 10.7326/M14-0361; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Krumholz HM, 2014, ANN INTERN MED, V161, P833, DOI 10.7326/M14-2308; Lipstein SH, 2014, ANN INTERN MED, V161, P594, DOI 10.7326/M14-1601; McHugh M, 2009, MED CARE RES REV, V66, P590, DOI 10.1177/1077558709334895; Mohan A, 2013, INT J HEALTH SERV, V43, P321, DOI 10.2190/HS.43.2.h; Nardin R., 2013, UNINSURED IMPLEMENTA; Neuhausen K, 2012, ARCH INTERN MED, V172, P1202, DOI 10.1001/archinternmed.2012.3175; Nicholas LH, 2010, ARCH SURG-CHICAGO, V145, P999, DOI 10.1001/archsurg.2010.191; Rau J, 2012, KAISER HLTH NEWS; Romley JA, 2011, ANN INTERN MED, V154, P160, DOI 10.7326/0003-4819-154-3-201102010-00005; Ross JS, 2007, HEALTH AFFAIR, V26, P238, DOI 10.1377/hlthaff.26.1.238; Ross JS, 2012, HEALTH AFFAIR, V31, P1739, DOI 10.1377/hlthaff.2011.1028; Ryan AM, 2015, HEALTH SERV RES, V50, P81, DOI 10.1111/1475-6773.12206; Ryan AM, 2009, INQUIRY-J HEALTH CAR, V46, P274, DOI 10.5034/inquiryjrnl_46.03.274; Suter LG, 2012, MEDICARE HOSP QUALIT; The Henry J, 2014, FACTS MED SPEND FIN; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694	38	96	96	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6					427	+		10.7326/M14-2813	http://dx.doi.org/10.7326/M14-2813			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR5FL	26343790				2022-12-28	WOS:000361365900017
J	Dubrovinsky, L; Dubrovinskaia, N; Bykova, E; Bykov, M; Prakapenka, V; Prescher, C; Glazyrin, K; Liermann, HP; Hanfland, M; Ekholm, M; Feng, Q; Pourovskii, LV; Katsnelson, MI; Wills, JM; Abrikosov, IA				Dubrovinsky, L.; Dubrovinskaia, N.; Bykova, E.; Bykov, M.; Prakapenka, V.; Prescher, C.; Glazyrin, K.; Liermann, H. -P.; Hanfland, M.; Ekholm, M.; Feng, Q.; Pourovskii, L. V.; Katsnelson, M. I.; Wills, J. M.; Abrikosov, I. A.			The most incompressible metal osmium at static pressures above 750 gigapascals	NATURE			English	Article							EQUATION-OF-STATE; VAN-DER-WAALS; ELECTRONIC-STRUCTURE; DIAMOND; TRANSITION; ANOMALIES; ALKALI; LIMIT; MGO; ZN	Metallic osmium (Os) is one of the most exceptional elemental materials, having, at ambient pressure, the highest known density and one of the highest cohesive energies and melting temperatures(1). It is also very incompressible(2-4), but its high-pressure behaviour is not well understood because it has been studied(2-6) so far only at pressures below 75 gigapascals. Here we report powder X-ray diffraction measurements on Os at multi-megabar pressures using both conventional and double-stage diamond anvil cells(7), with accurate pressure determination ensured by first obtaining self-consistent equations of state of gold, platinum, and tungsten in static experiments up to 500 gigapascals. These measurements allow us to show that Os retains its hexagonal close-packed structure upon compression to over 770 gigapascals. But although its molar volume monotonically decreases with pressure, the unit cell parameter ratio of Os exhibits anomalies at approximately 150 gigapascals and 440 gigapascals. Dynamical mean-field theory calculations suggest that the former anomaly is a signature of the topological change of the Fermi surface for valence electrons. However, the anomaly at 440 gigapascals might be related to an electronic transition associated with pressure-induced interactions between core electrons. The ability to affect the core electrons under static high-pressure experimental conditions, even for incompressible metals such as Os, opens up opportunities to search for new states of matter under extreme compression.	[Dubrovinsky, L.; Bykova, E.] Univ Bayreuth, Bavarian Res Inst Expt Geochem & Geophys, D-95440 Bayreuth, Germany; [Dubrovinskaia, N.; Bykova, E.; Bykov, M.] Univ Bayreuth, Crystallog Lab, D-95440 Bayreuth, Germany; [Prakapenka, V.; Prescher, C.] Univ Chicago, Ctr Adv Radiat Sources, Argonne, IL 60437 USA; [Glazyrin, K.; Liermann, H. -P.] Deutsch Elektronen Synchrotron DESY, Photon Sci, D-22603 Hamburg, Germany; [Hanfland, M.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Ekholm, M.; Feng, Q.; Pourovskii, L. V.] Linkoping Univ, Swedish E Sci Res Ctr SeRC, SE-58183 Linkoping, Sweden; [Ekholm, M.; Feng, Q.; Abrikosov, I. A.] Linkoping Univ, Dept Phys Chem & Biol IFM, SE-58183 Linkoping, Sweden; [Pourovskii, L. V.] Ecole Polytech, CNRS, Ctr Phys Theor, F-91128 Palaiseau, France; [Katsnelson, M. I.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Katsnelson, M. I.] Ural Fed Univ, Dept Theoret & Appl Mech, Ekaterinburg 620002, Russia; [Wills, J. M.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Abrikosov, I. A.] Natl Univ Sci & Technol MISIS, Mat Modeling & Dev Lab, Moscow 119049, Russia	University of Bayreuth; University of Bayreuth; University of Chicago; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European Synchrotron Radiation Facility (ESRF); Linkoping University; Linkoping University; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Radboud University Nijmegen; Ural Federal University; United States Department of Energy (DOE); Los Alamos National Laboratory; National University of Science & Technology (MISIS)	Dubrovinsky, L (corresponding author), Univ Bayreuth, Bavarian Res Inst Expt Geochem & Geophys, D-95440 Bayreuth, Germany.	Leonid.Dubrovinsky@uni-bayreuth.de; Igor.Abrikosov@ifm.liu.se	Pourovskii, Leonid V./F-1764-2015; Bykova, Elena/Q-6260-2018; Bykov, Maxim/I-1646-2013; Abrikosov, Igor A/I-7328-2013; Prescher, Clemens/AAA-9425-2021; Katsnelson, Mikhail I./D-4359-2012; Dubrovinskaia, Natalia/A-8013-2015; Prescher, Clemens/I-7387-2016; Ekholm, Marcus/Q-5120-2018; Feng, Qingguo/E-7879-2011	Pourovskii, Leonid V./0000-0003-4003-3539; Bykova, Elena/0000-0001-8652-024X; Bykov, Maxim/0000-0003-0248-1728; Dubrovinskaia, Natalia/0000-0002-8256-5675; Ekholm, Marcus/0000-0002-7563-1494; Feng, Qingguo/0000-0002-0242-8436; Liermann, Hanns-Peter/0000-0001-5039-1183; Dubrovinsky, Leonid/0000-0002-3717-7585	Deutsche Forschungsgemeinschaft (DFG); Federal Ministry of Education and Research (BMBF), Germany; DFG through Heisenberg Program; DFG [DU 954-8/1]; BMBF [5K13WC3, O5K2013]; Swedish Foundation for Strategic Research programme SRL [10-0026]; Swedish Research Council (VR) [621-2011-4426]; Swedish Government Strategic Research Area Grant Swedish e-Science Research Centre (SeRC); Materials Science "Advanced Functional Materials" (AFM); Ministry of Education and Science of the Russian Federation [14.Y26.31.0005]; ERC [338957]; NWO; National Science Foundation - Earth Sciences [EAR-1128799]; Department of Energy - GeoSciences [DE-FG02-94ER14466]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); DFG through Heisenberg Program(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Swedish Foundation for Strategic Research programme SRL; Swedish Research Council (VR)(Swedish Research Council); Swedish Government Strategic Research Area Grant Swedish e-Science Research Centre (SeRC); Materials Science "Advanced Functional Materials" (AFM); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); ERC(European Research Council (ERC)European Commission); NWO(Netherlands Organization for Scientific Research (NWO)); National Science Foundation - Earth Sciences(National Science Foundation (NSF)); Department of Energy - GeoSciences(United States Department of Energy (DOE)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE))	L.D. and N.D. acknowledge financial support from the Deutsche Forschungsgemeinschaft (DFG) and the Federal Ministry of Education and Research (BMBF), Germany. N.D. thanks the DFG for funding through the Heisenberg Program and the DFG project number DU 954-8/1, and the BMBF for grant number 5K13WC3 (Verbundprojekt O5K2013, Teilprojekt 2, PT-DESY). M.E., Q.F., and I.A.A. acknowledge support from the Swedish Foundation for Strategic Research programme SRL grant numbers 10-0026, the Swedish Research Council (VR) grant numbers 621-2011-4426, the Swedish Government Strategic Research Area Grant Swedish e-Science Research Centre (SeRC), and in Materials Science "Advanced Functional Materials" (AFM). The work was supported by the Ministry of Education and Science of the Russian Federation (grant number 14.Y26.31.0005). The simulations were carried out using supercomputer resources provided by the Swedish national infrastructure for computing (SNIC). M.I.K. acknowledges financial support from the ERC Advanced grant number 338957 FEMTO/NANO and from NWO via a Spinoza Prize. Portions of this work were performed at GeoSoilEnviroCARS (Sector 13), Advanced Photon Source (APS), Argonne National Laboratory. GeoSoilEnviroCARS is supported by the National Science Foundation - Earth Sciences (EAR-1128799) and Department of Energy - GeoSciences (DE-FG02-94ER14466). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract number DE-AC02-06CH11357.	Aichhorn M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054529; Aichhorn M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.085101; Armentrout MM, 2010, J APPL PHYS, V107, DOI 10.1063/1.3369283; Armiento R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085108; Beach K. S. D., 2004, PREPRINT; Blaha P., 2001, WIEN2K; Boehnke L, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075145; Cynn H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.135701; CZYZYK MT, 1994, PHYS REV B, V49, P14211, DOI 10.1103/PhysRevB.49.14211; Dewaele A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.094112; Dorfman SM, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009800; Dorfman SM, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009292; Dorogokupets PI, 2007, HIGH PRESSURE RES, V27, P431, DOI 10.1080/08957950701659700; Dubrovinsky L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2160; Fei YW, 2007, P NATL ACAD SCI USA, V104, P9182, DOI 10.1073/pnas.0609013104; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Glazyrin K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.117206; Godwal BK, 2012, J APPL PHYS, V111, DOI 10.1063/1.4726203; Gull E, 2011, REV MOD PHYS, V83, P349, DOI 10.1103/RevModPhys.83.349; Haas P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085104; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; HOLMES NC, 1989, J APPL PHYS, V66, P2962, DOI 10.1063/1.344177; KARAZIYA RI, 1981, USP FIZ NAUK+, V135, P79, DOI 10.3367/UFNr.0135.198109c.0079; KATSNELSON MI, 1988, FIZ TVERD TELA+, V30, P3299; Katsnelson MI, 2000, PHYS REV B, V61, P1643, DOI 10.1103/PhysRevB.61.1643; Kenichi T, 1997, PHYS REV B, V56, P5170, DOI 10.1103/PhysRevB.56.5170; Kenichi T, 1999, PHYS REV B, V60, P6171, DOI 10.1103/PhysRevB.60.6171; Kenichi T, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.012101; Klotz S, 1998, PHYS REV LETT, V81, P1239, DOI 10.1103/PhysRevLett.81.1239; Kotliar G, 2006, REV MOD PHYS, V78, P865, DOI 10.1103/RevModPhys.78.865; Koudela D, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.214103; Liang YC, 2006, J PHYS-CONDENS MAT, V18, P8749, DOI 10.1088/0953-8984/18/39/007; LIFSHITZ IM, 1960, SOV PHYS JETP-USSR, V11, P1130; Litasov KD, 2013, J APPL PHYS, V113, DOI 10.1063/1.4799018; Ma YM, 2009, NATURE, V458, P182, DOI 10.1038/nature07786; Ma YM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174103; Martin R. M., 2004, ELECT STRUCTURE BASI, P210; Matsuoka T, 2009, NATURE, V458, P186, DOI 10.1038/nature07827; Mattsson AE, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155101; NIZHANKOVSKII VI, 1994, JETP LETT+, V59, P733; Occelli F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.095502; Occelli F, 2003, NAT MATER, V2, P151, DOI 10.1038/nmat831; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pourovskii LV, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155120; REHR JJ, 1975, PHYS REV B, V12, P2062, DOI 10.1103/PhysRevB.12.2062; Ruban AV, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/4/046501; Sahu BR, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.113106; Smith RF, 2014, NATURE, V511, P330, DOI 10.1038/nature13526; Sokolova TS, 2013, RUSS GEOL GEOPHYS+, V54, P181, DOI 10.1016/j.rgg.2013.01.005; SOLOVYEV IV, 1994, PHYS REV B, V50, P16861, DOI 10.1103/PhysRevB.50.16861; Souvatzis P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.015901; Steinle-Neumann G, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054103; VAKS VG, 1991, J PHYS-CONDENS MAT, V3, P1409, DOI 10.1088/0953-8984/3/11/004; Vonsovskii S. V., 1993, PHYS MET METALLOGR, V76, P247; Voronin GA, 2005, J PHYS CHEM SOLIDS, V66, P706, DOI 10.1016/j.jpcs.2004.08.045; Weinberger MB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.045506; Wills JM, 2010, SPRINGER SER SOLID-S, V167, P3, DOI 10.1007/978-3-642-15144-6; Yokoo M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104114; Young DA, 1991, PHASE DIAGRAMS ELEME	59	128	135	2	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					226	+		10.1038/nature14681	http://dx.doi.org/10.1038/nature14681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26302297	Green Published			2022-12-28	WOS:000360927400033
J	Schulte, CHH; Hansom, J; Jones, AE; Matthiesen, C; Le Gall, C; Atature, M				Schulte, Carsten H. H.; Hansom, Jack; Jones, Alex E.; Matthiesen, Clemens; Le Gall, Claire; Atature, Mete			Quadrature squeezed photons from a two-level system	NATURE			English	Article							RESONANCE FLUORESCENCE; QUANTUM-DOT; STATES; NOISE; GENERATION; DEVICE; LIGHT	Resonance fluorescence arises from the interaction of an optical field with a two-level system, and has played a fundamental role in the development of quantum optics and its applications. Despite its conceptual simplicity, it entails a wide range of intriguing phenomena, such as the Mollow-triplet emission spectrum(1), photon antibunching(2) and coherent photon emission(3). One fundamental aspect of resonance fluorescence-squeezing in the form of reduced quantum fluctuations in the single photon stream from an atom in free space-was predicted more than 30 years ago(4). However, the requirement to operate in the weak excitation regime, together with the combination of modest oscillator strength of atoms and low collection efficiencies, has continued to necessitate stringent experimental conditions for the observation of squeezing with atoms. Attempts to circumvent these issues had to sacrifice antibunching, owing to either stimulated forward scattering from atomic ensembles(5,6) or multi-photon transitions inside optical cavities(7,8). Here, we use an artificial atom with a large optical dipole enabling 100-fold improvement of the photon detection rate over the natural atom counterpart(9) and reach the necessary conditions for the observation of quadrature squeezing in single resonance-fluorescence photons. By implementing phase-dependent homodyne intensity-correlation detection(9-11), we demonstrate that the electric field quadrature variance of resonance fluorescence is three per cent below the fundamental limit set by vacuum fluctuations, while the photon statistics remain antibunched. The presence of squeezing and antibunching simultaneously is a fully non-classical outcome of the wave-particle duality of photons.	[Schulte, Carsten H. H.; Hansom, Jack; Jones, Alex E.; Matthiesen, Clemens; Le Gall, Claire; Atature, Mete] Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England	University of Cambridge	Atature, M (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	ma424@cam.ac.uk	Atature, Mete/ABD-9297-2020	Atature, Mete/0000-0003-3852-0944; Matthiesen, Clemens/0000-0001-7842-6536; Jones, Alex/0000-0002-9167-7484	University of Cambridge; European Research Council ERC [617985]; EU-FP7 Marie Curie Initial Training Network [S3NANO]; Clare College Cambridge	University of Cambridge(University of Cambridge); European Research Council ERC(European Research Council (ERC)European Commission); EU-FP7 Marie Curie Initial Training Network; Clare College Cambridge	We acknowledge financial support from the University of Cambridge, the European Research Council ERC Consolidator Grant Agreement No. 617985 and the EU-FP7 Marie Curie Initial Training Network S3NANO. C.M. acknowledges Clare College Cambridge for financial support through a Junior Research Fellowship. We thank E. Clarke, M. Hugues and the EPSRC National Centre for III-V Technologies for the wafer and C. Baune, R. Moghadas Nia, W. Vogel, G. Rempe, H. J. Carmichael and A. Ourjoumtsev for discussions.	Akopian N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.130501; CAVES CM, 1982, PHYS REV D, V26, P1817, DOI 10.1103/PhysRevD.26.1817; Flagg EB, 2009, NAT PHYS, V5, P203, DOI 10.1038/NPHYS1184; Gerber S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.183601; Goda K, 2008, NAT PHYS, V4, P472, DOI 10.1038/nphys920; HEIDMANN A, 1985, J PHYS-PARIS, V46, P1937, DOI 10.1051/jphys:0198500460110193700; Hoffges JT, 1997, J MOD OPTIC, V44, P1999, DOI 10.1080/09500349708231861; Kim J, 1999, NATURE, V397, P500, DOI 10.1038/17295; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; LOUDON R, 1984, OPT COMMUN, V49, P24, DOI 10.1016/0030-4018(84)90083-X; Lu ZH, 1998, PHYS REV LETT, V81, P3635, DOI 10.1103/PhysRevLett.81.3635; Matthiesen C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2601; Matthiesen C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.093602; Michler P, 2000, NATURE, V406, P968, DOI 10.1038/35023100; Muller M, 2014, NAT PHOTONICS, V8, P224, DOI [10.1038/nphoton.2013.377, 10.1038/NPHOTON.2013.377]; OU ZY, 1987, PHYS REV A, V36, P192, DOI 10.1103/PhysRevA.36.192; Ourjoumtsev A, 2011, NATURE, V474, P623, DOI 10.1038/nature10170; RAIZEN MG, 1987, PHYS REV LETT, V59, P198, DOI 10.1103/PhysRevLett.59.198; SCHUDA F, 1974, J PHYS B-AT MOL OPT, V7, pL198, DOI 10.1088/0022-3700/7/7/002; Stanley MJ, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.195305; Teich M. C., 1989, Quantum Optics, V1, P153, DOI 10.1088/0954-8998/1/2/006; Vamivakas AN, 2009, NAT PHYS, V5, P198, DOI 10.1038/NPHYS1182; VOGEL W, 1995, PHYS REV A, V51, P4160, DOI 10.1103/PhysRevA.51.4160; WALLS DF, 1983, NATURE, V306, P141, DOI 10.1038/306141a0; WALLS DF, 1981, PHYS REV LETT, V47, P709, DOI 10.1103/PhysRevLett.47.709; Warburton RJ, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.113303; Xu XD, 2007, SCIENCE, V317, P929, DOI 10.1126/science.1142979; Young RJ, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/029; YUEN HP, 1976, PHYS REV A, V13, P2226, DOI 10.1103/PhysRevA.13.2226	30	83	83	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					222	+		10.1038/nature14868	http://dx.doi.org/10.1038/nature14868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26322581	Green Accepted, Green Submitted			2022-12-28	WOS:000360927400032
J	Waclaw, B; Bozic, I; Pittman, ME; Hruban, RH; Vogelstein, B; Nowak, MA				Waclaw, Bartlomiej; Bozic, Ivana; Pittman, Meredith E.; Hruban, Ralph H.; Vogelstein, Bert; Nowak, Martin A.			A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity	NATURE			English	Article							GROWTH IN-VITRO; STOCHASTIC-MODELS; DRUG-RESISTANCE; ACQUIRED-RESISTANCE; WAITING TIME; HYBRID MODEL; CANCER; EVOLUTION; DYNAMICS; PROGRESSION	Most cancers in humans are large, measuring centimetres in diameter, and composed of many billions of cells(1). An equivalent mass of normal cells would be highly heterogeneous as a result of the mutations that occur during each cell division. What is remarkable about cancers is that virtually every neoplastic cell within a large tumour often contains the same core set of genetic alterations, with heterogeneity confined to mutations that emerge late during tumour growth(2-5). How such alterations expand within the spatially constrained three-dimensional architecture of a tumour, and come to dominate a large, pre-existing lesion, has been unclear. Here we describe a model for tumour evolution that shows how short-range dispersal and cell turnover can account for rapid cell mixing inside the tumour. We show that even a small selective advantage of a single cell within a large tumour allows the descendants of that cell to replace the precursor mass in a clinically relevant time frame. We also demonstrate that the same mechanisms can be responsible for the rapid onset of resistance to chemotherapy. Our model not only provides insights into spatial and temporal aspects of tumour growth, but also suggests that targeting short-range cellular migratory activity could have marked effects on tumour growth rates.	[Waclaw, Bartlomiej] Univ Edinburgh, Sch Phys & Astron, Edinburgh EH9 3FD, Midlothian, Scotland; [Bozic, Ivana; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Bozic, Ivana; Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Pittman, Meredith E.; Hruban, Ralph H.; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA; [Vogelstein, Bert] Ludwig Ctr, Baltimore, MD 21287 USA; [Vogelstein, Bert] Howard Hughes Med Inst, Johns Hopkins Kimmel Canc Ctr, Baltimore, MD 21287 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Edinburgh; Harvard University; Harvard University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Harvard University	Nowak, MA (corresponding author), Harvard Univ, Program Evolutionary Dynam, 1 Brattle Sq, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Bozic, Ivana/C-5003-2008; Waclaw, Bartlomiej/N-5818-2019; Waclaw, Bartek/F-8928-2012	Bozic, Ivana/0000-0003-2761-825X; Waclaw, Bartlomiej/0000-0001-5355-7994; Waclaw, Bartek/0000-0001-5355-7994	John Templeton Foundation; Leverhulme Trust Early-Career Fellowship; Royal Society of Edinburgh Personal Research Fellowship; Foundational Questions in Evolutionary Biology [RFP-12-17]; Virginia and D.K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; NIH [CA43460, CA62924]; NATIONAL CANCER INSTITUTE [P30CA006973, R01CA043460, R37CA043460, P50CA062924] Funding Source: NIH RePORTER	John Templeton Foundation; Leverhulme Trust Early-Career Fellowship(Leverhulme Trust); Royal Society of Edinburgh Personal Research Fellowship; Foundational Questions in Evolutionary Biology; Virginia and D.K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support from The John Templeton Foundation is gratefully acknowledged. B.W. was supported by the Leverhulme Trust Early-Career Fellowship, and the Royal Society of Edinburgh Personal Research Fellowship. I.B. was supported by Foundational Questions in Evolutionary Biology Grant RFP-12-17. M.E.P., R.H.H. and B.V. acknowledge support from The Virginia and D.K. Ludwig Fund for Cancer Research, The Lustgarten Foundation for Pancreatic Cancer Research, The Sol Goldman Center for Pancreatic Cancer Research, and NIH grants CA43460 and CA62924.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Alcolea MP, 2014, NAT CELL BIOL, V16, P612, DOI 10.1038/ncb2963; Ali A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021923; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Antal T, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022705; Basan M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.158101; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Bordeleau F, 2014, AM J PHYSIOL-CELL PH, V306, pC110, DOI 10.1152/ajpcell.00283.2013; Bozic I, 2014, P NATL ACAD SCI USA, V111, P15964, DOI 10.1073/pnas.1412075111; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Bozic I, 2012, TRENDS MOL MED, V18, P311, DOI 10.1016/j.molmed.2012.04.006; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Chen EJ, 1996, IEEE T ULTRASON FERR, V43, P191, DOI 10.1109/58.484478; Choe SC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00031; COLDMAN AJ, 1983, MATH BIOSCI, V65, P291, DOI 10.1016/0025-5564(83)90066-4; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; Drasdo D, 2000, PHYS REV LETT, V84, P4244, DOI 10.1103/PhysRevLett.84.4244; Drasdo D, 2007, J STAT PHYS, V128, P287, DOI 10.1007/s10955-007-9289-x; Durrett R., 2015, J MATH BIOL; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; Durrett R, 2009, ANN APPL PROBAB, V19, P676, DOI 10.1214/08-AAP559; Eden M., 1961, 2 DIMENSIONAL GROWTH, P265; Ellison TA, 2014, ANN SURG, V259, P204, DOI 10.1097/SLA.0b013e31828f3174; Enderling H, 2009, BRIT J CANCER, V100, P1917, DOI 10.1038/sj.bjc.6605071; Foo J, 2014, J THEOR BIOL, V355, P10, DOI 10.1016/j.jtbi.2014.02.025; Foo J, 2014, J THEOR BIOL, V355, P170, DOI 10.1016/j.jtbi.2014.02.042; Gall TMH, 2013, J CLIN PATHOL, V66, P928, DOI 10.1136/jclinpath-2013-201768; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Gatenby RA, 2003, CANCER RES, V63, P6212; Gerlee P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002556; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GOLDIE JH, 1984, CANCER RES, V44, P3643; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054912; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; Gonzalez-Rodriguez D, 2012, SCIENCE, V338, P910, DOI 10.1126/science.1226418; Greulich P, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.088101; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hawkins-Daarud A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00066; HONDA H, 1979, J THEOR BIOL, V81, P745, DOI 10.1016/0022-5193(79)90279-0; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Jiao Y, 2012, AIP ADV, V2, DOI 10.1063/1.3697959; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Kansal AR, 2000, J THEOR BIOL, V207, P431, DOI 10.1006/jtbi.2000.2186; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kim Y, 2013, B MATH BIOL, V75, P1304, DOI 10.1007/s11538-012-9787-0; Komarova NL, 2006, B MATH BIOL, V68, P1573, DOI 10.1007/s11538-005-9046-8; Komarova NL, 2014, P NATL ACAD SCI USA, V111, P10789, DOI 10.1073/pnas.1400828111; Komarova NL, 2013, MATH BIOSCI ENG, V10, P761, DOI 10.3934/mbe.2013.10.761; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Korolev K. S., 2011, DRYAD DIGITAL REPOSI; Korolev KS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/2/026008; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x; Lavrentovich MO, 2015, THEOR POPUL BIOL, V102, P26, DOI 10.1016/j.tpb.2015.03.002; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Lindstrom LS, 2012, J CLIN ONCOL, V30, P2601, DOI 10.1200/JCO.2011.37.2482; Manem VSK, 2014, J THEOR BIOL, V349, P66, DOI 10.1016/j.jtbi.2014.01.009; Martens EA, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/115014; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Moglia B, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032713; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Poleszczuk J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004025; Radszuweit M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051907; Ramis-Conde I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016008; Ranft J, 2010, P NATL ACAD SCI USA, V107, P20863, DOI 10.1073/pnas.1011086107; Reiter JG, 2013, EVOL APPL, V6, P34, DOI 10.1111/eva.12020; Rodriguez-Brenes IA, 2013, TRENDS ECOL EVOL, V28, P597, DOI 10.1016/j.tree.2013.05.020; Samani A, 2003, PHYS MED BIOL, V48, P2183, DOI 10.1088/0031-9155/48/14/310; Schaller G, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051910; Sciume G, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015005; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Spencer SL, 2004, J THEOR BIOL, V231, P515, DOI 10.1016/j.jtbi.2004.07.006; Stirbat TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052554; Stylianopoulos T, 2013, P NATL ACAD SCI USA, V110, P18632, DOI 10.1073/pnas.1318415110; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Taloni A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094229; Thalhauser CJ, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-21; Torquato S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015017; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Voss MH, 2014, CLIN CANCER RES, V20, P1955, DOI 10.1158/1078-0432.CCR-13-2345; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Weber K, 2011, NAT MED, V17, P504, DOI 10.1038/nm.2338; Weinberg RA, 2007, BIOL CANC; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482; Winter JM, 2008, CLIN CANCER RES, V14, P412, DOI 10.1158/1078-0432.CCR-07-0487; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	100	288	294	4	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					261	+		10.1038/nature14971	http://dx.doi.org/10.1038/nature14971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26308893	Green Accepted, Green Submitted			2022-12-28	WOS:000360927400041
J	Handa, S; Wang, Y; Gallou, F; Lipshutz, BH				Handa, Sachin; Wang, Ye; Gallou, Fabrice; Lipshutz, Bruce H.			Sustainable Fe-ppm Pd nanoparticle catalysis of Suzuki-Miyaura cross-couplings in water	SCIENCE			English	Article							TRANSMETALATION; PALLADIUM	Most of today's use of transition metal-catalyzed cross-coupling chemistry relies on expensive quantities of palladium (Pd). Here we report that nanoparticles formed from inexpensive FeCl3 that naturally contains parts-per-million (ppm) levels of Pd can catalyze Suzuki-Miyaura reactions, including cases that involve highly challenging reaction partners. Nanomicelles are employed to both solubilize and deliver the reaction partners to the Fe-ppm Pd catalyst, resulting in carbon-carbon bond formation. The newly formed catalyst can be isolated and stored at ambient temperatures. Aqueous reaction mixtures containing both the surfactant and the catalyst can be recycled.	[Handa, Sachin; Wang, Ye; Lipshutz, Bruce H.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Gallou, Fabrice] Novartis Pharmaceut, Basel, Switzerland	University of California System; University of California Santa Barbara; Novartis	Lipshutz, BH (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	lipshutz@chem.ucsb.edu	Wang, Ye/L-9082-2015		Novartis; NSF through the Materials Research Science and Engineering Center (MRSEC) program; NSF's MRSEC program [DMR-1121053]; NIH [1S10OD012077-01A1]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012077] Funding Source: NIH RePORTER	Novartis(Novartis); NSF through the Materials Research Science and Engineering Center (MRSEC) program; NSF's MRSEC program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Novartis for financial support; J. Feng for technical assistance; M. Cornish for acquisition of the AFM images; S. Kraemer for obtaining the cryo-TEM, SEM, and EDX data; and J. Matthey for providing Pd salts. Parts of this work were carried out in the Characterization Facility, University of Minnesota, which receives partial support from NSF through the Materials Research Science and Engineering Center (MRSEC) program. This work also made use of the University of California-Santa Barbara (UCSB) Materials Research Laboratory Central Facilities, supported by NSF's MRSEC program under award no. DMR-1121053. ICP-MS analyses were provided by J. Reilly (Novartis, Cambridge, MA). We also acknowledge support from NIH in the form of a Shared Instrument Grant to UCSB(1S10OD012077-01A1). A preliminary patent covering this chemistry has been filed by the University of California-Santa Barbara. The experimental data reported in this paper are available in the supplementary materials.	Allred GD, 1996, J AM CHEM SOC, V118, P2748, DOI 10.1021/ja9541239; Bointon TH, 2014, NANO LETT, V14, P1751, DOI 10.1021/nl4040779; Buchwald SL, 2009, ANGEW CHEM INT EDIT, V48, P5586, DOI 10.1002/anie.200902237; Chun CL, 2010, ENVIRON SCI TECHNOL, V44, P5079, DOI 10.1021/es903278e; Darses S, 2008, CHEM REV, V108, P288, DOI 10.1021/cr0509758; Dube PN, 2014, CHEM BIOL DRUG DES, V84, P409, DOI 10.1111/cbdd.12324; Gurung SK, 2014, ORG LETT, V16, P1264, DOI 10.1021/ol500310u; Han FS, 2013, CHEM SOC REV, V42, P5270, DOI 10.1039/c3cs35521g; Isley NA, 2013, J AM CHEM SOC, V135, P17707, DOI 10.1021/ja409663q; Kooroshy J, 2009, SCARCITY MINERALS ST; Lee SJ, 2010, ANGEW CHEM INT EDIT, V49, P8860, DOI 10.1002/anie.201004911; Lennox AJJ, 2014, CHEM SOC REV, V43, P412, DOI 10.1039/c3cs60197h; Li HB, 2012, ACS CATAL, V2, P1147, DOI 10.1021/cs300082f; Lipshutz BH, 2013, ANGEW CHEM INT EDIT, V52, P10952, DOI 10.1002/anie.201302020; Lipshutz BH, 2011, J ORG CHEM, V76, P4379, DOI 10.1021/jo101974u; Molander GA, 2006, J ORG CHEM, V71, P2493, DOI 10.1021/jo052636k; Netherton MR, 2004, ADV SYNTH CATAL, V346, P1525, DOI 10.1002/adsc.200404223; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Sheldon RA, 2007, GREEN CHEM, V9, P1273, DOI 10.1039/b713736m; Sun YP, 2006, ADV COLLOID INTERFAC, V120, P47, DOI 10.1016/j.cis.2006.03.001; Tellis JC, 2014, SCIENCE, V345, P433, DOI 10.1126/science.1253647; Thome I, 2012, CHEM SOC REV, V41, P979, DOI 10.1039/c2cs15249e; Zhou Y., 2014, ANGEW CHEM, V126, P3543, DOI DOI 10.1021/ACSCATAL.7B01044	23	213	218	6	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1087	1091		10.1126/science.aac6936	http://dx.doi.org/10.1126/science.aac6936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339028				2022-12-28	WOS:000360628900039
J	Bowen, G				Bowen, Gabriel			HYDROLOGY The diversified economics of soil water	NATURE			English	Editorial Material							SEPARATION; FLUXES; MODEL	Soil water that evaporates or is tapped by plants is largely separate from that which runs into streams and recharges groundwater. This finding has big implications for our understanding of water cycling. See Letter P.91	Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Bowen, G (corresponding author), Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA.	gabe.bowen@utah.edu						Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; BEVEN K, 1982, WATER RESOUR RES, V18, P1311, DOI 10.1029/WR018i005p01311; Brooks JR, 2010, NAT GEOSCI, V3, P100, DOI 10.1038/NGEO722; Evaristo J, 2015, NATURE, V525, P91, DOI 10.1038/nature14983; Goldsmith GR, 2012, ECOHYDROLOGY, V5, P779, DOI 10.1002/eco.268; Good SP, 2015, SCIENCE, V349, P175, DOI 10.1126/science.aaa5931; Jasechko S, 2013, NATURE, V496, P347, DOI 10.1038/nature11983; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Moore J, 2012, GEOCHIM COSMOCHIM AC, V93, P235, DOI 10.1016/j.gca.2012.03.021; Neitsch S.L., 2011, SOIL WATER ASSESSMEN, DOI [10.1016/j.scitotenv.2015.11.063, DOI 10.1016/J.SCITOTENV.2015.11.063]	10	17	21	1	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					43	44		10.1038/525043a	http://dx.doi.org/10.1038/525043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26333464				2022-12-28	WOS:000360594100021
J	Yaqub, F				Yaqub, Farhat			Pain in the USA: states of suffering	LANCET			English	Editorial Material									Lancet, London EC2Y 5AS, England		Yaqub, F (corresponding author), Lancet, London EC2Y 5AS, England.	farhat.yaqub@lancet.com						[Anonymous], 2015, LANCET, V386, P743; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Knaul FM, 2015, LANCET, V386, P722, DOI 10.1016/S0140-6736(15)60289-6; Mossey JM, 2011, CLIN ORTHOP RELAT R, V469, P1859, DOI 10.1007/s11999-011-1770-9; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; The American Academy of Pain Medicine, FACTS FIG PAIN	6	8	8	0	57	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					839	839		10.1016/S0140-6736(15)00041-0	http://dx.doi.org/10.1016/S0140-6736(15)00041-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0MJ	26335863				2022-12-28	WOS:000360290000008
J	Hinson, JT; Chopra, A; Nafissi, N; Polacheck, WJ; Benson, CC; Swist, S; Gorham, J; Yang, L; Schafer, S; Sheng, CC; Haghighi, A; Homsy, J; Hubner, N; Church, G; Cook, SA; Linke, WA; Chen, CS; Seidman, JG; Seidman, CE				Hinson, John T.; Chopra, Anant; Nafissi, Navid; Polacheck, William J.; Benson, Craig C.; Swist, Sandra; Gorham, Joshua; Yang, Luhan; Schafer, Sebastian; Sheng, Calvin C.; Haghighi, Alireza; Homsy, Jason; Hubner, Norbert; Church, George; Cook, Stuart A.; Linke, Wolfgang A.; Chen, Christopher S.; Seidman, J. G.; Seidman, Christine E.			Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy	SCIENCE			English	Article							MESENCHYMAL STEM-CELLS; CARDIAC MICROTISSUES; DIFFERENTIATION; CARDIOMYOCYTES; HYPERTROPHY; FORCE	Human mutations that truncate the massive sarcomere protein titin [TTN-truncating variants (TTNtvs)] are the most common genetic cause for dilated cardiomyopathy (DCM), a major cause of heart failure and premature death. Here we show that cardiac microtissues engineered from human induced pluripotent stem (iPS) cells are a powerful system for evaluating the pathogenicity of titin gene variants. We found that certain missense mutations, like TTNtvs, diminish contractile performance and are pathogenic. By combining functional analyses with RNA sequencing, we explain why truncations in the A-band domain of TTN cause DCM, whereas truncations in the I band are better tolerated. Finally, we demonstrate that mutant titin protein in iPS cell-derived cardiomyocytes results in sarcomere insufficiency, impaired responses to mechanical and beta-adrenergic stress, and attenuated growth factor and cell signaling activation. Our findings indicate that titin mutations cause DCM by disrupting critical linkages between sarcomerogenesis and adaptive remodeling.	[Hinson, John T.; Haghighi, Alireza; Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Chopra, Anant; Polacheck, William J.; Chen, Christopher S.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Chopra, Anant; Polacheck, William J.; Yang, Luhan; Church, George; Chen, Christopher S.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Nafissi, Navid; Gorham, Joshua; Yang, Luhan; Sheng, Calvin C.; Haghighi, Alireza; Homsy, Jason; Church, George; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Benson, Craig C.] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Boston, MA 02215 USA; [Swist, Sandra; Linke, Wolfgang A.] Ruhr Univ Bochum, Dept Cardiovasc Physiol, D-44780 Bochum, Germany; [Schafer, Sebastian; Hubner, Norbert] Max Delbruck Ctr Mol Med, Cardiovasc & Metab Sci, Berlin, Germany; [Haghighi, Alireza; Seidman, Christine E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Hubner, Norbert] DZHK German Ctr Cardiovasc Res, Berlin, Germany; [Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton & Harefield Natl Hlth Serv NHS Tru, Biomed Res Unit Cardiovasc Dis, Natl Inst Hlth Res NIHR, London, England; [Cook, Stuart A.] Natl Heart Ctr, Singapore, Singapore; [Cook, Stuart A.] Duke Natl Univ, Singapore, Singapore	Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Ruhr University Bochum; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Howard Hughes Medical Institute; German Centre for Cardiovascular Research; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; National Heart Centre Singapore	Hinson, JT (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	jthinson@partners.org; cseidman@genetics.med.harvard.edu	Chen, Christopher S./ABD-8499-2021	Chen, Christopher S./0000-0003-2445-8449; Swist, Sandra/0000-0002-1269-2177; Schafer, Sebastian/0000-0002-6909-8275; Cook, Stuart/0000-0001-6628-194X; church, george/0000-0001-6232-9969; Linke, Wolfgang/0000-0003-0801-3773; Polacheck, William/0000-0003-2728-0746	LaDue Fellowship; American Heart Association; Sarnoff Foundation; Leducq Foundation; German Research Foundation [SFB 1002 TPB3]; NIH [HG005550, EB017103, HL115553, HL007374, HL125807]; NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust; RESBIO Technology Resource for Polymeric Biomaterials; Howard Hughes Medical Institute; Illumina, Inc.; MRC [MC_U120085815] Funding Source: UKRI; British Heart Foundation [SP/10/10/28431] Funding Source: researchfish; Medical Research Council [MC_U120085815] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL125807, R01HL080494, T32HL007208, T32HL007374, R01HL115553] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [UH2EB017103, UH3EB017103, T32EB016652] Funding Source: NIH RePORTER	LaDue Fellowship; American Heart Association(American Heart Association); Sarnoff Foundation; Leducq Foundation(Leducq Foundation); German Research Foundation(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust; RESBIO Technology Resource for Polymeric Biomaterials; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Illumina, Inc.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank M. von Frieling-Salewsky for titin gels and Innolign Biomedical for CMTs. This work was supported in part by grants from the LaDue Fellowship (J.T.H., J.H.), the American Heart Association (A.C.), the Sarnoff Foundation (N.N., C.C.S.), the Leducq Foundation (S.A.C., N.H., S.S., J.G.S., C.E.S.), the German Research Foundation [W.A.L. (SFB 1002 TPB3)], the NIH [L.Y. and G.C. (HG005550), C.S.C. (EB017103 and HL115553), C.C.B. (HL007374), J.T.H. (HL125807), C.E.S., and J.G.S.], the NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust (S.A.C.), the RESBIO Technology Resource for Polymeric Biomaterials (C.S.C.), and Howard Hughes Medical Institute (C.E.S., A.H.). C.E.S. and J.G.S. are cofounders of and own shares in Myokardia Inc., a company that is developing therapeutics for cardiomyopathies. C.S.C. is a cofounder of and owns equity in Innolign Biomedical, a company that is developing an organ-on-chip platform (based on the device used in this study) for measuring forces of cardiac microtissues. S.A.C. is a paid consultant for Illumina, Inc.	Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.TEA.2011.0341, 10.1089/ten.tea.2011.0341]; Cai BZ, 2012, STEM CELLS, V30, P1746, DOI 10.1002/stem.1154; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V4, P412; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Liu JL, 2012, LIFE SCI, V90, P1020, DOI 10.1016/j.lfs.2012.05.011; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Thavandiran N, 2013, P NATL ACAD SCI USA, V110, pE4698, DOI 10.1073/pnas.1311120110; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026	20	350	362	8	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					982	986		10.1126/science.aaa5458	http://dx.doi.org/10.1126/science.aaa5458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315439	Green Accepted, Green Submitted			2022-12-28	WOS:000360646800055
J	Cang, CL; Aranda, K; Seo, YJ; Gasnier, B; Ren, DJ				Cang, Chunlei; Aranda, Kimberly; Seo, Young-jun; Gasnier, Bruno; Ren, Dejian			TMEM175 Is an Organelle K+ Channel Regulating Lysosomal Function	CELL			English	Article							POTASSIUM CHANNELS; CA2+ STORES; CALCIUM; ACIDIFICATION; MUTATIONS; CHLORIDE; DISEASE; PH; CHARYBDOTOXIN; TRAFFICKING	Potassium is the most abundant ion to face both plasma and organelle membranes. Extensive research over the past seven decades has characterized how K+ permeates the plasma membrane to control fundamental processes such as secretion, neuronal communication, and heartbeat. However, how K+ permeates organelles such as lysosomes and endosomes is unknown. Here, we directly recorded organelle K+ conductance and discovered a major K+-selective channel K-EL on endosomes and lysosomes. K-EL is formed by TMEM175, a protein with unknown function. Unlike any of the similar to 80 plasma membrane K+ channels, TMEM175 has two repeats of 6-transmembrane-spanning segments and has no GYG K+ channel sequence signature-containing, pore-forming P loop. Lysosomes lacking TMEM175 exhibit no K+ conductance, have a markedly depolarized Delta Psi and little sensitivity to changes in [K+], and have compromised luminal pH stability and abnormal fusion with autophagosomes during autophagy. Thus, TMEM175 comprises a K+ channel that underlies the molecular mechanism of lysosomal K+ permeability.	[Cang, Chunlei; Aranda, Kimberly; Seo, Young-jun; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Gasnier, Bruno] Paris Descartes Univ, Sorbonne Paris Cite, Neurophoton Lab, CNRS,UMR8250, F-75006 Paris, France	University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Ren, DJ (corresponding author), Univ Penn, Dept Biol, 415 South Univ Ave, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu	Gasnier, Bruno/AAD-9124-2022; Cang, Chunlei/D-9185-2019	Gasnier, Bruno/0000-0003-4458-6296; Cang, Chunlei/0000-0002-3302-0927	NIH; University of Pennsylvania Research Foundation; Centre National de la Recherche Scientifique; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2012R1A6A3A03040071]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education	We thank Drs. Sora Lee, Carol Deutsch, and David Clapham for suggestions; Robert Edwards and Roger Chang for the use of Rab5-Q79L; Drs. Haijun Chen and Mickey Marks for reagents; and Dr. Bin Wu for pilot studies. This work was supported, in part, by funding from NIH, the University of Pennsylvania Research Foundation (to D.R.), the Centre National de la Recherche Scientifique (to B.G.), and the Basic Science Research Program (through the National Research Foundation of Korea funded by the Ministry of Education (number 2012R1A6A3A03040071 to Y.-j.S.).	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; [Anonymous], 2015, CELL, V162, P1101; Cang CL, 2014, NAT CHEM BIOL, V10, P463, DOI 10.1038/nchembio.1522; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Christensen KA, 2002, J CELL SCI, V115, P599; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Grimm C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5699; Haggie PM, 2009, AM J PHYSIOL-LUNG C, V296, pL859, DOI 10.1152/ajplung.00018.2009; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HENNING R, 1975, BIOCHIM BIOPHYS ACTA, V401, P307, DOI 10.1016/0005-2736(75)90314-4; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Huang P, 2014, J BIOL CHEM, V289, P17658, DOI 10.1074/jbc.M114.552158; Huang X, 2014, J CELL BIOL, V206, P151, DOI 10.1083/jcb.201404136; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koivusalo M, 2011, TRAFFIC, V12, P972, DOI 10.1111/j.1600-0854.2011.01215.x; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; LaPlante JM, 2004, BIOCHEM BIOPH RES CO, V322, P1384, DOI 10.1016/j.bbrc.2004.08.045; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tian XJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002103; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	47	101	111	3	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1101	1112		10.1016/j.cell.2015.08.002	http://dx.doi.org/10.1016/j.cell.2015.08.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317472	Bronze			2022-12-28	WOS:000360589900019
J	Licht, JD				Licht, Jonathan D.			DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension	CELL			English	Editorial Material							TUMOR-CELLS	DNA demethylating agents are approved for some blood malignancies and are under active investigation in solid tumors, but how these drugs work has remained unclear. In this issue of Cell, two groups show that these agents activate a toxic cellular antiviral program through transcriptional activation of endogenous retroviral sequences.	Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Licht, JD (corresponding author), Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, 303 East Super St,Lurie 5-123, Chicago, IL 60611 USA.	j-licht@northwestern.edu	Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369; 	NATIONAL CANCER INSTITUTE [U54CA193419] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA193419] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Fandy TE, 2009, BLOOD, V114, P2764, DOI 10.1182/blood-2009-02-203547; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Stubig T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/418292; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542	10	48	51	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					938	939		10.1016/j.cell.2015.08.005	http://dx.doi.org/10.1016/j.cell.2015.08.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317460	Bronze			2022-12-28	WOS:000360589900003
J	Roulois, D; Yau, HL; Singhania, R; Wang, YD; Danesh, A; Shen, SY; Han, H; Liang, GN; Jones, PA; Pugh, TJ; O'Brien, C; De Carvalho, DD				Roulois, David; Yau, Helen Loo; Singhania, Rajat; Wang, Yadong; Danesh, Arnavaz; Shen, Shu Yi; Han, Han; Liang, Gangning; Jones, Peter A.; Pugh, Trevor J.; O'Brien, Catherine; De Carvalho, Daniel D.			DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts	CELL			English	Article							SELF-RENEWAL; STEM-CELL; GENE-I; METHYLATION; EXPRESSION; TUMOR; MAVS; ACTIVATION	DNA-demethylating agents have shown clinical antitumor efficacy via an unknown mechanism of action. Using a combination of experimental and bioinformatics analyses in colorectal cancer cells, we demonstrate that low-dose 5-AZA-CdR targets colorectal cancer-initiating cells (CICs) by inducing viral mimicry. This is associated with induction of dsRNAs derived at least in part from endogenous retroviral elements, activation of the MDA5/MAVS RNA recognition pathway, and downstream activation of IRF7. Indeed, disruption of virus recognition pathways, by individually knocking down MDA5, MAVS, or IRF7, inhibits the ability of 5-AZA-CdR to target colorectal CICs and significantly decreases 5-AZA-CdR long-term growth effects. Moreover, transfection of dsRNA into CICs can mimic the effects of 5-AZA-CdR. Together, our results represent a major shift in understanding the anti-tumor mechanisms of DNA-demethylating agents and highlight the MDA5/MAVS/IRF7 pathway as a potentially druggable target against CICs.	[Roulois, David; Yau, Helen Loo; Singhania, Rajat; Wang, Yadong; Danesh, Arnavaz; Shen, Shu Yi; Pugh, Trevor J.; O'Brien, Catherine; De Carvalho, Daniel D.] Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON M5G 2M9, Canada; [Yau, Helen Loo; Pugh, Trevor J.; De Carvalho, Daniel D.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [O'Brien, Catherine] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Han, Han; Liang, Gangning; Jones, Peter A.] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90089 USA; [O'Brien, Catherine] Toronto Gen Hosp, Dept Surg, Toronto, ON M5T 1P5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Southern California; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	De Carvalho, DD (corresponding author), Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON M5G 2M9, Canada.	ddecarv@uhnres.utoronto.ca	Roulois, David/F-3732-2017; Pugh, Trevor/Y-2535-2019; De Carvalho, Daniel D/J-5503-2014; De Carvalho, Daniel/J-5503-2014	Roulois, David/0000-0002-8966-0608; Pugh, Trevor/0000-0002-8073-5888; De Carvalho, Daniel D/0000-0002-8572-5259; Shen, Shu Yi/0000-0001-7036-2291; De Carvalho, Daniel/0000-0003-0771-2265; Loo Yau, Helen/0000-0003-4867-8593; Liang, Gangning/0000-0001-8664-922X; O'Brien, Catherine/0000-0003-0682-3879	Cancer Research Society [CRS19092, CRS19091]; Canadian Cancer Society [CCSRI 703279, CCSRI 703716]; NSERC [489073]; Ontario Institute for Cancer Research (OICR); province of Ontario; Princess Margaret Cancer Foundation; University of Toronto McLaughlin Centre [MC-2015-02]; NCI [5R01CA082422]; Stand Up to Cancer; NATIONAL CANCER INSTITUTE [R01CA082422, R01CA170550] Funding Source: NIH RePORTER	Cancer Research Society; Canadian Cancer Society(Canadian Cancer Society (CCS)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Institute for Cancer Research (OICR); province of Ontario; Princess Margaret Cancer Foundation(University of Toronto); University of Toronto McLaughlin Centre; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up to Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work in D.D.C.'s laboratory is supported by grants from the Cancer Research Society (CRS19092 and CRS19091), Canadian Cancer Society (CCSRI 703279 and CCSRI 703716), NSERC (489073), Ontario Institute for Cancer Research (OICR) with funds from the province of Ontario, the Princess Margaret Cancer Foundation, and the University of Toronto McLaughlin Centre (MC-2015-02). T.J.P. is supported by the Princess Margaret Cancer Foundation. P.A.J. is supported by grants from NCI (5R01CA082422) and Stand Up to Cancer.	Ahuja N, 2014, J CLIN INVEST, V124, P56, DOI 10.1172/JCI69736; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Jiang LJ, 2011, P NATL ACAD SCI USA, V108, P1897, DOI 10.1073/pnas.1019059108; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Navada SC, 2014, J CLIN INVEST, V124, P40, DOI 10.1172/JCI69739; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Treppendahl MB, 2014, J CLIN INVEST, V124, P47, DOI 10.1172/JCI69737; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wicha MS, 2014, NAT MED, V20, P14, DOI 10.1038/nm.3434; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Zeng M, 2014, SCIENCE, V346, P1486, DOI 10.1126/science.346.6216.1486	33	729	742	6	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					961	973		10.1016/j.cell.2015.07.056	http://dx.doi.org/10.1016/j.cell.2015.07.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317465	Green Accepted, Bronze			2022-12-28	WOS:000360589900008
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Nagging people is a futile exercise	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2015	351								h4515	10.1136/bmj.h4515	http://dx.doi.org/10.1136/bmj.h4515			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2NF	26303155	Bronze			2022-12-28	WOS:000360437000002
J	Holmer, H; Shrime, MG; Riesel, JN; Meara, JG; Hagander, L				Holmer, Hampus; Shrime, Mark G.; Riesel, Johanna N.; Meara, John G.; Hagander, Lars			Towards closing the gap of the global surgeon, anaesthesiologist, and obstetrician workforce: thresholds and projections towards 2030	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Holmer, Hampus; Hagander, Lars] Lund Univ, Fac Med, Dept Clin Sci Lund, Paediat Surg & Global Paediat, Lund, Sweden; [Shrime, Mark G.] Harvard Interfac Initiat Hlth Policy, Boston, MA 02115 USA; [Shrime, Mark G.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Riesel, Johanna N.] Harvard Univ, Sch Med, Program Global Surg & Social Change, Massachusetts Gen Hosp,Dept Surg, Boston, MA 02115 USA; [Riesel, Johanna N.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA; [Meara, John G.] Harvard Univ, Sch Med, Program Global Surg & Social Change, Boston, MA 02115 USA; [Meara, John G.] Boston Childrens Hosp, Boston, MA USA	Lund University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital		hampus.holmer@med.lu.se	Holmer, Hampus/J-9907-2014	Holmer, Hampus/0000-0003-3745-7402					0	34	35	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			40	40		10.1016/S0140-6736(15)60835-2	http://dx.doi.org/10.1016/S0140-6736(15)60835-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313089				2022-12-28	WOS:000360573400041
J	Kalra, L; Irshad, S; Hodsoll, J; Simpson, M; Gulliford, M; Smithard, D; Patel, A; Rebollo-Mesa, I				Kalra, Lalit; Irshad, Saddif; Hodsoll, John; Simpson, Matthew; Gulliford, Martin; Smithard, David; Patel, Anita; Rebollo-Mesa, Irene		STROKE-INF Investigators	Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial	LANCET			English	Article							CLOSTRIDIUM-DIFFICILE; INFECTION; RISK; METAANALYSIS; DIAGNOSIS; OUTCOMES; CARE	Background Post-stroke pneumonia is associated with increased mortality and poor functional outcomes. This study assessed the effectiveness of antibiotic prophylaxis for reducing pneumonia in patients with dysphagia after acute stroke. Methods We did a prospective, multicentre, cluster-randomised, open-label controlled trial with masked endpoint assessment of patients older than 18 years with dysphagia after new stroke recruited from 48 stroke units in the UK, accredited and included in the UK National Stroke Audit. We excluded patients with contraindications to antibiotics, pre-existing dysphagia, or known infections, or who were not expected to survive beyond 14 days. We randomly assigned the units (1: 1) by computer to give either prophylactic antibiotics for 7 days plus standard stroke unit care or standard stroke unit care only to patients clustered in the units within 48 h of stroke onset. We did the randomisation with minimisation to stratify for number of admissions and access to specialist care. Patient and staff who did the assessments and analyses were masked to stroke unit allocation. The primary outcome was post-stroke pneumonia in the first 14 days, assessed with both a criteria-based, hierarchical algorithm and by physician diagnosis in the intention-to-treat population. Safety was also analysed by intention to treat. This trial is closed to new participants and is registered with isrctn.com, number ISRCTN37118456. Findings Between April 21, 2008, and May 17, 2014, we randomly assigned 48 stroke units (and 1224 patients clustered within the units) to the two treatment groups: 24 to antibiotics and 24 to standard care alone (control). 11 units and seven patients withdrew after randomisation before 14 days, leaving 1217 patients in 37 units for the intention-to-treat analysis (615 patients in the antibiotics group, 602 in control). Prophylactic antibiotics did not affect the incidence of algorithm-defined post-stroke pneumonia (71 [13%] of 564 patients in antibiotics group vs 52 [10%] of 524 in control group; marginal adjusted odds ratio [OR] 1.21 [95% CI 0.71-2.08], p=0.489, intraclass correlation coefficient [ICC] 0.06 [95% CI 0.02-0.17]. Algorithm-defined post-stroke pneumonia could not be established in 129 (10%) patients because of missing data. Additionally, we noted no differences in physician-diagnosed post-stroke pneumonia between groups (101 [16%] of 615 patients vs 91 [15%] of 602, adjusted OR 1.01 [95% CI 0.61-1.68], p=0.957, ICC 0.08 [95% CI 0.03-0.21]). The most common adverse events were infections unrelated to post-stroke pneumonia (mainly urinary tract infections), which were less frequent in the antibiotics group (22 [4%] of 615 vs 45 [7%] of 602; OR 0.55 [0.32-0.92], p=0.02). Diarrhoea positive for Clostridium difficile occurred in two patients (<1%) in the antibiotics group and four (<1%) in the control group, and meticillin-resistant Staphylococcus aureus colonisation occurred in 11 patients (2%) in the antibiotics group and 14 (2%) in the control group. Interpretation Antibiotic prophylaxis cannot be recommended for prevention of post-stroke pneumonia in patients with dysphagia after stroke managed in stroke units.	[Kalra, Lalit; Irshad, Saddif] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London SE5 8AF, England; [Hodsoll, John; Rebollo-Mesa, Irene] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat, Kings Clin Trials Unit, London SE5 8AF, England; [Patel, Anita] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Econ Mental & Phys Hlth, London SE5 8AF, England; [Simpson, Matthew] Guys & St Thomas Hosp, Kings Hlth Partners, UK Joint Clin Trials Off, London SE1 9RT, England; [Gulliford, Martin] Kings Coll London, Div Hlth & Social Care Res, Fac Life Sci & Med, London SE5 8AF, England; [Smithard, David] Univ Kent, Canterbury, Kent, England; [Hodsoll, John] South London & Maudsley NHS Fdn Trust, UK & NIHR Biomed Res Ctr Mental Hlth, London, England; [Hodsoll, John] Kings Coll London, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of Kent; South London & Maudsley NHS Trust; University of London; King's College London	Kalra, L (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London SE5 8AF, England.	lalit.kalra@kcl.ac.uk	Patel, Anita/F-9832-2010; Gulliford, Martin C/I-8606-2018	Gulliford, Martin C/0000-0003-1898-9075; Patel, Anita/0000-0003-0769-1732	UK National Institute for Health Research; National Institute for Health Research (NIHR) [PB-PG-0906-11103]; UK Stroke Research Network; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; NIHR Maudsley Biomedical Research Centre; National Institute for Health Research [PB-PG-0906-11103] Funding Source: researchfish	UK National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Stroke Research Network; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; NIHR Maudsley Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	UK National Institute for Health Research.; The views expressed in this publication are those of the authors, and not necessarily those of the NHS, NIHR, or the UK Department of Health. This report is independent research funded by the National Institute for Health Research (NIHR; project number PB-PG-0906-11103) and supported by the UK Stroke Research Network. MG was supported by the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. JH was supported by the NIHR Maudsley Biomedical Research Centre. The trial protocol, statistical analysis plan, and detailed governance arrangements have been submitted as online supplementary material. The study was approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA; EudraCT number 2007-004298-24), the West London National Research Ethics Committee (08/H0803/1), and the local Ethics Committee at each participating site. Oversight was provided by a trials steering committee and a data monitoring and ethics committee conforming to NIHR guidelines. The trial was done in accordance with Good Clinical Practice GCP standards. Data were monitored for quality and integrity by the King's Healthcare Partners Clinical Trials Office with established verification and validation processes. We did the statistical analyses in accordance with GCP and MHRA guidelines by the King's Clinical Trials Unit, Institute of Psychiatry, Psychology and Neurosciences, King's College London. The trial management group are Lalit Kalra, Saddif Irshad, Martin Gulliford, Matthew Simpson, Salma Ayis, Anita Patel, John Hodsoll, and Irene Rebello-Mesa. We thank the trial steering committee (Hugh Markus, Patrick Pullicino, David Smithard, Vivien Kearney, Ann Marie Murtagh, and Gaye Hadfield [Stroke Research Network representatives]), the data monitoring and ethics committee (Helen Rodgers, Thomas Chadwick, Sheila McCulloch, Jonathan Edgeworth, and Paul Holmes), all the patients who participated in this study, the clinical and pharmacy staff in all participating centres, and the NIHR Stroke Research Network staff involved; and the following people for their contributions: application for funding Charles Wolfe, Anthony Rudd, and Robin Cant; statistical advice Andrew Grieve and Salma Ayis; sponsor duties or study monitoring Jackie Pullen, Helen Critchley, Michelle Giles, and Jane Good; data management Michael Hong, Ramya Dhonti, and Jaya Buchupalli; and administration: Amanda Davies, Iram Ahmed, Claire Potter, and Isabelle Leung.	[Anonymous], 2014, PNEUM DIAGN MAN COMM; Brown K, 2015, JAMA INTERN MED, V175, P626, DOI 10.1001/jamainternmed.2014.8273; Campbell MK, 2001, STAT MED, V20, P391, DOI 10.1002/1097-0258(20010215)20:3<391::AID-SIM800>3.0.CO;2-Z; Eldridge S, 2012, PRACTICAL GUIDE CLUS, P150; Evans S, MINIM ALLOCATION MIN; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Harms H, 2012, J NEUROL NEUROSUR PS, V83, P1225, DOI 10.1136/jnnp-2012-302194; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Intercollegiate Stroke Working Party, 2008, NAT CLIN GUID STROK; Kishore AK, 2015, STROKE, V46, P1202, DOI 10.1161/STROKEAHA.114.007843; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Long J.S., 2014, REGRESSION MODELS CA; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Naidech AM, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.11.009; Ramsey DJC, 2003, STROKE, V34, P1252, DOI 10.1161/01.STR.0000066309.06490.B8; Royal College of Physicians, 2008, NAT SENT AUD STROK; Sentinel Stroke National Audit Programme, 2019, MOV DIAL STROK CAR 6; Team RC., 2022, LANG ENV STAT COMP; Titsworth WL, 2013, STROKE, V44, P3154, DOI 10.1161/STROKEAHA.111.000204; Vargas M, 2006, STROKE, V37, P461, DOI 10.1161/01.STR.0000199138.73365.b3; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Westendorp WF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub2; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110	26	157	167	4	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1835	1844		10.1016/S0140-6736(15)00126-9	http://dx.doi.org/10.1016/S0140-6736(15)00126-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26343840	Bronze			2022-12-28	WOS:000364194700034
J	Stuwe, T; Bley, CJ; Thierbach, K; Petrovic, S; Schilbach, S; Mayo, DJ; Perriches, T; Rundlet, EJ; Jeon, YE; Collins, LN; Huber, FM; Lin, DH; Paduch, M; Koide, A; Lu, V; Fischer, J; Hurt, E; Koide, S; Kossiakoff, AA; Hoelz, A				Stuwe, Tobias; Bley, Christopher J.; Thierbach, Karsten; Petrovic, Stefan; Schilbach, Sandra; Mayo, Daniel J.; Perriches, Thibaud; Rundlet, Emily J.; Jeon, Young E.; Collins, Leslie N.; Huber, Ferdinand M.; Lin, Daniel H.; Paduch, Marcin; Koide, Akiko; Lu, Vincent; Fischer, Jessica; Hurt, Ed; Koide, Shohei; Kossiakoff, Anthony A.; Hoelz, Andre			Architecture of the fungal nuclear pore inner ring complex	SCIENCE			English	Article							NUCLEOPORIN COMPLEX; STRUCTURAL-ANALYSIS; VERTEBRATE HOMOLOG; CYTOPLASMIC FACE; P62 COMPLEX; PROTEIN; CHANNEL; TRANSPORT; NSP1P; SUBCOMPLEXES	The nuclear pore complex (NPC) constitutes the sole gateway for bidirectional nucleocytoplasmic transport. We present the reconstitution and interdisciplinary analyses of the similar to 425-kilodalton inner ring complex (IRC), which forms the central transport channel and diffusion barrier of the NPC, revealing its interaction network and equimolar stoichiometry. The Nsp1.Nup49.Nup57 channel nucleoporin heterotrimer (CNT) attaches to the IRC solely through the adaptor nucleoporin Nic96. The CNT.Nic96 structure reveals that Nic96 functions as an assembly sensor that recognizes the three-dimensional architecture of the CNT, thereby mediating the incorporation of a defined CNT state into the NPC. We propose that the IRC adopts a relatively rigid scaffold that recruits the CNT to primarily form the diffusion barrier of the NPC, rather than enabling channel dilation.	[Stuwe, Tobias; Bley, Christopher J.; Thierbach, Karsten; Petrovic, Stefan; Schilbach, Sandra; Mayo, Daniel J.; Perriches, Thibaud; Rundlet, Emily J.; Jeon, Young E.; Collins, Leslie N.; Huber, Ferdinand M.; Lin, Daniel H.; Hoelz, Andre] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Paduch, Marcin; Koide, Akiko; Lu, Vincent; Koide, Shohei; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Fischer, Jessica; Hurt, Ed] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	California Institute of Technology; University of Chicago; Ruprecht Karls University Heidelberg	Hoelz, A (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	hoelz@caltech.edu	Ed Hurt, Dr./AAE-8874-2019; Hoelz, Andre/AAB-6978-2021	Ed Hurt, Dr./0000-0002-4535-8255; Bley, Christopher/0000-0003-2301-1290; Schilbach, Sandra/0000-0001-9071-8515; Koide, Shohei/0000-0001-5473-4358; Petrovic, Stefan/0000-0002-4979-8696	National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; Deutsche Forschungsgemeinschaft; Caltech-Amgen Research Collaboration; Boehringer Ingelheim Fonds; NIH [R01-GM090324, U54-GM087519, U01-GM094588, R01-GM111461]; University of Chicago Comprehensive Cancer Center [P30-CA014599]; Searle Funds at The Chicago Community Trust; Caltech; V Foundation for Cancer Research; Edward Mallinckrodt Jr. Foundation; Sidney Kimmel Foundation for Cancer Research; Camille and Henry Dreyfus Foundation; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, R01GM111461, R01GM090324, T32GM007616, U01GM094588] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Caltech-Amgen Research Collaboration; Boehringer Ingelheim Fonds(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center; Searle Funds at The Chicago Community Trust; Caltech; V Foundation for Cancer Research; Edward Mallinckrodt Jr. Foundation; Sidney Kimmel Foundation for Cancer Research; Camille and Henry Dreyfus Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. M. Clemons, A. Correia, G. Mobbs, A. Patke, D. C. Rees, S. O. Shan, and E. Stuwe for critical reading of the manuscript; M. Budd for help with yeast experiments; J. Herrmann, R. Kunze, and L. Zhang for technical support; and J. Kaiser and the scientific staff of the Stanford Synchrotron Radiation Lightsource (SSRL) Beamline 12-2, the National Institute of General Medical Sciences and National Cancer Institute Structural Biology Facility (GM/CA) at the Advanced Photon Source (APS), and the Advanced Light Source (ALS) beamline 8.2.1 for support with x-ray diffraction measurements. We acknowledge the Gordon and Betty Moore Foundation, the Beckman Institute, and the Sanofi-Aventis Bioengineering Research Program for support of the Molecular Observatory at the California Institute of Technology (Caltech). The operations at the SSRL, ALS, and APS are supported by the U.S. Department of Energy and the NIH. GM/CA has been funded in whole or in part with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). T.S. was supported by a Postdoctoral Fellowship of the Deutsche Forschungsgemeinschaft. S.P. and D.H.L are Amgen Graduate Fellows, supported through the Caltech-Amgen Research Collaboration. F.M.H. was supported by a Ph.D. student fellowship of the Boehringer Ingelheim Fonds. S.K. was supported by NIH Awards R01-GM090324 and U54-GM087519 and by the University of Chicago Comprehensive Cancer Center (P30-CA014599). A.A.K. was supported by NIH awards U01-GM094588 and U54-GM087519 and by Searle Funds at The Chicago Community Trust. A.H. was supported by Caltech startup funds, the Albert Wyrick V Scholar Award of the V Foundation for Cancer Research, the 54th Mallinckrodt Scholar Award of the Edward Mallinckrodt Jr. Foundation, a Kimmel Scholar Award of the Sidney Kimmel Foundation for Cancer Research, a Camille-Dreyfus Teacher Scholar Award of The Camille and Henry Dreyfus Foundation, and NIH grant R01-GM111461. The coordinates and structure factors have been deposited with the Protein Data Bank with accession codes 5CWV (Nup192<SUP>TAIL</SUP>), 5CWU (Nup188<SUP>TAIL</SUP>), 4JQ5 (hsNup49<SUP>CCS2+3</SUP>*), 4JNV and 4JNU (hsNup57<SUP>CCS3</SUP>*), 5CWT (Nup57<SUP>CCS3</SUP>*), 4JO7 (hsNup49<SUP>CCS2+3</SUP>*.hsNup57<SUP>CCS3</SUP>*, 2:2 stoichiometry), 4JO9 (hsNup49<SUP>CCS2+3</SUP>*.hsNup57<SUP>CCS3</SUP>*, 1:2 stoichiometry), 5CWW (Nup82<SUP>NTD</SUP>.Nup159<SUP>T</SUP>.Nup145<SUP>NAPD</SUP>), and 5CWS (CNT.Nic96<SUP>R1</SUP>.sAB-158). The authors declare no financial conflicts of interest. S.K. and A.K. are inventors on a patent application filed by the University of Chicago that covers a design of monobody libraries (US 13/813,409). Monobodies are available from S.K. under a material transfer agreement with the University of Chicago.	AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Andersen KR, 2013, ELIFE, V2, DOI 10.7554/eLife.00745; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Bradatsch B, 2012, NAT STRUCT MOL BIOL, V19, P1234, DOI 10.1038/nsmb.2438; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Eisenhardt N, 2014, J CELL SCI, V127, P908, DOI 10.1242/jcs.141739; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Koh J, 2015, CELL, V161, P1361, DOI 10.1016/j.cell.2015.05.013; Kosova B, 1999, J BIOL CHEM, V274, P22646, DOI 10.1074/jbc.274.32.22646; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; NEHRBASS U, 1990, CELL, V61, P979, DOI 10.1016/0092-8674(90)90063-K; Onischenko E, 2009, J CELL BIOL, V185, P475, DOI 10.1083/jcb.200810030; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sampathkumar P, 2013, STRUCTURE, V21, P560, DOI 10.1016/j.str.2013.02.005; Schlaich NL, 1997, MOL BIOL CELL, V8, P33, DOI 10.1091/mbc.8.1.33; Sharma A, 2015, J BIOL CHEM, V290, P18370, DOI 10.1074/jbc.M115.663500; Solmaz SR, 2013, P NATL ACAD SCI USA, V110, P5858, DOI 10.1073/pnas.1302655110; Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Stuwe T, 2015, SCIENCE, V347, P1148, DOI 10.1126/science.aaa4136; Stuwe T, 2014, P NATL ACAD SCI USA, V111, P2530, DOI 10.1073/pnas.1311081111; Stuwe T, 2012, J MOL BIOL, V419, P330, DOI 10.1016/j.jmb.2012.03.024; Ulrich A, 2014, MOL BIOL CELL, V25, P1484, DOI 10.1091/mbc.E13-12-0745; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yoshida K, 2011, P NATL ACAD SCI USA, V108, P16571, DOI 10.1073/pnas.1112846108	41	78	79	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2015	350	6256					56	64		10.1126/science.aac9176	http://dx.doi.org/10.1126/science.aac9176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS5EA	26316600	Green Accepted			2022-12-28	WOS:000362098300044
J	Brendish, NJ; Williams, S; Faust, SN; Tebruegge, M				Brendish, Nathan J.; Williams, Sarah; Faust, Saul N.; Tebruegge, Marc			CASE REVIEW Respiratory tract infection associated with seizures	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CENTRAL-NERVOUS-SYSTEM; MYCOPLASMA-PNEUMONIAE; ADENOVIRUS INFECTION; CHILDREN; MANIFESTATIONS; FEATURES; VIRUSES; DISEASE; ORIGIN		[Brendish, Nathan J.] Univ Hosp Southampton NHS Fdn Trust, Natl Inst Hlth Res NIHR Wellcome Trust Clin Res F, Southampton SO16 6YD, Hants, England; [Williams, Sarah] Univ Hosp Southampton NHS Fdn Trust, Dept Gen Paediat, Southampton SO16 6YD, Hants, England; [Faust, Saul N.; Tebruegge, Marc] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Faust, Saul N.; Tebruegge, Marc] Univ Hosp Southampton NHS Fdn Trust, Dept Paediat Immunol & Infect Dis, Southampton SO16 6YD, Hants, England; [Faust, Saul N.; Tebruegge, Marc] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Faust, Saul N.; Tebruegge, Marc] Univ Hosp Southampton NHS Fdn Trust, NIHR Resp Biomed Res Unit, Southampton SO16 6YD, Hants, England; [Tebruegge, Marc] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Melbourne	Tebruegge, M (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.	m.tebruegge@soton.ac.uk	Faust, Saul/J-9779-2014	Faust, Saul/0000-0003-3410-7642; Brendish, Nathan/0000-0002-9589-4937	National Institute for Health Research [CL-2011-26-004] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Atkinson TP, 2014, PEDIATR INFECT DIS J, V33, P92, DOI 10.1097/INF.0000000000000171; BERGMAN I, 1991, J PEDIATR-US, V119, P644, DOI 10.1016/S0022-3476(05)82420-5; Biondi E, 2014, PEDIATRICS, V133, P1081, DOI 10.1542/peds.2013-3729; Bryant PA, 2010, PEDIATR INFECT DIS J, V29, P694, DOI 10.1097/INF.0b013e3181de4b9c; Casaletto JJ, 2010, EMERG MED CLIN N AM, V28, P633, DOI 10.1016/j.emc.2010.03.013; Chevret L, 2014, PEDIATR CRIT CARE ME, V15, pE300, DOI 10.1097/PCC.0000000000000172; Clark Tristan W, 2011, J Med Case Rep, V5, P259, DOI 10.1186/1752-1947-5-259; Darville Toni, 2005, Semin Pediatr Infect Dis, V16, P235, DOI 10.1053/j.spid.2005.06.004; GARDNER PS, 1968, ARCH DIS CHILD, V43, P629, DOI 10.1136/adc.43.232.629; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Greenlee JE, 2000, SEMIN NEUROL, V20, P375, DOI 10.1055/s-2000-9429; Greenlee John E, 2012, Continuum (Minneap Minn), V18, P1271, DOI 10.1212/01.CON.0000423847.40147.06; Greig J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093716; Gupta RK, 2012, J MAGN RESON IMAGING, V35, P477, DOI 10.1002/jmri.22830; Hamano-Hasegawa Keiko, 2008, Journal of Infection and Chemotherapy, V14, P424, DOI 10.1007/s10156-008-0648-6; Hong JY, 2001, CLIN INFECT DIS, V32, P1423, DOI 10.1086/320146; Honkinen M, 2012, CLIN MICROBIOL INFEC, V18, P300, DOI 10.1111/j.1469-0691.2011.03603.x; Huang YC, 2013, J CLIN VIROL, V57, P300, DOI 10.1016/j.jcv.2013.03.017; KENNEDY CR, 1986, LANCET, V1, P989; Kim EA, 2002, RADIOGRAPHICS, V22, pS137, DOI 10.1148/radiographics.22.suppl_1.g02oc15s137; KING MD, 1981, BRIT MED J, V283, P663, DOI 10.1136/bmj.283.6292.663; Koskiniemi M, 2001, J NEUROVIROL, V7, P400, DOI 10.1080/135502801753170255; KRAJDEN S, 1983, CLIN PEDIATR, V22, P87, DOI 10.1177/000992288302200201; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; Nascimento-Carvalho CM, 2008, PEDIATR INFECT DIS J, V27, P939, DOI 10.1097/INF.0b013e3181723751; NUMAZAKI K, 1989, CAN MED ASSOC J, V140, P615; OSBORNE D, 1978, AM J ROENTGENOL, V130, P29, DOI 10.2214/ajr.130.1.29; Reyes-Andrade J, 2014, PEDIATR INFECT DIS J, V33, P416, DOI 10.1097/INF.0000000000000128; Sanchez-Vargas FM, 2008, CLIN MICROBIOL INFEC, V14, P105, DOI 10.1111/j.1469-0691.2007.01834.x; Tebruegge M, 2012, PEDIATR INFECT DIS J, V31, P626, DOI 10.1097/INF.0b013e318250b066; Tebruegge M, 2010, ADV EXP MED BIOL, V659, P153, DOI 10.1007/978-1-4419-0981-7_13; Tebruegge M, 2009, SEMIN FETAL NEONAT M, V14, P222, DOI 10.1016/j.siny.2009.02.002; Tsiodras S, 2005, J INFECTION, V51, P343, DOI 10.1016/j.jinf.2005.07.005; Wilking AN, 2014, PEDIATR NEUROL, V51, P370, DOI 10.1016/j.pediatrneurol.2014.04.026	34	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2015	351								h4659	10.1136/bmj.h4659	http://dx.doi.org/10.1136/bmj.h4659			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9KB	26341102				2022-12-28	WOS:000360932300001
J	Colglazier, W				Colglazier, William			Sustainable development agenda: 2030	SCIENCE			English	Editorial Material									Amer Assoc Advancement Sci, Ctr Sci Diplomacy, Washington, DC 20005 USA		Colglazier, W (corresponding author), Amer Assoc Advancement Sci, Ctr Sci Diplomacy, Washington, DC 20005 USA.	bcolglaz@aaas.org						Maskus K. E., 2014, WORKING PAPER; Mungiu-Pippidi A, 2015, NATURE, V518, P295, DOI 10.1038/518295a; UN, 2015, 2015 GLOB SUST DEV R; UN, 2015, 2030 AG SUST DEV; UN, 2012, CHIN 2012 NAT REP SU; United Nations, REP WORLD COMM ENV D; United Nations, 2015, ADDIS ABABA ACTION A	7	124	132	7	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1048	1050		10.1126/science.aad2333	http://dx.doi.org/10.1126/science.aad2333			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339011				2022-12-28	WOS:000360628900016
J	Goff, JA				Goff, John A.			Comment on "Glacial cycles drive variations in the production of oceanic crust"	SCIENCE			English	Editorial Material							SEA-FLOOR MORPHOLOGY; RIDGE; DEPENDENCE; MODELS	Crowley et al. (Reports, 13 March 2015, p. 1237) propose that abyssal hill topography can be generated by variations in volcanism at mid-ocean ridges modulated by Milankovitch cycle-driven changes in sea level. Published values for abyssal hill characteristic widths versus spreading rate do not generally support this hypothesis. I argue that abyssal hills are primarily fault-generated rather than volcanically generated features.	Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Goff, JA (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78712 USA.	goff@ig.utexas.edu			Div Atmospheric & Geospace Sciences [1338832] Funding Source: National Science Foundation	Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Buck WR, 2005, NATURE, V434, P719, DOI 10.1038/nature03358; Crowley JW, 2015, SCIENCE, V347, P1237, DOI 10.1126/science.1261508; Durand C, 1996, TECTONOPHYSICS, V265, P275, DOI 10.1016/S0040-1951(96)00049-2; GOFF JA, 1988, J GEOPHYS RES-SOLID, V93, P13589, DOI 10.1029/JB093iB11p13589; Goff JA, 1996, J GEOPHYS RES-SOL EA, V101, P8489, DOI 10.1029/96JB00110; Goff JA, 1997, J GEOPHYS RES-SOL EA, V102, P15521, DOI 10.1029/97JB00781; Macdonald KC, 1996, NATURE, V380, P125, DOI 10.1038/380125a0; MALINVERNO A, 1993, J GEOPHYS RES-SOL EA, V98, P17921, DOI 10.1029/93JB01571; MCNUTT MK, 1984, J GEOPHYS RES, V89, P1180, DOI 10.1029/JB089iB13p11180; MORGAN JP, 1993, NATURE, V364, P706, DOI 10.1038/364706a0; SHAW PR, 1993, J GEOPHYS RES-SOL EA, V98, P21839, DOI 10.1029/93JB01565; Shaw WJ, 1996, J GEOPHYS RES-SOL EA, V101, P17977, DOI 10.1029/96JB00949; Sloan H, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003850; Tolstoy M, 2015, GEOPHYS RES LETT, V42, P1346, DOI 10.1002/2014GL063015	14	16	17	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252								10.1126/science.aab2350	http://dx.doi.org/10.1126/science.aab2350			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339022				2022-12-28	WOS:000360628900030
J	Bedford, J; Dassan, P; Harvie, M; Mehta, S				Bedford, Jonathan; Dassan, Pooja; Harvie, Miranda; Mehta, Sanjeev			CASE SCENARIO An unusual cause of headache in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bedford, Jonathan; Mehta, Sanjeev] Ealing Gen Hosp, Dept Med, Middlesex UB1 3HW, England; [Dassan, Pooja] Ealing Gen Hosp, Dept Neurol, Middlesex UB1 3HW, England; [Harvie, Miranda] Ealing Gen Hosp, Dept Radiol, Middlesex UB1 3HW, England		Bedford, J (corresponding author), Ealing Gen Hosp, Dept Med, Middlesex UB1 3HW, England.		Bedford, Jonathan/AAP-1163-2021	Bedford, Jonathan/0000-0001-9455-022X					0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2015	351								h4681	10.1136/bmj.h4681	http://dx.doi.org/10.1136/bmj.h4681			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9JX	26338437				2022-12-28	WOS:000360931900012
J	Jin, J; MacMillan, DWC				Jin, Jian; MacMillan, David W. C.			Alcohols as alkylating agents in heteroarene C-H functionalization	NATURE			English	Article							POLARITY-REVERSAL CATALYSIS; PHOTOREDOX CATALYSIS; DIRECT ARYLATION; BONDS; RACEMIZATION; ACTIVATION; DISCOVERY; STRATEGY; ETHERS	Redox processes and radical intermediates are found in many biochemical processes, including deoxyribonucleotide synthesis and oxidative DNA damage(1). One of the core principles underlying DNA biosynthesis is the radical-mediated elimination of H2O to deoxygenate ribonucleotides, an example of 'spin-centre shift'(2), during which an alcohol C-O bond is cleaved, resulting in a carbon-centred radical intermediate. Although spin-centre shift is a well-understood biochemical process, it is underused by the synthetic organic chemistry community. We wondered whether it would be possible to take advantage of this naturally occurring process to accomplish mild, non-traditional alkylation reactions using alcohols as radical precursors. Because conventional radical-based alkylation methods require the use of stoichiometric oxidants, increased temperatures or peroxides(3-7), a mild protocol using simple and abundant alkylating agents would have considerable use in the synthesis of diversely functionalized pharmacophores. Here we describe the development of a dual catalytic alkylation of heteroarenes, using alcohols as mild alkylating reagents. This method represents the first, to our knowledge, broadly applicable use of unactivated alcohols as latent alkylating reagents, achieved via the successful merger of photoredox and hydrogen atom transfer catalysis. The value of this multi-catalytic protocol has been demonstrated through the late-stage functionalization of the medicinal agents, fasudil and milrinone.	[Jin, Jian; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu	Jin, Jian/J-6907-2016	Jin, Jian/0000-0003-3054-5215; JIN, JIAN/0000-0001-9685-3355	NIHGMS [R01 GM103558-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103558] Funding Source: NIH RePORTER	NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by NIHGMS (R01 GM103558-03), and gifts from Merck and Amgen. J.J. thanks J.A. Terrett for assistance in preparing this manuscript.	Antonchick AP, 2013, ANGEW CHEM INT EDIT, V52, P3267, DOI 10.1002/anie.201209584; BERKOWITZ J, 1994, J PHYS CHEM-US, V98, P2744, DOI 10.1021/j100062a009; Cai YD, 1998, CHEM COMMUN, P1145, DOI 10.1039/a801381k; Cuthbertson JD, 2015, NATURE, V519, P74, DOI 10.1038/nature14255; DiRocco DA, 2014, ANGEW CHEM INT EDIT, V53, P4802, DOI 10.1002/anie.201402023; Duncton MAJ, 2011, MEDCHEMCOMM, V2, P1135, DOI 10.1039/c1md00134e; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Escoubet S, 2006, J ORG CHEM, V71, P7288, DOI 10.1021/jo061033l; Hager D, 2014, J AM CHEM SOC, V136, P16986, DOI 10.1021/ja5102695; Halliwell B., 2007, FREE RADICALS BIOL M; Ji YN, 2011, P NATL ACAD SCI USA, V108, P14411, DOI 10.1073/pnas.1109059108; Jin J, 2015, ANGEW CHEM INT EDIT, V54, P1565, DOI 10.1002/anie.201410432; McNally A, 2011, SCIENCE, V334, P1114, DOI 10.1126/science.1213920; MINISCI F, 1989, J ORG CHEM, V54, P5224, DOI 10.1021/jo00283a011; MINISCI F, 1971, TETRAHEDRON, V27, P3575, DOI 10.1016/S0040-4020(01)97768-3; Molander GA, 2011, ORG LETT, V13, P1852, DOI 10.1021/ol2003572; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; OCHIAI M, 1967, TETRAHEDRON LETT, P2349; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qvortrup K, 2014, J AM CHEM SOC, V136, P626, DOI 10.1021/ja411596q; Roberts BP, 1999, CHEM SOC REV, V28, P25, DOI 10.1039/a804291h; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Shaidarova LG, 2003, J ANAL CHEM+, V58, P577, DOI 10.1023/A:1024124421268; Slinker JD, 2004, J AM CHEM SOC, V126, P2763, DOI 10.1021/ja0345221; STERMITZ FR, 1968, CHEM COMMUN, P482, DOI 10.1039/c19680000482; SUGIMORI A, 1986, B CHEM SOC JPN, V59, P3905, DOI 10.1246/bcsj.59.3905; Wessig P, 2007, EUR J ORG CHEM, V2007, P2219, DOI 10.1002/ejoc.200600915	28	463	464	6	389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					87	90		10.1038/nature14885	http://dx.doi.org/10.1038/nature14885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26308895	Green Accepted			2022-12-28	WOS:000360594100030
J	Nable, JV; Tupe, CL; Gehle, BD; Brady, WJ				Nable, Jose V.; Tupe, Christina L.; Gehle, Bruce D.; Brady, William J.			In-Flight Medical Emergencies during Commercial Travel	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PUBLIC-ACCESS DEFIBRILLATION; HEART-ASSOCIATION GUIDELINES; AIR-TRAVEL; CARDIOPULMONARY-RESUSCITATION; ISSUES; COMPRESSION; MANAGEMENT; MORTALITY; SURVIVAL; CPR		[Nable, Jose V.] Georgetown Univ, Sch Med, MedStar Georgetown Univ Hosp, Dept Emergency Med, Washington, DC USA; [Tupe, Christina L.] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA; [Gehle, Bruce D.] Piedmont Liabil Trust, Charlottesville, VA USA; [Brady, William J.] Univ Virginia, Sch Med, Dept Emergency Med, Charlottesville, VA 22908 USA	Georgetown University; University System of Maryland; University of Maryland Baltimore; University of Virginia	Brady, WJ (corresponding author), POB 800699, Charlottesville, VA 22908 USA.	wb4z@virginia.edu		Nable, Jose/0000-0002-8727-2740	Allianz Global Assistance	Allianz Global Assistance	Dr. Brady reports receiving salary support for serving as medical director for Allianz Global Assistance. No other potential conflict of interest relevant to this article was reported.	Aerosp Med Assoc, 2008, AVIAT SPACE ENVIR MD, V79, P433, DOI 10.3357/ASEM.2272.2008; Aerospace Med Assoc, 2003, AVIAT SPACE ENVIR MD, V74, pA1; Aerospace Medical Association Air Transport Medicine Committee, 2013, MED EM MAN IN FLIGHT; [Anonymous], 2006, 1234B AC FED AV ADM; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Baker SP, 2009, AVIAT SPACE ENVIR MD, V80, P1001, DOI 10.3357/ASEM.2575.2009; Baltsezak S, 2008, J TRAVEL MED, V15, P391, DOI 10.1111/j.1708-8305.2008.00233.x; Bunch Andy, 2013, Air Med J, V32, P268, DOI 10.1016/j.amj.2013.01.003; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Coker RK, 2007, EUR RESPIR J, V30, P1057, DOI 10.1183/09031936.00024707; Coker RK, 2002, THORAX, V57, P289; COTTRELL JJ, 1988, CHEST, V93, P81, DOI 10.1378/chest.93.1.81; CUMMINS RO, 1989, JAMA-J AM MED ASSOC, V261, P1295, DOI 10.1001/jama.261.9.1295; DeHart RL, 2003, ANNU REV PUBL HEALTH, V24, P133, DOI 10.1146/annurev.publhealth.24.100901.140853; Federal Aviation Administration (FAA) DOT, 2001, Fed Regist, V66, P19028; Gendreau MA, 2002, NEW ENGL J MED, V346, P1067, DOI 10.1056/NEJMra012774; Goodwin T, 2000, BRIT MED J, V321, P1338, DOI 10.1136/bmj.321.7272.1338; Gupta JK, 2012, INDOOR AIR, V22, P388, DOI 10.1111/j.1600-0668.2012.00773.x; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Han ZY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-434; Hu XW, 2014, CHEST, V145, P688, DOI 10.1378/chest.13-2363; Huff JS, 2007, ANN EMERG MED, V49, P431, DOI 10.1016/j.annemergmed.2007.02.001; Humphreys S, 2005, ANAESTHESIA, V60, P458, DOI 10.1111/j.1365-2044.2005.04124.x; International Air Transport Association, 2006, MED MAN; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Kurz MC, 2013, ROSENS EMERGENCY MED; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Madan K, 2012, RESPIRATION, V83, P554, DOI 10.1159/000334698; Matsumoto K, 2001, AVIAT SPACE ENVIR MD, V72, P919; Morrison LJ, 2010, CIRCULATION, V122, pS665, DOI 10.1161/CIRCULATIONAHA.110.970905; Mosesso VN, 1998, ANN EMERG MED, V32, P200, DOI 10.1016/S0196-0644(98)70137-4; Newman DG, 2006, B20060171 AUSTR TRAN; O'Connor RE, 2010, CIRCULATION, V122, pS787, DOI 10.1161/CIRCULATIONAHA.110.971028; Oh JH, 1999, ARCH INTERN MED, V159, P375, DOI 10.1001/archinte.159.4.375; Peterson DC, 2013, NEW ENGL J MED, V368, P2075, DOI 10.1056/NEJMoa1212052; Rea TD, 2010, NEW ENGL J MED, V363, P423, DOI 10.1056/NEJMoa0908993; Roubinian N, 2012, CHEST, V142, P885, DOI 10.1378/chest.11-2016; Silverman D, 2009, LANCET, V373, P2067, DOI 10.1016/S0140-6736(09)60209-9; Svensson L, 2010, NEW ENGL J MED, V363, P434, DOI 10.1056/NEJMoa0908991	40	54	55	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					939	945		10.1056/NEJMra1409213	http://dx.doi.org/10.1056/NEJMra1409213			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2OB	26332548				2022-12-28	WOS:000360439500009
J	Martin, TE				Martin, Thomas E.			Age-related mortality explains life history strategies of tropical and temperate songbirds	SCIENCE			English	Article							SURVIVAL RATES; PARENTAL CARE; EVOLUTION; GROWTH; BIRDS; SIZE; PERFORMANCE; PREDATION; FRAMEWORK; SELECTION	Life history theory attempts to explain why species differ in offspring number and quality, growth rate, and parental effort. I show that unappreciated interactions of these traits in response to age-related mortality risk challenge traditional perspectives and explain life history evolution in songbirds. Counter to a long-standing paradigm, tropical songbirds grow at similar overall rates to temperate species but grow wings relatively faster. These growth tactics are favored by predation risk, both in and after leaving the nest, and are facilitated by greater provisioning of individual offspring by parents. Increased provisioning of individual offspring depends on partitioning effort among fewer young because of constraints on effort from adult and nest mortality. These growth and provisioning responses to mortality risk finally explain the conundrum of small clutch sizes of tropical birds.	Univ Montana, Montana Cooperat Wildlife Res Unit, US Geol Survey, Missoula, MT 59812 USA	United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana	Martin, TE (corresponding author), Univ Montana, Montana Cooperat Wildlife Res Unit, US Geol Survey, Missoula, MT 59812 USA.	tom.martin@umontana.edu	Martin, Thomas E/F-6016-2011	Martin, Thomas E/0000-0002-4028-4867	NSF [DEB-1241041, IOS-1349178]; U.S. Geological Survey Climate Change Research Program; University of Montana IACUC [059-10TMMCWRU]	NSF(National Science Foundation (NSF)); U.S. Geological Survey Climate Change Research Program; University of Montana IACUC	I thank J. Maron, F. S. Dobson, two anonymous reviewers, and my graduate students for helpful comments; Z. Wang for providing initial R-code for growth analyses; Sabah Parks and the Sabah Biodiversity Centre in Malaysia; and C. Bosque, INPARQUES, and Fonacit in Venezuela. This work was supported by NSF grants DEB-1241041 and IOS-1349178 and by the U.S. Geological Survey Climate Change Research Program, and was conducted under auspices of University of Montana IACUC no. 059-10TMMCWRU. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. Data are available in Dryad: DOI 10.5061/dryad.2m15n; data files: Life_history_data.	ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Dawson RD, 2005, OECOLOGIA, V144, P499, DOI 10.1007/s00442-005-0075-7; Dial KP, 2006, BIOSCIENCE, V56, P437, DOI 10.1641/0006-3568(2006)056[0437:WUIHAW]2.0.CO;2; Dobzhansky T., 1950, American Scientist, V38, P209; Gill SA, 2012, J AVIAN BIOL, V43, P461, DOI 10.1111/j.1600-048X.2012.05637.x; LAW R, 1979, AM NAT, V114, P399, DOI 10.1086/283488; MAC ARTHUR ROBERT H., 1967; Martin TE, 1996, J AVIAN BIOL, V27, P263, DOI 10.2307/3677257; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; Martin TE, 2008, P NATL ACAD SCI USA, V105, P9268, DOI 10.1073/pnas.0709366105; Martin TE, 2015, AM NAT, V185, P380, DOI 10.1086/679612; Martin TE, 2014, AM NAT, V183, P313, DOI 10.1086/674966; Martin TE, 2011, EVOLUTION, V65, P1607, DOI 10.1111/j.1558-5646.2011.01227.x; Miles DB, 2004, EVOL ECOL RES, V6, P63; Morrison KW, 2009, CONDOR, V111, P433, DOI 10.1525/cond.2009.080099; Perez KO, 2015, FUNCT ECOL, V29, P393, DOI 10.1111/1365-2435.12343; Remes V, 2002, EVOLUTION, V56, P2505; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; SAETHER BE, 1989, ORNIS SCAND, V20, P13, DOI 10.2307/3676702; Sandercock BK, 2000, ECOLOGY, V81, P1351, DOI 10.2307/177213; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Tarwater CE, 2011, ECOLOGY, V92, P1271, DOI 10.1890/10-1386.1; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wang Z, 2014, EVOLUTION, V68, P81, DOI 10.1111/evo.12263; Watkins TB, 1996, PHYSIOL ZOOL, V69, P154, DOI 10.1086/physzool.69.1.30164205; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461	27	123	128	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					966	970		10.1126/science.aad1173	http://dx.doi.org/10.1126/science.aad1173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315435				2022-12-28	WOS:000360646800051
J	Nishimasu, H; Cong, L; Yan, WX; Ran, FA; Zetsche, B; Li, YQ; Kurabayashi, A; Ishitani, R; Zhang, F; Nureki, O				Nishimasu, Hiroshi; Cong, Le; Yan, Winston X.; Ran, F. Ann; Zetsche, Bernd; Li, Yinqing; Kurabayashi, Arisa; Ishitani, Ryuichiro; Zhang, Feng; Nureki, Osamu			Crystal Structure of Staphylococcus aureus Cas9	CELL			English	Article							RNA-GUIDED ENDONUCLEASE; TARGET DNA RECOGNITION; STREPTOCOCCUS-THERMOPHILUS; HOLLIDAY JUNCTION; IMMUNE-SYSTEM; DUAL-RNA; CRISPR; COMPLEX; TRANSCRIPTION; PROKARYOTES	The RNA-guided DNA endonuclease Cas9 cleaves double-stranded DNA targets with a protospacer adjacent motif (PAM) and complementarity to the guide RNA. Recently, we harnessed Staphylococcus aureus Cas9 (SaCas9), which is significantly smaller than Streptococcus pyogenes Cas9 (SpCas9), to facilitate efficient in vivo genome editing. Here, we report the crystal structures of SaCas9 in complex with a single guide RNA (sgRNA) and its double-stranded DNA targets, containing the 5'-TTGAAT-3' PAM and the 5'-TTGGGT-3' PAM, at 2.6 and 2.7 angstrom resolutions, respectively. The structures revealed the mechanism of the relaxed recognition of the 5'-NNGRRT-3' PAM by SaCas9. A structural comparison of SaCas9 with SpCas9 highlighted both structural conservation and divergence, explaining their distinct PAM specificities and orthologous sgRNA recognition. Finally, we applied the structural information about this minimal Cas9 to rationally design compact transcriptional activators and inducible nucleases, to further expand the CRISPR-Cas9 genome editing toolbox.	[Nishimasu, Hiroshi; Kurabayashi, Arisa; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Nishimasu, Hiroshi] JST, PRESTO, Bunkyo Ku, Tokyo 1130032, Japan; [Cong, Le; Yan, Winston X.; Ran, F. Ann; Zetsche, Bernd; Li, Yinqing; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Cong, Le; Yan, Winston X.; Zetsche, Bernd; Li, Yinqing; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Cong, Le; Yan, Winston X.; Zetsche, Bernd; Li, Yinqing; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Cong, Le; Yan, Winston X.; Zetsche, Bernd; Li, Yinqing; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Yan, Winston X.] Harvard Univ, Harvard Mit Div Hlth Sci & Technol, Grad Program Biophys, Sch Med, Boston, MA 02115 USA; [Ran, F. Ann] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA	University of Tokyo; Japan Science & Technology Agency (JST); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org; nureki@bs.s.u-tokyo.ac.jp	Macrae, Rhiannon/AAX-1536-2020; Cong, Le/M-9981-2013; NUREKI, OSAMU/G-4960-2014	Cong, Le/0000-0003-4725-8714; Li, Yinqing/0000-0002-9096-8482	JST; JSPS KAKENHI [26291010, 15H01463]; Ministry of Education, Culture, Sports, Science and Technology; National Institute of General Medical Sciences [T32GM007753]; Paul and Daisy Soros Fellowship; NIH [1DP1-MH100706]; Keck Foundation; McKnight Foundation; Poitras Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Simons Foundation; Japan Agency for Medical Research and Development, AMED; Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next-generation agriculture, forestry and fisheries'' (Bio-oriented Technology Research Advancement Institution, NARO); PRESTO; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706] Funding Source: NIH RePORTER	JST(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Paul and Daisy Soros Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Poitras Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next-generation agriculture, forestry and fisheries'' (Bio-oriented Technology Research Advancement Institution, NARO); PRESTO; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Tomohiro Nishizawa, Takanori Nakane, Kazuki Kato, Naoki Matsumoto, and Rhiannon Macrae for helpful comments on the manuscript. We thank the beam-line staffs at BL32XU and BL41XU of SPring-8, Japan, for assistance with data collection. H.N. is supported by JST, PRESTO, JSPS KAKENHI Grant Numbers 26291010 and 15H01463 and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology. W.X.Y. is supported by T32GM007753 from the National Institute of General Medical Sciences and a Paul and Daisy Soros Fellowship. F.A.R. is a Junior Fellow at the Harvard Society of Fellows. F.Z. is supported by an NIH Director's Pioneer Award (1DP1-MH100706), the Keck, McKnight, Poitras, Merkin, Vallee, Damon Runyon, Searle Scholars, Klingenstein, and Simons Foundations, Bob Metcalfe, and Jane Pauley. O.N. is supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development, AMED, and the Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries'' (funding agency: Bio-oriented Technology Research Advancement Institution, NARO), and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology. A patent application has been filed related to this work, and the authors plan to make the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang lab web site (www.genome-engineering.org).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gorecka KM, 2013, NUCLEIC ACIDS RES, V41, P9945, DOI 10.1093/nar/gkt769; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Liang FS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001449; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	41	254	339	4	120	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1113	1126		10.1016/j.cell.2015.08.007	http://dx.doi.org/10.1016/j.cell.2015.08.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317473	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000360589900020
J	Chew, EY; Clemons, TE; Agron, E; Launer, LJ; Grodstein, F; Bernstein, PS				Chew, Emily Y.; Clemons, Traci E.; Agron, Elvira; Launer, Lenore J.; Grodstein, Francine; Bernstein, Paul S.		Age-Related Eye Disease Study 2	Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function The AREDS2 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOCOSAHEXAENOIC ACID; BETA-CAROTENE; ALZHEIMERS-DISEASE; EYE DISEASE; ANTIOXIDANTS; CANCER	IMPORTANCE Observational data have suggested that high dietary intake of saturated fat and low intake of vegetables may be associated with increased risk of Alzheimer disease. OBJECTIVE To test the effects of oral supplementation with nutrients on cognitive function. DESIGN, SETTING, AND PARTICIPANTS In a double-masked randomized clinical trial (the Age-Related Eye Disease Study 2 [AREDS2]), retinal specialists in 82 US academic and community medical centers enrolled and observed participants who were at risk for developing late age-related macular degeneration (AMD) from October 2006 to December 2012. In addition to annual eye examinations, several validated cognitive function tests were administered via telephone by trained personnel at baseline and every 2 years during the 5-year study. INTERVENTIONS Long-chain polyunsaturated fatty acids (LCPUFAs) (1 g) and/or lutein (10mg)/zeaxanthin (2mg) vs placebo were tested in a factorial design. All participants were also given varying combinations of vitamins C, E, beta carotene, and zinc. MAIN OUTCOMES AND MEASURES The main outcome was the yearly change in composite scores determined from a battery of cognitive function tests from baseline. The analyses, which were adjusted for baseline age, sex, race, history of hypertension, education, cognitive score, and depression score, evaluated the differences in the composite score between the treated vs untreated groups. The composite score provided an overall score for the battery, ranging from -22 to 17, with higher scores representing better function. RESULTS A total of 89%(3741/4203) of AREDS2 participants consented to the ancillary cognitive function study and 93.6%(3501/3741) underwent cognitive function testing. The mean (SD) age of the participants was 72.7 (7.7) years and 57.5% were women. There were no statistically significant differences in change of scores for participants randomized to receive supplements vs those who were not. The yearly change in the composite cognitive function score was -0.19 (99% CI, -0.25 to -0.13) for participants randomized to receive LCPUFAs vs -0.18 (99% CI, -0.24 to -0.12) for those randomized to no LCPUFAs (difference in yearly change, -0.03 [99% CI, -0.20 to 0.13]; P = .63). Similarly, the yearly change in the composite cognitive function score was -0.18 (99% CI, -0.24 to -0.11) for participants randomized to receive lutein/zeaxanthin vs -0.19 (99% CI, -0.25 to -0.13) for those randomized to not receive lutein/zeaxanthin (difference in yearly change, 0.03 [99% CI, -0.14 to 0.19]; P = .66). Analyses were also conducted to assess for potential interactions between LCPUFAs and lutein/zeaxanthin and none were found to be significant. CONCLUSIONS AND RELEVANCE Among older persons with AMD, oral supplementation with LCPUFAs or lutein/zeaxanthin had no statistically significant effect on cognitive function.	[Chew, Emily Y.; Agron, Elvira] NEI, Div Epidemiol & Clin Applicat, Clin Trials Branch, NIH, Bethesda, MD 20892 USA; [Clemons, Traci E.] EMMES Corp, Rockville, MD USA; [Launer, Lenore J.] NIA, Neuroepidemiol Sect, NIH, Bethesda, MD 20892 USA; [Grodstein, Francine] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Grodstein, Francine] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Bernstein, Paul S.] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Emmes Corporation; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Utah System of Higher Education; University of Utah	Chew, EY (corresponding author), BG 10-CRC Room 3-2531,10 Ctr Dr MSC1204, Bethesda, MD 20892 USA.	echew@nei.nih.gov			NIH; National Eye Institute (NEI)/NIH, Department of Health and Human Services [HHS-N-260-2005-00007-C]; NIH, Office of Dietary Supplements (ODS); NIH, National Center for Complementary and Alternative Medicine (NCCAM); NIH, National Institute on Aging (NIA); NIH, National Heart, Lung, and Blood Institute (NHLBI); NIH, National Institute of Neurological Disorders and Stroke (NINDS);  [N01-EY-5-0007]; NATIONAL EYE INSTITUTE [ZIAEY000489, N01EY002127, ZIAEY000485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute (NEI)/NIH, Department of Health and Human Services; NIH, Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIH, National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH, National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH, National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was sponsored by the NIH; by the intramural program funds and contracts from the National Eye Institute (NEI)/NIH, Department of Health and Human Services, contract HHS-N-260-2005-00007-C. ADB and contract N01-EY-5-0007. Funds were generously contributed to these contracts by the following NIH institutes: Office of Dietary Supplements (ODS), National Center for Complementary and Alternative Medicine (NCCAM), National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), and National Institute of Neurological Disorders and Stroke (NINDS).	ALBANES D, 1995, AM J CLIN NUTR, V62, P1427, DOI 10.1093/ajcn/62.6.1427S; Bonds DE, 2014, JAMA INTERN MED, V174, P763, DOI 10.1001/jamainternmed.2014.328; Chew EY, 2014, JAMA OPHTHALMOL, V132, P142, DOI 10.1001/jamaophthalmol.2013.7376; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Chew EY, 2012, OPHTHALMOLOGY, V119, P2282, DOI 10.1016/j.ophtha.2012.05.027; Dangour AD, 2009, J NUTR HEALTH AGING, V13, P198, DOI 10.1007/s12603-009-0057-2; Dangour AD, 2010, AM J CLIN NUTR, V91, P1725, DOI 10.3945/ajcn.2009.29121; Evans DA, 2011, ALZHEIMERS DEMENT, V7, P110, DOI 10.1016/j.jalz.2010.11.008; Grodstein F, 2003, AM J CLIN NUTR, V77, P975, DOI 10.1093/ajcn/77.4.975; Grodstein F, 2007, ARCH INTERN MED, V167, P2184, DOI 10.1001/archinte.167.20.2184; Jama JW, 1996, AM J EPIDEMIOL, V144, P275, DOI 10.1093/oxfordjournals.aje.a008922; Johnson EJ, 2008, NUTR NEUROSCI, V11, P75, DOI 10.1179/147683008X301450; Kalmijn S, 1997, AM J EPIDEMIOL, V145, P33, DOI 10.1093/oxfordjournals.aje.a009029; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Kang JH, 2003, NEUROLOGY, V60, P1591; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; MYERSON J, 1990, PSYCHOL REV, V97, P475, DOI 10.1037/0033-295X.97.4.475; NEWMAN CW, 1991, EAR HEARING, V12, P355, DOI 10.1097/00003446-199110000-00009; Omenn GS, 1996, J NATL CANCER I, V88, P1550, DOI 10.1093/jnci/88.21.1550; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rankin MW, 2005, OPHTHAL EPIDEMIOL, V12, P271, DOI 10.1080/09286580591003815; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; Samieri C, 2013, EPIDEMIOLOGY, V24, P490, DOI 10.1097/EDE.0b013e318294a065; Samra SK, 2007, STROKE, V38, P1864, DOI 10.1161/STROKEAHA.106.477448; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tully AM, 2003, BRIT J NUTR, V89, P483, DOI 10.1079/BJN2002804; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Yaffe K, 2004, NEUROLOGY, V63, P1705, DOI 10.1212/01.WNL.0000142969.19465.8F	29	117	119	2	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					791	801		10.1001/jama.2015.9677	http://dx.doi.org/10.1001/jama.2015.9677			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305649	Green Accepted			2022-12-28	WOS:000360017200019
J	Morgan, DJ; Brownlee, S; Leppin, AL; Kressin, N; Dhruva, SS; Levin, L; Landon, BE; Zezza, MA; Schmidt, H; Saini, V; Elshaug, AG				Morgan, Daniel J.; Brownlee, Shannon; Leppin, Aaron L.; Kressin, Nancy; Dhruva, Sanket S.; Levin, Les; Landon, Bruce E.; Zezza, Mark A.; Schmidt, Harald; Saini, Vikas; Elshaug, Adam G.			Setting a research agenda for medical overuse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-PRACTICE GUIDELINES; SHARED DECISION-MAKING; HEALTH-CARE PRACTICES; REGIONAL-VARIATIONS; GEOGRAPHIC-VARIATION; OVERDIAGNOSIS; CANCER; RISK; PREVENTION; DIAGNOSIS		[Morgan, Daniel J.] Univ Maryland, Sch Med, Vet Affairs Maryland Healthcare Syst, Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Brownlee, Shannon] Dartmouth Med Sch, Lown Inst, Boston, MA USA; [Leppin, Aaron L.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Kressin, Nancy] Boston VA & Boston Univ, Boston, MA USA; [Dhruva, Sanket S.] Yale Univ & New Haven VA, New Haven, CT USA; [Levin, Les] Univ Toronto, Toronto, ON, Canada; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Dept Hlth Care Policy, Boston, MA 02215 USA; [Zezza, Mark A.] Lewin Grp Fed Hlth & Human Serv Practice, Washington, DC USA; [Schmidt, Harald] Univ Penn, Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Saini, Vikas] Harvard Univ, Sch Med, Lown Inst, Brookline, MA USA; [Elshaug, Adam G.] Univ Sydney, Menzies Ctr Hlth Policy, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Elshaug, Adam G.] Lown Inst, Sydney, NSW, Australia	University System of Maryland; University of Maryland Baltimore; Dartmouth College; Mayo Clinic; Yale University; University of Toronto; Harvard University; Beth Israel Deaconess Medical Center; University of Pennsylvania; Harvard University; University of Sydney	Morgan, DJ (corresponding author), Univ Maryland, Sch Med, Vet Affairs Maryland Healthcare Syst, Epidemiol & Publ Hlth, 685 W Baltimore St, Baltimore, MD 21201 USA.	dmorgan@epi.umaryland.edu		Elshaug, Adam/0000-0002-4939-5379; Kressin, Nancy/0000-0003-2767-4286	US National Institutes of Health; Agency for Healthcare Research and Quality; Patient Centered Outcomes Research Institute; Department of Veterans Affairs; CDC; United Kingdom research councils; European Commission; Australia's National Health and Medical Research Council	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Patient Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Department of Veterans Affairs(US Department of Veterans Affairs); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United Kingdom research councils; European Commission(European CommissionEuropean Commission Joint Research Centre); Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	These research agenda items will require creative approaches and determined individuals to better understand, describe, and ultimately improve medical care. Such work will require support. Public agencies such as the US National Institutes of Health, Agency for Healthcare Research and Quality, Patient Centered Outcomes Research Institute, Department of Veterans Affairs, CDC, United Kingdom research councils, European Commission, and Australia's National Health and Medical Research Council should devote a portion of funding towards the study of overuse. Foundations such as Robert Wood Johnson Foundation, ABIM Foundation, and the Commonwealth Fund also have an important role supporting novel ideas and initiatives.	Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; [Anonymous], 2013, Jt Comm Perspect, V33, P9; [Anonymous], 2009, AG HEALTHC RES QUAL; [Anonymous], 2014, NY TIMES; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; Blendon RJ, 2013, NEW ENGL J MED, V369, P1066, DOI 10.1056/NEJMsr1307622; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Bragg F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5065; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Brownlee S, 2008, OVERTREATED WHY TOO; Buist D, 2014, PROMOTING APPROPRIAT; Burns M, 2014, REDUCING OVERUSE MIS; Carter JL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7773; Carter SM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h869; Chassin MR, 1998, MILBANK Q, V76, P565, DOI 10.1111/1468-0009.00106; Coon ER, 2014, PEDIATRICS, V134, P1013, DOI 10.1542/peds.2014-1778; Cornell J, 2008, ANN INTERN MED, V149, P904, DOI 10.7326/0003-4819-149-12-200812160-00011; Deyo RA, 2005, HOPE HYPE OBSESSION; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Djulbegovic B, 2011, JAMA-J AM MED ASSOC, V305, P2005, DOI 10.1001/jama.2011.650; Elshaug A, 2013, MED J AUSTRALIA, V198, P85, DOI 10.5694/mja12.11770; Elshaug AG, 2013, MED J AUSTRALIA, V198, P598, DOI 10.5694/mja13.10473; Elshaug AG, 2013, JAMA-J AM MED ASSOC, V309, P775, DOI 10.1001/jama.2013.828; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Evans WK, 2009, J CLIN ONCOL, V27, P5607, DOI 10.1200/JCO.2009.22.1614; Fiks AG, 2012, PEDIATRICS, V129, P99, DOI 10.1542/peds.2011-1352; Fisher E, 2009, HEALTHCARE SPENDING; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Foy Andrew J., 2013, Yale Journal of Biology and Medicine, V86, P271; GARVIN J S, 1955, Ill Med J, V107, P171; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haines T, 2014, J CLIN EPIDEMIOL, V67, P144, DOI 10.1016/j.jclinepi.2013.08.014; Hannan EL, 2014, CIRC-CARDIOVASC INTE, V7, P19, DOI 10.1161/CIRCINTERVENTIONS.113.000741; Health Quality Ontario, VIT D TEST; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Institute of Medicine, 2001, CROSSING QUALITY CHA; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kachalia A, 2015, ANN INTERN MED, V162, P100, DOI 10.7326/M14-0694; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kale MS, 2013, JAMA INTERN MED, V173, P142, DOI 10.1001/2013.jamainternmed.1022; Keyhani S, 2008, HEALTH SERV RES, V43, P1923, DOI 10.1111/j.1475-6773.2008.00920.x; Keyhani S, 2013, MED CARE, V51, P503, DOI 10.1097/MLR.0b013e31828dbafe; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Kroenke K, 2014, ANN INTERN MED, V161, P579, DOI 10.7326/M14-0461; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6989; Levinson W, 2015, BMJ QUAL SAF, V24, P167, DOI 10.1136/bmjqs-2014-003821; Mair FS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6680; Man-Son-Hing M, 1999, JAMA-J AM MED ASSOC, V282, P737, DOI 10.1001/jama.282.8.737; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; McCulloch P, 2013, LANCET, V382, P1130, DOI 10.1016/S0140-6736(13)61216-7; MOLD JW, 1986, NEW ENGL J MED, V314, P512, DOI 10.1056/NEJM198602203140809; Morden NE, 2014, NEW ENGL J MED, V370, P589, DOI 10.1056/NEJMp1314965; Morgan DJ, 2015, JAMA INTERN MED, V175, P120, DOI 10.1001/jamainternmed.2014.5444; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; NNT Groups, QUICK SUMM EV BAS ME; Omer ZB, 2013, JAMA INTERN MED, V173, P1830, DOI 10.1001/jamainternmed.2013.8405; Parker L, 2010, AM J ROENTGENOL, V194, P1034, DOI 10.2214/AJR.09.3528; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; PerryUndem Research/Communication, 2014, UNN TESTS PROC HLTH; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Prasad V, 2013, MAYO CLIN PROC, V88, P790, DOI 10.1016/j.mayocp.2013.05.012; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schoen C, 2007, HEALTH AFFAIR, V26, pW717, DOI 10.1377/hlthaff.26.6.w717; Schwartz AL, 2014, JAMA INTERN MED, V174, P1067, DOI 10.1001/jamainternmed.2014.1541; Scott IA, 2013, INTERN MED J, V43, P107, DOI 10.1111/imj.12065; Siontis KC, 2014, J CLIN EPIDEMIOL, V67, P612, DOI 10.1016/j.jclinepi.2013.12.008; Sirovich BE, 2011, ARCH INTERN MED, V171, P1582, DOI 10.1001/archinternmed.2011.437; Smith AK, 2013, NEW ENGL J MED, V368, P2448, DOI 10.1056/NEJMp1303295; SMITH R, 1991, BRIT MED J, V303, P798, DOI 10.1136/bmj.303.6806.798; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Volk RJ, 1999, ARCH FAM MED, V8, P333, DOI 10.1001/archfami.8.4.333; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; Welch HG., 2012, OVERDIAGNOSED MAKING, V1st; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; Wennberg JE, 2002, HLTH AFFAIRS WEB EXC, V13, pW96, DOI DOI 10.1377/HLTHAFF.W2.96; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368; Yong PL, 2011, HEALTHCARE IMPERATIV	87	116	117	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2015	351								h4534	10.1136/bmj.h4534	http://dx.doi.org/10.1136/bmj.h4534			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ2NG	26306661	Green Published			2022-12-28	WOS:000360437200002
J	Raykar, NP; Bowder, AN; Liu, C; Vega, M; Kim, JH; Boye, G; Greenberg, SLM; Riesel, JN; Gillies, RD; Meara, JG; Roy, N				Raykar, Nakul P.; Bowder, Alexis N.; Liu, Charles; Vega, Martha; Kim, Jong H.; Boye, Gloria; Greenberg, Sarah L. M.; Riesel, Johanna N.; Gillies, Rowan D.; Meara, John G.; Roy, Nobhojit			Geospatial mapping to estimate timely access to surgical care in nine low-income and middle-income countries	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Raykar, Nakul P.; Bowder, Alexis N.; Liu, Charles; Vega, Martha; Greenberg, Sarah L. M.; Riesel, Johanna N.; Gillies, Rowan D.; Meara, John G.] Harvard Univ, Program Global Surg & Social Change, Sch Med, Boston, MA 02115 USA; [Raykar, Nakul P.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Bowder, Alexis N.] Univ Nebraska, Sch Med, Omaha, NE 68198 USA; [Kim, Jong H.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Boye, Gloria] Boston Childrens Hosp, Boston, MA USA; [Greenberg, Sarah L. M.] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Riesel, Johanna N.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Meara, John G.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA; [Roy, Nobhojit] BARC Hosp, Dept Surg, Mumbai, Maharashtra, India; [Roy, Nobhojit] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Nebraska System; Tufts University; Harvard University; Boston Children's Hospital; Medical College of Wisconsin; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Bhabha Atomic Research Center (BARC); Karolinska Institutet		nraykar@bidmc.harvard.edu	Liu, Charles/N-6135-2019	Roy, Nobhojit/0000-0003-2022-7416; Liu, Charles/0000-0003-0057-5309					0	22	23	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			16	16		10.1016/S0140-6736(15)60811-X	http://dx.doi.org/10.1016/S0140-6736(15)60811-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313062	Bronze			2022-12-28	WOS:000360573400017
J	Weiser, TG; Haynes, AB; Molina, G; Lipsitz, SR; Esquivel, MM; Uribe-Leitz, T; Fu, R; Azad, T; Chao, TE; Berry, WR; Gawande, AA				Weiser, Thomas G.; Haynes, Alex B.; Molina, George; Lipsitz, Stuart R.; Esquivel, Micaela M.; Uribe-Leitz, Tarsicio; Fu, Rui; Azad, Tej; Chao, Tiffany E.; Berry, William R.; Gawande, Atul A.			Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Weiser, Thomas G.; Esquivel, Micaela M.; Uribe-Leitz, Tarsicio] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA; [Haynes, Alex B.; Molina, George; Lipsitz, Stuart R.; Berry, William R.; Gawande, Atul A.] Ariadne Labs, Boston, MA USA; [Haynes, Alex B.; Molina, George; Chao, Tiffany E.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Haynes, Alex B.; Berry, William R.; Gawande, Atul A.] Harvard Univ, Dept Hlth Policy & Management, T H Chan Sch Publ Hlth, Boston, MA 02115 USA; [Lipsitz, Stuart R.; Berry, William R.; Gawande, Atul A.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Fu, Rui] Stanford Univ, Management Sci & Engn, Stanford, CA 94305 USA; [Fu, Rui; Azad, Tej] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Stanford University; Stanford University		tweiser@stanford.edu	Molina, George/ABC-5038-2021; Weiser, Thomas G/AAC-4609-2022	Weiser, Thomas G/0000-0002-3118-3888; Esquivel, Micaela/0000-0003-1892-6533; Chao, Tiffany/0000-0002-2964-282X					0	375	396	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			11	11		10.1016/S0140-6736(15)60806-6	http://dx.doi.org/10.1016/S0140-6736(15)60806-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313057	Bronze			2022-12-28	WOS:000360573400012
J	Docherty, A; Lone, N; Anderson, N; Walsh, T				Docherty, Annemarie; Lone, Nazir; Anderson, Niall; Walsh, Timothy			Epidemiology and outcomes of older patients admitted to Scottish intensive care units: a national database linkage study	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Docherty, Annemarie; Lone, Nazir; Anderson, Niall] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Docherty, Annemarie; Lone, Nazir] Royal Infirmary Edinburgh, Edinburgh EH16 4SA, Midlothian, Scotland; [Walsh, Timothy] Royal Infirmary Edinburgh, Crit Care, Edinburgh EH16 4SA, Midlothian, Scotland	University of Edinburgh		abdocherty79@gmail.com		Lone, Nazir I/0000-0003-2707-2779; Docherty, Annemarie/0000-0001-8277-420X	Chief Scientist Office [CAF/08/12] Funding Source: Medline	Chief Scientist Office			0	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			33	33		10.1016/S0140-6736(15)60348-8	http://dx.doi.org/10.1016/S0140-6736(15)60348-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312855				2022-12-28	WOS:000360570500033
J	Lokhorst, HM; Plesner, T; Laubach, JP; Nahi, H; Gimsing, P; Hansson, M; Minnema, MC; Lassen, U; Krejcik, J; Palumbo, A; van de Donk, NWCJ; Ahmadi, T; Khan, I; Uhlar, CM; Wang, J; Sasser, AK; Losic, N; Lisby, S; Basse, L; Brun, N; Richardson, PG				Lokhorst, H. M.; Plesner, T.; Laubach, J. P.; Nahi, H.; Gimsing, P.; Hansson, M.; Minnema, M. C.; Lassen, U.; Krejcik, J.; Palumbo, A.; van de Donk, N. W. C. J.; Ahmadi, T.; Khan, I.; Uhlar, C. M.; Wang, J.; Sasser, A. K.; Losic, N.; Lisby, S.; Basse, L.; Brun, N.; Richardson, P. G.			Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; MULTICENTER; ELOTUZUMAB; SAR650984; SURVIVAL; THERAPY; PROTEIN	BACKGROUND Multiple myeloma cells uniformly overexpress CD38. We studied daratumumab, a CD38-targeting, human IgG1 kappa monoclonal antibody, in a phase 1-2 trial involving patients with relapsed myeloma or relapsed myeloma that was refractory to two or more prior lines of therapy. METHODS In part 1, the dose-escalation phase, we administered daratumumab at doses of 0.005 to 24 mg per kilogram of body weight. In part 2, the dose-expansion phase, 30 patients received 8 mg per kilogram of daratumumab and 42 received 16 mg per kilogram, administered once weekly (8 doses), twice monthly (8 doses), and monthly for up to 24 months. End points included safety, efficacy, and pharmacokinetics. RESULTS No maximum tolerated dose was identified in part 1. In part 2, the median time since diagnosis was 5.7 years. Patients had received a median of four prior treatments; 79% of the patients had disease that was refractory to the last therapy received (64% had disease refractory to proteasome inhibitors and immunomodulatory drugs and 64% had disease refractory to bortezomib and lenalidomide), and 76% had received autologous stem-cell transplants. Infusion-related reactions in part 2 were mild (71% of patients had an event of any grade, and 1% had an event of grade 3), with no dose-dependent adverse events. The most common adverse events of grade 3 or 4 (in >= 5% of patients) were pneumonia and thrombocytopenia. The overall response rate was 36% in the cohort that received 16 mg per kilogram (15 patients had a partial response or better, including 2 with a complete response and 2 with a very good partial response) and 10% in the cohort that received 8 mg per kilogram (3 had a partial response). In the cohort that received 16 mg per kilogram, the median progression-free survival was 5.6 months (95% confidence interval [CI], 4.2 to 8.1), and 65% (95% CI, 28 to 86) of the patients who had a response did not have progression at 12 months. CONCLUSIONS Daratumumab monotherapy had a favorable safety profile and encouraging efficacy in patients with heavily pretreated and refractory myeloma. (Funded by Janssen Research and Development and Genmab; ClinicalTrials.gov number, NCT00574288.)	[Lokhorst, H. M.; Minnema, M. C.; van de Donk, N. W. C. J.] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands; [Lokhorst, H. M.; van de Donk, N. W. C. J.] Vrije Univ Amsterdam Med Ctr, Dept Hematol, NL-1081 HV Amsterdam, Netherlands; [Plesner, T.; Krejcik, J.] Vejle Hosp, Vejle, Denmark; [Plesner, T.; Krejcik, J.] Univ Southern Denmark, Vejle, Denmark; [Gimsing, P.; Lassen, U.] Rigshosp, DK-2100 Copenhagen, Denmark; [Gimsing, P.; Lassen, U.] Univ Copenhagen, Copenhagen, Denmark; [Losic, N.; Lisby, S.; Basse, L.; Brun, N.] Genmab, Copenhagen, Denmark; [Laubach, J. P.; Richardson, P. G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Nahi, H.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Stockholm, Sweden; [Nahi, H.] Karolinska Univ Hosp Huddinge, Dept Med, Div Hematol, Stockholm, Sweden; [Hansson, M.] Skane Univ Hosp, Lund, Sweden; [Hansson, M.] Lund Univ, Lund, Sweden; [Palumbo, A.] Univ Turin, Div Hematol, Myeloma Unit, Turin, Italy; [Ahmadi, T.; Uhlar, C. M.; Sasser, A. K.] Janssen Res & Dev, Spring House, PA USA; [Khan, I.; Wang, J.] Janssen Res & Dev, Raritan, NJ USA	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Rigshospitalet; University of Copenhagen; University of Copenhagen; Genmab; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Lund University; University of Turin; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals	Lokhorst, HM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Hematol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	h.lokhorst@vumc.nl	nahi, hareth/AAA-3445-2020; Lassen, Ulrik/AAH-2799-2021	Lassen, Ulrik/0000-0002-3865-4574; van de Donk, Niels/0000-0002-7445-2603; nahi, hareth/0000-0003-4711-5094; Krejcik, Jakub/0000-0003-1833-583X	Janssen Research and Development; Genmab	Janssen Research and Development; Genmab(Genmab)	Funded by Janssen Research and Development and Genmab	Axel AE, 2014, ANN M AM ASS CANC RE; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Deaglio S, 2007, BLOOD, V109, P5390, DOI 10.1182/blood-2006-12-061812; Deckert J, 2014, CLIN CANCER RES, V20, P4574, DOI 10.1158/1078-0432.CCR-14-0695; Department of Health and Human Services, COMM TERM CRIT ADV E; Konopleva M, 1998, J IMMUNOL, V161, P4702; Kumar SK, 2012, LEUKEMIA, V26, P149, DOI 10.1038/leu.2011.196; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lammerts van Bueren J, 2014, 56 ASH ANN M EXP SAN; Laubach JP, 2014, EXPERT REV HEMATOL, V7, P97, DOI 10.1586/17474086.2014.882764; Lin P, 2004, AM J CLIN PATHOL, V121, P482, DOI 10.1039/74R4TB90BUWH27JX; Lonial S, 2015, NEW ENGL J MED, V373, P621, DOI 10.1056/NEJMoa1505654; Martin TG, 2014, BLOOD, V124, P83; Martin TG., 2014, J CLIN ONCOL, V32, P8532; McCudden CR, 2010, CLIN CHEM, V56, P1897, DOI 10.1373/clinchem.2010.152116; Nijhof IS, 2015, CLIN CANCER RES, V21, P2802, DOI 10.1158/1078-0432.CCR-14-1813; Overdijk MB, 2015, MABS-AUSTIN, V7, P311, DOI 10.1080/19420862.2015.1007813; Plesner T, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.84.84; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Richardson P, 2014, BLOOD, V124, P302; Richardson PG, 2014, BLOOD, V123, P1826, DOI 10.1182/blood-2013-11-538835; Santonocito AM, 2004, LEUKEMIA RES, V28, P469, DOI 10.1016/j.leukres.2003.09.015; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934; Zonder JA, 2012, BLOOD, V120, P552, DOI 10.1182/blood-2011-06-360552	24	767	792	8	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1207	1219		10.1056/NEJMoa1506348	http://dx.doi.org/10.1056/NEJMoa1506348			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26308596	Green Published, Bronze			2022-12-28	WOS:000361635200006
J	Avraham, R; Haseley, N; Brown, D; Penaranda, C; Jijon, HB; Trombetta, JJ; Satija, R; Shalek, AK; Xavier, RJ; Regev, A; Hung, DT				Avraham, Roi; Haseley, Nathan; Brown, Douglas; Penaranda, Cristina; Jijon, Humberto B.; Trombetta, John J.; Satija, Rahul; Shalek, Alex K.; Xavier, Ramnik J.; Regev, Aviv; Hung, Deborah T.			Pathogen Cell-to-Cell Variability Drives Heterogeneity in Host Immune Responses	CELL			English	Article							2-COMPONENT REGULATORY SYSTEM; GENE-EXPRESSION; III SECRETION; RNA-SEQ; SALMONELLA; TYPHIMURIUM; INFECTION; VIRULENCE; RECOGNITION; MACROPHAGES	Encounters between immune cells and invading bacteria ultimately determine the course of infection. These interactions are usually measured in populations of cells, masking cell-to-cell variation that may be important for infection outcome. To characterize the gene expression variation that underlies distinct infection outcomes and monitor infection phenotypes, we developed an experimental system that combines single-cell RNA-seq with fluorescent markers. Probing the responses of individual macrophages to invading Salmonella, we find that variation between individual infected host cells is determined by the heterogeneous activity of bacterial factors in individual infecting bacteria. We illustrate how variable PhoPQ activity in the population of invading bacteria drives variable host type I IFN responses by modifying LPS in a subset of bacteria. This work demonstrates a causative link between host and bacterial variability, with cell-to-cell variation between different bacteria being sufficient to drive radically different host immune responses. This co-variation has implications for host-pathogen dynamics in vivo.	[Avraham, Roi; Haseley, Nathan; Brown, Douglas; Trombetta, John J.; Satija, Rahul; Shalek, Alex K.; Xavier, Ramnik J.; Regev, Aviv; Hung, Deborah T.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Haseley, Nathan] MIT, Dept Hlth Sci & Technol, Cambridge, MA 02139 USA; [Penaranda, Cristina; Hung, Deborah T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Jijon, Humberto B.; Xavier, Ramnik J.; Hung, Deborah T.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Jijon, Humberto B.] Univ Calgary, Div Gastroenterol, Dept Med, Calgary, AB T2N 1N4, Canada; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Ctr Study Inflammatory Bowe, Boston, MA 02114 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Hung, Deborah T.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Calgary; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Hung, DT (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	hung@molbio.mgh.harvard.edu	Satija, Rahul/AAF-9564-2019; Shalek, Alex/Y-2434-2019	Shalek, Alex/0000-0001-5670-8778; Penaranda, Cristina/0000-0002-2595-2863; Avraham, Roi/0000-0002-9098-3885	NIH [HG002295, DK043351, U19AI109725, F32 HD075541-02]; NHGRI Center of Excellence in Genome Science (CEGS) Center of Cell Circuits [P50 HG006193]; Klarman Cell Observatory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI Center of Excellence in Genome Science (CEGS) Center of Cell Circuits; Klarman Cell Observatory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Alan Grossman, Dan Kahne, Jon Kagan, Nir Hacohen, Itai Yanai, and Amy Barczak for discussions and comments. We thank Eduardo Villablanca for advice with in vivo experiments. We thank Ken Livak for help with Biomark experiments. We thank Leslie Gafney for help with graphical illustrations and figures. This work was supported by NIH grants (HG002295 to N.H.; DK043351 and U19AI109725 to R.J.X.; and F32 HD075541-02 to R.S.) and the NHGRI Center of Excellence in Genome Science (CEGS) Center of Cell Circuits (P50 HG006193) (to A.R.). A.R. was supported by the Klarman Cell Observatory. A.R. is a member of the Scientific Advisory Board of Thermo Fisher Scientific and Syros Pharmaceutical and is a consultant for Driver Group.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Claudi B, 2014, CELL, V158, P722, DOI 10.1016/j.cell.2014.06.045; Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x; Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Gutschow MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053222; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jin SQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03799; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; MCINTRYE J, 1967, AUST J EXP BIOL MED, V45, P675, DOI 10.1038/icb.1967.67; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Paciello I, 2013, P NATL ACAD SCI USA, V110, pE4345, DOI 10.1073/pnas.1303641110; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Rosenberger CM, 2000, J IMMUNOL, V164, P5894, DOI 10.4049/jimmunol.164.11.5894; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Strandberg KL, 2012, INFECT IMMUN, V80, P3930, DOI 10.1128/IAI.00672-12; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107	34	166	171	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1309	1321		10.1016/j.cell.2015.08.027	http://dx.doi.org/10.1016/j.cell.2015.08.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26343579	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000361247900020
J	Bennett, JW				Bennett, Joan W.			The fungi that ate my house	SCIENCE			English	Editorial Material									[Bennett, Joan W.] Rutgers State Univ, Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Bennett, Joan W.] Rutgers State Univ, Off Promot Women Sci Engn & Math, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Bennett, JW (corresponding author), Rutgers State Univ, Plant Biol & Pathol, New Brunswick, NJ 08903 USA.		Bennett, Joan W./AAT-1267-2021						0	3	3	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					1018	1018		10.1126/science.349.6251.1018	http://dx.doi.org/10.1126/science.349.6251.1018			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315441				2022-12-28	WOS:000360646800059
J	Meador, KJ				Meador, Kimford J.			Risks during pregnancy in women with epilepsy	LANCET			English	Editorial Material							ANTIEPILEPTIC DRUGS; EXPOSURE		Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Meador, KJ (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	kmeador@stanford.edu	Meador, Kimford/W-6167-2019	Meador, Kimford/0000-0002-7471-882X	NINDS NIH HHS [U01 NS038455] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS038455] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bobo WV, 2012, PAEDIATR PERINAT EP, V26, P578, DOI 10.1111/ppe.12004; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Harden CL, 2009, EPILEPSIA, V50, P1237, DOI 10.1111/j.1528-1167.2009.02129.x; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Hill DS, 2010, EXPERT REV NEUROTHER, V10, P943, DOI 10.1586/ERN.10.57; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Shallcross R, 2014, NEUROLOGY, V82, P213, DOI 10.1212/WNL.0000000000000030; Tomson T, 2012, LANCET NEUROL, V11, P803, DOI 10.1016/S1474-4422(12)70103-5; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Viale L, 2015, LANCET, V386, P1845, DOI 10.1016/S0140-6736(15)00045-8	10	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1804	1805		10.1016/S0140-6736(15)00047-1	http://dx.doi.org/10.1016/S0140-6736(15)00047-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26318521	Green Accepted			2022-12-28	WOS:000364194700012
J	Marchbein, D				Marchbein, Deane			The Response to Ebola-Looking Back and Looking Ahead The 2015 Lasker-Bloomberg Public Service Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Med Sans Frontieres Doctors Borders USA, New York, NY 10001 USA		Marchbein, D (corresponding author), Med Sans Frontieres Doctors Borders USA, 333 Seventh Ave, New York, NY 10001 USA.	deane.marchbein@newyork.msf.org						Balasegaram M, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001831; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Liu J, 2015, NATURE, V524, P27, DOI 10.1038/524027a; Nepal Earthquake, 2015, 19 WHO; Sissoko D, 2015, CROI C 2015 FEBR 23; United Nations Development Program (UNDP), ASS SOC IMP EB VIR D; van Griensven J, 2016, CLIN INFECT DIS, V62, P69, DOI 10.1093/cid/civ680	8	3	3	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1115	1116		10.1001/jama.2015.11645	http://dx.doi.org/10.1001/jama.2015.11645			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26348228				2022-12-28	WOS:000361284500012
J	Avorn, J; Sarpatwari, A; Kesselheim, AS				Avorn, Jerry; Sarpatwari, Ameet; Kesselheim, Aaron S.			Forbidden and Permitted Statements about Medications - Loosening the Rules	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONFLICTS-OF-INTEREST; DRUG; PROMOTION; RESTRICTIONS; QUALITY; SAFETY; FDA		[Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Avorn, J (corresponding author), Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Almashat S, 2012, PHARM IND CRIMINAL C; [Anonymous], 2010, RISP US PRESCR INF; [Anonymous], 2014, GUID IND DISTR SCI M; [Anonymous], 2015, COMMUNICATION; Avorn J, 2011, NEW ENGL J MED, V365, P2151, DOI 10.1056/NEJMp1110327; Boland GL., 1970, BOSTON COLL LAW REV, V12, P203; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Cohen PA, 2014, NEW ENGL J MED, V370, P1277, DOI 10.1056/NEJMp1315559; Conko Gregory, 2011, Health Matrix Clevel, V21, P149; Coyne DW, 2007, CLIN J AM SOC NEPHRO, V2, P3, DOI 10.2215/CJN.02170606; Eguale T, 2012, ARCH INTERN MED, V172, P781, DOI 10.1001/archinternmed.2012.340; Feuerstein JD, 2013, ALIMENT PHARM THER, V37, P937, DOI 10.1111/apt.12290; Food and Drug Administration, 1994, FED REGISTER, V59, P59820; Food and Drug Administration, 1997, FED REGISTER, V62, P64093; Food and Drug Administration, 2009, FDA APPR THAL THAL T; Gionfriddo MR, 2014, JAMA INTERN MED, V174, P179, DOI 10.1001/jamainternmed.2013.12971; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Isaac A, 2013, PEDIATRICS, V131, P732, DOI 10.1542/peds.2012-2027; Kesselheim AS, 2015, HEALTH AFFAIR, V34, P438, DOI 10.1377/hlthaff.2014.0515; Kesselheim AS, 2013, JAMA-J AM MED ASSOC, V309, P445, DOI 10.1001/jama.2012.207972; Kesselheim AS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000431; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Klasmeier C, 2011, AM J LAW MED, V37, P315, DOI 10.1177/009885881103700206; Larkin I, 2014, HEALTH AFFAIR, V33, P1014, DOI 10.1377/hlthaff.2013.0939; Lee DH, 2011, ARCH INTERN MED, V171, P18, DOI 10.1001/archinternmed.2010.482; MAY CD, 1961, J MED EDUC, V36, P1; Mello MM, 2009, NEW ENGL J MED, V360, P1557, DOI 10.1056/NEJMhle0807695; Nestel P, 2015, HEART LUNG CIRC, V24, P769, DOI 10.1016/j.hlc.2015.03.020; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Robertson C, 2012, J LAW MED ETHICS, V40, P452, DOI 10.1111/j.1748-720X.2012.00678.x; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Smith RM, 2013, NEW ENGL J MED, V369, P1598, DOI 10.1056/NEJMoa1213978; Staes C, 2013, AM J HEALTH-SYST PH, V70, P1301, DOI 10.2146/ajhp130049; Tabarrok AT, 2000, INDEPENDENT REV; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Von Eschenbach A., 2012, WALL STREET J; Waxman HA, 2003, FOOD DRUG LAW J, V58, P299; Wolfe SM, 2014, JAMA INTERN MED, V174, P1543, DOI 10.1001/jamainternmed.2014.4547	39	12	13	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					967	973		10.1056/NEJMhle1506365	http://dx.doi.org/10.1056/NEJMhle1506365			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ2OB	26332553				2022-12-28	WOS:000360439500016
J	Hattersley, AT; Thorens, B				Hattersley, Andrew T.; Thorens, Bernard			Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PANCREATIC ALPHA-CELLS; DAPAGLIFLOZIN		[Hattersley, Andrew T.] Univ Exeter, Sch Med, Dept Mol Med, Exeter, Devon, England; [Thorens, Bernard] Univ Lausanne, Lausanne, Switzerland	University of Exeter; University of Lausanne	Hattersley, AT (corresponding author), Univ Exeter, Sch Med, Dept Mol Med, Exeter, Devon, England.			Hattersley, Andrew/0000-0001-5620-473X	Wellcome Trust [098395] Funding Source: Medline; National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Campbell JE, 2015, NAT REV ENDOCRINOL, V11, P329, DOI 10.1038/nrendo.2015.51; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; HEIMBERG H, 1995, J BIOL CHEM, V270, P8971, DOI 10.1074/jbc.270.15.8971; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704	5	29	30	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					974	976		10.1056/NEJMcibr1506573	http://dx.doi.org/10.1056/NEJMcibr1506573			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2OB	26332554	Green Published			2022-12-28	WOS:000360439500017
J	Holmes, D				Holmes, David			Christine Chinkin: defender of human rights	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					847	847		10.1016/S0140-6736(15)00052-5	http://dx.doi.org/10.1016/S0140-6736(15)00052-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0MJ	26335868				2022-12-28	WOS:000360290000013
J	Fried, SD; Boxer, SG				Fried, Stephen D.; Boxer, Steven G.			Response to Comments on "Extreme electric fields power catalysis in the active site of ketosteroid isomerase"	SCIENCE			English	Editorial Material							GENERAL BASE; ENZYME	Natarajan et al. and Chen and Savidge comment that comparing the electric field in ketosteroid isomerase's (KSI's) active site to zero overestimates the catalytic effect of KSI's electric field because the reference reaction occurs in water, which itself exerts a sizable electrostatic field. To compensate, Natarajan et al. argue that additional catalytic weight arises from positioning of the general base, whereas Chen and Savidge propose a separate contribution from desolvation of the general base. We note that the former claim is not well supported by published results, and the latter claim is intriguing but lacks experimental basis. We also take the opportunity to clarify some of the more conceptually subtle aspects of electrostatic catalysis.	[Fried, Stephen D.; Boxer, Steven G.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Boxer, SG (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	sboxer@stanford.edu		Boxer, Steven/0000-0001-9167-4286	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027738] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM027738] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen DL, 2015, SCIENCE, V349, DOI 10.1126/science.aab0095; Debler EW, 2009, P NATL ACAD SCI USA, V106, P18539, DOI 10.1073/pnas.0902700106; DEWAR MJS, 1985, P NATL ACAD SCI USA, V82, P2225, DOI 10.1073/pnas.82.8.2225; Fried SD, 2015, ACCOUNTS CHEM RES, V48, P998, DOI 10.1021/ar500464j; Fried SD, 2014, SCIENCE, V346, P1510, DOI 10.1126/science.1259802; Jha SK, 2012, J PHYS CHEM B, V116, P11414, DOI 10.1021/jp305225r; Jha SK, 2011, P NATL ACAD SCI USA, V108, P16612, DOI 10.1073/pnas.1113874108; MARCUS RA, 1956, J CHEM PHYS, V24, P966, DOI 10.1063/1.1742723; Natarajan A, 2015, SCIENCE, V349, DOI 10.1126/science.aab1584; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Schwans JP, 2014, BIOCHEMISTRY-US, V53, P2541, DOI 10.1021/bi401671t; Schwans JP, 2013, P NATL ACAD SCI USA, V110, P11308, DOI 10.1073/pnas.1206710110; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106	14	10	10	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251								10.1126/science.aab1627	http://dx.doi.org/10.1126/science.aab1627			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315428	Green Accepted			2022-12-28	WOS:000360646800035
J	Kim, TK; Shiekhattar, R				Kim, Tae-Kyung; Shiekhattar, Ramin			Architectural and Functional Commonalities between Enhancers and Promoters	CELL			English	Review							RNA-POLYMERASE-II; IMMUNOGLOBULIN HEAVY-CHAIN; LONG NONCODING RNAS; BETA-GLOBIN GENE; SUPER-ENHANCERS; HS2 ENHANCER; U1 SNRNP; TRANSCRIPTIONAL PROMOTERS; INTERGENIC TRANSCRIPTION; CHROMATIN LANDSCAPE	With the explosion of genome-wide studies of regulated transcription, it has become clear that traditional definitions of enhancers and promoters need to be revisited. These control elements can now be characterized in terms of their local and regional architecture, their regulatory components, including histone modifications and associated binding factors, and their functional contribution to transcription. This Review discusses unifying themes between promoters and enhancers in transcriptional regulatory mechanisms.	[Kim, Tae-Kyung] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Shiekhattar, Ramin] Univ Miami, Dept Human Genet, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Miami	Kim, TK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	taekyung.kim@utsouthwestern.edu; rshiekhattar@med.miami.edu	Kim, Tae-Kyung/AAX-4230-2020	Kim, Tae-Kyung/0000-0001-5161-9864	Welch foundation [I-1786]; Klingenstein Fund; NIH-NINDS [R01NS085418]; Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine; National Institute of Health [R01 GM078455, R01 GM105754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078455, R01GM105754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085418] Funding Source: NIH RePORTER	Welch foundation(The Welch Foundation); Klingenstein Fund(Klingenstein Philanthropies); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by The Welch foundation (I-1786), The Klingenstein Fund, and NIH-NINDS R01NS085418 (T.-K.K). The work cited from the Shiekhattar laboratory was supported by funds from Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine and by grants R01 GM078455 and R01 GM105754 from the National Institute of Health (R.S.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Akbari OS, 2008, DEVELOPMENT, V135, P123, DOI 10.1242/dev.010744; Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; ATCHISON ML, 1988, ANNU REV CELL BIOL, V4, P127, DOI 10.1146/annurev.cellbio.4.1.127; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BIENZ M, 1986, CELL, V45, P753, DOI 10.1016/0092-8674(86)90789-0; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOHMANN D, 1987, NATURE, V325, P268, DOI 10.1038/325268a0; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Descostes N, 2014, ELIFE, V3, DOI 10.7554/eLife.02105; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duttke SHC, 2015, MOL CELL, V57, P674, DOI 10.1016/j.molcel.2014.12.029; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; GROSSCHEDL R, 1980, P NATL ACAD SCI-BIOL, V77, P7102, DOI 10.1073/pnas.77.12.7102; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GUARENTE L, 1988, CELL, V52, P303, DOI 10.1016/S0092-8674(88)80020-5; Hah N, 2015, P NATL ACAD SCI USA, V112, pE297, DOI 10.1073/pnas.1424028112; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; KHOURY G, 1983, CELL, V33, P313, DOI 10.1016/0092-8674(83)90410-5; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kohtz JD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00045; Kong SM, 1997, MOL CELL BIOL, V17, P3955, DOI 10.1128/MCB.17.7.3955; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lai F, 2015, NATURE, V525, P399, DOI 10.1038/nature14906; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Ling JH, 2005, J MOL BIOL, V350, P883, DOI 10.1016/j.jmb.2005.05.039; Ling JH, 2004, J BIOL CHEM, V279, P51704, DOI 10.1074/jbc.M404039200; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; MOREAU P, 1981, NUCLEIC ACIDS RES, V9, P6047, DOI 10.1093/nar/9.22.6047; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; MULLER MM, 1988, EUR J BIOCHEM, V176, P485, DOI 10.1111/j.1432-1033.1988.tb14306.x; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; PARSLOW TG, 1987, SCIENCE, V235, P1498, DOI 10.1126/science.3029871; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Routledge SJE, 2002, J MOL BIOL, V323, P601, DOI 10.1016/S0022-2836(02)01011-2; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; SERFLING E, 1985, EMBO J, V4, P3851, DOI 10.1002/j.1460-2075.1985.tb04157.x; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Travers A, 1999, P NATL ACAD SCI USA, V96, P13634, DOI 10.1073/pnas.96.24.13634; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Vieira KF, 2004, J BIOL CHEM, V279, P50350, DOI 10.1074/jbc.M408883200; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vucicevic D, 2015, CELL CYCLE, V14, P253, DOI 10.4161/15384101.2014.977641; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Weingarten-Gabbay S, 2014, NAT GENET, V46, P1253, DOI 10.1038/ng.3152; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yoo EJ, 2012, MOL CELL BIOL, V32, P2020, DOI 10.1128/MCB.06650-11	116	195	199	4	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					948	959		10.1016/j.cell.2015.08.008	http://dx.doi.org/10.1016/j.cell.2015.08.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317464	Green Accepted, Bronze			2022-12-28	WOS:000360589900007
J	Michel-Kerjan, E				Michel-Kerjan, Erwann			We must build resilience into our communities	NATURE			English	Editorial Material									Univ Penn, Wharton Sch, Ctr Risk Management & Decis Proc, Philadelphia, PA 19104 USA	University of Pennsylvania	Michel-Kerjan, E (corresponding author), Univ Penn, Wharton Sch, Ctr Risk Management & Decis Proc, Philadelphia, PA 19104 USA.	erwannmk@wharton.upenn.edu							0	18	18	4	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					389	389		10.1038/524389a	http://dx.doi.org/10.1038/524389a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP7LN	26310731	Bronze			2022-12-28	WOS:000360069300006
J	Gundlapalli, AV; Fargo, JD; Metraux, S; Carter, ME; Samore, MH; Kane, V; Culhane, DP				Gundlapalli, Adi V.; Fargo, Jamison D.; Metraux, Stephen; Carter, Marjorie E.; Samore, Matthew H.; Kane, Vincent; Culhane, Dennis P.			Military Misconduct and Homelessness Among US Veterans Separated From Active Duty, 2001-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Gundlapalli, Adi V.; Fargo, Jamison D.; Carter, Marjorie E.; Samore, Matthew H.] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci IDEAS Ctr, Salt Lake City, UT 84148 USA; [Metraux, Stephen; Kane, Vincent; Culhane, Dennis P.] VA Philadelphia Hlth Care Syst, Natl Ctr Homelessness Vet, Philadelphia, PA USA	US Department of Veterans Affairs	Gundlapalli, AV (corresponding author), VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci IDEAS Ctr, 500 Foothill Dr,Mail Stop 182, Salt Lake City, UT 84148 USA.	adi.gundlapalli@hsc.utah.edu		Metraux, Stephen/0000-0003-4741-1010				Baldor L., MISCONDUCT FORCES MO; Balshem H., 2011, CRITICAL REV LIT REG; Klein S, WHY RECRUITS SEPARAT; Seamone ER, 2014, AM J PUBLIC HEALTH, V104, P1805, DOI 10.2105/AJPH.2014.302117; US Department of Defense, INT SEP COD ACT SEP; US Department of Veterans Affairs Office of Inspector General, HOM INC RISK FACT BE	6	20	20	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					832	834		10.1001/jama.2015.8207	http://dx.doi.org/10.1001/jama.2015.8207			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305655				2022-12-28	WOS:000360017200025
J	Dyson, M; Watson, CJ; Liddell, K; Padfield, N; Bradley, JA; Saeb-Parsy, K				Dyson, Matthew; Watson, Christopher J.; Liddell, Kathleen; Padfield, Nicola; Bradley, J. Andrew; Saeb-Parsy, Kourosh			Transplanting suboptimum organs: medico-legal implications	LANCET			English	Editorial Material									[Dyson, Matthew; Liddell, Kathleen; Padfield, Nicola] Univ Cambridge, Fac Law, Cambridge CB2 0QQ, England; [Dyson, Matthew] Univ Cambridge Trinity Coll, Cambridge CB2 1TQ, England; [Watson, Christopher J.; Bradley, J. Andrew; Saeb-Parsy, Kourosh] Univ Cambridge, Dept Surg, Cambridge CB2 0QQ, England; [Watson, Christopher J.; Bradley, J. Andrew; Saeb-Parsy, Kourosh] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Liddell, Kathleen] Univ Cambridge, Ctr Law Med & Life Sci, Cambridge CB2 0QQ, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Saeb-Parsy, K (corresponding author), Univ Cambridge, Dept Surg, Cambridge CB2 0QQ, England.	ks10014@cam.ac.uk		Watson, Christopher/0000-0002-0590-4901; Saeb-Parsy, Kourosh/0000-0002-0633-3696				Bonser RS, 2012, LANCET, V380, P747, DOI 10.1016/S0140-6736(12)60160-3; Hamed MO, 2015, AM J TRANSPLANT, V15, P1632, DOI 10.1111/ajt.13162; National Health Service Blood and Transplant, 2015, US ORG DON HIGH RISK; Summers DM, 2015, KIDNEY INT, V88, P241, DOI 10.1038/ki.2015.88; Warrens AN, 2012, TRANSPLANTATION, V93, P348, DOI 10.1097/TP.0b013e31823f7f47	5	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					719	721		10.1016/S0140-6736(15)61413-1	http://dx.doi.org/10.1016/S0140-6736(15)61413-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LR	26333958				2022-12-28	WOS:000360287900006
J	Raykar, NP; Yorlets, RR; Liu, C; Greenberg, SLM; Kotagal, M; Goldman, R; Roy, N; Meara, JG; Gillies, RD				Raykar, Nakul P.; Yorlets, Rachel R.; Liu, Charles; Greenberg, Sarah L. M.; Kotagal, Meera; Goldman, Roberta; Roy, Nobhojit; Meara, John G.; Gillies, Rowan D.			A qualitative study exploring contextual challenges to surgical care provision in 21 LMICs	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Raykar, Nakul P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Raykar, Nakul P.; Liu, Charles; Greenberg, Sarah L. M.; Meara, John G.; Gillies, Rowan D.] Harvard Univ, Sch Med, Program Global Surg & Social Change, Boston, MA USA; [Yorlets, Rachel R.; Meara, John G.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA; [Greenberg, Sarah L. M.] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Kotagal, Meera] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Goldman, Roberta] Brown Univ, Dept Family Med, Warren Alpert Sch Med, Providence, RI 02912 USA; [Goldman, Roberta] Harvard Univ, T H Chan Sch Publ Hlth, Boston, MA 02115 USA; [Roy, Nobhojit] BARC Hosp, Dept Surg, Mumbai, Maharashtra, India; [Roy, Nobhojit] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Medical College of Wisconsin; University of Washington; University of Washington Seattle; Brown University; Harvard University; Harvard T.H. Chan School of Public Health; Bhabha Atomic Research Center (BARC); Karolinska Institutet		nraykar@bidmc.harvard.edu	Liu, Charles/N-6135-2019	Liu, Charles/0000-0003-0057-5309; Yorlets, Rachel/0000-0002-0986-5444; Roy, Nobhojit/0000-0003-2022-7416	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK070555] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK070555] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))			0	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			15	15		10.1016/S0140-6736(15)60810-8	http://dx.doi.org/10.1016/S0140-6736(15)60810-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313061	Bronze, Green Accepted			2022-12-28	WOS:000360573400016
J	Khanna, R; Bressler, B; Levesque, BG; Zou, GY; Stitt, LW; Greenberg, GR; Panaccione, R; Bitton, A; Pare, P; Vermeire, S; D'Haens, G; MacIntosh, D; Sandborn, WJ; Donner, A; Vandervoort, MK; Morris, JC; Feagan, BG				Khanna, Reena; Bressler, Brian; Levesque, Barrett G.; Zou, Guangyong; Stitt, Larry W.; Greenberg, Gordon R.; Panaccione, Remo; Bitton, Alain; Pare, Pierre; Vermeire, Severine; D'Haens, Geert; MacIntosh, Donald; Sandborn, William J.; Donner, Allan; Vandervoort, Margaret K.; Morris, Joan C.; Feagan, Brian G.		REACT Study Investigators	Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; HEALTH SURVEY; VALIDATION; INFLIXIMAB; SEVERITY; THERAPY; EUROQOL; INDEX; SF-36; SCORE	Background Conventional management of Crohn's disease features incremental use of therapies. However, early combined immunosuppression (ECI), with a TNF antagonist and antimetabolite might be a more effective strategy. We compared the efficacy of ECI with that of conventional management for treatment of Crohn's disease. Methods In this open-label cluster randomised controlled trial (Randomised Evaluation of an Algorithm for Crohn's Treatment, REACT), we included community gastroenterology practices from Belgium and Canada that were willing to be assigned to either of the study groups, participate in all aspects of the study, and provide data on up to 60 patients with Crohn's disease. These practices were randomly assigned (1: 1) to either ECI or conventional management. The computer-generated randomisation was minimised by country and practice size. Up to 60 consecutive adult patients were assessed within practices. Patients who were aged 18 years or older; documented to have Crohn's disease; able to speak or understand English, French, or Dutch; able to access a telephone; and able to provide written informed consent were followed up for 2 years. The primary outcome was the proportion of patients in corticosteroid-free remission (Harvey-Bradshaw Index score <= 4) at 12 months at the practice level. This trial is registered with ClinicalTrials.gov, number NCT01030809. Findings This study took place between March 15, 2010, and Oct 1, 2013. Of the 60 practices screened, 41 were randomly assigned to either ECI (n=22) or conventional management (n=19). Two practices (one in each group) discontinued because of insufficient resources. 921 (85%) of the 1084 patients at ECI practices and 806 (90%) of 898 patients at conventional management practices completed 12 months follow-up and were included in an intention-to-treat analysis. The 12 month practice-level remission rates were similar at ECI and conventional management practices (66.0% [SD 14.0] and 61.9% [16.9]; adjusted difference 2.5%, 95% CI -5.2% to 10.2%, p=0.5169). The 24 month patient-level composite rate of major adverse outcomes defined as occurrence of surgery, hospital admission, or serious disease-related complications was lower at ECI practices than at conventional management practices (27.7% and 35.1%, absolute difference [AD] 7.3%, hazard ratio [HR]: 0.73, 95% CI 0.62 to 0.86, p=0.0003). There were no differences in serious drug-related adverse events. Interpretation Although ECI was not more effective than conventional management for controlling Crohn's disease symptoms, the risk of major adverse outcomes was lower. The latter finding should be considered hypothesis-generating for future trials. ECI was not associated with an increased risk of serious drug-related adverse events or mortality.	[Khanna, Reena; Levesque, Barrett G.; Zou, Guangyong; Stitt, Larry W.; D'Haens, Geert; Sandborn, William J.; Donner, Allan; Vandervoort, Margaret K.; Morris, Joan C.; Feagan, Brian G.] Robarts Clin Trials Inc, Robarts Res Inst, London, ON, Canada; [Khanna, Reena; Feagan, Brian G.] Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada; [Zou, Guangyong; Donner, Allan; Feagan, Brian G.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON N6A 5K8, Canada; [Bressler, Brian] St Pauls Hosp, Dept Gastroenterol, Vancouver, BC V6Z 1Y6, Canada; [Levesque, Barrett G.; Sandborn, William J.] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA; [Greenberg, Gordon R.] Mt Sinai Hosp, Div Gastroenterol, Toronto, ON M5G 1X5, Canada; [Panaccione, Remo] Univ Calgary, Dept Med, Div Gastroenterol & Hepatol, Calgary, AB, Canada; [Bitton, Alain] McGill Univ, Ctr Hlth, Div Gastroenterol, Montreal, PQ, Canada; [Pare, Pierre] Univ Laval, Hop St Sacrement, CHAUQ, Quebec City, PQ, Canada; [Vermeire, Severine] Translat Res Ctr Gastrointestinal Disorders, Dept Clin & Expt Med, Leuven, Belgium; [D'Haens, Geert] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands; [MacIntosh, Donald] Dalhousie Univ, Div Gastroenterol, Halifax, NS, Canada	Robarts Clinical Trials Inc; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); St. Paul's Hospital; University of Saskatchewan; University of California System; University of California San Diego; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Calgary; McGill University; Laval University; University of Amsterdam; Academic Medical Center Amsterdam; Dalhousie University	Feagan, BG (corresponding author), Univ Western Ontario, Dept Med, Robarts Clin Trials, London, ON N6A 5K8, Canada.	brian.feagan@robartsinc.com	Zou, Guangyong/K-6408-2013; Feagan, Brian/G-3292-2011; Khanna, Reena/H-5626-2013; Panaccione, Remo/ABC-1140-2021; Sandborn, William/ABE-8342-2020	Zou, Guangyong/0000-0001-5773-4185; Panaccione, Remo/0000-0002-5247-940X; Vermeire, Severine/0000-0001-9942-3019	AbbVie Pharmaceuticals	AbbVie Pharmaceuticals(AbbVie)	AbbVie Pharmaceuticals.	Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Bodger K, 2011, PHARMACOECONOMICS, V29, P387, DOI 10.2165/11584820-000000000-00000; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brown H., 1999, APPL MIXED MODELS ME; CELLIER C, 1994, GUT, V35, P231, DOI 10.1136/gut.35.2.231; Cohen RD, 2000, AM J GASTROENTEROL, V95, P524; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Coteur G, 2009, ALIMENT PHARM THER, V29, P1032, DOI 10.1111/j.1365-2036.2009.03966.x; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Donovan M, 2007, DIGEST DIS SCI, V52, P1798, DOI 10.1007/s10620-006-9269-z; Feagan BG, 2000, AM J GASTROENTEROL, V95, P1955; Feagan BG, 2009, AM J GASTROENTEROL, V104, P1976, DOI 10.1038/ajg.2009.199; HARVEY RF, 1980, LANCET, V1, P514; Jones J, 2008, CLIN GASTROENTEROL H, V6, P1218, DOI 10.1016/j.cgh.2008.06.010; Konig HH, 2002, EUR J GASTROEN HEPAT, V14, P1205; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lichtenstein GR, 2012, AM J GASTROENTEROL, V107, P1409, DOI 10.1038/ajg.2012.218; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; MARY JY, 1989, GUT, V30, P983, DOI 10.1136/gut.30.7.983; MODIGLIANI R, 1990, GASTROENTEROLOGY, V98, P811, DOI 10.1016/0016-5085(90)90002-I; Odes S, 2008, WORLD J GASTROENTERO, V14, P6641, DOI 10.3748/wjg.14.6641; OLAISON G, 1990, GUT, V31, P325, DOI 10.1136/gut.31.3.325; Peyrin-Biroulet L, 2014, GUT, V63, P88, DOI 10.1136/gutjnl-2013-304984; Rogler G, 2013, DIGEST DIS, V31, P83, DOI 10.1159/000347190; Schoepfer AM, 2010, AM J GASTROENTEROL, V105, P162, DOI 10.1038/ajg.2009.545; St Charles M, 2009, INFLAMM BOWEL DIS, V15, P1467, DOI 10.1002/ibd.20904; Swaminath A, 2011, DIGEST DIS SCI, V56, P1160, DOI 10.1007/s10620-010-1530-9; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	32	259	267	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1825	1834		10.1016/S0140-6736(15)00068-9	http://dx.doi.org/10.1016/S0140-6736(15)00068-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26342731				2022-12-28	WOS:000364194700033
J	Reddy, VY; Exner, DV; Cantillon, DJ; Doshi, R; Bunch, TJ; Tomassoni, GF; Friedman, PA; Estes, NAM; Ip, J; Niazi, I; Plunkitt, K; Banker, R; Porterfield, J; Ip, JE; Dukkipati, SR				Reddy, Vivek Y.; Exner, Derek V.; Cantillon, Daniel J.; Doshi, Rahul; Bunch, T. Jared; Tomassoni, Gery F.; Friedman, Paul A.; Estes, N. A. Mark, III; Ip, John; Niazi, Imran; Plunkitt, Kenneth; Banker, Rajesh; Porterfield, James; Ip, James E.; Dukkipati, Srinivas R.		LEADLESS II Study Investigators	Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVERTER-DEFIBRILLATORS; VENOUS OBSTRUCTION; COMPLICATIONS; PREDICTORS; RISK; PERFORATION; REVISION; COHORT; LEADS	BACKGROUND Cardiac pacemakers are limited by device-related complications, notably infection and problems related to pacemaker leads. We studied a miniaturized, fully self-contained leadless pacemaker that is nonsurgically implanted in the right ventricle with the use of a catheter. METHODS In this multicenter study, we implanted an active-fixation leadless cardiac pacemaker in patients who required permanent single-chamber ventricular pacing. The primary efficacy end point was both an acceptable pacing threshold (<= 2.0 V at 0.4 msec) and an acceptable sensing amplitude (R wave >= 5.0 mV, or a value equal to or greater than the value at implantation) through 6 months. The primary safety end point was freedom from device-related serious adverse events through 6 months. In this ongoing study, the prespecified analysis of the primary end points was performed on data from the first 300 patients who completed 6 months of follow-up (primary cohort). The rates of the efficacy end point and safety end point were compared with performance goals (based on historical data) of 85% and 86%, respectively. Additional outcomes were assessed in all 526 patients who were enrolled as of June 2015 (the total cohort). RESULTS The leadless pacemaker was successfully implanted in 504 of the 526 patients in the total cohort (95.8%). The intention-to-treat primary efficacy end point was met in 270 of the 300 patients in the primary cohort (90.0%; 95% confidence interval [CI], 86.0 to 93.2, P = 0.007), and the primary safety end point was met in 280 of the 300 patients (93.3%; 95% CI, 89.9 to 95.9; P<0.001). At 6 months, device-related serious adverse events were observed in 6.7% of the patients; events included device dislodgement with percutaneous retrieval (in 1.7%), cardiac perforation (in 1.3%), and pacing-threshold elevation requiring percutaneous retrieval and device replacement (in 1.3%). CONCLUSIONS The leadless cardiac pacemaker met prespecified pacing and sensing requirements in the large majority of patients. Device-related serious adverse events occurred in approximately 1 in 15 patients.	[Reddy, Vivek Y.; Dukkipati, Srinivas R.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ip, James E.] Weill Cornell Med Ctr, New York, NY USA; [Exner, Derek V.] Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Cantillon, Daniel J.] Cleveland Clin, Cleveland, OH USA; [Doshi, Rahul] Univ So Calif, Keck Hosp, Los Angeles, CA USA; [Banker, Rajesh] Premier Cardiol, Newport Beach, CA USA; [Bunch, T. Jared] Intermt Med Ctr, Inst Heart, Salt Lake City, UT USA; [Tomassoni, Gery F.] Cent Baptist Hosp, Lexington, KY USA; [Friedman, Paul A.] Mayo Clin, Rochester, MN USA; [Estes, N. A. Mark, III] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Ip, John] Sparrow Clin Res Inst, Lansing, MI USA; [Niazi, Imran] Aurora Med Grp, Milwaukee, WI USA; [Plunkitt, Kenneth] Naples Community Hosp, Naples, FL USA; [Porterfield, James] Methodist Univ Hosp, Memphis, TN USA	Icahn School of Medicine at Mount Sinai; Cornell University; Libin Cardiovascular Institute Of Alberta; Cleveland Clinic Foundation; University of Southern California; University of Southern California Keck Hospital; Intermountain Healthcare; Intermountain Medical Center; Central Baptist Hospital; Mayo Clinic; Tufts University	Reddy, VY (corresponding author), Icahn Sch Med Mt Sinai, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.	vivek.reddy@mountsinai.org	E, D/AAH-1638-2020; Ip, James E./I-1235-2019	Ip, James E./0000-0002-3461-505X; Reddy, Vivek/0000-0002-5638-4993	St. Jude Medical	St. Jude Medical(St. Jude Medical)	Funded by St. Jude Medical; LEADLESS II ClinicalTrials.gov number, NCT02030418.)	Acha MR, 2015, PACE, V38, P334, DOI 10.1111/pace.12550; Al-Mohaissen MA, 2012, J AM SOC ECHOCARDIOG, V25, P245, DOI 10.1016/j.echo.2011.11.020; DeSimone CV, 2013, CIRCULATION, V128, P1433, DOI 10.1161/CIRCULATIONAHA.113.003540; Epstein Andrew E, 2008, J Am Coll Cardiol, V51, pe1, DOI 10.1016/j.hrthm.2008.04.014; Haghjoo M, 2007, EUROPACE, V9, P328, DOI 10.1093/europace/eum019; Hauser RG, 2007, HEART RHYTHM, V4, P154, DOI 10.1016/j.hrthm.2006.10.009; Healey JS, 2006, CIRCULATION, V114, P11, DOI 10.1161/CIRCULATIONAHA.105.610303; Johansen JB, 2011, EUR HEART J, V32, P991, DOI 10.1093/eurheartj/ehq497; Kirkfeldt RE, 2014, EUR HEART J, V35, P1186, DOI 10.1093/eurheartj/eht511; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Knops RE, 2015, J AM COLL CARDIOL, V65, P1497, DOI 10.1016/j.jacc.2015.02.022; Korkeila P, 2007, PACE, V30, P199, DOI 10.1111/j.1540-8159.2007.00650.x; Lamas GA, 2002, NEW ENGL J MED, V346, P1854, DOI 10.1056/NEJMoa013040; Mahapatra S, 2005, HEART RHYTHM, V2, P907, DOI 10.1016/j.hrthm.2005.06.011; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Palmisano P, 2013, EUROPACE, V15, P531, DOI 10.1093/europace/eus337; Reddy VY, 2014, CIRCULATION, V129, P1466, DOI 10.1161/CIRCULATIONAHA.113.006987; Ritter P., 2015, EUR HEART J; Tobin K, 2000, AM J CARDIOL, V85, P774, DOI 10.1016/S0002-9149(99)00861-9; Udo EO, 2012, HEART RHYTHM, V9, P728, DOI 10.1016/j.hrthm.2011.12.014; Wilkoff BL, 2011, HEART RHYTHM, V8, P65, DOI 10.1016/j.hrthm.2010.10.002	21	267	271	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1125	1135		10.1056/NEJMoa1507192	http://dx.doi.org/10.1056/NEJMoa1507192			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR7UG	26321198				2022-12-28	WOS:000361556400008
J	Wan, CH; Borgeson, B; Phanse, S; Tu, F; Drew, K; Clark, G; Xiong, XJ; Kagan, O; Kwan, J; Bezginov, A; Chessman, K; Pal, S; Cromar, G; Papoulas, O; Ni, ZY; Boutz, DR; Stoilova, S; Havugimana, PC; Guo, XH; Malty, RH; Sarov, M; Greenblatt, J; Babu, M; Derry, WB; Tillier, ER; Wallingford, JB; Parkinson, J; Marcotte, EM; Emili, A				Wan, Cuihong; Borgeson, Blake; Phanse, Sadhna; Tu, Fan; Drew, Kevin; Clark, Greg; Xiong, Xuejian; Kagan, Olga; Kwan, Julian; Bezginov, Alexandr; Chessman, Kyle; Pal, Swati; Cromar, Graham; Papoulas, Ophelia; Ni, Zuyao; Boutz, Daniel R.; Stoilova, Snejana; Havugimana, Pierre C.; Guo, Xinghua; Malty, Ramy H.; Sarov, Mihail; Greenblatt, Jack; Babu, Mohan; Derry, W. Brent; Tillier, Elisabeth R.; Wallingford, John B.; Parkinson, John; Marcotte, Edward M.; Emili, Andrew			Panorama of ancient metazoan macromolecular complexes	NATURE			English	Article							PROTEIN-INTERACTION; INTERACTION NETWORK; YEAST; GENE; INTERACTOME; MAP; RESOURCE; COMMD1; SIZE; CELL	Macromolecular complexes are essential to conserved biological processes, but their prevalence across animals is unclear. By combining extensive biochemical fractionation with quantitative mass spectrometry, here we directly examined the composition of soluble multiprotein complexes among diverse metazoan models. Using an integrative approach, we generated a draft conservation map consisting of more than one million putative high-confidence co-complex interactions for species with fully sequenced genomes that encompasses functional modules present broadly across all extant animals. Clustering reveals a spectrum of conservation, ranging from ancient eukaryotic assemblies that have probably served cellular housekeeping roles for at least one billion years, ancestral complexes that have accrued contemporary components, and rarer metazoan innovations linked to multicellularity. We validated these projections by independent co-fractionation experiments in evolutionarily distant species, affinity purification and functional analyses. The comprehensiveness, centrality and modularity of these reconstructed interactomes reflect their fundamental mechanistic importance and adaptive value to animal cell systems.	[Wan, Cuihong; Phanse, Sadhna; Kagan, Olga; Kwan, Julian; Ni, Zuyao; Stoilova, Snejana; Havugimana, Pierre C.; Guo, Xinghua; Greenblatt, Jack; Emili, Andrew] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Wan, Cuihong; Borgeson, Blake; Tu, Fan; Drew, Kevin; Papoulas, Ophelia; Boutz, Daniel R.; Wallingford, John B.; Marcotte, Edward M.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Clark, Greg; Bezginov, Alexandr; Tillier, Elisabeth R.] Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Xiong, Xuejian; Kwan, Julian; Chessman, Kyle; Cromar, Graham; Greenblatt, Jack; Derry, W. Brent; Parkinson, John; Emili, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Xiong, Xuejian; Chessman, Kyle; Pal, Swati; Cromar, Graham; Derry, W. Brent; Parkinson, John] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Malty, Ramy H.; Babu, Mohan] Univ Regina, Dept Biochem, Regina, SK S4S 0A2, Canada; [Sarov, Mihail] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Wallingford, John B.; Marcotte, Edward M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Toronto; University of Texas System; University of Texas Austin; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Regina; Max Planck Society; University of Texas System; University of Texas Austin	Marcotte, EM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu; andrew.emili@utoronto.ca	Mohan, Babu P./I-7362-2019; Derry, Brent/CAF-4503-2022; Parkinson, John/A-4424-2008	Parkinson, John/0000-0001-9815-1189; Clark, Greg/0000-0002-9805-4300; Tu, Fan/0000-0002-5673-5300; Derry, Brent/0000-0002-1977-8475; Phanse, Sadhna/0000-0001-6306-0551; Wan, Cuihong/0000-0002-6028-3239; Kwan, Julian/0000-0002-9199-1828; Marcotte, Edward/0000-0001-8808-180X; Drew, Kevin/0000-0002-1260-4413; Pal, Swati/0000-0001-6179-4316	CIHR; NSERC; ORF; CFI; Heart and Stroke; NIH [F32GM112495]; NIH; NSF; CPRIT; Welch Foundation [F-1515]; Division Of Integrative Organismal Systems [1237975] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM112495, R01GM067779, R01GM076536, DP1GM106408] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); ORF; CFI(Canada Foundation for Innovation); Heart and Stroke; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CPRIT; Welch Foundation(The Welch Foundation); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Bader, P. Kim, G. Moreno-Hagelsieb, S. Pu and S. Wodak for critical suggestions, illustrator A. Syrett for expert help drafting figures, T. Kwon (University of Texas) for X. laevis gene models, and K. Foltz (University of California, Santa Barbara), A. Brehm (Philipps-University Marburg), P. Paddison (Fred Hutchinson Cancer Research Center), J. Smith (Woods Hole Marine Biological Laboratory), P. Zandstra and J. Moffat (University of Toronto) for providing biological specimens and reagents. We thank members of the Emili and Marcotte laboratories for assistance and guidance, and SciNet (University of Toronto) and the Texas Advanced Computing Center (University of Texas) for high-performance computing resources. This work was supported by grants from the CIHR, NSERC, ORF and the CFI to A.E., from the CIHR and Heart and Stroke to J. P., from the NIH (F32GM112495) to K.D., and from the NIH, NSF, CPRIT, and Welch Foundation (F-1515) to E.M.M.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bezginov A, 2013, MOL BIOL EVOL, V30, P332, DOI 10.1093/molbev/mss218; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de Bie P, 2006, BIOCHEM J, V398, P63, DOI 10.1042/BJ20051664; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Kiemer Lars, 2007, Trends Biotechnol, V25, P448, DOI 10.1016/j.tibtech.2007.08.002; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kirkwood KJ, 2013, MOL CELL PROTEOMICS, V12, P3851, DOI 10.1074/mcp.M113.032367; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Kolanczyk M, 2015, EUR J HUM GENET, V23, P633, DOI 10.1038/ejhg.2014.109; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; McDonald FJ, 2013, AM J PHYSIOL-CELL PH, V305, pC129, DOI 10.1152/ajpcell.00128.2013; McKusick V.A., 1998, MENDELIAN INHERITANC; OVADI J, 1995, CELL ARCHITECTURE ME; Phillips-Krawczak CA, 2015, MOL BIOL CELL, V26, P91, DOI 10.1091/mbc.E14-06-1073; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Tan K, 2007, P NATL ACAD SCI USA, V104, P1283, DOI 10.1073/pnas.0606914104; Toledo CM, 2014, DEV CELL, V28, P282, DOI 10.1016/j.devcel.2013.12.014; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; Voineagu I, 2012, MOL PSYCHIATR, V17, P4, DOI 10.1038/mp.2011.95; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	48	303	308	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					339	+		10.1038/nature14877	http://dx.doi.org/10.1038/nature14877			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26344197	Green Accepted			2022-12-28	WOS:000361297900035
J	Baerlocher, GM; Leibundgut, EO; Ottmann, OG; Spitzer, G; Odenike, O; McDevitt, MA; Roth, A; Daskalakis, M; Burington, B; Stuart, M; Snyder, DS				Baerlocher, Gabriela M.; Leibundgut, Elisabeth Oppliger; Ottmann, Oliver G.; Spitzer, Gary; Odenike, Olatoyosi; McDevitt, Michael A.; Roth, Alexander; Daskalakis, Michael; Burington, Bart; Stuart, Monic; Snyder, David S.			Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WORLD-HEALTH-ORGANIZATION; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE NEOPLASMS; PROGNOSTIC-FACTORS; MYELOID NEOPLASMS; HYDROXYUREA; ANAGRELIDE; MUTATION; JAK2; CLASSIFICATION	BACKGROUND Imetelstat, a 13-mer oligonucleotide that is covalently modified with lipid extensions, competitively inhibits telomerase enzymatic activity. It has been shown to inhibit megakaryocytic proliferation in vitro in cells obtained from patients with essential thrombocythemia. In this phase 2 study, we investigated whether imetelstat could elicit hematologic and molecular responses in patients with essential thrombocythemia who had not had a response to or who had had unacceptable side effects from prior therapies. METHODS A total of 18 patients in two sequential cohorts received an initial dose of 7.5 or 9.4 mg of imetelstat per kilogram of body weight intravenously once a week until attainment of a platelet count of approximately 250,000 to 300,000 per cubic millimeter. The primary end point was the best hematologic response. RESULTS Imetelstat induced hematologic responses in all 18 patients, and 16 patients (89%) had a complete hematologic response. At the time of the primary analysis, 10 patients were still receiving treatment, with a median follow-up of 17 months (range, 7 to 32 [ ongoing]). Molecular responses were seen in 7 of 8 patients who were positive for the JAK2 V617F mutation (88%; 95% confidence interval, 47 to 100). CALR and MPL mutant allele burdens were also reduced by 15 to 66%. The most common adverse events during treatment were mild to moderate in severity; neutropenia of grade 3 or higher occurred in 4 of the 18 patients (22%) and anemia, headache, and syncope of grade 3 or higher each occurred in 2 patients (11%). All the patients had at least one abnormal liver-function value; all persistent elevations were grade 1 or 2 in severity. CONCLUSIONS Rapid and durable hematologic and molecular responses were observed in patients with essential thrombocythemia who received imetelstat. (Funded by Geron; ClinicalTrials. gov number, NCT01243073.)	[Baerlocher, Gabriela M.; Leibundgut, Elisabeth Oppliger; Daskalakis, Michael] Univ Hosp Bern, Dept Hematol, CH-3010 Bern, Switzerland; [Baerlocher, Gabriela M.; Leibundgut, Elisabeth Oppliger; Daskalakis, Michael] Univ Bern, Bern, Switzerland; [Ottmann, Oliver G.] Cardiff Univ, Sch Med, Dept Hematol, Cardiff CF10 3AX, S Glam, Wales; [Spitzer, Gary] Upstate Oncol Associates, Greenville, SC USA; [Odenike, Olatoyosi] Univ Chicago, Sect Hematol & Oncol, Chicago, IL 60637 USA; [McDevitt, Michael A.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Div Hematol Malignancies & Hematol, Baltimore, MD USA; [Roth, Alexander] Univ Hosp Essen, Dept Hematol, Essen, Germany; [Burington, Bart; Stuart, Monic] Geron, Menlo Pk, CA USA; [Snyder, David S.] Gehr Family Ctr Leukemia Res, City Hope, Dept ment Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA	University of Bern; University Hospital of Bern; University of Bern; Cardiff University; University of Chicago; Johns Hopkins University; Johns Hopkins Medicine; University of Duisburg Essen; City of Hope	Baerlocher, GM (corresponding author), Univ Hosp Bern, Stem Cell & Mol Diagnost Lab, Dept Hematol, Freiburgstr 4, CH-3010 Bern, Switzerland.	gabriela.baerlocher@insel.ch	Oppliger Leibundgut, Elisabeth/AGG-5030-2022; Daskalakis, Michael/AAH-9217-2019; Daskalakis, Michael/L-1645-2015; Ottmann, Oliver/D-5007-2016	Daskalakis, Michael/0000-0002-8138-0505; Daskalakis, Michael/0000-0002-8138-0505; Ottmann, Oliver/0000-0001-9559-1330; Oppliger Leibundgut, Elisabeth/0000-0002-6652-4160	Geron	Geron	Funded by Geron	Alvarez-Larran A, 2014, ANN HEMATOL, V93, P2037, DOI 10.1007/s00277-014-2152-7; Alvarez-Larran A, 2012, BLOOD, V119, P1363, DOI 10.1182/blood-2011-10-387787; Barbui T, 2011, J CLIN ONCOL, V29, P3179, DOI 10.1200/JCO.2010.34.5298; Barbui T, 2011, J CLIN ONCOL, V29, P761, DOI 10.1200/JCO.2010.31.8436; Barosi G, 2009, BLOOD, V113, P4829, DOI 10.1182/blood-2008-09-176818; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Brunold C., 2011, 53 AM SOC HEM ANN M; Gisslinger H, 2013, BLOOD, V121, P1720, DOI 10.1182/blood-2012-07-443770; Harrison CN, 2005, NEW ENGL J MED, V353, P33, DOI 10.1056/NEJMoa043800; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kanakura Y, 2014, INT J HEMATOL, V100, P353, DOI 10.1007/s12185-014-1631-x; Kiladjian JJ, 2006, BLOOD, V108, P2037, DOI 10.1182/blood-2006-03-009860; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Lau WWY, 2015, BLOOD, V125, P1679, DOI 10.1182/blood-2014-12-618074; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; National Cancer Institute, 2009, NIH PUBLICATION; Passamonti F, 2008, HAEMATOL-HEMATOL J, V93, P1645, DOI 10.3324/haematol.13346; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Quintas-Cardama A, 2013, BLOOD, V122, P893, DOI 10.1182/blood-2012-07-442012; Quintas-Cardama A, 2009, J CLIN ONCOL, V27, P5418, DOI 10.1200/JCO.2009.23.6075; Rey J, 2014, EUR J HAEMATOL, V92, P127, DOI 10.1111/ejh.12210; Roth A, 2010, RECENT RESULTS CANC, V184, P221, DOI 10.1007/978-3-642-01222-8_16; Tefferi A, 2015, NEW ENGL J MED, V373, P908, DOI 10.1056/NEJMoa1310523; Vardiman JW, 2010, CHEM-BIOL INTERACT, V184, P16, DOI 10.1016/j.cbi.2009.10.009; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wolanskyj AP, 2006, MAYO CLIN PROC, V81, P159, DOI 10.4065/81.2.159; Yamada Osamu, 2013, JAKSTAT, V2, pe25256, DOI 10.4161/jkst.25256	27	134	142	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					920	928		10.1056/NEJMoa1503479	http://dx.doi.org/10.1056/NEJMoa1503479			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2OB	26332546	Green Published, Bronze			2022-12-28	WOS:000360439500007
J	French, SW; Romanowicz, B				French, Scott W.; Romanowicz, Barbara			Broad plumes rooted at the base of the Earth's mantle beneath major hotspots	NATURE			English	Article							SHEAR VELOCITY STRUCTURE; SPECTRAL ELEMENT METHOD; WAVE-FORM TOMOGRAPHY; EXCESS TEMPERATURE; MODEL; EVOLUTION; REVEALS; SURFACE; FLOW	Plumes of hot upwelling rock rooted in the deep mantle have been proposed as a possible origin of hotspot volcanoes, but this idea is the subject of vigorous debate(1,2). On the basis of geodynamic computations, plumes of purely thermal origin should comprise thin tails, only several hundred kilometres wide(3), and be difficult to detect using standard seismic tomography techniques. Here we describe the use of a whole-mantle seismic imaging technique-combining accurate wavefield computations with information contained in whole seismic waveforms(4)-that reveals the presence of broad (not thin), quasi-vertical conduits beneath many prominent hotspots. These conduits extend from the core-mantle boundary to about 1,000 kilometres below Earth's surface, where some are deflected horizontally, as though entrained into more vigorous upper-mantle circulation. At the base of the mantle, these conduits are rooted in patches of greatly reduced shear velocity that, in the case of Hawaii, Iceland and Samoa, correspond to the locations of known large ultralow-velocity zones(5-7). This correspondence clearly establishes a continuous connection between such zones and mantle plumes. We also show that the imaged conduits are robustly broader than classical thermal plume tails, suggesting that they are long-lived(8), and may have a thermochemical origin(9-11). Their vertical orientation suggests very sluggish background circulation below depths of 1,000 kilometres. Our results should provide constraints on studies of viscosity layering of Earth's mantle and guide further research into thermochemical convection.	[French, Scott W.; Romanowicz, Barbara] Univ Calif Berkeley, Berkeley Seismol Lab, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Romanowicz, Barbara] Univ Paris Diderot, Inst Phys Globe, F-75238 Paris, France; [Romanowicz, Barbara] Coll France, F-75005 Paris, France	University of California System; University of California Berkeley; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Romanowicz, B (corresponding author), Univ Calif Berkeley, Berkeley Seismol Lab, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	barbara@seismo.berkeley.edu	Romanowicz, barbara A/H-6726-2017	Romanowicz, barbara A/0000-0002-6208-6044	NSF Graduate Research Fellowship; NSF [EAR-1417229]; ERC Advanced Grant WAVETOMO; US Department of Energy Office of Science [DE-AC02-05CH11231]	NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); ERC Advanced Grant WAVETOMO; US Department of Energy Office of Science(United States Department of Energy (DOE))	We thank the IRIS Data Management Center for providing the waveform data used in this study. This study was supported by an NSF Graduate Research Fellowship to S.W.F., NSF grant EAR-1417229, and ERC Advanced Grant WAVETOMO. Computations were performed at the National Energy Research Scientific Computing Center, supported by the US Department of Energy Office of Science (contract DE-AC02-05CH11231).	Albers M, 1996, GEOPHYS RES LETT, V23, P3567, DOI 10.1029/96GL03311; Anderson DL, 2005, GEOL SOC AM SPEC PAP, V388, DOI 10.1130/2005.2388(04); Boschi L, 2008, PHYS EARTH PLANET IN, V167, P230, DOI 10.1016/j.pepi.2008.03.009; CAMPBELL IH, 1990, EARTH PLANET SC LETT, V99, P79, DOI 10.1016/0012-821X(90)90072-6; Capdeville Y, 2003, GEOPHYS J INT, V152, P34, DOI 10.1046/j.1365-246X.2003.01808.x; Cottaar S, 2012, EARTH PLANET SC LETT, V355, P213, DOI 10.1016/j.epsl.2012.09.005; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; Davaille A., 2007, TREATISE GEOPHYS, V7, P89, DOI DOI 10.1016/B978-044452748-6.00116-4; Durek JJ, 1996, B SEISMOL SOC AM, V86, P144; Farnetani CG, 1997, GEOPHYS RES LETT, V24, P1583, DOI 10.1029/97GL01548; Forte AM, 2001, NATURE, V410, P1049, DOI 10.1038/35074000; French SW, 2014, GEOPHYS J INT, V199, P1303, DOI 10.1093/gji/ggu334; French S. W., 2015, P 29 IEEE INT PAR DI; French S, 2013, SCIENCE, V342, P227, DOI 10.1126/science.1241514; Fukao Y, 2013, J GEOPHYS RES-SOL EA, V118, P5920, DOI 10.1002/2013JB010466; Helmberger DV, 1998, NATURE, V396, P251, DOI 10.1038/24357; Houser C, 2008, GEOPHYS J INT, V174, P195, DOI 10.1111/J.1365-246X.2008.03763.X; Jellinek AM, 2002, NATURE, V418, P760, DOI 10.1038/nature00979; Karato SI, 2008, DEFORMATION OF EARTH MATERIALS: AN INTRODUCTION TO THE RHEOLOGY OF SOLID EARTH, P1, DOI 10.1017/CBO9780511804892; Komatitsch D, 1998, B SEISMOL SOC AM, V88, P368; Kreemer C, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2009JB006416; Kumagai I, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035079; Laske G, 2011, GEOPHYS J INT, V187, P1725, DOI 10.1111/j.1365-246X.2011.05238.x; Lekic V, 2011, GEOPHYS J INT, V185, P799, DOI 10.1111/j.1365-246X.2011.04969.x; LEVEQUE JJ, 1993, GEOPHYS J INT, V115, P313, DOI 10.1111/j.1365-246X.1993.tb05605.x; Li X, 2000, NATURE, V405, P938, DOI 10.1038/35016054; LI XD, 1995, GEOPHYS J INT, V121, P695, DOI 10.1111/j.1365-246X.1995.tb06432.x; Lin SC, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001072; Macpherson CG, 1998, GEOLOGY, V26, P1007, DOI 10.1130/0091-7613(1998)026<1007:HHHRIT>2.3.CO;2; Marquardt H, 2015, NAT GEOSCI, V8, P311, DOI 10.1038/NGEO2393; McNamara AK, 2010, EARTH PLANET SC LETT, V299, P1, DOI 10.1016/j.epsl.2010.07.042; Megnin C, 2000, GEOPHYS J INT, V143, P709, DOI 10.1046/j.1365-246X.2000.00298.x; Montelli R, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001248; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; NATAF HC, 1993, NATURE, V364, P115, DOI 10.1038/364115a0; Nolet G, 2000, J GEOPHYS RES-SOL EA, V105, P19043, DOI 10.1029/2000JB900161; Nolet G, 2006, EARTH PLANET SC LETT, V248, P685, DOI 10.1016/j.epsl.2006.06.011; Ritsema J, 2011, GEOPHYS J INT, V184, P1223, DOI 10.1111/j.1365-246X.2010.04884.x; Ritsema J, 1999, SCIENCE, V286, P1925, DOI 10.1126/science.286.5446.1925; Simmons NA, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007631; Steinberger B, 2000, J GEOPHYS RES-SOL EA, V105, P11127, DOI 10.1029/1999JB900398; Stixrude L, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB002965; SU WJ, 1994, J GEOPHYS RES-SOL EA, V99, P6945, DOI 10.1029/93JB03408; Suetsugu D, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002533; Tarantola A, 2005, INVERSE PROBLEM THEO, DOI DOI 10.1137/1.9780898717921; Thorne MS, 2013, EARTH PLANET SC LETT, V364, P59, DOI 10.1016/j.epsl.2012.12.034; Thorne MS, 2004, PHYS EARTH PLANET IN, V146, P47, DOI 10.1016/j.pepi.2003.09.026; WANG Z, 1995, GEOPHYS RES LETT, V22, P3099, DOI 10.1029/95GL03080; Wolfe CJ, 2011, EARTH PLANET SC LETT, V303, P267, DOI 10.1016/j.epsl.2011.01.004; Zhao DP, 2004, PHYS EARTH PLANET IN, V146, P3, DOI 10.1016/j.pepi.2003.07.032	51	485	506	10	249	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					95	+		10.1038/nature14876	http://dx.doi.org/10.1038/nature14876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26333468				2022-12-28	WOS:000360594100032
J	Nelson, KB; Blair, E				Nelson, Karin B.; Blair, Eve			Prenatal Factors in Singletons with Cerebral Palsy Born at or near Term	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FETAL THROMBOTIC VASCULOPATHY; MAJOR BIRTH-DEFECTS; RISK-FACTORS; CONGENITAL-ANOMALIES; INTRAUTERINE GROWTH; PRETERM BIRTH; CHILDREN; POPULATION; INFANTS; COMPLICATIONS		[Nelson, Karin B.] NINDS, NIH, Bethesda, MD 20892 USA; [Nelson, Karin B.] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Blair, Eve] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Children's National Health System; Telethon Kids Institute; University of Western Australia	Nelson, KB (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	nelsonk@ninds.nih.gov						Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066.pub2; [Anonymous], 2014, AM ACAD PEDIAT, P88; Bair E, 2007, DEV MED CHILD NEUROL, V49, P252; Blair E, 1993, Paediatr Perinat Epidemiol, V7, P272, DOI 10.1111/j.1365-3016.1993.tb00405.x; Blair E, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.022; Blair EM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.1103; Bonnin A, 2012, NEUROPSYCHOPHARMACOL, V37, P299, DOI 10.1038/npp.2011.194; Bower C, 2010, BIRTH DEFECTS RES A, V88, P251, DOI 10.1002/bdra.20658; Chisholm KM, 2015, AM J SURG PATHOL, V39, P274, DOI 10.1097/PAS.0000000000000334; Croen LA, 2001, J PEDIATR-US, V138, P804, DOI 10.1067/mpd.2001.114473; Dahlseng MO, 2014, DEV MED CHILD NEUROL, V56, P53, DOI 10.1111/dmcn.12293; Decoufle P, 2001, PEDIATRICS, V108, P728, DOI 10.1542/peds.108.3.728; Dodman Nancy, 2004, J Obstet Gynaecol Can, V26, P327; EASTMAN N J, 1962, Obstet Gynecol Surv, V17, P459, DOI 10.1097/00006254-196208000-00001; EASTMAN NJ, 1955, AM J OBSTET GYNECOL, V69, P950, DOI 10.1016/0002-9378(55)90094-6; Evrenos AN, 2014, ARCH GYNECOL OBSTET, V289, P499, DOI 10.1007/s00404-013-2979-5; Felix JF, 2000, DEV MED CHILD NEUROL, V42, P803; Folkerth RD, 2013, PEDIATR DEVEL PATHOL, V16, P391, DOI 10.2350/13-03-1316-CR.1; Garne E, 2008, EUR J PAEDIATR NEURO, V12, P82, DOI 10.1016/j.ejpn.2007.07.001; Graham EM, 2006, OBSTET GYNECOL, V108, P656, DOI 10.1097/01.AOG.0000230533.62760.ef; Hankins GDV, 2006, OBSTET GYNECOL, V107, P1382, DOI 10.1097/01.AOG.0000220531.25707.27; Hemminki K, 2007, PAEDIATR PERINAT EP, V21, P235, DOI 10.1111/j.1365-3016.2007.00798.x; Himmelmann K, 2011, ACTA OBSTET GYN SCAN, V90, P1070, DOI 10.1111/j.1600-0412.2011.01217.x; Honein MA, 2009, MATERN CHILD HLTH J, V13, P164, DOI 10.1007/s10995-008-0348-y; Hong T, 2008, SEMIN PERINATOL, V32, P438, DOI 10.1053/j.semperi.2008.09.011; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jacobsson B, 2004, BEST PRACT RES CL OB, V18, P425, DOI 10.1016/j.bpobgyn.2004.02.011; Janik MDC, 2013, J PEDIATR-US, V163, P1307, DOI 10.1016/j.jpeds.2013.06.062; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Khankhanian P, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-126; Kim YS, 2014, INT J EPIDEMIOL, V43, P465, DOI 10.1093/ije/dyu037; Kirton A, 2006, CLIN PERINATOL, V33, P367, DOI 10.1016/j.clp.2006.03.008; Lian DWQ, 2013, PEDIATR DEVEL PATHOL, V16, P28, DOI 10.2350/12-08-1242-CR.1; MacLennan AH, 2015, AM J OBSTET GYNECOL; MALAMUD N, 1964, J PEDIATR-US, V65, P270, DOI 10.1016/S0022-3476(64)80530-8; McDonald DGM, 2004, HUM PATHOL, V35, P875, DOI 10.1016/j.humpath.2004.02.014; McIntyre S, DEV MED CHI IN PRESS; Mcintyre S, 2015, DEV MED CHILD NEUROL, V57, P2, DOI 10.1111/dmcn.12725; McIntyre S, 2013, OBSTET GYNECOL, V122, P869, DOI 10.1097/AOG.0b013e3182a265ab; McMichael G, 2015, MOL PSYCHIATR, V20, P176, DOI 10.1038/mp.2014.189; Miquel-Verges F, 2015, J PERINATOL, V35, P198, DOI 10.1038/jp.2014.180; Mirzaa GM, 2014, AM J MED GENET A, V164, P1503, DOI 10.1002/ajmg.a.36517; Montenegro MA, 2005, J CHILD NEUROL, V20, P675, DOI 10.1177/08830738050200080801; Moreno-De-Luca A, 2012, LANCET NEUROL, V11, P208, DOI 10.1016/S1474-4422(12)70028-5; Moreno-De-Luca A, 2012, LANCET NEUROL, V11, P283, DOI 10.1016/S1474-4422(11)70287-3; Nelson K B, 1987, Epilepsia, V28 Suppl 1, pS16, DOI 10.1111/j.1528-1157.1987.tb05750.x; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; Nelson KB, 1998, AM J OBSTET GYNECOL, V179, P507, DOI 10.1016/S0002-9378(98)70387-4; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; NELSON KB, 1986, NEW ENGL J MED, V315, P81, DOI 10.1056/NEJM198607103150202; Ho NT, 2013, PEDIATR RES, V73, P450, DOI 10.1038/pr.2012.200; Nielsen LF, 2008, BJOG-INT J OBSTET GY, V115, P1518, DOI 10.1111/j.1471-0528.2008.01896.x; O'Leary CM, 2012, DEV MED CHILD NEUROL, V54, P224, DOI 10.1111/j.1469-8749.2011.04201.x; Oskoui M, 2013, DEV MED CHILD NEUROL, V55, P509, DOI 10.1111/dmcn.12080; Oyelese Y, 2006, OBSTET GYNECOL, V108, P1005, DOI 10.1097/01.AOG.0000239439.04364.9a; Parsa CF, 2013, JAMA OPHTHALMOL, V131, P439, DOI 10.1001/jamaophthalmol.2013.1111; Pharoah POD, 2007, ARCH DIS CHILD-FETAL, V92, P489, DOI 10.1136/adc.2006.107375; Pinar H, 2014, OBSTET GYNECOL, V123, P325, DOI 10.1097/AOG.0000000000000100; Rankin J, 2010, DEV MED CHILD NEUROL, V52, P345, DOI 10.1111/j.1469-8749.2009.03415.x; Redline RW, 2008, PEDIATR DEVEL PATHOL, V11, P456, DOI 10.2350/08-05-0468.1; Reid SM, 2014, DEV MED CHILD NEUROL, V56, P222, DOI 10.1111/dmcn.12228; Saleemuddin A, 2010, PEDIATR DEVEL PATHOL, V13, P459, DOI 10.2350/10-01-0774-OA.1; Saraswat L, 2010, BJOG-INT J OBSTET GY, V117, P245, DOI 10.1111/j.1471-0528.2009.02427.x; Sartwelle TP, 2015, J CHILD NEUROL, V30, P828, DOI 10.1177/0883073814543306; Sato Y, 2013, HISTOL HISTOPATHOL, V28, P127, DOI 10.14670/HH-28.127; Scher AI, 2002, PEDIATR RES, V52, P671, DOI [10.1203/00006450-200211000-00011, 10.1203/01.PDR.0000032159.88318.5B]; Segel R, 2015, NEUROLOGY, V84, P1660, DOI 10.1212/WNL.0000000000001494; Stoknes M, 2012, PEDIATRICS, V130, pE1629, DOI 10.1542/peds.2012-0152; Stoknes M, 2012, EUR J PAEDIATR NEURO, V16, P56, DOI 10.1016/j.ejpn.2011.10.004; Takenouchi T, 2012, PEDIATR NEUROL, V46, P106, DOI 10.1016/j.pediatrneurol.2011.11.011; Taylor CL, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.003; Tollanes MC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4294; TORFS CP, 1990, J PEDIATR-US, V116, P615, DOI 10.1016/S0022-3476(05)81615-4; Tronnes H, 2014, DEV MED CHILD NEUROL, V56, P779, DOI 10.1111/dmcn.12430; van Oppenraaij RHF, 2009, HUM REPROD UPDATE, V15, P409, DOI 10.1093/humupd/dmp009; Viscardi RM, 2001, EARLY HUM DEV, V62, P1, DOI 10.1016/S0378-3782(01)00114-1; Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425; Watson L, 2006, REPORT W AUSTR PALSY; Weber MA, 2010, SEMIN FETAL NEONAT M, V15, P313, DOI 10.1016/j.siny.2010.06.002; Wu YW, 2006, PEDIATRICS, V118, P690, DOI 10.1542/peds.2006-0278	81	60	63	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					946	953		10.1056/NEJMra1505261	http://dx.doi.org/10.1056/NEJMra1505261			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2OB	26332549				2022-12-28	WOS:000360439500010
J	Biffi, A; Anderson, CD; Battey, TWK; Ayres, AM; Greenberg, SM; Viswanathan, A; Rosand, J				Biffi, Alessandro; Anderson, Christopher D.; Battey, Thomas W. K.; Ayres, Alison M.; Greenberg, Steven M.; Viswanathan, Anand; Rosand, Jonathan			Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMYLOID ANGIOPATHY; STROKE	IMPORTANCE Intracerebral hemorrhage (ICH) is the most severe form of stroke. Survivors are at high risk of recurrence, death, and worsening functional disability. OBJECTIVE To investigate the association between blood pressure (BP) after index ICH and risk of recurrent ICH. DESIGN, SETTING, AND PARTICIPANTS Single-site, tertiary care referral center observational study of 1145 of 2197 consecutive patients with ICH presenting from July 1994 to December 2013. A total of 1145 patients with ICH survived at least 90 days and were followed up through December 2013 (median follow-up of 36.8 months [minimum, 9.8 months]). EXPOSURES Blood pressure measurements at 3, 6, 9, and 12 months, and every 6 months thereafter, obtained from medical personnel (inpatient hospital or outpatient clinic medical or nursing staff) or via patient self-report. Exposure was characterized in 3 ways: (1) recorded systolic and diastolic measurements; (2) classification as adequate or inadequate BP control based on American Heart Association/American Stroke Association recommendations; and (3) stage of hypertension based on Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 7 criteria. MAIN OUTCOMES AND MEASURES Recurrent ICH and its location within the brain (lobar vs nonlobar). RESULTS There were 102 recurrent ICH events among 505 survivors of lobar ICH and 44 recurrent ICH events among 640 survivors of nonlobar ICH. During follow-up adequate BP control was achieved on at least 1 measurement by 625 patients (54.6% of total [range, 49.2%-58.7%]) and consistently (ie, at all available time points) by 495 patients (43.2% of total [range, 34.5%-51.0%]). The event rate for lobar ICH was 84 per 1000 person-years among patients with inadequate BP control compared with 49 per 1000 person-years among patients with adequate BP control. For nonlobar ICH the event rate was 52 per 1000 person-years with inadequate BP control compared with 27 per 1000 person-years for patients with adequate BP control. In analyses modeling BP control as a time-varying variable, inadequate BP control was associated with higher risk of recurrence of both lobar ICH (hazard ratio [HR], 3.53 [95% CI, 1.65-7.54]) and nonlobar ICH (HR, 4.23 [95% CI, 1.02-17.52]). Systolic BP during follow-up was associated with increased risk of both lobar ICH recurrence (HR, 1.33 per 10-mm Hg increase [95% CI, 1.02-1.76]) and nonlobar ICH recurrence (HR, 1.54 [95% CI, 1.03-2.30]). Diastolic BP was associated with increased risk of nonlobar ICH recurrence (HR, 1.21 per 10-mm Hg increase [95% CI, 1.01-1.47]) but not with lobar ICH recurrence (HR, 1.36 [95% CI, 0.90-2.10]). CONCLUSIONS AND RELEVANCE In this observational single-center cohort study of ICH survivors, reported BP measurements suggesting inadequate BP control during follow-up were associated with higher risk of both lobar and nonlobar ICH recurrence. These data suggest that randomized clinical trials are needed to address the benefits and risks of stricter BP control in ICH survivors.	[Biffi, Alessandro; Anderson, Christopher D.; Battey, Thomas W. K.; Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Biffi, Alessandro; Anderson, Christopher D.; Battey, Thomas W. K.; Ayres, Alison M.; Greenberg, Steven M.; Viswanathan, Anand; Rosand, Jonathan] Massachusetts Gen Hosp, J Philip Kistler Stroke Res Ctr, Boston, MA 02114 USA; [Biffi, Alessandro; Anderson, Christopher D.; Battey, Thomas W. K.; Greenberg, Steven M.; Viswanathan, Anand; Rosand, Jonathan] Massachusetts Gen Hosp, Div Neurocrit Care & Emergency Neurol, Dept Neurol, Boston, MA 02114 USA; [Biffi, Alessandro; Anderson, Christopher D.; Battey, Thomas W. K.; Rosand, Jonathan] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rosand, J (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN 6818, Boston, MA 02114 USA.	jrosand@partners.org	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Anderson, Christopher/0000-0002-0053-2002	National Institute of Neurological Disorders and Stroke [R01 NS063925, R01 NS059727, P50 NS051343, K23 NS086873, AG26484]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS069208, P50NS051343, R01NS063925, U10NS077360, R01NS059727, K23NS086873, R01NS073344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026484, P50AG005134, R01AG047975] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors' work on this study was supported by funding from the National Institute of Neurological Disorders and Stroke (R01 NS063925, R01 NS059727, P50 NS051343, K23 NS086873, and AG26484).	Arima H, 2006, J HYPERTENS, V24, P1201, DOI 10.1097/01.hjh.0000226212.34055.86; Arima H, 2014, J NEUROL NEUROSUR PS, V85, P1284, DOI 10.1136/jnnp-2014-307856; Arima H, 2010, STROKE, V41, P394, DOI 10.1161/STROKEAHA.109.563932; Badjatia N, 2005, NEUROLOGIST, V11, P311, DOI 10.1097/01.nrl.0000178757.68551.26; Biffi A, 2010, Neurology, V75, P693, DOI 10.1212/WNL.0b013e3181eee40f; Biffi A, 2010, ANN NEUROL, V68, P934, DOI 10.1002/ana.22134; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Eigenbrodt ML, 2000, STROKE, V31, P2307, DOI 10.1161/01.STR.31.10.2307; Hyman DJ, 2009, CURR HYPERTENS REP, V11, P337, DOI 10.1007/s11906-009-0057-y; JAMES PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Kovesdy CP, 2014, JAMA INTERN MED, V174, P1442, DOI 10.1001/jamainternmed.2014.3279; Liu WH, 2012, STROKE, V43, P2916, DOI 10.1161/STROKEAHA.112.658369; Moran AE, 2015, NEW ENGL J MED, V372, P447, DOI 10.1056/NEJMsa1406751; Office of Management and Budget, 1997, FED REGISTER, V62, P58782; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Samarasekera N, 2012, J NEUROL NEUROSUR PS, V83, P275, DOI 10.1136/jnnp-2011-300371; Taylor BC, 2011, J GEN INTERN MED, V26, P685, DOI 10.1007/s11606-011-1660-6; Zahuranec DB, 2012, STROKE, V43, P2580, DOI 10.1161/STROKEAHA.112.663047; Zhao WH, 2013, DIABETES CARE, V36, P3287, DOI 10.2337/dc13-0189	20	146	152	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					904	912		10.1001/jama.2015.10082	http://dx.doi.org/10.1001/jama.2015.10082			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325559	Bronze, Green Accepted			2022-12-28	WOS:000360392100017
J	Snyder, A				Snyder, Alison			Annik Rouillon	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu						ROUILLON A, PUBLICATION LIST	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					850	850		10.1016/S0140-6736(15)00048-3	http://dx.doi.org/10.1016/S0140-6736(15)00048-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0MJ	26335870				2022-12-28	WOS:000360290000015
J	Guy, AT; Nagatsuka, Y; Ooashi, N; Inoue, M; Nakata, A; Greimel, P; Inoue, A; Nabetani, T; Murayama, A; Ohta, K; Ito, Y; Aoki, J; Hirabayashi, Y; Kamiguchi, H				Guy, Adam T.; Nagatsuka, Yasuko; Ooashi, Noriko; Inoue, Mariko; Nakata, Asuka; Greimel, Peter; Inoue, Asuka; Nabetani, Takuji; Murayama, Akiho; Ohta, Kunihiro; Ito, Yukishige; Aoki, Junken; Hirabayashi, Yoshio; Kamiguchi, Hiroyuki			Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord	SCIENCE			English	Article							GROWTH-FACTOR; HL60 CELLS; DIFFERENTIATION; LYSOPHOSPHATIDYLINOSITOL; IDENTIFICATION; ACTIVATION; ANTIBODIES; RECEPTORS; PROTEINS; KINASE	Glycerophospholipids, the structural components of cell membranes, have not been considered to be spatial cues for intercellular signaling because of their ubiquitous distribution. We identified lyso-phosphatidyl-beta-D-glucoside (LysoPtdGlc), a hydrophilic glycerophospholipid, and demonstrated its role in modality-specific repulsive guidance of spinal cord sensory axons. LysoPtdGlc is locally synthesized and released by radial glia in a patterned spatial distribution to regulate the targeting of nociceptive but not proprioceptive central axon projections. Library screening identified the G protein-coupled receptor GPR55 as a high-affinity receptor for LysoPtdGlc, and GPR55 deletion or LysoPtdGlc loss of function in vivo caused the misallocation of nociceptive axons into proprioceptive zones. These findings show that LysoPtdGlc/GPR55 is a lipid-based signaling system in glia-neuron communication for neural development.	[Guy, Adam T.; Nagatsuka, Yasuko; Ooashi, Noriko; Inoue, Mariko; Nakata, Asuka; Greimel, Peter; Nabetani, Takuji; Hirabayashi, Yoshio; Kamiguchi, Hiroyuki] RIKEN Brain Sci Inst, Wako, Saitama 3510198, Japan; [Greimel, Peter] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Inoue, Asuka; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Murayama, Akiho; Ohta, Kunihiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Ito, Yukishige] RIKEN, Synthet Cellular Chem Lab, Wako, Saitama 3510198, Japan; [Aoki, Junken] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Chiyoda Ku, Tokyo 1000004, Japan	RIKEN; RIKEN; Tohoku University; Japan Science & Technology Agency (JST); University of Tokyo; RIKEN	Kamiguchi, H (corresponding author), RIKEN Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kamiguchi@brain.riken.jp	Kamiguchi, Hiroyuki/N-5409-2015; Ito, Yukishige/M-5119-2014; Ito, Yukishige/ACL-6203-2022	Kamiguchi, Hiroyuki/0000-0003-1802-6324; Ito, Yukishige/0000-0001-6251-7249; Ito, Yukishige/0000-0001-6251-7249; Greimel, Peter/0000-0002-4931-6183; Hirabayashi, Yoshio/0000-0002-5774-7354; Aoki, Junken/0000-0001-9435-1896	Japan Society for the Promotion of Science Foreign Postdoctoral Fellowships; AMED-CREST; PRESTO; Mizutani Foundation for Glycoscience; Naito Foundation; Platform for Dynamic Approaches to Living System; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22116001, 23114003, 24110519, 21200009]	Japan Society for the Promotion of Science Foreign Postdoctoral Fellowships; AMED-CREST; PRESTO; Mizutani Foundation for Glycoscience; Naito Foundation(Naito Memorial Foundation); Platform for Dynamic Approaches to Living System; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Shinoda, Y. Osaka, A. Shuto, H. Akiyama, and E. Stoeckli for technical assistance; S. Higashiyama, J. Miyazaki, and F. Lefcort for reagents; and C. Yokoyama for critical reading of the manuscript. Funding for this research was provided by Japan Society for the Promotion of Science Foreign Postdoctoral Fellowships (A.T.G. and P.G.), AMED-CREST (J. A.), PRESTO (A. I.), the Mizutani Foundation for Glycoscience (P.G.), a Naito Foundation Subsidy for Promotion of Specific Research Projects (Y. H.), the Platform for Dynamic Approaches to Living System (K.O. and A.M.), and a Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-Aid for Scientific Research (22116001 to J.A.) and for Scientific Research on Innovative Areas (23114003 to K.O. and A.M., 24110519 to Y.H., and 21200009 to H.K.). All reagents in this study are available from H.K. or Y.H. under a materials transfer agreement with RIKEN. The authors declare the following financial interests: Y.H., H.K., K.O., A.M., and RIKEN have a patent issued (20130142813) relating to the production of anti-LysoPtdGlc, and K.O. is an executive director of Chiome Bioscience Inc. The supplemental material contains additional data.	AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; Cole GJ, 1997, DEV BRAIN RES, V101, P225, DOI 10.1016/S0165-3806(97)00068-0; EIDE AL, 1995, J COMP NEUROL, V353, P247, DOI 10.1002/cne.903530207; Friedel RH, 1997, P NATL ACAD SCI USA, V94, P12670, DOI 10.1073/pnas.94.23.12670; Fu SY, 2000, J NEUROBIOL, V45, P227, DOI 10.1002/1097-4695(200012)45:4<227::AID-NEU4>3.0.CO;2-N; Gilchrist A, 1999, J BIOL CHEM, V274, P6610, DOI 10.1074/jbc.274.10.6610; Greimel P, 2008, BIOORGAN MED CHEM, V16, P7210, DOI 10.1016/j.bmc.2008.06.041; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Kinoshita MO, 2009, BIOCHEM J, V419, P565, DOI 10.1042/BJ20081896; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Nagatsuka Y, 2003, P NATL ACAD SCI USA, V100, P7454, DOI 10.1073/pnas.1232503100; Nagatsuka Y, 2006, BIOCHEMISTRY-US, V45, P8742, DOI 10.1021/bi0606546; Obara Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024284; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Ozaki S, 1997, J COMP NEUROL, V380, P215; Perez-Gomez E, 2013, ONCOGENE, V32, P2534, DOI 10.1038/onc.2012.278; Rifkin JT, 2000, DEV BIOL, V227, P465, DOI 10.1006/dbio.2000.9841; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Strochlic L, 2008, DEVELOPMENT, V135, P333, DOI 10.1242/dev.009563; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Yamazaki Y, 2006, J IMMUNOL METHODS, V311, P106, DOI 10.1016/j.jim.2006.01.019	25	74	76	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					974	977		10.1126/science.aab3516	http://dx.doi.org/10.1126/science.aab3516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315437				2022-12-28	WOS:000360646800053
J	Schwartz, JH; Tattersall, I				Schwartz, Jeffrey H.; Tattersall, Ian			Defining the genus Homo	SCIENCE			English	Editorial Material									[Schwartz, Jeffrey H.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA USA; [Tattersall, Ian] Amer Museum Nat Hist, Div Anthropol, New York, NY 10024 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; American Museum of Natural History (AMNH)	Schwartz, JH (corresponding author), Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA USA.	jhs@pitt.edu; iant@amnh.org						Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Blumenbach J. F., 1969, NATURAL VARIETIES MA, V1795; Blumenbach J. F., 1969, NATURAL VARIETIES MA, V1775; de Heinzelin J., 1999, NATURE, V284, P625; Dobzhansky T, 1944, AM J PHYS ANTHROP-NE, V2, P251, DOI 10.1002/ajpa.1330020303; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Linnaeus C.Von., 1735, SYSTEMA NATURAE REGN; MAYR E, 1950, COLD SPRING HARB SYM, V15, P109, DOI 10.1101/SQB.1950.015.01.013; Oakley KPBM, 1949, MAN THE TOOLMAKER; Robinson JT, 1954, AM J PHYS ANTHROP-NE, V12, P181, DOI 10.1002/ajpa.1330120216; Schwartz JH, 2005, HUMAN FOSSIL RECORD, V4; Spoor F, 2015, NATURE, V519, P83, DOI 10.1038/nature14224; TATTERSALL I, 2000, EXTINCT HUMANS; Villmoare B, 2015, SCIENCE, V347, P1352, DOI 10.1126/science.aaa1343; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65	15	25	26	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					931	932		10.1126/science.aac6182	http://dx.doi.org/10.1126/science.aac6182			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315422				2022-12-28	WOS:000360646800023
J	Lopez, A; Cacoub, P; Macdougall, IC; Peyrin-Biroulet, L				Lopez, Anthony; Cacoub, Patrice; Macdougall, Iain C.; Peyrin-Biroulet, Laurent			Iron deficiency anaemia	LANCET			English	Review							SOLUBLE TRANSFERRIN RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; FERRIC GLUCONATE COMPLEX; CHRONIC KIDNEY-DISEASE; INTRAVENOUS IRON; NATIONAL-HEALTH; SERUM FERRITIN; ORAL IRON; HEMODIALYSIS-PATIENTS; RHEUMATOID-ARTHRITIS	Anaemia affects roughly a third of the world's population; half the cases are due to iron deficiency. It is a major and global public health problem that affects maternal and child mortality, physical performance, and referral to health-care professionals. Children aged 0-5 years, women of childbearing age, and pregnant women are particularly at risk. Several chronic diseases are frequently associated with iron deficiency anaemia-notably chronic kidney disease, chronic heart failure, cancer, and inflammatory bowel disease. Measurement of serum ferritin, transferrin saturation, serum soluble transferrin receptors, and the serum soluble transferrin receptors-ferritin index are more accurate than classic red cell indices in the diagnosis of iron deficiency anaemia. In addition to the search for and treatment of the cause of iron deficiency, treatment strategies encompass prevention, including food fortification and iron supplementation. Oral iron is usually recommended as first-line therapy, but the most recent intravenous iron formulations, which have been available for nearly a decade, seem to replenish iron stores safely and effectively. Hepcidin has a key role in iron homoeostasis and could be a future diagnostic and therapeutic target. In this Seminar, we discuss the clinical presentation, epidemiology, pathophysiology, diagnosis, and acute management of iron deficiency anaemia, and outstanding research questions for treatment.	[Lopez, Anthony; Peyrin-Biroulet, Laurent] Lorraine Univ, Univ Hosp Nancy, Dept Hepatogastroenterol, F-54511 Vandoeuvre Les Nancy, France; [Lopez, Anthony; Peyrin-Biroulet, Laurent] Lorraine Univ, Univ Hosp Nancy, INSERM, U954, F-54511 Vandoeuvre Les Nancy, France; [Cacoub, Patrice] Univ Paris 06, Sorbonne Univ, UMR 7211, Paris, France; [Cacoub, Patrice] Inflammat Immunopathol Biotherapy Dept, F-75005 Paris, France; [Cacoub, Patrice] Grp Hosp Pitie Salpetriere, AP HP, Dept Internal Med & Clin Immunol, F-75013 Paris, France; [Macdougall, Iain C.] Kings Coll Hosp London, Dept Renal Med, London, England	CHU de Nancy; Universite de Lorraine; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; King's College Hospital NHS Foundation Trust; King's College Hospital	Peyrin-Biroulet, L (corresponding author), Univ Lorraine, Univ Hosp Nancy Brabois, Dept Hepatogastroenterol, Allee Morvan, F-54511 Vandoeuvre Les Nancy, France.	peyrinbiroulet@gmail.com		Cacoub, Patrice/0000-0002-6727-4992; peyrin-biroulet, laurent/0000-0003-2536-6618	Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Gilead; GlaxoSmithKline; Janssen; Merck Sharp Dohme; Pfizer; Roche; Servier; Vifor; AMAG; Vifor Pharma; Pharmacosmos; Takeda; Amgen; Ortho Biotech; Astellas; FibroGen; Noxxon; Merck; Abbott; Genentech; Mitsubishi; Ferring; Norgine; Tillots; Shire; Therakos; Pilege; BMS; UCB-pharma; Hospira; Celltrion; Biogaran; Lilly; HAC-Pharma	Abbvie(AbbVie); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Gilead(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Sharp Dohme(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); Servier(Servier); Vifor; AMAG; Vifor Pharma; Pharmacosmos; Takeda(Takeda Pharmaceutical Company Ltd); Amgen(Amgen); Ortho Biotech; Astellas(Astellas Pharmaceuticals); FibroGen; Noxxon; Merck(Merck & Company); Abbott(Abbott Laboratories); Genentech(Roche HoldingGenentech); Mitsubishi; Ferring(Ferring Pharmaceuticals); Norgine; Tillots; Shire; Therakos; Pilege; BMS(Bristol-Myers Squibb); UCB-pharma(UCB Pharma SA); Hospira; Celltrion; Biogaran; Lilly(Eli Lilly); HAC-Pharma	AL declares no competing interests. PC has done consultancy for, served on advisory boards for, or received honoraria or speakers' fees from Abbvie, AstraZeneca, Bayer, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Janssen, Merck Sharp & Dohme, Pfizer, Roche, Servier, and Vifor. He is an inventor of a patent application owned by his academic institution that is licensed to ILTOO, a biotechnology company developing low dose interleukin 2 in autoimmune diseases in which he holds shares. ICM has received speakers' fees and honoraria from AMAG, Vifor Pharma, Pharmacosmos, and Takeda; consulting fees from Amgen, Ortho Biotech, Roche, Bayer, Astellas, AstraZeneca, FibroGen; and research funding from AMAG, Vifor Pharma, Bayer, Astellas, and Noxxon. LP-B has received consulting fees from Merck, Abbott, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillots, Vifor, Shire, Therakos, Pharmacosmos, Pilege, BMS, UCB-pharma, Hospira, Celltrion, Takeda, Biogaran, Boehringer Ingelheim, Lilly, Pfizer, and HAC-Pharma, and lecture fees from Merck, Abbott, Takeda, Janssen, Ferring, Norgine, Tillots, Vifor, Therakos, and HAC-pharma.	Aigner E, 2014, NUTRIENTS, V6, P3587, DOI 10.3390/nu6093587; Albaramki J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007857.pub2; Allen RP, 2013, AM J HEMATOL, V88, P261, DOI 10.1002/ajh.23397; Andro M, 2013, EUR J NEUROL, V20, P1234, DOI 10.1111/ene.12175; [Anonymous], 2006, PREV CHEM HUM HELM C; [Anonymous], IRON DEFICIENCY IRON; Aydingoz IE, 1999, J EUR ACAD DERMATOL, V13, P65, DOI 10.1111/j.1468-3083.1999.tb00849.x; Bacchetta J, 2014, J AM SOC NEPHROL, V25, P564, DOI 10.1681/ASN.2013040355; Bager P, 2014, DAN MED J, V61; Bager P, 2011, SCAND J GASTROENTERO, V46, P304, DOI 10.3109/00365521.2010.533382; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bergsjo P, 2008, TROP MED INT HEALTH, V13, P272, DOI 10.1111/j.1365-3156.2007.02000.x; Blanton CA, 2013, BRIT J NUTR, V109, P906, DOI 10.1017/S0007114512002620; Brugnara C, 2006, CLIN LAB HAEMATOL, V28, P303, DOI 10.1111/j.1365-2257.2006.00812.x; Canadian Agency for Drugs and Technologies in Health, FER VERS OTH INTR IR; Cantor AG, 2015, ANN INTERN MED, V162, P566, DOI 10.7326/M14-2932; Caruso R, 2013, ANN MED, V45, P522, DOI 10.3109/07853890.2013.849383; Cogswell ME, 2009, AM J CLIN NUTR, V89, P1334, DOI 10.3945/ajcn.2008.27151; Congdon EL, 2012, J PEDIATR-US, V160, P1027, DOI 10.1016/j.jpeds.2011.12.011; Cook JD, 2005, BEST PRACT RES CL HA, V18, P319, DOI 10.1016/j.beha.2004.08.022; Cooke KS, 2013, BLOOD, V122, P3054, DOI 10.1182/blood-2013-06-505792; Das S, 2008, INDIAN J PATHOL MICR, V51, P105, DOI 10.4103/0377-4929.40418; de Benoist B, 2008, WHO GLOBAL DATABASE; De Falco L, 2013, HAEMATOLOGICA, V98, P845, DOI 10.3324/haematol.2012.075515; De-Regil Luz Maria, 2013, Evid Based Child Health, V8, P112, DOI 10.1002/ebch.1895; Eisele L, 2013, ANN HEMATOL, V92, P731, DOI 10.1007/s00277-013-1697-1; Enjuanes C, 2014, INT J CARDIOL, V174, P268, DOI 10.1016/j.ijcard.2014.03.169; Evstatiev R, 2011, GASTROENTEROLOGY, V141, P846, DOI 10.1053/j.gastro.2011.06.005; Faich G, 1999, AM J KIDNEY DIS, V33, P464, DOI 10.1016/S0272-6386(99)70183-6; Falkingham M, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-4; Fernandez-Gaxiola AC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009218.pub2; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Fourn L, 2004, Sante Publique, V16, P123; Gasche C, 2015, INFLAMM BOWEL DIS, V21, P579, DOI 10.1097/MIB.0000000000000314; Gilreath JA, 2014, AM J HEMATOL, V89, P203, DOI 10.1002/ajh.23628; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Goodnough LT, 2013, LANCET, V381, P1845, DOI 10.1016/S0140-6736(13)60650-9; GRIFFITHS R A, 1975, Age and Ageing, V4, P99, DOI 10.1093/ageing/4.2.99; Gudzune KA, 2013, OBES SURG, V23, P1581, DOI 10.1007/s11695-013-0919-x; Gulani A, 2007, BMJ-BRIT MED J, V334, P1095, DOI 10.1136/bmj.39150.510475.AE; GUYATT GH, 1992, J GEN INTERN MED, V7, P145, DOI 10.1007/BF02598003; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Harvey LJ, 2005, BRIT J NUTR, V94, P557, DOI 10.1079/BJN20051493; Hurrell RF, 1999, BRIT J NUTR, V81, P289, DOI 10.1017/S0007114599000537; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Infusino I, 2012, AM J CLIN PATHOL, V138, P642, DOI 10.1309/AJCP16NTXZLZFAIB; Itkonen O, 2012, CLIN CHEM, V58, P1158, DOI 10.1373/clinchem.2012.186916; Cancelo-Hidalgo MJ, 2013, CURR MED RES OPIN, V29, P291, DOI 10.1185/03007995.2012.761599; Jolobe OMP, 2000, CLIN LAB HAEMATOL, V22, P79, DOI 10.1046/j.1365-2257.2000.00293.x; Jonker FAM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001555; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Koehler K, 2012, EUR J APPL PHYSIOL, V112, P513, DOI 10.1007/s00421-011-2002-4; Kruske SG, 1999, J PAEDIATR CHILD H, V35, P153, DOI 10.1046/j.1440-1754.1999.t01-1-00351.x; Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729; Kulnigg S, 2008, AM J GASTROENTEROL, V103, P1182, DOI 10.1111/j.1572-0241.2007.01744.x; Labbe RF, 2004, CLIN BIOCHEM, V37, P165, DOI 10.1016/j.clinbiochem.2003.10.006; Lin XM, 2008, BRIT J NUTR, V99, P416, DOI 10.1017/S0007114507797040; Litton E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4822; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Malope BI, 2001, BRIT J HAEMATOL, V115, P84, DOI 10.1046/j.1365-2141.2001.03063.x; Martorell R, 2015, AM J CLIN NUTR, V101, P210, DOI 10.3945/ajcn.114.097709; Masson C, 2011, JOINT BONE SPINE, V78, P131, DOI 10.1016/j.jbspin.2010.05.017; Mast AE, 1998, CLIN CHEM, V44, P45; Matteson KA, 2012, J REPROD MED, V57, P17; McDermid JM, 2012, ADV NUTR, V3, P532, DOI 10.3945/an.112.002261; Mei ZG, 2011, AM J CLIN NUTR, V93, P1312, DOI 10.3945/ajcn.110.007195; Merle U, 2007, ENDOCRINOLOGY, V148, P2663, DOI 10.1210/en.2006-1331; Michael B, 2002, KIDNEY INT, V61, P1830, DOI 10.1046/j.1523-1755.2002.00314.x; Moore R Andrew, 2011, BMC Blood Disord, V11, P4, DOI 10.1186/1471-2326-11-4; Mozaheb Z, 2011, TRANSFUS MED HEMOTH, V38, P190, DOI 10.1159/000328812; Muhsen K, 2008, HELICOBACTER, V13, P323, DOI 10.1111/j.1523-5378.2008.00617.x; Nagaraju SP, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-64; Novacek G, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-36; Okam MM, 2012, AM J HEMATOL, V87, pE123, DOI 10.1002/ajh.23322; Peeling P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093002; Peslova G, 2009, BLOOD, V113, P6225, DOI 10.1182/blood-2009-01-201590; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pisani A, 2015, NEPHROL DIAL TRANSPL, V30, P645, DOI 10.1093/ndt/gfu357; Pitarresi G, 2008, EUR J PHARM BIOPHARM, V68, P267, DOI 10.1016/j.ejpb.2007.05.006; PIZARRO F, 1991, J PEDIATR-US, V118, P687, DOI 10.1016/S0022-3476(05)80027-7; Poli M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00086; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Quinn JV, 2004, ANN EMERG MED, V43, P224, DOI 10.1016/S0196-0644(03)00823-0; Radlowski EC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00585; Rampton D, 2014, HAEMATOLOGICA, V99, P1671, DOI 10.3324/haematol.2014.111492; Ravindran V, 2008, RHEUMATOL INT, V28, P507, DOI 10.1007/s00296-007-0476-5; Salgado W, 2014, SURG OBES RELAT DIS, V10, P49, DOI 10.1016/j.soard.2013.06.012; Sawada T, 2014, BIOL TRACE ELEM RES, V159, P22, DOI 10.1007/s12011-014-9963-1; Shashiraj, 2006, EUR J CLIN NUTR, V60, P903, DOI 10.1038/sj.ejcn.1602398; Steinbicker AU, 2013, NUTRIENTS, V5, P3034, DOI 10.3390/nu5083034; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Stoltzfus RJ, 2004, J NUTR, V134, P348, DOI 10.1093/jn/134.2.348; Terrier B, 2012, QJM-INT J MED, V105, P345, DOI 10.1093/qjmed/hcr230; Tessitore N, 2001, NEPHROL DIAL TRANSPL, V16, P1416, DOI 10.1093/ndt/16.7.1416; Thomas DW, 2013, BRIT J HAEMATOL, V161, P639, DOI 10.1111/bjh.12311; Trotti LM, 2012, COCHRANE DB SYST REV, V5; van Eijk LT, 2014, BLOOD, V124, P2643, DOI 10.1182/blood-2014-03-559484; van Santen S, 2011, ARTHRITIS RHEUM-US, V63, P3672, DOI 10.1002/art.30623; Van Wyck DB, 2007, OBSTET GYNECOL, V110, P267, DOI 10.1097/01.AOG.0000275286.03283.18; Wang W, 2013, HAEMOPHILIA, V19, P225, DOI 10.1111/hae.12046; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WHO, 2011, GUID INT IR SUPPL PR; WHO, 2001, IRON DEFICIENCY ANAE; WHO FAO UNICEF GAIN MI FFI, 2009, REC WHEAT MAIZ FLOUR; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2011, GUID INT IR FOL AC S; Wu YC, 2014, J FORMOS MED ASSOC, V113, P83, DOI 10.1016/j.jfma.2013.11.010; Zhang ZF, 2010, CHINESE MED J-PEKING, V123, P1924, DOI 10.3760/cma.j.issn.0366-6999.2010.14.017	111	634	668	35	318	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					907	916		10.1016/S0140-6736(15)60865-0	http://dx.doi.org/10.1016/S0140-6736(15)60865-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE9RA	26314490				2022-12-28	WOS:000370974400035
J	Wilcken, B				Wilcken, Bridget			Treatments for rare diseases: molybdenum cofactor deficiency	LANCET			English	Editorial Material							ENZYME REPLACEMENT THERAPY		[Wilcken, Bridget] Sydney Childrens Hosp Network, Sydney, NSW 2145, Australia; [Wilcken, Bridget] Univ Sydney, Sydney, NSW 2145, Australia	University of Sydney	Wilcken, B (corresponding author), Sydney Childrens Hosp Network, Sydney, NSW 2145, Australia.	bridget.wilcken@health.nsw.gov.au						Augustine EF, 2013, CURR TREAT OPTION NE, V15, P634, DOI 10.1007/s11940-013-0256-3; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; Harding CO, 2010, BIOL-TARGETS THER, V4, P231; Johnson JL., 2001, METABOLIC MOL BASES, P3163; Kanters TA, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-75; Kemper AR, 2010, GENET MED, V12, P539, DOI 10.1097/GIM.0b013e3181e85721; Kishnani PS, 2014, PEDIATR ENDOCR REV P, V12, P114; Matern D, 2015, SEMIN PERINATOL, V39, P206, DOI 10.1053/j.semperi.2015.03.005; Pitt JJ, 2002, CLIN CHEM, V48, P1970; Schwahn B. C., 2015, LANCET	10	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1924	1925		10.1016/S0140-6736(15)00125-7	http://dx.doi.org/10.1016/S0140-6736(15)00125-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26343841				2022-12-28	WOS:000364763200010
J	Siu, AL				Siu, Albert L.		US Preventive Serv Task Force	Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women to Improve Maternal Health and Birth Outcomes: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-DOSE IRON; PROPHYLACTIC IRON; CONTROLLED TRIAL; STATUS MARKERS; ERYTHROPOIETIN	Description: Update of the 2006 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for iron deficiency anemia. Methods: The USPSTF reviewed the evidence on the association between change in iron status as a result of intervention (oral supplementation or treatment) in pregnant women and adolescents and improvement in maternal and infant health outcomes. Population: This recommendation applies to pregnant women and adolescents living in the United States who do not have symptoms of iron deficiency anemia. It does not address pregnant women who are malnourished, have symptoms of iron deficiency anemia, or have special hematologic conditions or nutritional needs that may increase their need for iron. Recommendations: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency anemia in pregnant women to prevent adverse maternal health and birth outcomes. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation for pregnant women to prevent adverse maternal health and birth outcomes. (I statement)	[Siu, Albert L.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD 20850 USA		Siu, AL (corresponding author), US Prevent Serv Task Force, Rockville, MD 20850 USA.							American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V112, P201, DOI 10.1097/AOG.0b013e3181809c0d; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], AHRQ PUBLICATION; [Anonymous], 2011, CLIN PREV SERV WOM C; [Anonymous], SER TERR CONC ASS IR; [Anonymous], NUTR CONTENT US FOOD; [Anonymous], CLIN PREV SERV REC I; BARTON DPJ, 1994, AM J OBSTET GYNECOL, V170, P896, DOI 10.1016/S0002-9378(94)70305-1; Branum AM, 2013, J NUTR, V143, P486, DOI 10.3945/jn.112.169987; Cantor AG, 2015, ANN INTERN MED, V162, P566, DOI 10.7326/M14-2932; Chan KKL, 2009, BJOG-INT J OBSTET GY, V116, P789, DOI 10.1111/j.1471-0528.2008.02014.x; Cogswell ME, 2003, AM J CLIN NUTR, V78, P773, DOI 10.1093/ajcn/78.4.773; Eskeland B, 1997, ACTA OBSTET GYN SCAN, V76, P822, DOI 10.3109/00016349709024359; Falahi E, 2011, FOOD NUTR BULL, V32, P213, DOI 10.1177/156482651103200305; Makrides M, 2003, AM J CLIN NUTR, V78, P145, DOI 10.1093/ajcn/78.1.145; Mei ZG, 2011, AM J CLIN NUTR, V93, P1312, DOI 10.3945/ajcn.110.007195; Meier Paul R, 2003, Clin Med Res, V1, P29; MILMAN N, 1994, ACTA OBSTET GYN SCAN, V73, P200, DOI 10.3109/00016349409023439; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Reveiz L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003094.pub3; ROMSLO I, 1983, BRIT J OBSTET GYNAEC, V90, P101, DOI 10.1111/j.1471-0528.1983.tb08891.x; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Siega-Riz AM, 2006, AM J OBSTET GYNECOL, V194, P512, DOI 10.1016/j.ajog.2005.08.011; Yu SM, 1996, AM J PUBLIC HEALTH, V86, P240, DOI 10.2105/AJPH.86.2.240; Ziaei S, 2007, BJOG-INT J OBSTET GY, V114, P684, DOI 10.1111/j.1471-0528.2007.01325.x; Ziaei S, 2008, INT J GYNECOL OBSTET, V100, P130, DOI 10.1016/j.ijgo.2007.07.027	26	66	71	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2015	163	7					529	+		10.7326/M15-1707	http://dx.doi.org/10.7326/M15-1707			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0OQ	26344176				2022-12-28	WOS:000362496400006
J	Dewar, JM; Budzowska, M; Walter, JC				Dewar, James M.; Budzowska, Magda; Walter, Johannes C.			The mechanism of DNA replication termination in vertebrates	NATURE			English	Article							TOPOISOMERASE-II; CROSS-LINK; SIMIAN-VIRUS-40 DNA; MCM2-7 HELICASE; T-ANTIGEN; ASSOCIATION; CHROMATIN; COMPLEX; CDC45; GINS	Eukaryotic DNA replication terminates when replisomes from adjacent replication origins converge. Termination involves local completion of DNA synthesis, decatenation of daughter molecules and replisome disassembly. Termination has been difficult to study because termination events are generally asynchronous and sequence nonspecific. To overcome these challenges, we paused converging replisomes with a site-specific barrier in Xenopus egg extracts. Upon removal of the barrier, forks underwent synchronous and site-specific termination, allowing mechanistic dissection of this process. We show that DNA synthesis does not slow detectably as forks approach each other, and that leading strands pass each other unhindered before undergoing ligation to downstream lagging strands. Dissociation of the replicative CMG helicase (comprising CDC45, MCM2-7 and GINS) occurs only after the final ligation step, and is not required for completion of DNA synthesis, strongly suggesting that converging CMGs pass one another and dissociate from double-stranded DNA. This termination mechanism allows rapid completion of DNA synthesis while avoiding premature replisome disassembly.	[Dewar, James M.; Budzowska, Magda; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu		Dewar, James/0000-0003-4153-3818; Walter, Johannes/0000-0002-4186-7570	NIH [GM62267, GM80676]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267, R01GM080676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Richardson and members of the Walter laboratory for feedback on the manuscript. We thank K. J. Marians and J. T. Yeeles for plasmids and the Lacl purification protocol. J.C.W. was supported by NIH grants GM62267 and GM80676. J.C.W. is an investigator of the Howard Hughes Medical Institute.	Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Budzowska M, 2015, EMBO J, V34, P1971, DOI 10.15252/embj.201490878; Charbin A, 2014, NUCLEIC ACIDS RES, V42, P340, DOI 10.1093/nar/gkt882; CHEN MCY, 1976, J VIROL, V17, P614, DOI 10.1128/JVI.17.2.614-621.1976; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Czajkowsky DM, 2008, J MOL BIOL, V375, P12, DOI 10.1016/j.jmb.2007.10.046; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Espeli O, 2003, MOL CELL, V11, P189, DOI 10.1016/S1097-2765(03)00013-3; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Fanning E, 2009, VIROLOGY, V384, P352, DOI 10.1016/j.virol.2008.11.038; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gaggioli V, 2013, NUCLEIC ACIDS RES, V41, P7313, DOI 10.1093/nar/gkt494; HIASA H, 1994, J BIOL CHEM, V269, P26959; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; Hook SS, 2007, CURR OPIN CELL BIOL, V19, P663, DOI 10.1016/j.ceb.2007.10.007; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; ISHIMI Y, 1992, J BIOL CHEM, V267, P462; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Kang YH, 2012, P NATL ACAD SCI USA, V109, P6042, DOI 10.1073/pnas.1203734109; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; LASKEY RA, 1977, CELL, V10, P237, DOI 10.1016/0092-8674(77)90217-3; Lebofsky Ronald, 2009, V521, P229, DOI [10.1007/978-1-60327-817-5_13, 10.1007/978-1-60327-815-7_13]; LEVINE AJ, 1970, J MOL BIOL, V50, P549; Long DT, 2014, MOL CELL, V56, P174, DOI 10.1016/j.molcel.2014.08.012; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Loveland AB, 2012, NAT METHODS, V9, P987, DOI [10.1038/NMETH.2174, 10.1038/nmeth.2174]; Lucas I, 2001, EMBO J, V20, P6509, DOI 10.1093/emboj/20.22.6509; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596; McGuffee SR, 2013, MOL CELL, V50, P123, DOI 10.1016/j.molcel.2013.03.004; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Prokhorova TA, 2003, P NATL ACAD SCI USA, V100, P13241, DOI 10.1073/pnas.2336104100; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rudolph CJ, 2013, NATURE, V500, P608, DOI 10.1038/nature12312; Santamaria D, 2000, NUCLEIC ACIDS RES, V28, P2099, DOI 10.1093/nar/28.10.2099; SEGAWA M, 1980, J VIROL, V35, P320, DOI 10.1128/JVI.35.2.320-330.1980; SEIDMAN MM, 1979, J VIROL, V30, P600, DOI 10.1128/JVI.30.2.600-609.1979; Sofueva S, 2011, NUCLEIC ACIDS RES, V39, P6568, DOI 10.1093/nar/gkr340; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; TACK LC, 1983, J VIROL, V48, P281, DOI 10.1128/JVI.48.1.281-295.1983; TAPPER DP, 1978, J MOL BIOL, V120, P401, DOI 10.1016/0022-2836(78)90427-8; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Zhang JQ, 2015, NAT STRUCT MOL BIOL, V22, P242, DOI 10.1038/nsmb.2956	50	88	90	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					345	+		10.1038/nature14887	http://dx.doi.org/10.1038/nature14887			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26322582	Green Submitted, Green Accepted			2022-12-28	WOS:000361297900036
J	Zhang, K; Donnelly, CJ; Haeusler, AR; Grima, JC; Machamer, JB; Steinwald, P; Daley, EL; Miller, SJ; Cunningham, KM; Vidensky, S; Gupta, S; Thomas, MA; Hong, I; Chiu, SL; Huganir, RL; Ostrow, LW; Matunis, MJ; Wang, JO; Sattler, R; Lloyd, TE; Rothstein, JD				Zhang, Ke; Donnelly, Christopher J.; Haeusler, Aaron R.; Grima, Jonathan C.; Machamer, James B.; Steinwald, Peter; Daley, Elizabeth L.; Miller, Sean J.; Cunningham, Kathleen M.; Vidensky, Svetlana; Gupta, Saksham; Thomas, Michael A.; Hong, Ingie; Chiu, Shu-Ling; Huganir, Richard L.; Ostrow, Lyle W.; Matunis, Michael J.; Wang, Jiou; Sattler, Rita; Lloyd, Thomas E.; Rothstein, Jeffrey D.			The C9orf72 repeat expansion disrupts nucleocytoplasmic transport	NATURE			English	Article							NUCLEAR IMPORT; SEGREGATION DISTORTION; GGGGCC REPEAT; DROSOPHILA; MUTATIONS; TDP-43; GENE; ALS; NEURODEGENERATION; PROTEINS	The hexanucleotide repeat expansion (HRE) GGGGCC (G(4)C(2)) in C9orf72 is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recent studies support an HRE RNA gain-of-function mechanism of neurotoxicity, and we previously identified protein interactors for the G(4)C(2) RNA including RanGAP1. A candidate-based genetic screen in Drosophila expressing 30G(4)C(2) repeats identified RanGAP (Drosophila orthologue of human RanGAP1), a key regulator of nucleocytoplasmic transport, as a potent suppressor of neurodegeneration. Enhancing nuclear import or suppressing nuclear export of proteins also suppresses neurodegeneration. RanGAP physically interacts with HRE RNA and is mislocalized in HRE-expressing flies, neurons from C9orf72 ALS patient-derived induced pluripotent stem cells (iPSC-derived neurons), and in C9orf72 ALS patient brain tissue. Nuclear import is impaired as a result of HRE expression in the fly model and in C9orf72 iPSC-derived neurons, and these deficits are rescued by small molecules and antisense oligonucleotides targeting the HRE G-quadruplexes. Nucleocytoplasmic transport defects may be a fundamental pathway for ALS and FTD that is amenable to pharmacotherapeutic intervention.	[Zhang, Ke; Machamer, James B.; Cunningham, Kathleen M.; Gupta, Saksham; Ostrow, Lyle W.; Lloyd, Thomas E.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Donnelly, Christopher J.; Grima, Jonathan C.; Daley, Elizabeth L.; Miller, Sean J.; Vidensky, Svetlana; Thomas, Michael A.; Sattler, Rita; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD 21205 USA; [Haeusler, Aaron R.; Steinwald, Peter; Matunis, Michael J.; Wang, Jiou] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Biochem & Mol Biol, Baltimore, MD 21205 USA; [Grima, Jonathan C.; Hong, Ingie; Chiu, Shu-Ling; Huganir, Richard L.; Lloyd, Thomas E.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Rothstein, JD (corresponding author), Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD 21205 USA.	tlloyd4@jhmi.edu; jrothstein@jhmi.edu	Chiu, Shu-Ling/F-3613-2014; Donnelly, Christopher/AGI-7461-2022; Zhang, Ke/B-8598-2018; Chiu, Shu-Ling/AAC-9478-2022	Chiu, Shu-Ling/0000-0003-4429-7830; Zhang, Ke/0000-0002-4794-8355; Cunningham, Kathleen/0000-0002-1347-9087; Daley, Elizabeth/0000-0003-2342-452X; Matunis, Michael/0000-0002-9350-6611; Ostrow, Lyle/0000-0001-7158-5243; Hong, Ingie/0000-0002-7246-9233; Donnelly, Christopher/0000-0002-2383-9015; Haeusler, Aaron/0000-0001-5566-3707; Lloyd, Thomas/0000-0003-4756-3700	NIH [R01NS085207, NS091046, R01 NS082563, R01 NS074324, NS089616, CA009110]; Brain Science Institute; Robert Packard Center for ALS Research at Johns Hopkins; Muscular Dystrophy Association; Alzheimer's Drug Discovery Foundation; Judith and Jean Pape Adams Charitable Foundation; Alzheimer's Disease Research Center - Johns Hopkins; Maryland TEDCO; Target ALS Springboard Fellowship; William and Ella Owens Foundation; ALS Association; NIH K99 award [NS091486]; National Science Foundation Graduate Research Fellowship; Thomas Shortman Training Fund Graduate Scholarship; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947, R01GM060980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085207, R01NS094239, RC2NS069395, K99NS091486, R01NS074324, U54NS091046, R01NS089616, R01NS082563, U24NS078736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG012992] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute; Robert Packard Center for ALS Research at Johns Hopkins; Muscular Dystrophy Association(Muscular Dystrophy Association); Alzheimer's Drug Discovery Foundation; Judith and Jean Pape Adams Charitable Foundation; Alzheimer's Disease Research Center - Johns Hopkins; Maryland TEDCO; Target ALS Springboard Fellowship; William and Ella Owens Foundation; ALS Association; NIH K99 award; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Thomas Shortman Training Fund Graduate Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Michaelis for discussions; K. Russell, M. Elrick and J. Ravits for human tissue and/or human histological studies. We also thank the Hetzer Laboratory for the CMV-NLS-tdTomato-NES construct; B. Ganetzky and C. Staber for the Drosophila RanGAP antibody; P. Jin for the UAS-(G<INF>4</INF>C<INF>2</INF>)<INF>30</INF> fly stock; C. Svendsen for some control iPS cell lines; L. Petrucelli for the GP antibody; F. Hirth for the TBPH antibody. We thank the TRiP at Harvard Medical School (NIH/NIGMSR01-GM084947) for providing transgenic RNAi fly stocks used in this study. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. This work was supported by grants from NIH (R01NS085207 and NS091046 to J.D.R. and R.S., R01 NS082563 to T.E.L., R01 NS074324 and NS089616 to J.W.), Brain Science Institute, Robert Packard Center for ALS Research at Johns Hopkins, Muscular Dystrophy Association (J.D.R.), Alzheimer's Drug Discovery Foundation (J.D.R. and R.S.), Judith and Jean Pape Adams Charitable Foundation (J.W. and R.S.), Alzheimer's Disease Research Center - Johns Hopkins (R.S.), Maryland TEDCO (C.J.D. and J.W.), Target ALS Springboard Fellowship (C.J.D.), William and Ella Owens Foundation (R.S.), and ALS Association (T.E.L., R.S. and J.D.R.). K.Z. is a Milton Safenowitz fellow in the ALS Association. A.R.H. is a fellow on an NIH training grant (CA009110) and a recipient of an NIH K99 award (NS091486). J.C.G. and S. J. M. are recipients of a National Science Foundation Graduate Research Fellowship Award and J.C.G. is a recipient of the Thomas Shortman Training Fund Graduate Scholarship.	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; BRAND AH, 1993, DEVELOPMENT, V118, P401; Corbett AH, 2004, EMBO REP, V5, P453, DOI 10.1038/sj.embor.7400155; D'Angelo MA, 2012, DEV CELL, V22, P446, DOI 10.1016/j.devcel.2011.11.021; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Devlin AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6999; Diaper DC, 2013, HUM MOL GENET, V22, P1539, DOI 10.1093/hmg/ddt005; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; FRASCH M, 1991, EMBO J, V10, P1225, DOI 10.1002/j.1460-2075.1991.tb08064.x; Freibaum B. D., 2015, NATURE; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545; Kinoshita Y, 2009, J NEUROPATH EXP NEUR, V68, P1184, DOI 10.1097/NEN.0b013e3181bc3bec; Kusano A, 2002, P NATL ACAD SCI USA, V99, P6866, DOI 10.1073/pnas.102165099; Kusano A, 2001, DEV CELL, V1, P351, DOI 10.1016/S1534-5807(01)00042-9; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Machamer JB, 2014, HUM MOL GENET, V23, P3810, DOI 10.1093/hmg/ddu094; Merrill C, 1999, SCIENCE, V283, P1742, DOI 10.1126/science.283.5408.1742; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mor A, 2014, CURR OPIN CELL BIOL, V28, P28, DOI 10.1016/j.ceb.2014.01.007; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Nelson HB, 1997, GENETICS, V147, P1783; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Schmidt J, 2013, LEUKEMIA, V27, P2357, DOI 10.1038/leu.2013.172; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Steggerda SM, 2002, INT REV CYTOL, V217, P41; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Ward ME, 2014, J EXP MED, V211, P1937, DOI 10.1084/jem.20140214; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Zamiri B, 2014, J BIOL CHEM, V289, P4653, DOI 10.1074/jbc.C113.502336	47	621	627	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					56	+		10.1038/nature14973	http://dx.doi.org/10.1038/nature14973			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26308891	Green Accepted			2022-12-28	WOS:000360594100024
J	Downey, L; Houten, R; Murch, S; Longson, D				Downey, Laura; Houten, Rachel; Murch, Simon; Longson, Damien		Guideline Dev Grp	Recognition, assessment, and management of coeliac disease: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Downey, Laura; Houten, Rachel; Murch, Simon; Longson, Damien; Guideline Dev Grp] Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England	National Institute for Health & Care Excellence	Downey, L (corresponding author), Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England.	laura.downey@nice.org.uk	Burden, Sorrel/C-6101-2015; Downey, Laura/AAQ-7913-2021	Burden, Sorrel/0000-0002-4967-647X; Holdoway, Anne/0000-0003-0780-7707; Downey, Laura/0000-0002-9563-7113				Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; National Institute for Health and Care Excellence, 2009, DEPR AD CHR PHYS HLT; National Institute for Health and Care Excellence, 2015, REC MAN ASS COEL DIS; National Institute for Health and Care Excellence, 2013, SOC ANX DIS REC ASS; National Institute for Health and Care Excellence, 2005, DEPR CHILD YOUNG PEO; National Institute for Health and Care Excellence, GEN ANX DIS PAN DIS, P1011	6	63	65	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2015	351								h4513	10.1136/bmj.h4513	http://dx.doi.org/10.1136/bmj.h4513			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9JT	26333593				2022-12-28	WOS:000360931400003
J	Mirelman, A; Giladi, N; Hausdorff, JM				Mirelman, Anat; Giladi, Nir; Hausdorff, Jeffrey M.			Body-Fixed Sensors for Parkinson Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GAIT; INSIGHTS		[Mirelman, Anat; Giladi, Nir; Hausdorff, Jeffrey M.] Tel Aviv Sourasky Med Ctr, Ctr Study Movement Cognit & Mobil, Dept Neurol, 6Weizmann St, IL-64239 Tel Aviv, Israel; [Mirelman, Anat; Giladi, Nir] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Mirelman, A (corresponding author), Tel Aviv Sourasky Med Ctr, Ctr Study Movement Cognit & Mobil, Dept Neurol, 6Weizmann St, IL-64239 Tel Aviv, Israel.	anatmi@tlvmc.gov.il	Giladi, Nir/AAU-8660-2020	Giladi, Nir/0000-0003-1482-8522				Cole BT, 2014, IEEE T NEUR SYS REH, V22, P982, DOI 10.1109/TNSRE.2014.2310904; CuPiD, CLOS LOOP SYST PERS; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; Mirelman A, 2014, J AM GERIATR SOC, V62, P673, DOI 10.1111/jgs.12734; Mirelman A, 2013, MOVEMENT DISORD, V28, P1683, DOI 10.1002/mds.25587; Plotnik M, 2014, J NEUROL, V261, P1329, DOI 10.1007/s00415-014-7347-2; Weiss A, 2015, J NEURAL TRANSM, V122, P403, DOI 10.1007/s00702-014-1279-y; Weiss A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096675	8	20	20	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					873	874		10.1001/jama.2015.8530	http://dx.doi.org/10.1001/jama.2015.8530			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325552				2022-12-28	WOS:000360392100010
J	Young, L				Young, Linda			PHOTONICS A stable narrow-band X-ray laser	NATURE			English	Editorial Material							FREE-ELECTRON LASER; OPERATION		Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Young, L (corresponding author), Argonne Natl Lab, Xray Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	young@anl.gov						Ackermann W, 2007, NAT PHOTONICS, V1, P336, DOI 10.1038/nphoton.2007.76; Alessi D, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021023; Amann J, 2012, NAT PHOTONICS, V6, P693, DOI [10.1038/nphoton.2012.180, 10.1038/NPHOTON.2012.180]; DUGUAY MA, 1967, APPL PHYS LETT, V10, P350, DOI 10.1063/1.1728208; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; MAIMAN TH, 1960, NATURE, V187, P493, DOI 10.1038/187493a0; MATTHEWS DL, 1985, PHYS REV LETT, V54, P110, DOI 10.1103/PhysRevLett.54.110; Popmintchev T, 2012, SCIENCE, V336, P1287, DOI 10.1126/science.1218497; Reagan BA, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.053820; RITSON DM, 1987, NATURE, V328, P487, DOI 10.1038/328487a0; Rohringer N, 2012, NATURE, V481, P488, DOI 10.1038/nature10721; SUCKEWER S, 1985, PHYS REV LETT, V55, P1753, DOI 10.1103/PhysRevLett.55.1753; Weninger C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.233902; Yoneda H, 2015, NATURE, V524, P446, DOI 10.1038/nature14894	16	0	0	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					424	425		10.1038/524424a	http://dx.doi.org/10.1038/524424a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26310762				2022-12-28	WOS:000360069300028
J	Amiel, SA; Lawrence, RD; Pursey, N; Higgins, B; Dawoud, D				Amiel, Stephanie A.; Lawrence, R. D.; Pursey, Nancy; Higgins, Bernard; Dawoud, Dalia		Guideline Dev Grp	GUIDELINES Diagnosis and management of type 1 diabetes in adults: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STRUCTURED EDUCATION; SEVERE HYPOGLYCEMIA; INSULIN		[Amiel, Stephanie A.; Lawrence, R. D.] Kings Coll London, Div Diabet & Nutr Sci, London, England; [Pursey, Nancy] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Higgins, Bernard] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Coll Phys, Natl Clin Guideline Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Dawoud, Dalia] Cairo Univ, Fac Pharm, Royal Coll Phys, Natl Clin Guideline Ctr, Cairo, Egypt	University of London; King's College London; Royal College of Physicians; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Royal College of Physicians; Egyptian Knowledge Bank (EKB); Cairo University	Pursey, N (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	nancy.pursey@rcplondon.ac.uk	Malik, Rayaz/H-9231-2019; Dawoud, Dalia M/N-9741-2019	Malik, Rayaz/0000-0002-7188-8903; Dawoud, Dalia M/0000-0002-2105-1937				Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; [Anonymous], 2014, NATL DIABETES AUDIT; Elliott J, 2014, DIABETIC MED, V31, P847, DOI 10.1111/dme.12441; GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697; Hopkins D, 2012, DIABETES CARE, V35, P1638, DOI 10.2337/dc11-1579; Hopkinson HE, 2015, DIABETIC MED, V32, P1071, DOI 10.1111/dme.12806; Kruger J, 2013, DIABETIC MED, V30, P1236, DOI 10.1111/dme.12270; Livingstone SJ, 2015, JAMA-J AM MED ASSOC, V313, P37, DOI 10.1001/jama.2014.16425; National Institute for Health and Care Excellence, 2008, CONT SUBC INS INF TR; National Institute for Health and Care Excellence, 2011, DIAB AD QUAL STAND; National Institute for Health and Care Excellence, 2015, TYP 1 DIAB AD DIAGN, DOI DOI 10.1016/J.ANNEMERGMED.2013.12.004; Orchard TJ, 2015, JAMA-J AM MED ASSOC, V313, P45, DOI 10.1001/jama.2014.16107; Savage MW, 2011, DIABETIC MED, V28, P508, DOI 10.1111/j.1464-5491.2011.03246.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401	14	23	26	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2015	351								h4188	10.1136/bmj.h4188	http://dx.doi.org/10.1136/bmj.h4188			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2NJ	26311706				2022-12-28	WOS:000360437600001
J	Shrime, MG; Daniels, KM; Meara, JG				Shrime, Mark G.; Daniels, Kimberly M.; Meara, John G.			How much surgery is enough? Aligning surgical delivery with best-performing health systems	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Shrime, Mark G.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Shrime, Mark G.] Harvard Univ, Sch Publ Hlth, Dept Otol & Laryngol, Boston, MA 02115 USA; [Shrime, Mark G.] Massachusetts Eye & Ear Infirm, Off Global Surg, Boston, MA 02114 USA; [Shrime, Mark G.; Meara, John G.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA USA; [Daniels, Kimberly M.; Meara, John G.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital		shrime@mail.harvard.edu							0	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			13	13		10.1016/S0140-6736(15)60808-X	http://dx.doi.org/10.1016/S0140-6736(15)60808-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313059				2022-12-28	WOS:000360573400014
J	Matheson, N; Wals, K; Weekes, M; Rapiteanu, R; Vigan, R; Antrobus, R; Smith, D; Neil, S; Lehner, P				Matheson, Nicholas; Wals, Kim; Weekes, Michael; Rapiteanu, Radu; Vigan, Raphael; Antrobus, Robin; Smith, Duncan; Neil, Stuart; Lehner, Paul			Antagonism of aminoacid transport in primary CD4 T cells by HIV-1 Vpu	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Matheson, Nicholas; Wals, Kim; Weekes, Michael; Rapiteanu, Radu; Antrobus, Robin; Lehner, Paul] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Vigan, Raphael; Neil, Stuart] Kings Coll London, Dept Infect Dis, London WC2R 2LS, England; [Smith, Duncan] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England	University of Cambridge; University of London; King's College London; Paterson Institute for Cancer Research; University of Manchester		njm25@cam.ac.uk		Matheson, Nicholas/0000-0002-3318-1851; Rapiteanu, Radu/0000-0002-6900-3053	Wellcome Trust [101835] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			66	66						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312888				2022-12-28	WOS:000360570500066
J	Sedlis, SP; Lorin, JD				Sedlis, Steven P.; Lorin, Jeffrey D.			Percutaneous coronary intervention: FAME is lasting	LANCET			English	Editorial Material							FRACTIONAL FLOW RESERVE; PACLITAXEL-ELUTING STENTS; FOLLOW-UP; ANGIOGRAPHY; DISEASE		[Sedlis, Steven P.] Vet Affairs New York Harbor Hlth Care Syst, New York, NY 10010 USA; NYU, Sch Med, New York, NY 10010 USA	New York University	Sedlis, SP (corresponding author), Vet Affairs New York Harbor Hlth Care Syst, New York, NY 10010 USA.	steven.sedlis@med.va.gov		Sedlis, Steven/0000-0002-8194-8017				Dangas GD, 2013, JACC-CARDIOVASC INTE, V6, P914, DOI 10.1016/j.jcin.2013.05.005; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Hannawi B, 2014, TEX HEART I J, V41, P579, DOI 10.14503/THIJ-13-3917; Johnson NP, 2014, J AM COLL CARDIOL, V64, P1641, DOI 10.1016/j.jacc.2014.07.973; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012; Silber S, 2011, LANCET, V377, P1241, DOI 10.1016/S0140-6736(11)60395-4; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; van Nunen LX, 2015, LANCET, V386, P1853, DOI 10.1016/S0140-6736(15)00057-4; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2015	386	10006					1806	1807		10.1016/S0140-6736(15)00044-6	http://dx.doi.org/10.1016/S0140-6736(15)00044-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3VO	26333475				2022-12-28	WOS:000364194700013
J	Prives, C; Lowe, SW				Prives, Carol; Lowe, Scott W.			CANCER Mutant p53 and chromatin regulation	NATURE			English	Editorial Material							MUTATIONS		[Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	Columbia University; Memorial Sloan Kettering Cancer Center	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	clp3@columbia.edu; lowes@mskcc.org			NCI NIH HHS [P01 CA013106, P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Ford DJ, 2015, CANCER GENET-NY, V208, P178, DOI 10.1016/j.cancergen.2015.01.005; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Garcia PB, 2014, SEMIN CELL DEV BIOL, V27, P74, DOI 10.1016/j.semcdb.2013.12.014; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Pfister NT, 2015, GENE DEV, V29, P1298, DOI 10.1101/gad.263202.115; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Zhang P, 2013, BIOPOLYMERS, V99, P136, DOI 10.1002/bip.22126; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	14	16	17	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					199	200		10.1038/nature15212	http://dx.doi.org/10.1038/nature15212			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26331537	Green Accepted			2022-12-28	WOS:000360927400027
J	Wang, JZ; Li, HJ; Han, ZF; Zhang, HQ; Wang, T; Lin, GZ; Chang, JB; Yang, WC; Chai, JJ				Wang, Jizong; Li, Hongju; Han, Zhifu; Zhang, Heqiao; Wang, Tong; Lin, Guangzhong; Chang, Junbiao; Yang, Weicai; Chai, Jijie			Allosteric receptor activation by the plant peptide hormone phytosulfokine	NATURE			English	Article							STRUCTURAL INSIGHT; GROWTH-FACTOR; ARABIDOPSIS; CELLS; PERCEPTION; KINASES; BAK1; PROLIFERATION; SOFTWARE; IMMUNITY	Phytosulfokine (PSK) is a disulfated pentapeptide that has a ubiquitous role in plant growth and development(1,2). PSK is perceived by its receptor PSKR3,4, a leucine-rich repeat receptor kinase (LRR-RK). The mechanisms underlying the recognition of PSK, the activation of PSKR and the identity of the components downstream of the initial binding remain elusive. Here we report the crystal structures of the extracellular LRR domain of PSKR in free, PSK-and co-receptor-bound forms. The structures reveal that PSK interacts mainly with a b-strand from the island domain of PSKR, forming an anti-b-sheet. The two sulfate moieties of PSK interact directly with PSKR, sensitizing PSKR recognition of PSK. Supported by biochemical, structural and genetic evidence, PSK binding enhances PSKR heterodimerization with the somatic embryogenesis receptor-like kinases (SERKs). However, PSK is not directly involved in PSKR-SERK interaction but stabilizes PSKR island domain for recruitment of a SERK. Our data reveal the structural basis for PSKR recognition of PSK and allosteric activation of PSKR by PSK, opening up new avenues for the design of PSKR-specific small molecules.	[Wang, Jizong; Han, Zhifu; Zhang, Heqiao; Lin, Guangzhong; Chai, Jijie] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Ctr Struct Biol Sch Life Sci, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Li, Hongju; Wang, Tong; Yang, Weicai] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [Chang, Junbiao] Zhengzhou Univ, Sch Chem & Mol Engn, Zhengzhou 450001, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Zhengzhou University	Chai, JJ (corresponding author), Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Ctr Struct Biol Sch Life Sci, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China.	wcyang@genetics.ac.cn; chaijj@mail.tsinghua.edu.cn	Li, Hong-Ju/AHD-3987-2022; Yang, Wei-Cai/AAX-7879-2021	Yang, Wei-Cai/0000-0003-0252-7079; Chai, Jijie/0000-0001-7591-3873; Zhang, Heqiao/0000-0003-0314-1573; Wang, Jizong/0000-0003-1085-5347	Projects of International Cooperation and Exchanges NSFC [31420103906]; Chinese Ministry of Science and Technology [2015CB910200]; State Key Program of National Natural Science of China [31130063]; Chinese Natural Science Foundation [31330053]; Ministry of Science and Technology of China [2015CB910202]	Projects of International Cooperation and Exchanges NSFC; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank S. Huang and J. He for assistance with data collection, J. Li for the serk1, serk2, bak1 single and triple mutant seeds and W. Li and W. Chu for providing facility support. This research was funded by Projects of International Cooperation and Exchanges NSFC (31420103906), Chinese Ministry of Science and Technology (2015CB910200) and State Key Program of National Natural Science of China (31130063) to J.C.; Chinese Natural Science Foundation (31330053) to W.Y. and Ministry of Science and Technology of China (2015CB910202) to H.L.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Belkhadirl Y, 2014, TRENDS BIOCHEM SCI, V39, P447, DOI 10.1016/j.tibs.2014.06.006; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DeLano W.L., 2002, PYMOL MOL VIEWER; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fritz-Laylin LK, 2005, PLANT PHYSIOL, V138, P611, DOI 10.1104/pp.104.054452; Gou XP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002452; Han ZF, 2014, CURR OPIN PLANT BIOL, V20, P55, DOI 10.1016/j.pbi.2014.04.008; Hanai H, 2000, PLANT CELL PHYSIOL, V41, P27, DOI 10.1093/pcp/41.1.27; Hartmann J, 2014, PLANT J, V78, P192, DOI 10.1111/tpj.12460; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Heyman J, 2013, SCIENCE, V342, P860, DOI 10.1126/science.1240667; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Igarashi D, 2012, PLANT J, V71, P194, DOI 10.1111/j.1365-313X.2012.04950.x; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; Kutschmar A, 2009, NEW PHYTOL, V181, P820, DOI 10.1111/j.1469-8137.2008.02710.x; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Matsubayashi Y, 2006, PLANT PHYSIOL, V142, P45, DOI 10.1104/pp.106.081109; Matsubayashi Y, 2014, ANNU REV PLANT BIOL, V65, P385, DOI 10.1146/annurev-arplant-050312-120122; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Mosher S, 2013, PLANT J, V73, P469, DOI 10.1111/tpj.12050; Murphy E, 2012, PLANT CELL, V24, P3198, DOI 10.1105/tpc.112.099010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Stuhrwohldt N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021054; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	40	140	154	11	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					265	+		10.1038/nature14858	http://dx.doi.org/10.1038/nature14858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26308901				2022-12-28	WOS:000360927400042
J	Zhu, JJ; Sammons, MA; Donahue, G; Dou, ZX; Vedadi, M; Getlik, M; Barsyte-Lovejoy, D; Al-Awar, R; Katona, BW; Shilatifard, A; Huang, J; Hua, XX; Arrowsmith, CH; Berger, SL				Zhu, Jiajun; Sammons, Morgan A.; Donahue, Greg; Dou, Zhixun; Vedadi, Masoud; Getlik, Matthaus; Barsyte-Lovejoy, Dalia; Al-Awar, Rima; Katona, Bryson W.; Shilatifard, Ali; Huang, Jing; Hua, Xianxin; Arrowsmith, Cheryl H.; Berger, Shelley L.			Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth	NATURE			English	Article							MIXED-LINEAGE LEUKEMIA; LI-FRAUMENI-SYNDROME; HOX GENE-EXPRESSION; METHYLTRANSFERASE ACTIVITY; HISTONE METHYLTRANSFERASE; MLL; MENIN; TRANSCRIPTION; INHIBITORS; BINDING	TP53 (which encodes p53 protein) is the most frequently mutated gene among all human cancers. Prevalent p53 missense mutations abrogate its tumour suppressive function and lead to a 'gain-of-function' (GOF) that promotes cancer. Here we show that p53 GOF mutants bind to and upregulate chromatin regulatory genes, including the methyltransferases MLL1 (also known as KMT2A), MLL2 (also known as KMT2D), and acetyltransferase MOZ (also known as KAT6A or MYST3), resulting in genome-wide increases of histone methylation and acetylation. Analysis of The Cancer Genome Atlas shows specific upregulation of MLL1, MLL2, and MOZ in p53 GOF patient-derived tumours, but not in wild-type p53 or p53 null tumours. Cancer cell proliferation is markedly lowered by genetic knockdown of MLL1 or by pharmacological inhibition of the MLL1 methyltransferase complex. Our study reveals a novel chromatin mechanism underlying the progression of tumours with GOF p53, and suggests new possibilities for designing combinatorial chromatin-based therapies for treating individual cancers driven by prevalent GOF p53 mutations.	[Zhu, Jiajun; Sammons, Morgan A.; Donahue, Greg; Dou, Zhixun; Berger, Shelley L.] Univ Penn, Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhu, Jiajun; Sammons, Morgan A.; Donahue, Greg; Dou, Zhixun; Berger, Shelley L.] Univ Penn, Epigenet Program, Philadelphia, PA 19104 USA; [Zhu, Jiajun] Univ Penn, Perelman Sch Med, Biomed Grad Studies, Philadelphia, PA 19104 USA; [Vedadi, Masoud; Barsyte-Lovejoy, Dalia; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Vedadi, Masoud; Al-Awar, Rima] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada; [Getlik, Matthaus; Al-Awar, Rima] Ontario Inst Canc Res, Drug Discovery Program, Toronto, ON M5G 0A3, Canada; [Katona, Bryson W.; Hua, Xianxin] Univ Penn, Perelman Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Shilatifard, Ali] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA; [Huang, Jing] NCI, Canc & Stem Cell Epigenet, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 2C4, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C4, Canada	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; Structural Genomics Consortium; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Pennsylvania; Pennsylvania Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Berger, SL (corresponding author), Univ Penn, Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.	bergers@upenn.edu	Zhu, Jiajun/GQP-3551-2022; Huang, Jing/A-2566-2009; ZHU, JIAJUN/AAM-1459-2021; Zhu, Jiajun/R-6196-2016	Huang, Jing/0000-0002-7163-5156; Zhu, Jiajun/0000-0002-1760-3081; Berger, Shelley/0000-0001-5398-4400; Arrowsmith, Cheryl/0000-0002-4971-3250; Katona, Bryson/0000-0001-8186-9119	NIH [R01 CA078831, R01 GM069905]; American Cancer Society; ITMAT of the University of Pennsylvania; AbbVie; Bayer; Boehringer Ingelheim; Genome Canada through the Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Merck; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Canadian Cancer Society Research Institute; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA078831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069905] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); ITMAT of the University of Pennsylvania; AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Merck(Merck & Company); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Tainsky for the LFS cell lines; A. Weller, J. Glover and the Stem Cell and Xenograft Core at the University of Pennsylvania for help with the tumour xenograft experiments. S.L.B. is supported by NIH grant R01 CA078831. M.A.S. is supported by a Postdoctoral Fellowship from the American Cancer Society. X.H. is supported in part by a pilot grant from ITMAT of the University of Pennsylvania. A.S. is supported by NIH grant R01 GM069905. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, Genome Canada through the Ontario Genomics Institute (OGI-055), GlaxoSmithKline, Janssen, Lilly Canada, Merck, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (092809/Z/10/Z). Funding was also provided to C.H.A. from the Canadian Cancer Society Research Institute.	Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Garritano S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.15; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Grembecka J, 2012, NAT CHEM BIOL, V8, P277, DOI [10.1038/NCHEMBIO.773, 10.1038/nchembio.773]; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q; Karatas H, 2010, J MED CHEM, V53, P5179, DOI 10.1021/jm100139b; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Scian MJ, 2004, CANCER RES, V64, P7447, DOI 10.1158/0008-5472.CAN-04-1568; Senisterra G, 2013, BIOCHEM J, V449, P151, DOI 10.1042/BJ20121280; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Shi AB, 2012, BLOOD, V120, P4461, DOI 10.1182/blood-2012-05-429274; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Subramanian M, 2015, ONCOGENE, V34, P1094, DOI 10.1038/onc.2014.46; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Thiel AT, 2012, BIOESSAYS, V34, P771, DOI 10.1002/bies.201200007; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Xiong SB, 2014, P NATL ACAD SCI USA, V111, P11145, DOI 10.1073/pnas.1404139111; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Zhang C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3935; Zhu QZ, 2001, CANCER RES, V61, P64	42	292	300	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					206	+		10.1038/nature15251	http://dx.doi.org/10.1038/nature15251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26331536	Green Accepted			2022-12-28	WOS:000360927400029
J	Feudtner, C				Feudtner, Chris			Love at the End of the Beginning of Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Feudtner, Chris] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Feudtner, Chris] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Feudtner, C (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	feudtner@email.chop.edu	Feudtner, Chris/AAI-1126-2019	Feudtner, Chris/0000-0002-5879-0434					0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					1001	1002		10.1001/jama.2015.5944	http://dx.doi.org/10.1001/jama.2015.5944			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348747				2022-12-28	WOS:000360840700009
J	Freemantle, N; Ray, D; McNulty, D; Rosser, D; Bennett, S; Keogh, BE; Pagano, D				Freemantle, Nick; Ray, Daniel; McNulty, David; Rosser, David; Bennett, Simon; Keogh, Bruce E.; Pagano, Domenico			Increased mortality associated with weekend hospital admission: a case for expanded seven day services?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Freemantle, Nick] UCL, Dept Primary Care & Populat Hlth, London, England; [Freemantle, Nick; Ray, Daniel; McNulty, David; Pagano, Domenico] Univ Hosp Birmingham NHS Fdn Trust, Qual & Outcomes Res Unit, Birmingham, W Midlands, England; [Ray, Daniel; McNulty, David] Univ Hosp Birmingham NHS Fdn Trust, Dept Informat, Birmingham, W Midlands, England; [Ray, Daniel] UCL, Farr Inst Hlth Informat Res, London, England; [Rosser, David] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Bennett, Simon; Keogh, Bruce E.] NHS England, London, England; [Pagano, Domenico] Univ Hosp Birmingham NHS Fdn Trust, Dept Cardiothorac Surg, Birmingham, W Midlands, England	University of London; University College London; University of Birmingham; University of Birmingham; University of London; University College London; University of Birmingham; University of Birmingham	Pagano, D (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Qual & Outcomes Res Unit, Birmingham, W Midlands, England.; Pagano, D (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Dept Cardiothorac Surg, Birmingham, W Midlands, England.	Domenico.Pagano@uhb.nhs.uk						Academy of Royal Colleges, 7 DAY CONS PRES CAR; Clinical Indicators Team, 2015, IND SPEC SUMM HOSP L; Clover B., 2013, HLTH SERV J; Collins J., 2010, FDN EXCELLENCE EVALU; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Freemantle N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002018; General Medical Council, NAT TRAIN SURV 2012; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Health Education England, BETT TRAIN BETT CAR; Keogh B, 2013, REV QUALITY CARE TRE; NHS Commissioning Board, 2012, EV COUNTS PLANN PAT; Royal College of Physicians, 2010, POS STAT CAR MED PAT; Temple J., 2010, TIME TRAINING	13	176	177	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2015	351								h4596	10.1136/bmj.h4596	http://dx.doi.org/10.1136/bmj.h4596			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VJ1XN	26342923	Green Published, Green Submitted			2022-12-28	WOS:000550693600002
J	Boekhoven, J; Hendriksen, WE; Koper, GJM; Eelkema, R; van Esch, JH				Boekhoven, Job; Hendriksen, Wouter E.; Koper, Ger J. M.; Eelkema, Rienk; van Esch, Jan H.			Transient assembly of active materials fueled by a chemical reaction	SCIENCE			English	Article							SELF-ORGANIZATION; DYNAMICS	Fuel-driven self-assembly of actin filaments and microtubules is a key component of cellular organization. Continuous energy supply maintains these transient biomolecular assemblies far from thermodynamic equilibrium, unlike typical synthetic systems that spontaneously assemble at thermodynamic equilibrium. Here, we report the transient self-assembly of synthetic molecules into active materials, driven by the consumption of a chemical fuel. In these materials, reaction rates and fuel levels, instead of equilibrium composition, determine properties such as lifetime, stiffness, and self-regeneration capability. Fibers exhibit strongly nonlinear behavior including stochastic collapse and simultaneous growth and shrinkage, reminiscent of microtubule dynamics.	[Boekhoven, Job; Hendriksen, Wouter E.; Koper, Ger J. M.; Eelkema, Rienk; van Esch, Jan H.] Delft Univ Technol, Dept Chem Engn, NL-2628 BL Delft, Netherlands; [Eelkema, Rienk; van Esch, Jan H.] Delft Univ Technol, Delft Proc Technol Inst, NL-2628 BL Delft, Netherlands	Delft University of Technology; Delft University of Technology	Eelkema, R (corresponding author), Delft Univ Technol, Dept Chem Engn, Julianalaan 136, NL-2628 BL Delft, Netherlands.	r.eelkema@tudelft.nl; j.h.vanesch@tudelft.nl	Boekhoven, Job/HDN-4362-2022; van Esch, Jan H/E-5543-2011; Koper, Ger JM/G-3068-2011; Eelkema, Rienk/D-7349-2011	Boekhoven, Job/0000-0002-9126-2430; van Esch, Jan H/0000-0001-6116-4808; Koper, Ger JM/0000-0002-7673-9704; Eelkema, Rienk/0000-0002-2626-6371	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research through a Vici grant (J.B. and J.H.v.E.) and a Complexity program grant (W.E.H., G.J.M.K., R.E., and J.H.v.E.). We thank E. Mendes for stimulating discussions, M. C. A. Stuart (University of Groningen) for carrying out initial cryo-TEM experiments, B. Norder for the initial rheology experiments, M. Bus for the atomic force microscopy measurements, and L. Palmer (Northwestern University) for proofreading the manuscript. The authors have no competing interests. Full data are in the supplementary materials.	Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Boekhoven J, 2010, ANGEW CHEM INT EDIT, V49, P4825, DOI 10.1002/anie.201001511; Debnath S, 2013, J AM CHEM SOC, V135, P16789, DOI 10.1021/ja4086353; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Fialkowski M, 2006, J PHYS CHEM B, V110, P2482, DOI 10.1021/jp054153q; Gao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2040; Hirst AR, 2010, NAT CHEM, V2, P1089, DOI [10.1038/nchem.861, 10.1038/NCHEM.861]; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Keber FC, 2014, SCIENCE, V345, P1135, DOI 10.1126/science.1254784; Lagzi I, 2010, ANGEW CHEM INT EDIT, V49, P8616, DOI 10.1002/anie.201004231; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Pappas CG, 2015, ANGEW CHEM INT EDIT, V54, P8119, DOI 10.1002/anie.201500867; van Bommel KJC, 2005, ORG BIOMOL CHEM, V3, P2917, DOI 10.1039/b507157g; von Maltzahn G, 2007, ADV MATER, V19, P3579, DOI 10.1002/adma.200701183; Weiss R. G., 2006, MOL GELS MAT SELF AS; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Zhang DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2965	17	465	464	22	422	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1075	1079		10.1126/science.aac6103	http://dx.doi.org/10.1126/science.aac6103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339025				2022-12-28	WOS:000360628900036
J	Freibaum, BD; Lu, YB; Lopez-Gonzalez, R; Kim, NC; Almeida, S; Lee, KH; Badders, N; Valentine, M; Miller, BL; Wong, PC; Petrucelli, L; Kim, HJ; Gao, FB; Taylor, JP				Freibaum, Brian D.; Lu, Yubing; Lopez-Gonzalez, Rodrigo; Kim, Nam Chul; Almeida, Sandra; Lee, Kyung-Ha; Badders, Nisha; Valentine, Marc; Miller, Bruce L.; Wong, Philip C.; Petrucelli, Leonard; Kim, Hong Joo; Gao, Fen-Biao; Taylor, J. Paul			GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR-PORE COMPLEX; RNA-EXPORT MEDIATOR; STEM-CELL MODELS; MESSENGER-RNA; FRONTOTEMPORAL DEMENTIA; HEXANUCLEOTIDE REPEAT; MUTATIONS; NUCLEOPORINS; TRAFFICKING	The GGGGCC (G(4)C(2)) repeat expansion in a noncoding region of C9orf72 is the most common cause of sporadic and familial forms of amyotrophic lateral sclerosis and frontotemporal dementia(1,2). The basis for pathogenesis is unknown. To elucidate the consequences of G(4)C(2) repeat expansion in a tractable genetic system, we generated transgenic fly lines expressing 8, 28 or 58 G(4)C(2)-repeat-containing transcripts that do not have a translation start site (AUG) but contain an open-reading frame for green fluorescent protein to detect repeat-associated non-AUG (RAN) translation. We show that these transgenic animals display dosage-dependent, repeat-length-dependent degeneration in neuronal tissues and RAN translation of dipeptide repeat (DPR) proteins, as observed in patients with C9orf72-related disease. This model was used in a large-scale, unbiased genetic screen, ultimately leading to the identification of 18 genetic modifiers that encode components of the nuclear pore complex (NPC), as well as the machinery that coordinates the export of nuclear RNA and the import of nuclear proteins. Consistent with these results, we found morphological abnormalities in the architecture of the nuclear envelope in cells expressing expanded G(4)C(2) repeats in vitro and in vivo. Moreover, we identified a substantial defect in RNA export resulting in retention of RNA in the nuclei of Drosophila cells expressing expanded G(4)C(2) repeats and also in mammalian cells, including aged induced pluripotent stem-cell-derived neurons from patients with C9orf72-related disease. These studies show that a primary consequence of G(4)C(2) repeat expansion is the compromise of nucleocytoplasmic transport through the nuclear pore, revealing a novel mechanism of neurodegeneration.	[Freibaum, Brian D.; Kim, Nam Chul; Lee, Kyung-Ha; Badders, Nisha; Valentine, Marc; Kim, Hong Joo] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA; [Lu, Yubing; Lopez-Gonzalez, Rodrigo; Almeida, Sandra; Gao, Fen-Biao] Univ Massachusetts, Dept Neurol, Sch Med, Worcester, MA 01605 USA; [Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94158 USA; [Wong, Philip C.] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21205 USA; [Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Taylor, J. Paul] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Dept Cell & Mol Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; Johns Hopkins University; Mayo Clinic; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, Dept Cell & Mol Biol, Memphis, TN 38105 USA.	fen-biao.gao@umassmed.edu; jpaul.taylor@stjude.org	Lu, Yubing/G-2644-2011; Taylor, J. Paul/N-2482-2018; Lee, Kyung-Ha/GRY-2640-2022	Lu, Yubing/0000-0002-7715-9867; Taylor, J. Paul/0000-0002-5794-0349; Lee, Kyung-Ha/0000-0003-0515-7392; Kim, Nam Chul/0000-0003-1332-3071; Kim, Hong Joo/0000-0002-9157-1612	Target ALS; Packard Center for ALS Research at the Johns Hopkins University; ALS Association; ALS Therapy Alliance; NIH [N079725, NS079725, AG019724]; American-Lebanese-Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057553, R01NS079725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, P01AG019724] Funding Source: NIH RePORTER	Target ALS; Packard Center for ALS Research at the Johns Hopkins University; ALS Association; ALS Therapy Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American-Lebanese-Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Bloomington Drosophila Stock Center, the VDRC Stock Center, K. McKim and E. Baehrecke for fly lines, V. Budnik for Lamin Cantibody, as well as the Cell and Tissue Imaging Center at St Jude Children's Research Hospital and the University of Massachusetts Medical School Confocal Core for assistance. This work was supported by grants from Target ALS, The Packard Center for ALS Research at the Johns Hopkins University, and the ALS Association to F.-B.G., and J.P.T., and ALS Therapy Alliance, NIH (N079725) to F.-B.G., NIH (NS079725 and AG019724) to B.L.M., and the American-Lebanese-Syrian Associated Charities to J.P.T.	Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Almeida S, 2012, CELL REP, V2, P789, DOI 10.1016/j.celrep.2012.09.007; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Bonnet A, 2014, GENES-BASEL, V5, P767, DOI 10.3390/genes5030767; Cesario J, 2011, J CELL SCI, V124, P3797, DOI 10.1242/jcs.084855; Chang CT, 2013, EMBO J, V32, P473, DOI 10.1038/emboj.2012.342; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cronshaw JM, 2004, TRENDS ENDOCRIN MET, V15, P34, DOI 10.1016/j.tem.2003.11.005; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Makise M, 2012, J BIOL CHEM, V287, P38515, DOI 10.1074/jbc.M112.378893; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mor A, 2014, CURR OPIN CELL BIOL, V28, P28, DOI 10.1016/j.ceb.2014.01.007; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Smith R, 2011, JOVE-J VIS EXP, DOI 10.3791/2676; van Blitterswijk M, 2012, CURR OPIN NEUROL, V25, P689, DOI 10.1097/WCO.0b013e32835a3efb; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Wu MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076000; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	36	521	523	2	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					129	+		10.1038/nature14974	http://dx.doi.org/10.1038/nature14974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26308899	Green Accepted			2022-12-28	WOS:000360594100039
J	Nicholls, A; Jacoby, J; Hartley, R; O'Connor, D				Nicholls, A.; Jacoby, J.; Hartley, R.; O'Connor, D.			Squamous cell carcinoma of the nail bed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nicholls, A.; Hartley, R.; O'Connor, D.] Poole Hosp NHS Trust, Dept Trauma & Orthopaed, Poole BH15 2JB, Dorset, England; [Jacoby, J.] Poole Hosp NHS Trust, Dept Radiol, Poole BH15 2JB, Dorset, England		Nicholls, A (corresponding author), Poole Hosp NHS Trust, Dept Trauma & Orthopaed, Poole BH15 2JB, Dorset, England.	alexnicholls@doctors.org.uk	Lai, Chung-Sheng/AAL-8778-2021	Lai, Chung-Sheng/0000-0002-1298-9325					0	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2015	351								h4640	10.1136/bmj.h4640	http://dx.doi.org/10.1136/bmj.h4640			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ9JT	26333426				2022-12-28	WOS:000360931400006
J	Mody, RJ; Wu, YM; Lonigro, RJ; Cao, XH; Roychowdhury, S; Vats, P; Frank, KM; Prensner, JR; Asangani, I; Palanisamy, N; Dillman, JR; Rabah, RM; Kunju, LP; Everett, J; Raymond, VM; Ning, Y; Su, FY; Wang, R; Stoffel, EM; Innis, JW; Roberts, JS; Robertson, PL; Yanik, G; Chamdin, A; Connelly, JA; Choi, S; Harris, AC; Kitko, C; Rao, RJ; Levine, JE; Castle, VP; Hutchinson, RJ; Talpaz, M; Robinson, DR; Chinnaiyan, AM				Mody, Rajen J.; Wu, Yi-Mi; Lonigro, Robert J.; Cao, Xuhong; Roychowdhury, Sameek; Vats, Pankaj; Frank, Kevin M.; Prensner, John R.; Asangani, Irfan; Palanisamy, Nallasivam; Dillman, Jonathan R.; Rabah, Raja M.; Kunju, Laxmi Priya; Everett, Jessica; Raymond, Victoria M.; Ning, Yu; Su, Fengyun; Wang, Rui; Stoffel, Elena M.; Innis, Jeffrey W.; Roberts, J. Scott; Robertson, Patricia L.; Yanik, Gregory; Chamdin, Aghiad; Connelly, James A.; Choi, Sung; Harris, Andrew C.; Kitko, Carrie; Rao, Rama Jasty; Levine, John E.; Castle, Valerie P.; Hutchinson, Raymond J.; Talpaz, Moshe; Robinson, Dan R.; Chinnaiyan, Arul M.			Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDRENS ONCOLOGY GROUP; INCIDENTAL FINDINGS; GENE FUSIONS; RHABDOMYOSARCOMA; REARRANGEMENTS; ATTITUDES; KINASE; TUMORS	IMPORTANCE Cancer is caused by a diverse array of somatic and germline genomic aberrations. Advances in genomic sequencing technologies have improved the ability to detect these molecular aberrations with greater sensitivity. However, integrating them into clinical management in an individualized manner has proven challenging. OBJECTIVE To evaluate the use of integrative clinical sequencing and genetic counseling in the assessment and treatment of children and young adults with cancer. DESIGN, SETTING, AND PARTICIPANTS Single-site, observational, consecutive case series (May 2012-October 2014) involving 102 children and young adults (mean age, 10.6 years; median age, 11.5 years, range, 0-22 years) with relapsed, refractory, or rare cancer. EXPOSURES Participants underwent integrative clinical exome (tumor and germline DNA) and transcriptome (tumor RNA) sequencing and genetic counseling. Results were discussed by a precision medicine tumor board, which made recommendations to families and their physicians. MAIN OUTCOMES AND MEASURES Proportion of patients with potentially actionable findings, results of clinical actions based on integrative clinical sequencing, and estimated proportion of patients or their families at risk of future cancer. RESULTS Of the 104 screened patients, 102 enrolled with 91 (89%) having adequate tumor tissue to complete sequencing. Only the 91 patients were included in all calculations, including 28 (31%) with hematological malignancies and 63 (69%) with solid tumors. Forty-two patients (46%) had actionable findings that changed their cancer management: 15 of 28 (54%) with hematological malignancies and 27 of 63 (43%) with solid tumors. Individualized actions were taken in 23 of the 91 (25%) based on actionable integrative clinical sequencing findings, including change in treatment for 14 patients (15%) and genetic counseling for future risk for 9 patients (10%). Nine of 91 (10%) of the personalized clinical interventions resulted in ongoing partial clinical remission of 8 to 16 months or helped sustain complete clinical remission of 6 to 21 months. All 9 patients and families with actionable incidental genetic findings agreed to genetic counseling and screening. CONCLUSIONS AND RELEVANCE In this single-center case series involving young patients with relapsed or refractory cancer, incorporation of integrative clinical sequencing data into clinical management was feasible, revealed potentially actionable findings in 46% of patients, and was associated with change in treatment and family genetic counseling for a small proportion of patients. The lack of a control group limited assessing whether better clinical outcomes resulted from this approach than outcomes that would have occurred with standard care.	[Mody, Rajen J.; Frank, Kevin M.; Innis, Jeffrey W.; Robertson, Patricia L.; Yanik, Gregory; Connelly, James A.; Choi, Sung; Harris, Andrew C.; Rao, Rama Jasty; Levine, John E.; Castle, Valerie P.; Hutchinson, Raymond J.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Mody, Rajen J.; Wu, Yi-Mi; Lonigro, Robert J.; Cao, Xuhong; Vats, Pankaj; Prensner, John R.; Asangani, Irfan; Palanisamy, Nallasivam; Ning, Yu; Su, Fengyun; Wang, Rui; Robinson, Dan R.; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Mody, Rajen J.; Lonigro, Robert J.; Robertson, Patricia L.; Yanik, Gregory; Connelly, James A.; Choi, Sung; Harris, Andrew C.; Kitko, Carrie; Rao, Rama Jasty; Levine, John E.; Castle, Valerie P.; Hutchinson, Raymond J.; Talpaz, Moshe; Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Wu, Yi-Mi; Cao, Xuhong; Asangani, Irfan; Rabah, Raja M.; Kunju, Laxmi Priya; Robinson, Dan R.; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Roychowdhury, Sameek; Talpaz, Moshe] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Prensner, John R.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Dillman, Jonathan R.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Everett, Jessica; Raymond, Victoria M.; Stoffel, Elena M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Roberts, J. Scott] Univ Michigan, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Chamdin, Aghiad] Michigan State Univ, Dept Pediat, E Lansing, MI 48824 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Michigan State University; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Howard Hughes Med Inst, Ctr Canc, Room 5316,1400 E Med Ctr Dr,SPC 5940, Ann Arbor, MI 48109 USA.	arul@umich.edu	Harris, Andrew C./L-5499-2019; Vats, Pankaj/AAL-1443-2020; Palanisamy, Nallasivam/ABC-8844-2020	Palanisamy, Nallasivam/0000-0002-0633-9772; Everett, Jessica/0000-0002-4894-8891; Harris, Andrew/0000-0002-4538-8817; asangani, irfan/0000-0001-5381-1702; Prensner, John/0000-0002-7024-636X; Vats, Pankaj/0000-0001-8441-7732; Talpaz, Moshe/0000-0003-3361-3981; Levine, John/0000-0002-5611-7828	National Institutes of Health Clinical Sequencing Exploratory Research Award [1UM1HG006508]; Prostate Cancer Foundation; Good Charity Inc; Raymond and Eva Shapiro family; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006508] Funding Source: NIH RePORTER	National Institutes of Health Clinical Sequencing Exploratory Research Award; Prostate Cancer Foundation; Good Charity Inc; Raymond and Eva Shapiro family; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grant 1UM1HG006508 from the National Institutes of Health Clinical Sequencing Exploratory Research Award, the Prostate Cancer Foundation, Mr Tim Wadham, Good Charity Inc, and the Raymond and Eva Shapiro family.	[Anonymous], 2011, PRECISION MED BUILDI; Bourgeois JM, 2000, AM J SURG PATHOL, V24, P937, DOI 10.1097/00000478-200007000-00005; BRADFORD R, 1985, NEUROSURGERY, V17, P101, DOI 10.1227/00006123-198507000-00019; Carbone M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-179; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Fernandez CV, 2009, J CLIN ONCOL, V27, P878, DOI 10.1200/JCO.2008.18.5223; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; Goltsov A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00013; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Haga SB, 2011, GENET MED, V13, P723, DOI 10.1097/GIM.0b013e31821afcc0; Janeway KA, 2013, J CLIN ONCOL, V31, P1893, DOI 10.1200/JCO.2012.46.8470; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; London WB, 2011, J CLIN ONCOL, V29, P3286, DOI 10.1200/JCO.2010.34.3392; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Moroz V, 2011, EUR J CANCER, V47, P561, DOI 10.1016/j.ejca.2010.10.022; Mosquera JM, 2013, GENE CHROMOSOME CANC, V52, P538, DOI 10.1002/gcc.22050; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Nand R, 2009, LEUKEMIA RES, V33, P1144, DOI 10.1016/j.leukres.2009.03.011; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; O'Brien SG, 2002, BLOOD, V99, P3465, DOI 10.1182/blood.V99.9.3465; Oberlin O, 2008, J CLIN ONCOL, V26, P2384, DOI 10.1200/JCO.2007.14.7207; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Sumegi J, 2010, GENE CHROMOSOME CANC, V49, P224, DOI 10.1002/gcc.20731; Tabor HK, 2011, J EMPIR RES HUM RES, V6, P41, DOI 10.1525/jer.2011.6.4.41; Thiele CJ, 2012, CLIN CANCER RES, V18, P2735, DOI 10.1158/1078-0432.CCR-11-1940; Vaishnavi A, 2013, NAT MED, V19, P1469, DOI 10.1038/nm.3352; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Widemann BC, 2012, CLIN CANCER RES, V18, P6011, DOI 10.1158/1078-0432.CCR-11-3284; Wilfond BS, 2008, J LAW MED ETHICS, V36, P332, DOI 10.1111/j.1748-720X.2008.00277.x; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	39	251	253	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					913	925		10.1001/jama.2015.10080	http://dx.doi.org/10.1001/jama.2015.10080			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325560	Bronze, Green Accepted			2022-12-28	WOS:000360392100018
J	Touma, JR; Sridhar, S				Touma, Jihad R.; Sridhar, S.			The disruption of multiplanet systems through resonance with a binary orbit	NATURE			English	Article							STELLAR MULTIPLICITY; PLANETARY SYSTEM; PERTURBATIONS; EVOLUTION; ORIGIN; COMPANIONS; MIGRATION	Most exoplanetary systems in binary stars are of S-type, and consist of one or more planets orbiting a primary star with a wide binary stellar companion(1,2). Planetary eccentricities and mutual inclinations can be large(3,4), perhaps forced gravitationally by the binary companion(4-6). Earlier work on single planet systems(5,7-10) appealed to the Kozai-Lidov instability(11,12) wherein a sufficiently inclined binary orbit excites large-amplitude oscillations in the planet's eccentricity and inclination. The instability, however, can be quenched by many agents that induce fast orbital precession, including mutual gravitational forces in a multiplanet system(5,13). Here we report that orbital precession, which inhibits Kozai-Lidov cycling in a multiplanet system, can become fast enough to resonate with the orbital motion of a distant binary companion. Resonant binary forcing results in dramatic outcomes ranging from the excitation of large planetary eccentricities and mutual inclinations to total disruption. Processes such as planetary migration(14,15) can bring an initially non-resonant system into resonance. As it does not require special physical or initial conditions, binary resonant driving is generic and may have altered the architecture of many multiplanet systems. It can also weaken the multiplanet occurrence rate in wide binaries, and affect planet formation in close binaries.	[Touma, Jihad R.] Amer Univ Beirut, Dept Phys, Beirut 11072020, Lebanon; [Sridhar, S.] Raman Res Inst, Bangalore 560080, Karnataka, India	American University of Beirut; Department of Science & Technology (India); Raman Research Institute (RRI)	Touma, JR (corresponding author), Amer Univ Beirut, Dept Phys, POB 11-0236, Beirut 11072020, Lebanon.	jihad.touma@aub.edu.lb	Sridhar, S/D-4895-2012					Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Dvorak R., 1982, Sitzungsberichte. Oesterreichische Akademie der Wissenschaften, Mathematisch-Naturwissenschaftliche Klasse, Abteilung II (Mathematische, Physikalische und Technische Wissenschaften), V191, P423; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Hahn JM, 2005, ASTRON J, V130, P2392, DOI 10.1086/452638; Holman M, 1997, NATURE, V386, P254, DOI 10.1038/386254a0; Kaib NA, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L24; Katz B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.181101; KOZAI Y, 1962, ASTRON J, V67, P591, DOI 10.1086/108790; Levison H. F., 2007, PROTOSTARS PLANETS, P669; LIDOV ML, 1962, PLANET SPACE SCI, V9, P719, DOI 10.1016/0032-0633(62)90129-0; Lithwick Y, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/94; Lykawka PS, 2009, MON NOT R ASTRON SOC, V398, P1715, DOI 10.1111/j.1365-2966.2009.15243.x; MALHOTRA R, 1993, NATURE, V365, P819, DOI 10.1038/365819a0; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Murray N, 1998, SCIENCE, V279, P69, DOI 10.1126/science.279.5347.69; Poveda A., 2007, IAU S, V240, P417; Rafikov RR, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/2/69; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Rein H., 2012, PREPRINT; Takeda G, 2008, ASTROPHYS J, V683, P1063, DOI 10.1086/589852; Tamuz O, 2008, ASTRON ASTROPHYS, V480, pL33, DOI 10.1051/0004-6361:20078737; Touma J, 1998, ASTRON J, V115, P1653, DOI 10.1086/300312; Touma JR, 2009, MON NOT R ASTRON SOC, V394, P1085, DOI 10.1111/j.1365-2966.2009.14409.x; Wang J, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/111; Wang J, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/4; Wu Y, 2003, ASTROPHYS J, V589, P605, DOI 10.1086/374598	29	10	10	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					439	441		10.1038/nature14873	http://dx.doi.org/10.1038/nature14873			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26310763	Green Submitted			2022-12-28	WOS:000360069300031
J	Vanmaekelbergh, D				Vanmaekelbergh, Daniel			MATERIALS SCIENCE Superlattice substitution	NATURE			English	Editorial Material							NANOCRYSTALS; ATTACHMENT		Univ Utrecht, Debye Inst Nanomat Sci, Dept Chem, NL-3584 CC Utrecht, Netherlands	Utrecht University	Vanmaekelbergh, D (corresponding author), Univ Utrecht, Debye Inst Nanomat Sci, Dept Chem, NL-3584 CC Utrecht, Netherlands.	d.vanmaekelbergh@uu.nl						Boneschanscher MP, 2014, SCIENCE, V344, P1377, DOI 10.1126/science.1252642; Cargnello M, 2015, NATURE, V524, P450, DOI 10.1038/nature14872; Evers WH, 2010, NANO LETT, V10, P4235, DOI 10.1021/nl102705p; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Schliehe C, 2010, SCIENCE, V329, P550, DOI 10.1126/science.1188035; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Talapin DV, 2012, MRS BULL, V37, P63, DOI 10.1557/mrs.2011.337; Vanmaekelbergh D, 2011, NANO TODAY, V6, P419, DOI 10.1016/j.nantod.2011.06.005; Zolotavin P, 2012, ACS NANO, V6, P8094, DOI 10.1021/nn302709d	10	0	0	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					418	419		10.1038/524418a	http://dx.doi.org/10.1038/524418a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26310760				2022-12-28	WOS:000360069300023
J	Matousek, A; Paik, K; Winkler, E; Denike, J; Addington, SR; Exe, C; Louis, RREJ; Riviello, R				Matousek, Alexi; Paik, Ken; Winkler, Eric; Denike, Jennifer; Addington, Stephen R.; Exe, Chauvet; Louis, Rodolphe R. E. Jean; Riviello, Robert			Community health workers and smartphones for the detection of surgical site infections in rural Haiti: a pilot study	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Matousek, Alexi; Addington, Stephen R.; Riviello, Robert] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Paik, Ken; Winkler, Eric] MIT, Sana, Cambridge, MA 02139 USA; [Denike, Jennifer; Exe, Chauvet; Louis, Rodolphe R. E. Jean] Hop Albert Schweitzer, Gabon, Haiti	Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT)		amatousek@partners.org							0	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			47	47		10.1016/S0140-6736(15)60842-X	http://dx.doi.org/10.1016/S0140-6736(15)60842-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313096	Bronze			2022-12-28	WOS:000360573400048
J	Jose, R; Williams, A; Sulikowski, M; Brealey, D; Brown, J; Chambers, R				Jose, Ricardo; Williams, Andrew; Sulikowski, Michal; Brealey, David; Brown, Jeremy; Chambers, Rachel			Regulation of neutrophilic inflammation in lung injury induced by community-acquired pneumonia	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Jose, Ricardo; Williams, Andrew; Sulikowski, Michal; Brown, Jeremy; Chambers, Rachel] UCL, Ctr Inflammat & Tissue Repair, London WC1E 6JF, England; [Brealey, David] Univ Coll London Hosp, Dept Intens Care Med, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London		r.jose@ucl.ac.uk	Brealey, David/AAL-1777-2021	Brown, Jeremy/0000-0002-5650-5361; Brealey, David/0000-0002-1982-3379					0	21	23	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			52	52		10.1016/S0140-6736(15)60367-1	http://dx.doi.org/10.1016/S0140-6736(15)60367-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312874	Bronze			2022-12-28	WOS:000360570500052
J	Asin, MAPJ; Robles, GR				Perez-Jacoiste Asin, Maria Asuncion; Ruiz Robles, Gemma			Skull erythropoiesis in a patient with congenital dyserythropoietic anaemia	LANCET			English	Editorial Material									[Perez-Jacoiste Asin, Maria Asuncion; Ruiz Robles, Gemma] Univ Hosp 12 Octubre, Dept Internal Med, Madrid 28041, Spain	Hospital Universitario 12 de Octubre	Asin, MAPJ (corresponding author), Univ Hosp 12 Octubre, Madrid 28041, Spain.	mperezja82@hotmail.com							0	3	3	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2016	387	10020					787	787		10.1016/S0140-6736(15)00054-9	http://dx.doi.org/10.1016/S0140-6736(15)00054-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE1WU	26321260				2022-12-28	WOS:000370418000038
J	Jasin, M				Jasin, Maria			Accolades for the DNA Damage Response	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ESCHERICHIA-COLI B		Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Jasin, M (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [R01CA185660] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; WITKIN EM, 1974, P NATL ACAD SCI USA, V71, P1930, DOI 10.1073/pnas.71.5.1930; WITKIN EM, 1967, P NATL ACAD SCI USA, V57, P1275, DOI 10.1073/pnas.57.5.1275; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	5	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2015	373	16					1492	1495		10.1056/NEJMp1509698	http://dx.doi.org/10.1056/NEJMp1509698			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VX	26348215				2022-12-28	WOS:000362880300005
J	Manaker, S				Manaker, Scott			Time to Get Off the Diagnosis Dime Onto the 10th Revision of the International Classification of Diseases	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Manaker, S (corresponding author), Hosp Univ Penn, Dept Med, 100 Centrex Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	scott.manaker@uphs.upenn.edu						American Academy of Professional Coders, 2015, ICD 10 COD TRANSL; American College of Physicians, 2015, ICD 10; Carr Kimberly Janet, 2013, Healthc Financ Manage, V67, P118; Centers for Medicare & Medicaid Services, 2015, 2016 ICD 10 CM GEMS; Centers for Medicare & Medicaid Services, MED COV DAT; Medical Group Management Association, 2014, ICD 10 IMPL STUD JAN; Moriyama IM, 2011, HIST STAT CLASSIFICA; Office of the Secretary HHS, 2014, FED REGISTER, V79, P45128; US Department of Health and Human Services Federal Register, 2015, FED REG; Walker RL, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-149	10	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2015	163	7					557	+		10.7326/M15-1773	http://dx.doi.org/10.7326/M15-1773			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT0OQ	26344554				2022-12-28	WOS:000362496400010
J	Alarcon, CR; Goodarzi, H; Lee, H; Liu, XH; Tavazoie, S; Tavazoie, SF				Alarcon, Claudio R.; Goodarzi, Hani; Lee, Hyeseung; Liu, Xuhang; Tavazoie, Saeed; Tavazoie, Sohail F.			HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events	CELL			English	Article							MESSENGER-RNA; PRIMARY MICRORNAS; METHYLATION; REVEALS; N-6-METHYLADENOSINE; COMPLEX; M6A; N6-METHYLADENOSINE; IDENTIFICATION; SPECIFICITY	N-6-methyladenosine (m(6)A) is the most abundant internal modification of messenger RNA. While the presence of m(6)A on transcripts can impact nuclear RNA fates, a reader of this mark that mediates processing of nuclear transcripts has not been identified. We find that the RNA-binding protein HNRNPA2B1 binds m(6)A-bearing RNAs in vivo and in vitro and its biochemical footprint matches the m(6)A consensus motif. HNRNPA2B1 directly binds a set of nuclear transcripts and elicits similar alternative splicing effects as the m(6)A writer METTL3. Moreover, HNRNPA2B1 binds to m(6)A marks in a subset of primary miRNA transcripts, interacts with the microRNA Microprocessor complex protein DGCR8, and promotes primary miRNA processing. Also, HNRNPA2B1 loss and METTL3 depletion cause similar processing defects for these pri-miRNA precursors. We propose HNRNPA2B1 to be a nuclear reader of the m(6)A mark and to mediate, in part, this mark's effects on primary microRNA processing and alternative splicing.	[Alarcon, Claudio R.; Goodarzi, Hani; Lee, Hyeseung; Liu, Xuhang; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Tavazoie, Saeed] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Tavazoie, Saeed] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA	Rockefeller University; Columbia University; Columbia University	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu		Goodarzi, Hani/0000-0002-9648-8949	Robert S. Bennett Postdoctoral Fellowship; Debra and Leon Black Challenge Grant; Ruth L. Kirschstein National Research Service Award from the NIH [T32CA009673-36A1]; National Human Genome Research Institute [R01 HG003219]; Department of Defense Breast Cancer Collaborative Scholars and Innovators Award; NATIONAL CANCER INSTITUTE [K99CA194077, T32CA009673, R00CA194077] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003219] Funding Source: NIH RePORTER	Robert S. Bennett Postdoctoral Fellowship; Debra and Leon Black Challenge Grant; Ruth L. Kirschstein National Research Service Award from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Defense Breast Cancer Collaborative Scholars and Innovators Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to Alexander Nguyen for insightful comments and technical advice. We thank C. Zhao and C. Lai of the Rockefeller Genomics Resource Center for expert assistance with next-generation RNA sequencing. C.R.A. is the recipient of the Robert S. Bennett Postdoctoral Fellowship and is supported by the Debra and Leon Black Challenge Grant. H.G. is currently the recipient of a Ruth L. Kirschstein National Research Service Award from the NIH (T32CA009673-36A1). S.F.T. is a Department of Defense Era of Hope Scholar and a Department of Defense Breast Cancer Collaborative Scholars and Innovators Award recipient. S.T. was supported by the National Human Genome Research Institute (R01 HG003219).	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; CARROLL SM, 1990, MOL CELL BIOL, V10, P4456, DOI 10.1128/MCB.10.9.4456; CSEPANY T, 1990, J BIOL CHEM, V265, P20117; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; GRANADINO B, 1990, EMBO J, V9, P2597, DOI 10.1002/j.1460-2075.1990.tb07441.x; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Horiuchi K, 2013, J BIOL CHEM, V288, P33292, DOI 10.1074/jbc.M113.500397; Jaffrey SR, 2014, NAT STRUCT MOL BIOL, V21, P945, DOI 10.1038/nsmb.2911; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Ortega A, 2003, J BIOL CHEM, V278, P3040, DOI 10.1074/jbc.M210737200; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; ROTTMAN FM, 1994, BIOCHIMIE, V76, P1109, DOI 10.1016/0300-9084(94)90038-8; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; SCHIBLER U, 1977, J MOL BIOL, V115, P695, DOI 10.1016/0022-2836(77)90110-3; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; STOLTZFUS CM, 1982, J VIROL, V42, P918, DOI 10.1128/JVI.42.3.918-931.1982; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1974, P NATL ACAD SCI USA, V71, P3014, DOI 10.1073/pnas.71.8.3014; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151	45	723	773	10	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1299	1308		10.1016/j.cell.2015.08.011	http://dx.doi.org/10.1016/j.cell.2015.08.011			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26321680	Bronze, Green Accepted			2022-12-28	WOS:000361247900019
J	Eshel, N; Bukwich, M; Rao, V; Hemmelder, V; Tian, J; Uchida, N				Eshel, Neir; Bukwich, Michael; Rao, Vinod; Hemmelder, Vivian; Tian, Ju; Uchida, Naoshige			Arithmetic and local circuitry underlying dopamine prediction errors	NATURE			English	Article							VENTRAL TEGMENTAL AREA; NEGATIVE REWARD SIGNALS; LATERAL HABENULA; GABA NEURONS; IN-VIVO; RESPONSES; INHIBITION; MODEL; REPRESENTATION; INTERNEURONS	Dopamine neurons are thought to facilitate learning by comparing actual and expected reward(1,2). Despite two decades of investigation, little is known about how this comparison is made. To determine how dopamine neurons calculate prediction error, we combined optogenetic manipulations with extracellular recordings in the ventral tegmental area while mice engaged in classical conditioning. Here we demonstrate, by manipulating the temporal expectation of reward, that dopamine neurons perform subtraction, a computation that is ideal for reinforcement learning but rarely observed in the brain. Furthermore, selectively exciting and inhibiting neighbouring GABA (c-aminobutyric acid) neurons in the ventral tegmental area reveals that these neurons are a source of subtraction: they inhibit dopamine neurons when reward is expected, causally contributing to prediction-error calculations. Finally, bilaterally stimulating ventral tegmental area GABA neurons dramatically reduces anticipatory licking to conditioned odours, consistent with an important role for these neurons in reinforcement learning. Together, our results uncover the arithmetic and local circuitry underlying dopamine prediction errors.	[Eshel, Neir; Bukwich, Michael; Rao, Vinod; Hemmelder, Vivian; Tian, Ju; Uchida, Naoshige] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University	Uchida, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	uchida@mcb.harvard.edu	Eshel, Neir/AAV-5548-2021; Snyder, Lawrence H/A-4593-2017; Core, Vector/CAF-4832-2022	Eshel, Neir/0000-0002-5976-2013; Uchida, Naoshige/0000-0002-5755-9409	Sackler Fellowship in Psychobiology; National Institutes of Health [T32GM007753, F30MH100729, R01MH095953, R01MH101207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095953, R25MH094612, F30MH100729, R01MH101207] Funding Source: NIH RePORTER	Sackler Fellowship in Psychobiology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Andermann, J. Assad, R. Born, J. Buckholtz, P. Glimcher, J. Maunsell, B. Sabatini, W. Schultz, R. Wilson, andmembers of the Uchida laboratory for comments on the manuscript; S. Haesler for technical expertise and discussions on experimental design; E. Molnar for histology assistance; C. Dulac for sharing resources; K. Deisseroth for the AAV-FLEX-ChR2 construct; and E. Boyden for the AAV-FLEX-ArchT construct. This work was supported by a Sackler Fellowship in Psychobiology (N.E.) and National Institutes of Health grants T32GM007753 (to N.E.), F30MH100729 (to N.E.), R01MH095953 (to N.U.), and R01MH101207 (to N.U.).	Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Ayaz A, 2009, J NEUROPHYSIOL, V101, P958, DOI 10.1152/jn.90547.2008; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BUSH RR, 1951, PSYCHOL REV, V58, P313, DOI 10.1037/h0054388; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Fiorillo CD, 2013, J NEUROSCI, V33, P4710, DOI 10.1523/JNEUROSCI.3883-12.2013; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hazy TE, 2010, NEUROSCI BIOBEHAV R, V34, P701, DOI 10.1016/j.neubiorev.2009.11.019; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Houk JC, 1995, MODELS INFORMATION P, P249; Kawato M, 2007, CURR OPIN NEUROBIOL, V17, P205, DOI 10.1016/j.conb.2007.03.004; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Ludvig EA, 2008, NEURAL COMPUT, V20, P3034, DOI 10.1162/neco.2008.11-07-654; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Murphy BK, 2003, J NEUROSCI, V23, P10040; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Omelchenko N, 2009, SYNAPSE, V63, P895, DOI 10.1002/syn.20668; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rivest F, 2014, BIOL CYBERN, V108, P23, DOI 10.1007/s00422-013-0575-1; Roy JE, 2004, J NEUROSCI, V24, P2102, DOI 10.1523/JNEUROSCI.3988-03.2004; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Tan CO, 2008, J NEUROSCI, V28, P10062, DOI 10.1523/JNEUROSCI.0259-08.2008; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Vitay J, 2014, FRONT NEUROROBOTICS, V8, P1, DOI 10.3389/fnbot.2014.00004; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347	39	178	177	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					243	+		10.1038/nature14855	http://dx.doi.org/10.1038/nature14855			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26322583	Green Accepted			2022-12-28	WOS:000360927400037
J	Crump, H				Crump, Helen			Seven day working: why the health secretary's proposal is not as simple as it sounds	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Crump, Helen] Nuffield Trust, Hlth Policy, London, England		Crump, H (corresponding author), Nuffield Trust, Hlth Policy, London, England.	helen.crump@nuffieldtrust.org.uk						Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; Campbell D., 2015, GUARDIAN; Chesterfield Royal Hospital NHS Foundation Trust, RED MED ROT EN SEN C; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; Healthcare Financial Management Association NHS England, 2013, NHS SERV 7 DAY SERV; Hunt J., 2015, SPEECH; Meacock R., 2015, GUEST POST EC ELEVAT; NCEPOD, 2005, ABD AORT AN SERV NEE; *NHS ENGL, 2013, NHS SERV 7 DAYS WEEK	11	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2015	351								h4473	10.1136/bmj.h4473	http://dx.doi.org/10.1136/bmj.h4473			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VJ1XN	26347532				2022-12-28	WOS:000550693600001
J	Rowe, MJ				Rowe, M. John, III			Beliefs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jvrowe96@gmail.com						American Medical Association, OP 2 211 PHYS ASS SU; EDDY DM, 1994, JAMA-J AM MED ASSOC, V272, P179, DOI 10.1001/jama.272.3.179	2	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					877	878		10.1001/jama.2015.2146	http://dx.doi.org/10.1001/jama.2015.2146			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325554				2022-12-28	WOS:000360392100012
J	Hegazy, AN; Powrie, F				Hegazy, Ahmed N.; Powrie, Fiona			Microbiota RORgulates intestinal suppressor T cells	SCIENCE			English	Editorial Material							DIFFERENTIATION; INFLAMMATION; IMMUNITY		[Hegazy, Ahmed N.; Powrie, Fiona] Univ Oxford, Nuffeld Dept Orthopaed Rheumatol & Musculoskeleta, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Hegazy, Ahmed N.; Powrie, Fiona] Univ Oxford, Nuffeld Dept Clin Med, John Radclif Hosp, Translat Gastroenterol Unit,Expt Med Div, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Hegazy, AN (corresponding author), Univ Oxford, Nuffeld Dept Orthopaed Rheumatol & Musculoskeleta, Kennedy Inst Rheumatol, Oxford OX3 7FY, England.	fiona.powrie@kennedy.ox.ac.uk		Hegazy, Ahmed N./0000-0002-2946-8251	European Molecular Biology Organization [ALTF 116-2012]; Wellcome Trust; Wellcome Trust [095688/Z/11/Z] Funding Source: researchfish	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	A.N.H. was supported by a European Molecular Biology Organization fellowship (ALTF 116-2012) and currently is a Marie Curie fellow (FP7-PEOPLE-2012-IEF, Proposal 330621). F.P. is supported by a Wellcome Trust Investigator Award.	Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456	12	24	26	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					929	930		10.1126/science.aad0865	http://dx.doi.org/10.1126/science.aad0865			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315421				2022-12-28	WOS:000360646800022
J	Silver, SA; Shah, PM; Chertow, GM; Harel, S; Wald, R; Harel, Z				Silver, Samuel A.; Shah, Prakesh M.; Chertow, Glenn M.; Harel, Shai; Wald, Ron; Harel, Ziv			Risk prediction models for contrast induced nephropathy: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE KIDNEY INJURY; PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR RISK; COMPUTED-TOMOGRAPHY; PREPROCEDURAL SCORE; CLINICAL-OUTCOMES; ANGIOGRAPHY; VALIDATION; PREVENTION; DERIVATION	OBJECTIVES To look at the available literature on validated prediction models for contrast induced nephropathy and describe their characteristics. DESIGN Systematic review. DATA SOURCES Medline, Embase, and CINAHL (cumulative index to nursing and allied health literature) databases. REVIEW METHODS Databases searched from inception to 2015, and the retrieved reference lists hand searched. Dual reviews were conducted to identify studies published in the English language of prediction models tested with patients that included derivation and validation cohorts. Data were extracted on baseline patient characteristics, procedural characteristics, modelling methods, metrics of model performance, risk of bias, and clinical usefulness. Eligible studies evaluated characteristics of predictive models that identified patients at risk of contrast induced nephropathy among adults undergoing a diagnostic or interventional procedure using conventional radiocontrast media (media used for computed tomography or angiography, and not gadolinium based contrast). RESULTS 16 studies were identified, describing 12 prediction models. Substantial interstudy heterogeneity was identified, as a result of different clinical settings, cointerventions, and the timing of creatinine measurement to define contrast induced nephropathy. Ten models were validated internally and six were validated externally. Discrimination varied in studies that were validated internally (C statistic 0.61-0.95) and externally (0.57-0.86). Only one study presented reclassification indices. The majority of higher performing models included measures of pre-existing chronic kidney disease, age, diabetes, heart failure or impaired ejection fraction, and hypotension or shock. No prediction model evaluated its effect on clinical decision making or patient outcomes. CONCLUSIONS Most predictive models for contrast induced nephropathy in clinical use have modest ability, and are only relevant to patients receiving contrast for coronary angiography. Further research is needed to develop models that can better inform patient centred decision making, as well as improve the use of prevention strategies for contrast induced nephropathy.	[Silver, Samuel A.; Harel, Shai; Wald, Ron; Harel, Ziv] Univ Toronto, St Michaels Hosp, Div Nephrol, Toronto, ON, Canada; [Shah, Prakesh M.] Univ Toronto, Mt Sinai Hosp, Dept Paediat, Toronto, ON M5G 1X5, Canada; [Chertow, Glenn M.] Stanford Univ, Div Nephrol, Sch Med, Palo Alto, CA 94304 USA; [Wald, Ron; Harel, Ziv] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5C 2T2, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Stanford University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Harel, Z (corresponding author), Univ Toronto, St Michaels Hosp, Div Nephrol, Toronto, ON, Canada.	harelz@smh.ca	Shah, Prakesh S/I-8098-2013; Shah, Prakesh/AAA-9884-2020	Chertow, Glenn/0000-0002-7599-0534	Kidney Research Scientist Core Education; National Training Program; Kidney Foundation of Canada; Canadian Society of Nephrology; Canadian Institutes of Health Research	Kidney Research Scientist Core Education; National Training Program; Kidney Foundation of Canada; Canadian Society of Nephrology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; SAS is supported by a postdoctoral fellowship through the Kidney Research Scientist Core Education and National Training Program (cofunded by the Kidney Foundation of Canada, Canadian Society of Nephrology, and Canadian Institutes of Health Research); no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Adams ST, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8312; Alhosaini MN, 2010, RENAL FAILURE, V32, P928, DOI 10.3109/0886022X.2010.502280; Anderson SM, 2011, ANN PHARMACOTHER, V45, P101, DOI 10.1345/aph.1P275; Bartholomew BA, 2004, AM J CARDIOL, V93, P1515, DOI 10.1016/j.amjcard.2004.03.008; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; Brown JR, 2014, CIRC-CARDIOVASC QUAL, V7, P693, DOI 10.1161/CIRCOUTCOMES.114.000903; Chen YL, 2014, CATHETER CARDIO INTE, V83, pE8, DOI 10.1002/ccd.25109; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Christiansen C, 2005, TOXICOLOGY, V209, P185, DOI 10.1016/j.tox.2004.12.020; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; Fu NK, 2013, ANGIOLOGY, V64, P188, DOI 10.1177/0003319712467224; Gao YM, 2014, CLIN EXP NEPHROL, V18, P892, DOI 10.1007/s10157-014-0942-9; Ghani AA, 2009, SAUDI J KIDNEY DIS T, V20, P240; Goo JJ, 2014, KOREAN J INTERN MED, V29, P203, DOI 10.3904/kjim.2014.29.2.203; Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; Guitterez Noel V, 2002, J Interv Cardiol, V15, P349; Gurm HS, 2013, J AM COLL CARDIOL, V61, P2242, DOI 10.1016/j.jacc.2013.03.026; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; James MT, 2013, CIRC-CARDIOVASC INTE, V6, P37, DOI 10.1161/CIRCINTERVENTIONS.112.974493; Kidney Disease: Improving Global Outcomes (KDIGO), 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Kwok CS, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120272; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Liu Y, 2015, INT J CARDIOL, V180, P69, DOI 10.1016/j.ijcard.2014.11.133; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Maioli M, 2010, J CARDIOVASC MED, V11, P444, DOI 10.2459/JCM.0b013e328335227c; Marenzi G, 2004, J AM COLL CARDIOL, V44, P1780, DOI 10.1016/j.jacc.2004.07.043; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Mitchell AM, 2010, CLIN J AM SOC NEPHRO, V5, P4, DOI 10.2215/CJN.05200709; Owen R, 2011, CONSENSUS GUIDELINES; Pannu N, 2006, JAMA-J AM MED ASSOC, V295, P2765, DOI 10.1001/jama.295.23.2765; Rao QA, 2006, RADIOLOGY, V239, P392, DOI 10.1148/radiol.2392050413; Reddan D, 2008, EUR J RADIOL, V66, P235, DOI 10.1016/j.ejrad.2007.05.012; Sgura FA, 2010, CIRC-CARDIOVASC INTE, V3, P491, DOI 10.1161/CIRCINTERVENTIONS.110.955310; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tangri N, 2013, ANN INTERN MED, V158, P596, DOI 10.7326/0003-4819-158-8-201304160-00004; Toll DB, J CLIN EPIDEMIOL; Tziakas D, 2013, INT J CARDIOL, V163, P46, DOI 10.1016/j.ijcard.2011.05.079; Tziakas D, 2014, AM J CARDIOL, V113, P1487, DOI 10.1016/j.amjcard.2014.02.004; Victor Suma M, 2014, Indian Heart J, V66, P517, DOI 10.1016/j.ihj.2014.05.025; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Weisbord SD, 2013, CLIN J AM SOC NEPHRO, V8, P1618, DOI 10.2215/CJN.11161012; Steven DW, 2010, CURR OPIN NEPHROL HY, V19, P539, DOI 10.1097/MNH.0b013e32833d42e3; Yealy DM, 2003, NEW ENGL J MED, V349, P2553, DOI 10.1056/NEJMe038184	47	102	108	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2015	351								h4395	10.1136/bmj.h4395	http://dx.doi.org/10.1136/bmj.h4395			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2NP	26316642	Green Published, hybrid			2022-12-28	WOS:000360438200001
J	Daniel, H; Sulmasy, LS				Daniel, Hilary; Sulmasy, Lois Snyder		American Coll Physicians	Policy Recommendations to Guide the Use of Telemedicine in Primary Care Settings: An American College of Physicians Position Paper	ANNALS OF INTERNAL MEDICINE			English	Review							SPECIALTY CARE; DISEASE MANAGEMENT; TELEHEALTH; SAVINGS; IMPACT; ADOPTION; PROGRAM; ACCESS	Telemedicine-the use of technology to deliver care at a distance-is rapidly growing and can potentially expand access for patients, enhance patient-physician collaboration, improve health outcomes, and reduce medical costs. However, the potential benefits of telemedicine must be measured against the risks and challenges associated with its use, including the absence of the physical examination, variation in state practice and licensing regulations, and issues surrounding the establishment of the patient-physician relationship. This paper offers policy recommendations for the practice and use of telemedicine in primary care and reimbursement policies associated with telemedicine use. The positions put forward by the American College of Physicians highlight a meaningful approach to telemedicine policies and regulations that will have lasting positive effects for patients and physicians.	[Daniel, Hilary] Amer Coll Physicians, Washington, DC 20001 USA; [Sulmasy, Lois Snyder] Amer Coll Physicians, Philadelphia, PA 19160 USA	American College of Physicians; American College of Physicians	Daniel, H (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.				ACP	ACP	Financial support for the development of this paper comes exclusively from the ACP operating budget.	Adler-Milstein J, 2014, HEALTH AFFAIR, V33, P207, DOI 10.1377/hlthaff.2013.1054; Agha Z, 2009, TELEMED J E-HEALTH, V15, P830, DOI 10.1089/tmj.2009.0030; Alverson DC, 2008, TELEMED J E-HEALTH, V14, P957, DOI 10.1089/tmj.2008.0115; American College of Physicians, 2008, E HLTH ITS IMP MED P; American Medical Association, COV PAYM TEL; American Telemedicine Association, WHAT IS TELEMEDICINE; American Telemedicine Association, ATA STAT POL TOOLK I; [Anonymous], LIC SCOP PRACT; [Anonymous], MOB TECHN FACT SHEET; Baker LC, 2011, HEALTH AFFAIR, V30, P1689, DOI 10.1377/hlthaff.2011.0216; Bashshur RL, 2014, TELEMED E-HEALTH, V20, P769, DOI 10.1089/tmj.2014.9981; Burke JF, 2011, NEUROLOGY, V77, pE52, DOI 10.1212/WNL.0b013e31822f48fb; Bynum AB, 2003, TELEMED J E-HEALTH, V9, P361, DOI 10.1089/153056203772744680; Center for Connected Health Policy, 2014, STAT TEL POL REIMB S; Center for Connected Health Policy, CRED PRIV; Center for Connected Health Policy, BEST PRACT ARCH ARK; Center for Telehealth & e-Health Law, 2014, CMS MED REIMB NEARL; Centers for Medicare & Medicaid Services, TEL; Charles B L, 2000, Healthc Financ Manage, V54, P66; Cocchi R., 2014, TELEHEALTH SERVICES; Courneya PT, 2013, HEALTH AFFAIR, V32, P385, DOI 10.1377/hlthaff.2012.1157; Cryer L, 2012, HEALTH AFFAIR, V31, P1237, DOI 10.1377/hlthaff.2011.1132; Darkins A, 2008, TELEMED J E-HEALTH, V14, P1118, DOI 10.1089/tmj.2008.0021; Demaerschalk BM, 2013, AM J MANAG CARE, V19, P976; Doarn CR, 2014, TELEMED E-HEALTH, V20, P409, DOI 10.1089/tmj.2013.0336; Ekeland AG, 2010, INT J MED INFORM, V79, P736, DOI 10.1016/j.ijmedinf.2010.08.006; Federal Communications Commission, FCC CHAIRM GEN OWSK; Federal Communications Commission, CONN AM NAT BROADB P; Federation of State Medical Boards, 2014, MOD POL APPR US TEL; Federation of State Medical Boards, 2014, INT MED LIC COMP; Federation of State Medical Boards, 2013, TEL POL BOARD; Ferguson AS, IMPACT STORE FORWARD; Field MJ, 1996, TELEMEDICINE GUIDE A; Freeman N., 2014, HIPAA REQUIRES PROVI; Georgia Composite Medical Board, 360 3 07 PRACT EL OT; Graham JR, 2013, TOP HLTH TREND 2014; Grubaugh AL, 2008, J NERV MENT DIS, V196, P166, DOI 10.1097/NMD.0b013e318162aa2d; Health Resources and Services Administration, TEL; Health Resources and Services Administration, CAN TEL TECHN BEN PR; HIMSS, 2014, HIMSS AN 2014 TEL ST; Hofstetter PJ, 2010, TELEMED J E-HEALTH, V16, P551, DOI 10.1089/tmj.2009.0142; Lee P., 2014, TECHNOLOGY MEDIA TEL; LeRouge C, 2013, INT J ENV RES PUB HE, V10, P6472, DOI 10.3390/ijerph10126472; Manhattan Research, 2014, STETH SMARTPH PHYS T; Mayo Clinic, TESTS PROC STROK TEL; Mazmanian A, 2014, VA IS DRIVING TELEME; Mehrotra A, 2013, JAMA INTERN MED, V173, P72, DOI 10.1001/2013.jamainternmed.305; National Rural Health Association, GEOGR RESTR MED TEL; Natoli CM, 2009, SUMMARU FINDINGS MAL; Nuffield Council on Bioethics, 2010, MED PROF ONL MED ETH, P124; Patient-Centered Outcomes Research Institute, CAN CIRT HOUS CALLS; Rannefeld Lisa, 2004, J Law Health, V19, P75; Salgia RJ, 2014, TELEMED E-HEALTH, V20, P1004, DOI 10.1089/tmj.2013.0302; Sequist TD, 2011, NEW ENGL J MED, V364, P2258, DOI 10.1056/NEJMe1103390; Shea S, 2006, J AM MED INFORM ASSN, V13, P40, DOI 10.1197/jamia.M1917; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; State Medical Board of Ohio, POS STAT TEL; Steinbrook R, 2014, JAMA-J AM MED ASSOC, V312, P695, DOI 10.1001/jama.2014.9809; Thomas L, 2014, STATE TELEMEDICINE G; U.S. Food and Drug Administration, MOB MED APPL GUID IN; University of Maryland School of Law & Health Care Program, 2011, J HLTH CARE LAW POLI, V14, P1; Verghese A, 2011, ANN INTERN MED, V155, P550, DOI 10.7326/0003-4819-155-8-201110180-00013; Whitten P, 2011, J TELEMED TELECARE, V17, P31, DOI 10.1258/jtt.2010.091208	63	117	119	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 17	2015	163	10					787	+		10.7326/M15-0498	http://dx.doi.org/10.7326/M15-0498			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CX5MQ	26344925				2022-12-28	WOS:000365746400021
J	Mechanic, RE				Mechanic, Robert E.			Mandatory Medicare Bundled Payment - Is It Ready for Prime Time?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02454 USA	Brandeis University	Mechanic, RE (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02454 USA.							Bozic KJ, 2008, HLTH AFF MILLWOOD, V27, P1587; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Mechanic R, 2014, NEW ENGL J MED, V370, P692, DOI 10.1056/NEJMp1315607; Newhouse JP, 2013, NEW ENGL J MED, V368, P1465, DOI 10.1056/NEJMp1302981; US Food and Drug Administration. National Environmental Policy Act; Environmental Assessments for Tobacco Products; Categorical Exclusions, 2015, FED REG	5	58	58	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14					1291	1293		10.1056/NEJMp1509155	http://dx.doi.org/10.1056/NEJMp1509155			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS3CI	26308595				2022-12-28	WOS:000361948600003
J	Fazal, FM; Meng, CA; Murakami, K; Kornberg, RD; Block, SM				Fazal, Furqan M.; Meng, Cong A.; Murakami, Kenji; Kornberg, Roger D.; Block, Steven M.			Real-time observation of the initiation of RNA polymerase II transcription	NATURE			English	Article							PREINITIATION COMPLEX; DNA-REPAIR; PROMOTER DNA; TFIIH; ELONGATION; MECHANISM; KINASE; PC4; ATP; BACKTRACKING	Biochemical and structural studies have shown that the initiation of RNA polymerase II transcription proceeds in the following stages: assembly of the polymerase with general transcription factors and promoter DNA in a 'closed' preinitiation complex (PIC)(1,2); unwinding of about 15 base pairs of the promoter DNA to form an 'open' complex(3,4); scanning downstream to a transcription start site; synthesis of a short transcript, thought to be about 10 nucleotides long; and promoter escape. Here we have assembled a 32-protein, 1.5-megadalton PIC5 derived from Saccharomyces cerevisiae, and observe subsequent initiation processes in real time with optical tweezers(6). Contrary to expectation, scanning driven by the transcription factor IIH7-12 involved the rapid opening of an extended transcription bubble, averaging 85 base pairs, accompanied by the synthesis of a transcript up to the entire length of the extended bubble, followed by promoter escape. PICs that failed to achieve promoter escape nevertheless formed open complexes and extended bubbles, which collapsed back to closed or open complexes, resulting in repeated futile scanning.	[Fazal, Furqan M.; Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Meng, Cong A.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Murakami, Kenji; Kornberg, Roger D.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Block, Steven M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	kornberg@stanford.edu; sblock@stanford.edu	Meng, Cong A./I-1461-2017; Fazal, Furqan/X-8030-2019	Meng, Cong A./0000-0002-5352-6095; Fazal, Furqan/0000-0003-0758-4582	NIH [GM36659, AI21144, GM57035]; NSF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035, R01GM036659, R01GM049985, R37GM057035, R37GM036659] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Chakraborty and B. Milic for careful reading of the manuscript, P.-J. Mattei for help with protein purification, and R. Landick and J. Gelles for discussions. This research was supported by NIH grants GM36659 and AI21144 to R.D.K. and GM57035 to S.M.B., and an NSF graduate fellowship to F.M.F.	CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; Fazal FM, 2011, NAT PHOTONICS, V5, P318, DOI 10.1038/nphoton.2011.100; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Henry NL, 1996, J BIOL CHEM, V271, P21842, DOI 10.1074/jbc.271.36.21842; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Koslover DJ, 2012, J MOL BIOL, V423, P664, DOI 10.1016/j.jmb.2012.07.027; Larson MH, 2012, P NATL ACAD SCI USA, V109, P6555, DOI 10.1073/pnas.1200939109; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Murakami K, 2015, MOL CELL, V59, P133, DOI 10.1016/j.molcel.2015.05.021; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Murakami K, 2013, J BIOL CHEM, V288, P6325, DOI 10.1074/jbc.M112.433623; Murakami K, 2012, P NATL ACAD SCI USA, V109, P4816, DOI 10.1073/pnas.1201448109; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Schweikhard V, 2014, P NATL ACAD SCI USA, V111, P6642, DOI 10.1073/pnas.1405181111; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Spangler L, 2001, P NATL ACAD SCI USA, V98, P5544, DOI 10.1073/pnas.101004498; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6	38	64	65	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					274	+		10.1038/nature14882	http://dx.doi.org/10.1038/nature14882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26331540	Green Accepted			2022-12-28	WOS:000360927400044
J	Melgaard, L; Gorst-Rasmussen, A; Lane, DA; Rasmussen, LH; Larsen, TB; Lip, GYH				Melgaard, Line; Gorst-Rasmussen, Anders; Lane, Deidre A.; Rasmussen, Lars Hvilsted; Larsen, Torben Bjerregaard; Lip, Gregory Y. H.			Assessment of the CHA(2)DS(2)-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPETING RISKS; MORTALITY; SURVIVAL; CHADS(2); CURVES	IMPORTANCE The CHA(2)DS(2)-VASc score (congestive heart failure, hypertension, age >= 75 years [doubled], diabetes, stroke/transient ischemic attack/thromboembolism [doubled], vascular disease [prior myocardial infarction, peripheral artery disease, or aortic plaque], age 65-75 years, sex category [female]) is used clinically for stroke risk stratification in atrial fibrillation (AF). Its usefulness in a population of patients with heart failure (HF) is unclear. OBJECTIVE To investigate whether CHA(2)DS(2)-VASc predicts ischemic stroke, thromboembolism, and death in a cohort of patients with HF with and without AF. DESIGN, SETTING, AND POPULATION Nationwide prospective cohort study using Danish registries, including 42 987 patients (21.9% with concomitant AF) not receiving anticoagulation who were diagnosed as having incident HF during 2000-2012. End of follow-up was December 31, 2012. EXPOSURES Levels of the CHA(2)DS(2)-VASc score (based on 10 possible points, with higher scores indicating higher risk), stratified by concomitant AF at baseline. Analyses took into account the competing risk of death. MAIN OUTCOMES AND MEASURES Ischemic stroke, thromboembolism, and death within 1 year after HF diagnosis. RESULTS In patients without AF, the risks of ischemic stroke, thromboembolism, and death were 3.1% (n = 977), 9.9%(n = 3187), and 21.8%(n = 6956), respectively; risks were greater with increasing CHA(2)DS(2)-VASc scores as follows, for scores of 1 through 6, respectively: (1) ischemic stroke with concomitant AF: 4.5%, 3.7%, 3.2%, 4.3%, 5.6%, and 8.4%; without concomitant AF: 1.5%, 1.5%, 2.0%, 3.0%, 3.7%, and 7% and (2) all-cause death with concomitant AF: 19.8%, 19.5%, 26.1%, 35.1%, 37.7%, and 45.5%; without concomitant AF: 7.6%, 8.3%, 17.8%, 25.6%, 27.9%, and 35.0%. At high CHA(2)DS(2)-VASc scores (>= 4), the absolute risk of thromboembolism was high regardless of presence of AF (for a score of 4, 9.7% vs 8.2% for patients without and with concomitant AF, respectively; overall P<.001 for interaction). C statistics and negative predictive values indicate that the CHA(2)DS(2)-VASc score performed modestly in this HF population with and without AF (for ischemic stroke, 1-year C statistics, 0.67 [95% CI, 0.65-0.68] and 0.64 [95% CI, 0.61-0.67], respectively; 1-year negative predictive values, 92%[95% CI, 91%-93%] and 91%[95% CI, 88%-95%], respectively). CONCLUSIONS AND RELEVANCE Among patients with incident HF with or without AF, the CHA(2)DS(2)-VASc score was associated with risk of ischemic stroke, thromboembolism, and death. The absolute risk of thromboembolic complications was higher among patients without AF compared with patients with concomitant AF at high CHA(2)DS(2)-VASc scores. However, predictive accuracy was modest, and the clinical utility of the CHA(2)DS(2) -VASc score in patients with HF remains to be determined.	[Melgaard, Line; Gorst-Rasmussen, Anders; Rasmussen, Lars Hvilsted; Larsen, Torben Bjerregaard; Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Fac Hlth, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Gorst-Rasmussen, Anders] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Lane, Deidre A.; Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England	Aalborg University; Aalborg University; Aalborg University Hospital; University of Birmingham	Lip, GYH (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Dudley Rd, Birmingham B18 7QH, W Midlands, England.	g.y.h.lip@bham.ac.uk	Larsen, Torben Bjerregaard/I-5081-2012	Larsen, Torben Bjerregaard/0000-0002-8485-8674; Lane, Deirdre/0000-0002-5604-9378	Bayer Healthcare; Boehringer Ingelheim	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Boehringer Ingelheim(Boehringer Ingelheim)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lane has received investigator-initiated educational grants from Bayer Healthcare and Boehringer Ingelheim and has served as a speaker for Boehringer Ingelheim, Bayer Healthcare, and Bristol-Myers Squibb/Pfizer. Drs Rasmussen and Larsen have been on the speakers bureaus for Bayer, Bristol-Myers Squibb/Pfizer, Janssen Pharmaceuticals, Takeda, Roche Diagnostics, and Boehringer Ingelheim. Dr Larsen has served as an investigator for Janssen Scientific Affairs LLC and Boehringer Ingelheim. Dr Lip has served as a consultant for Bayer, Astellas, Merck, Sanofi, Bristol-Myers Squibb/Pfizer, Daiichi-Sankyo, Biotronik, Portola, and Boehringer Ingelheim and has served as a speaker for Bayer, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Roche, and Sanofi-Aventis. No other disclosures are reported.	Agarwal M, 2014, CLIN THER, V36, P1135, DOI 10.1016/j.clinthera.2014.07.015; Alberts VP, 2010, EUR J EPIDEMIOL, V25, P807, DOI 10.1007/s10654-010-9520-y; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; Camm AJ, 2012, EUR HEART J, V33; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; DUNKMAN WB, 1993, CIRCULATION, V87, P94; Eckman MH, 2011, CIRC-CARDIOVASC QUAL, V4, P14, DOI 10.1161/CIRCOUTCOMES.110.958108; Forman Daniel E, 2013, Curr Heart Fail Rep, V10, P387, DOI 10.1007/s11897-013-0163-7; Freudenberger RS, 2007, CIRCULATION, V115, P2637, DOI 10.1161/CIRCULATIONAHA.106.661397; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Homma S, 2012, NEW ENGL J MED, V366, P1859, DOI 10.1056/NEJMoa1202299; Jacqmin-Gadda H, 2014, AM J EPIDEMIOL, V180, P790, DOI 10.1093/aje/kwu202; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klein JP, 2007, STAT MED, V26, P4505, DOI 10.1002/sim.2864; Klein JP, 2005, BIOMETRICS, V61, P223, DOI 10.1111/j.0006-341X.2005.031209.x; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Lip G, 2012, BMJ OPEN, V2, P1; Lip GYH, 2013, INT J CARDIOL, V168, P414, DOI 10.1016/j.ijcard.2012.09.148; Lip GYH, 2012, THROMB HAEMOSTASIS, V108, P1009, DOI 10.1160/TH12-08-0578; Lip GYH, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003186.pub3; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Melgaard L, 2015, AM HEART J, V169, P396, DOI 10.1016/j.ahj.2014.12.004; Mitchell LB, 2014, HEART, V100, P1524, DOI 10.1136/heartjnl-2013-305303; Nielsen PB, 2015, THROMB HAEMOSTASIS, V113, P1170, DOI 10.1160/TH15-03-0210; Olesen JB, 2015, THROMB HAEMOSTASIS, V113, P1165, DOI 10.1160/TH15-02-0154; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Potpara TS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P319, DOI 10.1161/CIRCEP.111.966713; Taillandier S, 2012, J CARDIOVASC ELECTR, V23, P708, DOI 10.1111/j.1540-8167.2011.02257.x; Witt BJ, 2006, AM HEART J, V152, P102, DOI 10.1016/j.ahj.2005.10.018	33	227	231	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					1030	1038		10.1001/jama.2015.10725	http://dx.doi.org/10.1001/jama.2015.10725			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26318604	Bronze			2022-12-28	WOS:000360840700015
J	Heczey, A; Louis, C				Heczey, Andras; Louis, Chrystal			Osteopetrosis and Erlenmeyer-Flask Deformity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heczey, Andras; Louis, Chrystal] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Heczey, A (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	culouis@txch.org			NATIONAL CANCER INSTITUTE [K12CA090433] Funding Source: NIH RePORTER; NCI NIH HHS [K12 CA090433] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					E12	E12		10.1056/NEJMicm1407743	http://dx.doi.org/10.1056/NEJMicm1407743			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2OB	26332566	Green Accepted			2022-12-28	WOS:000360439500001
J	Cargnello, M; Johnston-Peck, AC; Diroll, BT; Wong, E; Datta, B; Damodhar, D; Doan-Nguyen, VVT; Herzing, AA; Kagan, CR; Murray, CB				Cargnello, Matteo; Johnston-Peck, Aaron C.; Diroll, Benjamin T.; Wong, Eric; Datta, Bianca; Damodhar, Divij; Doan-Nguyen, Vicky V. T.; Herzing, Andrew A.; Kagan, Cherie R.; Murray, Christopher B.			Substitutional doping in nanocrystal superlattices	NATURE			English	Article							METAL TRANSITION; CONDUCTIVITY; FILMS	Doping is a process in which atomic impurities are intentionally added to a host material to modify its properties. It has had a revolutionary impact in altering or introducing electronic(1,2), magnetic(3,4), luminescent(5,6), and catalytic(7) properties for several applications, for example in semiconductors. Here we explore and demonstrate the extension of the concept of substitutional atomic doping to nanometre-scale crystal doping, in which one nanocrystal is used to replace another to form doped self-assembled superlattices. Towards this goal, we show that gold nanocrystals act as substitutional dopants in superlattices of cadmium selenide or lead selenide nanocrystals when the size of the gold nanocrystal is very close to that of the host. The gold nanocrystals occupy random positions in the superlattice and their density is readily and widely controllable, analogous to the case of atomic doping, but here through nanocrystal self-assembly. We also show that the electronic properties of the superlattices are highly tunable and strongly affected by the presence and density of the gold nanocrystal dopants. The conductivity of lead selenide films, for example, can be manipulated over at least six orders of magnitude by the addition of gold nanocrystals and is explained by a percolation model. As this process relies on the self-assembly of uniform nanocrystals, it can be generally applied to assemble a wide variety of nanocrystal-doped structures for electronic, optical, magnetic, and catalytic materials.	[Cargnello, Matteo; Diroll, Benjamin T.; Kagan, Cherie R.; Murray, Christopher B.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Johnston-Peck, Aaron C.; Herzing, Andrew A.] NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA; [Wong, Eric] Univ Penn, Dept Phys, Philadelphia, PA 19104 USA; [Datta, Bianca; Damodhar, Divij; Doan-Nguyen, Vicky V. T.; Kagan, Cherie R.; Murray, Christopher B.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Kagan, Cherie R.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; National Institute of Standards & Technology (NIST) - USA; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Murray, CB (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	cbmurray@sas.upenn.edu	Doan-Nguyen, Vicky/AAY-6277-2020	Doan-Nguyen, Vicky/0000-0003-4204-3271; /0000-0003-2900-4577; Cargnello, Matteo/0000-0002-7344-9031	Office of Naval Research MURI program [ONR-N00014-10-1-0942]; US Department of Energy Office of Basic Energy Sciences, Division of Materials Science and Engineering [DE-SC0002158]; National Research Council; US Department of Energy, Office of Basic Energy Sciences [DE-SC0012704]; Richard Perry University Professorship	Office of Naval Research MURI program(MURI); US Department of Energy Office of Basic Energy Sciences, Division of Materials Science and Engineering(United States Department of Energy (DOE)); National Research Council(Consiglio Nazionale delle Ricerche (CNR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Richard Perry University Professorship	We thank Y. Lai and D. Straus (University of Pennsylvania) for discussions about electrical characterization. This work received primary support from the Office of Naval Research MURI program(award number ONR-N00014-10-1-0942) for the development of the multicomponent assembly techniques, and secondary support from the US Department of Energy Office of Basic Energy Sciences, Division of Materials Science and Engineering (award number DE-SC0002158) for the development of the semiconductor nanocrystal chemistry and the characterization of electrical conductivity. Electron microscopy research was performed while A.C.J.-P. held a National Research Council Research Associateship Award at the National Institute of Standards and Technology. We thank K. Yager (Brookhaven National Laboratory) for help with SAXS experiments. Work performed at the National Synchrotron Light Source I (Brookhaven National Laboratory) was supported by the US Department of Energy, Office of Basic Energy Sciences, under contract number DE-SC0012704. C.R.K. thanks the Stephen J. Angello Professorship for support. C.B.M. is grateful for the support of the Richard Perry University Professorship.	Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Bo XZ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1906316; Bodnarchuk MI, 2010, J AM CHEM SOC, V132, P11967, DOI 10.1021/ja103083q; Boneschanscher MP, 2014, SCIENCE, V344, P1377, DOI 10.1126/science.1252642; Dong AG, 2013, ACS NANO, V7, P10978, DOI 10.1021/nn404566b; Dong AG, 2010, NATURE, V466, P474, DOI 10.1038/nature09188; EFROS AL, 1976, PHYS STATUS SOLIDI B, V76, P475, DOI 10.1002/pssb.2220760205; Erwin SC, 2005, NATURE, V436, P91, DOI 10.1038/nature03832; Fafarman AT, 2013, NANO LETT, V13, P350, DOI 10.1021/nl303161d; Fafarman AT, 2011, J AM CHEM SOC, V133, P15753, DOI 10.1021/ja206303g; Houtepen AJ, 2008, NANO LETT, V8, P3516, DOI 10.1021/nl8020347; Lorenz CD, 2000, J STAT PHYS, V98, P961, DOI 10.1023/A:1018648130343; Meledina M, 2015, NANOSCALE, V7, P3196, DOI 10.1039/c4nr06060a; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Norris DJ, 2008, SCIENCE, V319, P1776, DOI 10.1126/science.1143802; Overgaag K, 2008, ACS NANO, V2, P600, DOI 10.1021/nn7003876; Park J, 2005, ANGEW CHEM INT EDIT, V44, P2872, DOI 10.1002/anie.200461665; Pearton SJ, 2003, J APPL PHYS, V93, P1, DOI 10.1063/1.1517164; Peng S, 2008, NANO RES, V1, P229, DOI 10.1007/s12274-008-8026-3; Pileni MP, 2012, J COLLOID INTERF SCI, V388, P1, DOI 10.1016/j.jcis.2012.07.086; Rintoul MD, 1997, J PHYS A-MATH GEN, V30, pL585, DOI 10.1088/0305-4470/30/16/005; Roder H, 1996, PHYS REV LETT, V76, P1356, DOI 10.1103/PhysRevLett.76.1356; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Tanemura M., 2003, FORMA, V18, P221; Urban JJ, 2007, NAT MATER, V6, P115, DOI 10.1038/nmat1826; Wang F, 2010, NATURE, V463, P1061, DOI 10.1038/nature08777; Ye XC, 2010, P NATL ACAD SCI USA, V107, P22430, DOI 10.1073/pnas.1008958107; Yu WW, 2004, CHEM MATER, V16, P3318, DOI 10.1021/cm049476y; Zabet-Khosousi A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.156403	30	138	138	13	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					450	+		10.1038/nature14872	http://dx.doi.org/10.1038/nature14872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26310766				2022-12-28	WOS:000360069300034
J	Hangya, B; Ranade, SP; Lorenc, M; Kepecs, A				Hangya, Balazs; Ranade, Sachin P.; Lorenc, Maja; Kepecs, Adam			Central Cholinergic Neurons Are Rapidly Recruited by Reinforcement Feedback	CELL			English	Article							BASAL FOREBRAIN NEURONS; NUCLEUS BASALIS; ACETYLCHOLINE-RELEASE; NEOCORTICAL ACTIVITY; MODULATION; TIME; SYSTEMS; REWARD; SIGNAL; RAT	Basal forebrain cholinergic neurons constitute a major neuromodulatory system implicated in normal cognition and neurodegenerative dementias. Cholinergic projections densely innervate neocortex, releasing acetylcholine to regulate arousal, attention, and learning. However, their precise behavioral function is poorly understood because identified cholinergic neurons have never been recorded during behavior. To determine which aspects of cognition their activity might support, we recorded cholinergic neurons using optogenetic identification in mice performing an auditory detection task requiring sustained attention. We found that a non-cholinergic basal forebrain population-but not cholinergic neurons-were correlated with trial-to-trial measures of attention. Surprisingly, cholinergic neurons responded to reward and punishment with unusual speed and precision (18 +/- 3 ms). Cholinergic responses were scaled by the unexpectedness of reinforcement and were highly similar across neurons and two nuclei innervating distinct cortical areas. These results reveal that the cholinergic system broadcasts a rapid and precisely timed reinforcement signal, supporting fast cortical activation and plasticity.	[Hangya, Balazs; Ranade, Sachin P.; Lorenc, Maja; Kepecs, Adam] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hangya, Balazs] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary	Cold Spring Harbor Laboratory; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Hangya, B (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	hangya.balazs@koki.mta.hu; kepecs@cshl.edu	Hangya, Balazs/H-5964-2019	Hangya, Balazs/0000-0003-2709-7407; Kepecs, Adam/0000-0003-0049-8120; Ranade, Sachin/0000-0002-5150-5776; Lorenc, Maja/0000-0003-2665-0135	John Merck Foundation; McKnight Foundation; National Institute of Neurological Disorders and Stroke [R01NS075531]; Swartz Foundation; Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088661, R01NS075531] Funding Source: NIH RePORTER	John Merck Foundation; McKnight Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swartz Foundation; Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the John Merck and McKnight Foundations and the National Institute of Neurological Disorders and Stroke (R01NS075531) (to A.K.). B.H. received support from the Swartz Foundation and Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development. The authors are grateful to Barry Burbach and Rob Eifert for invaluable technical assistance; Goncalo Lopez for help with Bonsai; Sanchari Ghosh for assisting in recording cholinergic neurons outside the behavioral task; and Hyun-Jae Pi, Duda Kvitsiani, Joshua I. Sanders, Michael Long, Stephen Shea, and Jessica Tollkuhn for helpful comments and discussions.	Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Avila I, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001811; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Chubykin AA, 2013, NEURON, V77, P723, DOI 10.1016/j.neuron.2012.12.039; Cohen JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06346; Coull JT, 1998, J NEUROSCI, V18, P7426; Dayan P, 2006, NETWORK-COMP NEURAL, V17, P335, DOI 10.1080/09548980601004024; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Demars MP, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0075-9; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Duque A, 2000, J NEUROPHYSIOL, V84, P1627, DOI 10.1152/jn.2000.84.3.1627; Eggermann E, 2014, CELL REP, V9, P1654, DOI 10.1016/j.celrep.2014.11.005; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fremaux N, 2010, J NEUROSCI, V30, P13326, DOI 10.1523/JNEUROSCI.6249-09.2010; Freund HJ, 2009, ARCH NEUROL-CHICAGO, V66, P781, DOI 10.1001/archneurol.2009.102; FREUND TF, 1991, J COMP NEUROL, V314, P187, DOI 10.1002/cne.903140117; Froemke RC, 2013, NAT NEUROSCI, V16, P79, DOI 10.1038/nn.3274; Gritti I, 2006, NEUROSCIENCE, V143, P1051, DOI 10.1016/j.neuroscience.2006.09.024; Gritti I, 1997, J COMP NEUROL, V383, P163; Gu ZL, 2012, J NEUROSCI, V32, P12337, DOI 10.1523/JNEUROSCI.2129-12.2012; Gu ZL, 2011, NEURON, V71, P155, DOI 10.1016/j.neuron.2011.04.026; Hassani OK, 2009, J NEUROSCI, V29, P11828, DOI 10.1523/JNEUROSCI.1259-09.2009; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kaifosh P, 2013, NAT NEUROSCI, V16, P1182, DOI 10.1038/nn.3482; Kalmbach A, 2012, J NEUROPHYSIOL, V107, P2008, DOI 10.1152/jn.00870.2011; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kuhn J, 2015, MOL PSYCHIATR, V20, P353, DOI 10.1038/mp.2014.32; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; LEHMANN J, 1980, NEUROSCIENCE, V5, P1161, DOI 10.1016/0306-4522(80)90195-5; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; Liu CH, 2015, CURR BIOL, V25, P1551, DOI 10.1016/j.cub.2015.04.028; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; McGaughy J, 2000, BEHAV BRAIN RES, V115, P251, DOI 10.1016/S0166-4328(00)00262-X; Nelson CL, 2005, NEUROSCIENCE, V132, P347, DOI 10.1016/j.neuroscience.2004.12.007; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pinto L, 2013, NAT NEUROSCI, V16, P1857, DOI 10.1038/nn.3552; Rezende DJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00038; Richardson R T, 1991, Adv Exp Med Biol, V295, P233; SAPER CB, 1984, J COMP NEUROL, V222, P313, DOI 10.1002/cne.902220302; Sarter M, 2009, NAT REV NEUROSCI, V10, P383, DOI 10.1038/nrn2635; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WILSON FAW, 1990, J NEUROSCI, V10, P1254; Wrenn CC, 1998, INT J DEV NEUROSCI, V16, P595, DOI 10.1016/S0736-5748(98)00071-9; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zaborszky L, 2015, CEREB CORTEX, V25, P118, DOI 10.1093/cercor/bht210; Zaborszkyy L, 2012, MOUSE NERVOUS SYSTEM, P684, DOI 10.1016/B978-0-12-369497-3.10028-7; Zhang H, 2011, J NEUROPHYSIOL, V106, P2749, DOI 10.1152/jn.00267.2011	56	205	207	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1155	1168		10.1016/j.cell.2015.07.057	http://dx.doi.org/10.1016/j.cell.2015.07.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317475	Bronze, Green Accepted			2022-12-28	WOS:000360589900023
J	Wilkie, M; Lau, A; Vlatkovic, N; Jones, T; Boyd, M				Wilkie, Mark; Lau, Andrew; Vlatkovic, Nikolina; Jones, Terence; Boyd, Mark			Tumour metabolism in squamous cell carcinoma of the head and neck: an in-vitro study of the consequences of TP53 mutation and therapeutic implications	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Wilkie, Mark; Lau, Andrew; Vlatkovic, Nikolina; Jones, Terence; Boyd, Mark] Univ Liverpool, Liverpool Canc Res Ctr, Liverpool L3 9TA, Merseyside, England; [Wilkie, Mark; Lau, Andrew; Jones, Terence] Aintree Univ Hosp NHS Fdn Trust, Dept Otorhinolaryngol Head & Neck Surg, Liverpool L9 7AL, Merseyside, England	University of Liverpool; Aintree University Hospitals NHS Foundation Trust		mdwilkie@doctors.org.uk	Vlatkovic, Nikolina/AAH-6654-2020; Vlatkovic, Nikolina/I-3481-2013; Boyd, Mark T/I-6792-2012; Boyd, Mark/AAB-8564-2021	Vlatkovic, Nikolina/0000-0003-3003-794X; Vlatkovic, Nikolina/0000-0003-3003-794X; Boyd, Mark T/0000-0002-2336-2106; Boyd, Mark/0000-0002-2336-2106					0	10	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			101	101		10.1016/S0140-6736(15)60416-0	http://dx.doi.org/10.1016/S0140-6736(15)60416-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312831	Bronze			2022-12-28	WOS:000360570500101
J	Chua, MLK; Wee, JTS; Hui, EP; Chan, ATC				Chua, Melvin L. K.; Wee, Joseph T. S.; Hui, Edwin P.; Chan, Anthony T. C.			Nasopharyngeal carcinoma	LANCET			English	Review							EPSTEIN-BARR-VIRUS; INTENSITY-MODULATED RADIOTHERAPY; PHASE-II TRIAL; INDUCTION-CONCURRENT CHEMORADIOTHERAPY; LONG-TERM SURVIVAL; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; RADIATION-THERAPY; FRACTIONATED RADIOTHERAPY; PERFUSION CHARACTERISTICS	Epidemiological trends during the past decade suggest that although incidence of nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from the disease has fallen substantially. This finding is probably a result of a combination of lifestyle modification, population screening coupled with better imaging, advances in radiotherapy, and effective systemic agents. In particular, intensity-modulated radiotherapy has driven the improvement in tumour control and reduction in toxic effects in survivors. Clinical use of Epstein-Barr virus (EBV) as a surrogate biomarker in nasopharyngeal carcinoma continues to increase, with quantitative assessment of circulating EBV DNA used for population screening, prognostication, and disease surveillance. Randomised trials are investigating the role of EBV DNA in stratification of patients for treatment intensification and deintensification. Among the exciting developments in nasopharyngeal carcinoma, vascular endothelial growth factor inhibition and novel immunotherapies targeted at immune checkpoint and EBV-specific tumour antigens off er promising alternatives to patients with metastatic disease.	[Chua, Melvin L. K.; Wee, Joseph T. S.] Natl Canc Ctr Singapore, Div Radiat Oncol, 11 Hosp Dr, Singapore 169610, Singapore; [Chua, Melvin L. K.; Wee, Joseph T. S.] Duke NUS, Grad Sch Med, Singapore, Singapore; [Hui, Edwin P.; Chan, Anthony T. C.] Chinese Univ Hong Kong, Hong Kong Canc Inst, Sir YK Pao Ctr Canc, State Key Lab Oncol South China,Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	National Cancer Centre Singapore (NCCS); National University of Singapore; Chinese University of Hong Kong; State Key Lab Oncology South China	Chua, MLK (corresponding author), Natl Canc Ctr Singapore, Div Radiat Oncol, 11 Hosp Dr, Singapore 169610, Singapore.	melvin.chua.l.k@nccs.com.sg	Chua, Melvin LK/ABG-6045-2020; Chan, Anthony Tak Cheung/R-3940-2018	Chua, Melvin LK/0000-0002-1648-1473; Chan, Anthony Tak Cheung/0000-0002-6912-8091				Al-Sarraf M, 2001, 37 ANN M AM SOC CLIN; Bei JX, 2012, SEMIN CANCER BIOL, V22, P96, DOI 10.1016/j.semcancer.2012.01.012; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Birdwell CE, 2014, J VIROL, V88, P11442, DOI 10.1128/JVI.00972-14; Blanchard P, 2015, RADIOTHER ONCOL S1, V114, P6; Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Cao SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019100; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chan ASC, 2000, CANCER RES, V60, P5365; Chan ATC, 2005, J NATL CANCER I, V97, P536, DOI 10.1093/jnci/dji084; Chan ATC, 2004, J CLIN ONCOL, V22, P3053, DOI 10.1200/JCO.2004.05.178; Chan ATC, 2005, J CLIN ONCOL, V23, P3568, DOI 10.1200/JCO.2005.02.147; Chan JYW, 2013, HEAD NECK-J SCI SPEC, V35, P1726, DOI 10.1002/hed.23214; Chan JKC, 2005, WHO CLASSIFICATION T, P85, DOI DOI 10.1016/J.ORGGEOCHEM.2004.10.007; Chan OSH, 2014, ORAL ONCOL, V50, P791, DOI 10.1016/j.oraloncology.2014.01.004; Chan YH, 2014, ORAL ONCOL, V50, P326, DOI 10.1016/j.oraloncology.2013.12.025; Chang KP, 2012, J NUCL MED, V53, P21, DOI 10.2967/jnumed.111.090696; Chang MC, 2013, EUR J RADIOL, V82, P366, DOI 10.1016/j.ejrad.2012.06.031; Chen C, 2012, ORAL ONCOL, V48, P1146, DOI 10.1016/j.oraloncology.2012.05.021; Chen L, 2012, LANCET ONCOL, V13, P163, DOI 10.1016/S1470-2045(11)70320-5; Chen QY, 2011, JNCI-J NATL CANCER I, V103, P1761, DOI 10.1093/jnci/djr432; Chen WH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-583; Chen YP, 2015, ANN ONCOL, V26, P205, DOI 10.1093/annonc/mdu507; Chen Y, 2013, CANCER-AM CANCER SOC, V119, P2230, DOI 10.1002/cncr.28049; Chen YB, 2014, MAGN RESON IMAGING, V32, P630, DOI 10.1016/j.mri.2014.02.009; Chia CS, 2016, HEAD NECK-J SCI SPEC, V38, P21, DOI 10.1002/hed.23841; Chia WK, 2012, ANN ONCOL, V23, P997, DOI 10.1093/annonc/mdr341; Chia WK, 2014, MOL THER, V22, P132, DOI 10.1038/mt.2013.242; Chin YM, 2015, INT J CANCER, V136, P678, DOI 10.1002/ijc.29035; Chua DTT, 2006, INT J RADIAT ONCOL, V65, P1300, DOI 10.1016/j.ijrobp.2006.02.016; Chua DTT, 2003, ORAL ONCOL, V39, P361, DOI 10.1016/S1368-8375(02)00120-3; Chua M, 2014, INT J RADIAT ONCOL, V90, pS120, DOI 10.1016/j.ijrobp.2014.05.555; Chua MLK, 2009, HEAD NECK-J SCI SPEC, V31, P346, DOI 10.1002/hed.20974; Daoud J, 2007, RADIOTHER ONCOL, V85, P17, DOI 10.1016/j.radonc.2007.01.013; Dogan S, 2014, HEAD NECK-J SCI SPEC, V36, P511, DOI 10.1002/hed.23318; Fang WF, 2014, ONCOTARGET, V5, P12189, DOI 10.18632/oncotarget.2608; Ferlay J, 2012, IARC CANCERBASE; Foo KF, 2002, ANN ONCOL, V13, P150, DOI 10.1093/annonc/mdf002; Fountzilas G, 2012, ANN ONCOL, V23, P427, DOI 10.1093/annonc/mdr116; Guo SS, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0246-y; Guo XC, 2009, INT J CANCER, V124, P2942, DOI 10.1002/ijc.24293; Han F, 2012, CLIN ONCOL-UK, V24, P569, DOI 10.1016/j.clon.2011.11.010; Hara W, 2015, CANCER-AM CANCER SOC, V121, P2671, DOI 10.1002/cncr.29418; Henke M, 2011, J CLIN ONCOL, V29, P2815, DOI 10.1200/JCO.2010.32.4103; Hildesheim A, 2012, SEMIN CANCER BIOL, V22, P107, DOI 10.1016/j.semcancer.2012.01.007; Hong JS, 2013, OTOLARYNG HEAD NECK, V149, P707, DOI 10.1177/0194599813496537; Hong RL, 2004, CANCER, V100, P1429, DOI 10.1002/cncr.20129; Hsu WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041779; Huang Y, 2013, 2013 ASCO ANN M CHIC; Hui EP, 2011, ANN ONCOL, V22, P1280, DOI 10.1093/annonc/mdq629; Hui EP, 2015, CANCER-AM CANCER SOC, V121, P2720, DOI 10.1002/cncr.29413; Hui EP, 2013, CANCER RES, V73, P1676, DOI 10.1158/0008-5472.CAN-12-2448; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Hui EP, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-1373; Hui EP, 2011, INVEST NEW DRUG, V29, P1123, DOI 10.1007/s10637-010-9451-1; Hui EP, 2004, CANCER-AM CANCER SOC, V101, P300, DOI 10.1002/cncr.20358; Jin HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101256; Jin Y, 2013, EUR J CANCER, V49, P1619, DOI 10.1016/j.ejca.2012.11.032; Jin Y, 2012, EUR J CANCER, V48, P882, DOI 10.1016/j.ejca.2011.09.004; Jin Y, 2012, J CANCER RES CLIN, V138, P1717, DOI 10.1007/s00432-012-1219-x; Ko JMY, 2014, INT J CANCER, V135, P1634, DOI 10.1002/ijc.28802; Kong L, 2013, CANCER-AM CANCER SOC, V119, P4111, DOI 10.1002/cncr.28324; Kwong DL, 2006, INT J RAD ONCOL BI S, V66, pS15; Kwong DLW, 1999, CANCER, V85, P1446, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1446::AID-CNCR4>3.0.CO;2-3; Lai V, 2014, EUR RADIOL, V24, P176, DOI 10.1007/s00330-013-2995-7; Lai V, 2013, EUR RADIOL, V23, P2793, DOI 10.1007/s00330-013-2889-8; Lam WWM, 2001, HEAD NECK-J SCI SPEC, V23, P780, DOI 10.1002/hed.1111.abs; Le QT, 2005, CLIN CANCER RES, V11, P5700, DOI 10.1158/1078-0432.CCR-05-0648; Le QT, 2011, J CLIN ONCOL, V29, P2808, DOI 10.1200/JCO.2010.32.4095; Lee AWM, 2015, CANCER-AM CANCER SOC, V121, P1328, DOI 10.1002/cncr.29208; Lee AWM, 2014, RADIOTHER ONCOL, V110, P377, DOI 10.1016/j.radonc.2014.02.003; Lee AWM, 2011, RADIOTHER ONCOL, V98, P15, DOI 10.1016/j.radonc.2010.09.023; Lee AWM, 2011, EUR J CANCER, V47, P656, DOI 10.1016/j.ejca.2010.10.026; Lee AWM, 2010, JNCI-J NATL CANCER I, V102, P1188, DOI 10.1093/jnci/djq258; Lee AWM, 2005, INT J RADIAT ONCOL, V63, P1331, DOI 10.1016/j.ijrobp.2005.05.061; Lee AWM, 2003, INT J CANCER, V103, P680, DOI 10.1002/ijc.10894; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Leenstra JL, 2014, J CLIN ONCOL, V32, P1571, DOI 10.1200/JCO.2013.53.2630; Leong SS, 2005, CANCER-AM CANCER SOC, V103, P569, DOI 10.1002/cncr.20804; Leung SF, 2014, ANN ONCOL, V25, P1204, DOI 10.1093/annonc/mdu117; Leung SF, 2004, CLIN CHEM, V50, P339, DOI 10.1373/clinchem.2003.022426; Li CS, 2010, CLIN NEUROL NEUROSUR, V112, P682, DOI 10.1016/j.clineuro.2010.05.007; Lim AM, 2013, ORAL ONCOL, V49, P468, DOI 10.1016/j.oraloncology.2012.12.012; Lim TC, 2012, HEAD NECK ONCOL, V4, P49, DOI DOI 10.1016/J.EJRAD.2012.06.031; Lim WT, 2011, CLIN CANCER RES, V17, P5481, DOI 10.1158/1078-0432.CCR-10-3409; Lin CC, 2013, FUTURE ONCOL, V9, P1469, DOI 10.2217/fon.13.100; Lin DC, 2014, NAT GENET, V46, P866, DOI 10.1038/ng.3006; Lin JC, 2004, INT J RADIAT ONCOL, V60, P156, DOI 10.1016/j.ijrobp.2004.03.002; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Lin JC, 2007, INT J RADIAT ONCOL, V68, P1342, DOI 10.1016/j.ijrobp.2007.02.012; Lin ZX, 2014, HEAD NECK-J SCI SPEC, V36, P709, DOI 10.1002/hed.23362; Liu T, 2007, RADIOTHER ONCOL, V85, P327, DOI 10.1016/j.radonc.2007.11.002; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Lo YMD, 1999, CANCER RES, V59, P1188; Lo YMD, 1999, CANCER RES, V59, P5452; Loong HH, 2012, RADIOTHER ONCOL, V104, P300, DOI 10.1016/j.radonc.2011.12.022; Louis CU, 2010, J IMMUNOTHER, V33, P983, DOI 10.1097/CJI.0b013e3181f3cbf4; Maxwell JH, 2010, HEAD NECK-J SCI SPEC, V32, P562, DOI 10.1002/hed.21216; Ngeow J, 2011, ANN ONCOL, V22, P718, DOI 10.1093/annonc/mdq425; Nicholls JM, 1997, ADV ANAT PATHOL, V4, P71; Pan CC, 2012, EXP THER MED, V4, P334, DOI 10.3892/etm.2012.584; Pan CC, 2012, EUR J RADIOL, V81, pE473, DOI 10.1016/j.ejrad.2011.05.037; Pan ZQ, 2012, AM J CLIN ONCOL-CANC, V35, P600, DOI 10.1097/COC.0b013e31822dfd55; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Shao JY, 2004, CANCER, V100, P1162, DOI 10.1002/cncr.20099; Smith C, 2012, CANCER RES, V72, P1116, DOI 10.1158/0008-5472.CAN-11-3399; Sobin LH, 2010, PHARYNX INT UNION CA, P30; Soria JC, 2011, ANN ONCOL, V22, P1247, DOI 10.1093/annonc/mdq775; Stenmark MH, 2014, INT J RADIAT ONCOL, V88, P580, DOI 10.1016/j.ijrobp.2013.11.246; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Tan T, 2015, INT J RADIAT ONCOL, V91, P952, DOI 10.1016/j.ijrobp.2015.01.002; Tang LQ, 2014, BRIT J CANCER, V111, P1102, DOI 10.1038/bjc.2014.393; Tang LQ, 2015, INT J RADIAT ONCOL, V91, P325, DOI 10.1016/j.ijrobp.2014.10.005; Tang LQ, 2013, J CLIN ONCOL, V31, P2861, DOI 10.1200/JCO.2012.46.0816; Tang LL, 2009, CANCER-AM CANCER SOC, V115, P680, DOI 10.1002/cncr.24049; Tang MZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003103; Tao CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110765; Taylor GS, 2014, CLIN CANCER RES, V20, P5009, DOI 10.1158/1078-0432.CCR-14-1122-T; Taylor GS, 2004, J VIROL, V78, P768, DOI 10.1128/JVI.78.2.768-778.2004; Teo PML, 2000, INT J RADIAT ONCOL, V48, P1311, DOI 10.1016/S0360-3016(00)00786-0; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Tian YM, 2014, BRIT J CANCER, V110, P297, DOI 10.1038/bjc.2013.715; Tsang CM, 2012, P NATL ACAD SCI USA, V109, pE3473, DOI 10.1073/pnas.1202637109; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Tuan JKL, 2012, RADIOTHER ONCOL, V104, P305, DOI 10.1016/j.radonc.2011.12.028; Twu CW, 2014, INT J RADIAT ONCOL, V89, P21, DOI 10.1016/j.ijrobp.2014.01.052; Vellayappan BA, 2014, RADIOL ONCOL, V48, P331, DOI 10.2478/raon-2014-0011; Wang WY, 2013, CANCER-AM CANCER SOC, V119, P963, DOI 10.1002/cncr.27853; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wee Joseph Tien Seng, 2010, Chin J Cancer, V29, P517; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wu X, 2013, ANN ONCOL, V24, P2131, DOI 10.1093/annonc/mdt163; Xu FH, J NATL CANC I, V104, P1396; Yang ZY, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-014-0268-5; Yau TK, 2012, ORAL ONCOL, V48, P441, DOI 10.1016/j.oraloncology.2011.12.001; Yen RF, 2003, CANCER, V98, P283, DOI 10.1002/cncr.11519; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yu KJ, 2011, CLIN CANCER RES, V17, P1906, DOI 10.1158/1078-0432.CCR-10-1681; Zeng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108070; Zeng L, 2014, HEAD NECK-J SCI SPEC, V36, P687, DOI 10.1002/hed.23359; Zhang AM, 2012, RADIOTHER ONCOL, V104, P279, DOI 10.1016/j.radonc.2012.08.022; Zhang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-558; Zhang P, 2015, ONCOL LETT, V9, P113, DOI 10.3892/ol.2014.2631; Zhao ML, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-57	145	858	904	7	208	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					1012	1024		10.1016/S0140-6736(15)00055-0	http://dx.doi.org/10.1016/S0140-6736(15)00055-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26321262				2022-12-28	WOS:000371644200034
J	Willem, M; Tahirovic, S; Busche, MA; Ovsepian, SV; Chafai, M; Kootar, S; Hornburg, D; Evans, LDB; Moore, S; Daria, A; Hampel, H; Muller, V; Giudici, C; Nuscher, B; Wenninger-Weinzierl, A; Kremmer, E; Heneka, MT; Thal, DR; Giedraitis, V; Lannfelt, L; Muller, U; Livesey, FJ; Meissner, F; Herms, J; Konnerth, A; Marie, H; Haass, C				Willem, Michael; Tahirovic, Sabina; Busche, Marc Aurel; Ovsepian, Saak V.; Chafai, Magda; Kootar, Scherazad; Hornburg, Daniel; Evans, Lewis D. B.; Moore, Steven; Daria, Anna; Hampel, Heike; Mueller, Veronika; Giudici, Camilla; Nuscher, Brigitte; Wenninger-Weinzierl, Andrea; Kremmer, Elisabeth; Heneka, Michael T.; Thal, Dietmar R.; Giedraitis, Vilmantas; Lannfelt, Lars; Mueller, Ulrike; Livesey, Frederick J.; Meissner, Felix; Herms, Jochen; Konnerth, Arthur; Marie, Helene; Haass, Christian			eta-Secretase processing of APP inhibits neuronal activity in the hippocampus	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; PLURIPOTENT STEM-CELLS; ALZHEIMERS-DISEASE; BETA-PROTEIN; TRANSGENIC MICE; SYNAPTIC PLASTICITY; MOUSE MODEL; OLIGOMERS; PEPTIDE; IDENTIFICATION	Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-beta peptide(1). Two principal physiological pathways either prevent or promote amyloid-beta generation from its precursor, beta-amyloid precursor protein (APP), in a competitive manne(r)1. Although APP processing has been studied in great detail, unknown proteolytic events seem to hinder stoichiometric analyses of APP metabolism in vivo(2). Here we describe a new physiological APP processing pathway, which generates proteolytic fragments capable of inhibiting neuronal activity within the hippocampus. We identify higher molecular mass carboxy-terminal fragments (CTFs) of APP, termed CTF-eta, in addition to the long-known CTF-alpha and CTF-beta fragments generated by the alpha- and beta-secretases ADAM10 (a disintegrin and metalloproteinase 10) and BACE1 (beta-site APP cleaving enzyme 1), respectively. CTF-eta generation is mediated in part by membrane-bound matrix metalloproteinases such as MT5-MMP, referred to as g-secretase activity. g-Secretase cleavage occurs primarily at amino acids 504-505 of APP(695), releasing a truncated ectodomain. After shedding of this ectodomain, CTF-eta is further processed by ADAM10 and BACE1 to release long and short A eta peptides (termed A eta-alpha and A eta-beta). CTFs produced by g-secretase are enriched in dystrophic neurites in an AD mouse model and in human AD brains. Genetic and pharmacological inhibition of BACE1 activity results in robust accumulation of CTF-eta and A eta-alpha. In mice treated with a potent BACE1 inhibitor, hippocampal long-term potentiation was reduced. Notably, when recombinant or synthetic A eta-alpha was applied on hippocampal slices ex vivo, long-term potentiation was lowered. Furthermore, in vivo single-cell two-photon calcium imaging showed that hippocampal neuronal activity was attenuated by A eta-alpha. These findings not only demonstrate a major functionally relevant APP processing pathway, but may also indicate potential translational relevance for therapeutic strategies targeting APP processing.	[Willem, Michael; Daria, Anna; Hampel, Heike; Mueller, Veronika; Giudici, Camilla; Nuscher, Brigitte; Haass, Christian] Univ Munich, Biomed Ctr BMC, D-81377 Munich, Germany; [Tahirovic, Sabina; Ovsepian, Saak V.; Wenninger-Weinzierl, Andrea; Kremmer, Elisabeth; Herms, Jochen; Haass, Christian] German Ctr Neurodegenerat Dis DZNE Munich, D-81377 Munich, Germany; [Busche, Marc Aurel] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany; [Busche, Marc Aurel; Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany; [Busche, Marc Aurel; Kremmer, Elisabeth; Konnerth, Arthur; Haass, Christian] Univ Munich, Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Chafai, Magda; Kootar, Scherazad; Marie, Helene] Univ Nice Sophia Antipolis, UMR 7275, CNRS, IPMC, F-06560 Valbonne, France; [Hornburg, Daniel; Meissner, Felix] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Evans, Lewis D. B.; Moore, Steven; Livesey, Frederick J.] Univ Cambridge, Gurdon Inst, Cambridge Stem Cell Inst, Cambridge CB2 1QN, England; [Evans, Lewis D. B.; Moore, Steven; Livesey, Frederick J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Inst Mol Immunol, D-81377 Munich, Germany; [Heneka, Michael T.] Univ Bonn, Clin Neurosci Unit, Dept Neurol, D-53127 Bonn, Germany; [Heneka, Michael T.] German Ctr Neurodegenerat Dis DZNE Bonn, D-53175 Bonn, Germany; [Thal, Dietmar R.] Univ Ulm, Inst Pathol, Neuropathol Lab, D-89081 Ulm, Germany; [Giedraitis, Vilmantas; Lannfelt, Lars] Uppsala Univ, Dept Publ Hlth Geriatr, S-75185 Uppsala, Sweden; [Mueller, Ulrike] Heidelberg Univ, Funct Genom, Inst Pharm & Mol Biotechnol IPMB, D-69120 Heidelberg, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Munich; Technical University of Munich; University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Max Planck Society; University of Cambridge; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Ulm University; Uppsala University; Ruprecht Karls University Heidelberg	Willem, M (corresponding author), Univ Munich, Biomed Ctr BMC, D-81377 Munich, Germany.	michael.willem@mail03.med.uni-muenchen.de; christian.haass@mail03.med.uni-muenchen.de	Heneka, Michael/AAE-8011-2019; Thal, Dietmar R/O-7483-2018; Marie, Hélène/F-1404-2011; MEISSNER, Felix/C-8767-2015; Ovsepian, Saak/J-6207-2017; Heneka, Michael/E-8072-2015	Thal, Dietmar R/0000-0002-1036-1075; Marie, Hélène/0000-0003-2310-6097; MEISSNER, Felix/0000-0003-1000-7989; Evans, Lewis/0000-0001-7279-7651; Busche, Marc Aurel/0000-0002-4416-7553; Wenninger-Weinzierl, Andrea/0000-0001-5984-7714; Livesey, Rick/0000-0001-6128-3372; Moore, Steven James/0000-0003-1641-4315; Hampel, Harald/0000-0003-0894-8982; Heneka, Michael/0000-0003-4996-1630	European Research Council under European Union/ERC [321366-Amyloid, 318987]; AFI [13803]; Deutsche Forschungsgemeinschaft [MU 1457/9-1, MU 1457/9-2]; ERA-Net Neuron [01EW1305A]; ATIP/AVENIR program (Centre national de la recherche scientifique, CNRS); French Fondation pour la Cooperation Scientifique - Plan Alzheimer; French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE: program [ANR-11-LABX-0028-01]; Langmatz Stiftung; MRC [MR/L023784/1, MR/L023784/2] Funding Source: UKRI	European Research Council under European Union/ERC(European Research Council (ERC)); AFI; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERA-Net Neuron; ATIP/AVENIR program (Centre national de la recherche scientifique, CNRS); French Fondation pour la Cooperation Scientifique - Plan Alzheimer; French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE: program(French National Research Agency (ANR)); Langmatz Stiftung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank S. Lammich, N. Exner and H. Steiner for critical comments. We thank A. Sulzen, N. Astola, S. Diederich, E. Griessinger and J. Gobbert for technical help. The APPPS1-21 colony was established from a breeding pair provided by M. Jucker. MT1-MMP<SUP>-/-</SUP> mouse brains were obtained from Z. Zhou. MT5-MMP<SUP>-/-</SUP> mouse brains were obtained from I. Farinas. We thank H. Jacobsen for the BACE1 inhibitor RO5508887. This work was supported by the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no. 321366-Amyloid (advanced grant to C.H.). The work of D.R.T. was supported by AFI (grant 13803). The research leading to these results has received funding (F. M. and D. H.) from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 318987 [TOPAG]. We thank J. Cox and M. Mann for critical discussions and the mass spectrometry infrastructure. We also acknowledge support by grants from Deutsche Forschungsgemeinschaft (MU 1457/9-1, 9-2 to U.M.) and the ERA-Net Neuron (01EW1305A to U.M.). Further support came from the ATIP/AVENIR program (Centre national de la recherche scientifique, CNRS) to H. M.; the French Fondation pour la Cooperation Scientifique - Plan Alzheimer (Senior Innovative Grant 2010) to M. C. and H. M., and the French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE: program reference ANR-11-LABX-0028-01 to S.K. M.A.B. was supported by the Langmatz Stiftung. F.J.L. is a Wellcome Trust Investigator. In vivo BACE1 inhibition experiments with APP transgenic mice were performed together with reMYND (Bio-Incubator, 3001 Leuven-Heverlee, Belgium).	Ahmad M, 2006, J BIOCHEM, V139, P517, DOI 10.1093/jb/mvj054; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dobrowolska JA, 2014, J NEUROSCI, V34, P8336, DOI 10.1523/JNEUROSCI.0540-14.2014; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; Folgueras AR, 2009, P NATL ACAD SCI USA, V106, P16451, DOI 10.1073/pnas.0908507106; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Higashi S, 2003, BIOCHEMISTRY-US, V42, P6514, DOI 10.1021/bi020643m; Houeland G, 2010, J NEUROSCI, V30, P13089, DOI 10.1523/JNEUROSCI.0457-10.2010; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jacobsen H, 2014, J NEUROSCI, V34, P11621, DOI 10.1523/JNEUROSCI.1405-14.2014; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; LANNFELT L, 1994, NEUROSCI LETT, V168, P254, DOI 10.1016/0304-3940(94)90463-4; LANNFELT L, 1995, NEUROSCI LETT, V199, P203, DOI 10.1016/0304-3940(95)12059-D; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nolan RL, 2006, J BIOCHEM BIOPH METH, V68, P127, DOI 10.1016/j.jbbm.2006.04.002; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Portelius E, 2013, J ALZHEIMERS DIS, V33, P85, DOI 10.3233/JAD-2012-120994; R Development Core Team, 2014, R LANG ENV STAT COMP; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Scheltema RA, 2014, MOL CELL PROTEOMICS, V13, P3698, DOI 10.1074/mcp.M114.043489; Sekine-Aizawa Y, 2001, EUR J NEUROSCI, V13, P935, DOI 10.1046/j.0953-816x.2001.01462.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Vella LJ, 2012, FASEB J, V26, P2930, DOI 10.1096/fj.11-200295; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Welzel AT, 2014, BIOCHEMISTRY-US, V53, P3908, DOI 10.1021/bi5003053; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	53	255	261	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					443	+		10.1038/nature14864	http://dx.doi.org/10.1038/nature14864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26322584	Green Accepted			2022-12-28	WOS:000362730200054
J	Allison, JP				Allison, James P.			Immune Checkpoint Blockade in Cancer Therapy The 2015 Lasker-DeBakey Clinical Medical Research Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							T-CELLS; CTLA-4; MELANOMA; IPILIMUMAB		[Allison, James P.] Univ Texas MD Anderson Canc Ctr, Dept Immunol & Immunotherapy Platform, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Allison, JP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol & Immunotherapy, Houston, TX 77030 USA.	JAllison@mdanderson.org		Allison, James/0000-0001-8980-5697	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X	8	60	65	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1113	1114		10.1001/jama.2015.11929	http://dx.doi.org/10.1001/jama.2015.11929			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26348357				2022-12-28	WOS:000361284500011
J	Crowther, TW; Glick, HB; Covey, KR; Bettigole, C; Maynard, DS; Thomas, SM; Smith, JR; Hintler, G; Duguid, MC; Amatulli, G; Tuanmu, MN; Jetz, W; Salas, C; Stam, C; Piotto, D; Tavani, R; Green, S; Bruce, G; Williams, SJ; Wiser, SK; Huber, MO; Hengeveld, GM; Nabuurs, GJ; Tikhonova, E; Borchardt, P; Li, CF; Powrie, LW; Fischer, M; Hemp, A; Homeier, J; Cho, P; Vibrans, AC; Umunay, PM; Piao, SL; Rowe, CW; Ashton, MS; Crane, PR; Bradford, MA				Crowther, T. W.; Glick, H. B.; Covey, K. R.; Bettigole, C.; Maynard, D. S.; Thomas, S. M.; Smith, J. R.; Hintler, G.; Duguid, M. C.; Amatulli, G.; Tuanmu, M. -N.; Jetz, W.; Salas, C.; Stam, C.; Piotto, D.; Tavani, R.; Green, S.; Bruce, G.; Williams, S. J.; Wiser, S. K.; Huber, M. O.; Hengeveld, G. M.; Nabuurs, G. -J.; Tikhonova, E.; Borchardt, P.; Li, C. -F.; Powrie, L. W.; Fischer, M.; Hemp, A.; Homeier, J.; Cho, P.; Vibrans, A. C.; Umunay, P. M.; Piao, S. L.; Rowe, C. W.; Ashton, M. S.; Crane, P. R.; Bradford, M. A.			Mapping tree density at a global scale	NATURE			English	Article							CLIMATE-CHANGE; FOREST; BIOMASS; HYPERDOMINANCE; MAP	The global extent and distribution of forest trees is central to our understanding of the terrestrial biosphere. We provide the first spatially continuous map of forest tree density at a global scale. This map reveals that the global number of trees is approximately 3.04 trillion, an order of magnitude higher than the previous estimate. Of these trees, approximately 1.39 trillion exist in tropical and subtropical forests, with 0.74 trillion in boreal regions and 0.61 trillion in temperate regions. Biome-level trends in tree density demonstrate the importance of climate and topography in controlling local tree densities at finer scales, as well as the overwhelming effect of humans across most of the world. Based on our projected tree densities, we estimate that over 15 billion trees are cut down each year, and the global number of trees has fallen by approximately 46% since the start of human civilization.	[Crowther, T. W.; Glick, H. B.; Covey, K. R.; Bettigole, C.; Maynard, D. S.; Smith, J. R.; Hintler, G.; Duguid, M. C.; Jetz, W.; Umunay, P. M.; Rowe, C. W.; Ashton, M. S.; Crane, P. R.; Bradford, M. A.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Thomas, S. M.] Univ Helsinki, Dept Environm Sci, FIN-00014 Helsinki, Finland; [Amatulli, G.; Tuanmu, M. -N.; Jetz, W.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA; [Jetz, W.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Salas, C.] Univ La Frontera, Dept Ciencias Forestales, Temuco 4811230, Chile; [Stam, C.] RedCastle Resources, Salt Lake City, UT 84103 USA; [Piotto, D.] Univ Fed Sul Bahia, BR-45613204 Ferradas, Itabuna, Brazil; [Tavani, R.] Food & Agr Org United Nat, Forestry Dept, I-00153 Rome, Italy; [Green, S.; Bruce, G.] Operat Wallacea, Spilbsy PE23 4EX, Leics, England; [Green, S.] Univ Kent, DICE, SAC, Canterbury ME4 4AG, Kent, England; [Williams, S. J.] CEA, URA 2210, CNRS, Mol Imaging Res Ctr MIRCen, F-91401 Orsay, France; [Wiser, S. K.] Landcare Res, Lincoln 7640, New Zealand; [Huber, M. O.] Snowand Landscape Res, Swiss Fed Inst Forest, WSL, CH-8903 Birmensdorf, Switzerland; [Hengeveld, G. M.; Nabuurs, G. -J.] Univ Wageningen & Res Ctr, Environm Sci Grp, NL-6708 PB Wageningen, Netherlands; [Tikhonova, E.] Ctr Forest Ecol & Prod RAS, Moscow 117997, Russia; [Borchardt, P.] Univ Hamburg, Inst Geog, CEN Ctr Earth Syst Res & Sustainabil, D-20146 Hamburg, Germany; [Li, C. -F.] Masaryk Univ, Dept Bot & Zool, Brno 61137, Czech Republic; [Powrie, L. W.] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, ZA-7735 Claremont, South Africa; [Fischer, M.] Univ Bern, Inst Plant Sci, Bot Garden, CH-3013 Bern, Switzerland; [Fischer, M.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3013 Bern, Switzerland; [Fischer, M.] Biodivers & Climate Res Ctr BIK F, Senckenberg Gesell Nat Forsch, D-60325 Frankfurt, Germany; [Hemp, A.] Univ Bayreuth, Dept Plant Systemat, D-95447 Bayreuth, Germany; [Homeier, J.] Univ Gottingen, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany; [Cho, P.] Univ Lancaster, Trop Ecol Res Grp, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Vibrans, A. C.] Univ Reg Blumenau, Dept Engn Florestal, BR-89030000 Blumenau, SC, Brazil; [Piao, S. L.] Peking Univ, Sinofrench Inst Earth Syst Sci, Coll Urban & Environm Sci, Beijing 100871, Peoples R China	Yale University; University of Helsinki; Yale University; Imperial College London; Universidad de La Frontera; Universidade Federal do Sul da Bahia; Food & Agriculture Organization of the United Nations (FAO); University of Kent; CEA; Centre National de la Recherche Scientifique (CNRS); Landcare Research - New Zealand; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Wageningen University & Research; University of Hamburg; Masaryk University Brno; South African National Biodiversity Institute; University of Bern; University of Bern; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Bayreuth; University of Gottingen; Lancaster University; Universidade Regional de Blumenau (FURB); Peking University	Crowther, TW (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	thomas.crowther11@gmail.com	Tuanmu, Mao-Ning/ABI-5979-2020; Piotto, Daniel/V-1232-2019; Hengeveld, Geerten/O-8943-2019; Fischer, Markus/C-6411-2008; Umunay, Peter/AAS-4870-2020; Bradford, Mark A/G-3850-2012; Noojipady, Praveen/B-2511-2010; Wiser, Susan K./G-1975-2011; Salas-Eljatib, Christian/I-3588-2013; Li, Ching-Feng/I-6504-2015; Vibrans, Alexander C./C-3089-2013; Jetz, Walter/ABF-1517-2020; Homeier, Jürgen/G-1662-2011; Nabuurs, Gert-Jan/D-8048-2015	Tuanmu, Mao-Ning/0000-0002-8233-2935; Piotto, Daniel/0000-0002-6505-0098; Fischer, Markus/0000-0002-5589-5900; Bradford, Mark A/0000-0002-2022-8331; Wiser, Susan K./0000-0002-8938-8181; Salas-Eljatib, Christian/0000-0002-8468-0829; Li, Ching-Feng/0000-0003-0744-490X; Vibrans, Alexander C./0000-0002-8789-5833; Homeier, Jürgen/0000-0001-5676-3267; Powrie, Leslie Ward/0000-0001-6942-8484; Crowther, Thomas/0000-0001-5674-8913; Tikhonova, Elena/0000-0003-4641-3735; Jetz, Walter/0000-0002-1971-7277; Maynard, Daniel/0000-0003-0142-9100; Hengeveld, Geerten/0000-0002-9592-3080; Amatulli, Giuseppe/0000-0002-8341-2830; Duguid, Marlyse/0000-0003-1465-0947	Yale Climate and Energy Institute; British Ecological Society; Chilean research grants FONDECYT [1151495]; National Science Foundation; Center for Tropical Forest Science; Smithsonian Tropical Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund; Ucross High Plains Stewardship Initiative; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Yale Climate and Energy Institute; British Ecological Society; Chilean research grants FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); National Science Foundation(National Science Foundation (NSF)); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund; Ucross High Plains Stewardship Initiative; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank P. Peterkins for her support throughout the study. We also thank Plant for the Planet for initial discussions and for collaboration during the study. The main project was funded by grants to T.W.C. from the Yale Climate and Energy Institute and the British Ecological Society. We acknowledge various sources for tree density measurements and estimates: the Canadian National Forest Inventory (https://nfi.nfis.org/index.php), the US Department of Agriculture Forest Service for their National Forest Inventory and Analysis (http://fia.fs.fed.us/), the Taiwan Forestry Bureau (which provided the National Vegetation Database of Taiwan), the DFG (German Research Foundation), BMBF (Federal Ministry of Education and Science of Germany), the Floristic and Forest Inventory of Santa Catarina (IFFSC), the National Vegetation Database of South Africa, and the Chilean research grants FONDECYT no. 1151495. For Europe NFI plot data were brought together with input from J. Rondeux and M. Waterinckx, Belgium, T. Belouard, France, H. Polley, Germany, W. Daamen and H. Schoonderwoerd, Netherlands, S. Tomter, Norway, J. Villanueva and A. Trasobares, Spain, G. Kempe, Sweden. New Zealand Natural Forest plot data were collected by the LUCAS programme for the Ministry for the Environment (New Zealand) and sourced from the National Vegetation Survey Databank (New Zealand) (http://nvs.landcareresearch.co.nz). We also acknowledge the BCI forest dynamics research project, which was funded by National Science Foundation grants to S. P. Hubbell, support from the Center for Tropical Forest Science, the Smithsonian Tropical Research Institute, the John D. and Catherine T. MacArthur Foundation, the Mellon Foundation, the Small World Institute Fund, numerous private individuals, the Ucross High Plains Stewardship Initiative, and the hard work of hundreds of people from 51 countries over the past two decades. The plot project is part of the Center for Tropical Forest Science, a global network of large-scale demographic tree plots.	Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Barton K., 2015, MUMIN MODEL SELECTIO; BONAN GB, 1989, ANNU REV ECOL SYST, V20, P1, DOI 10.1146/annurev.es.20.110189.000245; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brus DJ, 2012, EUR J FOREST RES, V131, P145, DOI 10.1007/s10342-011-0513-5; Cao SX, 2011, AMBIO, V40, P828, DOI 10.1007/s13280-011-0150-8; Chavent M, 2012, J STAT SOFTW, V50, P1; Crowther TW, 2014, GLOBAL CHANGE BIOL, V20, P2983, DOI 10.1111/gcb.12565; Fauset S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7857; Guldin RW, 2003, FOREST POLICY ECON, V5, P329, DOI 10.1016/S1389-9341(03)00042-X; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hengeveld GM, 2012, ECOL SOC, V17, DOI 10.5751/ES-05149-170453; Kindermann GE, 2008, SILVA FENN, V42, P387, DOI 10.14214/sf.244; Leathwick JR, 2001, ECOLOGY, V82, P2560, DOI 10.1890/0012-9658(2001)082[2560:CIBTSI]2.0.CO;2; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; MacKenzie D.I., 2005, OCCUPANCY ESTIMATION; MacLean MG, 2013, INT J REMOTE SENS, V34, P2531, DOI 10.1080/01431161.2012.747017; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Nadkarni N, 2008, EARTH SKY OUR INTIMA; O'Neil-Dunne J, 2014, REMOTE SENS-BASEL, V6, P12837, DOI 10.3390/rs61212837; Oldfield E. E., 2015, RESTORATION ECOL; Oliver C.D., 1996, FOREST STAND DYNAMIC; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pfeifer M, 2012, GLOBAL ECOL BIOGEOGR, V21, P603, DOI 10.1111/j.1466-8238.2011.00712.x; Riginos C, 2008, ECOLOGY, V89, P2228, DOI 10.1890/07-1250.1; Rudel TK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0405; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Stahl G, 2011, CAN J FOREST RES, V41, P96, DOI 10.1139/X10-161; STEINWAND DR, 1995, PHOTOGRAMM ENG REM S, V61, P1487; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Tuanmu M.-N., 2015, GLOB ECOL BIOGEOGR; Tuanmu MN, 2014, GLOBAL ECOL BIOGEOGR, V23, P1031, DOI 10.1111/geb.12182; USDA Forest Service, 2010, FOR INV AN NAT PROGR; Walker AP, 2015, GLOBAL BIOGEOCHEM CY, V29, P476, DOI 10.1002/2014GB004995; Zhu K, 2014, GLOBAL CHANGE BIOL, V20, P251, DOI 10.1111/gcb.12382	36	414	434	42	523	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					201	+		10.1038/nature14967	http://dx.doi.org/10.1038/nature14967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26331545				2022-12-28	WOS:000360927400028
J	Hatton, IA; McCann, KS; Fryxell, JM; Davies, TJ; Smerlak, M; Sinclair, ARE; Loreau, M				Hatton, Ian A.; McCann, Kevin S.; Fryxell, John M.; Davies, T. Jonathan; Smerlak, Matteo; Sinclair, Anthony R. E.; Loreau, Michel			The predator-prey power law: Biomass scaling across terrestrial and aquatic biomes	SCIENCE			English	Article							NET PRIMARY PRODUCTION; NORTH-AMERICAN GRASSLANDS; PRIMARY PRODUCTIVITY; DENSITY-DEPENDENCE; NATIONAL-PARK; CARNIVORE DENSITIES; POPULATION-DENSITY; TROPHIC STRUCTURE; SPECIES TURNOVER; METABOLIC THEORY	Ecosystems exhibit surprising regularities in structure and function across terrestrial and aquatic biomes worldwide. We assembled a global data set for 2260 communities of large mammals, invertebrates, plants, and plankton. We find that predator and prey biomass follow a general scaling law with exponents consistently near 3/4. This pervasive pattern implies that the structure of the biomass pyramid becomes increasingly bottom-heavy at higher biomass. Similar exponents are obtained for community production-biomass relations, suggesting conserved links between ecosystem structure and function. These exponents are similar to many body mass allometries, and yet ecosystem scaling emerges independently from individual-level scaling, which is not fully understood. These patterns suggest a greater degree of ecosystem-level organization than previously recognized and a more predictive approach to ecological theory.	[Hatton, Ian A.; Davies, T. Jonathan] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [McCann, Kevin S.; Fryxell, John M.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Smerlak, Matteo] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Sinclair, Anthony R. E.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Sinclair, Anthony R. E.] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Loreau, Michel] CNRS, Ctr Biodivers Theory & Modeling, Expt Ecol Stn, F-09200 Moulis, France	McGill University; University of Guelph; Perimeter Institute for Theoretical Physics; University of British Columbia; Centre National de la Recherche Scientifique (CNRS)	Hatton, IA (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	i.a.hatton@gmail.com	Smerlak, Matteo/AAA-5639-2022	Smerlak, Matteo/0000-0002-0844-8868	Natural Sciences and Engineering Research Council of Canada CGS-D fellowship; TULIP Laboratory of Excellence [ANR-10-LABX-41]; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation	Natural Sciences and Engineering Research Council of Canada CGS-D fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); TULIP Laboratory of Excellence; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	We thank N. Owen-Smith, L. Glass, J. H. Brown, V. M. Savage, J. P. Lessard, J. P. DeLong, J. M. Grady, and three anonymous reviewers for helpful comments on earlier drafts; X. Irigoien, S. K. M. Ernest, and H. Cyr for providing data; S. N. Driscoll for mapping assistance; and C. Miki for database assistance. I. A. H. was supported by a Natural Sciences and Engineering Research Council of Canada CGS-D fellowship. M. L. was supported by the TULIP Laboratory of Excellence (ANR-10-LABX-41). Research at Perimeter Institute was supported by the Government of Canada through Industry Canada and by the Province of Ontario through the Ministry of Research and Innovation. Data are available in the supplementary materials at Science Online.	Arditi R., 2012, SPECIES INTERACT; BANSE K, 1980, ECOL MONOGR, V50, P355, DOI 10.2307/2937256; BILLINGTON N, 1991, HYDROBIOLOGIA, V226, P1, DOI 10.1007/BF00007775; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; Cannell MGR, 1982, WORLD FOREST BIOMASS; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Carbone C, 2011, BIOL LETTERS, V7, P312, DOI 10.1098/rsbl.2010.0996; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Cebrian J, 2004, ECOL MONOGR, V74, P237, DOI 10.1890/03-4019; CEBRIAN J, 1994, FUNCT ECOL, V8, P518, DOI 10.2307/2390077; Cebrian J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004929; Chase JM, 2000, ECOLOGY, V81, P2485, DOI 10.1890/0012-9658(2000)081[2485:TEOPHA]2.0.CO;2; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Coupland R. T., 1993, NATURAL GRASSLANDS B, V8B; CYR H, 1993, ECOLOGY, V74, P1234, DOI 10.2307/1940493; Cyr H, 1996, CAN J FISH AQUAT SCI, V53, P994, DOI 10.1139/cjfas-53-5-994; CYR H, 1993, NATURE, V361, P148, DOI 10.1038/361148a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Del Giorgio PA, 1999, ECOLOGY, V80, P1422, DOI 10.1890/0012-9658(1999)080[1422:LPBAMT]2.0.CO;2; DELGIORGIO PA, 1995, AM NAT, V146, P135, DOI 10.1086/285790; DeLong JP, 2014, J ANIM ECOL, V83, P51, DOI 10.1111/1365-2656.12065; DeLong JP, 2012, ECOLOGY, V93, P470, DOI 10.1890/11-1138.1; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; DORTCH Q, 1989, DEEP-SEA RES, V36, P223, DOI 10.1016/0198-0149(89)90135-0; DOWNING JA, 1990, CAN J FISH AQUAT SCI, V47, P1929, DOI 10.1139/f90-217; DOWNING JA, 1993, CAN J FISH AQUAT SCI, V50, P110, DOI 10.1139/f93-013; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Duncan RP, 2007, ECOLOGY, V88, P324, DOI 10.1890/0012-9658(2007)88[324:TTMTOE]2.0.CO;2; Duursma RA, 2010, FUNCT ECOL, V24, P723, DOI 10.1111/j.1365-2435.2010.01690.x; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; East R., 1999, AFRICAN ANTELOPE DAT; Elton C., 1927, ANIMAL ECOLOGY; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Fagan WF, 2010, OIKOS, V119, P455, DOI 10.1111/j.1600-0706.2009.18002.x; FARLOW JO, 1976, ECOLOGY, V57, P841, DOI 10.2307/1941052; FENCHEL T, 1974, OECOLOGIA, V14, P317, DOI 10.1007/BF00384576; Frank SA, 2009, J EVOLUTION BIOL, V22, P1563, DOI 10.1111/j.1420-9101.2009.01775.x; FRITZ H, 1994, P ROY SOC B-BIOL SCI, V256, P77, DOI 10.1098/rspb.1994.0052; FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; Fryxell JM, 2007, NATURE, V449, P1041, DOI 10.1038/nature06177; FULLER TK, 1989, WILDLIFE MONOGR, P1; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Goodwin NB, 2006, CAN J FISH AQUAT SCI, V63, P494, DOI 10.1139/f05-234; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; Grange S, 2006, ECOGRAPHY, V29, P899, DOI 10.1111/j.2006.0906-7590.04684.x; Gros PM, 1996, OIKOS, V77, P197, DOI 10.2307/3546058; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Harris GP., 1986, PHYTOPLANKTON ECOLOG; Harris L. D., 1972, RANGE SCI DEP SCI SE, V11; Harte J, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199593415.001.0001; HEMSON G, 2003, THESIS U OXFORD OXFO; Hou C, 2008, SCIENCE, V322, P736, DOI 10.1126/science.1162302; Huston MA, 2009, ECOL MONOGR, V79, P343, DOI 10.1890/08-0588.1; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Jackson P., 1996, BIOL CONSERVATION; Jedrzejewska B., 1998, PREDATION VERTEBRATE, V135; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; JOLICOEUR P, 1990, J THEOR BIOL, V144, P275, DOI 10.1016/S0022-5193(05)80326-1; Kalff J., 2002, LIMNOLOGY INLAND WAT, V592; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Kawanishi K, 2004, BIOL CONSERV, V120, P329, DOI 10.1016/j.biocon.2004.03.005; Kerkhoff AJ, 2006, ECOL LETT, V9, P419, DOI 10.1111/j.1461-0248.2006.00888.x; Kiffner C, 2009, ORYX, V43, P52, DOI 10.1017/S0030605307002335; Lamprey H. F., 1963, Tanganyika Notes, VNo. 60, P10; Legendre P., 2012, NUMERICAL ECOLOGY, V24; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LONG SP, 1991, ECOL APPL, V1, P139, DOI 10.2307/1941807; Loreau M., 2010, POPULATIONS ECOSYSTE; Lotka AJ, 1924, ELEMENTS PHYS BIOL; Luo T. X., 1996, THESIS CHINESE ACAD; Makarieva AM, 2004, ECOL MODEL, V176, P15, DOI 10.1016/j.ecolmodel.2003.09.037; Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; McCann K.S., 2011, FOOD WEBS MPB 50; MCCAULEY E, 1981, CAN J FISH AQUAT SCI, V38, P458, DOI 10.1139/f81-063; MCCAULEY E., 1984, MANUAL METHODS ASSES, P228, DOI DOI 10.1002/IROH.19860710218; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Michaletz ST, 2014, NATURE, V512, P39, DOI 10.1038/nature13470; Mills M.G.L., 1990, KALAHARI HYENAS COMP; Nee S, 2005, SCIENCE, V309, P1236, DOI 10.1126/science.1114488; Ni J, 2001, ANN FOR SCI, V58, P351, DOI 10.1051/forest:2001131; NIKLAS KJ, 2004, BIOMASS ALLOCATION G; ODUM E P, 1971, P574; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Pawar S, 2012, NATURE, V486, P485, DOI 10.1038/nature11131; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; PLANTE C, 1989, CAN J FISH AQUAT SCI, V46, P1489, DOI 10.1139/f89-191; PLANTE C, 1990, J N AM BENTHOL SOC, V9, P9, DOI 10.2307/1467929; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Power RJ, 2009, AFR ZOOL, V44, P36, DOI 10.3377/004.044.0104; Project Tiger Directorate, RES GUID PROJ TIG RE; RANDALL RG, 1995, CAN J FISH AQUAT SCI, V52, P631, DOI 10.1139/f95-063; RICKER WE, 1973, J FISH RES BOARD CAN, V30, P409, DOI 10.1139/f73-072; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Sibly R. M., 2012, METABOLIC ECOLOGY A; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; SIMS PL, 1978, J ECOL, V66, P251, DOI 10.2307/2259192; SIMS PL, 1978, J ECOL, V66, P573, DOI 10.2307/2259152; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; SINGH JS, 1975, BOT REV, V41, P181, DOI 10.1007/BF02860829; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Treves A, 2009, ORYX, V43, P60, DOI 10.1017/S003060530700124X; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Wang GM, 2009, POPUL ECOL, V51, P123, DOI 10.1007/s10144-008-0095-3; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; WATSON S, 1988, CAN J FISH AQUAT SCI, V45, P915, DOI 10.1139/f88-112; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; White CR, 2011, COMP BIOCHEM PHYS A, V158, P346, DOI 10.1016/j.cbpa.2010.10.004; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Whitfield E, 2012, MARY PICKFORD: QUEEN OF THE MOVIES, P7; Wilson V. J., 1975, MUSEUM MEMOIR, V5	128	152	158	14	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1070	+		10.1126/science.aac6284	http://dx.doi.org/10.1126/science.aac6284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339034				2022-12-28	WOS:000360628900033
J	Noctor, G				Noctor, Graham			Lighting the fuse on toxic TNT	SCIENCE			English	Editorial Material							GLUTATHIONE; ARABIDOPSIS; ASCORBATE; PLANTS; CHLOROPLASTS; STRESS; CYCLE; ACID		Univ Paris Diderot, Sorbonne Paris Cite, Univ Paris 11,UMR 9213,UMR1403, Univ dEvry,CNRS,INRA,Inst Plant Sci Paris Saclay, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Noctor, G (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Univ Paris 11,UMR 9213,UMR1403, Univ dEvry,CNRS,INRA,Inst Plant Sci Paris Saclay, Batiment 630, F-91405 Orsay, France.	graham.noctor@u-psud.fr						Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Awad J, 2015, PLANT PHYSIOL, V167, P1592, DOI 10.1104/pp.114.255356; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Creissen G, 1999, PLANT CELL, V11, P1277, DOI 10.1105/tpc.11.7.1277; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gunning V, 2014, PLANT PHYSIOL, V165, P854, DOI 10.1104/pp.114.237180; Hackenberg T, 2013, PLANT CELL, V25, P4616, DOI 10.1105/tpc.113.117192; Han Y, 2013, ANTIOXID REDOX SIGN, V18, P2106, DOI 10.1089/ars.2012.5052; Johnston EJ, 2015, SCIENCE, V349, P1072, DOI 10.1126/science.aab3472; Miyake C, 1998, PLANT CELL PHYSIOL, V39, P821, DOI 10.1093/oxfordjournals.pcp.a029440; Smirnoff N, 2011, ADV BOT RES, V59, P107, DOI 10.1016/B978-0-12-385853-5.00003-9	12	12	12	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1052	1053		10.1126/science.aad0941	http://dx.doi.org/10.1126/science.aad0941			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339013				2022-12-28	WOS:000360628900018
J	Begley, CG; Buchan, AM; Dirnagl, U				Begley, C. Glenn; Buchan, Alastair M.; Dirnagl, Ulrich			Robust research Institutions must do their part for reproducibility	NATURE			English	Editorial Material									[Begley, C. Glenn] TetraLog Pharmaceut, Malvern, PA 19355 USA; [Buchan, Alastair M.] Univ Oxford, Oxford NIHR Biomed Res Ctr, Med, Oxford OX1 2JD, England; [Buchan, Alastair M.] Univ Oxford, Oxford NIHR Biomed Res Ctr, Div Med Sci, Oxford OX1 2JD, England; [Dirnagl, Ulrich] Charite, Ctr Stroke Res, D-13353 Berlin, Germany	University of Oxford; University of Oxford; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Begley, CG (corresponding author), TetraLog Pharmaceut, Malvern, PA 19355 USA.	cgbegley@tlog.com	Buchan, Alastair M/B-9095-2009	Buchan, Alastair M/0000-0002-2918-5200; Dirnagl, Ulrich/0000-0003-0755-6119				Begley CG, 2013, NATURE, V497, P433, DOI 10.1038/497433a; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V312, P483, DOI 10.1001/jama.2014.6932; Mobley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063221; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1	6	69	69	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					25	27		10.1038/525025a	http://dx.doi.org/10.1038/525025a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4SE	26333454	Bronze			2022-12-28	WOS:000360594100010
J	Kleinjans, J; Botsivali, M; Kogevinas, M; Merlo, DF				Kleinjans, Jos; Botsivali, Maria; Kogevinas, Manolis; Merlo, Domenico Franco		NewGeneris Consortium	Fetal exposure to dietary carcinogens and risk of childhood cancer: what the NewGeneris project tells us	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSPECTIVE MOTHER-CHILD; MATERNAL DIET; CORD BLOOD; IN-UTERO; PRENATAL EXPOSURE; GENE-EXPRESSION; BIRTH-WEIGHT; POLYMORPHISMS; ASSOCIATIONS; LYMPHOCYTES	Jos Kleinjans and colleagues summarise the evidence from a European study using biomarkers to assess how maternal diet affects the child	[Kleinjans, Jos] Maastricht Univ, Dept Toxicogenom, Environm Hlth Sci, Maastricht, Netherlands; [Botsivali, Maria] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens, Greece; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Merlo, Domenico Franco] IRCCS, AOU San Martino IST, Ist Nazl Ric Cancro, Genoa, Italy	Maastricht University; National Hellenic Research Foundation; Pompeu Fabra University; University of Genoa; IRCCS AOU San Martino IST	Kleinjans, J (corresponding author), Maastricht Univ, Dept Toxicogenom, Environm Hlth Sci, Maastricht, Netherlands.	j.kleinjans@maastrichtuniversity.nl	Kogevinas, Manolis/C-3918-2017; Merlo, Domenico Franco/ABI-1345-2020	Kogevinas, Manolis/0000-0002-9605-0461; Merlo, Domenico Franco/0000-0002-1832-4754				American Cancer Society, 2011, GLOB CANC FACTS FIG; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Englund-Ogge Linda, 2014, BMJ, V348, pg1446, DOI 10.1136/bmj.g1446; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Godfrey K M, 2001, Public Health Nutr, V4, P611; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; Hochstenbach K, 2012, CANCER EPIDEM BIOMAR, V21, P1756, DOI 10.1158/1055-9965.EPI-12-0304; Hochstenbach K, 2012, TOXICOL SCI, V129, P315, DOI 10.1093/toxsci/kfs214; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Kind KL, 2006, REPROD BIOMED ONLINE, V12, P532, DOI 10.1016/S1472-6483(10)61178-9; Kwan ML, 2009, PUBLIC HEALTH REP, V124, P503, DOI 10.1177/003335490912400407; Merlo DF, 2009, CANCER EPIDEM BIOMAR, V18, P5, DOI 10.1158/1055-9965.EPI-08-0876; Merlo DF, 2014, ENVIRON HEALTH PERSP, V122, P193, DOI 10.1289/ehp.1206324; Mose T, 2012, PLACENTA, V33, P433, DOI 10.1016/j.placenta.2012.02.004; Nanovskaya TN, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.073; Norrgard K., 2022, NAT ED, V1, P87; Ovsyannikova IG, 2004, VACCINE, V22, P1914, DOI 10.1016/j.vaccine.2003.11.016; Papadopoulou E, 2014, SCI TOTAL ENVIRON, V484, P121, DOI 10.1016/j.scitotenv.2014.03.047; Pedersen M, 2013, ENVIRON HEALTH PERSP, V121, P1200, DOI 10.1289/ehp.1206333; Pedersen M, 2012, ENVIRON HEALTH PERSP, V120, P1739, DOI 10.1289/ehp.1205327; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Sugimura T, 2000, CARCINOGENESIS, V21, P387, DOI 10.1093/carcin/21.3.387; Vafeiadi M, 2014, EPIDEMIOLOGY, V25, P215, DOI 10.1097/EDE.0000000000000046; Vande Loock K, 2014, MUTAGENESIS, V29, P393, DOI 10.1093/mutage/geu052; Wiemels JL, 2002, BLOOD, V99, P3801, DOI 10.1182/blood.V99.10.3801; Wild CP, 2003, CANCER EPIDEM BIOMAR, V12, P1389; Williams JA, 2001, CARCINOGENESIS, V22, P209, DOI 10.1093/carcin/22.2.209	28	12	12	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2015	351								h4501	10.1136/bmj.h4501	http://dx.doi.org/10.1136/bmj.h4501			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2NX	26320143				2022-12-28	WOS:000360439100001
J	Kamerow, D; Graham, R				Kamerow, Douglas; Graham, Robert			Fuming about e-cigarettes and harm YANKEE DOODLING	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING		[Kamerow, Douglas; Graham, Robert] Georgetown Univ, Ctr Policy Studies Primary Care, Washington, DC 20057 USA; [Kamerow, Douglas; Graham, Robert] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Ctr Policy Studies Primary Care, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Kaplan K, 2014, LOS ANGELES TIMES; Leventhal AM, 2015, JAMA-J AM MED ASSOC, V314, P700, DOI 10.1001/jama.2015.8950; McNeill A., 2015, REPORT COMMISSIONED; Rigotti NA, 2015, JAMA-J AM MED ASSOC, V314, P673, DOI 10.1001/jama.2015.8382; Torjesen I, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4518	5	0	0	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2015	351								h4634	10.1136/bmj.h4634	http://dx.doi.org/10.1136/bmj.h4634			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2NJ	26311715				2022-12-28	WOS:000360437600005
J	Faith, MS; Stettler, N; Pietrobelli, A				Faith, Myles S.; Stettler, Nicolas; Pietrobelli, Angelo			Engaging Primary Care Clinicians in Early Obesity Prevention Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILDHOOD	Addressing the childhood obesity epidemic continues to be a challenge. Given that once obesity develops it is likely to persist, there has been an increasing focus on prevention at earlier stages of the life course. Research to develop and implement effective prevention and intervention strategies in the first 2 years after birth has been limited. In fall 2013, the National Institute of Diabetes and Digestive and Kidney Diseases convened a multidisciplinary workshop to summarize the current state of knowledge regarding the prevention of infant and early childhood obesity and to identify research gaps and opportunities. The questions addressed included (1) "What is known regarding risk for excess weight gain in infancy and early childhood?" (2) "What is known regarding interventions that are promising or have been shown to be efficacious?" and (3) "What are the challenges and opportunities in implementing and evaluating behavioral interventions for parents and other caregivers and their young children?"	[Faith, Myles S.] SUNY Buffalo, Grad Sch Educ, Dept Counseling Sch & Educ Psychol, 420 Baldy Hall, Buffalo, NY 14260 USA; [Stettler, Nicolas] Lewin Grp, Falls Church, VA USA; [Pietrobelli, Angelo] Univ Verona, Sch Med, Pediat Unit, I-37100 Verona, Italy; [Pietrobelli, Angelo] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Verona; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Faith, MS (corresponding author), SUNY Buffalo, Grad Sch Educ, Dept Counseling Sch & Educ Psychol, 420 Baldy Hall, Buffalo, NY 14260 USA.	mfaith@buffalo.edu						Kazdin AE, 2011, PERSPECT PSYCHOL SCI, V6, P21, DOI 10.1177/1745691610393527; Lumeng JC, 2015, JAMA PEDIATR, V169, P484, DOI 10.1001/jamapediatrics.2014.3554; Nowicka P, 2008, INT J PEDIATR OBES, V3, P141, DOI 10.1080/17477160802102475; Quattrin T, 2012, PEDIATRICS, V130, P660, DOI 10.1542/peds.2012-0701; Sargent GM, 2011, OBES REV, V12, pe219, DOI 10.1111/j.1467-789X.2010.00777.x; Stettler N, 2015, PEDIATR OBES, V10, P267, DOI 10.1111/ijpo.260; Taveras EM, 2014, OBESITY, V22, P27, DOI 10.1002/oby.20612; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5	8	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					823	+		10.1001/jama.2015.6262	http://dx.doi.org/10.1001/jama.2015.6262			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305652				2022-12-28	WOS:000360017200022
J	Smith, JM				Smith, Jeanette M.			Mahabalipooram Edward Lear	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		DAVIDSON A, 1939, E LEAR LANDSCAPE PAI, P1; NOAKES V, 1991, PAINTER E LEAR, P6	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					754	755		10.1001/jama.2014.11937	http://dx.doi.org/10.1001/jama.2014.11937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305634				2022-12-28	WOS:000360017200034
J	Husted, SE; Ohman, EM				Husted, Steen E.; Ohman, E. Magnus			Pharmacological and emerging therapies in the treatment of chronic angina	LANCET			English	Article							CORONARY-ARTERY-DISEASE; CHRONIC STABLE ANGINA; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED CLINICAL-TRIAL; BETA-BLOCKER THERAPY; QUALITY-OF-LIFE; I-F INHIBITOR; DOUBLE-BLIND; REFRACTORY ANGINA	Chronic angina is a common manifestation of ischaemic heart disease. Medical treatments are the mainstay approach to reduce the occurrence of angina and improve patients' quality of life. This Series paper focuses on commonly used standard treatments (eg, nitrates, beta blockers, and calcium-channel blockers), emerging anti-angina treatments ( which are not available in all parts of the world), and experimental treatments. Although many emerging treatments are available, evidence is scarce about their ability to reduce angina and ischaemia.	[Husted, Steen E.] Hosp Unit West, Dept Med, Herning, Denmark; [Husted, Steen E.] Aarhus Univ, Inst Biomed, Dept Clin Pharmacol, Aarhus, Denmark; [Ohman, E. Magnus] Duke Univ, Program Adv Coronary Dis, Div Cardiol, Durham, NC 27710 USA; [Ohman, E. Magnus] Duke Clin Res Inst, Durham, NC USA	Aarhus University; Duke University; Duke University	Ohman, EM (corresponding author), Duke Univ, Med Ctr, Box 3126 DUMC, Durham, NC 27710 USA.	ohman001@mc.duke.edu						Abernethy DR, 1999, NEW ENGL J MED, V341, P1447, DOI 10.1056/NEJM199911043411907; Alderman MH, 1997, LANCET, V349, P594, DOI 10.1016/S0140-6736(96)08359-6; Arnold SV, 2008, CIRC-CARDIOVASC QUAL, V1, P107, DOI 10.1161/CIRCOUTCOMES.108.798009; Attanasio S, 2011, CARDIOVASC THER, V29, pE1, DOI 10.1111/j.1755-5922.2010.00153.x; BOMAN K, 1995, EUR J CLIN PHARMACOL, V49, P27; Borer JS, 2003, CIRCULATION, V107, P817, DOI 10.1161/01.CIR.0000048143.25023.87; Bottcher M, 2002, AM J CARDIOL, V89, P1019, DOI 10.1016/S0002-9149(02)02268-3; Brogden RN, 1996, DRUGS, V51, P792, DOI 10.2165/00003495-199651050-00007; BURNSCOX CJ, 1971, BMJ-BRIT MED J, V4, P586, DOI 10.1136/bmj.4.5787.586; Chaitman BR, 2006, CIRCULATION, V113, P2462, DOI 10.1161/CIRCULATIONAHA.105.597500; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; COLE PL, 1990, CIRCULATION, V81, P1260, DOI 10.1161/01.CIR.81.4.1260; Dargie HJ, 2002, LANCET, V359, P1269, DOI 10.1016/s0140-6736(02)08265-x; Dessy C, 2010, ADV PHARMACOL, V59, P135, DOI 10.1016/S1054-3589(10)59005-7; DETRY JM, 1994, BRIT J CLIN PHARMACO, V37, P279, DOI 10.1111/j.1365-2125.1994.tb04276.x; DISOMMA S, 1993, CARDIOVASC DRUG THER, V7, P119, DOI 10.1007/BF00878320; DORING G, 1992, J CARDIOVASC PHARM, V20, pS74; Dzerve V, 2011, MEDICINA-LITHUANIA, V47, P544; Ekelund UEG, 1999, CIRC RES, V85, P437, DOI 10.1161/01.RES.85.5.437; Escolar E, 2014, CIRC-CARDIOVASC QUAL, V7, P15, DOI 10.1161/CIRCOUTCOMES.113.000663; EZEKOWITZ MD, 1995, AM HEART J, V129, P527, DOI 10.1016/0002-8703(95)90281-3; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430; Frishman WH, 2003, CARDIOVASCULAR PHARM; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Grines CL, 2003, J AM COLL CARDIOL, V42, P1339, DOI 10.1016/S0735-1097(03)00988-4; Grines CL, 2002, CIRCULATION, V105, P1291, DOI 10.1161/hc1102.105595; Gupta AK, 2013, EXPERT OPIN PHARMACO, V14, P2323, DOI 10.1517/14656566.2013.834329; HANSEN JF, 1990, AM J CARDIOL, V66, P779; HAYATA N, 1986, AM HEART J, V112, P1245, DOI 10.1016/0002-8703(86)90355-8; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; Henry TD, 1999, BMJ-BRIT MED J, V318, P1536, DOI 10.1136/bmj.318.7197.1536; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Henry TD, 2007, J AM COLL CARDIOL, V50, P1038, DOI 10.1016/j.jacc.2007.06.010; HORGAN JH, 1981, J CARDIOVASC PHARM, V3, P566, DOI 10.1097/00005344-198105000-00015; Joannides R, 2006, BRIT J CLIN PHARMACO, V61, P127, DOI 10.1111/j.1365-2125.2005.02544.x; Jolicoeur EM, 2008, AM HEART J, V155, P435, DOI 10.1016/j.ahj.2007.12.005; Kastrup J, 2005, J AM COLL CARDIOL, V45, P982, DOI 10.1016/j.jacc.2004.12.068; Kernis SJ, 2004, J AM COLL CARDIOL, V43, P1773, DOI 10.1016/j.jacc.2003.09.071; Kones R, 2010, VASC HEALTH RISK MAN, V6, P635; Koren MJ, 2007, J AM COLL CARDIOL, V49, P1027, DOI 10.1016/j.jacc.2006.10.067; Kosiborod M, 2013, J AM COLL CARDIOL, V61, P2038, DOI 10.1016/j.jacc.2013.02.011; Lamas GA, 2013, JAMA-J AM MED ASSOC, V309, P1241, DOI 10.1001/jama.2013.2107; Li N, 2013, CAN J CARDIOL, V29, P908, DOI 10.1016/j.cjca.2012.12.003; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Losordo DW, 2002, CIRCULATION, V105, P2012, DOI 10.1161/01.CIR.0000015982.70785.B7; LYON LJ, 1971, LANCET, V1, P1272; Marzilli M, 2003, CORONARY ARTERY DIS, V14, P171, DOI 10.1097/00019501-200304000-00010; Mathiasen AB, 2013, INT J CARDIOL, V170, P246, DOI 10.1016/j.ijcard.2013.10.079; MEANY TB, 1989, AM J CARDIOL, V63, pJ66, DOI 10.1016/0002-9149(89)90208-7; Messin R, 2005, INT J CARDIOL, V98, P79, DOI 10.1016/j.ijcard.2004.01.007; MESSIN R, 1995, J CARDIOVASC PHARM, V25, P558, DOI 10.1097/00005344-199504000-00008; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; MOSS AJ, 1988, NEW ENGL J MED, V319, P385; O'Rourke ST, 2002, AM J PHARM EDUC, V66, P177; Oh KS, 2013, EUR J PHARMACOL, V702, P218, DOI 10.1016/j.ejphar.2013.01.027; Ohman EM, 2014, NEW ENGL J MED, V371, P1152, DOI 10.1056/NEJMe1409369; Parker JD, 1998, NEW ENGL J MED, V338, P520, DOI 10.1056/NEJM199802193380807; PARKER JO, 1987, NEW ENGL J MED, V316, P1440, DOI 10.1056/NEJM198706043162303; PEPINE CJ, 1981, AM HEART J, V101, P719, DOI 10.1016/0002-8703(81)90606-2; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; Povsic TJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001287; Povsic TJ, 2013, AM HEART J, V165, P854, DOI 10.1016/j.ahj.2013.03.003; PSATY BM, 1990, JAMA-J AM MED ASSOC, V263, P1653, DOI 10.1001/jama.263.12.1653; Rajaratnam R, 1999, AM J CARDIOL, V83, P1120, DOI 10.1016/S0002-9149(99)00025-9; Ruzyllo W, 2007, DRUGS, V67, P393, DOI 10.2165/00003495-200767030-00005; SCHARTL M, 1985, AM HEART J, V109, P649, DOI 10.1016/0002-8703(85)90672-6; Shimokawa H, 2002, J CARDIOVASC PHARM, V40, P749; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Simons M, 2000, CIRCULATION, V102, pE73, DOI 10.1161/01.CIR.102.11.e73; Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407; Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044; SURYAPRANATA H, 1988, AM J CARDIOL, V61, P292, DOI 10.1016/0002-9149(88)90933-2; Szwed H, 2001, EUR HEART J, V22, P2267, DOI 10.1053/euhj.2001.2896; Tanguay JF, 2003, J AM COLL CARDIOL, V41, p404A; Tardif JC, 2005, EUR HEART J, V26, P2529, DOI 10.1093/eurheartj/ehi586; Tardif JC, 2009, EUR HEART J, V30, P540, DOI 10.1093/eurheartj/ehn571; TEO KK, 1983, CLIN PHARMACOL THER, V34, P744, DOI 10.1038/clpt.1983.244; Tepper David, 1999, Congest Heart Fail, V5, P184; Vicari RM, 2005, J AM COLL CARDIOL, V46, P1803, DOI 10.1016/j.jacc.2005.07.047; WAGNER F, 1991, EUR HEART J, V12, P994, DOI 10.1093/eurheartj/12.9.994; Werdan K, 2012, CLIN RES CARDIOL, V101, P365, DOI 10.1007/s00392-011-0402-4; WHITE HD, 1983, INT J CARDIOL, V3, P145, DOI 10.1016/0167-5273(83)90030-X	86	29	32	3	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					691	701		10.1016/S0140-6736(15)61283-1	http://dx.doi.org/10.1016/S0140-6736(15)61283-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26334161				2022-12-28	WOS:000359849200036
J	Federspiel, F; Mukhopadhyay, S; Milsom, P; Scott, JW; Riesel, JN; Meara, JG				Federspiel, Frederik; Mukhopadhyay, Swagoto; Milsom, Penelope; Scott, John W.; Riesel, Johanna N.; Meara, John G.			Global surgical and anaesthetic task shifting: a systematic literature review and survey	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Federspiel, Frederik] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Federspiel, Frederik] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Mukhopadhyay, Swagoto] Univ Connecticut, Integrated Residency Programs, Dept Surg, Storrs, CT USA; [Mukhopadhyay, Swagoto; Riesel, Johanna N.; Meara, John G.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA; [Mukhopadhyay, Swagoto; Milsom, Penelope; Scott, John W.; Riesel, Johanna N.; Meara, John G.] Harvard Univ, Sch Med, Program Global Surg & Social Change, Boston, MA USA; [Scott, John W.] Brigham & Womens Hosp, Dept Surg, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Riesel, Johanna N.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA	University of Copenhagen; Harvard University; Harvard Medical School; University of Connecticut; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital		frederikfederspiel@gmail.com		Scott, John/0000-0002-9916-6523					0	29	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			46	46		10.1016/S0140-6736(15)60841-8	http://dx.doi.org/10.1016/S0140-6736(15)60841-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313095				2022-12-28	WOS:000360573400047
J	Peter, NA; Pandit, H; Le, G; Muguti, G; Lavy, C				Peter, Noel Aaron; Pandit, Hermant; Le, Grace; Muguti, Godfrey; Lavy, Christopher			Delivering trauma training to multiple health-worker cadres in nine sub-Saharan African countries: lessons learnt from the COOL programme	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Peter, Noel Aaron; Pandit, Hermant; Le, Grace; Lavy, Christopher] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Nuffield Orthopaed Ctr, Oxford OX37HE, England; [Muguti, Godfrey] Univ Zimbabwe Campus, Dept Surg, Harare, Zimbabwe	Nuffield Orthopaedic Centre; University of Oxford		noel.peter@ndorms.ox.ac.uk		Drury, Grace/0000-0003-3367-2076					0	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			45	45		10.1016/S0140-6736(15)60840-6	http://dx.doi.org/10.1016/S0140-6736(15)60840-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313094				2022-12-28	WOS:000360573400046
J	Mukherjee, A; Joseph, C; Craze, M; Chrysanthou, E; Ellis, IO				Mukherjee, Abhik; Joseph, Chitra; Craze, Madeleine; Chrysanthou, Eleni; Ellis, Ian O.			The role of BUB and CDC proteins in low-grade breast cancers	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Mukherjee, Abhik; Joseph, Chitra; Craze, Madeleine; Chrysanthou, Eleni; Ellis, Ian O.] Univ Nottingham, Nottingham NG5 1PB, England; [Mukherjee, Abhik; Ellis, Ian O.] Nottingham Univ Hosp NHS Trust, Nottingham, England	University of Nottingham; Nottingham University Hospital NHS Trust		drabhikmukherjee@hotmail.com		MUKHERJEE, ABHIK/0000-0003-1828-4155					0	20	23	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			72	72		10.1016/S0140-6736(15)60387-7	http://dx.doi.org/10.1016/S0140-6736(15)60387-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312894	Bronze			2022-12-28	WOS:000360570500072
J	Impagliazzo, A; Milder, F; Kuipers, H; Wagner, MV; Zhu, XY; Hoffman, RMB; van Meersbergen, R; Huizingh, J; Wanningen, P; Verspuij, J; de Man, M; Ding, ZQ; Apetri, A; Kukrer, B; Sneekes-Vriese, E; Tomkiewicz, D; Laursen, NS; Lee, PS; Zakrzewska, A; Dekking, L; Tolboom, J; Tettero, L; van Meerten, S; Yu, WL; Koudstaal, W; Goudsmit, J; Ward, AB; Meijberg, W; Wilson, IA; Radosevic, K				Impagliazzo, Antonietta; Milder, Fin; Kuipers, Harmjan; Wagner, Michelle V.; Zhu, Xueyong; Hoffman, Ryan M. B.; van Meersbergen, Ruud; Huizingh, Jeroen; Wanningen, Patrick; Verspuij, Johan; de Man, Martijn; Ding, Zhaoqing; Apetri, Adrian; Kuekrer, Basak; Sneekes-Vriese, Eveline; Tomkiewicz, Danuta; Laursen, Nick S.; Lee, Peter S.; Zakrzewska, Anna; Dekking, Liesbeth; Tolboom, Jeroen; Tettero, Lisanne; van Meerten, Sander; Yu, Wenli; Koudstaal, Wouter; Goudsmit, Jaap; Ward, Andrew B.; Meijberg, Wim; Wilson, Ian A.; Radosevic, Katarina			A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen	SCIENCE			English	Article							NEUTRALIZING ANTIBODIES; VIRUS HEMAGGLUTININ; THERAPEUTIC ANTIBODIES; GLOBULAR HEAD; STALK DOMAIN; A VIRUSES; VACCINE; DESIGN; EPITOPE; CELLS	The identification of human broadly neutralizing antibodies (bnAbs) targeting the hemagglutinin (HA) stem revitalized hopes of developing a universal influenza vaccine. Using a rational design and library approach, we engineered stable HA stem antigens ("mini-HAs") based on an H1 subtype sequence. Our most advanced candidate exhibits structural and bnAb binding properties comparable to those of full-length HA, completely protects mice in lethal heterologous and heterosubtypic challenge models, and reduces fever after sublethal challenge in cynomolgus monkeys. Antibodies elicited by this mini-HA in mice and nonhuman primates bound a wide range of HAs, competed with human bnAbs for HA stem binding, neutralized H5N1 viruses, and mediated antibody-dependent effector activity. These results represent a proof of concept for the design of HA stem mimics that elicit bnAbs against influenza A group 1 viruses.	[Impagliazzo, Antonietta; Milder, Fin; Kuipers, Harmjan; van Meersbergen, Ruud; Huizingh, Jeroen; Wanningen, Patrick; Verspuij, Johan; de Man, Martijn; Apetri, Adrian; Kuekrer, Basak; Sneekes-Vriese, Eveline; Tomkiewicz, Danuta; Zakrzewska, Anna; Dekking, Liesbeth; Tolboom, Jeroen; Tettero, Lisanne; van Meerten, Sander; Koudstaal, Wouter; Goudsmit, Jaap; Meijberg, Wim; Radosevic, Katarina] Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, NL-2301 CA Leiden, Netherlands; [Wagner, Michelle V.; Ding, Zhaoqing] Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, San Diego, CA 92121 USA; [Zhu, Xueyong; Hoffman, Ryan M. B.; Laursen, Nick S.; Lee, Peter S.; Yu, Wenli; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Impagliazzo, A (corresponding author), Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, Archimedesweg 4-6, NL-2301 CA Leiden, Netherlands.	aimpagli@its.jnj.com; wilson@scripps.edu	Ward, Andrew/ABD-7728-2021; Laursen, Nick Stub/Q-5051-2017; Zhu, Xueyong/ABE-3068-2021; Ward, Andrew B/F-9203-2014	Ward, Andrew/0000-0001-7153-3769; Laursen, Nick Stub/0000-0002-7512-2649; Ward, Andrew B/0000-0001-7153-3769	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institute of General Medical Sciences (NIGMS) [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Vogels, R. van der Vlugt, D. Zuijdgeest, N. Kroos, V. Klaren, S. Schmit-Tillemans, L. Kil, S. Barens, and O. Diefenbach for scientific input and technical support; J. Klap, M. Koldijk, and G. J. Weverling for statistical support; Algonomics for input in early designs; Novavax for supplying Matrix-M; Promega for early access to mouse surrogate ADCC assay; E. Montomoli, D. Perini, and S. Piccirella from VisMederi for pseudoparticle assay; Janssen Diagnostics for quantitative polymerase chain reaction of tracheal swabs; P. Mooij and G. Koopman of the Biomedical Primate Research Center (BPRC), TNO Triskelion, Central Veterinary Institute, and PreClinBiosystems AG for performing the animal studies; and L. Dolfing and A. Dingemans for critical reading of the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. X-ray diffraction data sets were collected at the Stanford Synchrotron Radiation Lightsource (SSRL) beamline 12-2. Use of the SSRL, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by National Institute of General Medical Sciences (NIGMS) grants including P41GM103393. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. Coordinates and structure factors of the crystal structures are deposited in the Protein Data Bank as entries 5CJQ and 5CJS. Crucell Holland B.V., a Janssen company, has the following pending patent applications in this field: WO 2013/079473, WO 2014/191435, WO2008/028946, WO2013/007770, U.S. 62/062,746, and U.S. 62/062,754. Sharing of materials will be subject to standard material transfer agreements.	Alberini I, 2009, VACCINE, V27, P5998, DOI 10.1016/j.vaccine.2009.07.079; Bommakanti G, 2012, J VIROL, V86, P13434, DOI 10.1128/JVI.01429-12; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chen GL, 2009, NAT MED, V15, P1251, DOI 10.1038/nm1109-1251; Cheng ZJ, 2014, J IMMUNOL METHODS, V414, P69, DOI 10.1016/j.jim.2014.07.010; Cohen J, 2013, SCIENCE, V341, P1168, DOI 10.1126/science.341.6151.1171; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Eggink D, 2014, J VIROL, V88, P699, DOI 10.1128/JVI.02608-13; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Friesen RHE, 2014, P NATL ACAD SCI USA, V111, P445, DOI 10.1073/pnas.1319058110; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Lu Y, 2014, P NATL ACAD SCI USA, V111, P125, DOI 10.1073/pnas.1308701110; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Parekh BS, 2012, MABS-AUSTIN, V4, P310, DOI 10.4161/mabs.19873; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Roozendaal R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103550; Schneemann A, 2012, J VIROL, V86, P11686, DOI 10.1128/JVI.01694-12; Schnueriger A, 2011, MOL IMMUNOL, V48, P1512, DOI 10.1016/j.molimm.2011.04.010; SKEHEL JJ, 1975, P NATL ACAD SCI USA, V72, P93, DOI 10.1073/pnas.72.1.93; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang TT, 2011, SCIENCE, V333, P834, DOI 10.1126/science.1210724; Wang TT, 2009, NAT STRUCT MOL BIOL, V16, P233, DOI 10.1038/nsmb.1574; Wei H, 2014, DRUG DISCOV TODAY, V19, P95, DOI 10.1016/j.drudis.2013.07.019; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0	37	375	393	3	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1301	1306		10.1126/science.aac7263	http://dx.doi.org/10.1126/science.aac7263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26303961				2022-12-28	WOS:000361357700040
J	Rosen, BR; Huang, SY; Stufflebeam, SM				Rosen, Bruce R.; Huang, Susie Y.; Stufflebeam, Steven M.			Pushing the Limits of Human Neuroimaging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORTEX		[Rosen, Bruce R.; Huang, Susie Y.; Stufflebeam, Steven M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Rosen, Bruce R.; Huang, Susie Y.; Stufflebeam, Steven M.] Massachusetts Gen Hosp East, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Rosen, BR (corresponding author), Massachusetts Gen Hosp East, NMR Ctr 23011, 149 13th St, Charlestown, MA 02129 USA.	bruce@nmr.mgh.harvard.edu	Huang, Susie/H-8357-2019					BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Liu HS, 2009, J NEUROSURG, V111, P746, DOI 10.3171/2008.10.JNS08846; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280	5	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					993	994		10.1001/jama.2015.10229	http://dx.doi.org/10.1001/jama.2015.10229			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348745				2022-12-28	WOS:000360840700005
J	Evaristo, J; Jasechko, S; McDonnell, JJ				Evaristo, Jaivime; Jasechko, Scott; McDonnell, Jeffrey J.			Global separation of plant transpiration from groundwater and streamflow	NATURE			English	Article							WATER-USE STRATEGIES; STABLE-ISOTOPES; SUMMER PRECIPITATION; UPTAKE PATTERNS; TREES; SOIL; LAND; RIPARIAN; RAINFALL; DROUGHT	Current land surface models assume that groundwater, streamflow and plant transpiration are all sourced and mediated by the same well mixed water reservoir-the soil. However, recent work in Oregon(1) and Mexico(2) has shown evidence of ecohydrological separation, whereby different subsurface compartmentalized pools of water supply either plant transpiration fluxes or the combined fluxes of groundwater and streamflow. These findings have not yet been widely tested. Here we use hydrogen and oxygen isotopic data (H-2/H-1 (delta H-2) and O-18/O-16 (delta O-18)) from 47 globally distributed sites to show that ecohydrological separation is widespread across different biomes. Precipitation, stream water and groundwater from each site plot approximately along the delta H-2/delta O-18 slope of local precipitation inputs. But soil and plant xylem waters extracted from the 47 sites all plot below the local stream water and groundwater on the meteoric water line, suggesting that plants use soil water that does not itself contribute to groundwater recharge or streamflow. Our results further show that, at 80% of the sites, the precipitation that supplies groundwater recharge and streamflow is different from the water that supplies parts of soil water recharge and plant transpiration. The ubiquity of subsurface water compartmentalization found here, and the segregation of storm types relative to hydrological and ecological fluxes, may be used to improve numerical simulations of runoff generation, stream water transit time and evaporation-transpiration partitioning. Future land surface model parameterizations should be closely examined for how vegetation, groundwater recharge and streamflow are assumed to be coupled.	[Evaristo, Jaivime; McDonnell, Jeffrey J.] Univ Saskatchewan, Global Inst Water Secur, Saskatoon, SK S7N 3H5, Canada; [Evaristo, Jaivime; McDonnell, Jeffrey J.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK S7N 3H5, Canada; [Jasechko, Scott] Univ Calgary, Dept Geog, Calgary, AB T2N 1N4, Canada; [McDonnell, Jeffrey J.] Univ Aberdeen, Sch Geosci, Aberdeen AB34 3FX, Scotland; [McDonnell, Jeffrey J.] Oregon State Univ, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA	University of Saskatchewan; Global Institute for Water Security; University of Saskatchewan; University of Calgary; University of Aberdeen; Oregon State University	Evaristo, J (corresponding author), Univ Saskatchewan, Global Inst Water Secur, Saskatoon, SK S7N 3H5, Canada.	jaivime.evaristo@usask.ca	McDonnell, Jeffrey J/I-6400-2013	McDonnell, Jeffrey J/0000-0002-3880-3162; Evaristo, Jaivime/0000-0003-1387-229X; Jasechko, Scott/0000-0001-6470-7708	Saskatchewan Innovation and Opportunity Scholarship; Global Institute for Water Security; School of Environment and Sustainability (University of Saskatchewan); Saskatchewan Innovation and Opportunity Scholarship, Global Institute for Water Security, and School of Environment and Sustainability (University of Saskatchewan)	Saskatchewan Innovation and Opportunity Scholarship; Global Institute for Water Security; School of Environment and Sustainability (University of Saskatchewan); Saskatchewan Innovation and Opportunity Scholarship, Global Institute for Water Security, and School of Environment and Sustainability (University of Saskatchewan)	J.E. thanks the Saskatchewan Innovation and Opportunity Scholarship, Global Institute for Water Security, and School of Environment and Sustainability (University of Saskatchewan) for financial support.	Aemisegger F, 2014, ATMOS CHEM PHYS, V14, P4029, DOI 10.5194/acp-14-4029-2014; Anderegg LDL, 2013, GLOBAL CHANGE BIOL, V19, P1526, DOI 10.1111/gcb.12146; Berkelhammer M, 2013, J GEOPHYS RES-ATMOS, V118, P10225, DOI 10.1002/jgrd.50701; Berry ZC, 2014, OECOLOGIA, V174, P319, DOI 10.1007/s00442-013-2770-0; Bertrand G, 2014, ECOHYDROLOGY, V7, P319, DOI 10.1002/eco.1347; Bijoor NS, 2012, URBAN ECOSYST, V15, P195, DOI 10.1007/s11252-011-0196-1; Birkel C, 2010, HYDROL PROCESS, V24, P260, DOI 10.1002/hyp.7478; Boutton TW, 1999, RAPID COMMUN MASS SP, V13, P1263, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1263::AID-RCM653>3.0.CO;2-J; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Brooks JR, 2010, NAT GEOSCI, V3, P100, DOI 10.1038/NGEO722; Brunel JP, 1997, J HYDROL, V188, P466; BRUNEL JP, 1995, J HYDROL, V167, P351, DOI 10.1016/0022-1694(94)02575-V; Clinton BD, 2004, INT J PHYTOREMEDIAT, V6, P239, DOI 10.1080/16226510490496438; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Dai A, 2002, J HYDROMETEOROL, V3, P660, DOI 10.1175/1525-7541(2002)003<0660:EOFDFC>2.0.CO;2; DANSGAARD W, 1964, TELLUS, V16, P436; Darling WG, 2003, HYDROL EARTH SYST SC, V7, P183, DOI 10.5194/hess-7-183-2003; Deng Y, 2012, ENVIRON EARTH SCI, V66, P635, DOI 10.1007/s12665-011-1272-9; Dirmeyer PA, 2006, B AM METEOROL SOC, V87, P1381, DOI 10.1175/BAMS-87-10-1381; DUTTON AR, 1995, QUATERNARY RES, V43, P221, DOI 10.1006/qres.1995.1022; Eggemeyer KD, 2009, TREE PHYSIOL, V29, P157, DOI 10.1093/treephys/tpn019; Evaristo J. A., HYDROL PROCESS UNPUB; February EC, 2007, AUSTRAL ECOL, V32, P397, DOI 10.1111/j.1442-9993.2007.01711.x; February EC, 2007, J BIOGEOGR, V34, P270, DOI 10.1111/j.1365-2699.2006.01583.x; Ferguson PR, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002702; FRIEDMAN I, 1953, GEOCHIM COSMOCHIM AC, V4, P89, DOI 10.1016/0016-7037(53)90066-0; Garcin Y, 2012, GEOCHIM COSMOCHIM AC, V79, P106, DOI 10.1016/j.gca.2011.11.039; Genty D, 2014, GEOCHIM COSMOCHIM AC, V131, P323, DOI 10.1016/j.gca.2014.01.043; Gibson JJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001839; Goldsmith GR, 2012, ECOHYDROLOGY, V5, P779, DOI 10.1002/eco.268; Good SP, 2014, WATER RESOUR RES, V50, P8034, DOI 10.1002/2014WR015884; Gouet-Kaplan M, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007350; Hartsough P, 2008, ARCT ANTARCT ALP RES, V40, P343, DOI 10.1657/1523-0430(06-117)[HARTSOUGH]2.0.CO;2; Holland KL, 2006, AUST J BOT, V54, P193, DOI 10.1071/BT05019; Hrachowitz M, 2013, HYDROL EARTH SYST SC, V17, P533, DOI 10.5194/hess-17-533-2013; Jasechko S, 2014, WATER RESOUR RES, V50, P8845, DOI 10.1002/2014WR015809; Jasechko S, 2013, NATURE, V496, P347, DOI 10.1038/nature11983; Jia GD, 2012, J FOOD AGRIC ENVIRON, V10, P1035; Kendall C, 2001, HYDROL PROCESS, V15, P1363, DOI 10.1002/hyp.217; Klaus J, 2013, HYDROL EARTH SYST SC, V17, P103, DOI 10.5194/hess-17-103-2013; Kukowski KR, 2013, OECOLOGIA, V171, P819, DOI 10.1007/s00442-012-2466-x; Kurz-Besson C, 2006, PLANT SOIL, V282, P361, DOI 10.1007/s11104-006-0005-4; Landwehr J., 2006, ISOTOPES ENV STUDIES, P132; Lawrence DM, 2007, J HYDROMETEOROL, V8, P862, DOI 10.1175/JHM596.1; Legout C, 2007, J HYDROL, V332, P427, DOI 10.1016/j.jhydrol.2006.07.017; Levin NE, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012166; Liu YH, 2011, EUR J SOIL BIOL, V47, P380, DOI 10.1016/j.ejsobi.2011.07.012; McCole AA, 2007, J HYDROL, V342, P238, DOI 10.1016/j.jhydrol.2007.05.024; McDonnell JJ, 2014, WIRES WATER, V1, P323, DOI 10.1002/wat2.1027; McKeon C, 2006, J ARID ENVIRON, V64, P1, DOI 10.1016/j.jaridenv.2005.04.008; Meissner M, 2014, PLANT SOIL, V376, P327, DOI 10.1007/s11104-013-1970-z; MENSFORTH LJ, 1994, OECOLOGIA, V100, P21, DOI 10.1007/BF00317126; Nie YP, 2011, PLANT SOIL, V341, P399, DOI 10.1007/s11104-010-0653-2; Oerter E, 2014, J HYDROL, V515, P1, DOI 10.1016/j.jhydrol.2014.04.029; Ohte N, 2003, ECOL APPL, V13, P337, DOI 10.1890/1051-0761(2003)013[0337:WUONAP]2.0.CO;2; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Or D, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0163; Orlowski N, 2013, J SENS SENS SYST, V2, P179, DOI 10.5194/jsss-2-179-2013; Page T, 2007, HYDROL PROCESS, V21, P292, DOI 10.1002/hyp.6186; Penna D, 2013, PROCEDIA ENVIRON SCI, V19, P106, DOI 10.1016/j.proenv.2013.06.012; PHILLIPS SL, 1995, TREES-STRUCT FUNCT, V9, P214, DOI 10.1007/BF00195275; Rong L, 2011, HYDROL PROCESS, V25, P3666, DOI 10.1002/hyp.8093; Rosado BHP, 2013, AN ACAD BRAS CIENC, V85, P1035, DOI 10.1590/S0001-37652013005000051; Rose KL, 2003, OECOLOGIA, V134, P46, DOI 10.1007/s00442-002-1084-4; Schlesinger WH, 2014, AGR FOREST METEOROL, V189, P115, DOI 10.1016/j.agrformet.2014.01.011; Scholl MA, 2014, WATER RESOUR RES, V50, P4305, DOI 10.1002/2013WR014413; Schwendenmann L, 2015, ECOHYDROLOGY, V8, P1, DOI 10.1002/eco.1479; Snyder KA, 2000, AGR FOREST METEOROL, V105, P227, DOI 10.1016/S0168-1923(00)00193-3; Stockli R, 2007, J HYDROMETEOROL, V8, P1002, DOI 10.1175/JHM613.1; Sun SF, 2008, TREES-STRUCT FUNCT, V22, P717, DOI 10.1007/s00468-008-0232-9; Sutanto SJ, 2014, HYDROL EARTH SYST SC, V18, P2815, DOI 10.5194/hess-18-2815-2014; Swaffer BA, 2014, HYDROL PROCESS, V28, P2003, DOI 10.1002/hyp.9739; Syed TH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031254; Tang KL, 2001, EARTH PLANET SC LETT, V185, P355, DOI 10.1016/S0012-821X(00)00385-X; Taylor RG, 2013, NAT CLIM CHANGE, V3, P374, DOI [10.1038/NCLIMATE1731, 10.1038/nclimate1731]; van der Velde Y, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011310; Wada Y, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034036; Wang P, 2010, AGR WATER MANAGE, V97, P475, DOI 10.1016/j.agwat.2009.11.008; Wang-Erlandsson L, 2014, EARTH SYST DYNAM, V5, P441, DOI 10.5194/esd-5-441-2014; Wei L, 2013, OECOLOGIA, V172, P485, DOI 10.1007/s00442-012-2495-5; Wei YF, 2013, TREES-STRUCT FUNCT, V27, P1249, DOI 10.1007/s00468-013-0873-1; West AG, 2012, NEW PHYTOL, V195, P396, DOI 10.1111/j.1469-8137.2012.04170.x; Williams DG, 2000, ECOL MONOGR, V70, P517, DOI 10.1890/0012-9615(2000)070[0517:IAIVFS]2.0.CO;2; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142; Yakir D, 1996, NATURE, V380, P515, DOI 10.1038/380515a0; Zhang WG, 2010, HYDROL PROCESS, V24, P3270, DOI 10.1002/hyp.7754; Zhou Hai, 2013, Chinese Journal of Plant Ecology, V37, P665, DOI 10.3724/SP.J.1258.2013.00069; Zhou Ya-Dan, 2011, Chinese Journal of Plant Ecology, V35, P789, DOI 10.3724/SP.J.1258.2011.00789; Zhu Lin, 2012, Chinese Journal of Plant Ecology, V36, P618, DOI 10.3724/SP.J.1258.2012.00618	89	290	309	29	703	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					91	+		10.1038/nature14983	http://dx.doi.org/10.1038/nature14983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26333467				2022-12-28	WOS:000360594100031
J	Li, D; Shao, L; Chen, BC; Zhang, X; Zhang, MS; Moses, B; Milkie, DE; Beach, JR; Hammer, JA; Pasham, M; Kirchhausen, T; Baird, MA; Davidson, MW; Xu, PY; Betzig, E				Li, Dong; Shao, Lin; Chen, Bi-Chang; Zhang, Xi; Zhang, Mingshu; Moses, Brian; Milkie, Daniel E.; Beach, Jordan R.; Hammer, John A., III; Pasham, Mithun; Kirchhausen, Tomas; Baird, Michelle A.; Davidson, Michael W.; Xu, Pingyong; Betzig, Eric			Extended-resolution structured illumination imaging of endocytic and cytoskeletal dynamics	SCIENCE			English	Article							LIVE CELLS; FLUORESCENT PROTEIN; CELLULAR STRUCTURES; ACTIN DYNAMICS; MICROSCOPY; NANOSCOPY; ENDOSOMES; MECHANISM; CAVEOLAE; FUSION	Super-resolution fluorescence microscopy is distinct among nanoscale imaging tools in its ability to image protein dynamics in living cells. Structured illumination microscopy (SIM) stands out in this regard because of its high speed and low illumination intensities, but typically offers only a twofold resolution gain. We extended the resolution of live-cell SIM through two approaches: ultrahigh numerical aperture SIM at 84-nanometer lateral resolution for more than 100 multicolor frames, and nonlinear SIM with patterned activation at 45- to 62-nanometer resolution for approximately 20 to 40 frames. We applied these approaches to image dynamics near the plasma membrane of spatially resolved assemblies of clathrin and caveolin, Rab5a in early endosomes, and a-actinin, often in relationship to cortical actin. In addition, we examined mitochondria, actin, and the Golgi apparatus dynamics in three dimensions.	[Li, Dong; Shao, Lin; Chen, Bi-Chang; Betzig, Eric] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Zhang, Xi; Zhang, Mingshu; Xu, Pingyong] Chinese Acad Sci, Key Lab RNA Biol, Beijing 100101, Peoples R China; [Zhang, Xi; Zhang, Mingshu; Xu, Pingyong] Chinese Acad Sci, Beijing Key Lab Noncoding RNA, Inst Biophys, Beijing 100101, Peoples R China; [Zhang, Xi] Cent China Normal Univ, Coll Life Sci, Wuhan 430079, Hubei, Peoples R China; [Moses, Brian; Milkie, Daniel E.] Coleman Technol, Newtown Sq, PA 19073 USA; [Beach, Jordan R.; Hammer, John A., III; Baird, Michelle A.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Pasham, Mithun; Kirchhausen, Tomas] Harvard Univ, Sch Med, Dept Cell Biol & Pediat, Boston, MA 02115 USA; [Pasham, Mithun; Kirchhausen, Tomas] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA	Howard Hughes Medical Institute; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS; Central China Normal University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); State University System of Florida; Florida State University; State University System of Florida; Florida State University	Betzig, E (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	betzige@janelia.hhmi.org	Chen, Bi-Chang/F-3480-2014; Zhang, Xi/ABF-2885-2020	Chen, Bi-Chang/0000-0002-1876-7432; Zhang, Xi/0000-0001-7836-4064; Beach, Jordan/0000-0003-0633-4928; Milkie, Daniel/0000-0002-3917-6965	Howard Hughes Medical Institute (HHMI); National Basic Research Program (973 Program) of China [2013CB910103]; National Natural Science Foundation of China [31370851]; Beijing Natural Science Foundation, China [7131011]; NIH [GM-075252]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation, China(Beijing Natural Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Shared Resource teams at Janelia for their skill and dedication in specimen handling and preparation and the Instrument Design and Fabrication team for their manufacturing expertise. D.L., L.S., B.-C.C., and E.B. are funded by the Howard Hughes Medical Institute (HHMI). X.Z., M.Z., and P.X. are funded by the National Basic Research Program (973 Program) of China (2013CB910103), the National Natural Science Foundation of China (31370851), and the Beijing Natural Science Foundation, China (7131011). M.P. and T.K. were funded in part by NIH grant GM-075252. Skylan-NS is available from P.X. upon execution of a materials transfer agreement with the Institute of Biophysics. Other fluorescent protein constructs used in this work are from the Michael Davidson Collection and are available, along with sequence information, from Addgene (www.addgene.org/fluorescent-proteins/davidson). Researchers can apply to access the microscope as visitors through the Advanced Imaging Center at Janelia (www.janelia.org/open-science/advanced-imaging-center). Technical information for the construction of a copy of the microscope is available to nonprofit entities upon execution of a no-cost Research License with HHMI. Nonlinear SIM with patterned activation, in two or three dimensions, as described here is covered within U.S. provisional patent application 62/057,220 filed by E.B. and D.L. and assigned to HHMI.	Boucrot E, 2011, J CELL SCI, V124, P1965, DOI 10.1242/jcs.076570; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chmyrov A, 2013, NAT METHODS, V10, P737, DOI 10.1038/nmeth.2556; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Grotjohann T, 2012, ELIFE, V1, DOI 10.7554/eLife.00248; Grove J, 2014, MOL BIOL CELL, V25, P3581, DOI 10.1091/mbc.E14-06-1154; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hein B, 2008, P NATL ACAD SCI USA, V105, P14271, DOI 10.1073/pnas.0807705105; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Lavoie-Cardinal F, 2014, CHEMPHYSCHEM, V15, P655, DOI 10.1002/cphc.201301016; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Mavrakis M, 2014, NAT CELL BIOL, V16, P322, DOI 10.1038/ncb2921; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Muller CB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.198101; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rego EH, 2012, P NATL ACAD SCI USA, V109, pE135, DOI 10.1073/pnas.1107547108; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roberts RL, 1999, J CELL SCI, V112, P3667; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/NMETH.1855, 10.1038/nmeth.1855]; Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/NMETH.1734, 10.1038/nmeth.1734]; SHEPPARD CJR, 1988, OPTIK, V80, P53; Shevchuk AI, 2012, J CELL BIOL, V197, P499, DOI 10.1083/jcb.201109130; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; TOOZE J, 1992, J CELL BIOL, V118, P813, DOI 10.1083/jcb.118.4.813; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/nmeth.1841, 10.1038/NMETH.1841]; York AG, 2012, NAT METHODS, V9, P749, DOI [10.1038/NMETH.2025, 10.1038/nmeth.2025]; Zhang X, 2015, ACS NANO, V9, P2659, DOI 10.1021/nn5064387	53	448	469	50	613	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251							aab3500	10.1126/science.aab3500	http://dx.doi.org/10.1126/science.aab3500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315442	Green Accepted			2022-12-28	WOS:000360646800044
J	Liddelow, S; Barres, B				Liddelow, Shane; Barres, Ben			SnapShot: Astrocytes in Health and Disease	CELL			English	Editorial Material									[Liddelow, Shane; Barres, Ben] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Liddelow, Shane] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia	Stanford University; University of Melbourne	Liddelow, S (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.		Liddelow, Shane/ABE-6456-2020	Liddelow, Shane/0000-0002-0840-1437				Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tasdemir-Yilmaz OE, 2014, GENE DEV, V28, P20, DOI 10.1101/gad.229518.113; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	10	77	81	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1170	U269		10.1016/j.cell.2015.08.029	http://dx.doi.org/10.1016/j.cell.2015.08.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317476	Bronze			2022-12-28	WOS:000360589900026
J	Snyder, A				Snyder, Alison			Paul J Lioy Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					736	736		10.1016/S0140-6736(15)61531-8	http://dx.doi.org/10.1016/S0140-6736(15)61531-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LR	26333966				2022-12-28	WOS:000360287900014
J	Ghalambor, CK; Hoke, KL; Ruell, EW; Fischer, EK; Reznick, DN; Hughes, KA				Ghalambor, Cameron K.; Hoke, Kim L.; Ruell, Emily W.; Fischer, Eva K.; Reznick, David N.; Hughes, Kimberly A.			Non-adaptive plasticity potentiates rapid adaptive evolution of gene expression in nature	NATURE			English	Article							LIFE-HISTORY EVOLUTION; PHENOTYPIC PLASTICITY; TRINIDADIAN GUPPIES; ADAPTATION; DIVERGENCE; POPULATIONS; PREDATION; SELECTION; MARINE	Phenotypic plasticity is the capacity for an individual genotype to produce different phenotypes in response to environmental variation(1). Most traits are plastic, but the degree to which plasticity is adaptive or non-adaptive depends on whether environmentally induced phenotypes are closer or further away from the local optimum(2-4). Existing theories make conflicting predictions about whether plasticity constrains or facilitates adaptive evolution(4-12). Debate persists because few empirical studies have tested the relationship between initial plasticity and subsequent adaptive evolution in natural populations. Here we show that the direction of plasticity in gene expression is generally opposite to the direction of adaptive evolution. We experimentally transplanted Trinidadian guppies (Poecilia reticulata) adapted to living with cichlid predators to cichlid-free streams, and tested for evolutionary divergence in brain gene expression patterns after three to four generations. We find 135 transcripts that evolved parallel changes in expression within the replicated introduction populations. These changes are in the same direction exhibited in a native cichlid-free population, suggesting rapid adaptive evolution. We find 89% of these transcripts exhibited non-adaptive plastic changes in expression when the source population was reared in the absence of predators, as they are in the opposite direction to the evolved changes. By contrast, the remaining transcripts exhibiting adaptive plasticity show reduced population divergence. Furthermore, the most plastic transcripts in the source population evolved reduced plasticity in the introduction populations, suggesting strong selection against non-adaptive plasticity. These results support models predicting that adaptive plasticity constrains evolution(6-8), whereas non-adaptive plasticity potentiates evolution by increasing the strength of directional selection(11,12). The role of non-adaptive plasticity in evolution has received relatively little attention; however, our results suggest that it may be an important mechanism that predicts evolutionary responses to new environments.	[Ghalambor, Cameron K.; Hoke, Kim L.; Ruell, Emily W.; Fischer, Eva K.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Ghalambor, Cameron K.; Hoke, Kim L.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Reznick, David N.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Hughes, Kimberly A.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	Colorado State University; Colorado State University; University of California System; University of California Riverside; State University System of Florida; Florida State University	Ghalambor, CK (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	cameron1@colostate.edu; kahughes@bio.fsu.edu	Ghalambor, Cameron/V-4486-2019; Ghalambor, Cameron/HGE-0411-2022	Ghalambor, Cameron/0000-0003-2515-4981; Fischer, Eva K/0000-0002-2916-0900; reznick, david/0000-0002-1144-0568	National Science Foundation [DEB-0846175, EF-0623632, IOS-0934451, IOS-1354775]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the National Science Foundation (DEB-0846175 to C.K.G., EF-0623632 to D.N.R., and IOS-0934451 and IOS-1354775 to K.A.H.). We thank C. Handelsman, K. Langin, D. Broder, E. Duval, I. Janowitz, E. Lange, A. Shah, J. Havrid, E. Kane and L. Angeloni for helpful comments on the study. Computing for this project was performed on the Spear cluster at the Research Computing Center at the Florida State University	Ancel LW, 2000, THEOR POPUL BIOL, V58, P307, DOI 10.1006/tpbi.2000.1484; Baldwin J. M., 1902, DEV EVOLUTION; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; Fitzpatrick SW, 2015, ECOL LETT, V18, P37, DOI 10.1111/ele.12388; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Gingerich PD, 2001, GENETICA, V112, P127, DOI 10.1023/A:1013311015886; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Grether GF, 2005, AM NAT, V166, pE115, DOI 10.1086/432023; Handelsman CA, 2013, INTEGR COMP BIOL, V53, P975, DOI 10.1093/icb/ict057; JACKSON DA, 1991, OECOLOGIA, V86, P147, DOI 10.1007/BF00317404; KOHLER TJ, 2012, FRESHWATER SCI, V31, P1019, DOI DOI 10.1899/11-141.1; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Leder EH, 2015, MOL BIOL EVOL, V32, P674, DOI 10.1093/molbev/msu328; Leinonen T, 2006, J EVOLUTION BIOL, V19, P1803, DOI 10.1111/j.1420-9101.2006.01182.x; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Losos JB, 2000, EVOLUTION, V54, P301, DOI 10.1111/j.0014-3820.2000.tb00032.x; McCairns RJS, 2010, EVOLUTION, V64, P1029, DOI 10.1111/j.1558-5646.2009.00886.x; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Paenke I, 2007, AM NAT, V170, pE47, DOI 10.1086/518952; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; REZNICK D, 1982, EVOLUTION, V36, P1236, DOI 10.1111/j.1558-5646.1982.tb05493.x; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Ruell E W, 2013, Proc Biol Sci, V280, P20122019, DOI 10.1098/rspb.2012.2019; Schaum CE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1486; Schmalhausen II, 1949, FACTORS EVOLUTION TH; Scoville AG, 2010, P NATL ACAD SCI USA, V107, P4260, DOI 10.1073/pnas.0912748107; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; Torres-Dowdall J, 2012, EVOLUTION, V66, P3432, DOI 10.1111/j.1558-5646.2012.01694.x; WADDINGTON C, 1961, ADV GENET, V10, P257, DOI 10.1016/S0065-2660(08)60119-4; West-Eberhard Mary Jane, 2003, pi; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x; Wright S, 1931, GENETICS, V16, P0097; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966	41	339	348	13	384	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					372	+		10.1038/nature15256	http://dx.doi.org/10.1038/nature15256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26331546				2022-12-28	WOS:000361297900042
J	Reubold, TF; Faelber, K; Plattner, N; Posor, Y; Ketel, K; Curth, U; Schlegel, J; Anand, R; Manstein, DJ; Noe, F; Haucke, V; Daumke, O; Eschenburg, S				Reubold, Thomas F.; Faelber, Katja; Plattner, Nuria; Posor, York; Ketel, Katharina; Curth, Ute; Schlegel, Jeanette; Anand, Roopsee; Manstein, Dietmar J.; Noe, Frank; Haucke, Volker; Daumke, Oliver; Eschenburg, Susanne			Crystal structure of the dynamin tetramer	NATURE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MOLECULAR-DYNAMICS; MEMBRANE FISSION; STALK REGION; DOMAIN; PROTEIN; SOFTWARE; INSIGHTS; GTPASE; ULTRACENTRIFUGATION	The mechanochemical protein dynamin is the prototype of the dynamin superfamily of large GTPases, which shape and remodel membranes in diverse cellular processes(1). Dynamin forms predominantly tetramers in the cytosol, which oligomerize at the neck of clathrin-coated vesicles to mediate constriction and subsequent scission of the membrane(1). Previous studies have described the architecture of dynamin dimers(2,3), but the molecular determinants for dynamin assembly and its regulation have remained unclear. Here we present the crystal structure of the human dynamin tetramer in the nucleotide-free state. Combining structural data with mutational studies, oligomerization measurements and Markov state models of molecular dynamics simulations, we suggest a mechanism by which oligomerization of dynamin is linked to the release of intramolecular autoinhibitory interactions. We elucidate how mutations that interfere with tetramer formation and autoinhibition can lead to the congenital muscle disorders Charcot-Marie-Tooth neuropathy(4) and centronuclear myopathy(5), respectively. Notably, the bent shape of the tetramer explains how dynamin assembles into a right-handed helical oligomer of defined diameter, which has direct implications for its function in membrane constriction.	[Reubold, Thomas F.; Curth, Ute; Anand, Roopsee; Manstein, Dietmar J.; Eschenburg, Susanne] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Faelber, Katja; Schlegel, Jeanette; Daumke, Oliver] Max Delbruck Ctr Mol Med, Kristallog, D-13125 Berlin, Germany; [Plattner, Nuria] Free Univ Berlin, Inst Math, D-14195 Berlin, Germany; [Posor, York; Ketel, Katharina; Haucke, Volker] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Curth, Ute; Manstein, Dietmar J.] Hannover Med Sch, Forsch Einrichtung Strukt Analyse, D-30625 Hannover, Germany; [Haucke, Volker; Daumke, Oliver] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Hannover Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Hannover Medical School; Free University of Berlin	Faelber, K (corresponding author), Max Delbruck Ctr Mol Med, Kristallog, Robert Rossle Str 10, D-13125 Berlin, Germany.	katja.faelber@mdc-berlin.de; oliver.daumke@mdc-berlin.de; Eschenburg.Susanne@mh-hannover.de	Manstein, Dietmar J./AAG-2640-2019; Manstein, Dietmar J. J/M-1034-2013; Noe, Frank/Y-2766-2019	Manstein, Dietmar J./0000-0003-0763-0147; Manstein, Dietmar J. J/0000-0003-0763-0147; Plattner, Nuria/0000-0003-4115-6741; Haucke, Volker/0000-0003-3119-6993	Deutsche Forschungsgemeinschaft [MA1081/8-2, SFB740/D7, SFB958/A04, SFB740/C8, SFB 958/A7, SFB 740/C7, SFB958/A12, ES410/2-1]; ERC consolidator grant [ERC-2013-CoG-616024]; ERC starting grant; Einstein Foundation Berlin (SOoPiC); Cluster of Excellence REBIRTH [DFG EXC 62/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC consolidator grant; ERC starting grant; Einstein Foundation Berlin (SOoPiC); Cluster of Excellence REBIRTH	This project was supported by grants from the Deutsche Forschungsgemeinschaft (MA1081/8-2 to D.J.M.; SFB740/D7 and SFB958/A04 to F.N.; SFB740/C8 and SFB 958/A7 to V.H.; SFB 740/C7 and SFB958/A12 to O.D.; and ES410/2-1 to S.E.), an ERC consolidator grant (ERC-2013-CoG-616024 to O.D.), an ERC starting grant (pcCell to F.N.) and a grant from the Einstein Foundation Berlin (SOoPiC to N.P.). T.F.R. acknowledges partial financial support by the Cluster of Excellence REBIRTH (DFG EXC 62/1). We thank B. Purfurst for help with electron microscopy; S. Hertel, L. Litz, P. StraubandS. Wohlgemuth for experimental assistance; and the staff at beamlines X06SA (PXI) and X06DA (PXIII) at the Swiss Light Source (Villigen, Switzerland) for help during data collection. We thank Y.-W. Liu for discussions, and A. Wittinghofer for his support and discussions in the initial stages of the project.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; [Anonymous], PYMOL MOL GRAPH SYST; Bowman GR, 2014, INTRO MARKOV STATE M; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chappie JS, 2013, J CELL SCI, V126, P2773, DOI 10.1242/jcs.108845; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Cocucci E, 2014, MOL BIOL CELL, V25, P3595, DOI 10.1091/mbc.E14-07-1240; Cowling BS, 2012, PLOS GENET, V8, P31, DOI 10.1371/journal.pgen.1002595; Daumke O, 2014, CELL, V156, P882, DOI 10.1016/j.cell.2014.02.017; Deuflhard P, 2005, LINEAR ALGEBRA APPL, V398, P161, DOI 10.1016/j.laa.2004.10.026; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Edelstein A., 2010, CURR PROTOC MOL BIOL, V14, P20; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faelber K, 2012, STRUCTURE, V20, P1621, DOI 10.1016/j.str.2012.08.028; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Graham ME, 2002, P NATL ACAD SCI USA, V99, P7124, DOI 10.1073/pnas.102645099; Grassart A, 2014, J CELL BIOL, V205, P721, DOI 10.1083/jcb.201403041; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Kohlhoff KJ, 2014, NAT CHEM, V6, P15, DOI [10.1038/NCHEM.1821, 10.1038/nchem.1821]; Koutsopoulos OS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027498; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laue M. T., 1992, ANAL ULTRACENTRIFUGA, P90; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu YW, 2011, P NATL ACAD SCI USA, V108, pE234, DOI 10.1073/pnas.1102710108; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schtitte C., 2013, COURANT LECT NOTES, V24; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Senne M, 2012, J CHEM THEORY COMPUT, V8, P2223, DOI 10.1021/ct300274u; Sidiropoulos PNM, 2012, BRAIN, V135, P1395, DOI 10.1093/brain/aws061; Srinivasan S, 2014, BIOCHEMISTRY-US, V53, P5724, DOI 10.1021/bi500998s; Stanley N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6272; Sundborger AC, 2014, CELL REP, V8, P734, DOI 10.1016/j.celrep.2014.06.054; Swope WC, 2004, J PHYS CHEM B, V108, P6582, DOI 10.1021/jp037422q; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6	53	81	81	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2015	525	7569					404	+		10.1038/nature14880	http://dx.doi.org/10.1038/nature14880			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR4JL	26302298	Green Accepted			2022-12-28	WOS:000361297900049
J	Ho, PC; Bihuniak, JD; Macintyre, AN; Staron, M; Liu, XJ; Amezquita, R; Tsui, YC; Cui, GL; Micevic, G; Perales, JC; Kleinstein, SH; Abel, ED; Insogna, KL; Feske, S; Locasale, JW; Bosenberg, MW; Rathmell, JC; Kaech, SM				Ho, Ping-Chih; Bihuniak, Jessica Dauz; Macintyre, Andrew N.; Staron, Matthew; Liu, Xiaojing; Amezquita, Robert; Tsui, Yao-Chen; Cui, Guoliang; Micevic, Goran; Perales, Jose C.; Kleinstein, Steven H.; Abel, E. Dale; Insogna, Karl L.; Feske, Stefan; Locasale, Jason W.; Bosenberg, Marcus W.; Rathmell, Jeffrey C.; Kaech, Susan M.			Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses	CELL			English	Article							EFFECTOR RESPONSES; ACTIVATION; EXPRESSION; TUMORS; PD-1	Activated T cells engage aerobic glycolysis and anabolic metabolism for growth, proliferation, and effector functions. We propose that a glucose-poor tumor microenvironment limits aerobic glycolysis in tumor-infiltrating T cells, which suppresses tumoricidal effector functions. We discovered a new role for the glycolytic metabolite phosphoenolpyruvate (PEP) in sustaining T cell receptor-mediated Ca2+-NFAT signaling and effector functions by repressing sarco/ER Ca2+-ATPase (SERCA) activity. Tumor-specific CD4 and CD8 T cells could be metabolically reprogrammed by increasing PEP production through overexpression of phosphoenolpyruvate carboxykinase 1 (PCK1), which bolstered effector functions. Moreover, PCK1-overexpressing T cells restricted tumor growth and prolonged the survival of melanoma-bearing mice. This study uncovers new metabolic checkpoints for T cell activity and demonstrates that metabolic reprogramming of tumor-reactive T cells can enhance anti-tumor T cell responses, illuminating new forms of immunotherapy.	[Ho, Ping-Chih; Staron, Matthew; Amezquita, Robert; Tsui, Yao-Chen; Cui, Guoliang; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Bihuniak, Jessica Dauz; Insogna, Karl L.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06519 USA; [Macintyre, Andrew N.; Rathmell, Jeffrey C.] Duke Univ, Duke Mol Physiol Inst, Dept Pharmacol & Canc Biol, Immunol, Durham, NC 27710 USA; [Liu, Xiaojing; Locasale, Jason W.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Amezquita, Robert; Kleinstein, Steven H.; Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06519 USA; [Tsui, Yao-Chen; Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Micevic, Goran; Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06519 USA; [Perales, Jose C.] Univ Barcelona, Biophys Unit, Dept Physiol Sci 2, IDIBELL, Barcelona 08907, Spain; [Abel, E. Dale] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Div Endocrinol & Metab, Dept Med,Carver Coll Med, Iowa City, IA 52242 USA; [Feske, Stefan] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA	Yale University; Yale University; Duke University; Cornell University; Yale University; Howard Hughes Medical Institute; Yale University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Iowa; New York University; NYU Langone Medical Center	Ho, PC (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06519 USA.	ping-chih.ho@unil.ch; susan.kaech@yale.edu	Locasale, Jason W/ABE-6505-2020; Micevic, Goran/M-5427-2017; PERALES, JOSE C/J-7457-2017; Feske, stefan/ABB-3554-2021; PERALES, JOSE C. C/D-5586-2012; PERALES, JOSE C./AAC-3156-2019	Locasale, Jason W/0000-0002-7766-3502; PERALES, JOSE C/0000-0001-7363-2226; Feske, stefan/0000-0001-5431-8178; PERALES, JOSE C. C/0000-0001-7363-2226; PERALES, JOSE C./0000-0001-7363-2226; Insogna, Karl/0000-0001-6973-5679; Macintyre, Andrew/0000-0002-5297-0207; Ho, Ping-Chih/0000-0003-3078-3774; Abel, E. Dale/0000-0001-5290-0738; Cui, Guoliang/0000-0001-5559-7957; Liu, Xiaojing/0000-0002-4231-6017; Micevic, Goran/0000-0003-0329-1053	Yale Cancer Center, Yale SPORE in Skin Cancer [5 P50 CA121974]; Wade F.B. Thompson/Cancer Research Institute-CLIP grant; Howard Hughes Medical Institute; Melanoma Research Alliance; Melanoma Research Foundation; National Cancer Center; CCFA award [284879]; Alliance for Lupus Research; NIH [R37AI066232, R01AI074699, R01HL108006, R00CA168997, R01AI110613]; NATIONAL CANCER INSTITUTE [P50CA121974, P30CA016359, R01CA123350, R00CA168997, F30CA196089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063345, R37AI066232, R01AI110613, R01AI097302, R01AI074699, R01AI066232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Yale Cancer Center, Yale SPORE in Skin Cancer; Wade F.B. Thompson/Cancer Research Institute-CLIP grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Melanoma Research Alliance; Melanoma Research Foundation; National Cancer Center; CCFA award; Alliance for Lupus Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the Yale Cancer Center, Yale SPORE in Skin Cancer (5 P50 CA121974, R. Halaban, PI), Wade F.B. Thompson/Cancer Research Institute-CLIP grant, Howard Hughes Medical Institute, Melanoma Research Alliance (S.M.K), Melanoma Research Foundation (M.W.B), National Cancer Center (P-C. H.), CCFA award (284879, A.N.M.), Alliance for Lupus Research (J.C.R.) and NIH grants R37AI066232 and R01AI074699 to S.M.K., R01HL108006 to J.C.R., R00CA168997 and R01AI110613 to J.W.L.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Baitsch L, 2012, TRENDS IMMUNOL, V33, P364, DOI 10.1016/j.it.2012.02.006; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Borge PD, 2003, J BIOL CHEM, V278, P11359, DOI 10.1074/jbc.M209521200; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Callahan MK, 2010, SEMIN ONCOL, V37, P473, DOI 10.1053/j.seminoncol.2010.09.001; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; GULLINO PM, 1964, CANCER RES, V24, P780; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Ho PC, 2014, CANCER RES, V74, P3205, DOI 10.1158/0008-5472.CAN-13-3461; Ho PC, 2011, CELL SIGNAL, V23, P1396, DOI 10.1016/j.cellsig.2011.03.023; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Qin FZ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000184; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sharov VS, 2006, BIOCHEM J, V394, P605, DOI 10.1042/BJ20051214; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Srinivasan M, 2007, J IMMUNOL, V179, P3734, DOI 10.4049/jimmunol.179.6.3734; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang S.Q., 2011, SHANGHAI PLASTICS, V1, P1, DOI DOI 10.1016/J.SUSC0M.2010.10.002; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510	43	776	808	11	151	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 10	2015	162	6					1217	1228		10.1016/j.cell.2015.08.012	http://dx.doi.org/10.1016/j.cell.2015.08.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CR3QL	26321681	Green Accepted, Bronze			2022-12-28	WOS:000361247900013
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: One of the best-a GP who campaigned against corporal punishment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020						0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2015	351								h4582	10.1136/bmj.h4582	http://dx.doi.org/10.1136/bmj.h4582			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4CL	26346660	Bronze			2022-12-28	WOS:000361279300002
J	Panagiotou, OA; Befano, BL; Gonzalez, P; Rodriguez, AC; Herrero, R; Schiller, JT; Kreimer, AR; Schiffman, M; Hildesheim, A; Wilcox, AJ; Wacholder, S				Panagiotou, Orestis A.; Befano, Brian L.; Gonzalez, Paula; Cecilia Rodriguez, Ana; Herrero, Rolando; Schiller, John T.; Kreimer, Aimee R.; Schiffman, Mark; Hildesheim, Allan; Wilcox, Allen J.; Wacholder, Sholom		Costa Rica HPV Vaccine Trial Cvt	Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AS04-ADJUVANTED VACCINE; POOLED ANALYSIS; CLINICAL-TRIAL; POSITIVE REPORT; DOUBLE-BLIND; SAFETY; EFFICACY; IMMUNIZATION; WOMEN; RECOMMENDATIONS	OBJECTIVE To examine the effect of the bivalent human papillomavirus (HPV) vaccine on miscarriage. DESIGN Observational long term follow-up of a randomized, double blinded trial combined with an independent unvaccinated population based cohort. SETTING Single center study in Costa Rica. PARTICIPANTS 7466 women in the trial and 2836 women in the unvaccinated cohort enrolled at the end of the randomized trial and in parallel with the observational trial component. INTERVENTION Women in the trial were assigned to receive three doses of bivalent HPV vaccine (n=3727) or the control hepatitis A vaccine (n=3739). Crossover bivalent HPV vaccination occurred in the hepatitis A vaccine arm at the end of the trial. Women in the unvaccinated cohort received (n=2836) no vaccination. MAIN OUTCOME MEASURE Risk of miscarriage, defined by the US Centers for Disease Control and Prevention as fetal loss within 20 weeks of gestation, in pregnancies exposed to bivalent HPV vaccination in less than 90 days and any time from vaccination compared with pregnancies exposed to hepatitis A vaccine and pregnancies in the unvaccinated cohort. RESULTS Of 3394 pregnancies conceived at any time since bivalent HPV vaccination, 381 pregnancies were conceived less than 90 days from vaccination. Unexposed pregnancies comprised 2507 pregnancies conceived after hepatitis A vaccination and 720 conceived in the unvaccinated cohort. Miscarriages occurred in 451 (13.3%) of all exposed pregnancies, in 50 (13.1%) of the pregnancies conceived less than 90 days from bivalent HPV vaccination, and in 414 (12.8%) of the unexposed pregnancies, of which 316 (12.6%) were in the hepatitis A vaccine group and 98 (13.6%) in the unvaccinated cohort. The relative risk of miscarriage for pregnancies conceived less than 90 days from vaccination compared with all unexposed pregnancies was 1.02 (95% confidence interval 0.78 to 1.34, one sided P=0.436) in unadjusted analyses. Results were similar after adjusting for age at vaccination (relative risk 1.15, one sided P=0.17), age at conception (1.03, P=0.422), and calendar year (1.06, P=0.358), and in stratified analyses. Among pregnancies conceived at any time from bivalent HPV vaccination, exposure was not associated with an increased risk of miscarriage overall or in subgroups, except for miscarriages at weeks 13-20 of gestation (relative risk 1.35, 95% confidence interval 1.02 to 1.77, one sided P=0.017). CONCLUSIONS There is no evidence that bivalent HPV vaccination affects the risk of miscarriage for pregnancies conceived less than 90 days from vaccination. The increased risk estimate for miscarriages in a subgroup of pregnancies conceived any time after vaccination may be an artifact of a thorough set of sensitivity analyses, but since a genuine association cannot totally be ruled out, this signal should nevertheless be explored further in existing and future studies.	[Panagiotou, Orestis A.; Kreimer, Aimee R.; Schiffman, Mark; Hildesheim, Allan; Wacholder, Sholom] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Befano, Brian L.] Informat Management Serv Inc, Calverton, MD USA; [Gonzalez, Paula; Cecilia Rodriguez, Ana] Fdn INCIENSA, Proyecto Epidemiol Guanacaste, San Jose, Costa Rica; [Gonzalez, Paula; Herrero, Rolando] Int Agcy Res Canc, Prevent & Implementat Grp, F-69372 Lyon, France; [Schiller, John T.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; World Health Organization; International Agency for Research on Cancer (IARC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Panagiotou, OA (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	orestis.panagiotou@nih.gov; wacholds@mail.nih.gov	Panagiotou, Orestis/AAI-1268-2021; Schiller, John/ABK-8287-2022; Schiffman, Mark/B-9766-2015; Rodríguez, Ana/GQR-0554-2022; Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311	NCI [N01-CP-11005]; National Institutes of Health Office of Research on Women's Health; National Institute of Environmental Health Sciences, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC009052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Costa Rica HPV Vaccine Trial is a longstanding collaboration between investigators in Costa Rica and the US National Cancer Institute (NCI). The trial is sponsored and funded by the NCI (contract N01-CP-11005), with funding support from the National Institutes of Health Office of Research on Women's Health. GlaxoSmithKline (GSK) Biologicals provided vaccine and support for aspects of the trial associated with regulatory submission needs of the company under a clinical trials agreement (FDA BB-IND 7920) during the four year, randomized blinded phase of our study. This manuscript was not prepared in collaboration with GSK Biologicals investigators, and GSK Biologicals had no role in the study design and the collection, analysis, and interpretation of data from CVT in this paper, or in the writing of the article. GSK Biologicals took no part in the decision to submit an article for publication. The analysis reported here was supported by the intramural research programs of the NCI and the National Institute of Environmental Health Sciences, both parts of the National Institutes of Health.	Angelo MG, 2014, PHARMACOEPIDEM DR S, V23, P456, DOI 10.1002/pds.3593; Angelo MG, 2014, PHARMACOEPIDEM DR S, V23, P466, DOI 10.1002/pds.3554; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Barfield WD, 2011, PEDIATRICS, V128, P177, DOI 10.1542/peds.2011-1037; Canfell K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1666; Christakis DA, 2013, JAMA-J AM MED ASSOC, V310, P2499, DOI 10.1001/jama.2013.281337; Clark LR, 2013, J ADOLESCENT HEALTH, V52, P322, DOI 10.1016/j.jadohealth.2012.07.003; Descamps D, 2009, HUM VACCINES, V5, P332, DOI 10.4161/hv.5.5.7211; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; Ferris D, 2014, PEDIATRICS, V134, pE657, DOI 10.1542/peds.2013-4144; Global Advisory Committee on Vaccine Safety, 2014, WKLY EPIDEMIOL REC, V89, P53; Goldhaber M K, 1991, Epidemiology, V2, P33; Gonzalez P, 2015, VACCINE, V33, P2141, DOI 10.1016/j.vaccine.2015.03.015; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Herrero R, 2008, VACCINE, V26, P4795, DOI 10.1016/j.vaccine.2008.07.002; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hildesheim A, 2014, VACCINE, V32, P5087, DOI 10.1016/j.vaccine.2014.06.038; Hudson KL, 2015, JAMA-J AM MED ASSOC, V313, P355, DOI 10.1001/jama.2014.10716; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Irving GJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009051.pub2; Kmietowicz Z, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6942; Kreimer AR, 2015, LANCET ONCOL, V16, P775, DOI 10.1016/S1470-2045(15)00047-9; Krumholz HM, 2014, JAMA-J AM MED ASSOC, V312, P1002, DOI 10.1001/jama.2014.9647; Kuehn BM, 2012, JAMA-J AM MED ASSOC, V307, P1353, DOI 10.1001/jama.2012.367; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154; Lathyris D, 2014, PEDIATRICS, V133, pE666, DOI 10.1542/peds.2013-3128; Lucke JE, 2009, GENET EPIDEMIOL, V33, P145, DOI 10.1002/gepi.20363; Maglione MA, 2014, EVIDENCE REPORT TECH; Maglione MA, 2014, PEDIATRICS, V134, P325, DOI 10.1542/peds.2014-1079; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Moro PL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.036; National Center for Health Statistics (US), 1997, STAT DEF REP REQ LIV; Noronha AS, 2014, VACCINE, V32, P2670, DOI 10.1016/j.vaccine.2013.12.037; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Schuchat A, 2015, NEW ENGL J MED, V372, P775, DOI 10.1056/NEJMe1415742; Skinner SR, 2014, LANCET, V384, P2213, DOI 10.1016/S0140-6736(14)60920-X; Stratton K., 2011, Adverse effects of vaccines: evidence and causality; Tavares F, 2013, VACCINE, V31, P1759, DOI 10.1016/j.vaccine.2013.01.002; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wacholder S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c712; Westra TA, 2011, J INFECT DIS, V204, P377, DOI 10.1093/infdis/jir281	45	23	30	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2015	351								h4358	10.1136/bmj.h4358	http://dx.doi.org/10.1136/bmj.h4358			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4CL	26346155	Green Published, hybrid			2022-12-28	WOS:000361279300001
J	Chen, Y; Kim, JK; Hirning, AJ; Josic, K; Bennett, MR				Chen, Ye; Kim, Jae Kyoung; Hirning, Andrew J.; Josic, Kresimir; Bennett, Matthew R.			Emergent genetic oscillations in a synthetic microbial consortium	SCIENCE			English	Article							ESCHERICHIA-COLI; COMMUNICATION; NETWORK; QUORUM; ROBUST; PATTERN; SYSTEM	A challenge of synthetic biology is the creation of cooperative microbial systems that exhibit population-level behaviors. Such systems use cellular signaling mechanisms to regulate gene expression across multiple cell types. We describe the construction of a synthetic microbial consortium consisting of two distinct cell types-an "activator" strain and a "repressor" strain. These strains produced two orthogonal cell-signaling molecules that regulate gene expression within a synthetic circuit spanning both strains. The two strains generated emergent, population-level oscillations only when cultured together. Certain network topologies of the two-strain circuit were better at maintaining robust oscillations than others. The ability to program population-level dynamics through the genetic engineering of multiple cooperative strains points the way toward engineering complex synthetic tissues and organs with multiple cell types.	[Chen, Ye; Hirning, Andrew J.; Bennett, Matthew R.] Rice Univ, Dept Biosci, Houston, TX 77005 USA; [Kim, Jae Kyoung] Korea Adv Inst Sci & Technol, Dept Math Sci, Taejon 305701, South Korea; [Kim, Jae Kyoung] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Josic, Kresimir] Univ Houston, Dept Math, Houston, TX 77204 USA; [Josic, Kresimir] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Bennett, Matthew R.] Rice Univ, Inst Biosci & Bioengn, Houston, TX 77005 USA	Rice University; Korea Advanced Institute of Science & Technology (KAIST); University System of Ohio; Ohio State University; University of Houston System; University of Houston; University of Houston System; University of Houston; Rice University	Bennett, MR (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.	matthew.bennett@rice.edu	Kim, Jae Kyoung/F-1297-2015; Chen, Ye/AAB-2796-2021; Bennett, Matthew/B-3700-2008	Kim, Jae Kyoung/0000-0001-7842-2172; Chen, Ye/0000-0003-1247-5444; Bennett, Matthew/0000-0002-4975-8854; Hirning, Andrew/0000-0001-5127-9193	National Institutes of Health through NSF-National Institute of General Medical Sciences Mathematical Biology Program [R01GM104974]; Robert A. Welch Foundation [C-1729]; Hamill Foundation; NSF [DMS-0931642]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104974] Funding Source: NIH RePORTER	National Institutes of Health through NSF-National Institute of General Medical Sciences Mathematical Biology Program; Robert A. Welch Foundation(The Welch Foundation); Hamill Foundation; NSF(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health, through the joint NSF-National Institute of General Medical Sciences Mathematical Biology Program grant R01GM104974 (M.R.B. and K.J.), the Robert A. Welch Foundation grant C-1729 (M.R.B.), the Hamill Foundation (M.R.B.), NSF grant DMS-0931642 to the Mathematical Biosciences Institute (J.K.K.), and the China Scholarship Council (Y.C.). M.R.B., Y.C., K.J., and J.K.K. conceived and designed the study. Y.C. performed the experiments and analyzed the data. A.J.H. designed and fabricated the microfluidic devices. J.K.K. performed the computational modeling and analyzed simulations. M.R.B. supervised the project. All authors wrote the manuscript. The mathematical model and experimental data are archived in the BioModels Database at www.ebi.ac.uk/biomodels-main/MODEL1505050000.	Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hussain F, 2014, P NATL ACAD SCI USA, V111, P972, DOI 10.1073/pnas.1316298111; Kim JK, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.62; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lithgow JK, 2000, MOL MICROBIOL, V37, P81, DOI 10.1046/j.1365-2958.2000.01960.x; Marchand N, 2013, BIOTECHNOL BIOENG, V110, P3003, DOI 10.1002/bit.24975; Mather W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068105; Mather WH, 2010, BIOPHYS J, V99, P3172, DOI 10.1016/j.bpj.2010.09.057; Naqib F, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046210; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; O'Brien EL, 2012, MATH BIOSCI, V236, P1, DOI 10.1016/j.mbs.2012.01.001; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	29	172	182	11	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					986	989		10.1126/science.aaa3794	http://dx.doi.org/10.1126/science.aaa3794			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26315440	Green Accepted, Green Submitted			2022-12-28	WOS:000360646800056
J	Arpaia, N; Green, JA; Moltedo, B; Arvey, A; Hemmers, S; Yuan, SP; Treuting, PM; Rudensky, AY				Arpaia, Nicholas; Green, Jesse A.; Moltedo, Bruno; Arvey, Aaron; Hemmers, Saskia; Yuan, Shaopeng; Treuting, Piper M.; Rudensky, Alexander Y.			A Distinct Function of Regulatory T Cells in Tissue Protection	CELL			English	Article							AMPHIREGULIN; INFLAMMATION; FOXP3; DIFFERENTIATION; INTERLEUKIN-10; POPULATION; RESPONSES	Regulatory T (Treg) cells suppress immune responses to a broad range of non-microbial and microbial antigens and indirectly limit immune inflammation-inflicted tissue damage by employing multiple mechanisms of suppression. Here, we demonstrate that selective Treg cell deficiency in amphiregulin leads to severe acute lung damage and decreased blood oxygen concentration during influenza virus infection without any measureable alterations in Treg cell suppressor function, antiviral immune responses, or viral load. This tissue repair modality is mobilized in Treg cells in response to inflammatory mediator IL-18 or alarmin IL-33, but not by TCR signaling that is required for suppressor function. These results suggest that, during infectious lung injury, Treg cells have a major direct and non-redundant role in tissue repair and maintenance-distinct from their role in suppression of immune responses and inflammation-and that these two essential Treg cell functions are invoked by separable cues.	[Arpaia, Nicholas; Green, Jesse A.; Moltedo, Bruno; Arvey, Aaron; Hemmers, Saskia; Yuan, Shaopeng; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Arpaia, Nicholas; Green, Jesse A.; Moltedo, Bruno; Arvey, Aaron; Hemmers, Saskia; Yuan, Shaopeng; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Yuan, Shaopeng] Rockefeller Univ, David Rockefeller Grad Program, New York, NY 10065 USA; [Treuting, Piper M.] Univ Washington, Dept Comparat Med, Sch Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Treuting, Piper M./AAB-2721-2019; Yuan, Shaopeng/B-4343-2015; Yuan, Shaopeng/Z-4410-2019; Arpaia, Nicholas/R-2549-2018	Treuting, Piper M./0000-0002-1812-1519; Yuan, Shaopeng/0000-0001-9554-1325; Arpaia, Nicholas/0000-0002-0657-0528; Arvey, Aaron/0000-0002-8789-0290	NIH/NCI Cancer Center Support Grant (CCSG) [P30CA008748]; NIH [R37AI034206]; Ludwig Center at Memorial Sloan Kettering Cancer Center; Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation); Hilton-Ludwig Cancer Prevention Initiative (Ludwig Cancer Research); Robert Black Fellowship of the Damon Runyon Cancer Research Foundation [DRG-2143-13]; Irvington Fellowship of the Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, R01AI034206] Funding Source: NIH RePORTER	NIH/NCI Cancer Center Support Grant (CCSG); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center at Memorial Sloan Kettering Cancer Center; Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation); Hilton-Ludwig Cancer Prevention Initiative (Ludwig Cancer Research); Robert Black Fellowship of the Damon Runyon Cancer Research Foundation; Irvington Fellowship of the Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B.W. Johnson for assistance with histopathological analysis, S. Dikiy, C. Campbell, A.G. Levine, B. Hoyos, S.Y. Lee, and A.H. Bravo for experimental support. This work was supported by NIH/NCI Cancer Center Support Grant (CCSG) P30CA008748, NIH grant R37AI034206 (A.Y.R.), the Ludwig Center at Memorial Sloan Kettering Cancer Center, the Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation and Ludwig Cancer Research) (A.Y.R.), the Robert Black Fellowship of the Damon Runyon Cancer Research Foundation DRG-2143-13 (N.A.), and an Irvington Fellowship of the Cancer Research Institute (J.A.G.). A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bedoya F, 2013, J IMMUNOL, V190, P6115, DOI 10.4049/jimmunol.1203302; Berasain C, 2014, SEMIN CELL DEV BIOL, V28, P31, DOI 10.1016/j.semcdb.2014.01.005; Brincks EL, 2013, J IMMUNOL, V190, P3438, DOI 10.4049/jimmunol.1203140; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Meulenbroeks C, 2015, J INVEST DERMATOL, V135, P222, DOI 10.1038/jid.2014.329; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moser EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004315; Qi YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039072; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Shao JY, 2010, ENDOCRINOLOGY, V151, P3728, DOI 10.1210/en.2010-0319; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	31	539	554	14	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1078	1089		10.1016/j.cell.2015.08.021	http://dx.doi.org/10.1016/j.cell.2015.08.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317471	Green Accepted, Bronze			2022-12-28	WOS:000360589900017
J	Powe, NR; Peterson, PG; Mark, EJ				Powe, Neil R.; Peterson, P. Gabriel; Mark, Eugene J.			Case 27-2015: A 78-Year-Old Man with Hypercalcemia and Renal Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LYMPH-NODE BIOPSY; MULTIPLE-MYELOMA; SARCOIDOSIS; CANCER		[Powe, Neil R.] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; [Powe, Neil R.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; [Peterson, P. Gabriel] Walter Reed Natl Mil Med Ctr, Dept Radiol, Bethesda, MD USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Walter Reed National Military Medical Center; Harvard University; Massachusetts General Hospital; Harvard University	Powe, NR (corresponding author), San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA.							BELL NH, 1979, J CLIN INVEST, V64, P218, DOI 10.1172/JCI109442; ESPINEL CH, 1980, CLIN NEPHROL, V13, P73; Hamzeh N, 2011, MED CLIN N AM, V95, P1223, DOI 10.1016/j.mcna.2011.08.004; Io M., 2011, DIETARY REFERENCE IN; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Marcocci C, 2011, NEW ENGL J MED, V365, P2389, DOI 10.1056/NEJMcp1106636; MIKHAIL JR, 1979, ENDOSCOPY, V11, P5, DOI 10.1055/s-0028-1098315; ROSOL TJ, 1992, LAB INVEST, V67, P680; Shah R, 2011, INT J NEPHROL RENOV, V4, P131, DOI 10.2147/IJNRD.S22549; Sharma O P, 2000, Curr Opin Pulm Med, V6, P397, DOI 10.1097/00063198-200009000-00001; Stewart AF, 2005, NEW ENGL J MED, V352, P373, DOI 10.1056/NEJMcp042806; Yanardag H, 2007, CAN RESPIR J, V14, P209, DOI 10.1155/2007/218947	13	2	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					864	873		10.1056/NEJMcpc1310003	http://dx.doi.org/10.1056/NEJMcpc1310003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP8VC	26308688				2022-12-28	WOS:000360171700013
J	Komarova, NL				Komarova, Natalia L.			CANCER A moving target	NATURE			English	Editorial Material							SPATIAL STOCHASTIC-MODELS		[Komarova, Natalia L.] Univ Calif Irvine, Dept Math, Irvine, CA 92697 USA; [Komarova, Natalia L.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Komarova, NL (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92697 USA.	komarova@uci.edu						Durrett R, 2015, ANN APPL PROBAB, V25, P104, DOI 10.1214/13-AAP989; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Komarova NL, 2006, B MATH BIOL, V68, P1573, DOI 10.1007/s11538-005-9046-8; Komarova NL, 2014, P NATL ACAD SCI USA, V111, P10789, DOI 10.1073/pnas.1400828111; Komarova NL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0014; Michor F, 2004, CELL CYCLE, V3, P358; Thalhauser CJ, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-21; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971	8	5	7	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2015	525	7568					198	199		10.1038/nature15210	http://dx.doi.org/10.1038/nature15210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9IM	26308890				2022-12-28	WOS:000360927400026
J	Schmidt, H				Schmidt, Harald			The Ethics of Incentivizing Mammography Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schmidt, Harald] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Schmidt, Harald] Univ Penn, Ctr Hlth Incent & Behav Econ, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Schmidt, H (corresponding author), Univ Penn, Med Eth & Hlth Policy, Perelman Sch Med, 3401 Market St, Philadelphia, PA 19104 USA.	Schmidth@mail.med.upenn.edu						Aschwanden C, 2015, JAMA INTERN MED, V175, P164, DOI 10.1001/jamainternmed.2014.6394; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Hersch J, 2015, LANCET, V385, P1642, DOI 10.1016/S0140-6736(15)60123-4; Institute of Medicine, 2015, VIT SIGNS COR METR H; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Sabatino SA, 2015, MMWR-MORBID MORTAL W, V64, P464; Wong FL, 2008, MANUAL INTERVENTION	7	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					995	996		10.1001/jama.2015.8852	http://dx.doi.org/10.1001/jama.2015.8852			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26348746				2022-12-28	WOS:000360840700006
J	Xin, GQ; Yao, TK; Sun, HT; Scott, SM; Shao, DL; Wang, GK; Lian, J				Xin, Guoqing; Yao, Tiankai; Sun, Hongtao; Scott, Spencer Michael; Shao, Dali; Wang, Gongkai; Lian, Jie			Highly thermally conductive and mechanically strong graphene fibers	SCIENCE			English	Article							X-RAY-SCATTERING; LIQUID-CRYSTALS; CARBON; OXIDE; POLYACRYLONITRILE; ULTRASTRONG; TRANSPORT; STRENGTH; MODULUS	Graphene, a single layer of carbon atoms bonded in a hexagonal lattice, is the thinnest, strongest, and stiffest known material and an excellent conductor of heat and electricity. However, these superior properties have yet to be realized for graphene-derived macroscopic structures such as graphene fibers. We report the fabrication of graphene fibers with high thermal and electrical conductivity and enhanced mechanical strength. The inner fiber structure consists of large-sized graphene sheets forming a highly ordered arrangement intercalated with small-sized graphene sheets filling the space and microvoids. The graphene fibers exhibit a submicrometer crystallite domain size through high-temperature treatment, achieving an enhanced thermal conductivity up to 1290 watts per meter per kelvin. The tensile strength of the graphene fiber reaches 1080 megapascals.	[Xin, Guoqing; Yao, Tiankai; Sun, Hongtao; Scott, Spencer Michael; Wang, Gongkai; Lian, Jie] Rensselaer Polytech Inst, Dept Mech Aerosp & Nucl Engn, Troy, NY 12180 USA; [Shao, Dali] Rensselaer Polytech Inst, Dept Elect Comp & Syst Engn, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Lian, J (corresponding author), Rensselaer Polytech Inst, Dept Mech Aerosp & Nucl Engn, 110,8th St, Troy, NY 12180 USA.	lianj@rpi.edu	YAO, TIANKAI/I-4771-2018; Wang, Gongkai/A-6504-2015; Wang, Gongkai/O-3503-2019; Sun, Hongtao/N-6597-2013; Scott, Spencer M./G-5842-2019	YAO, TIANKAI/0000-0001-8330-7638; Wang, Gongkai/0000-0003-3589-9020; Sun, Hongtao/0000-0003-3259-6091; Scott, Spencer M./0000-0002-9968-7425	U.S. National Science Foundation [DMR 1151028, CMMI 1463083]	U.S. National Science Foundation(National Science Foundation (NSF))	This work is financially supported by the U.S. National Science Foundation under awards DMR 1151028 and CMMI 1463083.	Adams PM, 1998, CARBON, V36, P233, DOI 10.1016/S0008-6223(97)00189-9; Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/nmat3064, 10.1038/NMAT3064]; Behabtu N, 2013, SCIENCE, V339, P182, DOI 10.1126/science.1228061; Cancado LG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196057; Chen L, 2013, NANOSCALE, V5, P5809, DOI 10.1039/c3nr01083j; Cong HP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00613; Du X, 2008, NAT NANOTECHNOL, V3, P491, DOI 10.1038/nnano.2008.199; Emmerich FG, 2014, CARBON, V79, P274, DOI 10.1016/j.carbon.2014.07.068; Endo M, 1998, PHYS REV B, V58, P8991, DOI 10.1103/PhysRevB.58.8991; Gallego NC, 2000, CARBON, V38, P1003, DOI 10.1016/S0008-6223(99)00203-1; GUPTA A, 1994, J APPL CRYSTALLOGR, V27, P627, DOI 10.1107/S002188989400227X; Hu XZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02374; Jang WY, 2010, NANO LETT, V10, P3909, DOI 10.1021/nl101613u; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Naito K, 2008, CARBON, V46, P189, DOI 10.1016/j.carbon.2007.11.001; Pei SF, 2012, CARBON, V50, P3210, DOI 10.1016/j.carbon.2011.11.010; Qin XY, 2012, CARBON, V50, P4459, DOI 10.1016/j.carbon.2012.05.024; Seol JH, 2010, SCIENCE, V328, P213, DOI 10.1126/science.1184014; Shin MK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1661; Song L, 2013, CARBON, V52, P608, DOI 10.1016/j.carbon.2012.09.060; Thunemann AF, 2000, MACROMOLECULES, V33, P1848, DOI 10.1021/ma991427x; Wang JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4415; Wang JL, 2008, NEW CARBON MATER, V23, P259, DOI 10.1016/S1872-5805(08)60029-3; Xiang CS, 2013, ADV MATER, V25, P4592, DOI 10.1002/adma.201301065; Xiang CS, 2013, ACS NANO, V7, P1628, DOI 10.1021/nn305506s; Xin GQ, 2014, ADV MATER, V26, P4521, DOI 10.1002/adma.201400951; Xu Z, 2014, ACCOUNTS CHEM RES, V47, P1267, DOI 10.1021/ar4002813; Xu Z, 2013, ADV MATER, V25, P3249, DOI 10.1002/adma.201300774; Xu Z, 2013, ADV MATER, V25, P188, DOI 10.1002/adma.201203448; Xu Z, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1583; Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/NMAT2778, 10.1038/nmat2778]; Zhu CZ, 2012, CARBON, V50, P235, DOI 10.1016/j.carbon.2011.08.040	32	490	511	56	1067	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1083	1087		10.1126/science.aaa6502	http://dx.doi.org/10.1126/science.aaa6502			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339027				2022-12-28	WOS:000360628900038
J	Templin, C; Ghadri, JR; Diekmann, J; Napp, LC; Bataiosu, DR; Jaguszewski, M; Cammann, VL; Sarcon, A; Geyer, V; Neumann, CA; Seifert, B; Hellermann, J; Schwyzer, M; Eisenhardt, K; Jenewein, J; Franke, J; Katus, HA; Burgdorf, C; Schunkert, H; Moeller, C; Thiele, H; Bauersachs, J; Tschope, C; Schultheiss, HP; Laney, CA; Rajan, L; Michels, G; Pfister, R; Ukena, C; Bohm, M; Erbel, R; Cuneo, A; Kuck, KH; Jacobshagen, C; Hasenfuss, G; Karakas, M; Koenig, W; Rottbauer, W; Said, SM; Braun-Dullaeus, RC; Cuculi, F; Banning, A; Fischer, TA; Vasankari, T; Airaksinen, KEJ; Fijalkowski, M; Rynkiewicz, A; Pawlak, M; Opolski, G; Dworakowski, R; MacCarthy, P; Kaiser, C; Osswald, S; Galiuto, L; Crea, F; Dichtl, W; Franz, WM; Empen, K; Felix, SB; Delmas, C; Lairez, O; Erne, P; Bax, JJ; Ford, I; Ruschitzka, F; Prasad, A; Luscher, TF				Templin, C.; Ghadri, J. R.; Diekmann, J.; Napp, L. C.; Bataiosu, D. R.; Jaguszewski, M.; Cammann, V. L.; Sarcon, A.; Geyer, V.; Neumann, C. A.; Seifert, B.; Hellermann, J.; Schwyzer, M.; Eisenhardt, K.; Jenewein, J.; Franke, J.; Katus, H. A.; Burgdorf, C.; Schunkert, H.; Moeller, C.; Thiele, H.; Bauersachs, J.; Tschoepe, C.; Schultheiss, H-P.; Laney, C. A.; Rajan, L.; Michels, G.; Pfister, R.; Ukena, C.; Boehm, M.; Erbel, R.; Cuneo, A.; Kuck, K-H.; Jacobshagen, C.; Hasenfuss, G.; Karakas, M.; Koenig, W.; Rottbauer, W.; Said, S. M.; Braun-Dullaeus, R. C.; Cuculi, F.; Banning, A.; Fischer, T. A.; Vasankari, T.; Airaksinen, K. E. J.; Fijalkowski, M.; Rynkiewicz, A.; Pawlak, M.; Opolski, G.; Dworakowski, R.; MacCarthy, P.; Kaiser, C.; Osswald, S.; Galiuto, L.; Crea, F.; Dichtl, W.; Franz, W. M.; Empen, K.; Felix, S. B.; Delmas, C.; Lairez, O.; Erne, P.; Bax, J. J.; Ford, I.; Ruschitzka, F.; Prasad, A.; Luescher, T. F.			Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TAKO-TSUBO CARDIOMYOPATHY; APICAL BALLOONING SYNDROME; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY STENOSIS; HEART; DYSFUNCTION	BACKGROUND The natural history, management, and outcome of takotsubo (stress) cardiomyopathy are incompletely understood. METHODS The International Takotsubo Registry, a consortium of 26 centers in Europe and the United States, was established to investigate clinical features, prognostic predictors, and outcome of takotsubo cardiomyopathy. Patients were compared with age- and sex-matched patients who had an acute coronary syndrome. RESULTS Of 1750 patients with takotsubo cardiomyopathy, 89.8% were women (mean age, 66.8 years). Emotional triggers were not as common as physical triggers (27.7% vs. 36.0%), and 28.5% of patients had no evident trigger. Among patients with takotsubo cardiomyopathy, as compared with an acute coronary syndrome, rates of neurologic or psychiatric disorders were higher (55.8% vs. 25.7%) and the mean left ventricular ejection fraction was markedly lower (40.7 +/- 11.2% vs. 51.5 +/- 12.3%) (P < 0.001 for both comparisons). Rates of severe in-hospital complications including shock and death were similar in the two groups (P = 0.93). Physical triggers, acute neurologic or psychiatric diseases, high troponin levels, and a low ejection fraction on admission were independent predictors for in-hospital complications. During long-term follow-up, the rate of major adverse cardiac and cerebrovascular events was 9.9% per patient-year, and the rate of death was 5.6% per patient-year. CONCLUSIONS Patients with takotsubo cardiomyopathy had a higher prevalence of neurologic or psychiatric disorders than did those with an acute coronary syndrome. This condition represents an acute heart failure syndrome with substantial morbidity and mortality. (Funded by the Mach-Gaensslen Foundation and others; ClinicalTrials.gov number, NCT01947621.)	[Templin, C.; Ghadri, J. R.; Diekmann, J.; Bataiosu, D. R.; Jaguszewski, M.; Cammann, V. L.; Geyer, V.; Neumann, C. A.; Schwyzer, M.; Erne, P.; Ruschitzka, F.; Luescher, T. F.] Univ Zurich Hosp, Univ Heart Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland; [Eisenhardt, K.; Jenewein, J.] Univ Zurich Hosp, Dept Psychiat & Psychotherapy, CH-8091 Zurich, Switzerland; [Seifert, B.] Univ Zurich, Div Biostat, Epidemiol Biostat & Prevent Inst, CH-8006 Zurich, Switzerland; [Hellermann, J.] Spital Region Rheintal Werdenberg Sarganserland, Altstatten, Switzerland; [Cuculi, F.; Erne, P.] Kantonsspital Lucerne, Dept Cardiol, Luzern, Switzerland; [Fischer, T. A.] Kantonsspital Winterthur, Dept Cardiol, Winterthur, Switzerland; [Kaiser, C.; Osswald, S.] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; [Napp, L. C.; Bauersachs, J.] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Franke, J.; Katus, H. A.] Univ Heidelberg Hosp, Dept Cardiol, Heidelberg, Germany; [Burgdorf, C.; Schunkert, H.; Koenig, W.] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Schunkert, H.; Koenig, W.] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany; [Moeller, C.; Thiele, H.] Univ Heart Ctr Lubeck, Med Clin 2, Dept Cardiol Angiol & Intens Care Med, Lubeck, Germany; [Moeller, C.; Thiele, H.; Karakas, M.] DZHK, Lubeck, Germany; [Cuneo, A.; Kuck, K-H.] St Georg Hosp, Asklepios Clin, Div Cardiol, Hamburg, Germany; [Karakas, M.] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Tschoepe, C.; Schultheiss, H-P.] Campus Rudolf Virchow, Charite, Dept Cardiol, Berlin, Germany; [Michels, G.; Pfister, R.] Univ Cologne, Ctr Heart, Dept Internal Med 3, D-50931 Cologne, Germany; [Ukena, C.; Boehm, M.] Univ Saarland, Dept Internal Med 3, Cardiol Angiol & Intens Care Med, Homburg, Germany; [Erbel, R.] Univ Hosp Essen, Dept Cardiol, Essen, Germany; [Jacobshagen, C.; Hasenfuss, G.] Univ Gottingen, Clin Cardiol & Pneumol, Gottingen, Germany; [Jacobshagen, C.; Hasenfuss, G.] DZHK, Gottingen, Germany; [Karakas, M.; Koenig, W.; Rottbauer, W.] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Said, S. M.; Braun-Dullaeus, R. C.] Univ Magdeburg, Internal Med Cardiol Angiol & Pneumol, D-39106 Magdeburg, Germany; [Empen, K.; Felix, S. B.] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Empen, K.; Felix, S. B.] DZHK, Greifswald, Germany; [Sarcon, A.] Univ Calif Davis, Med Ctr, Davis, CA 95616 USA; [Laney, C. A.; Rajan, L.] Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, Lexington, KY 40506 USA; [Cuculi, F.; Banning, A.] Oxford Univ Hosp, John Radcliffe Hosp, Dept Cardiol, Oxford, England; [Dworakowski, R.; MacCarthy, P.] Kings Coll Hosp London, Kings Hlth Partners, Dept Cardiol, London, England; [Prasad, A.] Univ London, Cardiac Ctr, London, England; [Ford, I.] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Vasankari, T.; Airaksinen, K. E. J.] Turku Univ Hosp, Ctr Heart, FIN-20520 Turku, Finland; [Vasankari, T.; Airaksinen, K. E. J.] Univ Turku, Turku, Finland; [Fijalkowski, M.] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland; [Rynkiewicz, A.] Univ Warmia & Mazury, Dept Cardiol & Cardiosurg, Olsztyn, Poland; [Pawlak, M.; Opolski, G.] Med Univ Warsaw, Dept Cardiol, Warsaw, Poland; [Galiuto, L.; Crea, F.] Univ Cattolica Sacro Cuore, Dept Cardiovasc Sci, I-00168 Rome, Italy; [Dichtl, W.; Franz, W. M.] Med Univ Innsbruck, Univ Hosp Internal Med 3 Cardiol & Angiol, A-6020 Innsbruck, Austria; [Delmas, C.; Lairez, O.] Univ Hosp Rangueil, Dept Cardiol, Toulouse, France; [Delmas, C.; Lairez, O.] Univ Hosp Rangueil, Cardiac Imaging Ctr, Toulouse, France; [Bax, J. J.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Prasad, A.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Lucerne Cantonal Hospital; University of Basel; Hannover Medical School; Ruprecht Karls University Heidelberg; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; German Centre for Cardiovascular Research; Asklepios Klinik St. Georg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; Saarland University; University of Duisburg Essen; University of Gottingen; German Centre for Cardiovascular Research; Ulm University; Otto von Guericke University; Greifswald Medical School; German Centre for Cardiovascular Research; University of California System; University of California Davis; University of Kentucky; University of Oxford; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of London; University of Glasgow; University of Turku; University of Turku; Fahrenheit Universities; Medical University Gdansk; University of Warmia & Mazury; Medical University of Warsaw; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Medical University of Innsbruck; CHU de Toulouse; CHU de Toulouse; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Mayo Clinic	Templin, C (corresponding author), Univ Zurich Hosp, Univ Heart Ctr, Dept Cardiol, Ramistr 100, CH-8091 Zurich, Switzerland.	christian.templin@usz.ch	Hellermann, Jens/ABB-2889-2020; Franke, Jennifer C/L-8440-2015; Kaiser, Christoph/AAA-9284-2022; Perlini, Stefano/E-2670-2012; Jenewein, Josef/B-2390-2016; O, Lairez/B-7152-2016; Böhm, Michael/C-3638-2011; banning, adrian p/AAF-7229-2021; Airaksinen, Juhani/AAC-7857-2021; Ukena, Christian/AAA-4812-2019; Dichtl, Wolfgang/H-7128-2017; Jaguszewski, Milosz/AAL-3169-2020; Thiele, Holger/ABE-6792-2020; Ford, Ian/ABE-6145-2020; Napp, L. Christian/AAD-2498-2020; Braun-Dullaeus, Ruediger C/G-1844-2013; Jenewein, Josef/AAN-4666-2021; Osswald, Stefan/A-6904-2018; Rynkiewicz, Andrzej/AAW-8733-2021	Perlini, Stefano/0000-0002-0320-8574; Jenewein, Josef/0000-0003-4271-918X; O, Lairez/0000-0001-8141-6582; Airaksinen, Juhani/0000-0002-0193-568X; Ukena, Christian/0000-0002-9810-4662; Dichtl, Wolfgang/0000-0002-0421-2110; Thiele, Holger/0000-0002-0169-998X; Braun-Dullaeus, Ruediger C/0000-0003-3888-6532; Osswald, Stefan/0000-0002-9240-6731; Tschope, Carsten/0000-0001-5243-8985; Jaguszewski, Milosz/0000-0002-2555-593X; Delmas, Clement/0000-0001-9180-9128; Banning, Adrian/0000-0002-2842-7861; Rynkiewicz, Andrzej/0000-0002-5284-9511; Napp, L. Christian/0000-0001-9945-0842; Opolski, Grzegorz/0000-0003-4744-2554; Fijalkowski, Marcin/0000-0002-2913-5457; Prasad, Abhiram/0000-0001-9252-5602; Diekmann, Johanna/0000-0002-7008-3601; Koenig, Wolfgang/0000-0002-2064-9603	Mach-Gaensslen Foundation	Mach-Gaensslen Foundation	Funded by the Mach-Gaensslen Foundation and others	Aizawa K, 2013, HEART FAIL CLIN, V9, P243, DOI 10.1016/j.hfc.2012.12.001; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Brandspiegel HZ, 1998, CIRCULATION, V98, P1349, DOI 10.1161/01.CIR.98.13.1349; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; Cheung RTF, 2000, ARCH NEUROL-CHICAGO, V57, P1685, DOI 10.1001/archneur.57.12.1685; Citro R, 2014, JACC-CARDIOVASC IMAG, V7, P119, DOI 10.1016/j.jcmg.2013.09.020; Eitel I, 2011, JAMA-J AM MED ASSOC, V306, P277, DOI 10.1001/jama.2011.992; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Galiuto L, 2010, EUR HEART J, V31, P1319, DOI 10.1093/eurheartj/ehq039; Hurst RT, 2010, JACC-CARDIOVASC IMAG, V3, P641, DOI 10.1016/j.jcmg.2010.01.009; Kyuma M, 2002, CIRC J, V66, P1181, DOI 10.1253/circj.66.1181; Le Ven F, 2011, INT J CARDIOL, V146, P475, DOI 10.1016/j.ijcard.2010.12.028; Lee VH, 2006, J NEUROSURG, V105, P264, DOI 10.3171/jns.2006.105.2.264; Medeiros K, 2014, CIRCULATION, V129, P1659, DOI 10.1161/CIRCULATIONAHA.113.002781; Parodi G, 2013, CORONARY ARTERY DIS, V24, P527, DOI 10.1097/MCA.0b013e3283645c4e; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Previtali M, 2011, AM J CARDIOL, V107, P120, DOI 10.1016/j.amjcard.2010.08.055; Riera Maria, 2010, J Trauma, V68, pE13, DOI 10.1097/TA.0b013e3181469d5b; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Sato H, 1990, CLIN ASPECT MYOCARDI, P56; Schneider B, 2013, INT J CARDIOL, V166, P584, DOI 10.1016/j.ijcard.2011.11.027; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Sharp RP, 2011, ANN PHARMACOTHER, V45, P1559, DOI 10.1345/aph.1Q393; Summers MR, 2010, J AM COLL CARDIOL, V55, P700, DOI 10.1016/j.jacc.2009.10.031; Suzuki H, 2014, CIRC J, V78, P256, DOI 10.1253/circj.CJ-13-1276; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Yoshimura S, 2008, ANN NEUROL, V64, P547, DOI 10.1002/ana.21459	29	1259	1303	3	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2015	373	10					929	938		10.1056/NEJMoa1406761	http://dx.doi.org/10.1056/NEJMoa1406761			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2OB	26332547	Green Published			2022-12-28	WOS:000360439500008
J	Krause, PR				Krause, Philip R.			Interim results from a phase 3 Ebola vaccine study in Guinea	LANCET			English	Editorial Material									US FDA, Ctr Biol Evaluat & Res, Off Vaccines Res & Review, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Krause, PR (corresponding author), US FDA, Ctr Biol Evaluat & Res, Off Vaccines Res & Review, Silver Spring, MD 20993 USA.	philip.krause@fda.hhs.gov						Berkley S, 2015, NY TIMES; Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; World Health Organization, 2015, EBOLA SITUATION REPO	4	18	19	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					831	833		10.1016/S0140-6736(15)00002-1	http://dx.doi.org/10.1016/S0140-6736(15)00002-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0MJ	26335862				2022-12-28	WOS:000360290000004
J	Chiappinelli, KB; Strissel, PL; Desrichard, A; Li, HL; Henke, C; Akman, B; Hein, A; Rote, NS; Cope, LM; Snyder, A; Makarov, V; Buhu, S; Slamon, DJ; Wolchok, JD; Pardoll, DM; Beckmann, MW; Zahnow, CA; Mergoub, T; Chan, TA; Baylin, SB; Strick, R				Chiappinelli, Katherine B.; Strissel, Pamela L.; Desrichard, Alexis; Li, Huili; Henke, Christine; Akman, Benjamin; Hein, Alexander; Rote, Neal S.; Cope, Leslie M.; Snyder, Alexandra; Makarov, Vladimir; Buhu, Sadna; Slamon, Dennis J.; Wolchok, Jedd D.; Pardoll, Drew M.; Beckmann, Matthias W.; Zahnow, Cynthia A.; Mergoub, Taha; Chan, Timothy A.; Baylin, Stephen B.; Strick, Reiner			Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses	CELL			English	Article							CODING ENVELOPE GENES; HUMAN BREAST-CANCER; CELL LUNG-CANCER; HERV-K; CPG METHYLATION; OVARIAN-CANCER; NONCODING RNA; PD-1 BLOCKADE; HUMAN GENOME; TUMOR-CELLS	We show that DNA methyltransferase inhibitors (DNMTis) upregulate immune signaling in cancer through the viral defense pathway. In ovarian cancer (OC), DNMTis trigger cytosolic sensing of double-stranded RNA ( dsRNA) causing a type I interferon response and apoptosis. Knocking down dsRNA sensors TLR3 and MAVS reduces this response 2-fold and blocking interferon beta or its receptor abrogates it. Upregulation of hypermethylated endogenous retrovirus (ERV) genes accompanies the response and ERV overexpression activates the response. Basal levels of ERV and viral defense gene expression significantly correlate in primary OC and the latter signature separates primary samples for multiple tumor types from The Cancer Genome Atlas into low versus high expression groups. In melanoma patients treated with an immune checkpoint therapy, high viral defense signature expression in tumors significantly associates with durable clinical response and DNMTi treatment sensitizes to anti-CTLA4 therapy in a preclinical melanoma model.	[Chiappinelli, Katherine B.; Li, Huili; Akman, Benjamin; Cope, Leslie M.; Zahnow, Cynthia A.; Baylin, Stephen B.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD 21287 USA; [Strissel, Pamela L.; Henke, Christine; Hein, Alexander; Beckmann, Matthias W.; Strick, Reiner] Univ Clin Erlangen, Dept Obstet & Gynaecol, Mol Med Lab, D-91054 Erlangen, Germany; [Desrichard, Alexis; Snyder, Alexandra; Makarov, Vladimir; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Rote, Neal S.] Case Western Reserve Univ, Dept Reprod Biol, Cleveland, OH 44106 USA; [Snyder, Alexandra; Buhu, Sadna; Wolchok, Jedd D.; Mergoub, Taha; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Slamon, Dennis J.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Erlangen Nuremberg; Memorial Sloan Kettering Cancer Center; Case Western Reserve University; Memorial Sloan Kettering Cancer Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Baylin, SB (corresponding author), Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD 21287 USA.	sbaylin@jhmi.edu; reiner.strick@uk-erlangen.de	Chan, Timothy A/ABD-5850-2021; Hein, Alexander/F-6999-2010; Merghoub, Taha/ABD-8362-2021	Hein, Alexander/0000-0003-2601-3398; Snyder Charen, Alexandra/0000-0002-2606-3523; Desrichard, Alexis/0000-0002-1335-7813	National Cancer Institute (NCI) [CA058184]; Stand Up To Cancer (SU2C) Epigenetic Dream Team; Hodson Trust; Samuel Waxman Cancer Research Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Department of Defense (DOD) Teal Award [BC031272]; Pershing Square Sohn Cancer Research Alliance; STARR Cancer Consortium; Ludwig Foundation; NIH [F32CA183214]; German Cancer Aid [Deutsche Krebshilfe 108215]; Bristol-Myers Squibb; NATIONAL CANCER INSTITUTE [P30CA008748, P50CA058184, F32CA183214] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up To Cancer (SU2C) Epigenetic Dream Team; Hodson Trust; Samuel Waxman Cancer Research Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Department of Defense (DOD) Teal Award; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); STARR Cancer Consortium; Ludwig Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Cancer Aid(Deutsche Krebshilfe); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by grants from The National Cancer Institute (NCI) CA058184 (S.B.B.), Stand Up To Cancer (SU2C) Epigenetic Dream Team (S.B.B.), the Hodson Trust (S.B.B.), the Samuel Waxman Cancer Research Foundation (S.B.B.), The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (S.B.B., D.J.S.), Department of Defense (DOD) Teal Award BC031272 (S.B.B.), the Pershing Square Sohn Cancer Research Alliance (T.A.C.), the STARR Cancer Consortium (T.A.C.), the Ludwig Foundation (J.D.W.), and NIH award F32CA183214 (K.B.C.), and German Cancer Aid (Deutsche Krebshilfe 108215) (R.S.). We acknowledge Mrs. Elizabeth Stiegler and Florentine Koppitz for their expert technical help and Kathy Bender for manuscript preparation. ABI TLDA qRT-PCR was conducted at the Genetic Resources Core Facility, Johns Hopkins Institute of Genetic Medicine, Baltimore, MD. We thank Ms. Jennifer Meyers and the Next Generation Sequencing Center at the Sidney Kimmel Comprehensive Cancer Center for Agilent Bioanalyzer analysis. D.M.P. is a consultant for Pfizer and Amplimmune. J.D.W. is a consultant for Bristol-Myers Squibb and receives research funding. S.B.B. consults for MDxHealth. Methylation-specific PCR (MSP) is licensed to MDxHealth in agreement with Johns Hopkins University (JHU), and S.B.B. and JHU are entitled to royalty shares received from sales.	Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Blaise S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-19; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Brahmer J., 2015, PHASE 2 ANTIPD1 EPIG; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Chiappinelli KB, 2012, MOL CANCER RES, V10, P316, DOI 10.1158/1541-7786.MCR-11-0520; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; Ding SY, 2014, NAT IMMUNOL, V15, P700, DOI 10.1038/ni.2924; Ding SY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001758; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; Gimenez J, 2010, NUCLEIC ACIDS RES, V38, P2229, DOI 10.1093/nar/gkp1214; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Guan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep07857; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurst TP, 2015, J GEN VIROL, V96, P1207, DOI 10.1099/jgv.0.000017; Issa Jean-Pierre, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS24, DOI 10.1038/ncponc0355; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; James SR, 2013, EPIGENETICS-US, V8, P849, DOI 10.4161/epi.25500; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kaminskas E, 2005, CLIN CANCER RES, V11, P3604, DOI 10.1158/1078-0432.CCR-04-2135; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Krishnamurthy J, 2015, CLIN CANCER RES, V21, P3241, DOI 10.1158/1078-0432.CCR-14-3197; Kulaeva OI, 2003, ONCOGENE, V22, P4118, DOI 10.1038/sj.onc.1206594; Larsen JM, 2009, CANCER LETT, V280, P44, DOI 10.1016/j.canlet.2009.02.008; Laska MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053895; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; LOWER R, 1993, VIROLOGY, V192, P501, DOI 10.1006/viro.1993.1066; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Mankan AK, 2014, EMBO J, V33, P2937, DOI 10.15252/embj.201488726; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Rote NS, 2004, PLACENTA, V25, P673, DOI 10.1016/j.placenta.2004.02.008; Ruebner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056145; Rycaj K, 2015, CLIN CANCER RES, V21, P471, DOI 10.1158/1078-0432.CCR-14-0388; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Schaefer M, 2009, CANCER RES, V69, P8127, DOI 10.1158/0008-5472.CAN-09-0458; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stengel S, 2010, GENE CHROMOSOME CANC, V49, P401, DOI 10.1002/gcc.20751; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Strissel PL, 2012, ONCOTARGET, V3, P1204; Su WY, 2012, CELL RES, V22, P1374, DOI 10.1038/cr.2012.57; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Wang-Johanning F, 2003, ONCOGENE, V22, P1528, DOI 10.1038/sj.onc.1206241; Wang-Johanning F, 2001, CLIN CANCER RES, V7, P1553; Wang-Johanning F, 2012, JNCI-J NATL CANCER I, V104, P189, DOI 10.1093/jnci/djr540; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095	86	906	926	17	166	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					974	986		10.1016/j.cell.2015.07.011	http://dx.doi.org/10.1016/j.cell.2015.07.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317466	Green Accepted, Bronze			2022-12-28	WOS:000360589900009
J	Schneider, M; Hellerschmied, D; Schubert, T; Amlacher, S; Vinayachandran, V; Reja, R; Pugh, BF; Clausen, T; Kohler, A				Schneider, Maren; Hellerschmied, Doris; Schubert, Tobias; Amlacher, Stefan; Vinayachandran, Vinesh; Reja, Rohit; Pugh, B. Franklin; Clausen, Tim; Koehler, Alwin			The Nuclear Pore-Associated TREX-2 Complex Employs Mediator to Regulate Gene Expression	CELL			English	Article							RNA-POLYMERASE-II; EXPORT MACHINERY; TRANSCRIPTION; YEAST; PROTEINS; BINDING; SACCHAROMYCES; DISSOCIATION; ARCHITECTURE; PATHWAY	Nuclear pore complexes (NPCs) influence gene expression besides their established function in nuclear transport. The TREX-2 complex localizes to the NPC basket and affects gene-NPC interactions, transcription, and mRNA export. How TREX-2 regulates the gene expression machinery is unknown. Here, we show that TREX-2 interacts with the Mediator complex, an essential regulator of RNA Polymerase (Pol) II. Structural and biochemical studies identify a conserved region on TREX-2, which directly binds the Mediator Med31/Med7N submodule. TREX-2 regulates assembly of Mediator with the Cdk8 kinase and is required for recruitment and site-specific phosphorylation of Pol II. Transcriptome and phenotypic profiling confirm that TREX-2 and Med31 are functionally interdependent at specific genes. TREX-2 additionally uses its Mediator-interacting surface to regulate mRNA export suggesting a mechanism for coupling transcription initiation and early steps of mRNA processing. Our data provide mechanistic insight into how an NPC-associated adaptor complex accesses the core transcription machinery.	[Schneider, Maren; Schubert, Tobias; Amlacher, Stefan; Koehler, Alwin] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Hellerschmied, Doris; Clausen, Tim] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Vinayachandran, Vinesh; Reja, Rohit; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kohler, A (corresponding author), Med Univ Vienna, Max F Perutz Labs, VBC,Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	alwin.koehler@mfpl.ac.at	Vinayachandran, Vinesh/ABD-6386-2020	Clausen, Tim/0000-0003-1582-6924; Vinayachandran, Vinesh/0000-0002-2045-6086; Hellerschmied, Doris/0000-0003-1431-2470	ERC [281354]; Austrian Science Fund (FWF) [Y557-B11]; Boehringer Ingelheim; NIH [GM059055]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059055] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [Y 557] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Boehringer Ingelheim(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank J. Cibulka and K. Lipp for assistance, the CSF NGS unit for RNA-seq, and S. Juntilla (CSF Biocomp) for bioinformatic analyses. We acknowledge R. Young, Y. Takagi, C. Dargemont, and D. Bentley for antibodies, S. Tan for the pST44 vector and G. Warren and J. Brennecke for comments on the manuscript. A. Kohler is funded by an ERC grant (281354; NPC GENEXPRESS) and a START grant from the Austrian Science Fund (FWF; Y557-B11). The IMP is funded by Boehringer Ingelheim. B.F.P. is funded by NIH grant GM059055 and has a financial interest in Peconic, LLC, which utilizes ChIP-exo and could potentially benefit from the outcomes of this research.	Ahmed S, 2010, NAT CELL BIOL, V12, P111, DOI 10.1038/ncb2011; Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; de la Cera T, 2002, J MOL BIOL, V319, P703, DOI 10.1016/S0022-2836(02)00377-7; Ellisdon AM, 2012, NAT STRUCT MOL BIOL, V19, P328, DOI 10.1038/nsmb.2235; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Gonzalez-Aguilera C, 2008, MOL BIOL CELL, V19, P4310, DOI 10.1091/mbc.E08-04-0355; Ibarra A, 2015, GENE DEV, V29, P337, DOI 10.1101/gad.256495.114; Jeronimo C, 2014, NAT STRUCT MOL BIOL, V21, P449, DOI 10.1038/nsmb.2810; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Park D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083506; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Santos-Pereira JM, 2014, NUCLEIC ACIDS RES, V42, P12000, DOI 10.1093/nar/gku906; Sogaard TMM, 2007, J BIOL CHEM, V282, P14113, DOI 10.1074/jbc.M701345200; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Texari L, 2013, MOL CELL, V51, P807, DOI 10.1016/j.molcel.2013.08.047; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Wong KH, 2014, MOL CELL, V54, P601, DOI 10.1016/j.molcel.2014.03.024	39	71	74	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					1016	1028		10.1016/j.cell.2015.07.059	http://dx.doi.org/10.1016/j.cell.2015.07.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317468	Green Published, hybrid			2022-12-28	WOS:000360589900012
J	D'Silva, J				D'Silva, Jeetha			India's problem with toxic alcohol	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						[Anonymous], 2015, HINDUSTAN TIMES 0605; Basu I, 2015, HUFFINGTON POST; Hindu The, 2015, HINDU; Pal S., 2015, DNA; Press Trust of India, 2015, DNA; Press Trust of India, 2015, HINDUSTAN TIMES 0429; World Health Organization, 2014, METH POIS OUTBR	7	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2015	351									10.1136/bmj.h4536	http://dx.doi.org/10.1136/bmj.h4536			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ2NG	26306757				2022-12-28	WOS:000360437200003
J	Siontis, GCM; Stefanini, GG; Mavridis, D; Siontis, KC; Alfonso, F; Perez-Vizcayno, MJ; Byrne, RA; Kastrati, A; Meier, B; Salanti, G; Juni, P; Windecker, S				Siontis, George C. M.; Stefanini, Giulio G.; Mavridis, Dimitris; Siontis, Konstantinos C.; Alfonso, Fernando; Perez-Vizcayno, Maria J.; Byrne, Robert A.; Kastrati, Adnan; Meier, Bernhard; Salanti, Georgia; Jueni, Peter; Windecker, Stephan			Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis	LANCET			English	Article							PACLITAXEL-COATED BALLOON; DRUG-ELUTING STENT; BARE-METAL STENTS; SR-90/Y-90 BETA-RADIATION; RANDOMIZED-TRIAL; FOLLOW-UP; VASCULAR BRACHYTHERAPY; ROTATIONAL ATHERECTOMY; CLINICAL-OUTCOMES; PLACEBO CONTROL	Background Percutaneous coronary intervention (PCI) with drug-eluting stents is the standard of care for treatment of native coronary artery stenoses, but optimum treatment strategies for bare metal stent and drug-eluting stent in-stent restenosis (ISR) have not been established. We aimed to compare and rank percutaneous treatment strategies for ISR. Methods We did a network meta-analysis to synthesise both direct and indirect evidence from relevant trials. We searched PubMed, the Cochrane Library Central Register of Controlled Trials, and Embase for randomised controlled trials published up to Oct 31, 2014, of different PCI strategies for treatment of any type of coronary ISR. The primary outcome was percent diameter stenosis at angiographic follow-up. This study is registered with PROSPERO, number CRD42014014191. Findings We deemed 27 trials eligible, including 5923 patients, with follow-up ranging from 6 months to 60 months after the index intervention. Angiographic follow-up was available for 4975 (84%) of 5923 patients 6-12 months after the intervention. PCI with everolimus-eluting stents was the most effective treatment for percent diameter stenosis, with a difference of -9.0% (95% CI -15.8 to -2.2) versus drug-coated balloons (DCB), -9.4% (-17.4 to -1.4) versus sirolimus-eluting stents, -10.2% (-18.4 to -2.0) versus paclitaxel-eluting stents, -19.2% (-28.2 to -10.4) versus vascular brachytherapy, -23.4% (-36.2 to -10.8) versus bare metal stents, -24.2% (-32.2 to -16.4) versus balloon angioplasty, and -31.8% (-44.8 to -18.6) versus rotablation. DCB were ranked as the second most effective treatment, but without significant differences from sirolimus-eluting (-0.2% [95% CI -6.2 to 5.6]) or paclitaxel-eluting (-1.2% [-6.4 to 4.2]) stents. Interpretation These findings suggest that two strategies should be considered for treatment of any type of coronary ISR: PCI with everolimus-eluting stents because of the best angiographic and clinical outcomes, and DCB because of its ability to provide favourable results without adding a new stent layer.	[Siontis, George C. M.; Stefanini, Giulio G.; Meier, Bernhard; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Stefanini, Giulio G.] Humanitas Res Hosp, Cardiovasc Dept, Milan, Italy; [Mavridis, Dimitris; Salanti, Georgia] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Mavridis, Dimitris] Univ Ioannina, Dept Primary Educ, GR-45110 Ioannina, Greece; [Siontis, Konstantinos C.] Mayo Clin, Dept Med, Rochester, MN USA; [Alfonso, Fernando] Hosp Univ La Princesa Madrid, Dept Cardiac, Madrid, Spain; [Perez-Vizcayno, Maria J.] Hosp Clin San Carlos, Unidad Cardiol Intervencionista, Serv Cardiol, Madrid, Spain; [Byrne, Robert A.; Kastrati, Adnan] Tech Univ Munich, Deutsch Herzzentrum, D-80290 Munich, Germany; [Byrne, Robert A.; Kastrati, Adnan] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res, Munich, Germany; [Jueni, Peter] Univ Bern, Inst Primary Hlth Care, Bern, Switzerland; [Jueni, Peter] Univ Bern, Clin Trials Unit, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Ioannina; University of Ioannina; Mayo Clinic; Hospital Clinico San Carlos; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Bern; University of Bern	Windecker, S (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	stephan.windecker@insel.ch	Juni, Peter/Q-8700-2016; Stefanini, Giulio/GZG-4754-2022; , Kastrati/Y-2389-2019; Mavrids, Dimitris/H-5452-2019; Stefanini, Giulio G/K-7406-2016; Byrne, Robert/C-3902-2016	Juni, Peter/0000-0002-5985-0670; Stefanini, Giulio/0000-0002-3558-6967; Mavrids, Dimitris/0000-0003-1041-4592; Stefanini, Giulio G/0000-0002-3558-6967; Salanti, Georgia/0000-0002-3830-8508; Byrne, Robert/0000-0001-5224-6393	Biosensors; St Jude Medical; Abbott Vascular; Ablynx; Amgen; AstraZeneca; Biotronik; Boehrhinger Ingelheim; Eisai; Eli Lilly; Exelixis; Geron; Gilead Sciences; Nestle; Novartis; Novo Nordisc; Padma; Roche; Schering-Plough; Swiss Cardio Technologies; Terumo; Medicines Company	Biosensors; St Jude Medical(St. Jude Medical); Abbott Vascular(Abbott Laboratories); Ablynx(Ablynx); Amgen(Amgen); AstraZeneca(AstraZeneca); Biotronik; Boehrhinger Ingelheim; Eisai(Eisai Co Ltd); Eli Lilly(Eli Lilly); Exelixis; Geron; Gilead Sciences(Gilead Sciences); Nestle(Nestle SA); Novartis(Novartis); Novo Nordisc(Novo Nordisk); Padma; Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Swiss Cardio Technologies; Terumo; Medicines Company	GGS has received speaker's fees from Abbott Vascular, AstraZeneca, Biosensors, and Biotronik, outside the submitted work. RAB has received speaker's fees from Biotronik and B Braun Melsungen, outside the submitted work. AK has submitted patents in relation to several drug-eluting stent technologies and received consulting or lecture fees from Abbott, Biosensors, and Biotronik, outside the submitted work. BM has received research grants to his institution (Bern University Hospital) and personal fees from Abbott, Biotronik, Boston Scientific, Biosensors, and Medtronic, outside the submitted work. PJ is an unpaid member of a steering group of trials funded by Biosensors and St Jude Medical. PJ's institution (Clinical Trials Unit Bern, part of the University of Bern), has a staff policy to not accept individual honoraria or consultancy fees. However, the Clinical Trials Unit Bern is involved in design, conduct, or analysis of clinical studies funded by Abbott Vascular, Ablynx, Amgen, AstraZeneca, Biosensors, Biotronik, Boehrhinger Ingelheim, Eisai, Eli Lilly, Exelixis, Geron, Gilead Sciences, Nestle, Novartis, Novo Nordisc, Padma, Roche, Schering-Plough, St Jude Medical, Swiss Cardio Technologies, Terumo, and The Medicines Company. PJ has received institutional grants and a grant from the Swiss National Science Foundation (33CM30_140336 I 1), neither of which were specifically used for this study. SW has received research grants to his institution (Bern University Hospital) from Abbott, Biotronik, Boston Scientific, Edwards Lifesciences, Medtronic, Medicines Company, and St Jude Medical, and speaker's fees from AstraZeneca, Eli Lilly, Abbott, Biotronik, Boston Scientific, Bayer, and Biosensors, outside the submitted work. SW has received a grant from the Swiss National Science Foundation (33CM30_140336 I 1), which was not specifically used for this study. DM and GS have received research funding from the European Research Council (IMMA 260559), which were not used specifically for this study. All other authors declare no competing interests.	Alfonso F, 2005, J AM COLL CARDIOL, V46, P756, DOI 10.1016/j.jacc.2005.05.050; Alfonso F, 2004, EUR HEART J, V25, P1829, DOI 10.1016/j.ehj.2004.07.019; Alfonso F, 2003, J AM COLL CARDIOL, V42, P796, DOI 10.1016/S0735-1097(03)00852-0; Alfonso F, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.06.022; Alfonso F, 2008, J AM COLL CARDIOL, V52, P1621, DOI 10.1016/j.jacc.2008.08.025; Alfonso F, 2006, J AM COLL CARDIOL, V47, P2152, DOI 10.1016/j.jacc.2005.10.078; Alfonso F, 2015, J AM COLL CARDIOL, V66, P23, DOI 10.1016/j.jacc.2015.04.063; Alfonso F, 2014, J AM COLL CARDIOL, V63, P2659, DOI 10.1016/j.jacc.2014.02.545; Alfonso F, 2014, J AM COLL CARDIOL, V63, P1378, DOI 10.1016/j.jacc.2013.12.006; Alli OO, 2012, AM HEART J, V163, P438, DOI 10.1016/j.ahj.2011.11.019; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Booth A, 2011, LANCET, V377, P108, DOI 10.1016/S0140-6736(10)60903-8; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Byrne RA, 2014, NAT REV CARDIOL, V11, P13, DOI 10.1038/nrcardio.2013.165; Byrne RA, 2013, LANCET, V381, P461, DOI 10.1016/S0140-6736(12)61964-3; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Campo G, 2014, J AM COLL CARDIOL, V63, P506, DOI 10.1016/j.jacc.2013.09.043; Cassese S, 2014, HEART, V100, P153, DOI 10.1136/heartjnl-2013-304933; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chevalier B, 2012, J INTERV CARDIOL, V25, P586, DOI 10.1111/j.1540-8183.2012.00769.x; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dietz U, 2002, AM J CARDIOL, V90, P843, DOI 10.1016/S0002-9149(02)02705-4; Ellis SG, 2008, EUR HEART J, V29, P1625, DOI 10.1093/eurheartj/ehn231; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Haager PK, 2003, CATHETER CARDIO INTE, V60, P25, DOI 10.1002/ccd.10627; Habara S, 2013, AM HEART J, V166, P527, DOI 10.1016/j.ahj.2013.07.002; Habara S, 2011, JACC-CARDIOVASC INTE, V4, P149, DOI 10.1016/j.jcin.2010.10.012; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holmes DR, 2008, JACC-CARDIOVASC INTE, V1, P439, DOI 10.1016/j.jcin.2008.05.010; Holmes DR, 2006, JAMA-J AM MED ASSOC, V295, P1264, DOI 10.1001/jama.295.11.1264; Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P9, DOI 10.1161/CIRCINTERVENTIONS.110.940320; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Lee JM, 2015, JACC-CARDIOVASC INTE, V8, P382, DOI 10.1016/j.jcin.2014.09.023; Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Mehilli J, 2010, J AM COLL CARDIOL, V55, P2710, DOI 10.1016/j.jacc.2010.02.009; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park SW, 2008, INT J CARDIOL, V131, P70, DOI 10.1016/j.ijcard.2007.09.003; Piccolo R, 2014, AM J CARDIOL, V114, P1339, DOI 10.1016/j.amjcard.2014.07.069; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Popma JJ, 2002, CIRCULATION, V106, P1090, DOI 10.1161/01.CIR.0000027814.96651.72; Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560; Ragosta M, 2004, CATHETER CARDIO INTE, V61, P344, DOI 10.1002/ccd.10779; Reynen K, 2006, CORONARY ARTERY DIS, V17, P371, DOI 10.1097/00019501-200606000-00008; Richardt G, 2013, JACC-CARDIOVASC INTE, V6, P905, DOI 10.1016/j.jcin.2013.04.017; Rittger H, 2012, J AM COLL CARDIOL, V59, P1377, DOI 10.1016/j.jacc.2012.01.015; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0; Scheller B, 2008, CLIN RES CARDIOL, V97, P773, DOI 10.1007/s00392-008-0682-5; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Scheller B, 2012, JACC-CARDIOVASC INTE, V5, P323, DOI 10.1016/j.jcin.2012.01.008; Schukro C, 2007, RADIOTHER ONCOL, V82, P18, DOI 10.1016/j.radonc.2006.08.016; Sharma SK, 2004, AM HEART J, V147, P16, DOI 10.1016/j.ahj.2003.07.002; Silber S, 2005, AM HEART J, V149, P689, DOI 10.1016/j.ahj.2004.05.061; Silber S, 2011, LANCET, V377, P1241, DOI 10.1016/S0140-6736(11)60395-4; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Song HG, 2012, J AM COLL CARDIOL, V59, P1093, DOI 10.1016/j.jacc.2011.11.047; Stefanini GG, 2013, LANCET, V382, P1879, DOI 10.1016/S0140-6736(13)61782-1; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2006, JAMA-J AM MED ASSOC, V295, P1253, DOI 10.1001/jama.295.11.1253; Taniwaki M, 2014, J AM COLL CARDIOL, V63, P1617, DOI 10.1016/j.jacc.2013.12.036; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; vom Dahl J, 2002, CIRCULATION, V105, P583, DOI 10.1161/hc0502.103347; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; White IR, 2011, STATA J, V11, P255, DOI 10.1177/1536867X1101100206; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Xu B, 2014, JACC-CARDIOVASC INTE, V7, P204, DOI 10.1016/j.jcin.2013.08.011	77	203	215	0	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					655	664		10.1016/S0140-6736(15)60657-2	http://dx.doi.org/10.1016/S0140-6736(15)60657-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26334160				2022-12-28	WOS:000359849200032
J	Watts, G				Watts, Geoff			Brian Edmond Henderson Obituary	LANCET			English	Biographical-Item																		HENDERSON BA, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					648	648		10.1016/S0140-6736(15)61494-5	http://dx.doi.org/10.1016/S0140-6736(15)61494-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26334150	Bronze			2022-12-28	WOS:000359849200022
J	Nguyen, H; Ivers, R; Jan, S; Pham, C				Ha Nguyen; Ivers, Rebecca; Jan, Stephen; Cuong Pham			Cost of surgery and catastrophic expenditure in people admitted to hospital for injuries: estimates from a cohort study in Vietnam	LANCET			English	Meeting Abstract	Lancet Commission on Global Surgery Meeting	JAN 17-18, 2014	Harvard Med Sch, Boston, MA		Harvard Med Sch				[Ha Nguyen] Univ Adelaide, Sch Populat Hlth, Adelaide, SA 5000, Australia; [Ivers, Rebecca; Jan, Stephen] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Cuong Pham] Hanoi Sch Publ Hlth, Ctr Injury Policy & Prevent Res, Hanoi, Vietnam	University of Adelaide; George Institute for Global Health; University of Sydney; Hanoi University of Public Health		ha.nguyen2@unisa.edu.au	Pham, Cuong/AAU-5721-2020; Nguyen, Ha/O-1586-2019; Jan, Stephen/AAG-3333-2021	Pham, Cuong/0000-0002-2309-8253; Nguyen, Ha/0000-0001-8327-5488; Jan, Stephen/0000-0003-2839-1405; Ivers, Rebecca/0000-0003-3448-662X					0	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2015	385			2			50	50		10.1016/S0140-6736(15)60845-5	http://dx.doi.org/10.1016/S0140-6736(15)60845-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4KK	26313100	Bronze			2022-12-28	WOS:000360573400051
J	Yacoub, S; Wertheim, H; Simmons, CP; Screaton, G; Wills, B				Yacoub, Sophie; Wertheim, Heiman; Simmons, Cameron P.; Screaton, Gavin; Wills, Bridget			Microvascular and endothelial function for risk prediction in dengue: an observational study	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Yacoub, Sophie; Screaton, Gavin] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England; [Yacoub, Sophie; Simmons, Cameron P.; Wills, Bridget] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Wertheim, Heiman; Wills, Bridget] Ctr Trop Med, Nuffield Dept Clin Med, Oxford, England; [Simmons, Cameron P.] Univ Melbourne, Melbourne, Vic, Australia	Imperial College London; University of Oxford; University of Oxford; University of Melbourne		s.yacoub@imperial.ac.uk	Simmons, Cameron P/ABA-3896-2021; Wertheim, Heiman FL/F-3338-2016	Simmons, Cameron P/0000-0002-9039-7392; Wertheim, Heiman FL/0000-0002-5003-5565; Yacoub, Sophie/0000-0002-2910-7819; Wills, Bridget/0000-0001-9086-8804; Screaton, Gavin/0000-0002-3549-4309	Medical Research Council [G0801508, G0600000, G0400720] Funding Source: Medline; Wellcome Trust [095541, 089276] Funding Source: Medline; National Institute for Health Research [NF-SI-0507-10303] Funding Source: researchfish; MRC [G0801508, G0400720] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	17	19	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			102	102		10.1016/S0140-6736(15)60417-2	http://dx.doi.org/10.1016/S0140-6736(15)60417-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312832	Bronze			2022-12-28	WOS:000360570500102
J	Appelboam, A; Reuben, A; Mann, C; Gagg, J; Ewings, P; Barton, A; Lobban, T; Dayer, M; Vickery, J; Benger, J				Appelboam, Andrew; Reuben, Adam; Mann, Clifford; Gagg, James; Ewings, Paul; Barton, Andrew; Lobban, Trudie; Dayer, Mark; Vickery, Jane; Benger, Jonathan		REVERT Trial Collaborators	Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial	LANCET			English	Article							TERMINATION	Background The Valsalva manoeuvre is an internationally recommended treatment for supraventricular tachycardia, but cardioversion is rare in practice (5-20%), necessitating the use of other treatments including adenosine, which patients often find unpleasant. We assessed whether a postural modification to the Valsalva manoeuvre could improve its effectiveness. Methods We did a randomised controlled, parallel-group trial at emergency departments in England. We randomly allocated adults presenting with supraventricular tachycardia (excluding atrial fibrillation and flutter) in a 1: 1 ratio to undergo a modified Valsalva manoeuvre (done semi-recumbent with supine repositioning and passive leg raise immediately after the Valsalva strain), or a standard semi-recumbent Valsalva manoeuvre. A 40 mm Hg pressure, 15 s standardised strain was used in both groups. Randomisation, stratified by centre, was done centrally and independently, with allocation with serially numbered, opaque, sealed, tamper-evident envelopes. Patients and treating clinicians were not masked to allocation. The primary outcome was return to sinus rhythm at 1 min after intervention, determined by the treating clinician and electrocardiogram and confirmed by an investigator masked to treatment allocation. This study is registered with Current Controlled Trials (ISRCTN67937027). Findings We enrolled 433 participants between Jan 11, 2013, and Dec 29, 2014. Excluding second attendance by five participants, 214 participants in each group were included in the intention-to-treat analysis. 37 (17%) of 214 participants assigned to standard Valsalva manoeuvre achieved sinus rhythm compared with 93 (43%) of 214 in the modified Valsalva manoeuvre group (adjusted odds ratio 3.7 (95% CI 2.3-5.8; p<0.0001). We recorded no serious adverse events. Interpretation In patients with supraventricular tachycardia, a modified Valsalva manoeuvre with leg elevation and supine positioning at the end of the strain should be considered as a routine first treatment, and can be taught to patients. Copyright (C) Appelboam et al. Open Access article distributed under the terms of CC BY-ND-NC.	[Appelboam, Andrew; Reuben, Adam] Royal Devon & Exeter Hosp NHS Fdn Trust, Emergency Dept, Exeter EX2 3DW, Devon, England; [Mann, Clifford; Gagg, James] Taunton & Somerset NHS Fdn Trust, Musgrove Pk Hosp, Dept Emergency Med, Taunton, Somerset, England; [Dayer, Mark] Taunton & Somerset NHS Fdn Trust, Musgrove Pk Hosp, Dept Cardiol, Taunton, Somerset, England; [Ewings, Paul] Univ Exeter, Sch Med, Exeter, Devon, England; [Barton, Andrew] Univ Plymouth, Peninsula Sch Med, Plymouth PL4 8AA, Devon, England; [Barton, Andrew] Univ Plymouth, Peninsula Sch Dent, Plymouth PL4 8AA, Devon, England; [Lobban, Trudie] Arrhythmia Alliance, Stratford Upon Avon, England; [Vickery, Jane] Univ Plymouth, Peninsula Clin Trials Unit, Plymouth PL4 8AA, Devon, England; [Benger, Jonathan] Univ W England, Fac Hlth & Life Sci, Bristol BS16 1QY, Avon, England	Musgrove Park Hospital; Musgrove Park Hospital; University of Exeter; University of Plymouth; University of Plymouth; University of Plymouth; University of West England	Appelboam, A (corresponding author), Royal Devon & Exeter Hosp NHS Fdn Trust, Emergency Dept, Exeter EX2 3DW, Devon, England.	andy.appelboam@nhs.net	Dayer, Mark/AAE-4654-2020	barton, andy/0000-0003-2245-1446	National Institute for Health Research through its Research for Patient Benefit Programme [PB-PG-0211-24145]; National Institute for Health Research, through the Clinical Research Network; National Institute for Health Research [PB-PG-0211-24145] Funding Source: researchfish	National Institute for Health Research through its Research for Patient Benefit Programme; National Institute for Health Research, through the Clinical Research Network; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research through its Research for Patient Benefit Programme (grant number PB-PG-0211-24145). The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. The study was adopted by the NIHR Clinical Research Network. We acknowledge the support of the National Institute for Health Research, through the Clinical Research Network, and the participating centres and principal investigators. We also acknowledge and thank Corinna Phillips and Wendy Ingram (Peninsula Clinical Trials Unit), for all their hard work and administrative skills in support of this project and all members of the steering committee. We are most grateful to Paula Garrett and Sian Williams, our patient representatives, for their help and advice in the ethics application, views on the protocol, and for their work and advice on the trial management group. We thank Andrew Sharp for his expert and independent ECG review and Steve Harvey and Jennie Small for their practical help and oversight of trial procedures. The study development and design benefited significantly from support given by the South West National Institute for Health Research Research Design Service for which we are most grateful, and we thank Sue Anderson for her administrative support. Finally we thank Mike Roberts who originally introduced the lead author to the technique.	Appelboam Andrew, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2013-202699; Appelboam A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004525; Arrhythmia alliance, PAT CAR STOR; Bhagat K., 1999, Central African Journal of Medicine, V45, P246; Chance JF, 1998, J CLIN NEUROPHYSIOL, V15, P535; Cohn AE, 1914, HEART, V5, P93; Gagg J, 2011, EMTA C APR 13 15 BRI; Gaspar JL, 2005, COMP VALSALVA MANOEU; Innes JA, 2008, EMERG MED AUSTRALAS, V20, P209, DOI 10.1111/j.1742-6723.2008.01100.x; Lim SH, 1998, ANN EMERG MED, V31, P30, DOI 10.1016/S0196-0644(98)70277-X; Looga R, 2005, RESP PHYSIOL NEUROBI, V147, P39, DOI 10.1016/j.resp.2005.01.003; MEHTA D, 1988, LANCET, V1, P1181; Murman DH, 2007, ACAD EMERG MED, V14, P578, DOI 10.1197/j.aem.2007.01.013; Orejarena LA, 1998, J AM COLL CARDIOL, V31, P150, DOI 10.1016/S0735-1097(97)00422-1; Resuscitation Council (UK), RES GUID 2010; Smith G, 2009, EMERG MED J, V26, P8, DOI 10.1136/emj.2008.061572; Smith G, 2009, EMERG MED AUSTRALAS, V21, P449, DOI 10.1111/j.1742-6723.2009.01228.x; Smith GD, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009502.pub3; Taylor David McD, 2004, Emerg Med Australas, V16, P284, DOI 10.1111/j.1742-6723.2004.00628.x; Walker S, 2010, EMERG MED J, V27, P287, DOI 10.1136/emj.2009.073866; Wong LF, 2004, ANN EMERG MED, V43, P477, DOI 10.1016/j.annemergmed.2003.10.044; Wood KA, 1997, AM J CARDIOL, V79, P145, DOI 10.1016/S0002-9149(96)00701-1	22	82	85	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1747	1753		10.1016/S0140-6736(15)61485-4	http://dx.doi.org/10.1016/S0140-6736(15)61485-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0WK	26314489	Green Submitted, hybrid			2022-12-28	WOS:000363974200034
J	Macklin, C; O'Brien, K; Hover, D; Schwartz, ME; Bolkhovsky, V; Zhang, X; Oliver, WD; Siddiqi, I				Macklin, C.; O'Brien, K.; Hover, D.; Schwartz, M. E.; Bolkhovsky, V.; Zhang, X.; Oliver, W. D.; Siddiqi, I.			A near-quantum-limited Josephson traveling-wave parametric amplifier	SCIENCE			English	Article							NOISE; AMPLIFICATION; BAND	Detecting single-photon level signals-carriers of both classical and quantum information-is particularly challenging for low-energy microwave frequency excitations. Here we introduce a superconducting amplifier based on a Josephson junction transmission line. Unlike current standing-wave parametric amplifiers, this traveling wave architecture robustly achieves high gain over a bandwidth of several gigahertz with sufficient dynamic range to read out 20 superconducting qubits. To achieve this performance, we introduce a subwavelength resonant phase-matching technique that enables the creation of nonlinear microwave devices with unique dispersion relations. We benchmark the amplifier with weak measurements, obtaining a high quantum efficiency of 75% (70% including noise added by amplifiers following the Josephson amplifier). With a flexible design based on compact lumped elements, this Josephson amplifier has broad applicability to microwave metrology and quantum optics.	[Macklin, C.; Schwartz, M. E.; Siddiqi, I.] Univ Calif Berkeley, Quantum Nanoelect Lab, Berkeley, CA 94720 USA; [Macklin, C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Computat Res Div, Berkeley, CA 94720 USA; [O'Brien, K.; Zhang, X.] Univ Calif Berkeley, Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Hover, D.; Bolkhovsky, V.; Oliver, W. D.] MIT, Lincoln Lab, Lexington, MA 02420 USA; [Zhang, X.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Zhang, X.] King Abdulaziz Univ, Dept Phys, Jeddah 21589, Saudi Arabia; [Oliver, W. D.] MIT, Elect Res Lab, Cambridge, MA 02139 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Lincoln Laboratory; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; King Abdulaziz University; Massachusetts Institute of Technology (MIT)	Macklin, C (corresponding author), Univ Calif Berkeley, Quantum Nanoelect Lab, Berkeley, CA 94720 USA.	chris.macklin@berkeley.edu	Zhang, Xiang/F-6905-2011; Schwartz, Mollie E/B-5012-2012; Schwartz, Mollie/S-3525-2019	Schwartz, Mollie E/0000-0003-4406-8974; Schwartz, Mollie/0000-0003-4406-8974; Zhang, Xiang/0000-0002-3272-894X	Army Research Office [W911NF-14-1-0078]; Office of the Director of National Intelligence (ODNI); Intelligence Advanced Research Projects Activity (IARPA); MIT Lincoln Laboratory under Air Force Contract [FA8721-05-C-0002]; Multidisciplinary University Research Initiative from the Air Force Office of Scientific Research MURI [FA9550-12-1-0488]; Hertz Foundation Fellowship	Army Research Office; Office of the Director of National Intelligence (ODNI); Intelligence Advanced Research Projects Activity (IARPA); MIT Lincoln Laboratory under Air Force Contract; Multidisciplinary University Research Initiative from the Air Force Office of Scientific Research MURI; Hertz Foundation Fellowship	We acknowledge A. Kamal, S. Tolpygo, and G. Fitch for useful discussions and technical assistance. C. M. acknowledges E. Hassell and J. Luke for useful discussions. This research is based on work supported in part by the Army Research Office (under grant no. W911NF-14-1-0078); the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), via MIT Lincoln Laboratory under Air Force Contract FA8721-05-C-0002; and a Multidisciplinary University Research Initiative from the Air Force Office of Scientific Research MURI grant no. FA9550-12-1-0488. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of ODNI, IARPA, or the U.S. government. The U.S. government is authorized to reproduce and distribute reprints for governmental purpose notwithstanding any copyright annotation thereon. M. E. S. acknowledges support from a Hertz Foundation Fellowship.	Agrawal GP, 2013, 2013 OPTICAL FIBER COMMUNICATION CONFERENCE AND EXPOSITION AND THE NATIONAL FIBER OPTIC ENGINEERS CONFERENCE (OFC/NFOEC); Bergeal N, 2010, NATURE, V465, P64, DOI 10.1038/nature09035; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Bockstiegel C, 2014, J LOW TEMP PHYS, V176, P476, DOI 10.1007/s10909-013-1042-z; Boissonneault M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013819; Campagne-Ibarcq P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.180402; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Castellanos-Beltrana MA, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773988; CAVES CM, 1982, PHYS REV D, V26, P1817, DOI 10.1103/PhysRevD.26.1817; Chow JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5015; de Lange G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.080501; Eichler C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.110502; Eichler C, 2014, EPJ QUANTUM TECHNOL, V1, DOI 10.1140/epjqt2; Eom BH, 2012, NAT PHYS, V8, P623, DOI [10.1038/NPHYS2356, 10.1038/nphys2356]; Fernandez J. E., 1998, TMO PROG REP, V42-135; Flurin E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.183901; Hatridge M, 2013, SCIENCE, V339, P178, DOI 10.1126/science.1226897; Hatridge M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134501; Johnson JE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.050506; Korotkov AN, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.115403; Mutus JY, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4886408; O'Brien K, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.157001; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Riste D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7983; Roch N, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.170501; Roch N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.147701; Shankar S, 2013, NATURE, V504, P419, DOI 10.1038/nature12802; Spietz L, 2003, SCIENCE, V300, P1929, DOI 10.1126/science.1084647; Tolpygo SK, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2374836; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Weber SJ, 2014, NATURE, V511, P570, DOI 10.1038/nature13559; Yamamoto T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2964182	33	354	360	10	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2015	350	6258					307	310		10.1126/science.aaa8525	http://dx.doi.org/10.1126/science.aaa8525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT5HD	26338795				2022-12-28	WOS:000362838700037
J	Lantos, JD				Lantos, John D.			Vindication for SUPPORT	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Mercy Hosp, Kansas City, MO 64108 USA	Children's Mercy Hospital	Lantos, JD (corresponding author), Childrens Mercy Hosp, Kansas City, MO 64108 USA.							Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Cole CH, 2003, PEDIATRICS, V112, P1415, DOI 10.1542/peds.112.6.1415; Hudson KL, 2013, NEW ENGL J MED, V368, P2349, DOI 10.1056/NEJMp1306986; Lantos JD, 2013, AM J BIOETHICS, V13, P31, DOI 10.1080/15265161.2013.849308	4	10	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2015	373	15					1393	1395		10.1056/NEJMp1510876	http://dx.doi.org/10.1056/NEJMp1510876			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8XI	26332442	Bronze			2022-12-28	WOS:000362372800004
J	Morillo, CA; Marin-Neto, JA; Avezum, A; Sosa-Estani, S; Rassi, A; Rosas, F; Villena, E; Quiroz, R; Bonilla, R; Britto, C; Guhl, F; Velazquez, E; Bonilla, L; Meeks, B; Rao-Melacini, P; Pogue, J; Mattos, A; Lazdins, J; Rassi, A; Connolly, SJ; Yusuf, S				Morillo, C. A.; Marin-Neto, J. A.; Avezum, A.; Sosa-Estani, S.; Rassi, A., Jr.; Rosas, F.; Villena, E.; Quiroz, R.; Bonilla, R.; Britto, C.; Guhl, F.; Velazquez, E.; Bonilla, L.; Meeks, B.; Rao-Melacini, P.; Pogue, J.; Mattos, A.; Lazdins, J.; Rassi, A.; Connolly, S. J.; Yusuf, S.		BENEFIT Investigators	Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRYPANOSOMA-CRUZI; HEART-DISEASE; TRYPANOCIDE TREATMENT; BLOOD-SAMPLES; IDENTIFICATION; CHEMOTHERAPY; RATIONALE; EFFICACY; OUTCOMES; PHASE	BACKGROUND The role of trypanocidal therapy in patients with established Chagas' cardiomyopathy is unproven. METHODS We conducted a prospective, multicenter, randomized study involving 2854 patients with Chagas' cardiomyopathy who received benznidazole or placebo for up to 80 days and were followed for a mean of 5.4 years. The primary outcome in the time-to-event analysis was the first event of any of the components of the composite outcome of death, resuscitated cardiac arrest, sustained ventricular tachycardia, insertion of a pacemaker or implantable cardioverter-defibrillator, cardiac transplantation, new heart failure, stroke, or other thromboembolic event. RESULTS The primary outcome occurred in 394 patients (27.5%) in the benznidazole group and in 414 (29.1%) in the placebo group (hazard ratio, 0.93; 95% confidence interval [CI], 0.81 to 1.07; P = 0.31). At baseline, a polymerase-chain-reaction (PCR) assay was performed on blood samples obtained from 1896 patients; 60.5% had positive results for Trypanosoma cruzi on PCR. The rates of conversion to negative PCR results (PCR conversion) were 66.2% in the benznidazole group and 33.5% in the placebo group at the end of treatment, 55.4% and 35.3%, respectively, at 2 years, and 46.7% and 33.1%, respectively, at 5 years or more (P<0.001 for all comparisons). The effect of treatment on PCR conversion varied according to geographic region: in Brazil, the odds ratio for PCR conversion was 3.03 (95% CI, 2.12 to 4.34) at 2 years and 1.87 (95% CI, 1.33 to 2.63) at 5 or more years; in Colombia and El Salvador, the odds ratio was 1.33 (95% CI, 0.90 to 1.98) at 2 years and 0.96 (95% CI, 0.63 to 1.45) at 5 or more years; and in Argentina and Bolivia, the odds ratio was 2.63 (95% CI, 1.89 to 3.66) at 2 years and 2.79 (95% CI, 1.99 to 3.92) at 5 or more years (P<0.001 for interaction). However, the rates of PCR conversion did not correspond to effects on clinical outcome (P = 0.16 for interaction). CONCLUSIONS Trypanocidal therapy with benznidazole in patients with established Chagas' cardiomyopathy significantly reduced serum parasite detection but did not significantly reduce cardiac clinical deterioration through 5 years of follow-up.	[Morillo, C. A.; Bonilla, L.; Meeks, B.; Rao-Melacini, P.; Pogue, J.; Connolly, S. J.; Yusuf, S.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Morillo, C. A.; Bonilla, L.; Meeks, B.; Rao-Melacini, P.; Pogue, J.; Connolly, S. J.; Yusuf, S.] McMaster Univ, Hamilton, ON L8L 2X2, Canada; [Marin-Neto, J. A.] Med Sch Riberao Preto, Dept Internal Med, Div Cardiol, Sao Paulo, Brazil; [Avezum, A.; Mattos, A.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Rassi, A., Jr.; Rassi, A.] Hosp Coracao Anis Rassi, Goiania, Go, Brazil; [Britto, C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil; [Sosa-Estani, S.; Velazquez, E.] Adm Nacl Labs & Inst Salud, Inst Nacl Parasitol Dr Mario Fatala Chaben, Buenos Aires, DF, Argentina; [Rosas, F.] Univ Los Andes, Fdn Clin Abood Shaio, Bogota, Colombia; [Guhl, F.] Univ Los Andes, CIMPAT, Fac Ciencias, Bogota, Colombia; [Quiroz, R.] Fdn Cardiovasc Colombia, Bucaramanga, Colombia; [Villena, E.] Hosp Eduardo Eguia, Programa Chagas, Tupiza, Bolivia; [Bonilla, R.] Hosp Nacl Ros, San Salvador, El Salvador	McMaster University; Population Health Research Institute; McMaster University; Instituto Dante Pazzanese de Cardiologia; Fundacao Oswaldo Cruz; Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Morillo, CA (corresponding author), Hamilton Hlth Sci, Populat Hlth Res Inst, David Braley CVSRI Rm 3C-120, Hamilton, ON L8L 2X2, Canada.	morillo@hhsc.ca	Marin-Neto, Jose Antonio/F-6099-2012; Zaky, Mohammad/I-3187-2017; Sousa, Andrea S/K-7885-2012; Mady, Charles/C-8870-2012; Avezum, Alvaro AA/K-6137-2016; Mattos, Antonio/E-9839-2013; Mattos, Antonio/AAC-8318-2020; Schmidt, André/G-1569-2011; Rassi, Anis/AAJ-3368-2020; Avezum, Alvaro/AAP-7687-2020; Britto, Constanca/L-7658-2016	Zaky, Mohammad/0000-0003-3547-2588; Sousa, Andrea S/0000-0001-8266-4801; Mady, Charles/0000-0002-8838-199X; Avezum, Alvaro AA/0000-0002-3073-6890; Mattos, Antonio/0000-0001-8420-098X; Mattos, Antonio/0000-0001-8420-098X; Schmidt, André/0000-0002-1090-8165; Mursalin, Adi/0000-0002-1867-0868; Guhl, Felipe/0000-0001-7180-7125; Yusuf, Salim/0000-0003-4776-5601; Morillo, Carlos/0000-0002-8739-2099; Britto, Constanca/0000-0003-0788-7030; Rao, Purnima/0000-0002-7537-9057; Marin-Neto, Jose Antonio/0000-0002-8651-8833	Population Health Research Institute	Population Health Research Institute	Funded by the Population Health Research Institute and others; ClinicalTrials.gov number, NCT00123916; Current Controlled Trials number, ISRCTN13967269.	ANDRADE SG, 1991, MEM I OSWALDO CRUZ, V86, P187, DOI 10.1590/S0074-02761991000200008; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Bellotti G, 1996, AM HEART J, V131, P301, DOI 10.1016/S0002-8703(96)90358-0; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Carmo AAL, 2015, INT J CARDIOL, V189, P182, DOI 10.1016/j.ijcard.2015.04.061; Coura J R, 1997, Rev Soc Bras Med Trop, V30, P139, DOI 10.1590/S0037-86821997000200009; CunhaNeto E, 1996, J CLIN INVEST, V98, P1709, DOI 10.1172/JCI118969; de Andrade JP, 2011, ARQ BRAS CARDIOL, V96, DOI 10.1590/S0066-782X2011000600002; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Fabbro DL, 2007, REV SOC BRAS MED TRO, V40, P1, DOI 10.1590/S0037-86822007000100001; Fabbro DL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003312; Garcia S, 2005, ANTIMICROB AGENTS CH, V49, P1521, DOI 10.1128/AAC.49.4.1521-1528.2005; HIGUCHI MD, 1993, CARDIOVASC PATHOL, V2, P101, DOI 10.1016/1054-8807(93)90021-S; Iwai LK, 2005, J AUTOIMMUN, V24, P111, DOI 10.1016/j.jaut.2005.01.006; JONES EM, 1992, T ASSOC AM PHYSICIAN, V105, P182; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Maciel BC, 2010, EVIDENCE BASED CARDI, P823; Marin-Neto JA, 2015, UPTODATE CARDIOVASCU; Marin-Neto JA, 2008, AM HEART J, V156, P37, DOI 10.1016/j.ahj.2008.04.001; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; *ORG PAN SAL, 2006, OPSHDMCD42506, P1; Perez-Molina JA, 2009, J ANTIMICROB CHEMOTH, V64, P1139, DOI 10.1093/jac/dkp357; Ramirez JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000899; Rassi A, 2000, TRYPANOSOMA CRUZI DO, P231; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; Tarleton RL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003219; Veloso VM, 2001, MEM I OSWALDO CRUZ, V96, P1005, DOI 10.1590/S0074-02762001000700021; Villar J. C, 2014, COCHRANE DB SYST REV, V5; Villar JC, 2002, COCHRANE DB SYST REV, V1; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; WINCKER P, 1994, AM J TROP MED HYG, V51, P771, DOI 10.4269/ajtmh.1994.51.771; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zingales B, 2014, MEM I OSWALDO CRUZ, V109, P828, DOI 10.1590/0074-0276140156; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	39	595	614	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2015	373	14					1295	1306		10.1056/NEJMoa1507574	http://dx.doi.org/10.1056/NEJMoa1507574			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS3CI	26323937				2022-12-28	WOS:000361948600004
J	Pomeroy, C				Pomeroy, Claire			The Lasker Awards at 70	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Albert & Mary Lasker Fdn, New York, NY 10174 USA		Pomeroy, C (corresponding author), Albert & Mary Lasker Fdn, 405 Lexington Ave,32nd Floor,Ste A, New York, NY 10174 USA.	cpomeroy@laskerfoundation.org						Berg P, 2005, JAMA-J AM MED ASSOC, V294, P1419, DOI 10.1001/jama.294.11.1419; Bishop JM, 2005, JAMA-J AM MED ASSOC, V294, P1418, DOI 10.1001/jama.294.11.1418; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Edwards RG, 2005, JAMA-J AM MED ASSOC, V294, P1422, DOI 10.1001/jama.294.11.1422; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Marshall BJ, 2005, JAMA-J AM MED ASSOC, V294, P1420, DOI 10.1001/jama.294.11.1420; Nathan DG, 2001, JAMA-J AM MED ASSOC, V285, P533, DOI 10.1001/jama.285.5.533; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976	8	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2015	314	11					1117	1118		10.1001/jama.2015.10116	http://dx.doi.org/10.1001/jama.2015.10116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4EL	26347921				2022-12-28	WOS:000361284500013
J	Cebrian, J				Cebrian, Just			Energy flows in ecosystems	SCIENCE			English	Editorial Material							METABOLIC THEORY; PATTERNS; BIOMASS		[Cebrian, Just] Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; [Cebrian, Just] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Dauphin Island Sea Lab; University of South Alabama	Cebrian, J (corresponding author), Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA.	jcebrian@disl.org						Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Cebrian J, 2004, ECOL MONOGR, V74, P237, DOI 10.1890/03-4019; Cebrian J, 2004, ECOL LETT, V7, P232, DOI 10.1111/j.1461-0248.2004.00574.x; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Hatton IA, 2015, SCIENCE, V349, P1070, DOI 10.1126/science.aac6284; Lafferty KD, 2015, SCIENCE, V349, P854, DOI 10.1126/science.aaa6224; Lotka AJ, 1924, ELEMENTS PHYS BIOL; Schmitz OJ, 2014, ECOSYSTEMS, V17, P344, DOI 10.1007/s10021-013-9715-7; Schramski JR, 2015, P NATL ACAD SCI USA, V112, P2617, DOI 10.1073/pnas.1423502112; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0	12	12	12	1	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2015	349	6252					1053	1054		10.1126/science.aad0684	http://dx.doi.org/10.1126/science.aad0684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5FO	26339014				2022-12-28	WOS:000360628900019
J	Dong, JC; Panchakshari, RA; Zhang, TT; Zhang, Y; Hu, JZ; Volpi, SA; Meyers, RM; Ho, YJ; Du, Z; Robbiani, DF; Meng, FL; Gostissa, M; Nussenzweig, MC; Manis, JP; Alt, FW				Dong, Junchao; Panchakshari, Rohit A.; Zhang, Tingting; Zhang, Yu; Hu, Jiazhi; Volpi, Sabrina A.; Meyers, Robin M.; Ho, Yu-Jui; Du, Zhou; Robbiani, Davide F.; Meng, Feilong; Gostissa, Monica; Nussenzweig, Michel C.; Manis, John P.; Alt, Frederick W.			Orientation-specific joining of AID-initiated DNA breaks promotes antibody class switching	NATURE			English	Article							B-CELLS; REGION RECOMBINATION; V(D)J RECOMBINATION; CHROMOSOME BREAKS; TRANSLOCATIONS; MECHANISMS; RESECTION; LYMPHOMA; 53BP1; REARRANGEMENTS	During B-cell development, RAG endonuclease cleaves immunoglobulin heavy chain (IgH) V, D, and J gene segments and orchestrates their fusion as deletional events that assemble a V(D) J exon in the same transcriptional orientation as adjacent C mu constant region exons(1,2). In mice, six additional sets of constant region exons (C(H)s) lie 100-200 kilobases downstream in the same transcriptional orientation as V(D) J and C mu exons(2). Long repetitive switch (S) regions precede C mu and downstream C(H)s. In mature B cells, class switch recombination (CSR) generates different antibody classes by replacing C mu with a downstream C-H (ref. 2). Activation-induced cytidine deaminase (AID) initiates CSR by promoting deamination lesions within S mu and a downstream acceptor S region(2,3); these lesions are converted into DNA double-strand breaks (DSBs) by general DNA repair factors(3). Productive CSR must occur in a deletional orientation by joining the upstream end of an S mu DSB to the downstream end of an acceptor S-region DSB. However, the relative frequency of deletional to inversional CSR junctions has not been measured. Thus, whether orientation-specific joining is a programmed mechanistic feature of CSR as it is for V(D) J recombination and, if so, how this is achieved is unknown. To address this question, we adapt high-throughput genome-wide translocation sequencing(4) into a highly sensitive DSB end-joining assay and apply it to endogenous AID-initiated S-region DSBs in mouse B cells. We show that CSR is programmed to occur in a productive deletional orientation and does so via an unprecedented mechanism that involves in cis Igh organizational features in combination with frequent S-region DSBs initiated by AID. We further implicate ATM-dependent DSB-response factors in enforcing this mechanism and provide an explanation of why CSR is so reliant on the 53BP1 DSB-response factor.	[Dong, Junchao; Panchakshari, Rohit A.; Zhang, Tingting; Zhang, Yu; Hu, Jiazhi; Meyers, Robin M.; Ho, Yu-Jui; Du, Zhou; Meng, Feilong; Gostissa, Monica; Alt, Frederick W.] Harvard Univ, Sch Med, Boston Childrens Hosp, Howard Hughes Med Inst,Program Cellular & Mol Med, Boston, MA 02115 USA; [Dong, Junchao; Panchakshari, Rohit A.; Zhang, Tingting; Zhang, Yu; Hu, Jiazhi; Meyers, Robin M.; Ho, Yu-Jui; Du, Zhou; Meng, Feilong; Gostissa, Monica; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Volpi, Sabrina A.; Manis, John P.] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Volpi, Sabrina A.; Manis, John P.] Harvard Univ, Sch Med, Joint Program Transfus Med, Boston, MA 02115 USA; [Robbiani, Davide F.; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10065 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Rockefeller University	Alt, FW (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Howard Hughes Med Inst,Program Cellular & Mol Med, Boston, MA 02115 USA.	manis@enders.tch.harvard.edu; alt@enders.tch.harvard.edu	Robbiani, Davide F./AAF-7662-2019; Dong, Junchao/G-5719-2016; Nussenzweig, Michel/AAE-7292-2019	Robbiani, Davide F./0000-0001-7379-3484; Dong, Junchao/0000-0001-7404-3562; Hu, Jiazhi/0000-0002-6345-0039; Meng, Feilong/0000-0003-0333-6872; Meyers, Robin/0000-0002-1802-7231; Ho, Yu-jui/0000-0002-7540-024X	National Institute of Health [AI077595, CA133781, AI112602, AI037526, AI072529]; NIH [T32HL066987]; Robertson Foundation/Cancer Research Institute Irvington Fellowship; NATIONAL CANCER INSTITUTE [R21CA133781] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077595, R01AI037526, R01AI072529, R21AI088510, R21AI112602, R37AI077595, R37AI037526] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson Foundation/Cancer Research Institute Irvington Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Yu for providing the CH12F3-RMCE (1F7) cell line and exchange cassette plasmid. This work was supported by National Institute of Health grants AI077595 to F.W.A., CA133781 to J.M., AI112602 to D.F.R., and AI037526 and AI072529 to M.C.N. S.V. was supported by NIH training grant T32HL066987. F.W.A. and M.C.N. are investigators of the Howard Hughes Medical Institute. J.H. is supported by a Robertson Foundation/Cancer Research Institute Irvington Fellowship. F.M. is a Lymphoma Research Foundation postdoctoral fellow and was a Cancer Research Institute postdoctoral fellow.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; BISHOP GA, 1986, P NATL ACAD SCI USA, V83, P7410, DOI 10.1073/pnas.83.19.7410; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daniel JA, 2013, MOL CELL, V50, P309, DOI 10.1016/j.molcel.2013.04.017; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Faust GG, 2012, BIOINFORMATICS, V28, P2417, DOI 10.1093/bioinformatics/bts456; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; Han L, 2011, P NATL ACAD SCI USA, V108, P11584, DOI 10.1073/pnas.1018726108; HARRIMAN W, 1993, ANNU REV IMMUNOL, V11, P361, DOI 10.1146/annurev.iy.11.040193.002045; HAUGHTON G, 1986, IMMUNOL REV, V93, P35, DOI 10.1111/j.1600-065X.1986.tb01501.x; Helmink BA, 2011, NATURE, V469, P245, DOI 10.1038/nature09585; JACK HM, 1988, P NATL ACAD SCI USA, V85, P1581, DOI 10.1073/pnas.85.5.1581; Khamlichi AA, 2004, BLOOD, V103, P3828, DOI 10.1182/blood-2003-10-3470; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Reynaud S, 2005, J IMMUNOL, V174, P6176, DOI 10.4049/jimmunol.174.10.6176; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Vaandrager JW, 1998, BLOOD, V92, P2871, DOI 10.1182/blood.V92.8.2871.420k08_2871_2878; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhang TT, 2010, P NATL ACAD SCI USA, V107, P3040, DOI 10.1073/pnas.0915072107; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003	40	72	73	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					134	+		10.1038/nature14970	http://dx.doi.org/10.1038/nature14970			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26308889	Green Accepted, Green Submitted			2022-12-28	WOS:000360594100040
J	Cole, TB				Cole, Thomas B.			Gasometers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					860	861		10.1001/jama.2014.11951	http://dx.doi.org/10.1001/jama.2014.11951			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325543				2022-12-28	WOS:000360392100001
J	Sanford, T; McCulloch, CE; Callcut, RA; Carroll, PR; Breyer, BN				Sanford, Thomas; McCulloch, Charles E.; Callcut, Rachael A.; Carroll, Peter R.; Breyer, Benjamin N.			Bicycle Trauma Injuries and Hospital Admissions in the United States, 1998-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sanford, Thomas; Carroll, Peter R.; Breyer, Benjamin N.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94110 USA; [McCulloch, Charles E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94110 USA; [Callcut, Rachael A.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Breyer, BN (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Urol, 1001 Potrero Ave, San Francisco, CA 94110 USA.	bbreyer@urology.ucsf.edu	Callcut, Rachael/ABE-1484-2021	Sanford, Thomas/0000-0002-7123-9807	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK083021] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR000143, 8KL2TR000143-09] Funding Source: Medline; NIDDK NIH HHS [K12DK083021, K12 DK083021] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Division of Hazard and Injury Data Systems United States consumer product safety commission, NAT EL INJ SURV SYST; Edmonson B, US BICYCLE MARKET TR; Lopez DS, 2012, J TRAUMA ACUTE CARE, V73, P1602, DOI 10.1097/TA.0b013e318265fc04; Pucher J, 2011, TRANSPORT RES A-POL, V45, P451, DOI 10.1016/j.tra.2011.03.001; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; USA Cycling and the USA Cycling Development Foundation, 2013, 2013 ANN REP	6	37	37	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2015	314	9					947	949		10.1001/jama.2015.8295	http://dx.doi.org/10.1001/jama.2015.8295			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ1WX	26325564	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000360392100022
J	Martyn, E; Marks, M; Edwards, S; Bandula, S; Gupta-Wright, A; Morris-Jones, S; Moore, DA				Martyn, Emily; Marks, Michael; Edwards, Simon; Bandula, Steven; Gupta-Wright, Ankur; Morris-Jones, Stephen; Moore, David A.			Fever and weight loss in a patient with HIV	LANCET			English	Editorial Material									[Martyn, Emily; Marks, Michael; Edwards, Simon; Bandula, Steven; Gupta-Wright, Ankur; Morris-Jones, Stephen; Moore, David A.] Hosp Trop Dis, London WC1E 6JB, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Martyn, E (corresponding author), Hosp Trop Dis, London WC1E 6JB, England.			Gupta-Wright, Ankur/0000-0002-5150-2970; Marks, Michael/0000-0002-7585-4743	National Institute for Health Research [ACF-2013-20-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	0	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					E8	E8		10.1016/S0140-6736(15)61545-8	http://dx.doi.org/10.1016/S0140-6736(15)61545-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LR	26333981				2022-12-28	WOS:000360287900002
J	Krucoff, MW; Sedrakyan, A; Normand, SLT				Krucoff, Mitchell W.; Sedrakyan, Art; Normand, Sharon-Lise T.			Bridging Unmet Medical Device Ecosystem Needs With Strategically Coordinated Registries Networks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURVEILLANCE		[Krucoff, Mitchell W.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27705 USA; [Sedrakyan, Art] Weill Cornell Med Coll, MDEpiNet Sci & Infrastruct Ctr, New York, NY USA; [Normand, Sharon-Lise T.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, MDEpiNet Methodol Ctr, Boston, MA USA	Duke University; Cornell University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Krucoff, MW (corresponding author), Duke Univ, Sch Med, Dept Med, Div Cardiol, 508 Fulton St A3006, Durham, NC 27705 USA.	mitchell.krucoff@duke.edu		Normand, Sharon-Lise/0000-0001-7027-4769				Carroll JD, 2013, J AM COLL CARDIOL, V62, P1026, DOI 10.1016/j.jacc.2013.03.060; Daniel G., 2015, STRENGTHENING PATIEN; Sedrakyan A, 2014, J BONE JOINT SURG AM, V96A, P1, DOI 10.2106/JBJS.N.00739; US Food and Drug Administration, REC NAT MED DEV EV S; US Food and Drug Administration, STRENGTH OUR NAT SYS	5	34	33	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2015	314	16					1691	1692		10.1001/jama.2015.11036	http://dx.doi.org/10.1001/jama.2015.11036			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7HC	26302152				2022-12-28	WOS:000363706300014
J	Jeffrey, JL; Terrett, JA; MacMillan, DWC				Jeffrey, Jenna L.; Terrett, Jack A.; MacMillan, David W. C.			O-H hydrogen bonding promotes H-atom transfer from alpha C-H bonds for C-alkylation of alcohols	SCIENCE			English	Article							POLARITY-REVERSAL CATALYSIS; DISSOCIATION ENERGIES; PHOTOREDOX CATALYSIS; MERGING PHOTOREDOX; DIRECT ARYLATION; METAL-COMPLEXES; RATE CONSTANTS; ACTIVATION; ABSTRACTION; FUNCTIONALIZATION	The efficiency and selectivity of hydrogen atom transfer from organic molecules are often difficult to control in the presence of multiple potential hydrogen atom donors and acceptors. Here, we describe the mechanistic evaluation of a mode of catalytic activation that accomplishes the highly selective photoredox alpha-alkylation/lactonization of alcohols with methyl acrylate via a hydrogen atom transfer mechanism. Our studies indicate a particular role of tetra-n-butylammonium phosphate in enhancing the selectivity for alpha C-H bonds in alcohols in the presence of allylic, benzylic, alpha-C=O, and alpha-ether C-H bonds.	[Jeffrey, Jenna L.; Terrett, Jack A.; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu			NIH General Medical Sciences [R01 GM078201-05]; NIH Postdoctoral Fellowship [F32GM109536-01]; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM109536, R01GM078201] Funding Source: NIH RePORTER	NIH General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for financial support provided by the NIH General Medical Sciences (R01 GM078201-05) and gifts from Merck and Amgen. J.L.J. is grateful for a NIH Postdoctoral Fellowship (F32GM109536-01), and J.A.T. thanks Bristol-Myers Squibb for a Graduate Fellowship.	ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; Balcells D, 2010, CHEM REV, V110, P749, DOI 10.1021/cr900315k; Balci M, 2005, BASIC 1H- AND I3C-NMR SPECTROSCOPY, P325; Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; BORDWELL FG, 1990, CAN J CHEM, V68, P1714, DOI 10.1139/v90-266; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; CHOI SY, 1995, TETRAHEDRON, V51, P657, DOI 10.1016/0040-4020(94)00972-W; Cismesia MA, 2015, CHEM SCI, V6, P5426, DOI 10.1039/c5sc02185e; Cradlebaugh JA, 2004, ORG BIOMOL CHEM, V2, P2083, DOI 10.1039/b405074f; Cuthbertson JD, 2015, NATURE, V519, P74, DOI 10.1038/nature14255; EVANS DA, 1978, TETRAHEDRON LETT, P3315; Gawlita E, 2000, J AM CHEM SOC, V122, P11660, DOI 10.1021/ja001891d; Hager D, 2014, J AM CHEM SOC, V136, P16986, DOI 10.1021/ja5102695; Jin J, 2015, ANGEW CHEM INT EDIT, V54, P1565, DOI 10.1002/anie.201410432; Laarhoven LJJ, 1999, ACCOUNTS CHEM RES, V32, P342, DOI 10.1021/ar9703443; Lawrence JD, 2004, J AM CHEM SOC, V126, P15334, DOI 10.1021/ja044933x; Lowry MS, 2005, CHEM MATER, V17, P5712, DOI 10.1021/cm051312+; Mader EA, 2007, J AM CHEM SOC, V129, P5153, DOI 10.1021/ja0686918; Maiti NC, 2006, J ORG CHEM, V71, P2878, DOI 10.1021/jo052389k; Mayer JM, 2011, ACCOUNTS CHEM RES, V44, P36, DOI 10.1021/ar100093z; MINISCI F, 1967, TETRAHEDRON LETT, P2207; NELSEN SF, 1972, J AM CHEM SOC, V94, P7114, DOI 10.1021/ja00775a041; Newcomb M, 2000, ACCOUNTS CHEM RES, V33, P449, DOI 10.1021/ar960058b; NEWCOMB M, 1993, TETRAHEDRON LETT, V34, P6363, DOI 10.1016/0040-4039(93)85045-X; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Pal U, 2014, J PHYS CHEM A, V118, P1024, DOI 10.1021/jp411488a; PAUL V, 1987, J CHEM SOC CHEM COMM, P1322, DOI 10.1039/c39870001322; Pirnot MT, 2013, SCIENCE, V339, P1593, DOI 10.1126/science.1232993; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qvortrup K, 2014, J AM CHEM SOC, V136, P626, DOI 10.1021/ja411596q; Roberts BP, 1999, CHEM SOC REV, V28, P25, DOI 10.1039/a804291h; STEIGERWALD ML, 1979, J AM CHEM SOC, V101, P1994, DOI 10.1021/ja00502a011; Tarantino KT, 2015, J AM CHEM SOC, V137, P6440, DOI 10.1021/jacs.5b03428; Warren JJ, 2010, P NATL ACAD SCI USA, V107, P5282, DOI 10.1073/pnas.0910347107; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	37	311	311	17	364	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2015	349	6255					1532	1536		10.1126/science.aac8555	http://dx.doi.org/10.1126/science.aac8555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR9WA	26316601	Green Accepted			2022-12-28	WOS:000361707000046
J	Friis, S; Riis, AH; Erichsen, R; Baron, JA; Sorensen, HT				Friis, Soren; Riis, Anders H.; Erichsen, Rune; Baron, John A.; Sorensen, Henrik T.			Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk A Population-Based, Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							FOLLOW-UP; PRIMARY PREVENTION; RANDOMIZED-TRIAL; CHEMOPREVENTION; ASSOCIATION; METAANALYSIS; MORTALITY; CELECOXIB; REGISTRY; COHORT	Background: A recent comprehensive review concluded that additional research is needed to determine the optimal use of aspirin for cancer prevention. Objective: To assess associations between the use of low-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) and colorectal cancer risk. Design: Population-based, case-control study. Setting: Northern Denmark. Patients: Patients with first-time colorectal cancer in northern Denmark between 1994 and 2011. Population control participants were selected by risk set sampling. Measurements: Data on drug use, comorbid conditions, and history of colonoscopy were obtained from prescription and patient registries. Use of low-dose aspirin (75 to 150 mg) and nonaspirin NSAIDs was defined according to type, estimated dose, duration, and consistency of use. Results: Among 10 280 case patients and 102 800 control participants, the adjusted odds ratios (ORs) for colorectal cancer associated with ever use (2 prescriptions) of low-dose aspirin and nonaspirin NSAIDs were 1.03 (95% Cl, 0.98 to 1.09) and 0.94 (Cl, 0.90 to 0.98), respectively. Continuous long-term use (>= 5 years) of low-dose aspirin was associated with a 27% reduction in colorectal cancer risk (OR, 0.73 [Cl, 0.54 to 0.99]), whereas the overall OR for cumulative long-term use (continuous or non-continuous) was close to unity. Nonaspirin NSAID use was associated with a substantial reduction in colorectal cancer risk, particularly for long-term, high-intensity use (average defined daily dose >= 0.3) of agents with high cyclooxygenase-2 selectivity (OR, 0.57 [Cl, 0.44 to 0.74]). Limitations: Data were unavailable on over-the-counter purchases of high-dose aspirin and low-dose ibuprofen or NSAID dosing schedules, there were several comparisons, and the authors were unable to adjust for confounding by some risk factors. Conclusion: Long-term, continuous use of low-dose aspirin and long-term use of nonaspirin NSAIDs were associated with reduced colorectal cancer risk. Persons who continuously used low-dose aspirin comprised only a small proportion of the low-dose aspirin users.	[Friis, Soren] Danish Canc Soc Res Ctr, Copenhagen, Denmark; Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; Univ N Carolina, Sch Med, Chapel Hill, NC USA	Danish Cancer Society; Aarhus University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Friis, S (corresponding author), Danish Canc Soc Res Ctr, Copenhagen, Denmark.	friis@cancer.dk; ar@clin.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Riis, Anders Hammerich/0000-0002-6684-4068; Erichsen, Rune/0000-0001-9398-9185	Danish Cancer Society; Aarhus University Research Foundation	Danish Cancer Society(Danish Cancer Society); Aarhus University Research Foundation	Danish Cancer Society, Aarhus University Research Foundation.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Allison M, 2006, AM J EPIDEMIOL, V164, P567, DOI 10.1093/aje/kwj250; Andersen Finn Heidemann, 2007, Ugeskr Laeger, V169, P514; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Cuzick J, 2015, ANN ONCOL, V26, P47, DOI 10.1093/annonc/mdu225; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Edge SB, 2010, AJCC CANC STAGING MA; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fischer SM, 2011, CANCER PREV RES, V4, P1728, DOI 10.1158/1940-6207.CAPR-11-0166; FLANDERS WD, 1986, AM J EPIDEMIOL, V124, P684, DOI 10.1093/oxfordjournals.aje.a114442; Friedman GD, 1998, PHARMACOEPIDEM DR S, V7, P99, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0; Friis S, 2003, BRIT J CANCER, V88, P684, DOI 10.1038/sj.bjc.6600760; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hawk ET, 2005, J CLIN ONCOL, V23, P378, DOI 10.1200/JCO.2005.08.097; Hoffmeister M, 2007, INT J CANCER, V121, P1325, DOI 10.1002/ijc.22796; Hollestein LM, 2014, INT J CANCER, V135, P157, DOI 10.1002/ijc.28634; Huang WK, 2013, ALIMENT PHARM THER, V38, P432, DOI 10.1111/apt.12388; Ishikawa H, 2014, GUT, V63, P1755, DOI 10.1136/gutjnl-2013-305827; Jorgensen TL, 2012, J GERIATR ONCOL, V3, P33, DOI 10.1016/j.jgo.2011.09.001; Lansdorp-Vogelaar I, 2011, EPIDEMIOL REV, V33, P88, DOI 10.1093/epirev/mxr004; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mahipal A, 2006, CANCER EPIDEM BIOMAR, V15, P1785, DOI 10.1158/1055-9965.EPI-05-0674; Northover JMA, 2012, OXFORD TXB ONCOLOGY, P1545; Ostenfeld Eva Bjerre, 2012, Clin Epidemiol, V4 Suppl 2, P33; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Sahin IH, 2014, CANCER LETT, V345, P249, DOI 10.1016/j.canlet.2013.09.001; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schmidt M, 2014, CLIN EPIDEMIOL, V6, P155, DOI 10.2147/CLEP.S59156; Storm HH, 1997, DAN MED BULL, V44, P535; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Varas-Lorenzo C, 2013, PHARMACOEPIDEM DR S, V22, P559, DOI 10.1002/pds.3437; Wallace K, 2009, CANCER EPIDEM BIOMAR, V18, P2310, DOI 10.1158/1055-9965.EPI-09-0211; Wang DZ, 2013, ANNU REV MED, V64, P131, DOI 10.1146/annurev-med-112211-154330; WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUID ATC CLASS DDD A	56	105	109	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2015	163	5					347	U70		10.7326/M15-0039	http://dx.doi.org/10.7326/M15-0039			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0OM	26302241				2022-12-28	WOS:000360296000006
J	Corde, S; Adli, E; Allen, JM; An, W; Clarke, CI; Clayton, CE; Delahaye, JP; Frederico, J; Gessner, S; Green, SZ; Hogan, MJ; Joshi, C; Lipkowitz, N; Litos, M; Lu, W; Marsh, KA; Mori, WB; Schmeltz, M; Vafaei-Najafabadi, N; Walz, D; Yakimenko, V; Yocky, G				Corde, S.; Adli, E.; Allen, J. M.; An, W.; Clarke, C. I.; Clayton, C. E.; Delahaye, J. P.; Frederico, J.; Gessner, S.; Green, S. Z.; Hogan, M. J.; Joshi, C.; Lipkowitz, N.; Litos, M.; Lu, W.; Marsh, K. A.; Mori, W. B.; Schmeltz, M.; Vafaei-Najafabadi, N.; Walz, D.; Yakimenko, V.; Yocky, G.			Multi-gigaelectronvolt acceleration of positrons in a self-loaded plasma wakefield	NATURE			English	Article							CODE; ELECTRONS; OSIRIS	Electrical breakdown sets a limit on the kinetic energy that particles in a conventional radio-frequency accelerator can reach. New accelerator concepts must be developed to achieve higher energies and to make future particle colliders more compact and affordable. The plasma wakefield accelerator (PWFA) embodies one such concept, in which the electric field of a plasma wake excited by a bunch of charged particles (such as electrons) is used to accelerate a trailing bunch of particles. To apply plasma acceleration to electron-positron colliders, it is imperative that both the electrons and their antimatter counterpart, the positrons, are efficiently accelerated at high fields using plasmas(1). Although substantial progress has recently been reported on high-field, high-efficiency acceleration of electrons in a PWFA powered by an electron bunch(2), such an electron-driven wake is unsuitable for the acceleration and focusing of a positron bunch. Here we demonstrate a new regime of PWFAs where particles in the front of a single positron bunch transfer their energy to a substantial number of those in the rear of the same bunch by exciting a wakefield in the plasma. In the process, the accelerating field is altered-'self-loaded'-so that about a billion positrons gain five gigaelectronvolts of energy with a narrow energy spread over a distance of just 1.3 metres. They extract about 30 per cent of the wake's energy and form a spectrally distinct bunch with a root-mean-square energy spread as low as 1.8 per cent. This ability to transfer energy efficiently from the front to the rear within a single positron bunch makes the PWFA scheme very attractive as an energy booster to an electron-positron collider.	[Corde, S.; Adli, E.; Allen, J. M.; Clarke, C. I.; Delahaye, J. P.; Frederico, J.; Gessner, S.; Green, S. Z.; Hogan, M. J.; Lipkowitz, N.; Litos, M.; Schmeltz, M.; Walz, D.; Yakimenko, V.; Yocky, G.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Corde, S.] Univ Paris Saclay, Ecole Polytech, CNRS, LOA,ENSTA ParisTech, F-91762 Palaiseau, France; [Adli, E.] Univ Oslo, Dept Phys, N-0316 Oslo, Norway; [An, W.; Clayton, C. E.; Joshi, C.; Marsh, K. A.; Mori, W. B.; Vafaei-Najafabadi, N.] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA; [An, W.; Mori, W. B.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Lu, W.] Tsinghua Univ, Dept Engn Phys, Beijing 100084, Peoples R China	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay; University of Oslo; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Tsinghua University	Corde, S (corresponding author), SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA.	corde@slac.stanford.edu	Lu, Wei/F-2504-2016; Lu, YuCheng/L-2929-2015	Litos, Michael/0000-0003-2434-8207; Schmeltz, Margaux/0000-0002-0286-7850; Gessner, Spencer/0000-0002-9713-1116	United States Department of Energy (US DOE); DOE [DE-AC02-76SF00515, DE-SC0010064, DE-SC0008491, DE-SC0008316]; Research Council of Norway; NSF [ACI-1339893, PHY-0960344]; NSFC [11425521, 11175102]; National Basic Research Program of China [2013CBA01501]	United States Department of Energy (US DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Research Council of Norway(Research Council of Norway); NSF(National Science Foundation (NSF)); NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	The FACET E200 plasma wakefield acceleration experiment was built and has been operated with funding from the United States Department of Energy (US DOE). Work at SLAC was supported by DOE contract DE-AC02-76SF00515 and also through the Research Council of Norway. Work at the University of California Los Angeles (UCLA) was supported by DOE contract DE-SC0010064. Simulations were performed on the UCLA Hoffman2 and Dawson2 computers and on Blue Waters through NSF OCI-1036224. Simulation work at UCLA was supported by DOE contracts DE-SC0008491 and DE-SC0008316, and NSF contracts ACI-1339893 and PHY-0960344. The work of W.L. was partially supported by NSFC 11425521, 11175102, and the National Basic Research Program of China Grant No. 2013CBA01501. We are grateful to P. Muggli for many discussions regarding plasma wakefield acceleration.	Adli E, 2015, NUCL INSTRUM METH A, V783, P35, DOI 10.1016/j.nima.2015.02.003; Adli E., 2013, PREPRINT; Aicheler M., 2012, MULTI TEV LINEAR COL, DOI DOI 10.5170/CERN-2012-007; Alexahin Y., 2013, PREPRINT; An WM, 2013, J COMPUT PHYS, V250, P165, DOI 10.1016/j.jcp.2013.05.020; Barish B., 2013, ILCREPORT2013040; Blue BE, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.214801; Blumenfeld I, 2007, NATURE, V445, P741, DOI 10.1038/nature05538; Davidson A, 2015, J COMPUT PHYS, V281, P1063, DOI 10.1016/j.jcp.2014.10.064; Erikson R., 1984, SLAC LINEAR COLLIDER, VSLAC-R-714; Fonseca RA, 2002, LECT NOTES COMPUT SC, V2331, P342; Green SZ, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/8/084011; Hogan MJ, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/055030; Hogan MJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.205002; Huang C, 2006, J PHYS CONF SER, V46, P190, DOI 10.1088/1742-6596/46/1/026; Joshi C, 2003, PHYS TODAY, V56, P47, DOI 10.1063/1.1595054; Kimura WD, 2011, PHYS REV SPEC TOP-AC, V14, DOI 10.1103/PhysRevSTAB.14.041301; Lee S, 2002, PHYS REV SPEC TOP-AC, V5, DOI 10.1103/PhysRevSTAB.5.011001; Lee S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.045501; Litos M, 2014, NATURE, V515, P92, DOI 10.1038/nature13882; Lu W, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.165002; Muggli P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.055001; Muggli P, 1999, IEEE T PLASMA SCI, V27, P791, DOI 10.1109/27.774685; Particle Physics Project Prioritization Panel, 2014, BUILD DISC STRAT PLA; ROSENZWEIG JB, 1991, PHYS REV A, V44, pR6189, DOI 10.1103/PhysRevA.44.R6189; Schroeder CB, 2010, PHYS REV SPEC TOP-AC, V13, DOI 10.1103/PhysRevSTAB.13.101301; Tzoufras M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.145002; Vieira J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.215001; Yi LQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04171; Zimmermann F., 2014, P IPAC2014 MOXAA01	30	102	104	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					442	+		10.1038/nature14890	http://dx.doi.org/10.1038/nature14890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26310764	Green Submitted			2022-12-28	WOS:000360069300032
J	Denker, A; de Laat, W				Denker, Annette; de Laat, Wouter			A Long-Distance Chromatin Affair	CELL			English	Editorial Material								Changes in transcription factor binding sequences result in correlated changes in chromatin composition locally and at sites hundreds of kilobases away. New studies demonstrate that this concordance is mediated via spatial chromatin interactions that constitute regulatory modules of the human genome.	[Denker, Annette; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Denker, Annette; de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	de Laat, W (corresponding author), Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands.	w.delaat@hubrecht.eu		de Laat, Wouter/0000-0002-6393-595X				de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Schuettengruber B, 2014, CELL REP, V9, P219, DOI 10.1016/j.celrep.2014.08.072; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001	9	9	9	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					942	943		10.1016/j.cell.2015.08.022	http://dx.doi.org/10.1016/j.cell.2015.08.022			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317462	Bronze			2022-12-28	WOS:000360589900005
J	Stockwell, BR; Stockwell, MS; Cennamo, M; Jiang, E				Stockwell, Brent R.; Stockwell, Melissa S.; Cennamo, Michael; Jiang, Elise			Blended Learning Improves Science Education	CELL			English	Editorial Material								Blended learning is an emerging paradigm for science education but has not been rigorously assessed. We performed a randomized controlled trial of blended learning. We found that in-class problem solving improved exam performance, and video assignments increased attendance and satisfaction. This validates a new model for science communication and education.	[Stockwell, Brent R.; Jiang, Elise] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Stockwell, Melissa S.] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Stockwell, Melissa S.] Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY 10032 USA; [Stockwell, Melissa S.] NewYork Presbyterian Hosp, New York, NY 10032 USA; [Cennamo, Michael] Columbia Univ, Columbia Ctr New Media Teaching & Learning, New York, NY 10027 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University	Stockwell, BR (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, Northwest Corner Bldg,MC 4846,550 West 120th St, New York, NY 10027 USA.	bstockwell@columbia.edu	Stockwell, Melissa/AAS-5914-2021; Stockwell, Brent R/AAE-7200-2019	Stockwell, Brent R/0000-0002-3532-3868	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bloom B.S., 1956, TAXONOMY ED OBJECTIV; Che SL, 1998, FEBS LETT, V424, P225, DOI 10.1016/S0014-5793(98)00158-6; Drits-Esser D, 2014, CBE-LIFE SCI EDUC, V13, P593, DOI 10.1187/cbe.13-08-0164; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Glazer F S, 2012, BLENDED LEARNING; Haak DC, 2011, SCIENCE, V332, P1213, DOI 10.1126/science.1204820; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Handelsman J, 2007, SCI TEACHING; Kagohara DM, 2010, DEV NEUROREHABIL, V13, P129, DOI 10.3109/17518420903329281; Knight Jennifer K, 2005, Cell Biol Educ, V4, P298, DOI 10.1187/05-06-0082; Li L., 2015, J CHEM EDUC, DOI [http://dx.doi.org/10.1021/ed500667, DOI 10.1021/ED500667]; Peters, 2006, PRACTICE PROBLEM BAS; Reich J, 2015, SCIENCE, V347, P34, DOI 10.1126/science.1261627; Roediger HL, 2011, J EXP PSYCHOL-APPL, V17, P382, DOI 10.1037/a0026252; Wendell BA, 2011, ANN NY ACAD SCI, V1224, P63, DOI 10.1111/j.1749-6632.2010.05954.x	15	122	123	3	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 27	2015	162	5					933	936		10.1016/j.cell.2015.08.009	http://dx.doi.org/10.1016/j.cell.2015.08.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ4QO	26317458	Bronze			2022-12-28	WOS:000360589900001
J	Wilkin, T				Wilkin, Timothy			Primary Care for Men Who Have Sex with Men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C VIRUS-INFECTION; HIV-INFECTION; PREEXPOSURE PROPHYLAXIS; INTRAEPITHELIAL NEOPLASIA; NEISSERIA-MENINGITIDIS; COST-EFFECTIVENESS; HPV VACCINE; TRANSMISSION; PREVENTION; GAY	A 43-year-old gay man presents to a physician's office for primary care. He has one long-term partner who is not infected with the human immunodeficiency virus (HIV) and with whom he has anal sex without condoms. He reports having had occasional anal sex with two other men during the past 6 months, with inconsistent use of condoms. He reports no tobacco or drug use and has one alcoholic drink daily. The patient has received vaccinations against infection with hepatitis A virus (HAV) and hepatitis B virus (HBV). A test for HIV infection is negative. What additional tests would be appropriate, and what would you advise the patient to help him reduce his risk of HIV infection?	[Wilkin, Timothy] Cornell Univ, Weill Med Coll, New York, NY 10010 USA	Cornell University	Wilkin, T (corresponding author), Cornell Univ, Weill Med Coll, Div Infect Dis, 53 W 23rd St,6th Fl, New York, NY 10010 USA.				Gilead Sciences; GlaxoSmith-Kline-ViiV Healthcare; Bristol-Myers Squibb	Gilead Sciences(Gilead Sciences); GlaxoSmith-Kline-ViiV Healthcare(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb)	Dr. Wilkin reports serving as an ad hoc consultant for Merck and GlaxoSmithKline-ViiV Healthcare and receiving grant support (paid to Weill Cornell Medical College of Cornell University) from Gilead Sciences, GlaxoSmith-Kline-ViiV Healthcare, and Bristol-Myers Squibb. No other potential conflict of interest relevant to this article was reported.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; Amico KR, 2013, AIDS BEHAV, V17, P2143, DOI 10.1007/s10461-013-0429-9; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], ANT POST PROPH SEX I; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baggaley RF, 2008, INT J EPIDEMIOL, V37, P1255, DOI 10.1093/ije/dyn151; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Briere EC, 2014, MMWR RECOMM REP, V63, P1; Centers for Disease Control and Prevention, 2013, HIV SURV REP, V25; Centers for Disease Control and Prevention, PREEXP PROPH PREV HI; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; DALING JR, 1987, NEW ENGL J MED, V317, P973, DOI 10.1056/NEJM198710153171601; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Halkitis PN, 2013, AM PSYCHOL, V68, P261, DOI 10.1037/a0032746; Institute of Medicine (IOM), 2011, HLTH LESB GAY BIS TR; JANDA WM, 1980, JAMA-J AM MED ASSOC, V244, P2060, DOI 10.1001/jama.244.18.2060; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Landovitz R., 2015, 2015 C RETR OPP INF; Licht AS, 2012, AM J PUBLIC HEALTH, V102, P1868, DOI 10.2105/AJPH.2012.300717; Makadon HJ, 2006, JAMA-J AM MED ASSOC, V296, P2362, DOI 10.1001/jama.296.19.2362; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; McCormack S, 2015, 2015 C RETR OPP INF; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Molina J-M, 2015, 2015 C RETR OPP INF; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Rodger A, 2014, 2014 C RETR OPP INF; Schackman BR, 2012, CURR OPIN HIV AIDS, V7, P587, DOI 10.1097/COH.0b013e3283582c8b; Schmink S, 2007, J CLIN MICROBIOL, V45, P3768, DOI 10.1128/JCM.01190-07; Simon MS, 2013, ANN INTERN MED, V159, P300, DOI 10.7326/0003-4819-159-4-201308200-00674; Smith DK, 2015, JAIDS-J ACQ IMM DEF, V68, P337, DOI 10.1097/QAI.0000000000000461; Sultan B, 2014, HIV AIDS-RES PALLIAT, V6, P147, DOI 10.2147/HIV.S46585; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; Wilkin T, 2013, HIV CLIN TRIALS, V14, P75, DOI 10.1310/hct1402-75; Wilkin T, 2010, J INFECT DIS, V202, P1246, DOI 10.1086/656320; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566; ZAKI SR, 1992, AM J PATHOL, V140, P1345; Zucker JR, 2012, UPDATE INVASIVE MENI	47	15	16	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					854	862		10.1056/NEJMcp1401303	http://dx.doi.org/10.1056/NEJMcp1401303			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP8VC	26308686				2022-12-28	WOS:000360171700011
J	Andersen, L; Berg, KM; Saindon, BZ; Massaro, JM; Raymond, TT; Berg, RA; Nadkarni, VM; Donnino, MW				Andersen, Larsw.; Berg, Katherine M.; Saindon, Brian Z.; Massaro, Joseph M.; Raymond, Tia T.; Berg, Robert A.; Nadkarni, Vinay M.; Donnino, Michael W.		Amer Heart Assoc Get	Time to Epinephrine and Survival After Pediatric In-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EUROPEAN-RESUSCITATION-COUNCIL; AMERICAN-HEART-ASSOCIATION; EMERGENCY CARDIOVASCULAR CARE; STANDARD-DOSE EPINEPHRINE; CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; GUIDELINES-RESUSCITATION; PREHOSPITAL EPINEPHRINE; STROKE-FOUNDATION; NATIONAL REGISTRY	IMPORTANCE Delay in administration of the first epinephrine dose is associated with decreased survival among adults after in-hospital, nonshockable cardiac arrest. Whether this association is true in the pediatric in-hospital cardiac arrest population remains unknown. OBJECTIVE To determine whether time to first epinephrine dose is associated with outcomes in pediatric in-hospital cardiac arrest. DESIGN, SETTING. AND PARTICIPANTS We performed an analysis of data from the Get With the Guidelines-Resuscitation registry. We included US pediatric patients (age <18 years) with an in-hospital cardiac arrest and an initial nonshockable rhythm who received at least 1 dose of epinephrine. A total of 1558 patients (median age, 9 months [interquartile range [IQR], 13 days-5 years]) were included in the final cohort. EXPOSURE Time to epinephrine, defined as time in minutes from recognition of loss of pulse to the first dose of epinephrine. MAIN OUTCOMES AND MEASURES The primary outcome was survival to hospital discharge. Secondary outcomes included return of spontaneous circulation (ROSC), survival at 24 hours, and neurological outcome. A favorable neurological outcome was defined as a score of 1 to 2 on the Pediatric Cerebral Performance Category scale. RESULTS Among the 1558 patients, 487 (31.3%) survived to hospital discharge. The median time to first epinephrine dose was 1 minute (IQR, 0-4; range, 0-20; mean [SD], 2.6 [3.4] minutes). Longer time to epinephrine administration was associated with lower risk of survival to discharge in multivariable analysis (multivariable-adjusted risk ratio [RR] per minute delay, 0.95 [95% CI, 0.93-0.98]). Longer time to epinephrine administration was also associated with decreased risk of ROSC (multivariable-adjusted RR per minute delay, 0.97 [95% CI, 0.96-0.99]), decreased risk of survival at 24 hours (multivariable-adjusted RR per minute delay, 0.97 [95% CI, 0.95-0.99]), and decreased risk of survival with favorable neurological outcome (multivariable-adjusted RR per minute delay, 0.95 [95% CI, 0.91-0.99]). Patients with time to epinephrine administration of longer than 5 minutes (233/1558) compared with those with time to epinephrine of 5 minutes or less (1325/1558) had lower risk of in-hospital survival to discharge (21.0%[49/233] vs 33.1%[438/1325]; multivariable-adjusted RR, 0.75 [95% CI, 0.60-0.93]; P = .01). CONCLUSIONS AND RELEVANCE Among children with in-hospital cardiac arrest with an initial nonshockable rhythm who received epinephrine, delay in administration of epinephrine was associated with decreased chance of survival to hospital discharge, ROSC, 24-hour survival, and survival to hospital discharge with a favorable neurological outcome.	[Andersen, Larsw.; Saindon, Brian Z.; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Andersen, Larsw.] Aarhus Univ Hosp, Dept Anesthesiol, DK-8000 Aarhus, Denmark; [Berg, Katherine M.; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02215 USA; [Massaro, Joseph M.] Harvard Clin Res Inst, Boston, MA USA; [Massaro, Joseph M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Raymond, Tia T.] Med City Childrens Hosp, Dept Pediat, Div Cardiac Crit Care, Dallas, TX USA; [Berg, Robert A.; Nadkarni, Vinay M.] Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol Crit Care & Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	Harvard University; Beth Israel Deaconess Medical Center; Aarhus University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Boston University; Medical City Dallas Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Donnino, MW (corresponding author), Beth Israel Deaconess Med Ctr, One Deaconess Rd,W-CC 2, Boston, MA 02215 USA.	mdonnino@bidmc.harvard.edu	Raymond, Tia Tortoriello/ABA-7422-2021	Raymond, Tia Tortoriello/0000-0001-9454-8410; Andersen, Lars Wiuff/0000-0001-5752-8082; Sutton, Robert/0000-0002-2771-8931; Bembea, Melania/0000-0003-4984-520X	National Heart, Lung, and Blood Institute (NHLBI) [1K02HL107447-01A1]; American Heart Association (AHA) [14GRNT2001002, 13CRP16930000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL107447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS075363] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr Donnino is supported by the National Heart, Lung, and Blood Institute (NHLBI) (1K02HL107447-01A1) and American Heart Association (AHA) (14GRNT2001002). Dr K. Berg is supported by the AHA (13CRP16930000).	Berg MD, 2008, PEDIATR CLIN N AM, V55, P589, DOI 10.1016/j.pcl.2008.02.005; Biarent D, 2010, RESUSCITATION, V81, P1364, DOI 10.1016/j.resuscitation.2010.08.012; Callaway CW, 2012, JAMA-J AM MED ASSOC, V307, P1198, DOI 10.1001/jama.2012.313; Carpenter TC, 1997, PEDIATRICS, V99, P403, DOI 10.1542/peds.99.3.403; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; DIECKMANN RA, 1995, PEDIATRICS, V95, P901; Donnino MW, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3028; Donoghue AJ, 2006, PEDIATRICS, V118, P995, DOI 10.1542/peds.2006-0453; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Girotra S, 2013, CIRC-CARDIOVASC QUAL, V6, P42, DOI 10.1161/CIRCOUTCOMES.112.967968; Goto Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12872; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Kleinman ME, 2010, CIRCULATION, V122, P8466, DOI [10.1161/CIRCULATIONAHA.110.971093, 10.1542/peds.2010-2972A]; Kumar G, 2013, NEW ENGL J MED, V368, P680, DOI 10.1056/NEJMc1215155; Matos RI, 2013, CIRCULATION, V127, P442, DOI 10.1161/CIRCULATIONAHA.112.125625; Meaney PA, 2006, PEDIATRICS, V118, P2424, DOI 10.1542/peds.2006-1724; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Nakahara S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6829; NIEMANN JT, 1985, ANN EMERG MED, V14, P521, DOI 10.1016/S0196-0644(85)80774-5; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Olasveengen TM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7268; Ornato JP, 2012, RESUSCITATION, V83, P63, DOI 10.1016/j.resuscitation.2011.09.009; Ortmann L, 2011, CIRCULATION, V124, P2329, DOI 10.1161/CIRCULATIONAHA.110.013466; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Peng TJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0867-z; Perondi MBM, 2004, NEW ENGL J MED, V350, P1722, DOI 10.1056/NEJMoa032440; Reynolds JC, 2007, RESUSCITATION, V74, P13, DOI 10.1016/j.resuscitation.2006.10.032; SANDERS AB, 1984, CRIT CARE MED, V12, P871, DOI 10.1097/00003246-198410000-00007; Tibballs J, 2006, RESUSCITATION, V71, P310, DOI 10.1016/j.resuscitation.2006.05.009; Topjian AA, 2008, PEDIATRICS, V122, P1086, DOI 10.1542/peds.2007-3313; Weiner GM, 2012, CLIN PERINATOL, V39, P843, DOI 10.1016/j.clp.2012.09.005; Zou GY, 2013, STAT METHODS MED RES, V22, P661, DOI 10.1177/0962280211427759; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	39	124	125	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					802	810		10.1001/jama.2015.9678	http://dx.doi.org/10.1001/jama.2015.9678			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26305650	Bronze, Green Accepted			2022-12-28	WOS:000360017200020
J	Schwartz, ES				Schwartz, Eben S.			Metaphors and medically unexplained symptoms	LANCET			English	Editorial Material									ProHlth Care, Dept Neurosci, Waukesha, WI 53188 USA		Schwartz, ES (corresponding author), ProHlth Care, Dept Neurosci, Waukesha, WI 53188 USA.	eben.schwartz@phci.org							0	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					734	735		10.1016/S0140-6736(15)61530-6	http://dx.doi.org/10.1016/S0140-6736(15)61530-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LR	26333965				2022-12-28	WOS:000360287900013
J	Lewis, M; Vyse, S; Shields, A; Boeltz, S; Gordon, P; Spector, T; Lehner, P; Walczak, H; Vyse, T				Lewis, Myles; Vyse, Simon; Shields, Adrian; Boeltz, Sebastian; Gordon, Patrick; Spector, Timothy; Lehner, Paul; Walczak, Henning; Vyse, Timothy			Effect of UBE2L3 genotype on regulation of the linear ubiquitin chain assembly complex in systemic lupus erythematosus	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Lewis, Myles; Vyse, Simon] Queen Mary Univ London, Ctr Expt Med & Rheumatol, London EC1M 6BQ, England; [Shields, Adrian; Boeltz, Sebastian; Vyse, Timothy] Kings Coll Hosp London, Dept Med & Mol Genet, London, England; [Gordon, Patrick] Kings Coll Hosp London, Dept Rheumatol, London, England; [Spector, Timothy] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Lehner, Paul] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Walczak, Henning] UCL, Ctr Cell Death Canc & Inflammat, London, England	University of London; Queen Mary University London; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Cambridge; University of London; University College London		myles.lewis@qmul.ac.uk	Boeltz, Sebastian/H-3594-2014; Walczak, Henning/AAV-2214-2020	Boeltz, Sebastian/0000-0001-5227-8707; Walczak, Henning/0000-0002-6312-4591; Shields, Adrian/0000-0001-5345-2156; Vyse, Simon/0000-0002-0582-2869; Lewis, Myles J/0000-0001-9365-5345	Wellcome Trust [101835, 100140] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	13	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			9	9		10.1016/S0140-6736(15)60324-5	http://dx.doi.org/10.1016/S0140-6736(15)60324-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312912	Green Submitted			2022-12-28	WOS:000360570500009
J	McCarthy, F; Doyle, A; Khashan, A; Kenny, L				McCarthy, Fergus; Doyle, Aisling; Khashan, Ali; Kenny, Louise			Assessment of glycogen phosphorylase isoenzyme BB as a biomarker for pre-eclampsia and small for gestational age	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[McCarthy, Fergus; Doyle, Aisling; Khashan, Ali; Kenny, Louise] KHP, Womens Hlth Acad Ctr, London, England; [McCarthy, Fergus; Doyle, Aisling; Khashan, Ali; Kenny, Louise] Cork Univ, Matern Hosp, Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland; [Khashan, Ali] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland	King's Health Partners; University College Cork; University College Cork		fergus.mccarthy@kcl.ac.uk	Kenny, Louise/X-6329-2019	Kenny, Louise/0000-0002-9011-759X; McCarthy, Fergus/0000-0001-5062-6851					0	3	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			67	67		10.1016/S0140-6736(15)60382-8	http://dx.doi.org/10.1016/S0140-6736(15)60382-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312889				2022-12-28	WOS:000360570500067
J	Thomas, S; Fisher, K; Snowden, J; Danson, S; Brown, S; Zeidler, M				Thomas, Sally; Fisher, Katherine; Snowden, John; Danson, Sarah; Brown, Stephen; Zeidler, Martin			Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms	LANCET			English	Meeting Abstract	Spring Meeting on Clinician Scientists in Training	FEB 26, 2015	London, ENGLAND						[Thomas, Sally] Univ Sheffield, Sheffield Canc Res Ctr, Sheffield S10 2TN, S Yorkshire, England; [Fisher, Katherine; Zeidler, Martin] Univ Sheffield, Bateson Ctr, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Danson, Sarah] Univ Sheffield, Acad Unit Clin Oncol, Sheffield S10 2TN, S Yorkshire, England; [Snowden, John] Royal Hallamshire Hosp, Dept Haematol, Sheffield S10 2JF, S Yorkshire, England; [Danson, Sarah] Weston Pk Hosp, Sheffield Expt Canc Med Ctr, Sheffield, S Yorkshire, England; [Brown, Stephen] Univ Sheffield, Sheffield RNAi Screening Facil, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Weston Park Hospital; University of Sheffield		mdp12sjt@sheffield.ac.uk		Brown, Stephen/0000-0002-7581-7491; SNOWDEN, JOHN/0000-0001-6819-3476					0	23	24	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2015	385			1			98	98		10.1016/S0140-6736(15)60413-5	http://dx.doi.org/10.1016/S0140-6736(15)60413-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CQ4JI	26312921				2022-12-28	WOS:000360570500098
